0001213900-23-067282.txt : 20230814 0001213900-23-067282.hdr.sgml : 20230814 20230814172908 ACCESSION NUMBER: 0001213900-23-067282 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 119 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230814 DATE AS OF CHANGE: 20230814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Siyata Mobile Inc. CENTRAL INDEX KEY: 0001649009 STANDARD INDUSTRIAL CLASSIFICATION: RADIO TELEPHONE COMMUNICATIONS [4812] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39557 FILM NUMBER: 231172222 BUSINESS ADDRESS: STREET 1: 2200 - 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 BUSINESS PHONE: 514-500-1181 MAIL ADDRESS: STREET 1: 2200 - 885 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3E8 FORMER COMPANY: FORMER CONFORMED NAME: Siyata Mobile, Inc. DATE OF NAME CHANGE: 20200319 FORMER COMPANY: FORMER CONFORMED NAME: SIYATA MOBILE INC (INACTIVE) DATE OF NAME CHANGE: 20150804 FORMER COMPANY: FORMER CONFORMED NAME: SIYATA MOBILE INC DATE OF NAME CHANGE: 20150723 6-K 1 ea183026-6k_siyata.htm REPORT OF FOREIGN PRIVATE ISSUER

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of: August, 2023

 

Commission File Number: 001-39557

 

Siyata Mobile Inc.
(Translation of registrant’s name into English)

 

1751 Richardson Street, Suite #2207,

Montreal, Quebec H3K-1G6, Canada

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under

cover of Form 20-F or Form 40-F:

 

☒ Form 20-F          ☐ Form 40-F

 

 

 

 

 

Restatement of Financial Information for the Quarter Ended March 31, 2023

 

On August 14, 2023, the management and the audit committee of the board of directors (the “Audit Committee”) of the Company determined that the Company’s condensed consolidated unaudited interim financial statements for the three month period ended March 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on Form 6-K on May 24, 2023 (the “Prior Period Financial Statements”), should no longer be relied upon due to an error in the accounting treatment for the classification of the Company’s warrants (the “Warrants”) due to incorrect fair valuation and subsequent adjustment resulting in a decrease in loss on fair value of $2,705,253 and a reduction in the share capital of the Company for the same amount. In addition, investors should no longer rely upon any communications relating to these condensed consolidated unaudited interim financial statements.

 

As part of the Company’s normal quarterly reporting process for the six months ended June 30, 2023, management and the Audit Committee of the Company concluded that a material error was made related to the accounting for the warrants and therefore were misstated in the Company’s March 31, 2023 Prior Period Financial Statements. There is no impact on any of the year-end financial statements previously filed.

 

The information in this Form 6-K relating to the restatement of the Company’s condensed consolidated unaudited interim financial statements for the three-month period ended March 31, 2023 is being furnished to the SEC on this Form 6-K and such information is not deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that section. Moreover, unless otherwise stated in such filing, the information in this Form 6-K relating to the restatement of the Company’s condensed consolidated unaudited interim financial statements for the three month period ended March 31, 2023 shall not be deemed to be incorporated by reference into the filings of the registrant under the Securities Act of 1933.

 

The Company has attached its restated condensed consolidated unaudited interim financial statements for the three month period ended March 31, 2023 as Exhibit 99.1 and has attached its restated Management’s Discussion and Analysis of Results of Operations and Financial Condition for the three months ended March 31, 2023 as Exhibit 99.2 to this Form 6-K.

 

Release of Financial Information for the Quarter Ended June 30, 2023

 

On August 14, 2023, the Company issued its condensed consolidated unaudited interim financial statements as at June 30, 2023 and December 31, 2022, and for the three and six months ended June 30, 2023 and 2022, a copy of which is attached hereto as Exhibit 99.3, and its Management’s Discussion and Analysis For the Three Months and Six Months Ended June 30, 2023, a copy of which is attached hereto as Exhibit 99.4.

 

The Company issued a press release regarding the financial statements, a copy of which is attached as Exhibit 99.5 to this Form 6-K.

 

1

 

 

Forward Looking Statements

 

This Report of Foreign Private Issuer on Form 6-K contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on the Company’s current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of the Company could differ materially from those described in or implied by the statements in this Report. The forward-looking statements contained or implied in this Report are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in the Company’s Annual Report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on May 15, 2023, and in any subsequent filings with the SEC. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites and social media have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this Report. The Company is not responsible for the contents of third-party websites.

  

Exhibit No.   Description
99.1   Registrant’s restated condensed consolidated unaudited interim financial statements as at March 31, 2023 and December 31, 2022, and for the three months ended March 31, 2023 and 2022.
99.2   Restated Management’s Discussion and Analysis of Results of Operations and Financial Condition for the Three Months Ended March 31, 2023.
99.3   Registrant’s condensed consolidated unaudited interim financial statements as at June 30, 2023 and December 31, 2022, and for the three and six months ended June 30, 2023 and 2022.
99.4   Management’s Discussion and Analysis of Financial Condition and Results of Operations For the Three Month and Six Months Ended June 30, 2023.
99.5   Press release dated August 14, 2023.

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: August 14, 2023 SIYATA MOBILE INC.
     
  By: /s/ Marc Seelenfreund
  Name:  Marc Seelenfreund
  Title: Chief Executive Officer

 

 

3

 

 

2023-06-30
EX-99.1 2 ea183026ex99-1_siyata.htm REGISTRANT'S RESTATED CONDENSED CONSOLIDATED UNAUDITED INTERIM FINANCIAL STATEMENTS AS AT MARCH 31, 2023 AND DECEMBER 31, 2022, AND FOR THE THREE MONTHS ENDED MARCH 31, 2023 AND 2022

Exhibit 99.1

 

Notice of No Auditor review of RESTATED condensed interim consolidated financial statements

 

The Management of the Company is responsible for the preparation of the accompanying restated unaudited condensed interim consolidated financial statements. The restated unaudited condensed interim consolidated financial statements have been prepared using accounting policies in compliance with International Financial Reporting Standards (“IFRS”) for the preparation of consolidated interim financial statements and are in accordance with International Accounting Standards (“IAS”) 34 – Interim Financial Reporting.

 

The Company’s independent auditor has not performed a review of these restated condensed interim consolidated financial statements in accordance with the standards established by the Chartered Professional Accountants of Canada for a review of interim financial statements by an entity’s auditor.

 

These restated financial statements have been re-filed to reflect further disclosure in Note 17 of the Notes to the Restated Condensed Interim Consolidated Financial Statements in connection with a continuous disclosure review.

 

 

 

 

Siyata Mobile Inc.

Restated Unaudited Condensed Interim Consolidated Statements of Financial Position

(Expressed in US dollars)

 

   March 31,
2023
   December 31,
2022
 
ASSETS        
Current        
Cash  $1,179,694   $1,913,742 
Trade and other receivables (Note 3)   1,111,123    1,574,628 
Prepaid expenses   665,446    173,504 
Inventory (Note 4)   3,564,040    4,092,550 
Advance to suppliers   675,561    155,852 
    7,195,864    7,910,276 
Long term receivable   146,196    150,185 
Right of use assets   811,966    887,137 
Equipment   199,743    207,402 
Intangible assets   7,481,391    6,987,531 
Total assets  $15,835,160   $16,142,531 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current          
Accounts payable and accrued liabilities  $2,111,174   $3,078,650 
Deferred revenue   
-
    149,600 
Lease obligations   294,359    303,788 
Warrant liability (Note 6)   628,765    2,734,804 
    3,034,298    6,266,842 
Lease obligations   543,944    635,217 
Total liabilities   3,578,242    6,902,059 
Shareholders’ equity          
Share capital (Note 7)   76,921,437    73,312,866 
Reserves (Note 7)   17,933,273    13,647,399 
Accumulated other comprehensive loss   98,870    98,870 
Deficit   (82,696,662)   (77,818,663)
    12,256,918    9,240,472 
Total liabilities and shareholders’ equity  $15,835,160   $16,142,531 

 

 

Nature of operations and going concern (Note 1)    
Subsequent events (Note 16)    
     
Approved on August 14, 2023 on behalf of the Board:    
“Lourdes Felix”   “Marc Seelenfreund”
Lourdes Felix - Director   Marc Seelenfreund - Director

  

The accompanying notes are an integral part of these restated unaudited condensed interim consolidated financial statements.

 

2

 

 

Siyata Mobile Inc.

Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss

(Expressed in US dollars)

For the three months ended March 31

 

   2023   2022 
         
Revenue  $1,802,637   $832,974 
Cost of sales (Note 8)   (1,306,120)   (577,923)
Gross profit   496,517    255,051 
EXPENSES          
Amortization and depreciation   401,640    124,505 
Development expenses   53,985    123,316 
Selling and marketing (Note 9)   1,003,365    1,045,051 
General and administrative (Note 10)   1,392,430    1,659,079 
Inventory impairment (Note 4)   
-
    64,336 
Bad debts (recovered) (Note 3)   
-
    (7,358)
Share-based payments (Note 7)   310,828    812,735 
Total operating expenses   3,162,248    3,821,664 
Net operating loss   (2,665,731)   (3,566,613)
           
OTHER EXPENSES          
Finance expense   34,098    26,987 
Foreign exchange   163    (87,660)
Change in fair value of convertible promissory note (Note 5)   
-
    2,680,457 
Change in fair value of warrant liability (Note 6)   2,178,007    (3,272,735)
Transaction costs (Note 11)   
-
    965,247 
Total other expenses (income)   2,212,268    312,296 
Net loss for the year   (4,877,999)   (3,878,909)
Other comprehensive income          
Translation adjustment   
-
    (24,468)
Comprehensive loss for the year  $(4,877,999)  $(3,903,377)
           
Weighted average shares   59,102,369    12,976,363 
Basic and diluted loss per share
  $(0.08)  $(0.30)

 

The accompanying notes are an integral part of these restated unaudited condensed interim consolidated financial statements.

 

3

 

 

Siyata Mobile Inc.

Restated Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders’ Equity

(Expressed in US dollars)

For the three months ending March 31

 

   Share
capital
   Share
Capital
   Reserves   Accumulated other comprehensive income (loss)   Deficit   Total
shareholders’ equity
 
   #   $   $   $   $   $ 
Balance, December 31, 2021   5,276,695    54,655,244    10,389,555    (38,739)   (62,519,412)   2,486,648 
Shares issued on acquisition of ClearRF   138,958    190,095    
-
    
-
    
-
    190,095 
Shares issued on capital raise   7,215,652    10,936,974    
-
    
-
    
-
    10,936,974 
Share issuance costs on capital raise        (1,051,647)   307,189    
-
    
-
    (744,458)
Pre-funded warrants exercised   1,480,000    2,575,200    
-
    
-
    
-
    2,575,200 
Share based payments   -    
-
    812,735    
-
    
-
    812,735 
Translation adjustment   -    
-
    
-
    24,468    
-
    24,468 
Net loss   -    
-
    
-
    
-
    (3,878,909)   (3,878,909)
Balance, March 31, 2022   14,111,305    67,305,866    11,509,479    (14,271)   (66,398,321)   12,402,753 
                               
Balance, December 31, 2022   44,868,560    73,312,866    13,647,399    98,870    (77,818,663)   9,240,472 
Issue of common shares for warrants   18,042,857    3,608,571    
-
    
-
    
-
    3,608,571 
Warrants reclassified from warrant liability   -    
-
    3,975,046    
-
    
-
    3,975,046 
Share based payments   -    
-
    310,828    
-
    
-
    310,828 
Net loss   -    
-
    
-
    
-
    (4,877,999)   (4,877,999)
Balance, March 31, 2023   62,911,417    76,921,437    17,933,273    98,870    (82,696,662)   12,256,918 

 

The accompanying notes are an integral part of these restated unaudited condensed interim consolidated financial statements.

 

4

 

 

Siyata Mobile Inc.

Restated Unaudited Condensed Interim Consolidated Statements of Cash Flows

(Expressed in US dollars)

For the three months ended March 31

 

   2023   2022 
Operating activities        
Net loss for the year  $(4,877,999)  $(3,878,909)
Items not affecting cash:          
Amortization and depreciation   401,640    124,505 
Bad debt expense (recovered)   -    (7,358)
Impairment of inventory   
-
    64,336 
Fair value changes on derivatives   2,178,007    (592,278)
Interest expense, net of repayments   -    (4,651)
Foreign exchange   11,666    - 
Share based payments   310,828    812,735 
Change in non-cash working capital (Note 15)   (1,136,712)   (3,225,654)
Net cash used in operating activities   (3,112,570)   (6,707,274)
           
Investing activities          
Intangible asset additions   (817,849)   (739,579)
Equipment additions   (2,498)   - 
Acquisition of ClearRF   -    (155,014)
Net cash used in investing activities   (820,347)   (894,593)
           
Financing activities          
Lease payments   (100,702)   (78,731)
Bank loan   -    (27,159)
Convertible debt issued, net of repayments   
-
    (4,000,000)
Proceeds on share issuance, net of share issuance costs   -    16,711,184 
Transaction costs   (309.000)   - 
Exercise of warrants   3,608,571    2,575,200 
Net cash from financing activities   3,198,869    15,180,494 
           
Effect of foreign exchange on cash   -    22,680 
           
Change in cash for the year   (734,048)   7,601,307 
Cash, beginning of year   1,913,742    1,619,742 
Cash, end of year  $1,179,694   $9,221,049 

 

The accompanying notes are an integral part of these restated unaudited condensed interim consolidated financial statements.

 

5

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

1.NATURE OF OPERATIONS AND GOING CONCERN

 

Siyata Mobile Inc. (“Siyata” or the “Company”) was incorporated under the Business Corporations Act, British Columbia on October 15, 1986. The Company’s shares are listed on NASDAQ under the symbol SYTA and warrants issued on September 29, 2020, are traded under the symbol SYTAW. The Company’s principal activity is the sale of vehicle-mounted, cellular-based communications platforms over advanced mobile networks and cellular booster systems. The registered and records office is located at 2200 - 885 West Georgia Street, Vancouver, BC V6C 3E8.

 

These restated unaudited condensed interim consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) IAS 34 Interim Financial Reporting, with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business rather than a process of forced liquidation. These restated unaudited condensed interim consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

The Company incurred a net loss of $4,877,999 during the three month period ended March 31, 2023 (March 31, 2022- three month period net loss of $3,879,909), and, as of that date, the Company’s total deficit was $82,696,662 (December 31, 2022 - $77,818,663). The Company’s continuation as a going concern is dependent upon the success of the Company’s sale of inventory, the existing cash flows, and the ability of the Company to obtain additional debt or equity financing, all of which are uncertain. These material uncertainties raise substantial doubt on the Company’s ability to continue as a going concern.

 

2.BASIS OF PREPARATION

 

Statement of compliance

 

These restated unaudited condensed interim consolidated financial statements, including comparatives, have been prepared in accordance with International Accounting Standards (IAS) 34 Interim Financial Reporting. Omitted from these restated financial statements are certain information and note disclosures normally included in the annual financial statements. These financial statements and notes presented should be read in conjunction with the annual financial statements for the year ended December 31, 2022.

 

The accounting methods and principles of computation adopted in these restated financial statements are the same as those in annual consolidated financial statements for the year ended December 31, 2022.

 

The preparation of these restated unaudited condensed interim consolidated financial statements requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The significant judgements made by management when applying the Company’s accounting policies and the key sources of estimation uncertainty were the same as those that applied to the Company’s December 31, 2022 annual consolidated financial statements.

 

6

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

2.BASIS OF PREPARATION (cont’d)

 

Basis of consolidation and presentation

 

These restated unaudited condensed interim consolidated financial statements of the Company have been prepared on a historical cost basis, except for financial instruments classified as financial instruments at fair value through profit and loss, which are stated at their fair value. In addition, the restated condensed interim consolidated financial statements have been prepared using the accrual basis of accounting, except for the statement of cash flows.

 

These restated unaudited condensed interim consolidated financial statements incorporate the financial statements of the Company and its wholly controlled subsidiaries. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. These restated condensed interim consolidated financial statements include the accounts of the Company and its direct wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.

 

The restated unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:

 

Name of Subsidiary   Place of Incorporation   Ownership  
Queensgate Resources Corp.   British Columbia, Canada     100 %
Queensgate Resources US Corp.   Nevada, USA     100 %
Siyata Mobile (Canada) Inc.   British Columbia, Canada     100 %
Siyata Mobile Israel Ltd.   Israel     100 %
Signifi Mobile Inc.   Quebec, Canada     100 %
ClearRF Nevada Ltd.   Nevada, USA     100 %

 

Recent adoptions of accounting pronouncements

 

The following amendments became effective on January 1, 2023, and did not have a material impact on the Company’s condensed interim consolidated financial statements:

 

  In February 2021, the IASB issued Definition of Accounting Estimates (Amendments to IAS 8). The amendments define accounting estimates and clarify the distinction between changes in accounting estimates and changes in accounting policies.

 

  In February 2021, the IASB issued Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2). The amendments provide guidance to help entities disclose their material (previously “significant”) accounting policies.

 

  In May 2021, the IASB issued Deferred Tax related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12). The amendments narrow the scope of the recognition exemption so that companies would be required to recognize deferred tax for transactions that give rise to equal amounts of taxable and deductible temporary differences, such as leases.

 

7

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

2.BASIS OF PREPARATION (cont’d)

 

Future accounting pronouncements

 

The standards, amendments, and interpretations issued before 2023 but not yet adopted by the Company have been disclosed in Note 3 of the Company’s December 31, 2022 annual consolidated financial statements. The Company is currently considering the impact of adopting these standards, amendments and interpretations on its consolidated financial statement.

 

3.TRADE AND OTHER RECEIVABLES

 

   March 31,
2023
   December 31,
2022
 
Trade receivables  $1,645,627   $2,015,291 
Allowance for doubtful accounts   (1,062,052)   (1,056,393)
Taxes receivable   527,548    615,730 
Total  $1,111,123   $1,574,628 

 

4.INVENTORY

 

   March 31,
2023
   December 31,
2022
 
Finished products  $6,874,848   $7,392,002 
Impairment of finished products   (3,555,683)   (3,555,683)
Accessories and spare parts   663,645    675,001 
Impairment of accessories and spare parts   (418,770)   (418,770)
Total  $3,564,040   $4,092,550 
  
5.CONVERTIBLE DEBENTURES

 

On November 3, 2021, the Company issued a US$7,200,000 convertible promissory note (the “Promissory Note”) and 2,142,857 warrants for gross proceeds of US$6,000,000. The Company elected to measure the promissory note (hybrid contract) at fair value through profit or loss (“FVTPL”) on initial recognition and, as such, the embedded conversion feature was not separated. The warrants were recorded as a liability.

 

During the three months ended March 31, 2022, the Company completed a secondary offering of its common shares, and as a result of the terms of the convertible promissory note, the Company was required to direct 20% of the gross proceed of the offering to the lender. A total of US$4,000,000 was repaid to the lender on January 13, 2022. Commencing in May 2022, the Company made monthly payments of $400,000 through issuance of common shares towards the principal balance of the promissory note, resulting the promissory note being fully repaid by December 31, 2022. The Company issued 13,112,255 common shares, with a total market value of $4,138,002. The difference between the fair value of the shares issued, and the value of the principal repaid of $938,002 was included in profit and loss in the change in fair value of convertible promissory note.

 

For the three months ended March 31, 2022 the Company recorded a fair value loss of $2,023,751 on the Convertible debenture.

 

8

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

6.WARRANT LIABILITY

 

The balance of the warrant liability is as follows:

 

   November 3,
2021
   January 11,
2022
   October 12,
2022
   January 19,
2023
   Total 
Balance December 31, 2022  $197,733   $501,330   $2,035,741   $
-
   $2,734,804 
Exercise of warrants   (197,733)   
-
    (1,717,801)   
-
    (1,915,534)
Warrants issued   
-
    
-
    
-
    2,875,580    2,875,580 
Transfer to equity   
-
    
-
    (564,946)   (3,410,100)   (3,975,046)
Change in fair value        127,435    247,006    534,520    908,961 
Balance March 31, 2023  $
-
   $628,765   $
-
   $
-
   $628,765 

 

January 19, 2023 warrants

 

On January 19, 2023, the Company entered into warrant exercise agreements with fourteen existing accredited investors to exercise certain outstanding warrants to purchase up to an aggregate of 18,042,857 of the Company’s common shares. In consideration for the immediate exercise of the outstanding warrants for cash, the Company agreed to reduce the exercise price from $0.23 to $0.20 per share and issue new unregistered warrants to purchase up to an aggregate of 18,042,857 common shares with an exercise price of $0.20 per share. The gross proceeds to the Company from the exercise totaled approximately $3,608,571, prior to deducting warrant inducement agent fees and offering expenses.

 

The new warrants are exercisable immediately upon issuance at an exercise price of $0.20 per share and have a term of exercise equal to five years. In connection with the exercise, the Company will be required pursuant to the terms of 2,989,130 of its remaining unexercised common share purchase warrants, to reduce the exercise price of such warrants from $0.23 per common share to an exercise price of $0.20 per common share.

 

On March 30, 2023, the SEC accepted the registration statement of the Company to the effect that all of the 21,031,987 outstanding $0.20 warrants become immediately a cashless exercise and their underlying shares become immediately tradeable. Subsequent to the quarter ended March 31, 2023, 21,031,987 warrants were exercised cashless in exchange for 21,031,987 common shares of the Company. All of the warrants that became cashless exercise were transferred to equity at March 30, 2023, as they no longer met the definition of a liability.

 

The fair value of the warrants issued at January 19, 2023 was $2,875,580 and was determined using the stock price at the date of issue, with a 15% discount for lack of marketability. This method was used as the warrants contained an alternative cashless exercise feature.

 

The fair value of the warrants on March 30, 2023 was $3,410,100 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.

 

9

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

6.WARRANT LIABILITY (cont’d)

 

November 3, 2021 warrants

 

The warrants allowed for the purchase of 1,892,857 common shares of the Company at an exercise price of US 4.00 per common share and expired 5 years from the issue date of the related promissory note. Under the terms of the warrants, the exercise price of the warrant was adjusted to $2.30 when an offering was closed on January 3, 2022 that issued shares at a price lower than the exercise price. On January 19, 2023 the warrant holders entered into the agreement noted above to exercise the warrants, and receive new warrants in exchange.

 

At December 31, 2022 the fair value of the warrants was $197,733 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.15, strike rate $0.23 dividend yield 0%, term 3.84 years, volatility 110% and risk-free rate 4.08%.

 

At January 19, 2023 prior to exercise, the fair value of the warrants was $NIL and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.19, strike rate $0.20 dividend yield 0%, term 0 years, volatility 130% and risk-free rate 3.62%.

 

January 11, 2022 warrants

 

The Company assessed that the 8,519,999 warrants, and 1,480,000 pre-funded warrants issued in the January 2022 equity offering did not meet the “fixed for fixed” test and are therefore recorded as liabilities at fair value through profit and loss, and revalued at the end of each period.

 

At December 31, 2022 the fair value of the warrants was $501,330 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.15, strike rate $2.30, dividend yield 0%, term 4.03 years, volatility 110% and risk-free rate 4.08%.

 

At March 31, 2023 the fair value of the warrants was $628,765 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.19, strike rate $2.30, dividend yield 0%, term 3.79 years, volatility 125% and risk-free rate 3.69%.

 

October 12, 2022 warrants

 

The Company assessed that the 17,400,000 warrants and 1,590,000 pre-funded warrants issued as part of the October 2022 equity offering did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. On January 19, 2023 the warrant holders entered into the agreement noted above to exercise 16,150,000 of the 17,400,000 warrants, and receive new warrants in exchange. The remaining 1,250,000 warrants that were outstanding at January 19, 2023 were converted to cashless exercise warrants on March 30, 2023 as described above.

 

10

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

6.WARRANT LIABILITY (cont’d)

 

The fair value of the warrants as at December 31, 2022 was $1,850,758 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.15; exercise price $0.23; expected volatility: 100%; dividend yield 0%; risk free rate: 3.98%.

 

The fair value of the 1,250,000 unexercised warrants on January 19, 2023 was $132,957 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.19; exercise price $0.20; term 4.73 years; expected volatility: 115%; dividend yield 0%; risk free rate: 3.49%.

 

The fair value of the 16,150,000 exercised warrants immediately prior to exercise on January 19, 2023 was $NIL and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.19; exercise price $0.20; term 0 years; expected volatility: 115%; dividend yield 0%; risk free rate: 3.49%.

 

The fair value of the 2,989,130 (1,739,130 waiver warrants plus 1,250,000 unexercised warrants) outstanding warrants on March 30, 2023 prior to the transfer to equity was $564,946 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.

 

In connection with the October 2022 equity offering, the Company issued 1,739,130 waiver warrants exercisable at $0.23 per share which expire, if unexercised, on October 12, 2027, to entice the holder of the convertible promissory note to waive their right to block the equity offering. The waiver warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss and revalued at the end of each period. On March 30, 2023, the waiver warrants were modified to cashless exercise as described above, and therefore met the “fixed for fixed” test and were reclassified to equity.

 

The fair value of the waiver warrants as at December 31, 2022 was $184,983 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.15; exercise price $0.23; expected volatility: 100%; dividend yield 0%; risk free rate: 3.10%.

 

The fair value of the waiver warrants as at March 30, 2023 prior to transfer to equity was $328,696 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.

 

7.SHARE CAPITAL

 

(a)Authorized Unlimited number of common shares without par value

 

As at March 31, 2023, the Company had 62,911,417 common shares issued and outstanding (December 31, 2022 – 44,868,560).

 

As of the date of issuance of these restated financial statements total outstanding common shares is 1,853,955 post 100-to-1 reverse split that was effective as of August 3, 2023, (185,393,404 pre-split).

 

11

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

7.SHARE CAPITAL (cont’d)

 

  (b) Common share transactions

 

Transaction subsequent to the quarter ended March 31, 2023 is as follows:

 

Subsequent to the period end, a total of 21,031,987 cashless warrants were exercised in exchange for common shares of the Company.

 

On June 28, 2023 the Company issued 50,000,000 at $0.045 per share for gross proceeds of $2,250,000 before offering expenses and other expenses included in share issuance costs.

 

On July 13, 2023, the Company issued 51,450,000 shares at $0.045 per share for gross proceeds of $2,315,250.

 

On August 3, 2023, the Company affected a 100-to-1 reverse stock split resulting in 185,393,404 shares converted with rounding into 1,853,955 shares.

 

Transactions for the three months ended March 31, 2023 are as follows:

 

  The Company issued 18,042,857 common shares on the exercise of various warrants for gross proceeds of $3,608,571. Additionally, the Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 30, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,987 common shares were issued for cashless warrants subsequent to March 31, 2023 as described in Note 16.

 

Transactions for the three months ended March 31, 2022 are as follows:

 

  On January 11, 2022, the Company completed an underwritten public offering in the United States, raising a total of $20,013,043 in gross proceeds. The Company allocated the gross proceeds firstly to the warrant liabilities, with the remainder to the common shares. Direct costs have been allocated based on the percentage allocation of the proceeds. The underwritten public offering resulted in the sale to the public of 7,215,652 Units at $2.30 per Unit, with each Unit being comprised of one common share and one warrant (the “Unit Warrants”) exercisable at $2.30 per share. The Unit warrants are exercisable immediately and have a term of 5 years. Gross proceeds of $10,936,974 were allocated to the common shares, and $5,395,878 to the unit warrants liability.

 

In addition, the Company issued 1,480,000 pre-funded units (“Pre-Funded Units”) at $2.29 per Pre-Funded Unit. Each Pre-Funded Unit is comprised of a one-pre-funded warrant (a “Pre-Funded Warrant”) to purchase one common share, and one warrant to purchase one common share. The Pre-Funded Warrant allows the holder to acquire one common share of the Company at an exercise price of $0.01 per common share, and a warrant to purchase a common share at an exercise price of $2.30 per share. The warrants are exercisable immediately and have a term of 5 years. Each Pre-Funded Warrant is exercisable immediately and is exercisable until all Pre-Funded Warrants are exercised. Proceeds of $2,560,400 were allocated to the pre-funded warrants and $1,106,747 to the unit warrants in the warrant liability.

 

The Company determined that the pre-funded warrants within the Pre-funded Units are common shares in substance, as they require only a minimal exercise price of $0.01. In addition, the underwriting agreement includes both the Units and Pe-funded Units and were negotiated together in the equity raise. Given that the purpose of the Prefunded Unit is in substance the same as that of the Unit (i.e., resulting in the ownership of both common shares and common share warrants) and that the terms of the warrants in both the Units and Prefunded Units are the same (i.e., the obligations of the Company for the units are the same), the Company determined that the Units and Pre-funded Units are closely related and should be combined into one unit of account for the purposes of allocating proceeds.

 

12

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

7.SHARE CAPITAL (cont’d)

 

  (b) Common share transactions (cont’d)

 

Therefore, the proceeds from the sale of the Units and Pre-funded Units are combined and allocated among the common shares, pre-funded warrants, and the common share warrants using the residual method, with the warrant liability being initially recognized at fair value as of the registration date and the residual amount being allocated to the common shares (i.e., equity).

 

The Company concurrently sold an additional 1,304,347 warrants to purchase 1,304,347 common shares exercisable at $2.30 per share (the “Option Warrants”) pursuant to an over-allotment option exercised by the underwriter. The exercise price of the warrants issued in connection with the exercise of the over-allotment option was $0.0097 per warrant. Each Option Warrant is exercisable immediately and has a term of five years from the issue date. Proceeds of $975,393 were allocated to the option warrant liability. As the fair value of the warrant liability exceeded the proceeds received on the warrants of $13,043, a fair value loss of $962,350 was recognized in the statement of profit and loss as a fair value change in the opening warrant liability.

 

The fair value of the common shares and pre-funded units was determined by reference to the market price on the day of the offering, which was $1.73 per share. The Unit Warrants, Warrants, and Option Warrants were valued using the Black-Scholes model using the following assumptions: initial stock price $1.73, strike rate $2.30, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company also issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company assessed that the warrants issued under the public offering, excluding the Placement Agent Warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. The Placement Agent Warrants were assessed under IFRS 2 Share Based Payments, as equity-settled share-based payments and have been recorded in equity.

 

The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued.

 

13

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

7.SHARE CAPITAL (cont’d)

 

  (b) Common share transactions (cont’d)

 

  On March 31, 2022, as part of the ClearRF acquisition (Note 3), the Company issued 138,958 shares to the vendor with a fair value of $190,094.

 

  (c) Stock options

 

The Company has a shareholder-approved “rolling” stock option plan (the “Plan”) in compliance with Nasdaq policies. Under the Plan the maximum number of shares reserved for issuance may not exceed 15% of the total number of issued and outstanding common shares at the time of granting. The exercise price of each stock option shall not be less than the market price of the Company’s stock at the date of grant, less a discount of up to 25%. Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted.

 

A summary of the Company’s stock option activity is as follows:

 

   Number of
stock
options
  

Weighted
Average

Exercise
Price

 
Outstanding options, December 31, 2021   414,568   $13.88 
Granted   1,145,000   $1.15 
Expired/Cancelled   (53,430)  $30.90 
Outstanding options, December 31, 2022 and March 31, 2023   1,506,138   $3.53 

 

14

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

7.SHARE CAPITAL (cont’d)

 

  (c) Stock options (cont’d)

 

As at March 31, 2023 stock options outstanding are as follows:

 

Grant Date  Number of
options
outstanding
   Number of
options
exercisable
   Weighted
Average
Exercise
Price
   Expiry date  Remaining
contractual
life (years)
 
24-Dec-18   12,896    12,896   $54.00   24-Dec-23   0.63 
15-Jan-19   828    828   $54.00   15-Jan-24   0.69 
21-Mar-19   12,345    12,345   $59.00   21-Mar-24   0.87 
01-Jan-20   2,069    2,069   $54.00   01-Jan-24   0.65 
15-Nov-20   95,000    95,000   $6.00   15-Nov-30   7.53 
15-Nov-20   161,500    161,500   $6.00   15-Nov-25   2.52 
02-Jan-21   57,000    57,000   $11.50   02-Jan-26   2.65 
02-Jan-21   5,000    5,000   $11.50   02-Jan-31   7.66 
18-Jan-21   14,500    14,500   $11.50   18-Jan-26   2.70 
01-Jan-22   20,000    12,500   $4.00   29-Oct-26   3.48 
13-Apr-22   795,000    265,000   $1.10   13-Apr-27   3.93 
12-Jul-22   330,000    110,000   $1.10   12-Jul-25   2.18 
Total   1,506,138    748,638   $3.53       3.51 

 

Transactions for the three months ended March 31, 2022 are as follows:

 

  On January 1, 2022, the Company granted 20,000 stock options at $4.00 per share that vest in 8 equal quarterly periods with the first vesting occurring on the grant date. The fair value on the date of the grant was $54,480 ($2.724 per option).

 

15

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

7.SHARE CAPITAL (cont’d)

 

  (d) Restricted share units

 

The Company approved on February 14, 2022, the addition of the issuance of restricted share units to the existing executive stock option plan.

 

A summary of the Company’s restricted share unit activity is as follows:

 

   Number of RSU’s   Weighted Average
Issue
Price
 
Outstanding RSU, December 31, 2021   
-
   $
-
 
Granted   3,195,000   $1.05 
Exercised   (30,000)  $1.10 
Outstanding RSU, December 31, 2022 and March 31, 2023   3,165,000   $1.05 

 

As at March 31, 2023 restricted share units outstanding are as follows:

 

Grant Date  Number of
RSU’s
outstanding
   Number of
RSU’s
exercisable
   Weighted
Average
Issue Price
 
09-Mar-22   2,250,000    1,200,000   $1.03 
13-Apr-22   825,000    513,750   $1.10 
12-Jul-22   90,000    37,500   $1.10 
Outstanding RSU, March 31, 2023   3,165,000    1,751,250   $1.05 

 

Transactions for the three months ended March 31, 2022, are as follows:

 

  On March 9, 2022, the Company granted 450,000 RSU’s to Directors that vest immediately. On the date of granting, the fair value and stock price was $1.03/share.

 

  On March 9, 2022, the Company granted 1,800,000 RSU’s to a Director that vest quarterly over 12 periods with the first vesting of 150,000 RSU’s occurring on the date of the granted and another 150,000 vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.03/share.

 

16

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

7.SHARE CAPITAL (cont’d)

 

  (e) Agents’ options

 

A summary of the Company’s agent options activity is as follows:

 

   Number of
options
   Weighted
average
exercise price
 
Outstanding agent options, December 31, 2021   445,926   $7.51 
Granted   487,283   $2.51 
Expired   (1,702)  $20.49 
Outstanding agent options, December 31, 2022 and March 31, 2023   931,507   $4.12 

 

As at March 31, 2023 agent options outstanding are as follows:

 

Grant Date  Number of
options
outstanding
   Number of
options
exercisable
   Weighted
Average
Exercise Price
   Expiry date  Remaining
contractual life (years)
 
                    
29-Sep-20   113,500    113,500   $6.60   28-Sep-25   2.00 
29-Sep-20   266,000    266,000   $6.85   28-Sep-25   2.00 
31-Dec-20   64,724    64,724   $11.50   30-Jun-24   1.00 
11-Jan-22   434,783    434,783   $2.53   11-Jan-27   4.00 
01-Apr-22   52,500    52,500   $2.30   08-Mar-27   4.00 
Total   931,507    931,507   $4.12       2.98 

 

Transactions for the three months ended March 31, 2022 are as follows:

 

  The Company issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%. The Company also issued 52,500 agent’s options with a fair value of $61,950 with an exercise price of $2.30.

 

17

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

7.SHARE CAPITAL (cont’d)

 

  (f) Share purchase warrants

 

A summary of the Company’s share purchase warrant activity is as follows:

 

   Number of Warrants   Weighted average exercise price 
Outstanding, December 31, 2021   5,121,328   $7.64 
Granted   29,139,129   $0.94 
Expired   (128,386)  $33.47 
Outstanding, December 31, 2022   34,132,071   $1.76 
Granted   18,042,857    0.20 
Exercised   (18,042,857)   0.20 
Outstanding, March 31, 2023   34,132,071   $1.47 

 

As at March 31, 2023 the share purchase warrants outstanding are as follows:

 

Grant Date  Number of
Warrants
outstanding and
exercisable
   Exercise
Price
   Expiry date
29-Sep-20   1,805,585   $6.85   28-Sep-25
31-Dec-20   1,294,500   $11.50   30-Jun-24
11-Jan-22   9,999,999   $2.30   11-Jan-27
12-Oct-22   1,250,000    Cashless   11-Jan-27
12-Oct-22   1,739,130    Cashless   11-Jan-27
19-Jan-23   18,042,857    Cashless   18-Jan-28
Total   34,132,071   $1.47    

 

Transactions for the three months ended March 31, 2023 are as follows:

 

  18,042,857 warrants were exercised. The Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 31, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 17,116,987 cashless warrants were exercised subsequent to March 31, 2023.

 

Transactions for the three months ended March 31, 2022 are as follows:

 

  128,386 share purchase warrant expired in 2022.

 

  On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exercisable at $2.30 per warrant and with a term of five years.

 

18

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

8.COST OF SALES

 

(in thousands)  March 31,
2023
   March 31,
2022
 
         
Inventory expensed  $971   $359 
Royalties   106    54 
Other expenses   229    165 
Total  $1,306   $578 

 

9.SELLING AND MARKETING EXPENSES

 

(in thousands)  March 31,
2023
   March 31,
2022
 
         
Salaries and related expenses  $705   $618 
Advertising and marketing   249    398 
Travel and conferences   49    29 
Total  $1,003   $1,045 

 

10.GENERAL AND ADMINISTRATIVE EXPENSES

 

(in thousands)  March 31,
2023
   March 31,
2022
 
Salaries and related expenses  $151   $125 
Professional services   565    377 
Consulting and director fees   263    419 
Travel   14    36 
Office and general   326    442 
Regulatory and filing fees   27    21 
Shareholder relations   46    239 
Total  $1,392   $1,659 

 

19

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

11.TRANSACTION COSTS

 

Transaction costs incurred in relation to the January 2023 warrant raise and issuance described in Note 7 were $309,000 and were included in the change in fair value of warrant liability on the statement of operations.

 

Transaction costs incurred in the three months ended March 31, 2022 were $965,247, which are costs incurred for the January 11, 2022 capital raise that were allocated to the warrant liability and expensed through the statement of operations.

 

12.FINANCIAL INSTRUMENTS

 

The fair values of the Company’s cash, trade and other receivables, accounts payable and accrued liabilities and long-term debt, approximate carrying value, which is the amount recorded on the consolidated statement of financial position.

 

Credit risk

 

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company places its cash with institutions of high creditworthiness. Management has assessed there to be a low level of credit risk associated with its cash balances.

 

The Company’s exposure to credit risk is influenced mainly by the individual characteristics of each customer. However, management also considers the demographics of the Company’s customer base, including the default risk of the industry and country in which customers operate, as these factors may have an influence on credit risk. Approximately 34% of the Company’s revenue for the three months ended March 31, 2023 (March 31, 2022 -23%) is attributable to sales transactions with a single customer.

 

The Company has established a credit policy under which each new customer is analyzed individually for creditworthiness before the Company’s standard payment and delivery terms and conditions are offered. The Company’s review includes external ratings, when available, and in some cases bank references. Purchase limits are established for each customer, which represents the maximum open amount without requiring approval from the Risk Management Committee; these limits are reviewed quarterly. In prior years, certain key customers were offered extended payment terms on their purchases due to slow down from Covid-19 and budget approvals for government tenders.

 

As a result, the Company had customers with overdue receivables on their books which resulted in the Company taking a bad debt provision on these overdue receivables which amounted to $1,062,052 at March 31, 2023 (March 31, 2022 - $1,056,393).

 

20

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

12.FINANCIAL INSTRUMENTS (cont’d)

 

More than 50% (2022 – 18%) of the Company’s customers have been active with the Company for over four years, and the allowance for doubtful accounts of $1,062,052 (2022 - $1,056,393) has been recognized against these customers. In monitoring customer credit risk, customers are grouped according to their credit characteristics, including whether they are an individual or legal entity, whether they are a wholesale, retail or end-user customer, geographic location, industry, aging profile, maturity, and the existence of previous financial difficulties. Trade and other receivables relate mainly to the Company’s wholesale customers. Customers that are graded as “high risk” are placed on a restricted customer list and monitored by the Company.

 

The carrying amount of financial assets represents the maximum credit exposure, notwithstanding the carrying amount of security or any other credit enhancements.

 

Liquidity risk

 

Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities that are settled by delivering cash or another financial asset. The Company’s approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company’s reputation.

 

The Company examines current forecasts of its liquidity requirements so as to make certain that there is sufficient cash for its operating needs, and it is careful at all times to have enough unused credit facilities so that the Company does not exceed its credit limits and is in compliance with its financial covenants (if any). These forecasts take into consideration matters such as the Company’s plan to use debt for financing its activity, compliance with required financial covenants, compliance with certain liquidity ratios, and compliance with external requirements such as laws or regulation.

 

The Company uses activity-based costing to cost its products and services, which assists it in monitoring cash flow requirements and optimizing its cash return on investments. Typically, the Company ensures that it has sufficient cash on demand to meet expected operational expenses for a period of 90 days, including the servicing of financial obligations; this excludes the potential impact of extreme circumstances that cannot reasonably be predicted, such as natural disasters.

 

With the exception of employee benefits, the Company’s accounts payable and accrued liabilities have contractual terms of 90 days. The employment benefits included in accrued liabilities have variable maturities within the coming year.

 

21

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

12.FINANCIAL INSTRUMENTS (cont’d)

 

Market risk

 

  a) Currency Risk

 

Currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates.

 

  b) Interest Rate Risk

 

Interest rate risk is the risk that the fair value of future cash flows will fluctuate as a result of changes in interest rates. The Company’s sensitivity to interest rates is inherently involved in the calculation of the fair value of the warranty liability which are revalued based on changes parameters which include the prevailing interest rate.

 

  c) Price Risk

 

The Company is exposed to price risk with respect to equity prices. Equity price risk is defined as the potential adverse impact on the Company’s earnings due to movements in individual equity prices or general movements in the level of the stock market. The Company closely monitors individual equity movements, and the stock market to determine the appropriate course of action to be taken by the Company.

 

13.RELATED PARTY TRANSACTIONS

 

Key Personnel Compensation

 

Key management personnel includes those persons having authority and responsibility for planning, directing, and controlling the activities of the Company as a whole. The Company has determined that key management personnel consists of executive and non-executive members of the Company’s Board of Directors and corporate officers. The remuneration of directors and key management personnel for the three months ended March 31, 2023 and 2022 are as follows:

 

   2023   2022 
Payments to key management personnel:        
Salaries, consulting and directors’ fees  $285,413   $491,889 
Share-based payments   243,323    767,436 
Total  $528,736   $1,259,325 

  

22

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

13.RELATED PARTY TRANSACTIONS (cont’d)

 

Salaries, consulting and directors’ fees shown above are classified within profit and loss as shown below:

 

      (in thousands) 
Type of Service  Nature of Relationship  2023   2022 
Selling and marketing expenses  VP Technology/VP Sales International  $46   $84 
General and administrative expense  Companies controlled by the CEO, CFO and Directors  $239   $408 

 

14.SEGMENTED INFORMATION

 

The Company is domiciled in Canada, and it operates and produces its income primarily in Israel, Europe and North America. The Company operates as a single segment being the sale of cellular-based communications products.

 

The Company’s entity-wide disclosures include disaggregated information about product sales, geographical areas, and major customers.

 

Geographical area information is shown below:

 

External revenues by Geography for the three months ended March 31    
(in thousands)  2023   2022 
         
USA  $1,073   $245 
Canada   219    249 
EMEA   511    326 
Australia   
-
    13 
Total  $1,803   $833 

 

23

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

14.SEGMENTED INFORMATION (cont’d)

 

Non-current asset geographic area information is shown below:

 

(in thousands)  March 31,
2023
   December 31,
2022
 
         
Long-term receivable total  $146   $150 
Canada   
-
    
-
 
EMEA   146    150 
           
Right of use asset total  $812   $887 
Canada   118    177 
EMEA   694    710 
           
Equipment total  $200   $207 
Canada   
-
    
-
 
EMEA   200    207 
           
Intangibles total  $7,481   $6,988 
Canada   
-
    
-
 
EMEA   7,481    6,988 

 

Product information is shown below:

 

Revenue by product line for the three months ended March 31        
(in thousands)  2023   2022 
Cellular boosters and related accessories  $438   $463 
Rugged devices and related accessories   1,365    370 
Total  $1,803   $833 

 

24

 

 

Siyata Mobile Inc.

Notes to the Restated Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at March 31, 2023 and December 31, 2022 and for the three months ended March 31, 2023 and 2022

 

15.SUPPLEMENTAL INFORMATION WITH RESPECT TO CASH FLOWS

 

   Three months ended
March 31
 
   2023   2022 
Change in non-cash working capital:        
Trade and other receivables  $463,505   $(6,303)
Prepaids   (491,942)   (731,566)
Inventory   528,510    (1,060,581)
Advances to suppliers   (519,709)   (590,506)
Accounts payable and accrued liabilities   (967,476)   (836,698)
Deferred revenue   (149,600)   
-
 
   $(1,136,712)  $(3,225,654)

 

During the three months ended March 31, 2023, the Company paid $nil (March 31, 2022 - $2,659) in interest and $Nil (March 31, 2022 - $nil) in income taxes.

 

16.SUBSEQUENT EVENTS

 

Subsequent to the period end, a total of 21,031,987 cashless warrants were exercised in exchange for common shares of the Company.

 

On June 28, 2023 the Company issued 50,000,000 at $0.045 per share for gross proceeds of $2,250,000 before offering expenses and other expenses included in share issuance costs.

 

On July 13, 2023, the Company issued 51,450,000 shares at $0.045 per share for gross proceeds of $2,315,250.

 

On August 3, 2023, the Company affected a 100-to-1 reverse stock split resulting in 185,393,404 shares converted with rounding into 1,853,955 shares.

 

The Company was issued a cease trading order by the British Columbia Securities Exchange for late filing of these Q1 2023 financial statements that were due on May 15, 2023. The cease trading order was lifted upon filing of the Q1 2023 financial statements on May 24, 2023.

 

The Company entered into a factoring agreement for their receivables in North America.

 

17.RESTATEMENT OF FINANCIAL STATEMENTS

 

In conjunction with preparation of the Company’s financial statements for the three month period ended March 31, 2023 and as part of a continuous disclosure review by the Staff of Company’s principal securities regulator in relation to the accounting for warrant liability and share capital, the Company identified an error in how the fair value has been accounted for in the previously issued financial statements.

 

The Company evaluated the significance of the corrections and determined the adjustments were material to the unaudited condensed interim consolidated financial statements for the three month period ended March 31, 2023. The impact of these changes have been restated in these financial statements.

 

The above restatement reflects the impact of an error in the calculation of the fair value of warrant liability on January 19, 2023 due to an incorrect input parameter for the term to maturity of those warrants resulting in an overstatement of the change in fair value expense for the period of $2,705,253 and a resulting decrease in the same amount to share capital.

 

The above restatement did not impact the total assets nor liabilities and did not impact the net equity as the share capital decreased by $2,705,253 and the deficit was reduced by the same amount.

 

25

 

 

Financial impact

The following tables summarise the effects of the restatement.

Selected line items restated in the Consolidated Statements of Financial Position:

 

Siyata Mobile Inc.

Restated Balance Sheet

March 31, 2023

 

 

   As originally filed   Adjustment   As Restated 
ASSETS            
Current            
Cash  $1,179,694    
 
   $1,179,694 
Trade and other receivables (Note 3)   1,111,123    
 
    1,111,123 
Prepaid expenses   665,446    
 
    665,446 
Inventory (Note 4)   3,564,040    
 
    3,564,040 
Advance to suppliers   675,561    
 
    675,561 
    7,195,864    
 
    7,195,864 
Long term receivable   146,196    
 
    146,196 
Right of use assets   811,966    
 
    811,966 
Equipment   199,743    
 
    199,743 
Intangible assets   7,481,391    
 
    7,481,391 
Total assets  $15,835,160    
 
   $15,835,160 
                
LIABILITIES AND SHAREHOLDERS' EQUITY               
Current               
Accounts payable and accrued liabilities  $2,111,174    
 
   $2,111,174 
Deferred revenue   
-
    
 
    
-
 
Lease obligations   294,359    
 
    294,359 
Warrant liability (Note 6)   628,765    
 
    628,765 
    3,034,298    
 
    3,034,298 
Lease obligation   543,944    
 
    543,944 
Total liabilities   3,578,242    
 
    3,578,242 
Shareholders' equity               
Share capital (Note 7)   79,626,690    (2,705,253)   76,921,437 
Reserves (Note 7)   17,933,273    
 
    17,933,273 
Accumulated other comprehensive loss   98,870    
 
    98,870 
Deficit   (85,401,915)   2,705,253    (82,696,662)
    12,256,918    
-
    12,256,918 
Total liabilities and shareholders' equity  $15,835,160   $
-
   $15,835,160 

 

26

 

 

Selected line items restated in the Consolidated Statements of Loss and Comprehensive Loss:

 

   As originally filed   Adjustment   As Restated 
Revenue  $1,802,637    
 
   $1,802,637 
Cost of sales (Note 8)   (1,306,120)   
 
    (1,306,120)
Gross profit   496,517    
 
    496,517 
                
EXPENSES               
Amortization and depreciation   401,640    
 
    401,640 
Development expenses   53,985    
 
    53,985 
Selling and marketing (Note 9)   1,003,365    
 
    1,003,365 
General and administrative (Note 10)   1,392,430    
 
    1,392,430 
Share-based payments (Note 7)   310,828    
 
    310,828 
Total operating expenses   3,162,248    
 
    3,162,248 
                
Net operating loss   (2,665,731)   
 
    (2,665,731)
                
OTHER EXPENSES               
Finance expense (Note 11)   34,098    
 
    34,098 
Foreign exchange   163    
 
    163 
Change in fair value of convertible promissory note (Note 5)   
-
    
 
    
-
 
Change in fair value of warrant liability (Note 6)   4,883,260    (2,705,253)   2,178,007 
Transaction costs (Note 12)   -    
 
    
-
 
Total other expenses   4,917,521    (2,705,253)   2,212,268 
Net loss for the year   (7,583,252)   (2,705,253)   (4,877,999)
                
Other comprehensive income               
Translation adjustment   
-
    
 
    
-
 
                
Comprehensive loss for the year  $(7,583,252)  $(2,705,253)  $(4,877,999)
                
Weighted average shares   59,102,369    59,102,369    59,102,369 
Basic and diluted loss per share
  $(0.13)  $0.05   $(0.08)

 

27

 

 

Selected line items restated in the Consolidated Statements of Changes in Shareholder’s Equity:

 

Deficit  As originally filed   Adjustment   As Restated 
Deficit-Beginning of period   (77,818,663)   
 
    (77,818,663)
loss for the period   (7,583,252)   2,705,253    (4,877,999)
Deficit-end of period   (85,401,915)   2,705,253    (82,696,662)

 

Share Capital  As originally filed   Adjustment   As Restated 
Share capital-Beginning of period   73,312,866    
 
    73,312,866 
warrants exercised   6,313,824    (2,705,253)   3,608,571 
Share capital-end of period   79,626,690    (2,705,253)   76,921,437 

 

Selected line items restated in the Consolidated Statements of Cash Flows:

 

   As originally filed   Adjustment   As Restated 
Operating activities               
Net loss for the year  $(7,583,252)  $2,705,253   $(4,877,999)
Items not affecting cash:               
Amortization and depreciation   401,640    
 
    401,640 
Bad debt expense   
-
    
 
    
-
 
Fair value changes on derivatives   4,883,260    (2,705,253)   2,178,007 
Interest expense, net of repayments   
-
    
 
    
-
 
Foreign exchange   11,666    
 
    11,666 
Transaction costs   
-
    
 
    
-
 
Share based payments   310,828    
 
    310,828 
Change in non-cash working capital   (1,136,712)   
 
    (1,136,712)
Net cash used in operating activities   (3,112,570)   
-
    (3,112,570)
                
Investing activities               
Intangible asset additions   (817,849)   
 
    (817,849)
Equipment additions   (2,498)   
 
    (2,498)
Acquisition of ClearRF   
-
    
 
    
-
 
Net cash used in investing activities   (820,347)   
 
    (820,347)
                
Financing activities               
Lease payments   (100,702)   
 
    (100,702)
Bank loan   
-
    
 
    
-
 
Convertible debt issued, net of repayments   
-
    
 
    
-
 
Proceeds on share issuance, net of share issuance costs   
-
    
 
    
-
 
Transaction costs   (309,000)   
 
    (309,000)
Exercise of warrants   3,608,571    
 
    3,608,571 
Net cash from financing activities   3,198,869    
-
    3,198,869 
                
Effect of foreign exchange on cash   
-
    
 
    
-
 
                
Change in cash and restricted cash for the year   (734,048)   
 
    (734,048)
Cash and restricted cash, beginning of year   1,913,742    
 
    1,913,742 
Cash and restricted cash, end of year  $1,179,694   $
-
   $1,179,694 

 

28

 

0.08 0.30 The above restatement did not impact the total assets nor liabilities and did not impact the net equity as the share capital decreased by $2,705,253 and the deficit was reduced by the same amount. 0.05 0.08 0.13 false --12-31 Q2 0001649009 0001649009 2023-01-01 2023-06-30 0001649009 2023-03-31 0001649009 2022-12-31 0001649009 2023-01-01 2023-03-31 0001649009 2022-01-01 2022-03-31 0001649009 ifrs-full:ClassesOfShareCapitalMember 2021-12-31 0001649009 syta:ReservesMember 2021-12-31 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001649009 ifrs-full:RetainedEarningsMember 2021-12-31 0001649009 2021-12-31 0001649009 ifrs-full:ClassesOfShareCapitalMember 2022-01-01 2022-03-31 0001649009 syta:ReservesMember 2022-01-01 2022-03-31 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001649009 ifrs-full:RetainedEarningsMember 2022-01-01 2022-03-31 0001649009 ifrs-full:ClassesOfShareCapitalMember 2022-03-31 0001649009 syta:ReservesMember 2022-03-31 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001649009 ifrs-full:RetainedEarningsMember 2022-03-31 0001649009 2022-03-31 0001649009 ifrs-full:ClassesOfShareCapitalMember 2022-12-31 0001649009 syta:ReservesMember 2022-12-31 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001649009 ifrs-full:RetainedEarningsMember 2022-12-31 0001649009 ifrs-full:ClassesOfShareCapitalMember 2023-01-01 2023-03-31 0001649009 syta:ReservesMember 2023-01-01 2023-03-31 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001649009 ifrs-full:RetainedEarningsMember 2023-01-01 2023-03-31 0001649009 ifrs-full:ClassesOfShareCapitalMember 2023-03-31 0001649009 syta:ReservesMember 2023-03-31 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001649009 ifrs-full:RetainedEarningsMember 2023-03-31 0001649009 2023-06-30 0001649009 2022-01-01 2022-06-30 0001649009 2023-04-01 2023-06-30 0001649009 2022-04-01 2022-06-30 0001649009 syta:beforeThe1001ReverseSplitMember 2023-01-01 2023-06-30 0001649009 syta:beforeThe1001ReverseSplitMember 2022-01-01 2022-06-30 0001649009 syta:beforeThe1001ReverseSplitMember 2023-04-01 2023-06-30 0001649009 syta:beforeThe1001ReverseSplitMember 2022-04-01 2022-06-30 0001649009 syta:afterThe1001ReverseSplitMember 2023-01-01 2023-06-30 0001649009 syta:afterThe1001ReverseSplitMember 2022-01-01 2022-06-30 0001649009 syta:afterThe1001ReverseSplitMember 2023-04-01 2023-06-30 0001649009 syta:afterThe1001ReverseSplitMember 2022-04-01 2022-06-30 0001649009 ifrs-full:ClassesOfShareCapitalMember 2022-01-01 2022-06-30 0001649009 syta:ReservesMember 2022-01-01 2022-06-30 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001649009 ifrs-full:RetainedEarningsMember 2022-01-01 2022-06-30 0001649009 ifrs-full:ClassesOfShareCapitalMember 2022-06-30 0001649009 syta:ReservesMember 2022-06-30 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001649009 ifrs-full:RetainedEarningsMember 2022-06-30 0001649009 2022-06-30 0001649009 ifrs-full:ClassesOfShareCapitalMember 2023-01-01 2023-06-30 0001649009 syta:ReservesMember 2023-01-01 2023-06-30 0001649009 ifrs-full:RetainedEarningsMember 2023-01-01 2023-06-30 0001649009 ifrs-full:ClassesOfShareCapitalMember 2023-06-30 0001649009 syta:ReservesMember 2023-06-30 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001649009 ifrs-full:RetainedEarningsMember 2023-06-30 0001649009 syta:QueensgateResourcesCorpMember 2023-01-01 2023-03-31 0001649009 syta:QueensgateResourcesCorpMember 2023-03-31 0001649009 syta:QueensgateResourcesUSCorpMember 2023-01-01 2023-03-31 0001649009 syta:QueensgateResourcesUSCorpMember 2023-03-31 0001649009 syta:SiyataMobileCanadaIncMember 2023-01-01 2023-03-31 0001649009 syta:SiyataMobileCanadaIncMember 2023-03-31 0001649009 syta:SiyataMobileIsraelLtdMember 2023-01-01 2023-03-31 0001649009 syta:SiyataMobileIsraelLtdMember 2023-03-31 0001649009 syta:SignifiMobileIncMember 2023-01-01 2023-03-31 0001649009 syta:SignifiMobileIncMember 2023-03-31 0001649009 syta:ClearRFNevadaLtdMember 2023-01-01 2023-03-31 0001649009 syta:ClearRFNevadaLtdMember 2023-03-31 0001649009 2021-11-03 2021-11-03 0001649009 2022-01-01 2022-01-13 0001649009 2022-05-01 2022-05-31 0001649009 2023-01-01 2023-01-19 0001649009 ifrs-full:TopOfRangeMember 2023-01-01 2023-01-19 0001649009 ifrs-full:BottomOfRangeMember 2023-01-01 2023-01-19 0001649009 syta:CommonSharesMember 2023-01-01 2023-01-19 0001649009 syta:WarrantsMember 2023-01-01 2023-01-19 0001649009 syta:WarrantsMember 2023-01-19 0001649009 syta:CommonSharesMember 2023-01-19 0001649009 2023-01-01 2023-03-30 0001649009 syta:January192023WarrantsMember 2023-01-01 2023-01-19 0001649009 2021-11-01 2021-11-03 0001649009 syta:WarrantsMember 2021-11-01 2021-11-03 0001649009 syta:November32021WarrantsMember 2022-01-01 2022-12-31 0001649009 2022-01-01 2022-01-11 0001649009 syta:BlackScholesOptionPricingModelMember 2022-01-01 2022-12-31 0001649009 2022-10-01 2022-10-12 0001649009 syta:October122022WarrantsMember 2022-01-01 2022-12-31 0001649009 syta:October122022WarrantsMember 2022-12-31 0001649009 syta:October122022WarrantsMember 2023-01-01 2023-01-19 0001649009 syta:BlackScholesOptionPricingModelMember 2023-01-01 2023-01-19 0001649009 syta:October122022WarrantsMember 2023-01-19 0001649009 syta:October122022WarrantsMember syta:PriorToExerciseMember 2023-01-01 2023-01-19 0001649009 syta:BlackScholesOptionPricingModelMember syta:PriorToExerciseMember 2023-01-01 2023-01-19 0001649009 syta:October122022WarrantsMember syta:PriorToExerciseMember 2023-01-19 0001649009 syta:October122022WarrantsMember 2023-01-01 2023-03-31 0001649009 syta:October122022WarrantsMember 2023-01-01 2023-03-30 0001649009 2022-01-01 2022-12-31 0001649009 syta:November32021Member 2022-12-31 0001649009 syta:January112022Member 2022-12-31 0001649009 syta:October122022Member 2022-12-31 0001649009 syta:January192023Member 2022-12-31 0001649009 syta:November32021Member 2023-01-01 2023-03-31 0001649009 syta:January112022Member 2023-01-01 2023-03-31 0001649009 syta:October122022Member 2023-01-01 2023-03-31 0001649009 syta:January192023Member 2023-01-01 2023-03-31 0001649009 syta:November32021Member 2023-03-31 0001649009 syta:January112022Member 2023-03-31 0001649009 syta:October122022Member 2023-03-31 0001649009 syta:January192023Member 2023-03-31 0001649009 ifrs-full:OrdinarySharesMember 2023-03-31 0001649009 ifrs-full:OrdinarySharesMember 2022-12-31 0001649009 2023-07-25 2023-08-03 0001649009 2023-06-28 0001649009 2023-06-01 2023-06-28 0001649009 syta:NonAdjustingEventMember 2023-07-13 0001649009 syta:NonAdjustingEventMember 2023-07-13 2023-07-13 0001649009 syta:NonAdjustingEventMember 2023-07-25 2023-08-03 0001649009 syta:CommonShareTransactionsMember ifrs-full:OrdinarySharesMember 2023-03-31 0001649009 syta:WarrantsMember 2023-01-01 2023-03-31 0001649009 syta:WarrantsMember 2023-03-31 0001649009 syta:WarrantsMember 2023-01-01 2023-03-31 0001649009 2022-01-11 0001649009 syta:PreFundedUnitsMember 2023-01-01 2023-03-31 0001649009 syta:OptionWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:OptionWarrantsMember 2023-03-31 0001649009 syta:PlacementAgentWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:PlacementAgentWarrantsMember 2023-03-31 0001649009 syta:PlacementAgentWarrantsMember 2022-01-11 2022-01-11 0001649009 2022-01-11 2022-01-11 0001649009 syta:ClearRFAcquisitionMember 2022-03-01 2022-03-31 0001649009 syta:ClearRFAcquisitionMember 2022-03-31 0001649009 syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 2022-01-01 2022-01-01 0001649009 2022-01-01 0001649009 syta:StockOptionsMember 2021-12-31 0001649009 syta:StockOptionsMember 2022-01-01 2022-12-31 0001649009 syta:StockOptionsMember 2022-12-31 0001649009 syta:RestrictedShareUnitsMember 2021-12-31 0001649009 syta:RestrictedShareUnitsMember 2022-01-01 2022-12-31 0001649009 syta:RestrictedShareUnitsMember 2022-12-31 0001649009 syta:AgentsOptionsMember 2021-12-31 0001649009 syta:AgentsOptionsMember 2022-01-01 2022-12-31 0001649009 syta:AgentsOptionsMember 2022-12-31 0001649009 syta:SharePurchaseWarrantsMember 2021-12-31 0001649009 syta:SharePurchaseWarrantsMember 2022-01-01 2022-12-31 0001649009 syta:SharePurchaseWarrantsMember 2022-12-31 0001649009 syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:TwentyFourDecemberTwoThousandEighteenMember syta:StockOptionsMember 2023-03-31 0001649009 syta:TwentyFourDecemberTwoThousandEighteenMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:FifteenJanuaryTwoThousandNineteenMember syta:StockOptionsMember 2023-03-31 0001649009 syta:FifteenJanuaryTwoThousandNineteenMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:TwentyOneMarchTwoThousandNineteenMember syta:StockOptionsMember 2023-03-31 0001649009 syta:TwentyOneMarchTwoThousandNineteenMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:OneJanuaryTwoThousandAndTwentyMember 2023-03-31 0001649009 syta:OneJanuaryTwoThousandAndTwentyMember 2023-01-01 2023-03-31 0001649009 syta:FifteenNovemberTwoThousandTwentyMember syta:StockOptionsMember 2023-03-31 0001649009 syta:FifteenNovemberTwoThousandTwentyMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:FifteenNovemberThousandTwentyOneMember syta:StockOptionsMember 2023-03-31 0001649009 syta:FifteenNovemberThousandTwentyOneMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:SecondJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2023-03-31 0001649009 syta:SecondJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:SecondJanuaryTwoThousandTwentyOneOneMember syta:StockOptionsMember 2023-03-31 0001649009 syta:SecondJanuaryTwoThousandTwentyOneOneMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:EighteenthJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2023-03-31 0001649009 syta:EighteenthJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:OneJanuaryTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-03-31 0001649009 syta:OneJanuaryTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-03-31 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-03-31 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:StockOptionsMember 2023-03-31 0001649009 syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:NineMarchTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-03-31 0001649009 syta:NineMarchTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-01-01 2023-03-31 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-03-31 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-01-01 2023-03-31 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-03-31 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-01-01 2023-03-31 0001649009 syta:RestrictedShareUnitsMember 2023-03-31 0001649009 syta:RestrictedShareUnitsMember 2023-01-01 2023-03-31 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:AgentsOptionsMember 2023-03-31 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:AgentsOptionsMember 2023-01-01 2023-03-31 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyOneMember syta:AgentsOptionsMember 2023-03-31 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyOneMember syta:AgentsOptionsMember 2023-01-01 2023-03-31 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:AgentsOptionsMember 2023-03-31 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:AgentsOptionsMember 2023-01-01 2023-03-31 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:AgentsOptionsMember 2023-03-31 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:AgentsOptionsMember 2023-01-01 2023-03-31 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoOneMember syta:AgentsOptionsMember 2023-03-31 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoOneMember syta:AgentsOptionsMember 2023-01-01 2023-03-31 0001649009 syta:AgentsOptionsMember 2023-03-31 0001649009 syta:AgentsOptionsMember 2023-01-01 2023-03-31 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:TwelveOctoberTwoThousandAndTwentyTwoMember syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:TwelveOctoberTwoThousandAndTwentyTwoMember syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:TwelveOctoberTwoThousandAndTwentyTwoTwoMember syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:TwelveOctoberTwoThousandAndTwentyTwoTwoMember syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:NineteenJanuaryTwoThousandAndTwentyThreeMember syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:NineteenJanuaryTwoThousandAndTwentyThreeMember syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:CustomerOneMember 2023-01-01 2023-03-31 0001649009 syta:CustomerOneMember 2022-01-01 2022-03-31 0001649009 syta:VPTechnologyMember 2023-01-01 2023-03-31 0001649009 syta:VPTechnologyMember 2022-01-01 2022-03-31 0001649009 syta:CEOCFOAndDirectorsMember 2023-01-01 2023-03-31 0001649009 syta:CEOCFOAndDirectorsMember 2022-01-01 2022-03-31 0001649009 country:US 2023-01-01 2023-03-31 0001649009 country:US 2022-01-01 2022-03-31 0001649009 country:CA 2023-01-01 2023-03-31 0001649009 country:CA 2022-01-01 2022-03-31 0001649009 syta:EMEAOneMember 2023-01-01 2023-03-31 0001649009 syta:EMEAOneMember 2022-01-01 2022-03-31 0001649009 country:AU 2023-01-01 2023-03-31 0001649009 country:AU 2022-01-01 2022-03-31 0001649009 country:CA 2023-03-31 0001649009 country:CA 2022-12-31 0001649009 syta:EuropeTheMiddleEastAndAfricaMember 2023-03-31 0001649009 syta:EuropeTheMiddleEastAndAfricaMember 2022-12-31 0001649009 syta:CellularBoostersAndRelatedAccessoriesMember 2023-01-01 2023-03-31 0001649009 syta:CellularBoostersAndRelatedAccessoriesMember 2022-01-01 2022-03-31 0001649009 syta:RuggedDevicesAndRelatedAccessoriesMember 2023-01-01 2023-03-31 0001649009 syta:RuggedDevicesAndRelatedAccessoriesMember 2022-01-01 2022-03-31 0001649009 syta:NonAdjustingEventMember 2023-06-23 0001649009 syta:NonAdjustingEventMember 2023-06-01 2023-06-23 0001649009 syta:NonAdjustingEventMember 2023-07-01 2023-07-13 0001649009 syta:NonAdjustingEventMember 2023-07-29 2023-08-03 0001649009 srt:ScenarioPreviouslyReportedMember 2023-06-30 0001649009 srt:RestatementAdjustmentMember 2023-06-30 0001649009 syta:AsRestatedMember 2023-06-30 0001649009 srt:ScenarioPreviouslyReportedMember 2023-01-01 2023-06-30 0001649009 srt:RestatementAdjustmentMember 2023-01-01 2023-06-30 0001649009 syta:AsRestatedMember 2023-01-01 2023-06-30 0001649009 srt:ScenarioPreviouslyReportedMember 2022-12-31 0001649009 srt:RestatementAdjustmentMember 2022-12-31 0001649009 syta:AsRestatedMember 2022-12-31 0001649009 syta:QueensgateResourcesCorpMember 2023-01-01 2023-06-30 0001649009 syta:QueensgateResourcesCorpMember 2023-06-30 0001649009 syta:QueensgateResourcesUSCorpMember 2023-01-01 2023-06-30 0001649009 syta:QueensgateResourcesUSCorpMember 2023-06-30 0001649009 syta:SiyataMobileCanadaIncMember 2023-01-01 2023-06-30 0001649009 syta:SiyataMobileCanadaIncMember 2023-06-30 0001649009 syta:SiyataMobileIsraelLtdMember 2023-01-01 2023-06-30 0001649009 syta:SiyataMobileIsraelLtdMember 2023-06-30 0001649009 syta:SignifiMobileIncMember 2023-01-01 2023-06-30 0001649009 syta:SignifiMobileIncMember 2023-06-30 0001649009 syta:ClearRFNevadaLtdMember 2023-01-01 2023-06-30 0001649009 syta:ClearRFNevadaLtdMember 2023-06-30 0001649009 srt:NorthAmericaMember 2023-04-01 2023-04-30 0001649009 2023-04-30 0001649009 2023-04-01 2023-04-30 0001649009 ifrs-full:TopOfRangeMember 2022-01-01 2022-01-11 0001649009 ifrs-full:BottomOfRangeMember 2022-01-01 2022-01-11 0001649009 2022-10-01 2022-10-31 0001649009 syta:WarrantsNov32021Member 2022-12-31 0001649009 syta:WarrantsNov32021Member 2023-01-01 2023-06-30 0001649009 syta:January112022Member 2023-01-01 2023-06-30 0001649009 syta:October122022Member 2023-01-01 2023-06-30 0001649009 syta:January192023Member 2023-01-01 2023-06-30 0001649009 syta:WarrantsNov32021Member 2023-06-30 0001649009 syta:January112022Member 2023-06-30 0001649009 syta:October122022Member 2023-06-30 0001649009 syta:January192023Member 2023-06-30 0001649009 ifrs-full:OrdinarySharesMember 2023-06-30 0001649009 syta:NonAdjustingEventMember 2023-07-25 2023-08-09 0001649009 2023-03-01 2023-03-30 0001649009 syta:WarrantsMember 2023-01-01 2023-06-30 0001649009 syta:WarrantsLiabilityMember 2023-06-30 0001649009 syta:PreFundedUnitsMember 2023-01-01 2023-06-30 0001649009 syta:OptionWarrantsMember 2023-01-01 2023-06-30 0001649009 syta:OptionWarrantsMember 2023-06-30 0001649009 syta:PlacementAgentWarrantsMember 2023-01-01 2023-06-30 0001649009 syta:PlacementAgentWarrantsMember 2023-06-30 0001649009 2022-03-01 2022-03-31 0001649009 syta:StockOptionsMember 2023-01-01 2023-06-30 0001649009 2022-04-01 2022-04-13 0001649009 2022-04-13 0001649009 2023-01-01 2023-01-12 0001649009 syta:StockOptionsMember 2023-01-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:StockOptionsMember 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:StockOptionsMember 2023-06-30 0001649009 syta:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:RestrictedShareUnitsMember 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:RestrictedShareUnitsMember 2023-06-30 0001649009 syta:AgentsOptionsMember 2020-12-31 0001649009 syta:AgentsOptionsMember 2021-01-01 2021-12-31 0001649009 syta:AgentsOptionsMember 2023-01-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:TwentyFourDecemberTwoThousandEighteenMember syta:StockOptionsMember 2023-06-30 0001649009 syta:TwentyFourDecemberTwoThousandEighteenMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:FifteenJanuaryTwoThousandNineteenMember syta:StockOptionsMember 2023-06-30 0001649009 syta:FifteenJanuaryTwoThousandNineteenMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:TwentyOneMarchTwoThousandNineteenMember syta:StockOptionsMember 2023-06-30 0001649009 syta:TwentyOneMarchTwoThousandNineteenMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:OneJanuaryTwoThousandAndTwentyMember 2023-06-30 0001649009 syta:OneJanuaryTwoThousandAndTwentyMember 2022-07-01 2023-06-30 0001649009 syta:FifteenNovemberTwoThousandTwentyMember syta:StockOptionsMember 2023-06-30 0001649009 syta:FifteenNovemberTwoThousandTwentyMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:FifteenNovemberThousandTwentyOneMember syta:StockOptionsMember 2023-06-30 0001649009 syta:FifteenNovemberThousandTwentyOneMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:SecondJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2023-06-30 0001649009 syta:SecondJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:SecondJanuaryTwoThousandTwentyOneOneMember syta:StockOptionsMember 2023-06-30 0001649009 syta:SecondJanuaryTwoThousandTwentyOneOneMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:EighteenthJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2023-06-30 0001649009 syta:EighteenthJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:OneJanuaryTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-06-30 0001649009 syta:OneJanuaryTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-06-30 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-06-30 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:NineMarchTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-06-30 0001649009 syta:NineMarchTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2022-07-01 2023-06-30 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-06-30 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2022-07-01 2023-06-30 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-06-30 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2022-07-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:RestrictedShareUnitsMember 2022-07-01 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:RestrictedShareUnitsMember 2022-07-01 2023-06-30 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:AgentsOptionsMember 2022-07-01 2023-06-30 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyOneMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyOneMember syta:AgentsOptionsMember 2022-07-01 2023-06-30 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:AgentsOptionsMember 2022-07-01 2023-06-30 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:AgentsOptionsMember 2022-07-01 2023-06-30 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoOneMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoOneMember syta:AgentsOptionsMember 2022-07-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:AgentsOptionsMember 2022-07-01 2023-06-30 0001649009 syta:AgentsOptionsMember syta:afterThe1001ReverseStockSplitMember 2023-06-30 0001649009 syta:AgentsOptionsMember syta:afterThe1001ReverseStockSplitMember 2022-07-01 2023-06-30 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2022-07-01 2023-06-30 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2023-06-30 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2022-07-01 2023-06-30 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2023-06-30 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:SharePurchaseWarrantsMember 2022-07-01 2023-06-30 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:SharePurchaseWarrantsMember 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:SharePurchaseWarrantsMember 2022-07-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:SharePurchaseWarrantsMember 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:SharePurchaseWarrantsMember 2022-07-01 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:SharePurchaseWarrantsMember 2023-06-30 0001649009 2023-01-31 0001649009 syta:WarrantLiabilityMember 2022-01-01 2022-06-30 0001649009 syta:VPTechnologyMember 2023-01-01 2023-06-30 0001649009 syta:VPTechnologyMember 2022-01-01 2022-06-30 0001649009 syta:CEOCFOAndDirectorsMember 2023-01-01 2023-06-30 0001649009 syta:CEOCFOAndDirectorsMember 2022-01-01 2022-06-30 0001649009 country:US 2023-01-01 2023-06-30 0001649009 country:US 2022-01-01 2022-06-30 0001649009 country:US 2023-04-01 2023-06-30 0001649009 country:US 2022-04-01 2022-06-30 0001649009 country:CA 2023-01-01 2023-06-30 0001649009 country:CA 2022-01-01 2022-06-30 0001649009 country:CA 2023-04-01 2023-06-30 0001649009 country:CA 2022-04-01 2022-06-30 0001649009 syta:EMEAOneMember 2023-01-01 2023-06-30 0001649009 syta:EMEAOneMember 2022-01-01 2022-06-30 0001649009 syta:EMEAOneMember 2023-04-01 2023-06-30 0001649009 syta:EMEAOneMember 2022-04-01 2022-06-30 0001649009 country:AU 2023-01-01 2023-06-30 0001649009 country:AU 2022-01-01 2022-06-30 0001649009 country:AU 2023-04-01 2023-06-30 0001649009 country:AU 2022-04-01 2022-06-30 0001649009 country:CA 2023-06-30 0001649009 country:CA 2022-12-31 0001649009 syta:EMEAOneMember 2023-06-30 0001649009 syta:EMEAOneMember 2022-12-31 0001649009 syta:CellularBoostersAndRelatedAccessoriesMember 2023-01-01 2023-06-30 0001649009 syta:CellularBoostersAndRelatedAccessoriesMember 2022-01-01 2022-06-30 0001649009 syta:CellularBoostersAndRelatedAccessoriesMember 2023-04-01 2023-06-30 0001649009 syta:CellularBoostersAndRelatedAccessoriesMember 2022-04-01 2022-06-30 0001649009 syta:RuggedDevicesAndRelatedAccessoriesMember 2023-01-01 2023-06-30 0001649009 syta:RuggedDevicesAndRelatedAccessoriesMember 2022-01-01 2022-06-30 0001649009 syta:RuggedDevicesAndRelatedAccessoriesMember 2023-04-01 2023-06-30 0001649009 syta:RuggedDevicesAndRelatedAccessoriesMember 2022-04-01 2022-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure
EX-99.2 3 ea183026ex99-2_siyata.htm RESTATED MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION FOR THE THREE MONTHS ENDED MARCH 31, 2023

Exhibit 99.2

 

 

Restated Management Discussion and Analysis 

(Expressed in U.S. Dollars)

 

As at and for the three month period ended March 31, 2023 and March 31, 2022

Prepared on August 14, 2023

 

 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This restated MD&A contains “forward-looking statements,” which includes information relating to future events, future financial performance, financial projections, strategies, expectations, competitive environment and regulation. Words such as “may,” “should,” “could,” “would,” “predicts,” “potential,” “continue,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and similar expressions, as well as statements in future tense, identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved. Forward-looking statements are based on information we have when those statements are made or management’s good faith belief as of that time with respect to future events, and are subject to significant risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to:

 

  the size and growth potential of the markets for our products, and our ability to serve those markets;

 

  the rate and degree of market acceptance of our products;

  

  our ability to expand our sales organization to address effectively existing and new markets that we intend to target;

 

  impact from future regulatory, judicial, and legislative changes or developments in the U.S. and foreign countries;

  

  our ability to compete effectively in a competitive industry;

  

  our ability to obtain funding for our operations and effectively utilize the capital raised therefrom;

  

  our ability to attract collaborators and strategic partnerships;

 

  our ability to meet the continued listing requirements and standards of the Nasdaq Capital Market, or Nasdaq;

  

  our ability to meet our financial operating objectives;

  

  the availability of, and our ability to attract, qualified employees for our business operations;

  

  general business and economic conditions;

  

  our ability to meet our financial obligations as they become due;

 

  positive cash flows and financial viability of our operations and any new business opportunities;

 

i 

 

 

  our ability to secure intellectual property rights over our proprietary products or enter into license agreements to secure the legal use of certain patents and intellectual property;

 

  our ability to be successful in new markets;

 

  our ability to avoid infringement of intellectual property rights; and

 

  the effects of the global COVID-19 pandemic and the war in Ukraine.

 

The foregoing does not represent an exhaustive list of matters that may be covered by the forward-looking statements contained herein or risk factors that we are faced with that may cause our actual results to differ from those anticipated in our forward-looking statements. Please see “Item 3. Key Information – D. Risk Factors,” “Item 4. Information on the Company,” and “Item 5. Operating and Financial Review and Prospects” for additional factors that could adversely impact our business and financial performance.

 

Moreover, new risks regularly emerge and it is not possible for our management to predict or articulate all the risks we face, nor can we assess the impact of all risks on our business or the extent to which any risk, or combination of risks, may cause actual results to differ from those contained in any forward-looking statements. All forward-looking statements included in this Annual Report are based on information available to us on the date of this Annual Report. Except to the extent required by applicable laws or rules, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained above and throughout this Annual Report.

 

Readers are urged to carefully review and consider the various disclosures made throughout this MD&A which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

 

You should not put undue reliance on any forward-looking statements. Any forward-looking statements in this restated MD&A Report are made as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

ii 

 

 

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

 

Not applicable.

 

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

 

Not applicable.

 

ITEM 3. KEY INFORMATION

 

A. [Reserved]

 

B. Capitalization and Indebtedness

 

Not applicable.

 

C. Reasons for the Offer and Use of Proceeds

 

Not applicable.

 

D. Risk Factors

 

You should carefully consider the risks described below, together with all of the other information in this Annual Report. The risks described below are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect our business operations. If any of these risks actually occurs, our business and financial condition could suffer and the price of our Common Shares and warrants to purchase Common Shares, or the Warrants, could decline.

 

Summary of Risk Factors

 

Risks Related to Our Financial Condition and Capital Requirements

 

  We have a history of operating losses and we may never achieve or maintain profitability.

 

  Our consolidated audited financial statements for the fiscal year ended December 31, 2022 and our restated unaudited condensed interim consolidated financial statements for the three month period ended March 31, 2023, both include a “going concern” explanatory paragraph expressing substantial doubt about our ability to continue as an ongoing business for the next twelve months. Our consolidated financial statements do not include any adjustments that may result from the outcome of this uncertainty. If we cannot secure the financing needed to continue as a viable business, our shareholders may lose some or all of their investment in us.

 

  In 2022, our independent registered public accountants identified three material weaknesses in our internal controls over financial reporting. If we are unable to remediate these material weaknesses, we may not be able to report our financial results accurately, prevent fraud or file our periodic reports as a public company in a timely manner. In 2021, our independent registered public accountants identified five material weaknesses in our internal controls over financial reporting, which have only been partially remediated.

 

1

 

 

Risks Related to Our Business and Industry

 

  We rely on our channel partners to generate a substantial majority of our revenues. If these channel partners fail to perform or if we cannot enter into agreements with channel partners on favorable terms, our operating results could be significantly harmed.

 

  We are materially dependent on the adoption of our solutions by both the industrial enterprise and public sector markets, and if end customers in those markets do not purchase our solutions, our revenues will be adversely impacted, and we may not be able to expand into other markets.

  

  We participate in a competitive industry, which may become more competitive. Competitors with greater resources and significant experience in high-volume product manufacturing may be able to respond more quickly and cost-effectively than we can to new or emerging technologies and changes in customer requirements.

  

  Defects in our products could reduce demand for our products and result in a loss of sales, delay in market acceptance and injury to our reputation, which would adversely impact our business.

 

  If our business does not grow as we expect, or if we fail to manage our growth effectively, our operating results and business would suffer.

 

  We may not be able to continue to develop solutions to address user needs effectively in an industry characterized by ongoing change and rapid technological advances.

 

  The markets for our devices and related accessories may not develop as quickly as we expect, or may not develop at all. Our dependence on our cellular carrier channel partners and their success in promoting Push to Talk over Cellular to their client base is key for the success of the business.

 

  Our future success is dependent on our ability to create independent brand awareness for our company and products with end customers, and our inability to achieve such brand awareness could limit our prospects.

 

  We are dependent on the continued services and performance of a concentrated group of senior management and other key personnel, the loss of any of whom could adversely impact our business.

 

  We compete in a rapidly evolving market, and the failure to respond quickly and effectively to changing market requirements could cause our business and operating results to decline.

 

  If we are unable to sell our solutions into new markets, our revenues may not grow.

 

  If we are unable to attract, integrate and retain additional qualified personnel, including top technical talent, our business could be adversely impacted.

 

  A security breach or other significant disruption of our information technology (“IT”) systems or those of our partners, suppliers or manufacturers, caused by cyberattacks or other means, could have a negative impact on our operations, sales, and operating results.

 

  We experience lengthy sales cycles for our products and the delay of an expected large order could result in a significant unexpected revenue shortfall.

 

2

 

 

  We have a limited history of contracting with third party manufacturers in Asia for the high-volume commercial production of our devices, and we may face manufacturing capacity constraints.

 

  Our financial condition and results of operations as well as those of potential customers could be adversely affected by the Russian invasion of Ukraine, which has caused a material adverse effect on the level of economic activity around the world, including in the markets we serve.

 

  We rely on industry data and projections which may prove to be inaccurate.

 

Risks Related to our Reliance on Third Parties

 

  As we work with multiple vendors for our components, if we fail to adequately forecast demand for our inventory and supply needs, we could incur additional costs or experience manufacturing delays, which could reduce our gross margin or cause us to delay or even lose sales.

 

  Our dependence on third-party suppliers for key components of our products could delay shipment of our products and reduce our sales.

 

  Because we rely on a small number of channel partners/customers for a large portion of our revenue, the loss of any of these customers would have a material adverse effect on our operating results and cash flows.
     
  The application development ecosystem supporting our devices and related accessories is new and evolving.

 

  Failure of our suppliers, subcontractors, distributors, resellers, and representatives to use acceptable legal or ethical business practices, or to fail for any other reason, could negatively impact our business.

 

  Our products are subject to risks associated with sourcing and manufacturing.

 

  The nature of our business may result in undesirable press coverage or other negative publicity, which would adversely impact our brand identity, future sales and results of operations.

 

  Changes in the availability of federal funding to support local public safety or other public sector efforts could impact our opportunities with public sector end customers.

 

  Economic uncertainties or downturns, or political changes, could limit the availability of funds available to our customers and potential customers, which could significantly adversely impact our business.

 

  Natural or man-made disasters and other similar events may significantly disrupt our business, and negatively impact our operating results and financial condition.

 

  We are exposed to risks associated with strategic acquisitions and investments.

 

  We could be adversely impacted by changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters.

 

3

 

 

Risks Related to Government Regulation

 

  We are subject to anti-corruption, anti-bribery, anti-money laundering, economic sanctions, export control, and similar laws. Non- compliance with such laws can subject us to criminal or civil liability and harm our business, revenues, financial condition and results of operations.

 

  We are subject to a wide range of product regulatory and safety, consumer, worker safety and environmental laws and regulations.

 

  Changes in laws and regulations concerning the use of telecommunication bandwidth could increase our costs and adversely impact our business.

 

  We are subject to a wide range of privacy and data security laws, regulations and other legal obligations.

 

Risks Related to Our Intellectual Property

 

  If we are unable to successfully protect our intellectual property, our competitive position may be harmed.

 

  Others may claim that we infringe on their intellectual property rights, which may result in costly and time-consuming litigation and could delay or otherwise impair the development and commercialization of our products.

 

  Our use of open source software could subject us to possible litigation or otherwise impair the development of our products.

  

  Our inability to obtain and maintain any third-party license required to develop new products and product enhancements could seriously harm our business, financial condition and results of operations.

 

Risks Related to our Locations in Israel and Canada and Our International Operations

 

  Conditions in Israel could materially and adversely affect our business.

 

  It may be difficult to enforce a U.S. judgment against us, our officers and directors named herein in Israel or the United States, or to assert U.S. securities laws claims in Israel or serve process on our officers and directors.

 

  Because we are a corporation incorporated in British Columbia and some of our directors and officers are resident in Canada, it may be difficult for investors in the United States to enforce civil liabilities against us based solely upon the federal securities laws of the United States. Similarly, it may be difficult for Canadian investors to enforce civil liabilities against our directors and officers residing outside of Canada.

 

  We have operations in China, which exposes us to risks inherent in doing business there.

 

  The impact of potential changes in customs, tariffs, and trade policies in the United States and the potential corresponding actions by other countries, in which we do business could adversely impact our financial performance.

 

  Operating outside of the United States presents specific risks to our business, and we have substantial operations outside of the United States.

 

  Foreign currency fluctuations may reduce our competitiveness and sales in foreign markets.

 

4

 

 

Risks Related to Ownership of Our Securities

 

  We may require additional capital to fund our business and support our growth, and our inability to generate and obtain such capital on acceptable terms, or at all, could harm our business, operating results, financial condition and prospects. In addition, such funding may dilute our existing shareholders.

 

  We expect that our stock price will fluctuate significantly, and you may not be able to resell your shares at or above the public offering price you paid for your shares.

 

  The conversion of the Lind Partner Note and the exercise of the Lind Partner Warrant or future sales of our Common Shares may further dilute the Common Shares and adversely impact the price of our Common Shares.

 

  If we are not able to comply with the applicable continued listing requirements or standards of Nasdaq, Nasdaq could delist our Common Shares and Warrants which could negatively impact the price of our securities and an investor’s ability to sell them. We have until August 21, 2023 to regain compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”), resulting from the fact that the closing bid price of the Company’s Common Shares, no par value per share, was below $1.00 per share for a period of 30 consecutive business days.

 

  If our Common Shares become subject to the penny stock rules, it may be more difficult to sell our Common Shares.

 

  If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis could be impaired.

 

  We will continue to incur significant increased costs as a result of operating as a public company in the United States, and our management will be required to devote substantial time to new compliance initiatives.

 

  Because we are a foreign private issuer and are exempt from certain Nasdaq corporate governance standards applicable to U.S. issuers, you will have less protection than you would have if we were a domestic issuer.

 

  We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.

 

  We will continue to incur significant increased costs as a result of operating as a public company in the United States, and our management will be required to devote substantial time to new compliance initiatives.

 

  Our executive officers and directors, and their affiliated entities, along with our two other largest stockholders, own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.

 

  The exercise of the outstanding warrants may further dilute the Common Shares and adversely impact the price of our Common Shares.

  

  The market for our Common Shares may not provide investors with adequate liquidity.

 

  Since we do not expect to pay any cash dividends for the foreseeable future, investors in our common shares may be forced to sell their stock in order to obtain a return on their investment.

 

5

 

 

  If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.

 

  A possible “short squeeze” due to a sudden increase in demand of our Common Shares that largely exceeds supply may lead to price volatility in our Common Shares.

 

  The Company is presently under a cease trading order with the British Columbia Securities Commission, for late filing of the Company’s three month ended March 31, 2023 financial statements.

 

  The Company has received a notice from NASDAQ that the Company is in default of maintaining a minimum bid price of $1.00 per share. In the event this is not rectified by August 21, 2023, the Company will be de-listed from NASDAQ exchange.

 

Risks Related to Our Financial Position and Capital Requirements

 

We have a history of operating losses and we may never achieve or maintain profitability.

 

We have a limited operating history and a history of losses from operations. As of March 31, 2023 the restated accumulated deficit of $82,696,662. Our existing cash and cash equivalents will be insufficient to fully fund our business plan. Our ability to achieve profitability will depend on whether we can obtain additional capital when we need it, complete the development of our technology, obtain required regulatory approvals and continue to develop arrangements with channel partners. There can be no assurance that we will ever achieve profitability.

 

Our independent registered public accounting firm, in its report on our financial statements for the year ended December 31, 2022, concurs with management representation that raises substantial doubt about our ability to continue as a going concern.

 

We may require additional capital to fund our business and support our growth, and our inability to generate and obtain such capital on acceptable terms, or at all, could harm our business, operating results, financial condition and prospects.

 

We intend to continue to make substantial investments to fund our business and support our growth. In addition, we may require additional funds to respond to business challenges, including the need to develop new features or enhance our solutions, improve our operating infrastructure or acquire or develop complementary businesses and technologies. As a result, in addition to the revenues we generate from our business, we may need to engage in additional equity or debt financings to provide the funds required for these and other business endeavors. If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our Common Shares. Any debt financing that we may secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain such additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and to respond to business challenges could be significantly impaired, and our business may be adversely impacted. In addition, our inability to generate or obtain the financial resources needed may require us to delay, scale back, or eliminate some or all of our operations, which may have a significant adverse impact on our business, operating results and financial condition.

 

6

 

 

Our independent registered public accountants have noted that we may not survive as a going concern.

 

Our independent registered public accountants have included a “going concern” explanatory paragraph in its report on our consolidated financial statements for the fiscal year ended December 31, 2022, concurring with management representation of expressing substantial doubt about our ability to continue as an ongoing business for the next twelve months. Our consolidated financial statements do not include any adjustments that may result from the outcome of this uncertainty. If we cannot secure the financing needed to continue as a viable business, our shareholders may lose some or all of their investment in us. 

 

Our independent registered public accountants have identified material weaknesses in our internal controls over financial reporting in both 2022 and 2021. If we are unable to remediate these material weaknesses, we may not be able to report our financial results accurately, prevent fraud or file our periodic reports as a public company in a timely manner.

 

In connection with the audit of our consolidated financial statements for the years ended December 31, 2022 and 2021, our independent registered public accountants identified several material weaknesses in our internal control over financial reporting. A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

 

In 2022, our independent registered public accountants identified the following material weaknesses in our internal control over financial reporting. The first material weakness related to our revenue recognition practices where we do not sufficiently review (i) product returns in relation to product sales and (ii) for title transfer terms to determine when revenue should be recorded. The second material weakness related to insufficient documentation of inventory controls relating to our inventory balances, advances to suppliers, and off-site inventory tracking is limited. The third material weakness related to internal control weaknesses in the capitalization and coordination of development costs to prevent excess payments and erroneously recorded invoices.

 

For the material weaknesses identified in our 2022 audit, we have taken steps to remediate these material weaknesses, and to further strengthen our accounting staff and internal controls, as detailed below:

 

  With respect to the revenue recognition practices, management will consistently apply of IFRS15 with respect to the five criterion for revenue recognition, In addition, management will institute peer review of North American sales by the Israeli subsidiary’s chief financial officer and peer review by Company’s Chief Financial Officer of Israeli sales recognition policy on a quarterly basis and engage in dialogue on new customers to ensure the revenue recognition policy and the customer contracts are consistently applied.

 

  With respect to the inventory control weaknesses, management will institute the following remediation procedures:

 

  Monthly comparison of inventory first and last cost in USD$ between periods to note any changes and to investigate the reason for these discrepancies to provide a more accurate quantum of write downs and consistent costing.

 

  The implementation of an IT system to track the inventory movements in North America;

 

  Monthly comparison of inventory units between periods to note any changes and to investigate the reason for any inconsistencies.

 

  Obtain confirmation of goods in transit with external vendors and consignment customers on a more timely basis.

 

7

 

 

  With respect to the development cost weaknesses, the research and development team will be required to approve all invoices from the R&D sub-contractor and ensure they fall within the budget to ensure the amounts capitalized are not in excess of the original budget with its discounted cash flows. Once the R&D team has approved the invoice based on the above criteria, the Company’s Chief Executive Officer will review the documentation and once approved, will forward said documentation to the Company’s Chief Financial Officer in Canada for wire initiation.

 

In 2021, our independent registered public accountants identified the following material weaknesses in our internal control over financial reporting. The first material weakness related to the insufficient review of inventory balances for products which are slow-moving. The second material weakness related to the insufficient review of advances to suppliers on products that are no longer selling, the third material weakness relates to insufficient controls surrounding off-site inventory tracking. The fourth material weakness related to insufficient review whether product returns relate to sales recorded in the fiscal year. The fifth material weakness relates to insufficient review of title transfer terms to determine the period in which revenue should be recorded.

 

For the material weaknesses identified in our 2021 audit, we have taken steps to remediate these material weaknesses, and to further strengthen our accounting staff and internal controls, as detailed below:

 

  On a quarterly basis, the Company now reviews inventory on hand for slow moving merchandise and reviews inventory on hand regularly. For the year ended 2021, it was determined that $4,659,648 (2020- $1,571,649) of the inventory was impaired due to slow movement. The accessories and spare parts related to these products amounted to $839,693 (2020 - $316,000), which was also impaired.

 

  The Company now reviews quantities on hand before approving purchase orders.

 

  As of April 1, 2022, the Company signed a lease for their own exclusive warehouse space so that outside contract warehouses will not be required.

 

  The Company now reviews product returns to compare and ensure that they occur in the same fiscal year.

 

  The Company’s controller scrutinizes all revenues earned in the period to ensure compliance with IFRS15.

 

  The Company’s controller and CFO in Canada coordinates full scheduling of the year end process to ensure timely close off of accounting periods.

 

To date, we have only partially remediated the material weaknesses identified in 2022 and 2021 above. We cannot be certain that other material weaknesses and control deficiencies will not be discovered in the future. If our efforts are not successful or other material weaknesses or control deficiencies occur in the future, we may be unable to report our financial results accurately on a timely basis or help prevent fraud, which could cause our reported financial results to be materially misstated and result in the loss of investor confidence or delisting and cause the market price of our Common Shares to decline.

 

We began to take steps to remediate these material weaknesses and strengthen our internal control over financial reporting, including the following:

 

  (i) documenting and formally assessing our accounting and financial reporting policies and procedures; and

 

  (ii) increasing the use of third-party consultants in assessing significant accounting transactions and other technical accounting and financial reporting issues, preparing accounting memoranda addressing these issues and maintaining these memoranda in our corporate records.

  

8

 

 

While we believe that these efforts will improve our internal control over financial reporting, the implementation of these measures is ongoing and will require validation and testing of the design and operating effectiveness of internal controls over a sustained period of financial reporting cycles. We cannot assure you that the measures we have taken to date, and are continuing to implement, will be sufficient to maintain effective internal control over financial reporting. Accordingly, there could continue to be a reasonable possibility that a misstatement of our accounts or disclosures that would result in a material misstatement of our financial statements that would not be prevented or detected on a timely basis.

 

Risks Related to Our Business and Industry

  

We rely on our channel partners to generate a substantial majority of our revenues. If these channel partners fail to perform or if we cannot enter into agreements with channel partners on favorable terms, our operating results could be significantly harmed.

 

More than 50% of our revenues for the three months ended March 31, 2023 (49% of our revenues for the three month period ended March 31, 2022), were generated through sales by our channel partners, which are primarily wireless carriers who sell our devices through their sales channels. To the extent our channel partners are unsuccessful in selling or do not promote our products, or we are unable to obtain and retain a sufficient number of high-quality channel partners, our business and operating results could be significantly harmed. Our channel partners are wireless carriers who have direct and indirect sales channels which we are leveraging to get to their customers. Our wireless carrier channel partners currently include:

 

  AT&T, in the United States;

 

  FirstNet, in the United States;

  

  Verizon, in the United States;

 

  T-Mobile, in the United States;

 

  Bell Mobility, in Canada;

 

  Rogers, in Canada; and

 

  a leading global land mobile radio, or LMR, vendor and distributor in North America and international markets.

 

While these arrangements are typically long term, they generally do not contain any firm purchase volume commitments. As a result, our channel partners are not contractually obligated to purchase from us any minimum number of products. We are generally required to satisfy any and all purchase orders delivered to us within specified delivery windows, with limited exceptions (such as orders significantly in excess of forecasts). If we are unable to efficiently manage our supply and satisfy purchase orders on a timely basis to our channel partners, we may be in breach of our sales arrangements and lose potential sales. If a technical issue with any of our covered products exceeds certain present failure thresholds for the relevant performance standard or standards, the channel partner typically has the right to cease selling the product, cancel open purchase orders and levy certain monetary penalties. If our products suffer technical issues or failures following sales to our channel partners, we may be subject to significant monetary penalties and our channel partners may cease making purchase orders, which would significantly harm our business and results of operations. In addition, our channel partners retain sole discretion in which of their stocked products to offer their customers. While we may offer limited customer incentives, we generally have limited to no control over which products our channel partners decide to offer or promote, which directly impacts the number of products that our partners will purchase from us.

  

9

 

 

In addition, our channel partners may be unsuccessful in marketing, selling and supporting our solutions. They may also market, sell and support solutions that are somewhat competitive with ours, and may devote more resources to the marketing, sales and support of such products. They may have incentives to promote our competitors’ products in lieu of our products, particularly for our bigger competitors with larger volumes of orders, more diverse product offerings and a longer relationship with our generally large-scale channel partners. As a result, our channel partners may stop selling our products completely. While we employ a small direct sales force, our channel partners have significantly larger sales teams who are not contractually obligated to promote any of our devices and often have multiple competing devices in stock to offer their customers. In addition, downstream sales by our channel partners often succeed due to attractive device prices and monthly rate plans, which we do not control. In certain cases, we may promote our own devices through customer incentives, however, there can be no assurance that any such incentives would contribute to increased purchases of our products. Further, given the impact of attractive pricing on ultimate sales, we generally must offer increased promotional funding or price reductions for our more expensive products. This promotional funding or price reductions operate to reduce our margins and significantly impact our profitability.

 

New sales channel partners may take several months or more to achieve significant sales. Our channel partner sales structure could subject us to lawsuits, potential liability and reputational harm if, for example, any of our channel partners misrepresents the functionality of our products or services to their customers, or violate laws or our corporate policies.

 

If we fail to effectively manage our existing or future sales channel partners, our channel partners fail to promote our products effectively, we are unable to meet our obligations under our sales arrangements or future agreements that we may enter into with wireless carrier customers have terms that are more favorable to the customer, our business and results of operations would be harmed.

 

We are materially dependent on the adoption of our solutions by both the industrial enterprise and public sector markets, and if end customers in those markets do not purchase our solutions, our revenues will be adversely impacted, and we may not be able to expand into other markets.

 

Our revenues have been primarily in the industrial enterprise market, and we are materially dependent on the adoption of our solutions by both the industrial enterprise and public sector markets. End customers in the public sector market may remain, for reasons outside our control, tied to LMR solutions or other competitive alternatives to our devices. Sales of our products to these buyers may also be delayed or limited by these competitive conditions. If our products are not widely accepted by buyers in those markets, we may not be able to expand sales of our products into new markets, and our business, results of operations and financial condition may be adversely impacted.

 

We participate in a competitive industry, which may become more competitive. Competitors with greater resources and significant experience in high-volume product manufacturing may be able to respond more quickly and cost-effectively than we can to new or emerging technologies and changes in customer requirements.

 

We face significant competition in developing and selling our solutions. Our primary competitors in the non-rugged mobile device market include LG Corporation, Apple Inc. and Samsung Electronics Co. Ltd. Our primary competitors in the rugged mobile device market include Sonim Technologies Inc., Bullitt Mobile Ltd., and Kyocera Corporation. We also face competition from large system integrators and manufacturers of private and public wireless network equipment and devices. Competitors in this space include Harris Corporation, JVC KENWOOD Corporation, Motorola, and Tait International Limited. Within the Cellular Booster category, we have several direct competitors, including Wilson Electronics, LLC, or Wilson Electronics, Nextivity, Inc. and SureCall Company.

 

We cannot assure you that we will be able to compete successfully against current or future competitors. Increased competition in mobile computing platforms, data capture products, or related accessories and software developments may result in price reductions, lower gross profit margins, and loss of market share, and could require increased spending on research and development, sales and marketing, and customer support. Some competitors may make strategic acquisitions or establish cooperative relationships with suppliers or companies that produce complementary products, which may create additional pressures on our competitive position in the marketplace.

  

10

 

 

 Most of our competitors have longer operating histories, greater name recognition, larger customer bases and significantly greater financial, technical, sales, marketing and other resources and experience than we do. In addition, because of the higher volume of components that many of our competitors purchase from their suppliers, they are able to keep their supply costs relatively low and, as a result, may be able to recognize higher margins on their product sales than we do. Many of our competitors may also have existing relationships with the channel partners who we use to sell our products, or with our potential customers. This competition may result in reduced prices, reduced margins and longer sales cycles for our products. Our competitors may also be able to more quickly and cost-effectively respond to new or emerging technologies and changes in customer requirements. The combination of brand strength, extensive distribution channels and financial resources of the larger vendors could cause us to lose market share and could reduce our margins on our products. If any of our larger competitors were to commit greater technical, sales, marketing and other resources to our markets, our ability to compete would be adversely impacted. If we are unable to successfully compete with our competitors, our sales would suffer and as a result our financial condition will be adversely impacted.

 

Defects in our products could reduce demand for our products and result in a loss of sales, delay in market acceptance and injury to our reputation, which would adversely impact our business.

 

Complex software, as well as multiple components, displays, plastics and assemblies used in our products may contain undetected defects that are subsequently discovered at any point in the life of the product. Defects in our products may result in a loss of sales, product malfunction, delay in market acceptance and potential injuries to our customers which can bring to injury in our reputation and increased warranty costs.

 

Additionally, our software may contain undetected errors, defects or bugs. Although we have not suffered significant harm from any errors, defects or bugs to date, we may discover significant errors, defects, or bugs in the future that we may not be able to correct or correct in a timely manner. It is possible that errors, defects or bugs will be found in our existing or future software and/or hardware products and related services with the potential for delays in, or loss of market acceptance of, our products and services, diversion of our resources, injury to our reputation, increased service and warranty expenses, and payment of damages.

 

Further, errors, defects or bugs in our solutions could be exploited by hackers or could otherwise result in an actual or perceived breach of our information systems. Alleviating any of these problems could require significant expense and could cause interruptions, delays or cessation of our product licensing, which would reduce demand for our products and result in a loss of sales, delay in market acceptance and injure our reputation and could adversely impact our business, results of operations and financial condition.

   

If our business does not grow as we expect, or if we fail to manage our growth effectively, our operating results and business would suffer.

 

Our ability to successfully grow our business depends on a number of factors including our ability to:

 

  accelerate the adoption of our solutions by new end customers;

 

  expand into new vertical markets;

 

  develop and deliver new products and services;

 

  increase awareness of the benefits that our solutions offer; and

 

  expand our domestic and international footprint.

 

11

 

 

As usage of our solutions grows, we will need to continue to make investments to develop and implement new or updated solutions, software, technologies, security features and cloud-based infrastructure operations. In addition, we will need to appropriately scale our internal business systems and our services organization, including the suppliers of our products and customer support services, to serve our growing customer base. Any failure of, or delay in, these efforts could impair the performance of our solutions and reduce customer satisfaction.

 

Further, our growth could increase quickly and place a strain on our managerial, operational, financial and other resources, and our future operating results depend to a large extent on our ability to successfully manage our anticipated expansion and growth. To manage our growth successfully, we will need to continue to invest in sales and marketing, research and development, and general and administrative functions and other areas. We are likely to recognize the costs associated with these investments earlier than receiving some of the anticipated benefits, and the return on these investments may be lower, or may develop more slowly, than we expect, which could adversely impact our operating results.

 

If we are unable to manage our growth effectively, we may not be able to take advantage of market opportunities or develop new solutions or upgrades to our existing solutions, satisfy customer requirements, maintain the quality and security of our solutions or execute on our business plan, any of which could harm our business, operating results and financial condition.

 

We may not be able to continue to develop solutions to address user needs effectively in an industry characterized by ongoing change and rapid technological advances.

 

To be successful, we must adapt to rapidly changing technological and application needs by continually improving our products, as well as introducing new products and services, to address user demands.

 

Our industry is characterized by:

 

  evolving industry standards;

 

  frequent new product and service introductions;

 

  increasing demand for customized product and software solutions;

 

  rapid competitive developments;

  

  changing customer demands; and

 

  evolving distribution channels.

 

Future success will depend on our ability to effectively and economically adapt in this evolving environment. We could incur substantial costs if we must modify our business to adapt to these changes, and may even be unable to adapt to these changes.

 

The markets for our devices and related accessories may not develop as quickly as we expect, or may not develop at all. Our dependence on our cellular carrier channel partners and their success in promoting Push to Talk over Cellular to their client base is key for the success of the business.

 

Our future success is substantially dependent upon continued adoption of devices and related accessories in the industrial enterprise and public sector markets, including the transition from LMR to Push to Talk over Cellular and LTE networks. These market developments and transitions may take longer than we expect or may not occur at all, and may not be as widespread as we expect. If the market does not develop as we expect, our business, operating results and financial condition would be significantly harmed.

 

12

 

 

Our future success is dependent on our ability to create independent brand awareness for our company and products with end customers, and our inability to achieve such brand awareness could limit our prospects.

 

 We depend on wireless carriers to promote and distribute our products. While we intend to ramp up direct marketing and end-customer brand awareness initiatives in the future, our sales and marketing efforts have historically been predominantly focused on channel partners. To increase end-customer brand awareness, we intend to develop sales tools for key verticals within our target markets, increase usage of social media and expand product training efforts, among other things. As a result, we expect our sales and marketing expenses to increase in the future, primarily from increased sales personnel expenses, which will require us to cost-efficiently ramp up our sales and marketing capabilities and effectively target end customers. However, there can be no assurance that we will successfully increase our brand awareness or do so in a cost-efficient manner while maintaining market share within our existing sales channels. Our failure to establish stand-alone brand awareness with end customers of our products will leave us vulnerable to the marketing and selling success of others, including our channel partners, and these developments could have an adverse impact on our prospects. If we are unable to significantly increase the awareness of our brand and solutions with end customers in a cost-efficient manner, we will remain significantly dependent on our channel partners for sales of our products, and our business, financial condition and results of operations could be adversely impacted.

 

We are dependent on the continued services and performance of a concentrated group of senior management and other key personnel, the loss of any of whom could adversely impact our business.

 

Our future success depends in large part on the continued contributions of a concentrated group of senior management and other key personnel. In particular, the leadership of key management personnel is critical to the successful management of our company, the development of our solutions and our strategic direction. We also depend on the contributions of key technical personnel. Our senior management and key personnel are all employed on an at-will basis, which means that they could terminate their employment with us at any time, for any reason and without notice. The loss of any of our key personnel could significantly delay or prevent the achievement of our development and strategic objectives and harm our business.

 

We compete in a rapidly evolving market, and the failure to respond quickly and effectively to changing market requirements could cause our business and operating results to decline.

 

The mobile device market is characterized by rapidly changing technology, changing customer needs, evolving industry standards and frequent introductions of new products and services. In order to deliver a competitive mobile device, our solutions must be capable of operating in an increasingly complex network environment. As new wireless phones are introduced and standards in the mobile device market evolve, we may be required to modify our phones and services to make them compatible with these new products and standards. Likewise, if our competitors introduce new devices and services that compete with ours, we may be required to reposition our solutions or introduce new phones and solutions in response to such competitive pressure. We may not be successful in modifying our current devices or introducing new ones in a timely or appropriately responsive manner, or at all. If we fail to address these changes successfully, our business and operating results could be significantly harmed.

  

If we are unable to sell our solutions into new markets, our revenues may not grow.

 

Any new market into which we attempt to sell our solutions may not be receptive. Our ability to penetrate new markets depends on the quality of our solutions, the continued adoption of our public safety solution by first responders, the perceived value of our solutions as a risk management tool and our ability to design our solutions to meet the demands of our customers. If the markets for our solutions do not develop as we expect, our revenues may not grow.

 

13

 

 

Our ability to successfully face these challenges depends on several factors, including increasing the awareness of our solutions and their benefits, the effectiveness of our marketing programs, the costs of our solutions, our ability to attract, retain and effectively train sales and marketing personnel, and our ability to develop relationships with wireless carriers and other partners. If we are unsuccessful in developing and marketing our solutions into new markets, new markets for our solutions might not develop or might develop more slowly than we expect, either of which would harm our revenues and growth prospects.

  

If we are unable to attract, integrate and retain additional qualified personnel, including top technical talent, our business could be adversely impacted.

 

Our future success depends in part on our ability to identify, attract, integrate and retain highly skilled technical, managerial, sales and other personnel. We face intense competition for qualified individuals from numerous other companies, including other software and technology companies, many of whom have greater financial and other resources than we do. Some of these characteristics may be more appealing to high-quality candidates than those we have to offer. In addition, new hires often require significant training and, in many cases, take significant time before they achieve full productivity. We may incur significant costs to attract and retain qualified personnel, including significant expenditures related to salaries and benefits and compensation expenses related to equity awards, and we may lose new employees to our competitors or other companies before we realize the benefit of our investment in recruiting and training them. Moreover, new employees may not be or become as productive as we expect, as we may face challenges in adequately or appropriately integrating them into our workforce and culture. If we are unable to attract, integrate and retain suitably qualified individuals who are capable of meeting our growing technical, operational and managerial requirements on a timely basis or at all, our business will be adversely impacted.

 

Volatility or lack of positive performance in our stock price may also affect our ability to attract and retain our key employees. Many of our senior management personnel and other key employees have become, or will soon become, vested in a substantial amount of stock or stock options. Employees may be more likely to leave us if the shares they own or the shares underlying their vested options have significantly appreciated in value relative to the original purchase prices of the shares or the exercise prices of the options, or, conversely, if the exercise prices of the options that they hold are significantly above the market price of our Common Shares. If we are unable to appropriately incentivize and retain our employees through equity compensation, or if we need to increase our compensation expenses in order to appropriately incentivize and retain our employees, our business, operating results and financial condition would be adversely impacted.

 

A security breach or other significant disruption of our IT systems or those of our partners, suppliers or manufacturers, caused by cyberattacks or other means, could have a negative impact on our operations, sales, and operating results.

 

All IT systems are potentially vulnerable to damage, unauthorized access or interruption from a variety of sources, including but not limited to, cyberattacks, cyber intrusions, computer viruses, security breaches, energy blackouts, natural disasters, terrorism, sabotage, war, insider trading and telecommunication failures. A cyberattack or other significant disruption involving our IT systems or those of our outsource partners, suppliers or manufacturers could result in the unauthorized release of proprietary, confidential or sensitive information of ours or result in virus and malware installation on our devices. Such unauthorized access to, or release of, this information or other security breaches could: (i) allow others to unfairly compete with us, (ii) compromise safety or security, (iii) subject us to claims for breach of contract, tort, and other civil claims, and (iv) damage our reputation. Any or all of the foregoing could have a negative impact on our business, financial condition and results of operations.

  

14

 

 

We experience lengthy sales cycles for our products and the delay of an expected large order could result in a significant unexpected revenue shortfall.

 

The purchase of our products is often an enterprise-wide decision for prospective customers, which requires us to engage in sales efforts over an extended period of time and provide a significant level of education to prospective customers regarding the uses and benefits of such devices. Prospective customers, especially the wireless carriers that sell our products, often undertake a prolonged evaluation process that may take from several months to several years in certain cases. Consequently, if our forecasted sales from a specific customer are not realized, we may not be able to generate revenues from alternative sources in time to compensate for the shortfall. The loss or delay of an expected large order could also result in a significant unexpected revenue shortfall. Moreover, to the extent we enter into and deliver our products pursuant to significant contracts earlier than we expected, our operating results for subsequent periods may fall below expectations. We may spend substantial time, effort and money on our sales and marketing efforts without any assurance that our efforts will produce any sales. If we are unable to succeed in closing sales with new and existing customers, our business, operating results and financial condition will be harmed.

 

We have a limited history of contracting with third party manufacturers in Asia for the high-volume commercial production of our devices, and we may face manufacturing capacity constraints.

 

We have limited history and experience in contracting with third party manufacturers in Asia for the high-volume commercial production of our devices. Because of this limited production history, we face challenges in predicting our business and evaluating its prospects, which may result in breakdowns of our ability to timely supply our devices to our customers. Moreover, we face manufacturing capacity constraints that present further risks to our business. If overall demand of our devices increases in the future, we will need to expand our third party manufacturing capacity in a cost-efficient manner. Failing to meet customer demand due to our failure to successfully address these risks and challenges could adversely impact our reputation and future sales, which would significantly harm our business, results of operations and financial condition.

 

We face risks related to novel Coronavirus (COVID-19) which could significantly disrupt our research and development, operations, sales, supply chain and financial results.

 

Our business will be adversely impacted by the effects of the Novel Coronavirus (COVID-19). In addition to global macroeconomic effects, the novel Coronavirus (COVID-19) outbreak and any other related adverse public health developments will cause disruption to our operations, research and development, and sales activities. Our third-party manufacturers, third-party distributors, and our customers have been and will be disrupted by worker absenteeism, quarantines and restrictions on employees’ ability to work, office and factory closures, disruptions to ports and other shipping infrastructure, border closures, or other travel or health-related restrictions. Depending on the magnitude of such effects on our activities or the operations of our third-party manufacturers and third-party distributors, the supply of our products will be delayed, which could adversely affect our business, operations and customer relationships. In addition, the novel Coronavirus (COVID-19) or other disease outbreak will in the short-run, and may over the longer term, adversely affect the economies and financial markets of many countries, resulting in an economic downturn that will affect demand for our products and impact our operating results. There can be no assurance that any decrease in sales resulting from the novel Coronavirus (COVID-19) will be offset by increased sales in subsequent periods. Although the magnitude of the impact of the novel Coronavirus (COVID-19) outbreak on our business and operations remains uncertain, the continued spread of the novel Coronavirus (COVID-19) or the occurrence of other epidemics and the imposition of related public health measures and travel and business restrictions will adversely impact our business, financial condition, operating results and cash flows. In addition, we have experienced and will experience disruptions to our business operations resulting from quarantines, self-isolations, or other movement and restrictions on the ability of our employees to perform their jobs that may impact our ability to develop and design our products in a timely manner or meet required milestones or customer commitments.

 

Our business has not experienced any material impact from supply chain disruptions brought about by the novel Coronavirus (COVID-19) pandemic, however there is no certainty that this will continue into the future. Management is carefully monitoring the situation and is working with its partners, suppliers and manufacturers to ensure minimal impact on its business.

 

15

 

 

Our financial condition and results of operations as well as those of potential customers could be adversely affected by the Russian invasion of Ukraine, which has caused a material adverse effect on the level of economic activity around the world, including in the markets we serve.

 

In February 2022, the Russian Federation invaded Ukraine. As a result of the invasion, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus and certain of their citizens. While we currently have no customers or suppliers located in Belarus, the Russian Federation or Ukraine, nor have we experienced any supply disruptions directly related to the Russian invasion of Ukraine as we do not knowingly source any materials originating from Belarus, the Russian Federation or Ukraine, as the war in Ukraine continues or possibly escalates, this may lead to further disruption, instability and volatility in global markets and industries that could negatively impact our customers, operations and our supply chain. The impact of the conflict and related sanctions on the world economy are subject to rapid change and are difficult to predict. The war has created disruptions in the supply chain for certain of our products which, to date, has not had a substantive impact on our operations. None of our critical raw materials are sourced from, and none of our finished products are manufactured in, the sanctioned regions. We have no operations or other projects in that region.

 

We are monitoring any broader economic impact from Russia’s invasion of Ukraine and the ongoing war between the two nations, including heightened risk of cyberattacks, increased prices of fuel and other commodities, and potential impacts to our partners’ supply chains. Our financial condition, results of operations, and cash flows may be materially adversely affected, but the specific impact on our financial condition, results of operations, and cash flows is currently difficult to determine.

 

We rely on industry data and projections which may prove to be inaccurate.

 

We obtained statistical data, market data and other industry data and forecasts used in this prospectus from market research, publicly available information and industry publications. These industry data, including the vehicle communications industry, include projections that are based on a number of assumptions which have been derived from industry and government sources which we believe to be reasonable. The vehicle communications industry may not grow at the rate projected by industry data, or at all. The failure of the industry to grow as anticipated is likely to have a material adverse effect on our business and the market price of our Common Shares. In addition, the rapidly changing nature of the vehicle communications industry subjects any projections or estimates relating to the growth prospects or future condition of our industries to significant uncertainties. Furthermore, if any one or more of the assumptions underlying the industry data turns out to be incorrect, actual results may, and are likely to, differ from the projections based on these assumptions. While we believe that the statistical data, industry data and forecasts and market research are reliable, we have not independently verified the data.

 

16

 

 

Risks Related to our Reliance on Third Parties

 

As we work with multiple vendors for our components, if we fail to adequately forecast demand for our inventory and supply needs, we could incur additional costs or experience manufacturing delays, which could reduce our gross margin or cause us to delay or even lose sales.

 

Because our production volumes are based on a forecast of channel partner demand rather than purchase commitments from our major customers, there is a risk that our forecasts could be inaccurate and that we will be unable to sell our products at the volumes and prices we expect, which may result in excess inventory. We provide, and will continue to provide, forecasts of our demand to our third-party suppliers prior to the scheduled delivery of products to our channel partners. If we overestimate our requirements, our contract manufacturers may have excess component inventory, which could increase our costs. If we underestimate our requirements, our contract manufacturers may have inadequate component inventory, which could interrupt the manufacturing of our products and result in delays in shipments and revenues or even lost sales, or could incur unplanned overtime costs to meet our requirements, resulting in significant cost increases. For example, certain materials and components used to manufacture our products may reach end of life during any of our product’s life cycles, following which suppliers no longer provide such expired materials and components. This would require us to either source and qualify an alternative component, which could require a re-certification of the device by the wireless carriers and/or regulatory agencies, or forecast product demand for a final purchase of such materials and components that may reach end of life to ensure that we have sufficient product inventory through a product’s life cycle. If we overestimate forecasted demand, we would hold excess end-of-life materials and components resulting in increased costs. If we underestimate forecasted demand, we could experience delays in shipments and loss of revenues.

  

In addition, if we underestimate our requirements and the applicable supplier becomes insolvent or is no longer able to timely supply our needs in a cost-efficient manner or at all, we may be required to acquire components, which may need to be customized for our products, from alternative suppliers, including at significantly higher costs. If we cannot source alternative suppliers and/or alternative components, we may suffer delays in shipments or lost sales. Similarly, credit constraints at our suppliers could require us to accelerate payment of our accounts payable, impacting our cash flow. Further, lead times for materials and components that we order vary significantly and depend on factors such as the specific supplier, contract terms, customization needed for any particular component and demand for each component at a given time. Any such failure to accurately forecast demand and manufacturing and supply requirements, and any need to obtain alternative supply sources, could materially harm our business, results of operations and financial condition.

 

Our dependence on third-party suppliers for key components of our products could delay shipment of our products and reduce our sales.

 

We depend on certain suppliers for the delivery of components used in the assembly of our products. Our reliance on third-party suppliers creates risks related to our potential inability to obtain an adequate supply of components and reduced control over pricing and timing of delivery of components. In particular, we have little to no control over the prices at which our suppliers sell materials and components to us. Certain supplies of our components are available only from a single source or limited sources and we may not be able to diversify sources in a timely manner. We have experienced shortages in the past that have negatively impacted our results of operations and may experience such shortages in the future.

 

We also do not have long-term supply agreements with any of our suppliers. Our current contracts with certain suppliers may be cancelled or not extended by such suppliers and, therefore, do not afford us with sufficient protection against a reduction or interruption in supplies. Moreover, in the event any of these suppliers breach their contracts with us, our legal remedies associated with such a breach may be insufficient to compensate us for any damages we may suffer.

 

Any interruption of supply for any material components of our products, or inability to obtain required components from our third-party suppliers, could significantly delay the production and shipment of our products and harm our revenues, profitability and financial condition.

  

17

 

 

Because we rely on a small number of channel partners/customers for a large portion of our revenue, the loss of any of these customers would have a material adverse effect on our operating results and cash flows.

 

For our three month period ended March 31, 2023, we derived 50% of our revenue from five customers/channel partners. Any termination of a business relationship with, or a significant sustained reduction in business from, one or more of these channel partners/customers could have a material adverse effect on our operating results and cash flows.

 

If dedicated public safety LTE networks are not deployed at the rate we anticipate or at all, demand for our solutions may not grow as expected.

 

A key part of our strategy is to further expand the use of our solutions over dedicated LTE networks in the public safety market. If the deployment of dedicated LTE networks is delayed or such networks are not adopted at the rate we anticipate, demand for our solutions may not develop as we anticipate, which would have a negative effect on our revenues.

 

The application development ecosystem supporting our devices and related accessories is new and evolving.

 

The application development ecosystem supporting our devices and related accessories is new and evolving. Specifically, the number of application developers in the ecosystem supporting our devices and accessories is small. If the market or the application development ecosystem does not develop, timely or at all, demand for our products may be limited, and our business and results of operations will be significantly harmed.

 

Failure of our suppliers, subcontractors, distributors, resellers, and representatives to use acceptable legal or ethical business practices, or to fail for any other reason, could negatively impact our business.

 

We do not control the labor and other business practices of our suppliers, subcontractors, distributors, resellers and third-party sales representatives, or TPSRs, and cannot provide assurance that they will operate in compliance with applicable rules, and regulations regarding working conditions, employment practices, environmental compliance, anti-corruption, and trademark a copyright and patent licensing. If one of our suppliers, subcontractors, distributors, resellers, or TPSRs violates labor or other laws or implements labor or other business practices that are regarded as unethical, the shipment of finished products to us could be interrupted, orders could be cancelled, relationships could be terminated, and our reputation could be damaged. If one of our suppliers or subcontractors fails to procure the necessary license rights to trademarks, copyrights or patents, legal action could be taken against us that could impact the saleability of our products and expose us to financial obligations to a third party. Any of these events could have a negative impact on our sales and results of operations.

 

Moreover, any failure of our suppliers, subcontractors, distributors, resellers and TPSRs, for any reason, including bankruptcy or other business disruption, could disrupt our supply or distribution efforts and could have a negative impact on our sales and results of operations.

 

Our products are subject to risks associated with sourcing and manufacturing.

 

We do not own or operate any of the manufacturing facilities for our products and rely on a concentrated number of independent suppliers to manufacture all of the products we sell. For our business to be successful, our suppliers must provide us with quality products in substantial quantities, in compliance with regulatory requirements, at acceptable costs and on a timely basis. Our ability to obtain a sufficient selection or volume of merchandise on a timely basis at competitive prices could suffer as a result of any deterioration or change in our supplier relationships or events that adversely affect our suppliers.

 

18

 

 

There can be no assurance we will be able to detect, prevent or fix all defects that may affect our products manufactured by our suppliers. Failure to detect, prevent or fix defects, or the occurrence of real or perceived quality or safety problems or material defects in our current and future products, could result in a variety of consequences, including a greater number of product returns than expected from customers and our wholesale partners, litigation, product recalls and credit, warranty or other claims, among others, which could harm our brand, results of operations and financial condition. Such problems could hurt our brand image, which is critical to maintaining and expanding our business. Any negative publicity or lawsuits filed against us related to the perceived quality and safety of our products could harm our brand and decrease demand for our products.

 

If one or more of our significant suppliers were to sever their relationship with us or significantly alter the terms of our relationship, including due to changes in applicable trade policies, we may not be able to obtain replacement products in a timely manner, which could have a material adverse effect on our business, results of operations and financial condition.

  

In addition, if any of our primary suppliers fail to make timely shipments, do not meet our quality standards or otherwise fail to deliver us product in accordance with our plans, there could be a material adverse effect on our results of operations.

 

Our contractors and suppliers buy raw materials and are subject to wage rates that are oftentimes regulated by the governments of the countries in which our products are manufactured. The raw materials used to manufacture our products are subject to availability constraints and price volatility. There could be a significant disruption in the supply of raw materials from current sources or, in the event of a disruption, our suppliers might not be able to locate alternative suppliers of materials of comparable quality at an acceptable price or at all. Our business is dependent upon the ability of our unaffiliated suppliers to locate, train, employ and retain adequate personnel. Our unaffiliated suppliers have experienced, and may continue to experience in the future, unexpected increases in work wages, whether government-mandated or otherwise. Our suppliers may increase their pricing if their raw materials became more expensive. Our suppliers may pass the increase in sourcing costs to us through price increases, thereby impacting our margins. Material changes in the pricing practices of our suppliers could negatively impact our profitability.

 

In addition, we cannot be certain that our unaffiliated suppliers will be able to fill our orders in a timely manner. If we experience significant increases in demand, or reductions in the availability of materials, or need to replace an existing supplier, there can be no assurance additional supplies of raw materials or additional manufacturing capacity will be available when required on terms acceptable to us, or at all, or that any supplier would allocate sufficient capacity to us in order to meet our requirements. In addition, even if we are able to expand existing or find new manufacturing or sources of materials, we may encounter delays in production and added costs as a result of the time it takes to train suppliers in our methods, products, quality control standards and labor, health and safety standards. Any delays, interruption or increased costs in labor or wages, or the supply of materials or manufacture of our products, could have an adverse effect on our ability to meet wholesale partner and customer and consumer demand for our products and result in lower revenue and net income both in the short and long term.

 

Events that adversely impact our suppliers could impair our ability to obtain adequate and timely supplies. Such events include, among others, difficulties or problems associated with our suppliers’ business, the financial instability and labor problems of suppliers, merchandise quality and safety issues, natural or man-made disasters, inclement weather conditions, war, acts of terrorism and other political instability, economic conditions, transportation delays and shipment issues. Our suppliers may be forced to reduce their production, shut down their operations or file for bankruptcy. Our suppliers may consolidate, increasing their market power. The occurrence of one or more of these events could impact our ability to get products to our customers and/or wholesale partners, result in disruptions to our operations, increase our costs and decrease our profitability.

 

19

 

 

Global sourcing and foreign trade involve numerous factors and uncertainties beyond our control, including:

 

increased shipping costs;

 

  the imposition of additional import or trade restrictions;

 

  legal or economic restrictions on overseas suppliers’ ability to produce and deliver products;

 

  increased custom duties and tariffs;

 

  unforeseen delays in customs clearance of goods;

 

  more restrictive quotas;

 

  loss of a most favored nation trading status;

 

  currency exchange rates;

 

  transportation delays;

 

  port of entry issues; and

 

  foreign government regulations, political instability and economic uncertainties in the countries from which we or our suppliers source our products.

  

Our sourcing operations may also be hurt by health concerns regarding the outbreak of viruses, widespread illness, infectious diseases, contagions and the occurrence of unforeseen epidemics (including the outbreak of the novel Coronavirus (Covid-19) and its potential impact on our financial results) in countries in which our merchandise is produced. Moreover, negative press or reports about internationally manufactured products may sway public opinion, and thus customer confidence, away from our products. Furthermore, changes in U.S. trade policies, including new restrictions, tariffs or other changes could lead to additional costs, delays in shipments, embargos and other uncertainties that could negatively impact our relationships with our international suppliers and materially adversely affect our business. These and other issues affecting our international suppliers or internationally manufactured merchandise could have a material adverse effect on our business, results of operations and financial condition.

  

In addition, some of our suppliers may not have the capacity to supply us with sufficient merchandise to keep pace with our growth plans, especially if we need significantly greater amounts of inventory. In such cases, our ability to pursue our growth strategy will depend in part upon our ability to develop new supplier relationships.

 

The nature of our business may result in undesirable press coverage or other negative publicity, which would adversely impact our brand identity, future sales and results of operations.

 

Our solutions are used to assist law enforcement and other public safety personnel in situations involving public safety. The incidents in which our solutions are deployed may involve injury, loss of life and other negative outcomes, and such events are likely to receive negative publicity. Such negative publicity could have an adverse impact on new sales or renewals or expansions of coverage areas by existing customers, which would adversely impact our financial results and business.

 

20

 

 

Changes in the availability of federal funding to support local public safety or other public sector efforts could impact our opportunities with public sector end customers.

 

Many of our public sector end customers rely to some extent on funds from the U.S. federal government in order to purchase and pay for our solutions. Any reduction in federal funding for local public safety or other public sector efforts could result in our end customers having less access to funds required to continue, renew, expand or pay for our solutions. For example, changes in policies with respect to “sanctuary cities” may result in a reduction in federal funds available to our current or potential end customers. Additionally, any future U.S. government shutdowns could result in delayed public safety spending or re-allocation of funding into other areas of public safety. If federal funding is reduced or eliminated and our end customers cannot find alternative sources of funding to purchase our solutions, our business will be harmed.

 

Economic uncertainties or downturns, or political changes, could limit the availability of funds available to our customers and potential customers, which could significantly adversely impact our business.

 

Current or future economic uncertainties or downturns could adversely impact our business and operating results. Negative conditions in the general economy both in the United States and abroad, including conditions resulting from changes in gross domestic product growth, inflation, changes in general interest rates, decisions of central banks, financial and credit market fluctuations, political deadlock, natural catastrophes, warfare and terrorist attacks in North America, Europe, the Asia Pacific region or elsewhere, could cause a decrease in funds available to our customers and potential customers and negatively affect the growth rate of our business.

 

These economic conditions may make it extremely difficult for our customers and us to forecast and plan future budgetary decisions or business activities accurately, and they could cause our customers to re-evaluate their decisions to purchase our solutions, which could delay and lengthen our sales cycles or result in cancellations of planned purchases. Furthermore, during challenging economic times or as a result of political changes, our customers may tighten their budgets and face constraints in gaining timely access to sufficient funding or other credit, which could result in an impairment of their ability to make timely payments to us. In turn, we may be required to increase our allowance for doubtful accounts, which would adversely impact our financial results.

 

We cannot predict the timing, strength or duration of any economic slowdown, instability or recovery, generally or within any particular industry, or the impact of political changes. If the economic conditions of the general economy or industries in which we operate worsen from present levels, or if recent political changes result in less funding being available to purchase our solutions, our business, operating results and financial condition could be adversely impacted. 

 

Natural or man-made disasters and other similar events may significantly disrupt our business, and negatively impact our operating results and financial condition.

 

Any of our facilities may be harmed or rendered inoperable by natural or man-made disasters, including earthquakes, tornadoes, hurricanes, wildfires, floods, nuclear disasters, acts of terrorism or other criminal activities, infectious disease outbreaks, and power outages, which may render it difficult or impossible for us to operate our business for some period of time. Our facilities would likely be costly to repair or replace, and any such efforts would likely require substantial time. Any disruptions in our operations could negatively impact our business and operating results, and harm our reputation. In addition, we may not carry business insurance or may not carry sufficient business insurance to compensate for losses that may occur. Any such losses or damages could have a significant adverse impact on our business, operating results and financial condition. In addition, the facilities of significant vendors may be harmed or rendered inoperable by such natural or man-made disasters, which may cause disruptions, difficulties or significant adverse impact on our business.

 

21

 

 

We are exposed to risks associated with strategic acquisitions and investments.

 

We may consider strategic acquisitions of companies with complementary technologies or intellectual property in the future. Acquisitions hold special challenges in terms of successful integration of technologies, products, services and employees. We may not realize the anticipated benefits of these acquisitions or the benefits of any other acquisitions we have completed or may complete in the future, and we may not be able to incorporate any acquired services, products or technologies with our existing operations, or integrate personnel from the acquired businesses, in which case our business could be harmed.

 

Acquisitions and other strategic decisions involve numerous risks, including:

 

  problems integrating and divesting the operations, technologies, personnel, services or products over geographically disparate locations;

 

  unanticipated costs, taxes, litigation and other contingent liabilities;

 

  continued liability for discontinued businesses and pre-closing activities of divested businesses or certain post-closing liabilities which we may agree to assume as part of the transaction in which a particular business is divested;

 

  adverse impacts on existing business relationships with suppliers and customers;

 

  cannibalization of revenues as customers may seek multi-product discounts;

 

  risks associated with entering into markets in which we have no, or limited, prior experience;

 

  incurrence of significant restructuring charges if acquired products or technologies are unsuccessful;

 

  significant diversion of management’s attention from our core business and diversion of key employees’ time and resources;

 

  licensing, indemnity or other conflicts between existing businesses and acquired businesses;

 

  inability to retain key customers, distributors, suppliers, vendors and other business relations of the acquired business; and

 

  potential loss of our key employees or the key employees of an acquired organization or as a result of discontinued businesses.

 

Financing for future acquisitions may not be available on favorable terms, or at all. If we identify an appropriate acquisition candidate for any of our businesses, we may not be able to negotiate the terms of the acquisition successfully, finance the acquisition or integrate the acquired business, products, service offerings, technologies or employees into our existing business and operations. Future acquisitions and divestitures may not be well-received by the investment community, which may cause the value of our stock to fall. We cannot ensure that we will be able to identify or complete any acquisition, divestiture or discontinued business in the future. Further, the terms of our indebtedness constrain our ability to make and finance additional acquisitions or divestitures.

 

22

 

 

If we acquire businesses, new products, service offerings or technologies in the future, we may incur significant acquisition-related costs. In addition, we may be required to amortize significant amounts of finite-lived intangible assets and we may record significant amounts of goodwill or indefinite-lived intangible assets that would be subject to testing for impairment. We have in the past and may in the future be required to write off all or part of the intangible assets or goodwill associated with these investments that could harm our operating results. If we consummate one or more significant future acquisitions in which the consideration consists of stock or other securities, our existing stockholders’ ownership could be significantly diluted. If we were to proceed with one or more significant future acquisitions in which the consideration included cash, we could be required to use a substantial portion of our cash and investments. Acquisitions could also cause operating margins to fall depending on the businesses acquired.

 

Our strategic investments may involve joint development, joint marketing, or entry into new business ventures, or new technology licensing. Any joint development efforts may not result in the successful introduction of any new products or services by us or a third party, and any joint marketing efforts may not result in increased demand for our products or services. Further, any current or future strategic acquisitions and investments by us may not allow us to enter and compete effectively in new markets or enhance our business in our existing markets and we may have to impair the carrying amount of our investments.

 

We could be adversely impacted by changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters.

 

International Financial Reporting Standards and related accounting pronouncements, implementation guidelines, and interpretations with regard to a wide range of matters that are relevant to our businesses, including, but not limited to, revenue recognition, asset impairment, inventories, customer rebates and other customer consideration, tax matters, and litigation and other contingent liabilities are highly complex and involve many subjective assumptions, estimates and judgments. Changes in these rules or their interpretation or changes in underlying assumptions, estimates or judgments could significantly change our reported or expected financial performance or financial condition. New accounting guidance may also require systems and other changes that could increase our operating costs and/or change our financial statements. For example, implementing future accounting guidance related to revenue, accounting for leases and other areas could require us to make significant changes to our accounting systems, impact existing debt agreements and result in adverse changes to our financial statements.

 

Risks Related to Government Regulation

 

The impact of potential changes in customs, tariffs, and trade policies in the United States and the potential corresponding actions by other countries, including recent trade initiatives announced by the U.S. presidential administration against China, in which we do business could adversely impact our financial performance.

 

The U.S. government has made proposals that are intended to address trade imbalances, which include encouraging increased production in the United States. These proposals could result in increased customs duties and tariffs, and the renegotiation of some U.S. trade agreements. We import a significant percentage of our products into the United States, and an increase in customs duties and tariffs with respect to these imports could negatively impact our financial performance. If such customs duties and tariffs are implemented, it also may cause U.S. trading partners to take actions with respect to U.S. imports or U.S. investment activities in their respective countries. Any potential changes in trade policies in the United States and the potential corresponding actions by other countries in which we do business could adversely impact our financial performance. Given the level of uncertainty over which provisions will be enacted, we cannot predict with certainty the impact of the proposals.

 

23

 

 

For example, in 2018, the U.S. presidential administration and Chinese government imposed significant tariffs on exports between the two countries. This evolving policy dispute between China and the United States is likely to have significant impact on the industries in which we participate, directly and indirectly, and no assurance can be given that any individual customer or significant groups of companies or a particular industry, will not be adversely impacted by any governmental actions taken by either China or the United States. In addition, we manufacture our mobile phones at our facility in Shenzhen, China, which could result in significant additional costs to us when shipping our products to various customers in the United States. It is not possible to predict with any certainty the outcome of the trade dispute between the United States and China, and prolonged or increased tariffs on imports from China to the United States would adversely impact our business, results of operations and financial condition.

 

In 2020, a Phase One trade agreement was signed imposing specific targets for Chinese purchases of various exports from the United States. These ambitious commitments specified numerical targets in U.S. goods and services exports to China for increases of $77 billion in 2020 and $123 billion in 2021 from the 2017 baseline. The Phase One agreement also imposed numerous tariffs on a variety of goods including but not limited to imports from China along with steel and aluminum imports from across the world, creating an upward pressure on prices in the United States. These tariffs currently impact over $350 billion of imports and exports and increase consumer costs by roughly $51 billion annually based on 2021 import levels. The uncertainty of the Phase One deal, unilaterally imposed in 2020 and substantially still in effect today, lie in their conditions. For instance, Section 301 enables the president to impose tariffs or quotas wherever the United States Trade Representative (USTR) finds that other nations are engaging in unfair trade practices and Section 232 allows the president to impose trade barriers if the Department of Commerce finds that imports threaten U.S. national security. The Company will be unable to pre-empt decisions of this nature, and as such, the risks and consequences which accompany them.

 

In 2021, the U.S. presidential administration signed Executive Order 14017 into order, assessing vulnerabilities in four priority product areas: semiconductors, large capacity batteries, critical minerals and materials, and pharmaceuticals and active pharmaceutical ingredients. Executive Order 14017 established an interagency Supply Chain Trade Task Force led by USTR. This task force was directed to identify foreign trade practices that the U.S. deemed unfair or otherwise determined to cause erosion to U.S. critical supply chains. The impact and decisions of this task force may cause consequential action from other trading partners, potentially impacting the Company’s financial performance.

 

Later in 2021 and into 2022, the U.S. Administration replaced the Section 232 tariffs on steel and aluminum imports from the EU with a tariff rate quota system (TRQ), replaced the Section 232 tariffs on steel imports from Japan with a TRQ (the Section 232 aluminum imports from Japan are still in effect) and, as of March 2022, replaced the Section 232 tariffs on steel and aluminum imports from the UK with a TRQ. To date, the US Administration has kept in place all of the Section 301 tariffs on Chinese imports, which might influence importers to shift away from China and reorganize supply chains or otherwise cause decreased trade altogether – both imports and exports – raising prices and reducing options for consumers and businesses in the U.S. While a number of exclusions and extensions to these tariffs exist and evolve within the current administration, retaliatory actions by other nations remain a possibility.

 

In 2022, five nations had levied retaliatory tariffs up to 70 percent on approximately $73.2 billion of U.S. exports. These tariffs do not include retaliation by Canada and Mexico; following the reversal of U.S. steel and aluminum tariffs, both Canada and Mexico withdrew their retaliatory tariffs of 7 percent to 25 percent on approximately $20 billion of U.S. exports. These tariffs also no longer include retaliation by the EU, as it cancelled its retaliatory tariffs in exchange for the United States replacing the aluminum and steel tariffs with a TRQ for EU imports.

 

24

 

 

The invasion of Ukraine by Russia has resulted increased sanctions on trade with Russia which could reverberate to other countries, other economies and other markets. On February 24, 2023, the United States, in coordination with allies and G7 partners, announced a new set of sanctions, export controls and tariffs targeting key, revenue-generating sectors of the Russian economy and restricting trade with over 200 persons, including both Russian and third-country actors across Europe, Asia and the Middle East. These new measures, taken by the U.S. Department of the Treasury’s Office of Foreign Assets Control, or OFAC, US Department of Commerce’s Bureau of Industry and Security, or BIS, Office of the US Trade Representative, or USTR and U.S. Department of State, mark the one-year anniversary of Russia’s war against Ukraine. These measures include the following:

 

  OFAC: (i) announced a new determination targeting the metals and mining sector of the Russian Federation economy under Executive Order 14024; (ii) added 83 entities and 22 individuals to the Specially Designated Nationals and Blocked Persons List, including over 30 third-country individuals and entities, resulting in the freezing of their assets within U.S. jurisdiction and prohibitions on transactions by U,S, persons or within the U.S. that involve such persons and their 50 percent or more owned entities; and (iii) made additions and revisions to several existing general licenses.

 

  BIS: (i) announced four new rules targeting Russia’s defense-industrial base and military and third countries supporting Russia; (ii) expanded export controls under the Export Administration Regulations, including licensing requirements on several commercial and industrial items; and (iii) added 86 entities to the Entity List determined to have engaged in sanctions evasion and backfill activities in support of Russia’s defense-industrial sector, prohibiting the targeted companies from purchasing items, such as semiconductors, whether made in the US or with certain US technology or software abroad.

 

  USTR announced additional tariff increases, primarily targeting metals, minerals and chemical products.

 

These sanctions, export controls and tariffs are part of the U.S.’s ongoing to impose economic costs on Russia in response to its actions in Ukraine.  

 

We are subject to anti-corruption, anti-bribery, anti-money laundering, economic sanctions, export control, and similar laws. Non-compliance with such laws can subject us to criminal or civil liability and harm our business, revenues, financial condition and results of operations.

 

We are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. domestic bribery statute contained in 18 U.S.C. Section 201, the U.S. Travel Act, and other anti-bribery and anti-money laundering laws in the countries in which we conduct activities. Anti-corruption and anti-bribery laws have been enforced aggressively in recent years and are interpreted broadly to generally prohibit companies and their employees and third-party intermediaries from authorizing, offering, or providing, directly or indirectly, improper payments or benefits to recipients in the public or private sector. As we increase our international presence, we may engage with distributors and third-party intermediaries to market our solutions and to obtain necessary permits, licenses, and other regulatory approvals. In addition, we or our third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities. We can be held liable for the corrupt or other illegal activities of these third-party intermediaries, our employees, representatives, contractors, partners and agents, even if we do not explicitly authorize such activities.

 

The United States has imposed economic sanctions that affect transactions with designated foreign countries, nationals and others. In particular, the United States prohibits U.S. persons from engaging with individuals and entities identified as “Specially Designated Nationals,” such as terrorists and narcotics traffickers. These prohibitions are administered by the U.S. Department of the Treasury’s Office of Foreign Assets Control. OFAC rules prohibit U.S. persons from engaging in, or facilitating a foreign person’s engagement in, transactions with or relating to the prohibited individual, entity or country, and require the blocking of assets in which the individual, entity or country has an interest. Blocked assets (e.g., property or bank deposits) cannot be paid out, withdrawn, set off or transferred in any manner without a license from OFAC. Other countries in which we operate, including Canada and the United Kingdom, also maintain economic and financial sanctions regimes.

 

25

 

 

Some of our solutions, including software updates and third-party accessories, may be subject to U.S. export control laws, including the Export Administration Regulations; however, the vast majority of our products are non-U.S.-origin items, developed and manufactured outside of the United States, and therefore not subject to these laws. For third-party accessories, we rely on manufactures to supply the appropriate export control classification numbers that determine our obligations under these laws.

 

We cannot assure you that our employees and agents will not take actions in violation of our policies and applicable law, for which we may be ultimately held responsible. As we increase our international presence, our risks under these laws, rules, and regulations may increase. Further, any change in the applicability or enforcement of these laws, rules, and regulations could adversely impact our business operations and financial results.

 

Detecting, investigating and resolving actual or alleged violations can require a significant diversion of time, resources, and attention from senior management. In addition, noncompliance with anti-corruption, anti-bribery, anti-money laundering, or economic sanctions laws, rules, and regulations could subject us to whistleblower complaints, investigations, sanctions, settlements, prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension and/or debarment from contracting with certain persons, the loss of export privileges, reputational harm, adverse media coverage, and other collateral consequences. If any subpoenas or investigations are launched, or governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal litigation, our business, revenues, financial condition, and results of operations would be significantly harmed. In addition, responding to any action will likely result in a significant diversion of management’s attention and resources and significant defense costs and other professional fees. Enforcement actions and sanctions could further harm our business, financial condition and results of operations.

  

We are subject to a wide range of product regulatory and safety, consumer, worker safety and environmental laws and regulations.

 

Our operations and the products we manufacture and/or sell are subject to a wide range of product regulatory and safety, consumer, worker safety and environmental laws and regulations. Compliance with such existing or future laws and regulations could subject us to future costs or liabilities, impact our production capabilities, constrict our ability to sell, expand or acquire facilities, restrict what solutions we can offer and generally impact our financial performance. Our products are designed for use in potentially explosive or hazardous environments. If our product design fails for any reason in such environments, we may be subject to product liabilities and future costs. In addition, some of these laws are environmental and relate to the use, disposal, remediation, emission and discharge of, and exposure to hazardous substances. These laws often impose liability and can require parties to fund remedial studies or actions regardless of fault. Environmental laws have tended to become more stringent over time and any new obligations under these laws could have a negative impact on our operations or financial performance. 

 

Laws focused on the energy efficiency of electronic products and accessories, recycling of both electronic products and packaging, reducing or eliminating certain hazardous substances in electronic products, and the transportation of batteries continue to expand significantly. Laws pertaining to accessibility features of electronic products, standardization of connectors and power supplies, the transportation of lithium-ion batteries, and other aspects are also proliferating. There are also demanding and rapidly changing laws around the globe related to issues such as product safety, radio interference, radio frequency radiation exposure, medical related functionality, and consumer and social mandates pertaining to use of wireless or electronic equipment. These laws, and changes to these laws, could have a substantial impact on whether we can offer certain products, solutions, and services, and on what capabilities and characteristics our products or services can or must include.

 

These laws and regulations impact our products and could negatively impact our ability to manufacture and sell products competitively. In addition, we anticipate that we will see increased demand to meet voluntary criteria related to reduction or elimination of certain constituents from products, increasing energy efficiency and providing additional accessibility.

 

26

 

 

Changes in laws and regulations concerning the use of telecommunication bandwidth could increase our costs and adversely impact our business.

 

Our business depends on our ability to sell devices that use telecommunication bandwidth allocated to licensed and unlicensed wireless services, and that use of that bandwidth is subject to laws and regulations that are subject to change over time. Changes in the permitted uses of telecommunication bandwidth, reallocation of such bandwidth to different uses, and new or increased regulation of the capabilities, manufacture, importation, and use of devices that depend on such bandwidth could increase our costs, require costly modifications to our products before they are sold, or limit our ability to sell those products into our target markets. In addition, we are subject to regulatory requirements for certification and testing of our products before they can be marketed or sold. Those requirements may be onerous and expensive. Changes to those requirements could result in significant additional costs and could adversely impact our ability to bring new products to market in a timely fashion.

 

We are subject to a wide range of privacy and data security laws, regulations and other legal obligations.

 

Personal privacy and information security are significant issues in the United States and the other jurisdictions in which we operate or make our products and applications available. The legislative and regulatory framework for privacy and security issues worldwide is rapidly evolving and is likely to remain uncertain for the foreseeable future. Our handling of data is subject to a variety of laws and regulations, including regulation by various government agencies, including the U.S. Federal Trade Commission, or FTC, and various state, local and foreign agencies. We may collect personally identifiable information, or PII, and other data from our customers. We use this information to provide services to our customers and to support, expand and improve our business. We may also share customers’ PII with third parties as allowed by applicable law and agreements and authorized by the customer or as described in our privacy policy.

  

The U.S. federal and various state and foreign governments have adopted or proposed limitations on the collection, distribution, transfer, use and storage of PII. In the United States, the FTC and many state attorneys general are applying federal and state consumer protection laws as imposing standards for the online collection, use and dissemination of data. Many foreign countries and governmental bodies, including Canada, the European Union and other relevant jurisdictions, have laws and regulations concerning the collection and use of PII obtained from their residents or by businesses operating within their jurisdiction. These laws and regulations often are more restrictive than those in the United States. Laws and regulations in these jurisdictions apply broadly to the collection, use, storage, disclosure and security of data that identifies or may be used to identify or locate an individual, such as names, email addresses and, in some jurisdictions, Internet Protocol, or IP, addresses. Within the European Union, legislators have adopted the General Data Protection Regulation, or GDPR, effective May 2018 which may impose additional obligations and risk upon our business, and which may increase substantially the penalties to which we could be subject in the event of any non-compliance. We may incur substantial expense in complying with the obligations imposed by the governments of the foreign jurisdictions in which we do business or seek to do business and we may be required to make significant changes in our business operations, all of which may adversely impact our revenues and our business overall. 

 

27

 

 

Although we are working to comply with those federal, state, and foreign laws and regulations, industry standards, contractual obligations and other legal obligations that apply to us, those laws, regulations, standards and obligations are evolving and may be modified, interpreted and applied in an inconsistent manner from one jurisdiction to another, and may conflict with one another, other requirements or legal obligations, our practices or the features of our products or applications. At state level, lawmakers continue to pass new laws concerning privacy and data security. Particularly notable in this regard is the California Consumer Privacy Act, or CCPA, which became effective on January 1, 2020. The CCPA will introduce significant new disclosure obligations and provide California consumers with significant new privacy rights. Any failure or perceived failure by us to comply with federal, state or foreign laws or regulations, industry standards, contractual obligations or other legal obligations, or any actual or suspected security incident, whether or not resulting in unauthorized access to, or acquisition, release or transfer of PII or other data, may result in governmental enforcement actions and prosecutions, private litigation, fines and penalties or adverse publicity and could cause our customers to lose trust in us, which could have an adverse impact on our reputation and business. Any inability to adequately address privacy and security concerns, even if unfounded, or comply with applicable laws, regulations, policies, industry standards, contractual obligations, or other legal obligations could result in additional cost and liability to us, damage our reputation, inhibit sales and adversely impact our business.

 

We also expect that there will continue to be new proposed laws, regulations and industry standards concerning privacy, data protection and information security in the United States, the European Union and other jurisdictions, and we cannot yet determine the impact such future laws, regulations and standards may have on our business. New laws, amendments to or re-interpretations of existing laws and regulations, industry standards, contractual obligations and other obligations may require us to incur additional costs and restrict our business operations. Such laws and regulations may require companies to implement privacy and security policies, permit users to access, correct and delete personal information stored or maintained by such companies, inform individuals of security breaches that affect their personal information, and, in some cases, obtain individuals’ consent to use PII for certain purposes. In addition, a foreign government could require that any PII collected in a country not be disseminated outside of that country, and we are not currently equipped to comply with such a requirement.

 

Risks Related to Our Intellectual Property

 

If we are unable to successfully protect our intellectual property, our competitive position may be harmed.

 

Our ability to compete is heavily affected by our ability to protect our intellectual property. We rely on a combination of patent licenses, confidentiality procedures and contractual provisions to protect our proprietary rights. We also enter, and plan to continue to enter, into confidentiality, invention assignment or license agreements with our employees, consultants and other parties with whom we contract, and control access to and distribution of our software, documentation and other proprietary information. The steps we take to protect our intellectual property may be inadequate, and it is possible that some or all of our confidentiality agreements will not be honored and certain contractual provisions may not be enforceable. Existing trade secret, trademark and copyright laws offer only limited protection. Unauthorized parties may attempt to copy aspects of our products or obtain and use information which we regard as proprietary. Policing unauthorized use of our products is difficult, time consuming and costly, particularly in foreign countries where the laws may not protect our proprietary rights as fully as in the United States. We cannot assure you that our means of protecting our proprietary rights will be adequate or that our competitors will not independently develop similar technology, the effect of either of which would harm our competitive position in the market. Furthermore, disputes can arise with our strategic partners, customers or others concerning the ownership of intellectual property.

 

28

 

 

Others may claim that we infringe on their intellectual property rights, which may result in costly and time-consuming litigation and could delay or otherwise impair the development and commercialization of our products.

 

In recent years, there has been a significant increase in litigation in the United States involving patents and other intellectual property rights, and because our products are comprised of complex technology, we are often involved in or impacted by assertions, including both requests to take licenses and litigation, regarding infringement of patent and other intellectual property rights of third parties. Third parties have asserted, and in the future may assert, intellectual property infringement claims against us and against our channel partners, end customers and suppliers. For example, we had been approached by Wilson Electronics about potential infringement of several of their patents involving cellphone boosters. As a result, the Company entered into a product technology licensing agreement with Wilson Electronics that resolved their claim whereby Wilson is entitled to a 4.5% licensing fee on the revenues earned by the Company for every booster product sold Many of these assertions are brought by non-practicing entities whose principal business model is to secure patent licensing revenues from product manufacturing companies. Claims for alleged infringement and any resulting lawsuit, if successful, could subject us to significant liability for damages and invalidation of our intellectual property rights. Defending any such claims, with or without merit, including pursuant to indemnity obligations, could be time consuming, expensive, cause product shipment delays or require us to enter into a royalty or licensing agreement, any of which could delay the development and commercialization of our products or reduce our margins. If we are unable to obtain a required license, our ability to sell or use certain products may be impaired. In addition, if we fail to obtain a license, or if the terms of the license are burdensome to us, our operations could be significantly harmed.

 

Our use of open source software could subject us to possible litigation or otherwise impair the development of our products.

 

A portion of our technologies incorporates open source software, including open source operating systems such as Android, and we expect to continue to incorporate open source software into our platform in the future. Few of the licenses applicable to open source software have been interpreted by courts, and their application to the open source software integrated into our proprietary technology platform may be uncertain. If we fail to comply with these licenses, then pursuant to the terms of these licenses, we may be subject to certain requirements, including requirements that we make available the source code for our software that incorporates the open source software. We cannot assure you that we have not incorporated open source software in our software in a manner that is inconsistent with the terms of the applicable licenses or our current policies and procedures. If an author or other third party that distributes such open source software were to allege that we had not complied with the conditions of one or more of these licenses, we could incur significant legal expenses defending against such allegations. Litigation could be costly for us to defend, have a negative effect on our operating results and financial condition or require us to devote additional research and development resources to change our technology platform.

 

With respect to open source operating systems, if third parties cease continued development of such operating systems or restrict our access to such operating system, our business and financial results could be adversely impacted. We are dependent on third parties’ continued development of operating systems, software application ecosystem infrastructures, and such third parties’ approval of our implementations of their operating and system and associated applications. If such parties cease to continue development or support of such operating systems or restrict our access to such operating systems, we would be required to change our strategy for our devices. As a result, our financial results could be negatively impacted because a resulting shift away from the operating systems we currently use, and the associated applications ecosystem could be costly and difficult.

  

29

 

 

Our inability to obtain and maintain any third-party license required to develop new products and product enhancements could seriously harm our business, financial condition and results of operations.

 

From time to time, we are required to license technology from third parties to develop new products or product enhancements. Third-party licenses may not be available to us on commercially reasonable terms, or at all. If we fail to renew any intellectual property license agreements on commercially reasonable terms, or any such license agreements otherwise expire or terminate, we may not be able to use the patents and technologies of these third parties in our products, which are critical to our success. We cannot assure you that we will be able to effectively control the level of licensing and royalty fees paid to third parties, and significant increase in such fees could have a significant and adverse impact on our future profitability. Seeking alternative patents and technologies may be difficult and time-consuming, and we may not be successful in finding alternative technologies or incorporating them into our products. Our inability to obtain any third-party license necessary to develop new products or product enhancements could require us to obtain substitute technology of lower quality or performance standards, or at greater cost, which could seriously harm our business, financial condition and results of operations.

 

Risks relating to our locations in Israel and Canada and our international operations

 

Conditions in Israel could materially and adversely affect our business.

 

A number of our officers and directors are residents of Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region may directly affect our business and operations. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its neighboring countries, as well as terrorist acts committed within Israel by hostile elements. Any hostilities involving Israel or the interruption or curtailment of trade between Israel and its trading partners could adversely affect our operations and results of operations. During the summer of 2006, Israel was engaged in an armed conflict with Hezbollah, a Lebanese Islamist Shiite militia group and political party. In December 2008 and January 2009 there was an escalation in violence among Israel, Hamas, the Palestinian Authority and other groups, as well as extensive hostilities along Israel’s border with the Gaza Strip, which resulted in missiles being fired from the Gaza Strip into Southern Israel. During November 2012 and from July through August 2014, Israel was engaged in an armed conflict with a militia group and political party who controls the Gaza Strip, which resulted in missiles being fired from the Gaza Strip into Southern Israel, as well as at areas more centrally located near Tel Aviv and at areas surrounding Jerusalem. These conflicts involved missile strikes against civilian targets in various parts of Israel, including areas in which our employees and some of our consultants are located, and negatively affected business conditions in Israel. This pattern of activity erupts from time to time with varying degrees of intensity and for varying periods of time and typically ends with a cease fire until hostilities flare up again.

 

Since February 2011, Egypt has experienced political turbulence and an increase in terrorist activity in the Sinai Peninsula. Such political turbulence and violence may damage peaceful and diplomatic relations between Israel and Egypt, and could affect the region as a whole. Similar civil unrest and political turbulence has occurred in other countries in the region, including Syria, which shares a common border with Israel, and is affecting the political stability of those countries. Since April 2011, internal conflict in Syria has escalated and chemical weapons have been used in the region. Foreign actors have intervened and may continue to intervene in Syria. This instability and any intervention may lead to deterioration of the political and economic relationships that exist between the State of Israel and some of these countries and may lead to additional conflicts in the region. In addition, Iran has threatened to attack Israel and may be developing nuclear weapons. Iran also has a strong influence among extremist groups in the region, including Hamas in Gaza, Hezbollah in Lebanon and various rebel militia groups in Syria. These situations have escalated at various points in recent years and may escalate in the future to more violent events, which may affect Israel and us. Any armed conflicts, terrorist activities or political instability in the region could adversely affect business conditions and could harm our results of operations and could make it more difficult for us to raise capital. Parties with whom we do business have sometimes declined to travel to Israel during periods of heightened unrest or tension, forcing us to make alternative arrangements when necessary in order to meet our business partners face to face. In addition, the political and security situation in Israel may result in parties with whom we have agreements involving performance in Israel claiming that they are not obligated to perform their commitments under those agreements pursuant to force majeure provisions in such agreements.

 

30

 

 

Further, in the past, the State of Israel and Israeli companies have been subjected to economic boycotts. Several countries still restrict business with the State of Israel and with Israeli companies. These restrictive laws and policies may have an adverse impact on our operating results, financial condition or the expansion of our business. A campaign of boycotts, divestment and sanctions has been undertaken against Israel, which could also adversely impact our business.

 

In addition, many Israeli citizens are obligated to perform several days, and in some cases more, of annual military reserve duty each year until they reach the age of 40 (or older, for reservists who are military officers or who have certain occupations) and, in the event of a military conflict, may be called to active duty. In response to increases in terrorist activity, there have been periods of significant call-ups of military reservists. It is possible that there will be military reserve duty call-ups in the future. Our operations could be disrupted by such call-ups, which may include the call-up of members of our management. Such disruption could materially adversely affect our business, prospects, financial condition and results of operations.

  

It may be difficult to enforce a U.S. judgment against us, our officers and directors named in this annual report on Form 20-F in Israel or the United States, or to assert U.S. securities laws claims in Israel or serve process on our officers and directors.

 

Not all of our directors or officers are residents of the United States and most of their and our assets are located outside the United States. Service of process upon us or our non-U.S. resident directors and officers may be difficult to obtain within the United States. We have been informed by our legal counsel in Israel that it may be difficult to assert claims under U.S. securities laws in original actions instituted in Israel or obtain a judgment based on the civil liability provisions of U.S. federal securities laws. Israeli courts may refuse to hear a claim based on a violation of U.S. securities laws against us or our non-U.S. officers and directors because Israel may not be the most appropriate forum to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proved as a fact, which can be a time-consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding case law in Israel addressing the matters described above. Additionally, Israeli courts might not enforce judgments obtained in the United States against us or our non-U.S. our directors and executive officers, which may make it difficult to collect on judgments rendered against us or our non-U.S. officers and directors.

 

Moreover, an Israeli court will not enforce a non-Israeli judgment if it was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases), if its enforcement is likely to prejudice the sovereignty or security of the State of Israel, if it was obtained by fraud or in the absence of due process, if it is at variance with another valid judgment that was given in the same matter between the same parties, or if a suit in the same matter between the same parties was pending before a court or tribunal in Israel at the time the foreign action was brought. For more information, see “Enforceability of Civil Liabilities.”

 

Because we are a corporation incorporated in British Columbia and some of our directors and officers are resident in Canada, it may be difficult for investors in the United States to enforce civil liabilities against us based solely upon the federal securities laws of the United States. Similarly, it may be difficult for Canadian investors to enforce civil liabilities against our directors and officers residing outside of Canada.

 

We are a corporation incorporated under the laws of British Columbia with our principal place of business in Montreal, Canada. Some of our directors and officers and the auditors or other experts named herein are residents of Canada and all or a substantial portion of our assets and those of such persons are located outside the United States. Consequently, it may be difficult for U.S. investors to effect service of process within the United States upon us or our directors or officers or such auditors who are not residents of the United States, or to realize in the United States upon judgments of courts of the United States predicated upon civil liabilities under the Securities Act. Investors should not assume that Canadian courts: (i) would enforce judgments of U.S. courts obtained in actions against us or such persons predicated upon the civil liability provisions of the U.S. federal securities laws or the securities or blue-sky laws of any state within the United States or (ii) would enforce, in original actions, liabilities against us or such persons predicated upon the U.S. federal securities laws or any such state securities or blue-sky laws.

 

31

 

 

Similarly, some of our directors and officers are residents of countries other than Canada and all or a substantial portion of the assets of such persons are located outside Canada. As a result, it may be difficult for Canadian investors to initiate a lawsuit within Canada against these non-Canadian residents. In addition, it may not be possible for Canadian investors to collect from these non-Canadian residents’ judgments obtained in courts in Canada predicated on the civil liability provisions of securities legislation of certain of the provinces and territories of Canada. It may also be difficult for Canadian investors to succeed in a lawsuit in the United States, based solely on violations of Canadian securities laws.

 

We have operations in China, which exposes us to risks inherent in doing business there.

 

We use multiple third-party suppliers and manufacturers based primarily in China. With the rapid development of the Chinese economy, the cost of labor has increased and may continue to increase in the future. Furthermore, pursuant to Chinese labor laws, employers in China are subject to various requirements when signing labor contracts, paying remuneration, determining the term of employees’ probation and unilaterally terminating labor contracts. Our results of operations will be materially and adversely affected if the labor costs of our third-party suppliers and manufacturers increase significantly. In addition, we and our manufacturers and suppliers may not be able to find a sufficient number of qualified workers due to the intensely competitive and fluid market for skilled labor in China.

 

Operating in China exposes us to political, legal and economic risks. In particular, the political, legal and economic climate in China, both nationally and regionally, is fluid and unpredictable. Our ability to utilize parties that operate in China may be adversely affected by changes in U.S. and Chinese laws and regulations such as those related to, among other things, taxation, import and export tariffs, environmental regulations, land use rights, intellectual property, currency controls, network security, employee benefits, hygiene supervision and other matters. In addition, we may not obtain or retain the requisite legal permits to continue utilizing third-parties that operate in China, and costs or operational limitations may be imposed in connection with obtaining and complying with such permits. In addition, Chinese trade regulations are in a state of flux, and we may potentially become subject to other forms of taxation, tariffs and duties in China. Furthermore, the third parties we rely on in China may disclose our confidential information or intellectual property to competitors or third parties, which could result in the illegal distribution and sale of counterfeit versions of our products. If any of these events occur, our business, financial condition and results of operations could be materially and adversely affected.

 

Operating outside of the United States presents specific risks to our business, and we have substantial operations outside of the United States.

 

Most of our employee base and operations are located outside the United States, primarily in Canada and Israel. Most of our software development, third-party contract manufacturing, and product assembly operations are conducted outside the United States.

 

Risks associated with operations outside the United States include:

 

  effectively managing and overseeing operations that are distant and remote from corporate headquarters may be difficult and may impose increased operating costs;

 

  fluctuating foreign currency rates could restrict sales, increase costs of purchasing, and impact collection of receivables outside of the United States;

  

  volatility in foreign credit markets may affect the financial well-being of our customers and suppliers;

 

  violations of anti-corruption laws, including the Foreign Corrupt Practices Act and the U.K. Bribery Act could result in large fines and penalties;

  

  violations of privacy and data security laws could result in large fines and penalties; and

 

32

 

 

  tax disputes with foreign taxing authorities, and any resultant taxation in foreign jurisdictions associated with operations in such jurisdictions, including with respect to transfer pricing practices associated with such operations.

  

Foreign currency fluctuations may reduce our competitiveness and sales in foreign markets.

 

The relative change in currency values creates fluctuations in product pricing for international customers. These changes in foreign end-customer costs may result in lost orders and reduce the competitiveness of our products in certain foreign markets. These changes may also negatively impact the financial condition of some foreign customers and reduce or eliminate their future orders of our products. We also face adverse changes in, or uncertainty of, local business laws or practices, including the following:

 

  foreign governments may impose burdensome tariffs, quotas, taxes, trade barriers, or capital flow restrictions;

 

  restrictions on the export or import of technology may reduce or eliminate the ability to sell in or purchase from certain markets;

 

  political and economic instability, including deterioration of political relations between the United States and other countries, may reduce demand for our solutions or put our non-U.S. assets at risk;

 

  potentially limited intellectual property protection in certain countries may limit recourse against infringing on our solutions or cause us to refrain from selling in certain geographic territories;

 

  staffing may be difficult along with higher turnover at international operations;

 

  a government-controlled exchange rate and limitations on the convertibility of currencies, including the Chinese yuan;

 

  transportation delays and customs related delays that may affect production and distribution of our products; and

 

  integration and enforcement of laws vary significantly among jurisdictions and may change significantly over time.

 

Our failure to manage any of these risks successfully could harm our international operations and adversely impact our business, operating results and financial condition.

 

Risks Related to Ownership of Our Securities

 

We do not know whether an active, liquid and orderly trading market will develop for our Common Shares or Warrants or what the market price of our Common Shares or Warrants will be and as a result it may be difficult for you to sell your Common Shares.

 

You may not be able to sell your shares or Warrants quickly or at the market price if trading in our Common Shares or Warrants is not active. The initial public offering price for our Common Shares and Warrants was determined through negotiations with the underwriters, and the negotiated price may not have been indicative of the market price of the Common Shares and Warrants after the offering. As a result of these and other factors, an investor may be unable to resell its Common Shares or Warrants at or above the initial public offering price. Further, an inactive market may also impair our ability to raise capital by selling our securities and may impair our ability to enter into strategic partnerships or acquire companies or products by using our Common Shares as consideration.

 

33

 

 

We expect that our stock price will fluctuate significantly, and you may not be able to resell your shares at or above the price at which you purchased our Common Shares.

 

The trading price of our Common Shares is likely to be volatile and subject to wide price fluctuations in response to various factors, including:

 

  market conditions in the broader stock market in general, or in our industry in particular;

 

  actual or anticipated fluctuations in our quarterly financial and operating results;

 

  introduction of new products and services by us or our competitors;

 

  sales, or anticipated sales, of large blocks of our stock;

 

  issuance of new or changed securities analysts’ reports or recommendations;

 

  failure of industry or securities analysts to maintain coverage of our company, changes in financial estimates by any industry or securities analysts that follow our company, or our failure to meet such estimates;

 

  additions or departures of key personnel;

 

  regulatory or political developments;

 

  changes in accounting principles or methodologies;

 

  acquisitions by us or by our competitors;

 

  litigation and governmental investigations; and

 

  economic, political and geopolitical conditions or events.

 

These and other factors may cause the market price and demand for our Common Shares to fluctuate substantially, which may limit or prevent investors from readily selling their Common Shares and may otherwise negatively affect the liquidity of our Common Shares. In addition, in the past, when the market price of a stock has been volatile, holders of that stock have often instituted securities class action litigation against the company that issued the stock. If any of our stockholders brought a lawsuit against us, we could incur substantial costs defending the lawsuit. Such a lawsuit could also divert the time and attention of our management from our business.

 

The market for our Common Shares may not provide investors with adequate liquidity.

 

Liquidity of the market for our Common Shares depends on a number of factors, including our financial condition and operating results, the number of holders of our Common Shares, the market for similar securities and the interest of securities dealers in making a market in the securities. We cannot predict the extent to which investor interest in the Company will maintain a trading market in our Common Shares, or how liquid that market will be. If an active market is not maintained, investors may have difficulty selling Common Shares that they hold.

 

34

 

 

Since we do not expect to pay any cash dividends for the foreseeable future, investors may be forced to sell their stock in order to obtain a return on their investment.

 

We do not anticipate declaring or paying in the foreseeable future any cash dividends on our capital stock. Instead, we plan to retain any earnings to finance our operations and growth plans discussed elsewhere or incorporated by reference in this prospectus. Accordingly, investors must rely on sales of their Common Shares after price appreciation, which may never occur, as the only way to realize any return on their investment. As a result, investors seeking cash dividends should not purchase our Common Shares.

 

Outstanding warrants and future sales of our Common Shares may further dilute the Common Shares and adversely impact the price of our Common Shares.

 

As of March 31, 2023, we had 62,911,417 Common Shares issued and outstanding. Subsequent to the period ended March 31, 2023, an additional 101,450,000 common shares were issued and an additional 21,031,987 had been converted from cashless warrants into Common Shares. Total 13,100,084 Common Shares underlying outstanding warrants that have been registered with the SEC for resale are unrestricted and freely tradeable. We also have other outstanding unexercised agents’ options to purchase 931,507 Common Shares as of August 9, 2023 that expire between June 30, 2024 and March 8, 2027. If the holder of our free trading shares wanted to sell these shares, there might not be enough purchasers to maintain the market price of our Common Shares on the date of such sales. Any such sales, or the fear of such sales, could substantially decrease the market price of our Common Shares and the value of your investment.

 

If a substantial number of shares become available for sale and are sold in a short period of time, the market price of our Common Shares could decline.

 

We cannot predict whether future issuances of our Common Shares or the availability of shares for resale in the open market will decrease the market price per Common Share. We are not restricted from issuing additional Common Shares of, including any securities that are convertible into or exchangeable for, or that represent the right to receive Common Shares. Sales of a substantial number of our Common Shares in the public market or the perception that such sales might occur could materially adversely affect the market price of our Common Shares. Because our decision to issue securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of our future offerings. Thus, our shareholders bear the risk of any future stock issuances reducing the market price of our Common Shares and diluting their stock holdings in us.

 

If we are not able to comply with the applicable continued listing requirements or standards of Nasdaq, Nasdaq could delist our Common Shares

 

In order to maintain the listing of our Common Shares and Warrants on the Nasdaq Capital Market, we must satisfy minimum financial and other continued listing requirements and standards, including those regarding director independence and independent committee requirements, minimum stockholders’ equity, minimum share price, and certain corporate governance requirements. There can be no assurances that we will be able to comply with such applicable listing standards.

 

On August 26, 2022 we received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying us that we were not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”), resulting from the fact that the closing bid price of the Company’s Common Shares was below $1.00 per share for a period of 30 consecutive business days. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), we were given a period of 180 calendar days, or until February 22, 2023 (the “Compliance Period”), to regain compliance with Nasdaq’s minimum bid price requirement. We did not regain compliance by such date and submitted a written request to the Nasdaq to afford us an additional 180-day compliance period to cure the deficiency. On February 23, 2023, we received written notification from the Listing Qualifications Department of Nasdaq our request for a 180-day extension to regain compliance with Nasdaq’s minimum bid price requirement until August 21, 2023. If at any time prior to August 21, 2023, the bid price of the Common Shares closes at $1.00 per share or more for a minimum of 10 consecutive business days, we will regain compliance with the Bid Price Rule. On August 3, 2023 the Company affected a 100-to-1 reverse stock split which resulted in the stock trading above $1.00. If the common shares continue to trade over $1.00 for ten consecutive business days after the reverse split, the Company will be in compliance with NASDAQ minimum bid price requirement.

 

35

 

 

If we do not regain compliance with the Bid Price Rule during the additional 180-day extension, Nasdaq will notify us that our Common Shares will be delisted. At that time, we may appeal the delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance that, if we do appeal the delisting determination by Nasdaq to the hearings panel, that such appeal would be successful. We intend to actively monitor the closing bid price of our Common Shares and may, if appropriate, consider implementing available options to regain compliance with the Bid Price Rule under the Nasdaq Listing Rules.

 

Nasdaq’s extension notice has no immediate effect on the listing or trading of the Common Shares, which will continue to trade on the Nasdaq Capital Market under the symbol “SYTA.”

 

If the Common Shares are not listed on Nasdaq at any time after this offering, we could face significant material adverse consequences, including: 

 

  a limited availability of market quotations for our securities;

  

  reduced liquidity;

 

  a determination that the Common Shares are a “penny stock” which will require brokers trading in our shares to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for the Common Shares;

 

  a limited amount of news and analyst coverage for our Company; and

 

  a decreased ability to issue additional securities or obtain additional financing in the future.

 

Upon delisting from the Nasdaq Capital Market, our Common Shares would be traded over-the-counter inter-dealer quotation system, more commonly known as the OTC. OTC transactions involve risks in addition to those associated with transactions in securities traded on the securities exchanges, such as the Nasdaq Capital Market, or Exchange-listed Stocks. Many OTC stocks trade less frequently and in smaller volumes than Exchange-listed Stocks. Accordingly, our stock would be less liquid than it would be otherwise. Also, the values of OTC stocks are often more volatile than Exchange-listed Stocks. Additionally, institutional investors are usually prohibited from investing in OTC stocks, and it might be more challenging to raise capital when needed.

 

In addition, if our Common Shares are delisted, your ability to transfer or sell your Common Shares may be limited and the value of those securities will be materially adversely affected.

 

If our Common Shares become subject to the penny stock rules, it may be more difficult to sell our Common Shares.

 

The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00 (other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system). The OTC Bulletin Board does not meet such requirements and if the price of our Common Shares is less than $5.00 and our Common Shares are no longer listed on a national securities exchange such as Nasdaq, our stock may be deemed a penny stock. The penny stock rules require a broker-dealer, at least two business days prior to a transaction in a penny stock not otherwise exempt from those rules, to deliver to the customer a standardized risk disclosure document containing specified information and to obtain from the customer a signed and dated acknowledgment of receipt of that document. In addition, the penny stock rules require that prior to effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive: (i) the purchaser’s written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our Common Shares, and therefore shareholders may have difficulty selling their shares. 

 

36

 

 

Warrants are speculative in nature.

 

The Warrants do not confer any rights of Common Share ownership on their holders, such as voting rights or the right to receive dividends, but rather merely represent the right to acquire Common Shares at a fixed price for a limited period of time. Specifically, commencing on the date of issuance, holders of the Warrants may exercise their right to acquire the Common Shares and pay the Warrant exercise price per share, prior to five years from the date of issuance, after which date any unexercised Warrants will expire and have no further value.  

 

Because we are a foreign private issuer and are exempt from certain Nasdaq corporate governance standards applicable to U.S. issuers, you will have less protection than you would have if we were a domestic issuer.

 

Nasdaq Listing Rules require listed companies to have, among other things, a majority of its board members be independent. As a foreign private issuer, however, we are permitted to, and we may follow home country practice in lieu of the above requirements, or we may choose to comply with the above requirement within one year of listing. The corporate governance practice in our home country does not require a majority of our board to consist of independent directors. Thus, although a director must act in the best interests of the Company, it is possible that fewer board members will be exercising independent judgment and the level of board oversight on the management of our company may decrease as a result. In addition, Nasdaq Listing Rules also require foreign private issuers to have a compensation committee, a nominating/corporate governance committee composed entirely of independent directors, and an audit committee with a minimum of three members. We, as a foreign private issuer, are not subject to these requirements. Nasdaq Listing Rules may require shareholder approval for certain corporate matters, such as requiring that shareholders be given the opportunity to vote on all equity compensation plans and material revisions to those plans, and certain Common Share issuances. We intend to comply with the requirements of Nasdaq Listing Rules in determining whether shareholder approval is required on such matters and to appoint a nominating and corporate governance committee. We may, however, consider following home country practice in lieu of the requirements under Nasdaq Listing Rules with respect to certain corporate governance standards which may afford less protection to investors.

 

Our executive officers and directors, and their affiliated entities, along with our two other largest stockholders, own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.

 

Based on shares outstanding as of August 14, 2023, our executive officers and directors, together with entities affiliated with such individuals, along with our largest shareholder, will beneficially own approximately 10.0% of our Common Shares based on 185,393,404, pre-100-to-1 reverse stock split, (1,853,955 after the reverse stock split), Common Shares issued and outstanding on such date.

 

As of March 31, 2023, the Company had 62,911,417 Common Shares issued and outstanding.

 

General Risk Factors

 

The unfavorable outcome of any future litigation, arbitration or administrative action could have a significant adverse impact on our financial condition or results of operations.

 

From time to time, we are a party to litigation, arbitration, or administrative actions. Our financial results and reputation could be negatively impacted by unfavorable outcomes to any future litigation or administrative actions, including those related to the Foreign Corrupt Practices Act, the U.K. Bribery Act, or other anti-corruption laws. There can be no assurances as to the favorable outcome of any litigation or administrative proceedings. In addition, it can be very costly to defend litigation or administrative proceedings and these costs could negatively impact our financial results.

 

37

 

 

If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.

 

The trading market for our securities will depend in part on the research and reports that securities or industry analysts publish about us or our business. Securities and industry analysts do not currently, and may never, publish research on our company. If no securities or industry analysts commence coverage of our company, the trading price for our securities would likely be negatively impacted. In the event securities or industry analysts initiate coverage, if one or more of the analysts who covers us downgrades our stock or publishes inaccurate or unfavorable research about our business, our stock price may decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our securities could decrease, which might cause our stock price and trading volume to decline.

 

We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.

 

As discussed above, we are a foreign private issuer, and therefore, we are not required to comply with all of the periodic disclosure and current reporting requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act. In the future, we would lose our foreign private issuer status if (i) more than 50% of our outstanding voting securities are owned by U.S. residents and (ii) a majority of our directors or executive officers are U.S. citizens or residents, or we fail to meet additional requirements necessary to avoid loss of foreign private issuer status. If we lose our foreign private issuer status, we will be required to file with the SEC periodic reports and registration statements on U.S. domestic issuer forms, which are more detailed and extensive than the forms available to a foreign private issuer. We will also have to mandatorily comply with U.S. federal proxy requirements, and our officers, directors and principal shareholders will become subject to the short-swing profit disclosure and recovery provisions of Section 16 of the Exchange Act. In addition, we will lose our ability to rely upon exemptions from certain corporate governance requirements under the listing rules of the Nasdaq Capital Market. As a U.S. listed public company that is not a foreign private issuer, we will incur significant additional legal, accounting and other expenses that we will not incur as a foreign private issuer.

  

We incur significant increased costs as a result of operating as a public company in the United States, and our management is required to devote substantial time to new compliance initiatives.

 

As a public company in the United States, we incur significant legal, accounting and other expenses that we did not incur previously. We are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, which requires, among other things, that we file with the SEC annual, quarterly and current reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley Act, as well as rules subsequently adopted by the SEC and Nasdaq to implement provisions of the Sarbanes-Oxley Act, impose significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. Further, in July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, was enacted. There are significant corporate governance and executive-compensation-related provisions in the Dodd-Frank Act that require the SEC to adopt additional rules and regulations in these areas. Recent legislation permits emerging growth companies to implement many of these requirements over a longer period and up to five years from the pricing of their initial public offering. We intend to take advantage of this new legislation, but cannot assure you that we will not be required to implement these requirements sooner than planned and thereby incur unexpected expenses. Stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact the manner in which we operate our business in ways we cannot currently anticipate.

 

38

 

 

We expect the rules and regulations applicable to public companies to substantially increase our legal and financial compliance costs and to make some activities more time-consuming and costly. If these requirements divert the attention of our management and personnel from other business concerns, they could have a material adverse effect on our business, financial condition and results of operations. The increased costs will decrease our net income or increase our consolidated net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to incur substantial costs to maintain the same or similar coverage. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers.

 

Although as a Foreign Private Issuer we are exempt from certain corporate governance standards applicable to US issuers, if we cannot satisfy, or continue to satisfy, the initial listing requirements and other rules of the Nasdaq Capital Market, our securities may not be listed or may be delisted, which could negatively impact the price of our securities and your ability to sell them.

 

In order to maintain our listing on the Nasdaq Capital Market, we will be required to comply with certain rules of the Nasdaq Capital Market, including those regarding minimum shareholders’ equity, minimum share price, minimum market value of publicly held shares, and various additional requirements. Even if we initially meet the listing requirements and other applicable rules of the Nasdaq Capital Market, we may not be able to continue to satisfy these requirements and applicable rules. If we are unable to satisfy the Nasdaq Capital Market criteria for maintaining our listing, our securities could be subject to delisting. In that regard, on May 18, 2021, we received a notice from Nasdaq indicating that, as a result of not having timely filed our Annual Report on Form 20-F for the fiscal year ended December 31, 2020, we were not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission. Nasdaq required that we submit a plan no later than July 16, 2021 to regain compliance and we have in fact regained compliance with Nasdaq’s listing requirements since then.

   

If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis could be impaired.

 

We are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, the Sarbanes-Oxley Act and the rules and regulations of Nasdaq. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal controls over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with International Financial Reporting Standards.

 

In connection with the audit of our consolidated financial statements for the years ended December 31, 2022, 2021 and 2020, our independent registered public accountants identified three, six and two material weaknesses, respectively, in our internal control over financial reporting.

  

We have taken steps to remediate these material weaknesses, and to further strengthen our accounting staff and internal controls, as described above. These measures have only partially remediated the material weaknesses identified in 2022 and 2021 as discussed above. We cannot be certain that other material weaknesses and control deficiencies will not be discovered in the future. Any failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition or results of operations. If our efforts are not successful or other material weaknesses or control deficiencies occur in the future, we may be unable to report our financial results accurately on a timely basis or help prevent fraud, which could cause our reported financial results to be materially misstated and result in the loss of investor confidence or delisting, cause the market price of our Common Shares to decline, and we could be subject to sanctions or investigations by Nasdaq, the Securities and Exchange Commission, or other regulatory authorities. Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets.

 

39

 

 

ITEM 4. INFORMATION ON THE COMPANY

 

A. History and Development of the Company

 

We were incorporated on October 15, 1986 as Big Rock Gold Ltd. as a corporation under the Company Act of British Columbia incorporation number BC 0316008. On April 5, 1988, we changed our name to International Cruiseshipcenters Corp. On June 24, 1991, we changed our name to Riley Resources Ltd. Effective January 23, 1998, we changed our name to International Riley Resources Ltd. Effective November 22, 2001, we changed our name to Wind River Resources Ltd. On January 3, 2008, we changed our name to Teslin River Resources Corp. In 1998, in connection with the name change to International Riley Resources Ltd., we consolidated our share capital on an eight to one basis and in 2001, in connection with the name change to Wind River Resources Ltd., we further consolidated our share capital on a five to one basis.

 

On July 24, 2015, Teslin River Resources Corp. completed a reverse acquisition by way of a three-cornered amalgamation, pursuant to which we acquired certain telecom operations of an Israel-based cellular technology company and changed our name to Siyata Mobile Inc.

  

On June 7, 2016, we acquired all of the issued and outstanding shares of Signifi Mobile Inc., or Signifi. In consideration for such acquisition, we paid cash in the amount of CAD$200,000 and issued 1,000,000 (6,897 shares after the 145/1 stock split) Common Shares at a value of CAD$360,000.

 

The Company’s common shares were previously listed on the TSX Venture Exchange (the “TSXV”) under the symbol “SIM” and the Company voluntarily delisted from the TSXV at the end of trading on October 19, 2020. Our shares traded on the OTCQX under the symbol “SYATF” from May 11, 2017 until September 25, 2020, at which time our shares were listed on the Nasdaq Capital Market.

  

On January 2, 2021, we announced the closing of a previously announced private placement led by Phoenix Fund of 129,450 units of the Company at a price of $100 per unit for aggregate gross proceeds of $12,945,000 USD. Each Unit consisted of ten Common Shares of the Company and ten Common Share purchase warrants. Each warrant entitles the holder thereof to acquire an additional Common Share of the Company at a price of $11.50 for a period of 42 months from the date of issuance.

 

On February 9, 2021, we announced that Peter Goldstein was appointed to serve as the Chairman of the Board of Directors, or the Board, of the Company. The Company further announced that Luisa Ingargiola was appointed as a director and a member of the Audit Committee, which took effect following the Company’s annual shareholders meeting held on February 23, 2021. Ms. Ingargiola replaced Brian Budd on the Board due to Mr. Budd not being re-nominated to serve on the Board at the upcoming shareholder’s meeting. Ms. Ingargiola resigned from the Board on October 29, 2021.

 

In March 2021, we acquired, through a wholly owned subsidiary formed by Signifi, all of the outstanding units of Clear RF LLC, or Clear RF. In exchange for 100% of the units of Clear RF, we agreed to pay a total of $700,000, comprised of approximately $389,970 in our Common Shares and $310,030 in cash. At closing we issued 23,949 Common Shares valued at $194,985 as the share consideration as well as $155,015 in cash and are required to pay an additional $155,015 in cash and an additional $194,985 of our Common Shares, subject to adjustment on March 31, 2022.

 

On April 8, 2021, we were informed by the British Columbia Securities Commission that it had issued a cease trading order due to the Company’s failure to timely file its annual audited financial statements for the year ended December 31, 2020, its annual management’s discussion and analysis for the year ended December 31, 2020, its annual information form for the year ended December 31, 2020 and its certification of annual filings for the year ended December 31, 2020. The Order did not impact the trading of our Common Shares and Warrants, trading under the symbols SYTA and SYTAW, respectively, on the Nasdaq Capital Market. The Order was revoked as of July 8, 2021.

 

40

 

 

On May 18, 2021, we received a notice from the Nasdaq indicating that, as a result of not having timely filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2020, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission. We filed the Form 20-F on June 30, 2021 and believe that we regained compliance with the applicable Nasdaq rule.

 

On August 20, 2021, we were informed by the British Columbia Securities Commission that it had issued a cease trading order due to our failure to timely file its interim financial report for the period ended June 30, 2021, interim management’s discussion and analysis for the period ended June 30, 2021 and certification of interim filings for the period ended June 30, 2021. We filed our financial statements and other outstanding materials on October 14, 2021 and the cease trading order was revoked on October 15, 2021.

 

On October 27, 2021, we entered into a securities purchase agreement relating to the purchase and sale of a senior secured convertible note (the “Lind Note”) for gross proceeds of $6,000,000 with Lind Global Partners II, LP, or Lind, an investment fund managed by The Lind Partners, a New York based institutional fund manager (together “Lind”) which closed on November 3, 2021. The purchase agreement provided for, among other things, the issuance of a $7,200,000 Note with a 24-month maturity, 0% annual interest rate, and a fixed conversion price of $10.00 per share of the Company’s Common Shares. The Company is required to make principal payments in 18 equal monthly installments commencing 180 days after funding. At the discretion of the Company, the repayments can be made in: (i) cash; (ii) Common Shares (after Common Shares are registered) (the “Repayment Shares”); or a combination of both. Repayment Shares will be priced at 90% of the average of the five lowest daily VWAPs during the 20 trading days before the issuance of the Common Shares (the “Repayment Price”). The Company has the right to buy-back the outstanding face value of the Note at any time with no penalty (“Buy-Back Right”). Should the Company exercise its Buy-Back Right, Lind will have the option to convert up to 25% of the face value of the Note at the lesser of the conversion price of the Notes or the Repayment Price. Additionally, the Note ranks senior to other Company debt, excluding certain debt facilities, and is secured over Company assets, as more fully detailed in the Purchase Agreement and Note. Further, the purchase agreement provided that Lind will also receive a Common Shares purchase warrant to purchase up to 2,142,857 shares of the Company’s Common Shares (“Lind Warrant”). The Lind Warrant may be exercisable with cash payment for 60 months with an exercise price of $4.00 per Common Share (as later adjusted) and may be exercised on a cashless basis in the event that a registration statement covering the underlying Common Shares is not deemed effective. Both the Lind Note and the Lind Warrant contain certain anti-dilution protection in certain circumstances. The Company’s registration statement covering the Common Shares underlying the Note and Warrant was declared effective on December 3, 2021.

 

The Lind Note was repaid in full on November 14, 2022. Of the total repayment of principal and interest, the Company paid Lind $8,137,702 in cash and issued Lind 13,112,255 Common Shares. The Securities Purchase Agreement pursuant to which Lind Partners acquired the Lind Notes prohibits the Company from entering into any Prohibited Transactions without Lind’s prior written consent, until thirty days after such time as the Lind Note has been repaid in full and/or has been converted into Common Shares. That agreement also provides to Lind a 10 day right of first purchase if the Company makes a public offer of its Common Shares. On October 9, 2022, Lind entered into an agreement pursuant to which they waived such provisions in consideration of participating in the Company’s offering that closed on October 12, 2022 and receiving without payment therefor Common Share purchase warrants in the private placement to acquire up to 1,739,130 Common Shares at an exercise price of $0.23 per Common Share (the “Lind Waiver Warrants”). Lind did not exercise any of said Lind Waiver Warrants and did not participate in the Warrant Exercise Agreement discussed below.

 

Effective on October 29, 2021, the Board appointed Lourdes Felix as a director of the Board to fill the vacancy created by the resignation of Ms. Ingargiola. Ms. Felix will serve as a director until the Company’s next annual general meeting of shareholders and until her successor shall have been elected and qualified, subject to her earlier death, resignation, retirement, disqualification or removal. Ms. Felix was also appointed to serve as a member of the Company’s Audit Committee and Nominating and Corporate Governance Committee.

 

41

 

 

On November 15, 2021, Siyata announced the closing of a previously announced funding agreement for gross proceeds of $6,000,000 by Lind Global Partners II, LP, an investment fund managed by The Lind Partners. The proceeds were used to repay and terminate certain existing convertible notes.

 

On January 11, 2022, the Company closed its underwritten public offering of 8,695,652 Common Shares (or pre-funded warrants to purchase Common Shares in lieu thereof) and accompanying Warrants to purchase up to 8,695,652 Common Shares resulting in gross proceeds of approximately $20,000,000 and net proceeds of $18,358,028.

 

On May 24, 2022, we received a letter from Davidson & Company LLP (“Davidson”) that stated that Davidson did not wish to be reappointed as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Davidson ceased to serve as the Company’s independent registered accounting firm as of May 24, 2022. The Company requested that Davidson respond fully to the inquiries of Friedman, LLP, the Company’s successor independent registered public accounting firm, and Davidson agreed to cooperate with the Company and Friedman with respect to the transition. During the Company’s fiscal years ended December 31, 2021 and 2020 and the subsequent interim period through the filing of the Company’s Report of Foreign Private Issuer on Form 6-K on May 31, 2022, there were no “disagreements” (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions to Item 304 of Regulation S-K) with Davidson on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Davidson, would have caused Davidson to make reference to the subject matter of such disagreements in connection with its report. Davidson’s report on the consolidated financial statements for the Company’s fiscal years ended December 31, 2021 and 2020 did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles, except that Davidson’s report for the years ended December 31, 2021 and 2020 contained an explanatory paragraph indicating that there was substantial doubt about the ability of the Company to continue as a going concern. In a separate correspondence, Davidson identified five material weaknesses in our internal controls over financial reporting. During the Company’s fiscal years ended December 31, 2021 and 2020 and the subsequent interim period through May 31, 2022, there had been no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K), except for certain material weaknesses in the Company’s internal control over financial reporting. 

 

On May 24, 2022, management of the Company notified Friedman LLP, or Friedman, that Friedman had been approved by the Company’s audit committee of the board of directors and the board of directors as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2022. Friedman LLP combined with Marcum LLP, or Marcum, effective September 1, 2022. During the fiscal years ended December 31, 2021 and 2020 and the subsequent interim period through May 31, 2022, the Company did not consult with Friedman or Marcum with respect to: (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered with respect to the Company’s financial statements, and no written report or oral advice was provided to the Company by Friedman or Marcum that was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue, or (ii) any matter that was subject to any disagreement, as defined in the United States Securities and Exchange Commission’s Regulation SK, Item 304(a)(1)(iv) and the related instructions thereto, or a reportable event within the meaning set forth in Item 304(a)(1)(v) of Regulation S-K.

 

42

 

 

As part of the Company’s normal quarterly reporting process for the six months ended June 30, 2022, management and the Audit Committee concluded that a material error was made related to the accounting for the warrants entered into on January 11, 2022 (the “January Warrants”) and therefore were misstated in the Company’s March 31, 2022 prior period financial statements, or Prior Period Financial Statements. There was no impact on any of the year end financial statements previously filed. On August 15, 2022, management and the Audit Committee determined that the Company’s condensed consolidated unaudited interim financial statements for the three month period ended March 31, 2022, filed with the SEC on Form 6-K on May 17, 2022 should no longer be relied upon due to an error in the accounting treatment for the classification of the Company’s January Warrants as equity rather than as a derivative liability. In addition, investors were advised that they should no longer rely upon any communications relating to these condensed consolidated unaudited interim financial statements. The Company determined that the January Warrants should be accounted for as a derivative liability in accordance with International Accounting Standards No. 32.6 and International Financial Reporting Standards No. 9 that deal with the measurement of financial assets and financial liabilities. As a result of this change, the January Warrants for 9,999,999 Common shares have been classified as liabilities rather than equity, the fair value of the January Warrants decreased by $2.9 million, transaction costs increased by $0.96 million and the fair value loss increased by $0.96 million for the three months ended March 31, 2022. The Company filed its restated condensed consolidated unaudited interim financial statements for the three month period ended March 31, 2022 as Exhibit 99.1 to its Form 6-K with the SEC on August 18, 2022 together with its restated Management’s Discussion and Analysis of Results of Operations and Financial Condition for the three months ended March 31, 2022.On July 1, 2022, the Company filed a “shelf” registration statement with the SEC covering $100 million aggregate amount of Common Shares, warrants to purchase Common Shares or debt securities, or any combination thereof, subscription rights evidencing the right to purchase Common Shares or debt securities, or any combination thererof, purchase contracts to purchase Common Shares, warrants, rights, debt securities, or any combination thererof, as well as units that include any of these securities. That registration statement was declared effective by the SEC on July 18, 2022.

 

On October 10, 2022, we entered into a Securities Purchase Agreement or the Purchase Agreement with certain institutional investors named therein (the “Purchasers”), pursuant to which we agreed to issue and sell, in a registered direct offering from the shelf: (i) 15,810,000 Common Shares, (ii) 1,590,000 pre-funded warrants, or the Pre-Funded Warrants and, (iii) in a private placement under Rule 506 of Regulation D, 17,400,000 warrants, or the Purchase Warrants at a combined purchase price of $0.23 per Common Share and Purchase Warrant if purchasing the Common Shares, or $0.22 per Pre-Funded Warrant and Purchase Warrant if purchasing the Pre-Funded Warrants. Each Purchase Warrant entitles the Purchaser to purchase one Common Share for a period of five years from the date of issuance for an exercise price of $0.23 per share. The Purchase Agreement contained customary representations and warranties and agreements of the Company and the Purchasers and customary indemnification rights and obligations of the parties. The offering closed on October 13, 2022 resulting in gross proceeds of approximately $4.0 million.

 

On November 22, 2022, the Company filed a registration statement with the SEC registering the resale, from time to time, by the selling shareholders named therein of up to 17,400,000 of our Common Shares issuable upon the exercise of the Common Share purchase warrants issued to the Selling Shareholders in a private placement pursuant to the Securities Purchase Agreements dated October 10, 2022 by and between the Selling Shareholders and the Company. That registration statement went effective on December 15, 2022.

 

On December 26, 2022, we were notified that there had occurred a significant infiltration of water into our warehouse premises located at 1751 Richardson, Suite 2207, Montreal, Quebec, Canada, due to a leaking water pipe in the floor above (which floor is not leased by the Company). Upon inspection of the premises, we believed that there could be substantial damage to our warehoused inventory of communication devices and signal boosters, the dollar value of which was presently not determinable. We are continuing to assess the potential damages, which will require a special inspection to determine the condition of the merchandise. Management believes that any damage is covered by its current property insurance policy and has filed a claim with our commercial property insurer whose policy covers the selling price of damaged inventory. Because we store similar inventory in another location, we did not believe that this event would result in any interruption of our sales activities, and thus future revenues should not be impacted by the water damage to the subject inventory. Only new, non-damaged, quality products will be shipped to our customers. From a balance sheet and income statement perspective, any damaged inventory will be considered impaired and written off (expensed) on the Company’s income statement as an impairment due to the water damage, and the inventory values will be reduced on the balance sheet by the amount of the damages in the fourth quarter of 2022. Any insurance proceeds receivable will be recorded as income in the quarter (likely in 2023) when it is at least virtually certain that the proceeds to be paid by the Company’s insurer have been agreed by both parties. Under international accounting standards, insurance proceeds are accounted for as “reimbursements” and would be recognized as a separate asset (with related income) when the recovery is virtually certain.

 

43

 

 

On January 18, 2023, we entered into warrant exercise agreements with fourteen existing accredited investors to exercise certain outstanding warrants, or Existing Warrants, to purchase up to an aggregate of 18,042,857 of the Company’s Common Shares. The gross proceeds to the Company from the exercise of the Existing Warrants totaled approximately $3,608,571, prior to deducting warrant inducement agent fees and estimated offering expenses. In consideration for the immediate exercise of the Existing Warrants for cash, the exercising holders received new unregistered warrants, or New Warrants, to purchase up to an aggregate of 18,042,857 Common Shares (equal to 100% of the Common Shares issued in connection with the exercise) in a private placement pursuant to Section 4(a)(2) of the Securities Act. In connection with the warrant exercise, the Company also agreed to reduce the exercise price of the Existing Warrants from $0.23 to $0.20 per share. The warrant exercise agreements and the New Warrants each include a beneficial ownership limitation that prevents the warrant holder from owning more than 4.99% (which may be increased to 9.99% in accordance with the terms of the New Warrants) of the Company’s outstanding Common Shares at any time. The New Warrants are exercisable immediately upon issuance at a cash exercise price of $0.20 per share and have a term of exercise equal to five years. However, the holder of the New Warrant may also effect an “alternative cashless exercise” on or after the earlier of: (i) one hundred and eighty (180) day anniversary of the initial exercise date (January 19, 2023) or (ii) the day after effectiveness of the registration statement of which this prospectus is a part. In such event, the aggregate number of Common Shares issuable in such alternative cashless exercise pursuant to any given notice of exercise electing to effect an alternative cashless exercise will equal the product of (x) the aggregate number of Common Shares that would be issuable upon exercise of the New Warrant in accordance with the terms of the New Warrant if such exercise were by means of a cash exercise rather than a cashless exercise and (y) 1.0, which would result in an effective exercise price of $0 at such time. In connection with the exercise of the Existing Warrants, the Company reduced the exercise price of 2,989,130 of certain of its remaining unexercised Common Share purchase warrants from $0.23 per Common Share to an exercise price of $0.20 per Common Share, which warrants may subsequently be repriced to $0 if the cashless exercise price of the New Warrants is triggered. However, previously issued warrants: (i) for 1,805,585 Common Shares that currently trade on the Nasdaq Capital Market under the symbol “SYTAW” that have an exercise price of $6.85 per share; (ii) for 1,294,500 Common Shares that were issued in a private transaction that have an exercise price of $11.50 per share; and (iii) for 9,999,999 Common Shares that were issued in a private transaction that have an exercise price of $2.30 per share are not required by their terms to be repriced.

 

On February 15, 2023, we filed a registration statement with the SEC registering for resale, from time to time, by the selling shareholders named therein up to 19,781,987 of our Common Shares issuable upon the exercise of: (i) the Common Share purchase warrants for 18,042,857 Common Shares (the “New Warrants”) issued to certain of the selling shareholders in a private placement pursuant to Warrant Exercise Agreements dated January 18, 2023 by and between those selling shareholders and the Company and (ii) upon the exercise of the Lind Waiver Warrants (defined therein) for 1,739,130 Common Shares issued to Lind under the securities purchase agreement dated October 27, 2021. That registration statement went effective on March 30, 2023.

 

Our auditor has agreed with management’s decision to include a “going concern” explanatory paragraph in its report on our consolidated financial statements for the fiscal year ended December 31, 2022, expressing substantial doubt about our ability to continue as an ongoing business for the next twelve months. Our consolidated financial statements do not include any adjustments that may result from the outcome of this uncertainty. If we cannot secure the financing needed to continue as a viable business, our shareholders may lose some or all of their investment in us. The Canadian registered office of the Company is located at 885 West Georgia Suite 2200, Vancouver, British Columbia V6C-3E8 and our warehouse and Canadian sales headquarters is located at 1751 Richardson Street, Suite #2207, Montreal, Quebec H3K-1G6, Canada. Our agent for U.S. federal securities law purposes is c/o Cogency Global Inc., 122 East 42nd Street, 18th Floor, New York, NY 10168.

 

44

 

 

The following diagram illustrates our corporate structure as of the date of this MD&A:

 

 

 

Our website address is https://www.siyatamobile.com/. The information contained on our website or available through our website is not incorporated by reference into and should not be considered a part of this Annual Report, and the reference to our website in this Annual Report is an inactive textual reference only. The SEC also maintains an Internet website that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. Our filings with the SEC are also available to the public through the SEC’s website at www.sec.gov.

  

B. Business Overview

 

Siyata Mobile Inc. is a leading global developer of innovative cellular-based communications solutions over advanced mobile networks under the Uniden® Cellular and Siyata brands to global first responders and enterprise customers. Siyata’s three complementary product categories include rugged handheld mobile devices and in-vehicle communications solutions for first responders, enterprise customers, commercial fleet vehicles and industrial workers, and cellular amplifiers to boost the cellular signal inside homes, and buildings and vehicles.

 

Our customer base includes cellular network operators and their dealers, as well as commercial vehicle technology distributors for fleets of all sizes in the United States, Canada, Europe, Australia and the Middle East.

 

45

 

 

Products

 

The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (“PoC”) smartphone devices. These rugged business-to-business (“B2B”) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries.

 

Prior to 2021, Siyata sold rugged handsets, such as the Uniden UR5 and Uniden UR7 only in international markets. In Q2 2022, Siyata unveiled its next generation rugged device, the SD7. The SD7 is Siyata’s first mission critical push-to-talk device (“MCPTT”) and is also the first rugged handset that Siyata announced in North America in the fourth quarter of 2021, and is now shipping in North America, Europe, The Middle East and Australia. The SD7 Rugged PTT Handset is targeting first responders and enterprise customers who have previously used traditional legacy two-way Land Mobile Radios (“LMR”) but who would prefer a solution that provides wide-area coverage like a cellular device, and also one that provides the same core functionality of Push-to-Talk that they used with their previous older technology.

 

 

 

 

 

Our second product category is purpose built In-Vehicle communication devices. In Q4 2021, Siyata launched the VK7, a first-of-its-kind, patent-pending vehicle kit with an integrated 10-watt speaker, a simple slide-in connection sleeve for the SD7 Handset, and an external antenna connection for connecting an antenna to allow for an in-vehicle experience for the user that is similar to that from a traditional land mobile radio (“LMR”) device. The VK7 has been uniquely designed to be used with the SD7 Handset, while connecting directly into the vehicle’s power and can also connect to a Uniden cellular amplifier for better cellular connectivity. The VK7 can also be equipped with an external remote speaker microphone (“RSM”) to ensure compliance with hands-free communication legislation.

 

46

 

 

 

 

VK7 Vehicle Kit

 

The Uniden® UV350 4G/LTE, is a purpose built In-Vehicle communication device designed specifically for professional vehicles such as trucks, vans, buses, emergency service vehicles and other enterprise vehicles. This platform is designed to facilitate replacement of the current in-vehicle, multi-device status-quo with a single device that incorporates voice, PoC, data, fleet management solutions and other Android based professional applications. The UV350 also supports Band 14 for the First Responder Network Authority, or FirstNet®, compatibility which is the U.S. First Responders 4G/LTE network with PoC capabilities that aims to replace aging two-way radio systems currently in use.

 

 

 

UV350 In-Vehicle Device

 

The aforementioned portfolio of solutions offers the benefits of PoC without any of the difficulties managing the current generation of rugged smart/feature phones and is ideally suited as a perfect upgrade from Land Mobile Radios (“LMR”). Used for generations, LMR has a significant number of limitations, including network incompatibility, limited coverage areas, and restricted functionality that leave a huge need for a unified network and platform. Siyata’s innovative PoC product lines are helping to service the generational shift from LMR to PoC. According to VDC Research, the LMR market is growing at a 5.9% compound annual growth rate, while the PoC market is growing at 13.6% CAGR and annual PoC shipments are expected to grow to 2.7 million in 2023.  

 

47

 

 

Qualifications for the UV350 In-Vehicle device with North American carriers began with Bell Mobility in late Q4 2018, at AT&T as well as at its first responder cellular network FirstNet®, in late Q2 2019, with Rogers Wireless and Verizon Wireless in Q4 2019, and internationally with Telstra in Q4 2021. These were major milestones for the Company following Siyata’s seven years of experience perfecting in-vehicle cellular based technology, vehicle installations, software integration with various Push-to-Talk (“PTT”) solutions and intensive carrier certifications.

  

Siyata’s customer base includes cellular network operators and their dealers, as well as commercial vehicle technology distributors for fleets of all sizes in the U.S., Canada, Europe, Australia, The Middle East and other international markets.

 

Cellular boosters are our third product category with approximately 30 million of these devices sold globally every year. Siyata manufactures and sells Uniden® Cellular boosters and accessories for enterprise, first responder and consumer customers with a focus on the North America markets. Cellular communication provides a robust, secure environment not just for remote workers, in-home and in-vehicles; but also for restaurant patrons who wish to download menus; for patients at pharmacies who need to verify identity and download scripts; for remote workers who require strong clear cellular signals; and for first responders where connectivity literally means the difference between life and death - just to name a few examples. The vehicle vertical in this portfolio complements Siyata’s in-vehicle and rugged handheld smartphones as these sales can be bundled through the Company’s existing sales channels.

 

Uniden U70P In-Building Booster Uniden UM50 In-Vehicle Booster Uniden UM2M In-Vehicle Booster

 

We offer a full line of cellular boosters, to boost cellular reception, under the brand name Uniden®. We have entered into a partnership whereby Uniden America Corporation, the North American subsidiary of Japan-based Uniden Corporation, has granted the exclusive license to us to market cellular signal boosters under the Uniden® brand name within the U.S. and Canada, on a rolling three year contract term, with the current extension expiring December 31, 2031 unless sooner terminated pursuant to the terms of this Agreement. As a world-wide leader in wireless communications, Uniden America Corporation manufactures and markets wireless consumer electronic products. Based in Fort Worth, Texas, Uniden sells its products through dealers and distributors throughout North, Central and South America. Uniden Cellular booster kits solve issues of poor reception, dropped calls, lost data and transmission quality issues that users routinely experience on every cellular network. These easy-to-install cellular booster kits are designed for homes, cabins, offices, and buildings to improve the cellular signal reception indoors, allowing people to use their cellular phones indoors where they previously could not do so. We also offer models designed for vehicles, both wired and wireless boosters, to improve the cellular reception inside a vehicle that is driving in a weak cellular signal area. Uniden cellular signal boosters offer kits designed to offer cellphone coverage for difference distances, including kits for a small area of 1 or 2 rooms, and more expansive solutions that will cover over 100,000 sq. ft. Our cellular signal boosters are carrier agnostic to ensure the best signal integrity, supporting 2G, 3G, 4G and soon 5G (in development) technologies on all carriers operating in North America.

  

48

 

 

Customers and Channels

 

Qualifications for the UV350 In-Vehicle device with North American carriers including Bell Mobility, AT&T (as well as at its first responder cellular network FirstNet®), Rogers Wireless, Verizon Wireless and internationally with Telstra. These are major milestones for the Company following Siyata’s seven years of experience perfecting in-vehicle cellular based technology, vehicle installations, software integration with various Push-to-Talk (“PTT”) solutions and intensive carrier certifications.

 

Siyata’s customer base includes cellular network operators and their dealers, as well as commercial vehicle technology distributors for fleets of all sizes in the U.S., Canada, Europe, Australia, the Middle East and other international markets.

 

The North American Tier 1 cellular carriers that Siyata is working with have large scale distribution and sales channels. With an estimated 25 million commercial vehicles including 7.0 million first responder vehicles, the Company sees the North American market as its largest opportunity with a total addressable market over $19 billion. These Tier 1 cellular carriers have a keen interest in launching the UV350 as it allows for new SIM card activations in commercial vehicles and increased ARPU from existing customers with corporate and first responder fleets while targeting new customers with a unique, dedicated, multi-purpose in-vehicle IoT smartphone.

 

In addition, our rugged handsets are targeted to approximately 47 million enterprise task and public sector workers across North America including construction, transport& logistics, manufacturing, energy & utility, public safety and federal government. As of December 31, 2022, Siyata had secured North American wireless carrier approvals of the SD7 Handset for use on their networks from AT&T, FirstNet, Verizon, and Bell Mobility. During 2023, Siyata has since added T-Mobile and US Cellular to its list of North American wireless carriers who have approved SD7 for use on their networks. Internationally, Telstra from Australia has also approved SD7 for use on their network during 2023.

 

Our Pricing

 

For wireless carriers, they are free to price the device how they choose. In most cases for significant sales opportunities the carriers are willing to subsidize the cost of the device in order to secure the new activations with the associated monthly Average Revenue Per User, or ARPU.

 

Even our unsubsidized full price is competitive compared to other hardware solutions, but when our device is subsidized, the capital and operational expense benefits to customers compared to other solutions are even greater.

 

Competition

 

Rugged Handsets Category

 

Our direct competitors include Sonim Technologies, Kyocera, and one ruggedized model from Samsung. These competitors also target sales of Push-to-Talk over Cellular (PoC) solutions through wireless carriers in North America and internationally. None of these competitors offer a unique solution like our SD7 Handset which focuses on a simple upgrade from two-way radios, nor do they offer an equivalent to our VK7 Vehicle Kit. These direct competitors focus on more expensive ruggedized Smartphones.

 

Indirectly, we compete with low-cost Push-to-Talk over Cellular devices designed and developed by various Chinese companies including Telo, Inrico, and others. These products are not approved for sale by North America wireless carriers due to lower overall device specifications which do not meet requirements of North American wireless carriers. These devices are mostly sold in international markets to highly price sensitive customers.

 

49

 

 

Indirectly, we also compete with traditional two-way LMR radios, also known as “portables” that are carried or worn on a belt and used for PTT communications. These are sold by a small number of large LMR vendors who sell directly to large first responder organizations and to large enterprise customers. They also sell through dealers and distributors to small and medium-sized commercial customers. These products are generally not sold through wireless carriers in North America or internationally. The government and enterprise customers that they target are now often considering the alternative of Push-to-Talk over Cellular since customers do not need to purchase repeaters and towers nor any government licensing for the frequencies that they use. Also, Push-to-Talk over Cellular provides much wider-area coverage, and these PoC solutions tend to be less expensive than traditional LMR radios both to purchase the PoC hardware such as the Siyata SD7 Handset, as well as to subscribe to monthly PoC service from a wireless carrier.

 

In-Vehicle Category

 

We do not believe that we have any direct competitors within the in-vehicle market category in North America that provide a dedicated cellular based device for commercial and first responder vehicles, and we believe that no other company offers an In-Vehicle IoT device that is approved for sale in North America by wireless carriers.

 

We have several indirect competitors. Firstly, customers could choose a handheld phone along with a professionally installed third party car kit. There are car kit providers who attempt to make their car kits compatible with popular handheld phone models. By comparison, the UV350 device offers enhanced audio quality, safety, and reception. Furthermore, the UV350 is always active and can be used in temperature extremes. Furthermore, the UV350 kit is one complete solution from one supplier, as opposed to buying separately from two different companies and assembling a phone and a car kit that offers no proven compatibility.

 

Our second group of indirect competitors are rugged tablets that can be placed in a mount. The UV350 device offers better audio quality, better safety, better cellular reception, and it is always on and ready to be used. Also, compared to a tablet, the UV350 can also make cellular calls including emergency 911 calls whereas the tablet cannot as it is a data only device.

 

Our third group of indirect competitors are In-Vehicle Two-way LMR Radios also knows as “mobiles”. Not only can the UV350 make phone calls which the LMR radio cannot, but the UV350 offers much better coverage due to using the cellular network as opposed to a limited two-way radio network. And the UV350 can support downloadable Android apps and can serve as a modem for IoT devices and as a Wi-Fi hotspot for further connectivity options and more.

 

Our fourth group of indirect competition is a leading global LMR vendor who offers an In-Vehicle device which is a Push to Talk over Cellular device, compatible only with its own OEM’s PTT application, and as it is not a smartphone based device so it does not offer any downloadable apps (fleet management, GPS tracking, live video feed, etc.) nor the ability to make a phone call over the wireless network. This LMR vendor sells the In-Vehicle device directly to customers and through its dealer channel, but not through wireless carriers.

 

Cellular Boosters Category

 

Within the Cellular Booster category, we have several direct competitors, including Wilson Electronics, LLC, Nextivity Inc., and SureCall Company.

 

Intellectual Property

 

We own two patents that we acquired from ClearRF, as discussed below, and we have entered into several licensing agreements for the use of a trademark and certain patents.

  

50

 

 

Uniden America Corporation

 

In December 2012, Signifi Mobile, the Company’s wholly-owned subsidiary entered into a license agreement with Uniden America Corporation, as amended (the “Uniden Agreement”). The Uniden Agreement provides for the Company to use the trademark “Uniden®”, along with associated designs and trade dress to distribute, market and sell its In-Vehicle device, cellular signal booster and accessories during its term in North America. The agreement includes renewal options up to December 31, 2031 and is subject to certain minimum royalties.

 

Wilson Electronics LLC

 

Effective January 1, 2018, Signifi Mobile Inc., the Company’s wholly-owned subsidiary, entered into an agreement with Wilson Electronics, LLC to permit the Company to utilize several of Wilson Electronics’ patents related to cellphone boosters (the “Wilson Agreement”). The Wilson Agreement grants the Company an indefinite right to utilize its cellphone booster-related patents in exchange for paying Wilson Electronics, LLC a royalty fee for boosters sold by the Company. The Wilson Agreement remains in force until the Wilson patents on the Booster products expire.

 

Via Licensing Corporation

 

Effective June 8, 2018, the Company entered into two separate licensing agreements with Via Licensing Corporation to utilize worldwide patents related to the coding and decoding of “android” software as well as access and download within the “LTE/ 4G” network. This patent is for an initial period of 5 years and can be extended for a further 5-year term. The Company has the right at any time during the term on any extension hereof, to terminate these agreements upon providing 60 days advanced notice of termination. The quarterly royalty fees are based solely on product sales and is a percentage formula based upon the number of units sold, the country manufactured and the country location of the end customer. There are no minimum royalty fees payable according to the agreement.

 

eWave Mobile Ltd.

 

Effective October 1, 2017, we entered into an Asset Purchase Agreement with eWave Mobile Ltd., or eWave, for the purchase of certain distribution rights and contracts in connection with the right to sell and distribute in Israel certain cellular devices for the push to talk market, or the eWave Supplies, in exchange for $700,000 in cash and issued shares of common stock of the Company equal to $700,000. Additionally, we shall pay eWave 50% of up to $1,500,000 in net profit that we earn from sales related to the eWave Suppliers, and 25% thereafter of the net profit exceeding $1,500,000.

 

 Clear RF, LLC

 

On March 31, 2021, the Company’s indirectly and wholly-owned subsidiary ClearRF Nevada Inc. acquired all of the issued and outstanding interests of Clear RF, LLC, or ClearRF, a Washington State limited liability company, for a total purchase price of US$700,000 in a combination of cash and Common Shares. ClearRF produces M2M (machine-to-machine) cellular amplifiers for commercial and industrial M2M applications and offers patented direct connect cellular amplifiers and patented auto gain & oscillation control designed for M2M and “internet-of-things.” Or IoT, applications. Two patents (described below) held by ClearRF were subsequently transferred and assigned to ClearRF Nevada following the closing of this acquisition.

 

  i. RF Passive Bypass technology enables tethered devices to communicate through the amplifier network, even if the amplifier loses power, or when the signal is not required, a key differentiator amongst competitors, in particular for mission-critical applications and first responder vehicles that require constant clear cellular coverage and connectivity.

 

  ii. Auto Gain & Oscillation Control detects the level of incoming signal strength and self-adjusts output power to ensure maximum signal strength. This feature is vital for telematics (mobile) M2M applications because the amplifier will be in constant motion and will require periodic self-adjustment based on changing incoming signal environment.

 

51

 

 

Seasonality

 

We do not experience any effects of seasonality it our business. Our products are designed to function at full capacity under all weather conditions and therefore, we do not experience any shifts in our sales patterns.

  

C. Organizational Structure

 

Our subsidiaries as of December 31, 2022 are as follows:

 

Name of Subsidiary   Principal Activities   Place of Incorporation   Ownership  
Queensgate Resources Corp.   Inactive   British Columbia, Canada     100 %
Queensgate Resources US Corp.   Inactive   Nevada, USA     100 %
Siyata Mobile (Canada) Inc.   Inactive   British Columbia, Canada     100 %
Siyata Mobile Israel Ltd.   R&D and wholesale distribution   Israel     100 %
Signifi Mobile Inc.   Wholesale distribution   Quebec, Canada     100 %
ClearRF Nevada Ltd.   Inactive   Nevada, USA     100 %
ClearRF LLC   Inactive holding patents   Washington, USA     100 %

  

D. Property, Plant and Equipment

 

Our warehouse and Canadian sales headquarters are located at 1751 Richardson Street, Suite #2207, Montreal, Quebec H3K-1G6, Canada, with approximately 5,616 square feet of space. We entered into a lease agreement for its property for a 20-month term, beginning on October 1, 2022, and expiring on May 31, 2024. Under this Lease, we pay net rent of $2.00 per square foot per annum, approximately $11,232 annum, payable in monthly equal installments. Additional warehouse space was leased at 250 Ford Boulevard, town of Chateauguay, Quebec, J6J-4Z2 with approximately 2,837 square feet of space. We entered into a lease agreement for its property for a 26 month term, beginning on April 1, 2022 and expiring on May 31, 2024. Under this Lease, we pay net rent of $11.50 per square foot per annum, approximately $32,625 annum, payable in monthly equal installments.

 

We believe that our existing facilities are adequate to meet current requirements and that suitable additional or substitute space will be available as needed to accommodate any further physical expansion of operations and for any additional offices.

 

ITEM 4A. UNRESOLVED STAFF COMMENTS

 

None.

 

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

 

A. Operating Results

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes included elsewhere in this Annual Report. The discussion below contains forward-looking statements that are based upon our current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from these expectations due to inaccurate assumptions and known or unknown risks and uncertainties, including those identified in “Cautionary Note Regarding Forward-Looking Statements” and under “Risk Factors” elsewhere in this Annual Report.

 

52

 

 

Overview

 

Siyata Mobile Inc. is a leading global developer of innovative cellular-based communications solutions over advanced mobile networks under the Uniden® Cellular and Siyata brands to global first responders and enterprise customers. Siyata’s three complementary product categories include in-vehicle communications solutions and rugged handheld mobile devices for first responders, enterprise customers, commercial fleet vehicles and industrial workers, and cellular amplifiers to boost the cellular signal inside homes, buildings and vehicles.

  

On September 25, 2020 the Company listed on the Nasdaq Capital Markets (“Nasdaq”) under the symbol SYTA for its Common Shares, and the Company’s warrants issued on September 29, 2020 at $6.85 are traded under the symbol SYTAW, and expire in five (5) years from the date of issue.

 

The registered and records office is located at 2200 - 885 West Georgia Street, Vancouver, BC V6C 3E8, Canada.

 

Significant Highlights

 

The following highlights and developments for the year ended December 31, 2022:

 

On January 6, 2022, we priced our underwritten public offering of 8,695,652 Common Shares (or pre-funded warrants to purchase Common Shares in lieu thereof) and accompanying warrants to purchase up to 8,695,652 Common Shares. Each Common Share (or pre-funded warrant in lieu thereof) was sold together with one Common Share purchase warrant at a combined effective offering price of $2.30. The Company also granted the underwriter an option to purchase up to an additional 1,304,347 Common Shares and an additional 1,304,347 warrants.

 

On January 18, 2022, we announced that we entered into a new distribution agreement with U.S.-based TESSCO Technologies Incorporated, a leading value-added distributor of wireless communications products for network infrastructure, site support, and fixed and mobile broadband networks. Sales through this distribution agreement are expected to begin in the first quarter of 2022.

 

On February 2, 2022, we announced that Goosetown Communications a division of Goosetown Enterprises, Inc., will introduce the Siyata SD7 device with its Push-to-Talk over Cellular service TeamConnect®.

 

On February 7, 2022, we announced that we had received $750,000 in purchase orders from an emergency medical service provider and an international defense contractor both located in the European, Middle Eastern and African region with its handheld rugged Push-to-Talk devices.

 

On February 15, 2022, we announced that at our Annual General Meeting, our shareholders fixed the number of directors at five, approved the nominees of the Board of Directors, approved the appointment of Davidson & Company LLP, Chartered Professional Accountants, as auditor of the Company for the ensuing year, approved the Company’s amended and restated Equity Incentive Plan and approved the Lind financing.

 

On May 3, 2022, we announced that our SD7 push to talk over cellular device was certified and approved for use on FirstNet®, the first high-speed, nationwide wireless broadband network dedicated to public safety.

 

On June 7, 2022, we announced that Verizon Communications Inc., the largest mobile cellular telephone operator in the U.S. by total retail connections, agreed to fully integrate our rugged SD7 device into their network.

 

On June 27, 2022, we announced that our SD7 rugged device first became commercially available on and will be sold through the FirstNet® network and to AT&T Inc.’s enterprise channels.

 

On July 13, 2022, we announced that Logic Wireless Europe Ltd. a leading distributor of business-critical communication solutions across the United Kingdom, Australia, New Zealand and the Pacific Islands, agreed to introduce the Siyata SD7 rugged PoC device integrated with ChatterPTT.

 

53

 

 

On July 14, 2022, we announced that we launched a new product, a Siyata High Power User Equipment antenna, in conjunction with Assured Wireless Corporation.

 

On July 18, 2022, we announced that we signed an agreement with Spain’s Wireless Zeta Telecomunicaciones, S.L., or Azetti, to offer the Company’s SD7 rugged mission-critical push-to-talk device through Azetti’s existing enterprise sales channels.

  

On July 26, 2022, we announced our SD7 rugged mission-critical push-to-talk device became available for customers who need the integrated industry-leading PTT solutions from TASSTA, a global MCPTT software provider and end-to-end solution for critical communications.

 

On July 28, 2022, we announced that our SD7 rugged push-to-talk over cellular devices were used to provide critical emergency communications services for the World Athletics Championships “Oregon22” summer games.

 

On September 1, 2022, we announced that we had received a notification letter dated August 26, 2022 from the Listing Qualifications Department of Nasdaq, notifying us that we were currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2), resulting from the fact that the closing bid price of the Company’s Common Shares were below $1.00 per share for a period of 30 consecutive business days. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was given a compliance period of 180 calendar days, or until February 22, 2023 (the “Compliance Period”), to regain compliance with Nasdaq’s minimum bid price requirement. The Company did not regain compliance with the minimum $1.00 bid price per share requirement during the first 180-calendar-day Compliance Period and submitted a written request to the Nasdaq to afford it an additional 180-day compliance period to cure the deficiency.

  

On September 8, 2022, we announced that our SD7 rugged mission-critical push-to-talk device became able to be integrated with CrisisGo Inc.’s Panic App, giving teachers instant access to first responders with a single push of a button.

 

On September 22, 2022, we announced that we received a purchase order from a federal government contractor who will provide Uniden® cellular booster kits and accessories to the U.S. Navy.

 

On October 26, 2022, we announced that its SD7+ ruggedized handset would soon be powered with Visual Labs Inc.’s innovative body camera software, eliminating the need for users to carry two separate devices (a communication device and a body camera), creating an ideal upgrade solution from legacy land mobile radio technologies or proprietary stand-alone body cameras.

 

On October 31, 2022, we announced that we hired telecom industry veteran Dan Leech to join the Company’s sales team.

 

On November 16, 2022, we announced that Bell Mobility Inc., a leading wireless operator in Canada with more than 10 million subscribers and a division of Bell Canada, agreed to launch Siyata’s rugged SD7 device onto their network in the fourth quarter 2022.

 

On December 6, 2022, we announced that we added DCS 2 Way Radio Ltd. doing business as RadioTrader, the UK’s and Ireland’s premier two-way radio supplier, as a distributor of our SD7 ruggedized, mission critical PoC device and VK7 vehicle kit accessary in the United Kingdom and Ireland.

 

Outlook

 

Siyata has laid the foundation for greater distribution with expanded partnerships, key new sale hires, and expanded product offerings into North America. The pandemic caused by COVID-19 slowed the company’s growth plans for 2021, however business has resumed in 2022 in all three product categories. Management is hopeful that this momentum will continue, in particular, as it leverages its key sales channels, and with its expanded and refreshed product offerings.

 

54

 

 

Uniden® UV350 | Many large-scale programs were delayed due to the pandemic, therefore creating pent-up demand for this disruptive solution. Active engagements including many customer trials have resumed in 2022 which should translate into robust growth in this product line.

 

Rugged Handsets | Siyata’s rugged handsets are targeted to the approximately 47 million enterprise task and public sector workers across North America including construction, transport and logistics, manufacturing, energy and utility, public safety, and federal government. To date, Siyata has sold its rugged handsets only in international markets. Siyata expanded its footprint in this product category with the launch of the SD7 device, in the fourth quarter of 2021 in North America. The SD7 is a next-generation device and Siyata’s first mission-critical push-to-talk handset. [Source: U.S. Department of Transportation, VDC Research.]

 

Cellular Boosters | The pandemic has helped fuel strong demand for Siyata’s boosters in 2020 and 2021. This momentum accelerated in 2022 with programs with existing customers and expanding opportunities in new verticals.

 

The following highlights and developments for the three months ended March 31, 2023:

 

On January 9, 2023, we announced that T-Mobile US, Inc. planned to launch Siyata’s rugged SD7 device onto T-Mobile’s United States IoT network in the first quarter 2023.

 

On January 18, 2023, we announced that we received follow-on orders from an existing customer, a leading Saudi Arabian cellular carrier, for our Uniden® UV350, a 4G/LTE all-in-one in-vehicle communication device.

 

On January 23, 2023, we announced that we received an order for our next-generation mission critical push-to-talk solution, which includes its SD7 device and related accessories, from a multi-billion-dollar, integrated resort and residential property development located in The Bahamas.

 

On February 21, 2023, we announced that we had received an order for $750,000 for its next-generation MCPTT solution to equip an independent emergency management service provider. The order included the Company’s SD7 devices and related accessories.

 

On February 23, 2023, the Company received written notification from the Listing Qualifications Department of Nasdaq granting the Company’s request for a 180-day extension to regain compliance with Nasdaq’s minimum bid price requirement. The Company now has until August 21, 2023 to meet the requirement. If at any time prior to August 21, 2023, the bid price of the Company’s Common Shares closes at $1.00 per share or more for a minimum of 10 consecutive business days, the Company will regain compliance with the Bid Price Rule.

 

On February 27, 2023, we announced that we had launched the Siyata T600 Cellular Booster for T-Mobile 5G enterprise customers.

 

On March 6, 2023, we announced that we had successfully donated and deployed its mission critical push-to-talk solution for security and volunteer personnel at the 2023 Special Olympics New York Winter Games in Syracuse, New York.

 

On March 13, 2023, we announced that we would host an exhibitor’s booth at the International Wireless Communications Expo, or IWCE, 2023. Siyata Mobile will be showcasing our new SD7 Mission Critical Push-To-Talk solution, the SD7+ MCPTT with built in Body Camera and accessories in booth 2125 through the main entrance of the IWCE Welcome Pavilion from March 27-30 at the Las Vegas Convention Center, in the North Hall.

 

On March 20, 2023, we announced the successful certification and approval of its mission-critical PoC SD7 solution by Telstra, Australia’s largest wireless carrier.

 

55

 

 

On March 22, 2023, we announced the hiring of Zoila Hernandez as Director of Sales. Ms. Hernandez served as Development Manager for AT&T FirstNet®, a nationwide wireless communications network that was designed and built specifically for first responders. Previously, she served in various senior sales roles throughout the AT&T organization, having joined that firm in 1998.

 

On March 27, 2023, Siyata announced it is collaborating with CrisisGo to introduce cellular-based paging services.

 

Subsequent Events

 

On April 3, 2023, Siyata announced it had received an order from a US school district, its largest order to date in the Education vertical.

 

On April 17, 2023, Siyata announced it is accelerating European rollout of SD7 with Entropia Investments BV is commencing to sell Siyata’s SD7 solution.

 

On April 24, 2023, Siyata announced it has expanded its reseller network for SD7 with the addition of a leading US distributor called Two Way Direct who serves the two-way radio market.

 

On April 25, 2023, Siyata announced it is participating in 1x1 meetings at the inaugural EF Hutton Global Conference.

 

On April 26, 2023, Siyata announced its wholly-owned subsidiary, Signifi Mobile, Inc., entered into a Full Factoring Agreement for its accounts receivable with a private Canadian lending company as of April 21, 2023. Under the agreement, Signifi will assign virtually all of its accounts receivable up to $2.0 million to the lender who will pay Signifi 85% of the receivable balance and will charge a fee of 1.8% if the account is not collected in the first 30 days plus additional fees for late payments every 10 days and after 90 days. 

 

On April 27, 2023, Siyata filed Form 12b-25 on Form NT 20-F with the SEC.

 

On May 3, 2023, Siyata announced its wholly-owned subsidiary, Signifi Mobile, Inc., received a purchase order for over $900,000 to supply a U.S. public school district with its mission-critical PoC (MCPTT) SD7 handsets and accessories.

 

On May 16, 2023, Siyata announced its Q4 2022 and full year 2022 financial results.

 

On May 17, 2023, Siyata announced that KPN Royal Dutch Telecom (“KPN”) in the Netherlands are now selling the Siyata SD7 Handset.

 

On May 22, 2023, Siyata announced its participation in Critical Communications World tradeshow, held in Helsinki, Finland on May 23 to 25, 2023.

 

On May 24, 2023, Siyata announced its Q1, 2023 financial results.

 

On May 31, 2023, Siyata announced that it is presenting at the 13th annual LD Micro Invitational conference in Los Angeles, California from June 6 to 8, 2023.

 

On June 1, 2023, Siyata announced it had received an order from an Emergency Medical Services (“EMS”) organization for $1.2 million for In-Vehicle devices and for a new product called Siyata Real Time View, an in-fleet video monitoring solution.

 

On June 5, 2023, Siyata announced aggregate orders of $400,000 for its SD7 Handset and VK7 Vehicle Kit from the verticals of healthcare, education, and construction.

 

On June 12, 2023, Siyata announced that Minnesota Coaches, Inc, a privately held motor coach and school bus transportation company, has taken delivery of its first order of SD7 Handsets and VK7 Vehicle Kits.

 

56

 

 

On June 14, 2023, Siyata announced a new product called the Siyata Mobile Command Center for in-field communications for EMS organizations.

 

On June 15, 2023, Siyata announced its participation to showcase its SD7 Handset and VK7 Vehicle Kit in the Minnesota School Bus Operators Association’s Annual Summer Conference in Alexandria, Minnesota on June 19 to 21, 2023.

 

On June 20, 2023, Siyata announced that Mobile Tornado Group Plc will offer its robust PTT application on the Siyata SD7 Handset.

 

On June 21, 2023, Siyata announced its participation with CrisisGo to show its Mission Critical PTT and Emergency Response Management capabilities at NASRO 2023, a National School Safety Conference in Indianapolis, Indiana on June 28 to 29, 2023.

 

On June 22, 2023, Siyata announced new aggregate orders of approximately $600,000 for its Siyata SD7 Handset and VK7 Vehicle Kit in the vertical markets of education, construction, and logistics.

 

On June 27, 2023, Siyata announced the pricing of a new public offering of 50 million common shares at $0.045 per share. The gross proceeds to Siyata before fees, commissions, and expenses are expected to be $2.25 million, closing on or about June 28, 2023.

 

On July 6, 2023, Siyata announced the receipt of its single largest order for SD7 Handsets of $1.4 million, to be delivered in the second half of 2023.

 

On July 11, 2023, Siyata announced that it had entered into a securities purchase agreement with certain institutional investors to purchase 51.45 million common shares at a price of $0.045 per share. The gross proceeds to Siyata before fees, commissions, and expenses are expected to be $2.3 million, closing on or about July 13, 2023.

 

On July 12, 2023, Siyata announced that its 2023 Annual General Meeting of its stockholders will be held on Thursday August 3, 2023 at 1 pm ET.

 

On July 18, 2023, Siyata announced it had received orders from two large North American waste management companies for its SD7 Handset and VK7 Vehicle Kit, and for its UV350 In-Vehicle Device.

 

On July 20, 2023, Siyata announced its participation in APCO 2023, which is APCO’s International Annual Conference and Expo for public safety communications officials to be held on August 6 to 9, 2023, in Nashville, Tennessee.

 

On July 25, 2023, Siyata names public safety advocate and Business Development executive Doug Clark, formerly from AT&T FirstNet, as its new Assistant Vice President, Sales and Marketing.

 

See also Item 4. A. “Information on the Company – History and Development of the Company.”

 

Summary Of Quarterly Results

 

The following unaudited table sets out selected financial information for the Company on a consolidated basis for the last eight most recently completed quarters. 

 

   Quarter Ended 
   Mar 31,
2023
   Dec 31,
2022
   Sep 30,
2022
   Jun 30,
2022
   Mar 31,
2022
(restated)
   Dec 31,
2021
   Sep 30,
2021
   Jun 30,
2021
 
Income/(loss)  $(4,877,999)  $(6,588,309   $(527,948)  $(4,304,088)  $(3,878,909)  $(4,979,661)  $(5,667,937)  $(10,862,538)
Comprehensive income/(loss) for the period  $(4,877,999)  $(6,589,329)  $(390,838)  $(4,278,102)  $(3,903,377)  $(4,833,795)  $(5,677,274)  $(10,927,718)
Loss per share  $(0.08)  $(0.17)  $(0.03)  $(0.29)  $(0.30)  $(0.99)  $(1.18)  $(2.26)

 

57

 

 

RESTATED RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2023

 

The following is an analysis of the Company’s restated operating results for the three months ended March 31, 2023, and includes a comparison against the three months ended March 31, 2022.

 

Operations:

 

Revenues for the three months ended March 31, 2023, were $1,802,637 compared to $832,974 for the three months ended March 31, 2022. This increase of $969,663 (116%) is due mainly to the increase in the sale of rugged devices as a result of the launching of the SD7 in 2022 of $995,000 or 268% increase, offset by a $25,337 decrease in sales of boosters in the same period.  

 

Cost of sales for the three months ended March 31, 2023, were $1,306,120 compared to $577,923 for the three months ended March 31, 2022. The gross margin dollars for the three months ended March 31, 2023 and March 31, 2022 was $496,517 (27.5% of sales) and $255,051 (30.6% of sales), respectively, a positive variance in gross margin by $241,466 (3.1% decrease in gross margin percentage). This relates to the increase in sales of rugged and in-vehicle cellular devices at lower margins compared to the sale of industrial boosters in the USA marketplace at slightly higher margins.

  

Amortization and depreciation costs for the three months ended March 31, 2023, were $401,640 compared to $124,505 for the three months ended March 31, 2022, respectively, a negative variance of $277,135. This negative variance is due to the increased intangible asset amortization that began for the SD7 in late 2022 of $298,980 offset by the decrease in the right of use amortization in the period by $21,845.

 

Development expenses for the three months ended March 31, 2023, were $53,985 compared to $123,316 for the three months ended March 31, 2022, respectively. This positive variance is due to the decrease of the development costs incurred on the company’s rugged device development program that did not meet the criteria for capitalization was lower in 2022 due to more focused development activities on capitalizable products.

 

Selling and marketing costs for the three months ended March 31, 2023, were $1,003,365 compared to $1,045,061 for the three months ended March 31, 2022 respectively. This positive variance of $41,686 is due mainly to the decrease in promotional costs of $148,686, offset by both an increase in our U.S. sales team headcount of $87,000 and increased travel expense of $20,000.

 

General and administrative costs for the three months ended March 31, 2023, were $1,392,430 compared to $1,659,079 for the three months ended March 31, 2022, respectively. This positive variance of $266,649 (16%) relates mainly to the decrease consulting and director’s fees of $156,000 due to no bonuses paid in 2023, decreases in insurance included in office and general of $116,000, decrease in investor relations costs of $193,000, the decrease of $22,000 in travel costs, offset by an increase in professional services costs of $188,000 related to both the increase in fees for U.S. securities attorney and the additional costs for the annual PCAOB audit, increase of $26,000 in salaries expense related to additional employees, in 2023, a $6,351 increase in regulatory and filing fees.

 

Inventory Impairment costs for the three months ended March 31, 2023, were $NIL compared to $64,336 for the three months ended March 31, 2022, respectively.

 

Bad debts for the three months ended March 31, 2023, were $NIL compared to a recovery of $7,358 for the three months ended March 31, 2022, respectively.

 

Share-based compensation costs for the three months ended March 31, 2023, were $310,828 compared to $812,735 for the three months ended March 31, 2022, respectively. The decrease in share-based compensation relates to the valuation of stock options vested during the prior year period due to the issuance in Q1 2022 of 600,0000 RSU’s to directors and officers that vested immediately.

 

58

 

 

Finance expenses for the three months ended March 31, 2023, were $34,098 compared to $26,987 for the three months ended March 31, 2022, respectively. This negative variance of $7,111 consists of negative variance in other interest and bank charges of 1,728, negative variance interest on lease obligations of $12,603, offset by decrease in bank loan interest of $7,220.

 

Foreign exchange loss for the three months ended March 31, 2023, were $163 compared to a gain of $87,660 for the three months ended March 31, 2022, respectively This variance resulted from foreign currency fluctuations in the period.

 

Transaction costs for the three months ended March 31, 2023, were $NIL compared to $965,247 for the three months ended March 31, 2022, respectively In 2022, transaction cost related to share issuance costs incurred on the two equity raises undertaken in the year, which were allocated to the warrant liability and expensed when incurred.

 

Change in fair value of the convertible promissory note for the three months ended March 31, 2023, were $NIL compared to $2,680,457 for the three months ended March 31, 2022, respectively. In 2022, this resulted from both the repricing of the convertible feature of the promissory note when other capital raises reduced the convertible price and due to the full repayment of the promissory note via the issuance of share capital whose formula in the agreement between the parties required between 80%-90% of the lowest 5 day VWAP in a thirty day period which resulted in a significant fair value loss in the year.

 

Change in fair value of the warrant liability for the three months ended March 31, 2023, were $2,178,007 compared to a gain of $3,272,735 for the three months ended March 31, 2022, respectively. The three months ended 2023 amount relates to the inducement warrant fair value loss of $2,875,580 plus the transaction costs for the warrant exercise and re-issuance of $309,000 included in change in fair value plus the actual change in fair value for the period of a gain of $1,006,573. During the year ended December 31, 2022 additional warrants were issued which met the definition of a liability. 

 

Net loss for the period

 

The Company experienced a restated net loss for the three months ended March 31, 2023, were $4,877,999 compared to a net loss of $3,878,909 for the three months ended March 31, 2022, respectively, a negative variance of, ($999,090). This negative variance was due mainly to an increase in the fair value loss on financial derivatives of $2,770,285, increase in foreign exchange of $87,823, increase in finance expenses of $7,111, increase in bad debt expense by $7,358, and an increase in amortization of $277,135 offset by a decreases in inventory impairment of $64,336, decrease in development expense of $69,331, decrease in share-based payments of $501,907, a decrease in selling expenses of $41,686, increase in gross margin of $241,466 and a decrease in G&A expenses of $266,649.

 

Loss and comprehensive loss for the period

 

As a result of the activities discussed above, the Company experienced a restated comprehensive loss for the three months ended March 31, 2023, were $4,877,999 versus $3,903,377 for the three months ended March 31, 2022, respectively, representing a negative variance of $974,622.

 

Adjusted EBITDA

 

For the three months ended March 31, 2023, the adjusted EBITDA is negative ($1,953,263) versus negative ($2,629,373) in the prior year period, a positive variance of $676,110. Adjusted EBITDA is defined as the net operating loss excluding depreciation and amortization, intangible impairment, goodwill impairment and share-based compensation expense. It is a non-IFRS calculation that should be compared to our audited financial information included elsewhere in this Annual Report.

 

59

 

 

B. Liquidity and Capital Resources

 

The Company’s objective in managing liquidity risk is to maintain sufficient liquidity in order to meet operational and investing requirements at any point in time. The Company has historically financed its operations primarily through a combination of demand loans and the sale of share capital by way of private placements.

 

As at March 31, 2023 the Company had a cash balance $1,179,694 (Dec 31, 2022-$1,913,742). The Company had an accumulated deficit of $82,696,662 (Dec 31, 2022-$77,818,663) and working capital of $4,161,566 (December 31, 2022-$1,643,434).

 

Restated net cash flows related to operating activities used in the three month period ended March 31, 2023 and three months ended March 31, 2022 were negative ($3,112,570) and negative ($6,707,274), respectively. The decrease in cash used of $3,594,704 was primarily due to the decrease in the change in non-cash working capital items of $2,088,942, the decrease in foreign exchange of $11,666, a decrease of net loss including addbacks of $1,494,096.

 

The non-cash working capital variances consisting of decrease in trade and other receivables of $463,505, increase in prepaids of $491,942, decrease in inventory of $528,510, an increase in advances to suppliers of $519,709, a decrease in accounts payable and accrued liabilities of $967,476 and a decrease in deferred revenue of $149,600.

  

Restated net cash flows used in investing activities in three month period ended March 31, 2023 and three months ended March 31, 2022 were negative ($820,347) and negative ($894,593), respectively. A positive variance of $74,246. This positive variance relates primarily to the acquisition in q1 2022 of ClearRF of $155,014 that did not recur in 2023, offset by an increase in intangible asset additions of $78,270, and the increase in fixed asset additions of $2,498.

 

Restated net cash flows used in financing activities in the three month period ended March 31, 2023 and three months ended March 31, 2022 were $3,198,869 and $15,180,494, respectively. A negative variance of $11,981,625 relates to increase in Q1 2022 net proceeds of share capital raises after share issuance costs of $15,677,813, and an increase in cash transaction costs of $309,000, offset by both the $4,000,000 reduction in the convertible promissory note, and a $5,188 decrease in the lease payments and bank loan.

 

The future success of the Company is dependent on the continued success of its vehicle mounted communications products, its mobile rugged phones and its booster products together with the ability to finance the necessary working capital, at agreeable terms, to support the growth of the business.  

 

The Company’s restated unaudited condensed interim consolidated financial statements have been prepared in accordance with IFRS under the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business rather than a process of forced liquidation. These restated unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.

 

SHARE CAPITAL

 

  (a) Authorized Unlimited number of Common Shares without par value

 

Issued and Outstanding:

 

As at March 31, 2023, the Company had 62,911,417 common shares issued and outstanding (December 31, 2022 – 44,868,560).

 

As of the date of issuance of these financial statements total outstanding common shares is 185,393,404 pre 100-to-1 reverse stock split (1,853,955 after the reverse split that was effective as of August 9, 2023).

 

60

 

 

Transactions for the three months ended March 31, 2023 are as follows:

 

  The Company issued 18,042,857 common shares on the exercise of various warrants for gross proceeds of $3,608,571. Additionally, the Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 30, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 17,116,987 common shares were issued for cashless warrants subsequent to March 31, 2023.

 

As of the date of these restated unaudited condensed interim financial statements total outstanding common shares is 1,853,955 post 100-to-1 reverse split that was effective as of August 9, 2023, (185,393,404 pre-split).

   

(b)Common share transactions

 

 Transactions for the three months ended March 31, 2023 are as follows:

 

  The Company issued 18,042,857 common shares on the exercise of various warrants for gross proceeds of $3,608,571. Additionally, the Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 30, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,987 common shares were issued for cashless warrants subsequent to March 31, 2023.

 

Transaction subsequent to the quarter ended March 31, 2023 is as follows:

 

On June 28, 2023 the Company issued 50,000,000 at $0.045 per share for gross proceeds of $2,250,000 before offering expenses and other expenses included in share issuance costs.

 

On July 13, 2023, the Company issued 51,450,000 shares at $0.045 per share for gross proceeds of $2,315,250.

 

On August 3, 2023, the Company affected a 100-to-1 reverse stock split resulting in 185,393,404 shares converted with rounding into 1,853,955 shares.

 

Transactions for the three months ended March 31, 2022 are as follows:

 

  On January 11, 2022, the Company completed an underwritten public offering in the United States, raising a total of $20,013,043 in gross proceeds. The Company allocated the gross proceeds firstly to the warrant liabilities, with the remainder to the common shares. Direct costs have been allocated based on the percentage allocation of the proceeds. The underwritten public offering resulted in the sale to the public of 7,215,652 Units at $2.30 per Unit, with each Unit being comprised of one common share and one warrant (the “Unit Warrants”) exercisable at $2.30 per share. The Unit warrants are exercisable immediately and have a term of 5 years. Gross proceeds of $10,936,974 were allocated to the common shares, and $5,395,878 to the unit warrants liability.

 

In addition, the Company issued 1,480,000 pre-funded units (“Pre-Funded Units”) at $2.29 per Pre-Funded Unit. Each Pre-Funded Unit is comprised of a one-pre-funded warrant (a “Pre-Funded Warrant”) to purchase one common share, and one warrant to purchase one common share. The Pre-Funded Warrant allows the holder to acquire one common share of the Company at an exercise price of $0.01 per common share, and a warrant to purchase a common share at an exercise price of $2.30 per share. The warrants are exercisable immediately and have a term of 5 years. Each Pre-Funded Warrant is exercisable immediately and is exercisable until all Pre-Funded Warrants are exercised. Proceeds of $2,560,400 were allocated to the pre-funded warrants and $1,106,747 to the unit warrants in the warrant liability.

 

61

 

 

  (b) Common share transactions (cont’d)

 

The Company determined that the pre-funded warrants within the Pre-funded Units are common shares in substance, as they require only a minimal exercise price of $0.01. In addition, the underwriting agreement includes both the Units and Pe-funded Units and were negotiated together in the equity raise. Given that the purpose of the Prefunded Unit is in substance the same as that of the Unit (i.e., resulting in the ownership of both common shares and common share warrants) and that the terms of the warrants in both the Units and Prefunded Units are the same (i.e., the obligations of the Company for the units are the same), the Company determined that the Units and Pre-funded Units are closely related and should be combined into one unit of account for the purposes of allocating proceeds.

 

Therefore, the proceeds from the sale of the Units and Pre-funded Units are combined and allocated among the common shares, pre-funded warrants, and the common share warrants using the residual method, with the warrant liability being initially recognized at fair value as of the registration date and the residual amount being allocated to the common shares (i.e., equity).

 

62

 

 

  (b) Common share transactions (cont’d)

 

The Company concurrently sold an additional 1,304,347 warrants to purchase 1,304,347 common shares exercisable at $2.30 per share (the “Option Warrants”) pursuant to an over-allotment option exercised by the underwriter. The exercise price of the warrants issued in connection with the exercise of the over-allotment option was $0.0097 per warrant. Each Option Warrant is exercisable immediately and has a term of five years from the issue date. Proceeds of $975,393 were allocated to the option warrant liability. As the fair value of the warrant liability exceeded the proceeds received on the warrants of $13,043, a fair value loss of $962,350 was recognized in the statement of profit and loss as a fair value change in the opening warrant liability.

 

The fair value of the common shares and pre-funded units was determined by reference to the market price on the day of the offering, which was $1.73 per share. The Unit Warrants, Warrants, and Option Warrants were valued using the Black-Scholes model using the following assumptions: initial stock price $1.73, strike rate $2.30, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company also issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company assessed that the warrants issued under the public offering, excluding the Placement Agent Warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. The Placement Agent Warrants were assessed under IFRS 2 Share Based Payments, as equity-settled share-based payments and have been recorded in equity.

 

The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued. 

 

Therefore, the proceeds from the sale of the Units and Pre-funded Units are combined and allocated among the common shares, pre-funded warrants, and the common share warrants using the residual method, with the warrant liability being initially recognized at fair value as of the registration date and the residual amount being allocated to the common shares (i.e., equity).

 

The Company concurrently sold an additional 1,304,347 warrants to purchase 1,304,347 common shares exercisable at $2.30 per share (the “Option Warrants”) pursuant to an over-allotment option exercised by the underwriter. The exercise price of the warrants issued in connection with the exercise of the over-allotment option was $0.0097 per warrant. Each Option Warrant is exercisable immediately and has a term of five years from the issue date. Proceeds of $975,393 were allocated to the option warrant liability. As the fair value of the warrant liability exceeded the proceeds received on the warrants of $13,043, a fair value loss of $962,350 was recognized in the statement of profit and loss as a fair value change in the opening warrant liability.

 

The fair value of the common shares and pre-funded units was determined by reference to the market price on the day of the offering, which was $1.73 per share. The Unit Warrants, Warrants, and Option Warrants were valued using the Black-Scholes model using the following assumptions: initial stock price $1.73, strike rate $2.30, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

63

 

 

The Company also issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company assessed that the warrants issued under the public offering, excluding the Placement Agent Warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. The Placement Agent Warrants were assessed under IFRS 2 Share Based Payments, as equity-settled share-based payments and have been recorded in equity.

 

The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued.

 

  On March 31, 2022, as part of the ClearRF acquisition (Note 3), the Company issued 138,958 shares to the vendor with a fair value of $190,094.

 

Stock Options:

 

The Company has a shareholder-approved “rolling” stock option plan (the “Plan”) in compliance with Nasdaq policies. Under the Plan the maximum number of shares reserved for issuance may not exceed 15% of the total number of issued and outstanding Common Shares on a fully diluted basis at the time of granting. The exercise price of each stock option shall not be less than the market price of the Company’s stock at the date of grant, less a discount of up to 25%. Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted.

 

A summary of the Company’s stock option activity at March 31, 2023 is as follows:

 

   Number of
stock
options
   Weighted
Average
Exercise
Price
 
Outstanding options, December 31, 2021   414,568   $13.88 
Granted   1,145,000   $1.15 
Expired/Cancelled   (53,430)  $30.90 
Outstanding options, December 31, 2022 and March 31, 2023   1,506,138   $3.53 

  

Transactions for the three months ended March 31, 2022 are as follows:

 

On January 1, 2022, the Company granted 20,000 stock options at $4.00 per share that vest in 8 equal quarterly periods with the first vesting occurring on the grant date. The fair value on the date of the grant was $54,480 ($2.724 per option).

 

64

 

 

As of March 31, 2023 stock options outstanding are as follows:

 

Grant Date  Number of
options
outstanding
   Number of
options
exercisable
   Weighted
Average
Exercise
Price
   Expiry date  Remaining
contractual life
(years)
 
24-Dec-18   12,896    12,896   $54.00   24-Dec-23   0.63 
15-Jan-19   828    828   $54.00   15-Jan-24   0.69 
21-Mar-19   12,345    12,345   $59.00   21-Mar-24   0.87 
01-Jan-20   2,069    2,069   $54.00   01-Jan-24   0.65 
15-Nov-20   95,000    95,000   $6.00   15-Nov-30   7.53 
15-Nov-20   161,500    161,500   $6.00   15-Nov-25   2.52 
02-Jan-21   57,000    57,000   $11.50   02-Jan-26   2.65 
02-Jan-21   5,000    5,000   $11.50   02-Jan-31   7.66 
18-Jan-21   14,500    14,500   $11.50   18-Jan-26   2.70 
01-Jan-22   20,000    12,500   $4.00   29-Oct-26   3.48 
13-Apr-22   795,000    265,000   $1.10   13-Apr-27   3.93 
12-Jul-22   330,000    110,000   $1.10   12-Jul-25   2.18 
 Total   1,506,138    748,638   $3.53       3.51 

 

Restricted Share Units (“RSUs”)

 

The Company approved on February 14, 2022, an amended and restated equity incentive plan which permits the issuance of restricted share units in addition to stock options.

 

A summary of the Company’s restricted share unit activity during the year ended December 31, 2022 and for the interim period of March 31, 2023 is as follows:

 

    Number of
RSU’s
    Weighted
Average
Issue
Price
 
Outstanding RSU, December 31, 2021     -     $ -  
Granted     3,195,000     $ 1.05  
Exercised     (30,000 )   $ 1.10  
Outstanding RSU, December 31, 2022 and March 31, 2023     3,165,000     $ 1.05  

  

As at March 31, 2023 restricted share units outstanding are as follows:

 

Grant Date   Number of
RSU’s
outstanding
    Number of
RSU’s
exercisable
    Weighted
Average
Issue Price
 
09-Mar-22     2,250,000       1,050,000     $ 1.03  
13-Apr-22     825,000       416,250     $ 1.10  
12-Jul-22     90,000       22,500     $ 1.10  
Outstanding RSU, December 31, 2022 and March 31, 2023     3,165,000       1,488,750     $ 1.05  

 

Transactions for the three months ended March 31, 2022, are as follows:

 

  On March 9, 2022, the Company granted 450,000 RSU’s to Directors that vest immediately. On the date of granting, the fair value and stock price was $1.03/share.

 

65

 

 

On March 9, 2022, the Company granted 1,800,000 RSU’s to a Director that vest quarterly over 12 periods with the first vesting of 150,000 RSU’s occurring on the date of the granted and another 150,000 vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.03/share.  

 

Agent’s options

 

A summary of the Company’s agents’ options activity for the year ended December 31, 2022 is as follows:

 

   Number of   Weighted
average
exercise
 
   options   price 
Outstanding agent options, December 31, 2020   452,523    8.02 
Expired   (6,597)   52.68 
Outstanding agent options, December 31, 2021   445,926   $7.51 
Granted   487,283    2.51 
Expired   (1,702)   20.49 
Outstanding agent options, December 31, 2022 and March 31, 2023   931,507   $4.12 

 

As at March 31, 2023, agent’s options outstanding and exercisable are as follows:

 

Grant Date  Number of
options
outstanding
   Number of
options
exercisable
   Weighted
Average
Exercise
Price
   Expiry date  Remaining
contractual life
(years)
 
                    
29-Sep-20   113,500    113,500   $6.60   28-Sep-25   2.00 
29-Sep-20   266,000    266,000   $6.85   28-Sep-25   2.00 
31-Dec-20   64,724    64,724   $11.50   30-Jun-24   1.00 
11-Jan-22   434,783    434,783   $2.53   11-Jan-27   4.00 
01-Apr-22   52,500    52,500   $2.30   08-Mar-27   4.00 
Total   931,507    931,507   $4.12       2.98 

 

Transactions for the three months ended March 31, 2022 are as follows:

 

  The Company issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%. The Company also issued 52,500 agent’s options with a fair value of $61,950 with an exercise price of $2.30.

 

66

 

 

Share Purchase Warrants:

 

A summary of the Company’s warrant activity is as follows:

 

   Number of
Warrants
   Weighted
average
exercise
price
 
Outstanding, December 31, 2021   5,121,328   $7.64 
Granted   29,139,129   $0.94 
Expired   (128,386)  $33.47 
Outstanding, December 31, 2022   34,132,071   $1.76 
Granted   18,042,857    0.20 
Exercised   (18,042,857)   0.20 
Outstanding, March 31, 2023   34,132,071   $1.47 

 

As of March 31, 2023, share purchase warrants outstanding and exercisable are as follows:

 

Grant Date  Number of
Warrants
outstanding and
exercisable
   Exercise
Price
   Expiry date
29-Sep-20   1,805,585   $6.85   28-Sep-25
31-Dec-20   1,294,500   $11.50   30-Jun-24
11-Jan-22   9,999,999   $2.30   11-Jan-27
12-Oct-22   1,250,000    Cashless   11-Jan-27
12-Oct-22   1,739,130    Cashless   11-Jan-27
19-Jan-23   18,042,857    Cashless   18-Jan-28
Total   34,132,071   $1.47    

 

As of the date of this MD&A, share purchase warrants outstanding and exercisable are as follows:

 

Grant Date  Number of
Warrants
outstanding and
exercisable
   Exercise
Price
   Expiry date
29-Sep-20   1,805,585   $6.85   28-Sep-25
31-Dec-20   1,294,500   $11.50   30-Jun-24
11-Jan-22   9,999,999   $2.30   11-Jan-27
Total   13,100,084   $3.84    

 

Transactions for the three months ended March 31, 2023 are as follows:

 

  18,042,857 warrants were exercised. The Company issued 18,062,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 31, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,987 cashless warrants were exercised subsequent to March 31, 2023.

 

Transactions for the three months ended March 31, 2022 are as follows:

 

  128,386 share purchase warrant expired in 2022.

 

  On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exercisable at $2.30 per warrant and with a term of five years.

 

67

 

 

FINANCIAL INSTRUMENTS

 

The fair values of the Company’s cash, trade and other receivables, accounts payable and accrued liabilities and long-term debt, approximate carrying value, which is the amount recorded on the consolidated statement of financial position.

 

Credit risk

 

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company places its cash with institutions of high creditworthiness. Management has assessed there to be a low level of credit risk associated with its cash balances.

 

The Company’s exposure to credit risk is influenced mainly by the individual characteristics of each customer. However, management also considers the demographics of the Company’s customer base, including the default risk of the industry and country in which customers operate, as these factors may have an influence on credit risk. Approximately 34% of the Company’s revenue for the three months ended March 31, 2023 (March 31, 2022 -23%) is attributable to sales transactions with a single customer.

 

The Company has established a credit policy under which each new customer is analyzed individually for creditworthiness before the Company’s standard payment and delivery terms and conditions are offered. The Company’s review includes external ratings, when available, and in some cases bank references. Purchase limits are established for each customer, which represents the maximum open amount without requiring approval from the Risk Management Committee; these limits are reviewed quarterly. In prior years, certain key customers were offered extended payment terms on their purchases due to slow down from Covid-19 and budget approvals for government tenders.

 

As a result, the Company had customers with overdue receivables on their books which resulted in the Company taking a bad debt provision on these overdue receivables which amounted to $1,062,052 at March 31, 2023 (March 31, 2022 - $1,056,393).

 

More than 40% (2022 – 18%) of the Company’s customers have been active with the Company for over four years, and the allowance for doubtful accounts of $1,062,052 (2022 - $1,056,393) has been recognized against these customers. In monitoring customer credit risk, customers are grouped according to their credit characteristics, including whether they are an individual or legal entity, whether they are a wholesale, retail or end-user customer, geographic location, industry, aging profile, maturity, and the existence of previous financial difficulties. Trade and other receivables relate mainly to the Company’s wholesale customers. Customers that are graded as “high risk” are placed on a restricted customer list and monitored by the Company.

 

The carrying amount of financial assets represents the maximum credit exposure, notwithstanding the carrying amount of security or any other credit enhancements.

 

Liquidity risk

 

Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities that are settled by delivering cash or another financial asset. The Company’s approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company’s reputation.

 

68

 

 

The Company examines current forecasts of its liquidity requirements so as to make certain that there is sufficient cash for its operating needs, and it is careful at all times to have enough unused credit facilities so that the Company does not exceed its credit limits and is in compliance with its financial covenants (if any). These forecasts take into consideration matters such as the Company’s plan to use debt for financing its activity, compliance with required financial covenants, compliance with certain liquidity ratios, and compliance with external requirements such as laws or regulation.

 

The Company uses activity-based costing to cost its products and services, which assists it in monitoring cash flow requirements and optimizing its cash return on investments. Typically, the Company ensures that it has sufficient cash on demand to meet expected operational expenses for a period of 90 days, including the servicing of financial obligations; this excludes the potential impact of extreme circumstances that cannot reasonably be predicted, such as natural disasters.

 

With the exception of employee benefits, the Company’s accounts payable and accrued liabilities have contractual terms of 90 days. The employment benefits included in accrued liabilities have variable maturities within the coming year.

 

Market risk

 

  a) Currency Risk

 

Currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates.

  

  a) Interest Rate Risk

 

Interest rate risk is the risk that the fair value of future cash flows will fluctuate as a result of changes in interest rates. The Company’s sensitively to interest rates is currently immaterial as the Company’s debt bears interest at fixed rates.

 

  b) Price Risk

 

The Company is exposed to price risk with respect to equity prices. Equity price risk is defined as the potential adverse impact on the Company’s earnings due to movements in individual equity prices or general movements in the level of the stock market. The Company closely monitors individual equity movements, and the stock market to determine the appropriate course of action to be taken by the Company.

 

C. Research and development, patents and licenses, etc.

 

Research and development 

 

The Company undertakes research activities that present the prospect of gaining new scientific or technical knowledge and understanding, and the Company’s development activities involve a plan or design for the production of new or substantially improved products and processes. The Company conducts its own research and development with its internal engineering teams in Israel and complements that effort with subcontractors for both its hardware and software development. The Company analyzes market trends, evaluates emerging wireless technologies, and innovates to address anticipated customer needs.

 

Patents

 

The Company owns two patents that it acquired from Clear RF and the Corporation has entered into several licensing agreements for the use of a trademark and certain patents.

 

69

 

 

In March 2021, the Corporation, through a wholly-owned subsidiary of Signifi Mobile Inc., the Corporation’s wholly-owned subsidiary, also acquired all of the outstanding units of Clear RF LLC (“ClearRF”), a Washington State limited liability company, for a total purchase price of $700,000. The purchase price which was satisfied by the issuance of approximately $389,970 in Common Shares and a payment of $310,030 in cash. ClearRF produces M2M (machine-to-machine) cellular amplifiers for commercial and industrial M2M applications, and offers patented direct connect cellular amplifiers and patented auto gain & oscillation control designed for M2M and “internet-of-things” (“IoT”) applications. ClearRF’s flagship product is a 4G LTE direct connect cellular amplifier designed specifically for fixed and mobile M2M and IoT applications, used to connect directly to any cellular router, modem, embedded module, or alarm panel.

 

Licensing Agreements

 

Licensing Agreement with Uniden® America Corp

 

In December 2012, Signifi Mobile Inc., the Corporation’s wholly-owned subsidiary, entered into a license agreement (as amended, the “Uniden Agreement”) with Uniden America Corporation (“Uniden”). The Uniden Agreement includes renewal options up to December 31,2022, and has been successively renewed to date.

 

The Uniden Agreement, as in effect currently, provides the Corporation with the exclusive right to use the trademark “Uniden®” (along with associated designs and trade dress) and distribute, market, and sell its in-vehicle device, cellular signal booster and accessories under the Uniden® brand in the categories of cellular amplifiers, connected vehicle cellular devices, and rugged cellular products, during its term in North America. The Uniden® brand brings strong brand recognition for the Corporation’s devices and introduces a more unified brand to the current dealers, operators, and future customers in North America. 

 

The current Uniden Agreement which commenced on January 1, 2020, and expires on December 31, 2031. Minimum annual payments under the Uniden Agreement are $200,000 in 2023-2025 and $250,000 in each of 2026-2028 and $300,000 from 2029-2031 (collectively, the “Minimum Royalty Payments”). At the end of each fiscal year, Siyata has agreed to pay Uniden 3% of any sales from the licensed products under the Uniden Agreement that exceeds the Minimum Royalty Payments for such fiscal year.

 

Licensing Agreement with Via Licensing Corporation

 

Effective June 8, 2018, the Corporation entered into two separate patent licensing agreements (together, the “Via Licensing Agreements”) with Via Licensing Corporation to utilize worldwide patents related to the coding and decoding of Android software as well as access and download within the LTE/ 4G network. This patent license is for an initial period of five years and can be extended for a further five-year term. Management is completing the extension prior to the expiry date. Under the Via Licensing Agreements, the Corporation has the right, at any time during the term or any extension thereof, to terminate the agreements upon providing 60 days advanced notice of termination. The Via Licensing Agreements provide for the payment, to Via Licensing Corporation, of quarterly royalty fees that are based solely on product sales and is expressed as a percentage formula based upon the number of units sold, the country in which the units were manufactured, and the country location of the end customer. There are no minimum royalty fees payable under the Via Licensing Agreements.

 

Licensing Agreement with Wilson Electronics, LLC

 

Siyata, through its wholly-owned subsidiary, Signifi Mobile Inc., entered into a royalty agreement (the “Wilson Agreement”) with Wilson Electronics, LLC on November 30, 2017, with an effective date of January 1, 2018. The Wilson Agreement permits the Corporation to utilize several of Wilson Electronics’ LLC’s patents related to cellphone boosters. Specifically, under the Wilson Agreement, the Corporation has licensed a patent for its cellular booster portfolio of products, for the rights to the stand-alone cell phone radio signal booster on a worldwide basis. The Wilson Agreement is expected to remain in force until the expiration of all of the patents licensed under the Wilson Agreement expire, which is estimated to occur in December 2027. The Wilson Agreement requires Siyata to pay a royalty to Wilson Electronics, LLC of 4.5% of the sales of booster products, payable quarterly.

 

70

 

 

D. Trend Information

 

See Item 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS, Subsection A. “Outlook” for trend information.

 

E. Critical Accounting Estimates

 

The preparation of the consolidated financial statements in conformity with IFRS requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates:

  

  i) Critical accounting estimates

 

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected. Information about critical estimates in applying accounting policies that have the most significant effect on the amounts recognized in the consolidated financial statements are, but not limited to the following:

 

  Income taxes - Tax provisions are based on enacted or substantively enacted laws. Changes in those laws could affect amounts recognized in profit or loss both in the period of change, which would include any impact on cumulative provisions, and future periods. Deferred tax assets, if any, are recognized to the extent it is considered probable that those assets will be recoverable. This involves an assessment of when those deferred tax assets are likely to reverse.

 

  Fair value of stock options and warrants - Determining the fair value of warrants and stock options requires judgments related to the choice of a pricing model, the estimation of stock price volatility, the expected forfeiture rate and the expected term of the underlying instruments. Any changes in the estimates or inputs utilized to determine fair value could have a significant impact on the Company’s future operating results or on other components of shareholders’ equity.

 

  Capitalization of development costs and their amortization rate – Development costs are capitalized in accordance with the accounting policy. To determine the amounts earmarked for capitalization, management estimates the cash flows which are expected to be derived from the asset for which the development is carried out and the expected benefit period.

 

  Inventory - Inventory is valued at the lower of cost and net realizable value. Cost of inventory includes cost of purchase (purchase price, import duties, transport, handling, and other costs directly attributable to the acquisition of inventories), cost of conversion, and other costs incurred in bringing the inventories to their present location and condition. Net realizable value for inventories is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Provisions are made in profit or loss of the current period on any difference between book value and net realizable value.

 

71

 

 

  Estimated product returns - Revenue from product sales is recognized net of estimated sales discounts, credits, returns, rebates and allowances. The return allowance is determined based on an analysis of the historical rate of returns, industry return data, and current market conditions, which is applied directly against sales.

 

  Impairment of non-financial assets - The Company assesses impairment at each reporting date by evaluating conditions specific to the Company that may lead to asset impairment. The recoverable amount of an asset or a cash-generating unit (“CGU”) is determined using the greater of fair value less costs to sell and value in use which requires the use of various judgments, estimates, and assumptions.

 

  Useful life of intangible assets – The Company estimates the useful life used to amortize intangible assets which relates to the expected future performance of the assets acquired based on management estimate of the sales forecast.

 

  Future purchase consideration - In a business combination, the Company recognizes a contingent consideration at fair value at the acquisition date. Contingent consideration classified as an asset or liability that is a financial instrument and within the scope of IAS 39 Financial Instruments: Recognition and Measurement, is measured at fair value with changes in fair value recognized either in profit or loss, or as a change to other comprehensive income (“OCI”). If the contingent consideration is not within the scope of IAS 39, it is measured at fair value in accordance with the appropriate IFRS. Contingent consideration that is classified as equity is not re-measured and subsequent settlement is accounted for within equity.

 

  Contingent consideration from an asset acquisition is recognized when: the conditions associated with the contingency are met; the Company has a present legal or constructive obligation that can be estimated reliably; and it is probably that an outflow of economic benefits will be required to settle the obligation.

  

  ii) Critical accounting judgments

 

Information about critical judgments in applying accounting policies that have the most significant effect on the amounts recognized in the consolidated financial statements are, but are not limited to, the following:

 

  Deferred income taxes – judgments are made by management to determine the likelihood of whether deferred income tax assets at the end of the reporting period will be realized from future taxable earnings. To the extent that assumptions regarding future profitability change, there can be an increase or decrease in the amounts recognized in respect of deferred tax assets as well as the amounts recognized in profit or loss in the period in which the change occurs.

 

  Functional currency - The functional currency for the Company and each of the Company’s subsidiaries is the currency of the primary economic environment in which the respective entity operates. The Company has determined the functional currency of each entity to be the Canadian dollar with the exception of Siyata Israel which has the functional currency of the US dollar. Such determination involves certain judgments to identify the primary economic environment. The Company reconsiders the functional currency of its subsidiaries if there is a change in events and/or conditions that determine the primary economic environment.

 

  Going concern – As disclosed in Note 1 to the consolidated financial statements.

 

72

 

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

None than specifically apply to the Company as evaluated by management.

 

RELATED PARTY TRANSACTIONS

 

Key Personnel Compensation

 

Key Personnel Compensation

 

Key management personnel includes those persons having authority and responsibility for planning, directing, and controlling the activities of the Company as a whole. The Company has determined that key management personnel consists of executive and non-executive members of the Company’s Board of Directors and corporate officers. The remuneration of directors and key management personnel for the three months ended March 31, 2023 and 2022 are as follows:

 

   2023   2022 
Payments to key management personnel:        
Salaries, consulting and directors’ fees  $285,413   $491,889 
Share-based payments   243,323    767,436 
Total  $528,736   $1,259,325 

 

Other related party transactions are as follows: 

 

      (in thousands) 
Type of Service  Nature of Relationship  2023   2022 
Selling and marketing expenses  VP Technology/VP Sales International  $46   $84 
General and administrative expense  Companies controlled by the CEO, CFO and Directors  $239   $408 

 

C. Off-Balance Sheet Arrangements

 

The Company currently has no off-balance sheet arrangements.

 

Additional Information

 

Additional information relating to the Company can be found on SEDAR at www.sedar.com.

 

73

 

EX-99.3 4 ea183026ex99-3_siyata.htm REGISTRANT'S CONDENSED CONSOLIDATED UNAUDITED INTERIM FINANCIAL STATEMENTS AS AT JUNE 30, 2023 AND DECEMBER 31, 2022, AND FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2023 AND 2022

Exhibit 99.3

 

Notice of No Auditor review of condensed interim consolidated financial statements

 

The Management of the Company is responsible for the preparation of the accompanying unaudited condensed interim consolidated financial statements. The unaudited condensed interim consolidated financial statements have been prepared using accounting policies in compliance with International Financial Reporting Standards (“IFRS”) for the preparation of consolidated interim financial statements and are in accordance with International Accounting Standards (“IAS”) 34 – Interim Financial Reporting.

 

The Company’s independent auditor has not performed a review of these condensed interim consolidated financial statements in accordance with the standards established by the Chartered Professional Accountants of Canada for a review of interim financial statements by an entity’s auditor.

 

 

 

 

Siyata Mobile Inc.

Unaudited Condensed Interim Consolidated Statements of Financial Position

(Expressed in US dollars)

 

 

   June 30,
2023
   December 31,
2022
 
ASSETS        
Current        
Cash  $2,026,640   $1,913,742 
Trade and other receivables   2,455,711    1,574,628 
Prepaid expenses   262,481    173,504 
Inventory   2,505,957    4,092,550 
Advance to suppliers   588,970    155,852 
    7,839,759    7,910,276 
Long term receivable   142,838    150,185 
Right of use assets   770,840    887,137 
Equipment   190,706    207,402 
Intangible assets   7,633,427    6,987,531 
Total assets  $16,577,570   $16,142,531 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current          
Bank loan  $719,623   $
-
 
Accounts payable and accrued liabilities   2,742,429    3,078,650 
Deferred revenue   
-
    149,600 
Lease obligations   329,433    303,788 
Warrant liability   307,381    2,734,804 
    4,098,866    6,266,842 
Lease obligation   484,298    635,217 
Total liabilities   4,583,164    6,902,059 
Shareholders’ equity          
Share capital   82,706,883    73,312,866 
Reserves   14,218,932    13,647,399 
Accumulated other comprehensive loss   98,870    98,870 
Deficit   (85,030,279)   (77,818,663)
    11,994,406    9,240,472 
Total liabilities and shareholders’ equity  $16,577,570   $16,142,531 

 

Nature of operations and going concern (Note 1)

Subsequent events (Note 10) 

 

Approved on August 14, 2023 on behalf of the Board:    
“Lourdes Felix” “Marc Seelenfreund”  
Lourdes Felix - Director Marc Seelenfreund - Director  

 

The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements

 

2

 

 

Siyata Mobile Inc.

Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss

(Expressed in US dollars)

For the three and six months ended June 30

 

   6 months ended
June 30, 2023
   3 months ended
June 30, 2023
 
   USD   USD   USD   USD 
   2023   2022   2023   2022 
                 
Revenue  $4,513,354   $1,802,502   $2,710,717   $969,528 
Cost of sales   (3,212,347)   (1,438,778)   (1,906,227)   (860,855)
Gross Profit   1,301,007    363,724    804,490    108,673 
                     
EXPENSES                    
Amortization and depreciation   855,139    459,924    453,499    335,419 
Development expenses   85,450    263,370    31,465    140,054 
Selling and marketing   2,041,168    2,208,726    1,037,803    1,163,675 
General and administrative   3,095,812    3,510,661    1,703,382    1,851,582 
Inventory impairment   
-
    303,316    
-
    238,980 
Bad debts   10,148    63,285    10,148    70,643 
Share-based payments   571,533    1,939,035    260,705    1,126,300 
Total operating expenses   6,659,250    8,748,317    3,497,002    4,926,653 
                     
Net operating loss   (5,358,243)   (8,384,593)   (2,692,512)   (4,817,980)
                     
OTHER EXPENSES                    
Finance expense   75,349    45,726    41,251    18,739 
Foreign exchange   (78,599)   19,168    (78,762)   106,828 
Change in fair value of convertible promissory note   
-
    3,250,848    
-
    570,391 
Change in fair value of opening warrant liability   
-
    962,350    
-
    
-
 
Change in fair value of warrant liability   1,856,623    (5,444,935)   (321,384)   (1,209,850)
Transaction costs   
-
    965,247    
-
    
-
 
Total other expenses   1,853,373    (201,596)   (358,895)   (513,892)
Net loss for the year   (7,211,616)   (8,182,997)   (2,333,617)   (4,304,088)
                     
Other comprehensive income                    
Translation adjustment   
-
    1,518    
-
    25,986 
                     
Comprehensive loss for the year  $(7,211,616)  $(8,181,479)  $(2,333,617)  $(4,278,102)
                     
Weighted average shares (before the 100-1 reverse split)   68,257,292    13,805,757    77,394,214    14,635,152 
Basic and diluted loss per share (before the 100-1 reverse split)  $(0.11)  $(0.59)  $(0.03)  $(0.29)
                     
Weighted average shares (after the 100-1 reverse split)   682,573    138,058    773,942    146,352 
Basic and diluted loss per share (after the 100-1 reverse split)  $(10.57)  $(59.27)  $(3.02)  $(29.41)

 

The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.

 

3

 

 

Siyata Mobile Inc.

Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders’ Equity

(Expressed in US dollars)

For six month periods ending June 30, 2023 and 2022

 

   Share
capital
   Share
Capital
   Reserves   Accumulated
other
comprehensive
income (loss)
   Deficit   Total
shareholders’
equity
 
   #   $   $   $   $   $ 
Balance, December 31, 2021   5,276,695    54,655,244    10,389,555    (38,739)   (62,519,412)   2,486,648 
Shares issued on acquisition of ClearRF   138,958    190,095    -    -    -    190,095 
Share issued on capital raise   7,215,652    10,936,974    307,189    -    -    11,244,163 
Share issuance costs on capital raise   -    (1,051,647)   -    -    -    (1,051,647)
Pre-funded warrants exercised   1,480,000    2,575,200    -    -    -    2,575,200 
Shares issued for debt   1,009,219    1,172,961    -    -    -    1,172,961 
Share based payments   -    -    1,939,035    -         1,939,035 
Translation adjustment   -    -    -    1,518    -    1,518 
Net loss   -    -    -    -    (8,182,997)   (8,182,997)
Balance, June 30, 2022   15,120,524   $68,478,827   $12,635,779   $(37,221)  $(70,702,409)  $10,374,976 

 

   Share
capital
   Share
Capital
   Reserves   Accumulated
other
comprehensive
income (loss)
   Deficit   Total
shareholders’
equity
 
   #   $   $   $   $   $ 
Balance, December 31, 2022   44,868,560    73,312,866    13,647,399    98,870    (77,818,663)   9,240,472 
Warrants exercised   39,074,844    7,583,617    (3,975,046)   -    -    3,608,571 
Warrants transferred from liability   -    -    3,975,046    -    -    3,975,046 
Share issued on capital raise   50,000,000    2,250,000    -    -    -    2,250,000 
Share issuance costs on capital raise   -    (439,600)   -    -    -    (439,600)
Share based payments   -    -    571,533    -    -    571,533 
Net loss   -    -    -    -    (7,211,616)   (7,211,616)
Balance, June 30, 2023   133,943,404   $82,706,883   $14,218,932   $98,870   $(85,030,279)  $11,994,406 

  

The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements.

 

4

 

 

Siyata Mobile Inc.

Unaudited Condensed Interim Consolidated Statements of Cash Flows

(Expressed in US dollars)

For the six month period ended June 30

 

   June 30,   June 30, 
   2023   2022 
Operating activities        
Net loss for the year  $(7,211,616)  $(8,182,997)
Items not affecting cash:          
Amortization and depreciation   855,139    459,924 
Bad debt expense   10,148    63,285 
Impairment of inventory   
-
    303,316 
Fair value changes on convertible debenture   
-
    3,250,848 
Fair value changes on opening warrant liability   
-
    962,350 
Fair value changes on warrant liability   

1,856,623

    (5,444,936)
Interest expense, net of repayments   
-
    9,586 
Foreign exchange   7,347    
-
 
Share based payments   571,533    1,939,035 
Net Change in non-cash working capital   
 
    
 
 
Trade receivables   (891,231)   75,316 
Prepaids   (88,977)   (277,147)
Inventory   1,586,593    (2,590,511)
Advances to suppliers   (433,118)   (813,776)
Accounts payable and accrued liabilities   (336,221)   (928,706)
Deferred revenues   (149,600)   
-
 
Net cash used in operating activities   (4,223,380)   (11,174,413)
Investing activities          
Intangible asset additions   (1,329,175)   (1,389,620)
Equipment additions   (3,736)   (1,841)
Acquisition of ClearRF   
-
    (155,014)
Net cash used in investing activities   (1,332,911)   (1,546,475)
Financing activities          
Lease payments   (160,405)   (154,665)
Bank loan   719,623    9,937 
Convertible debt issued, net of repayments   
-
    (4,000,000)
Proceeds on share issuance, net of share issuance costs   2,250,000    16,711,184 
Transaction costs   (748,600)   
-
 
Exercise of warrants   3,608,571    2,575,200 
Net cash from financing activities   5,669,189    15,141,656 
Effect of foreign exchange on cash   
-
    13,910 
Change in cash and restricted cash for the period   112,898    2,434,678 
Cash and restricted cash, beginning of the period   1,913,742    1,619,742 
Cash and restricted cash, end of period  $2,026,640   $4,054,420 

 

During the six months ended June 30, 2023, the Company paid $16,959 (June 30, 2022 - $2,659) in interest and $Nil (June 30, 2022 - $nil) in income taxes. 

 

The accompanying notes are an integral part of these unaudited condensed interim consolidated financial statements. 

 

5

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

1. NATURE OF OPERATIONS AND GOING CONCERN

 

Siyata Mobile Inc. (“Siyata” or the “Company”) was incorporated under the Business Corporations Act, British Columbia on October 15, 1986. The Company’s shares are listed on NASDAQ under the symbol SYTA and warrants issued on September 29, 2020, are traded under the symbol SYTAW. The Company’s principal activity is the sale of vehicle-mounted, cellular-based communications platforms over advanced mobile networks and cellular booster systems. The registered and records office is located at 2200 - 885 West Georgia Street, Vancouver, BC V6C 3E8.

 

These unaudited condensed interim consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) IAS 34 Interim Financial Reporting, with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business rather than a process of forced liquidation. These unaudited condensed interim consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

The Company incurred a net loss of $7,211,616 during the six month period ended June 30, 2023 (June 30, 2022- six month period net loss of $8,182,997), and, as of that date, the Company’s total deficit was $85,030,279 (December 31, 2022 - $77,818,663). The Company’s continuation as a going concern is dependent upon the success of the Company’s sale of inventory, the existing cash flows, and the ability of the Company to obtain additional debt or equity financing, all of which are uncertain. These material uncertainties raise substantial doubt on the Company’s ability to continue as a going concern.

 

2. BASIS OF PREPARATION

 

Statement of compliance

 

These unaudited condensed interim consolidated financial statements, including comparatives, have been prepared in accordance with International Accounting Standards (IAS) 34 Interim Financial Reporting. Omitted from these financial statements are certain information and note disclosures normally included in the annual financial statements. These financial statements and notes presented should be read in conjunction with the annual financial statements for the year ended December 31, 2022.

 

The accounting methods and principles of computation adopted in these financial statements are the same as those in annual consolidated financial statements for the year ended December 31, 2022, except that the functional currency of Signifi Mobile Inc. is the $USD (formerly $CDN) as of January 1, 2023, and therefore all of the entities in the consolidated group of Siyata Mobile Inc. are all using the USD$ as the functional currency.

 

The preparation of these unaudited condensed interim consolidated financial statements requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The significant judgements made by management when applying the Company’s accounting policies and the key sources of estimation uncertainty were the same as those that applied to the Company’s December 31, 2022 annual consolidated financial statements.

 

6

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

2. BASIS OF PREPARATION (cont’d)

 

Basis of consolidation and presentation

 

These unaudited condensed interim consolidated financial statements of the Company have been prepared on a historical cost basis, except for financial instruments classified as financial instruments at fair value through profit and loss, which are stated at their fair value. In addition, the condensed interim consolidated financial statements have been prepared using the accrual basis of accounting, except for the statement of cash flows.

 

These unaudited condensed interim consolidated financial statements incorporate the financial statements of the Company and its wholly controlled subsidiaries. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. These condensed interim consolidated financial statements include the accounts of the Company and its direct wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.

 

The unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:

 

Name of Subsidiary  Place of Incorporation  Ownership 
Queensgate Resources Corp.  British Columbia, Canada   100%
Queensgate Resources US Corp.  Nevada, USA   100%
Siyata Mobile (Canada) Inc.  British Columbia, Canada   100%
Siyata Mobile Israel Ltd.  Israel   100%
Signifi Mobile Inc.  Quebec, Canada   100%
ClearRF Nevada Ltd.  Nevada, USA   100%

 

Recent adoptions of accounting pronouncements

 

The following amendments became effective on January 1, 2023, and did not have a material impact on the Company’s condensed interim consolidated financial statements:

 

In February 2021, the IASB issued Definition of Accounting Estimates (Amendments to IAS 8). The amendments define accounting estimates and clarify the distinction between changes in accounting estimates and changes in accounting policies.

 

In February 2021, the IASB issued Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2). The amendments provide guidance to help entities disclose their material (previously “significant”) accounting policies.

 

In May 2021, the IASB issued Deferred Tax related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12). The amendments narrow the scope of the recognition exemption so that companies would be required to recognize deferred tax for transactions that give rise to equal amounts of taxable and deductible temporary differences, such as leases.

 

7

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

2. BASIS OF PREPARATION (cont’d)

 

Future accounting pronouncements

 

The standards, amendments, and interpretations issued before 2023 but not yet adopted by the Company have been disclosed in Note 3 of the Company’s December 31, 2022 annual consolidated financial statements. The Company is currently considering the impact of adopting these standards, amendments and interpretations on its consolidated financial statement. 

 

3.BANK LOAN

 

The Company has obtained in April 2023, a $2,000,0000 line of credit factoring for its North American receivables with an 85% advance rate with interest of 1.8% for the first 30 days, then 0.5% every 10 days thereafter of the face value.

 

This loan is collateralized by the North American receivables, inventory and equipment. As at June 30, 2023 the loan balance is 719,623.

 

8

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

4. WARRANT LIABILITY

 

The balance of the warrant liability is as follows:

 

   November 3,
2021
   January 11,
2022
   October 12,
2022
   January 19,
2023
   Total 
Balance December 31, 2022  $197,733   $501,330   $2,035,741   $
-
   $2,734,804 

Change in fair value of warrants exercised

   (197,733)   
-
    (1,717,801)   
-
    (1,915,534)
Warrants issued   
-
    
-
    
-
    2,875,580    2,875,580 
Proceeds from Inducement warrants issued   
-
    
-
    
-
    
-
    
-
 
Transfer to equity   
-
    
-
    (564,946)   (3,410,100)   (3,975,046)
Change in fair value   
-
    (193,949)   247,006    534,520    587,577 
Balance June 30, 2023  $
-
   $307,381   $
-
   $
-
   $307,381 

 

Change in warrant fair value January 1, 2023-June 30, 2023    
Change in fair value of warrants exercised   (1,915,534)
Fair value of warrants issued as inducement   2,875,580 
Other changes in fair value of warrants   587,577 
Day 1 Loss - FV Change in Warrant Liability   309,000 
Total change in warrant fair value January 1, 2023-June 30, 2023   1,856,623 

 

January 19, 2023 warrants

 

On January 19, 2023, the Company entered into warrant exercise agreements with fourteen existing accredited investors to exercise certain outstanding warrants to purchase up to an aggregate of 18,042,857 of the Company’s common shares. In consideration for the immediate exercise of the outstanding warrants for cash, the Company agreed to reduce the exercise price from $0.23 to $0.20 per share and issue new unregistered warrants to purchase up to an aggregate of 18,042,857 common shares with an exercise price of $0.20 per share. The gross proceeds to the Company from the exercise totaled approximately $3,608,571, prior to deducting warrant inducement agent fees and offering expenses.

 

The new warrants are exercisable immediately upon issuance at an exercise price of $0.20 per share and have a term of exercise equal to five years. In connection with the exercise, the Company will be required pursuant to the terms of 2,989,130 of its remaining unexercised common share purchase warrants, to reduce the exercise price of such warrants from $0.23 per common share to an exercise price of $0.20 per common share.

 

On March 30, 2023, the SEC accepted the registration statement of the Company to the effect that all of the 21,031,987 outstanding $0.20 warrants become immediately a cashless exercise and their underlying shares become immediately tradeable. Subsequent to the quarter ended March 31, 2023, 21,031,987 warrants were exercised cashless in exchange for 21,031,987 common shares of the Company. All of the warrants that became cashless exercise were transferred to equity at March 30, 2023, as they no longer met the definition of a liability.

 

The fair value of the warrants issued at January 19, 2023 was $2,875,580 and was determined using the stock price at the date of issue, with a 15% discount for lack of marketability. This method was used as the warrants contained an alternative cashless exercise feature.

 

The fair value of the warrants on March 30, 2023 that was transferred to equity was $3,410,100 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.

 

9

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

4. WARRANT LIABILITY (Cont’d)

 

November 3, 2021 warrants

 

The warrants allowed for the purchase of 1,892,857 common shares of the Company at an exercise price of US 4.00 per common share and expired 5 years from the issue date of the related promissory note. Under the terms of these warrants, the exercise price of the warrant was adjusted to $2.30 when an offering was closed on January 3, 2022 that issued shares at a price lower than the exercise price. On January 19, 2023 the warrant holders entered into the agreement noted above to exercise the warrants, and receive new warrants in exchange.

 

At December 31, 2022 the fair value of the warrants was $197,733 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.15, strike rate $0.23 dividend yield 0%, term 3.84 years, volatility 110% and risk-free rate 4.08%.

 

At January 19, 2023 prior to exercise, the fair value of the warrants was $NIL and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.19, strike rate $0.20 dividend yield 0%, term 0.0 years, volatility 130% and risk-free rate 3.62%.

 

January 11, 2022 warrants

 

The Company assessed that the 8,519,999 warrants, and 1,480,000 pre-funded warrants issued in the January 2022 equity offering did not meet the “fixed for fixed” test and are therefore recorded as liabilities at fair value through profit and loss, and revalued at the end of each period.

 

At December 31, 2022 the fair value of the warrants was $501,330 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.15, strike rate $2.30, dividend yield 0%, term 4.03 years, volatility 110% and risk-free rate 4.08%.

 

At June 30, 2023 the fair value of the warrants was $307,381 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.05, strike rate $2.30, dividend yield 0%, term 3.54 years, volatility 170% and risk-free rate 4.35%. This is based on a level 3 output calculated as follows:

 

The expected volatility was based on the historical daily stock price volatility over a look-back period that was consistent with the balance-remaining term corresponding to each Instrument as of the Valuation Date(s). The historical volatility was then adjusted for:
   
The actual implied-to-historical volatility ratio observed for the Company’s publicly-traded warrants. This approach incorporated the differences between the implied volatility and the historical volatility for the publicly-traded warrant. The ratio was used to determine the volatility if the Instruments were publicly traded.

 

A 25% volatility haircut1 given that the Instruments were not publicly traded and were expected to have lower volatilities than the comparable publicly-traded instruments. The 25% volatility haircut is amortised over the balance-remaining term of the Instruments. As of the Valuation Date, the volatility haircut was 18% for the warrants issued on January 11, 2022. This adjustment informed the expected equity volatility for a privately-issued instrument

 

October 12, 2022 warrants

 

The Company assessed that the 17,400,000 warrants and 1,590,000 pre-funded warrants issued as part of the October 2022 equity offering did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. On January 19, 2023 the warrant holders entered into the agreement noted above to exercise 16,150,000 of the 17,400,000 warrants, and receive new warrants in exchange. The remaining 1,250,000 warrants that were outstanding at January 19, 2023 were converted to cashless exercise warrants on March 30, 2023 as described above.

 

10

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

4. WARRANT LIABILITY (Cont’d)

 

The fair value of the warrants as at December 31, 2022 was $1,850,758 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.15; exercise price $0.23; expected volatility: 100%; dividend yield 0%; risk free rate: 3.98%.

 

The fair value of the 1,250,000 unexercised warrants on January 19, 2023 was $132,957 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.19; exercise price $0.20; term 4.73 years; expected volatility: 115%; dividend yield 0%; risk free rate: 3.49%.

 

The fair value of the 16,150,000 exercised warrants immediately prior to exercise on January 19, 2023 was $NIL and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.19; exercise price $0.20; term 0 years; expected volatility: 115%; dividend yield 0%; risk free rate: 3.49%.

 

The fair value of the 2,989,130 (1,739,130 waiver warrants plus 1,250,000 unexercised warrants) outstanding warrants on March 30, 2023 prior to the transfer to equity was $564,946 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.

 

In connection with the October 2022 equity offering, the Company issued 1,739,130 waiver warrants exercisable at $0.23 per share which expire, if unexercised, on October 12, 2027, to entice the holder of the convertible promissory note to waive their right to block the equity offering. The waiver warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss and revalued at the end of each period. On March 30, 2023, the waiver warrants were modified to cashless exercise as described above, and therefore met the “fixed for fixed” test and were reclassified to equity.

 

The fair value of the waiver warrants as at December 31, 2022 was $184,983 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.15; exercise price $0.23; expected volatility: 100%; dividend yield 0%; risk free rate: 3.10%.

 

The fair value of the waiver warrants as at March 30, 2023 prior to transfer to equity was $328,696 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.

 

5. SHARE CAPITAL

 

  (a) Authorized Unlimited number of common shares without par value

 

As at June 30, 2023, the Company had 133,943,404 common shares issued and outstanding (December 31, 2022 – 44,868,560).

 

As of the date of issuance of these unaudited condensed interim consolidated financial statements total outstanding common shares is 1,853,955 post 100-to-1 reverse split that was effective as of August 9, 2023, (185,393,404 pre-split) as described in Subsequent Events Note 10.

 

11

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

5. SHARE CAPITAL (cont’d)

 

  (b) Common share transactions

 

Transactions for the six months ended June 30, 2023 are as follows:

 

The Company issued 18,042,857 common shares on the exercise of various warrants for gross proceeds of $3,608,571. Additionally, the Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 30, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,857 common shares were issued for cashless warrants in Q2 2023.

 

On June 28, 2023 the Company issued 50,000,000 at $0.045 per share for gross proceeds of $2,250,000 before offering expenses and other expenses included in share issuance costs.

 

Subsequent to June 30, 2023, the Company issued 51,250,000 shares at $0.045 per share for gross proceeds of $2,306,250 as described in Subsequent Events Note 10.

 

Transactions for the six months ended June 30, 2022 are as follows:

 

  On January 11, 2022, the Company completed an underwritten public offering in the United States, raising a total of $20,013,043 in gross proceeds. The Company allocated the gross proceeds firstly to the warrant liabilities, with the remainder to the common shares. Direct costs have been allocated based on the percentage allocation of the proceeds. The underwritten public offering resulted in the sale to the public of 7,215,652 Units at $2.30 per Unit, with each Unit being comprised of one common share and one warrant (the “Unit Warrants”) exercisable at $2.30 per share. The Unit warrants are exercisable immediately and have a term of 5 years. Gross proceeds of $10,936,974 were allocated to the common shares, and $5,395,878 to the unit warrants liability.

 

In addition, the Company issued 1,480,000 pre-funded units (“Pre-Funded Units”) at $2.29 per Pre-Funded Unit. Each Pre-Funded Unit is comprised of a one-pre-funded warrant (a “Pre-Funded Warrant”) to purchase one common share, and one warrant to purchase one common share. The Pre-Funded Warrant allows the holder to acquire one common share of the Company at an exercise price of $0.01 per common share, and a warrant to purchase a common share at an exercise price of $2.30 per share. The warrants are exercisable immediately and have a term of 5 years. Each Pre-Funded Warrant is exercisable immediately and is exercisable until all Pre-Funded Warrants are exercised. Proceeds of $2,560,400 were allocated to the pre-funded warrants and $1,106,747 to the unit warrants in the warrant liability.

 

The Company determined that the pre-funded warrants within the Pre-funded Units are common shares in substance, as they require only a minimal exercise price of $0.01. In addition, the underwriting agreement includes both the Units and Pe-funded Units and were negotiated together in the equity raise. Given that the purpose of the Prefunded Unit is in substance the same as that of the Unit (i.e., resulting in the ownership of both common shares and common share warrants) and that the terms of the warrants in both the Units and Prefunded Units are the same (i.e., the obligations of the Company for the units are the same), the Company determined that the Units and Pre-funded Units are closely related and should be combined into one unit of account for the purposes of allocating proceeds.

 

12

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

5.SHARE CAPITAL (cont’d)

 

  b) Common share transactions (cont’d)

 

Therefore, the proceeds from the sale of the Units and Pre-funded Units are combined and allocated among the common shares, pre-funded warrants, and the common share warrants using the residual method, with the warrant liability being initially recognized at fair value as of the registration date and the residual amount being allocated to the common shares (i.e., equity).

 

The Company concurrently sold an additional 1,304,347 warrants to purchase 1,304,347 common shares exercisable at $2.30 per share (the “Option Warrants”) pursuant to an over-allotment option exercised by the underwriter. The exercise price of the warrants issued in connection with the exercise of the over-allotment option was $0.0097 per warrant. Each Option Warrant is exercisable immediately and has a term of five years from the issue date. Proceeds of $975,393 were allocated to the option warrant liability. As the fair value of the warrant liability exceeded the proceeds received on the warrants of $13,043, a fair value loss of $962,350 was recognized in the statement of profit and loss as a fair value change in the opening warrant liability.

 

The fair value of the common shares and pre-funded units was determined by reference to the market price on the day of the offering, which was $1.73 per share. The Unit Warrants, Warrants, and Option Warrants were valued using the Black-Scholes model using the following assumptions: initial stock price $1.73, strike rate $2.30, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company also issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company assessed that the warrants issued under the public offering, excluding the Placement Agent Warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. The Placement Agent Warrants were assessed under IFRS 2 Share Based Payments, as equity-settled share-based payments and have been recorded in equity.

 

The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued.

 

13

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

5.SHARE CAPITAL (cont’d)

 

  (b) Common share transactions (cont’d)

 

On March 31, 2022, as part of the ClearRF acquisition, the Company issued 138,958 shares to the vendor with a fair value of $190,094.

 

The Company issued 155,000 common shares, with a fair value of $170,500 ($1.10 per share) to consultants as part of their compensation for services rendered.

 

The Company issued 854,219 common shares with a fair value of $1,002,461 as combined payments of the monthly principal repayment of $400,000 for the months of May and June 2022 payable in shares per the terms of the promissory note.

 

  (c) Stock options

 

The Company has a shareholder-approved “rolling” stock option plan (the “Plan”) in compliance with Nasdaq policies. Under the Plan the maximum number of shares reserved for issuance may not exceed 15% of the total number of issued and outstanding common shares at the time of granting. The exercise price of each stock option shall not be less than the market price of the Company’s stock at the date of grant, less a discount of up to 25%. Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted.

 

A summary of the Company’s stock option activity is as follows:

 

   Number of
Stock
Options
   Weighted
Average
Exercise
Price
 
Outstanding options, December 31, 2021   414,568   $13.88 
Granted   1,145,000    1.15 
Expired/Cancelled   (53,430)   30.90 
Outstanding options, December 31, 2022   1,506,138   $3.53 
Granted   
-
    
-
 
Expired/Cancelled   
-
    
-
 
Outstanding options, June 30, 2023 and date of MD&A (before the 100-1 reverse stock split)  1,506,138   $3.53 
Outstanding options, June 30, 2023 and date of MD&A (after the 100-1 reverse stock split)   15,061   $353.00 

 

14

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

5. SHARE CAPITAL (cont’d)

 

  (c) Stock options (cont’d)

 

As at June 30, 2023 stock options outstanding are as follows:

 

Grant Date  Number of
options
outstanding
   Number of
options exercisable
   Weighted
Average
Exercise
Price
   Expiry date  Remaining
contractual
life (years)
 
24-Dec-18   12,896    12,896    54.00   24-Dec-23   0.48 
15-Jan-19   828    828    54.00   15-Jan-24   0.55 
21-Mar-19   12,345    12,345    59.00   21-Mar-24   0.73 
1-Jan-20   2,069    2,069    54.00   1-Jan-24   0.51 
15-Nov-20   95,000    95,000    6.00   15-Nov-30   7.38 
15-Nov-20   161,500    161,500    6.00   15-Nov-25   2.38 
2-Jan-21   57,000    57,000    11.50   2-Jan-26   2.51 
2-Jan-21   5,000    5,000    11.50   2-Jan-31   7.52 
18-Jan-21   14,500    14,500    11.50   18-Jan-26   2.56 
1-Jan-22   20,000    12,500    4.00   29-Oct-26   3.33 
13-Apr-22   795,000    331,250    1.10   13-Apr-27   3.79 
12-Jul-22   330,000    110,000    1.10   12-Jul-25   2.04 
Total (before the 100-1 reverse stock split)   1,506,138    794, 888   $3.53       3.67 
Total (after the 100-1 reverse stock split)   15,061    7,949   $353.00       3.67 

 

Transactions for the six months ended June 30, 2022 are as follows:

 

 

On January 1, 2022, the Company granted 20,000 stock options at $4.00 per share that vest in 8 equal quarterly periods with the first vesting occurring on the grant date. The fair value on the date of the grant was $54,480 ($2.724 per option).

 

On April 13, 2022, the Company granted 795,000 stock options to executives and employees at an exercise price of $1.10 per share. These options vest quarterly over three years period with the first vesting taking place at the date of the grant. The fair value of these options on the date of the grant is $678,520 ($0.8535 per share).

 

15

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

5. SHARE CAPITAL (cont’d)

 

  (d) Restricted share units

 

The Company approved on February 14, 2022, the addition of the issuance of restricted share units to the existing executive stock option plan.

 

A summary of the Company’s restricted share unit activity is as follows:

 

    Number of RSU’s     Weighted
Average
Issue Price
 
             
Outstanding RSU, December 31, 2021     0     $ -  
Granted     3,195,000       1.05  
Exercised     (30,000 )     1.10  
Outstanding RSU, December 31, 2022     3,165,000     $ 1.05  
Granted     -       -  
Exercised     -       -  
Outstanding RSU, June 30, 2023 and date of MD&A (before 100-1 reverse stock split)     3,165,000     $ 1.05  
Outstanding RSU, June 30, 2023 and date of MD&A  (after 100-1 reverse stock split)     31,650     $ 105.00  

 

As at June 30, 2023 restricted share units outstanding are as follows:

 

Grant Date   Number of
RSU’s
outstanding
    Number of
RSU’s
exercisable
    Weighted
Average
Issue Price
 
9-Mar-22     2,250,000       1,350,000       1.03  
13-Apr-22     825,000       513,750       1.10  
12-Jul-22     90,000       30,000       1.10  
Outstanding RSU, June 30, 2023 and date of MD&A (before 100-1 reverse stock split)     3,165,000       1,893,750     $ 1.05  
Outstanding RSU, June 30, 2023 and date of MD&A (after 100-1 reverse stock split)     31,650       18,938     $ 105.00  

 

Transactions for the six month period ended June 30, 2022, are as follows:

 

  On March 9, 2022, the Company granted 450,000 RSU’s to Directors that vest immediately. On the date of granting, the fair value and stock price was $1.03/share.

 

 

On March 9, 2022, the Company granted 1,800,000 RSU’s to a Director that vest quarterly over 12 periods with the first vesting of 150,000 RSU’s occurring on the date of the granted and another 150,000 vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.03/share.

 

On April 13, 2022, the Company granted 240,000 RSU’s to consultants that vest immediately. On the date of granting, the fair value and the stock price was $1.10/share.

 

On April 13, 2022, the Company granted 585,000 RSU’s to employees of the Company that vest quarterly over 12 periods with the first vesting of 48,750 RSU’s occurring on the date of the granted and another 48,750 RSU’s vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.10/share.

 

16

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

5. SHARE CAPITAL (cont’d)

 

  (e) Agents’ options

 

A summary of the Company’s agent options activity is as follows:

 

    Number of
options
    Weighted
average
exercise price
 
             
Outstanding agent options, December 31, 2020     452,523     $ 8.02  
Expired     (6,597 )     52,68  
Outstanding agent options, December 31, 2021     445,926     $ 7.51  
Granted     487,283       2.51  
Expired     (1,702 )     20.49  
Outstanding agent options, December 31, 2022     931,507     $ 4.12  
Granted     -       -  
Expired     -       -  
Outstanding agent options, June 30, 2023 and date of MD&A (before the 100-1 reverse stock split)     931,507     $ 4.87  
Outstanding agent options, June 30, 2023 and date of MD&A (after the 100-1 reverse stock split)     9,315     $ 487.00  

 

As at June 30, 2023 agent options outstanding are as follows:

 

Grant Date   Number of
options
outstanding
    Number of
options
exercisable
    Weighted
Average
Exercise
Price
    Expiry date   Remaining
contractual
life (years)
 
                             
29-Sep-20     113,500       113,500     $ 6.60     28-Sep-25     2.00  
29-Sep-20     266,000       266,000     $ 6.85     28-Sep-25     2.00  
31-Dec-20     64,724       64,724     $ 11.50     30-Jun-24     1.00  
11-Jan-22     434,783       434,783     $ 2.53     11-Jan-27     4.00  
1-Apr-22     52,500       52,500     $ 2.30     8-Mar-27     4.00  
Total (before the 100-1 reverse stock split)     931,507       931,507     $ 4.87           2.98  
Total (after the 100-1 reverse stock split)     9,315       9,315     $ 487.00           2.98  

 

Transactions for the six month period ended June 30, 2022 are as follows:

 

  The Company issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%. The Company also issued 52,500 agent’s options with a fair value of $61,950 with an exercise price of $2.30.

 

17

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

5. SHARE CAPITAL (cont’d)

 

  (f) Share purchase warrants

 

A summary of the Company’s share purchase warrant activity is as follows:

 

    Number of
Warrants
    Weighted
average
exercise
price
 
Outstanding, December 31, 2021     5,121,328     $ 9.89  
Granted     29,139,129     $ 0.94  
Expired     (128,386 )   $ 33.47  
Outstanding, December 31, 2022     34,132,071     $ 1.76  
Granted     18,042,857     $ 0.20  
Exercised     (39,074,844 )   $ 0.09  
Outstanding, June 30, 2023 and the date of the MD&A (before the 100-1 reverse stock split)     13,100,084     $ 3.84  
Outstanding, June 30, 2023 and the date of the MD&A (after the 100-1 reverse stock split)     131,001     $ 384.00  

 

As at June 30, 2023 the share purchase warrants outstanding are as follows:

 

Grant Date   Number of Warrants outstanding and exercisable     Exercise Price     Expiry date
29-Sep-20     1,805,585       6.85     28-Sep-25
31-Dec-20     1,294,500       11.50     30-Jun-24
11-Jan-22     9,999,999       2.30     10-Jan-27
Total (before the 100-1 reverse stock split)     13,100,084     $ 3.84      
Total (before the 100-1 reverse stock split)     131,001     $ 384.00      

 

Transactions for the six months ended June 30, 2023 are as follows:

 

  18,042,857 warrants were exercised on January 12, 2023. The Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 31, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,857 cashless warrants were exercised in Q2 2023.

 

Transactions for the six month period ended June 30, 2022 are as follows:

 

 

On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exercisable at $2.30 per warrant and with a term of five years. 

 

18

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

6. TRANSACTION COSTS

 

Transaction costs incurred in relation to the January 2023 warrant raise and issuance described in Note 5 were $439,600 and were included in the change in fair value of warrant liability on the statement of operations.

 

Transaction costs incurred in the six months ended June 30, 2022 were $965,247, which are costs incurred for the January 11, 2022 capital raise that were allocated to the warrant liability and expensed through the statement of operations.

 

7. FINANCIAL INSTRUMENTS

 

The fair values of the Company’s cash, trade and other receivables, accounts payable and accrued liabilities and long-term debt, approximate carrying value, which is the amount recorded on the unaudited condensed interim consolidated statement of financial position.

 

19

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

8. RELATED PARTY TRANSACTIONS

 

Key Personnel Compensation

 

Key management personnel includes those persons having authority and responsibility for planning, directing, and controlling the activities of the Company as a whole. The Company has determined that key management personnel consists of executive and non-executive members of the Company’s Board of Directors and corporate officers. The remuneration of directors and key management personnel for the three and six month period ended June 30, 2023 and 2022 are as follows:

 

   2023   2022 
Payments to key management personnel:        
Salaries, consulting and directors’ fees  $667,582   $851,262 
Share-based payments   438,008    1,792,129 
Total  $1,105,590   $2,643,391 

 

21

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

8. RELATED PARTY TRANSACTIONS (cont’d)

 

Salaries, consulting and directors’ fees shown above are classified within profit and loss as shown below:

 

      (in thousands) 
Type of Service  Nature of Relationship  2023   2022 
Selling and marketing expenses  VP Technology/VP Sales International  $182   $152 
General and administrative expense  Companies controlled by the CEO, CFO and Directors  $486   $699 

 

9. SEGMENTED INFORMATION

 

The Company is domiciled in Canada, and it operates and produces its income primarily in Israel, Europe and North America. The Company operates as a single segment being the sale of cellular-based communications products.

 

The Company’s entity-wide disclosures include disaggregated information about product sales, geographical areas, and major customers.

 

Geographical area information is shown below:

 

External revenues by Geography for the three and six month period ended June 30  6 months ended
June 30
   3 months ended
June 30
 
(in thousands)  2023   2022   2023   2022 
USA  $3,342   $722   $2,270   $477 
Canada   521    625    302    376 
EMEA   650    443    139    104 
Australia   
-
    

13

    
-
    13 
Total  $4,513   $1,803   $2,711   $970 

 

22

 

 

Siyata Mobile Inc.

Notes to the Unaudited Condensed Interim Consolidated Financial Statements

(Expressed in US dollars)

As at June 30, 2023 and December 31, 2022 and for the three and six month period ended June 30, 2023 and 2022

 

9. SEGMENTED INFORMATION (cont’d)

 

Non-current asset geographic area information is shown below:

 

(in thousands)  June 30,
2023
   December 31,
2022
 
         
Long-term receivable total  $143   $150 
Canada   
-
    
-
 
EMEA   143    150 
           
Right of use asset total  $771   $887 
Canada   126    177 
EMEA   645    710 
           
Equipment total  $191   $207 
Canada   
-
    
-
 
EMEA   191    207 
           
Intangibles total  $7,633   $6,988 
Canada   70    
-
 
EMEA   7,563    6,988 

 

Product information is shown below:

 

Revenue by product line for the three and six month period ended June 30  6 months ended   3 months ended 
(in thousands)  2023   2022   2023   2022 
Cellular boosters and related accessories  $1,012    1,213   $575    750 
Rugged devices and related accessories  $3,501    590   $2,136    220 
Total  $4,513    1,803   $2,711    970 

 

10. SUBSEQUENT EVENTS

 

Subsequent to the period end, the Company issued 51,250,000 common shares at $0.45 for total gross proceeds of $2,306,250.

 

On August 9, 2023, the Company affected a 100-to-1 reverse stock split resulting in 185,393,404 common shares converted with rounding into 1,853,955 new common shares.

 

 

23

 

0.03 0.11 0.29 0.59 10.57 29.41 59.27 3.02 20000000 5268 794888
EX-99.4 5 ea183026ex99-4_siyata.htm MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE MONTH AND SIX MONTHS ENDED JUNE 30, 2023

Exhibit 99.4

 

A picture containing font, text, graphics, logo

Description automatically generated

 

Management Discussion and Analysis 

(Expressed in U.S. Dollars)

 

As at and for the three and six month period ended June 30 2023 and June 30, 2022

Prepared on August 10, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This MD&A contains “forward-looking statements,” which includes information relating to future events, future financial performance, financial projections, strategies, expectations, competitive environment and regulation. Words such as “may,” “should,” “could,” “would,” “predicts,” “potential,” “continue,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and similar expressions, as well as statements in future tense, identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and may not be accurate indications of when such performance or results will be achieved. Forward-looking statements are based on information we have when those statements are made or management’s good faith belief as of that time with respect to future events, and are subject to significant risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause such differences include, but are not limited to:

 

  the size and growth potential of the markets for our products, and our ability to serve those markets;

 

  the rate and degree of market acceptance of our products;

  

  our ability to expand our sales organization to address effectively existing and new markets that we intend to target;

 

  impact from future regulatory, judicial, and legislative changes or developments in the U.S. and foreign countries;

  

  our ability to compete effectively in a competitive industry;

  

  our ability to obtain funding for our operations and effectively utilize the capital raised therefrom;

  

  our ability to attract collaborators and strategic partnerships;

 

  our ability to meet the continued listing requirements and standards of the Nasdaq Capital Market, or Nasdaq;

  

  our ability to meet our financial operating objectives;

  

  the availability of, and our ability to attract, qualified employees for our business operations;

  

  general business and economic conditions;

  

  our ability to meet our financial obligations as they become due;

 

  positive cash flows and financial viability of our operations and any new business opportunities;

 

i

 

 

  our ability to secure intellectual property rights over our proprietary products or enter into license agreements to secure the legal use of certain patents and intellectual property;

 

  our ability to be successful in new markets;

 

  our ability to avoid infringement of intellectual property rights; and

 

  the effects of the global COVID-19 pandemic and the war in Ukraine.

 

The foregoing does not represent an exhaustive list of matters that may be covered by the forward-looking statements contained herein or risk factors that we are faced with that may cause our actual results to differ from those anticipated in our forward-looking statements. Please see “Item 3. Key Information – D. Risk Factors,” “Item 4. Information on the Company,” and “Item 5. Operating and Financial Review and Prospects” for additional factors that could adversely impact our business and financial performance.

 

Moreover, new risks regularly emerge and it is not possible for our management to predict or articulate all the risks we face, nor can we assess the impact of all risks on our business or the extent to which any risk, or combination of risks, may cause actual results to differ from those contained in any forward-looking statements. All forward-looking statements included in this Annual Report are based on information available to us on the date of this Annual Report. Except to the extent required by applicable laws or rules, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained above and throughout this Annual Report.

 

Readers are urged to carefully review and consider the various disclosures made throughout this MD&A which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects.

 

You should not put undue reliance on any forward-looking statements. Any forward-looking statements in this MD&A Report are made as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

ii

 

 

ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

 

Not applicable.

 

ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE

 

Not applicable.

 

ITEM 3. KEY INFORMATION

 

A. [Reserved]

 

B. Capitalization and Indebtedness

 

Not applicable.

 

C. Reasons for the Offer and Use of Proceeds

 

Not applicable.

 

D. Risk Factors

 

You should carefully consider the risks described below, together with all of the other information in this Annual Report. The risks described below are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also materially and adversely affect our business operations. If any of these risks actually occurs, our business and financial condition could suffer and the price of our Common Shares and warrants to purchase Common Shares, or the Warrants, could decline.

 

Summary of Risk Factors

 

Risks Related to Our Financial Condition and Capital Requirements

 

  We have a history of operating losses and we may never achieve or maintain profitability.

 

  Our consolidated audited financial statements for the fiscal year ended December 31, 2022 and our unaudited condensed interim consolidated financial statements for the three and six month period ended June 30, 2023, both include a “going concern” explanatory paragraph expressing substantial doubt about our ability to continue as an ongoing business for the next twelve months. Our consolidated financial statements do not include any adjustments that may result from the outcome of this uncertainty. If we cannot secure the financing needed to continue as a viable business, our shareholders may lose some or all of their investment in us.

 

  In 2022, our independent registered public accountants identified three material weaknesses in our internal controls over financial reporting. If we are unable to remediate these material weaknesses, we may not be able to report our financial results accurately, prevent fraud or file our periodic reports as a public company in a timely manner. In 2021, our independent registered public accountants identified five material weaknesses in our internal controls over financial reporting, which have only been partially remediated.

 

1

 

 

Risks Related to Our Business and Industry

 

  We rely on our channel partners to generate a substantial majority of our revenues. If these channel partners fail to perform or if we cannot enter into agreements with channel partners on favorable terms, our operating results could be significantly harmed.

 

  We are materially dependent on the adoption of our solutions by both the industrial enterprise and public sector markets, and if end customers in those markets do not purchase our solutions, our revenues will be adversely impacted, and we may not be able to expand into other markets.

  

  We participate in a competitive industry, which may become more competitive. Competitors with greater resources and significant experience in high-volume product manufacturing may be able to respond more quickly and cost-effectively than we can to new or emerging technologies and changes in customer requirements.

  

  Defects in our products could reduce demand for our products and result in a loss of sales, delay in market acceptance and injury to our reputation, which would adversely impact our business.

 

  If our business does not grow as we expect, or if we fail to manage our growth effectively, our operating results and business would suffer.

 

  We may not be able to continue to develop solutions to address user needs effectively in an industry characterized by ongoing change and rapid technological advances.

 

  The markets for our devices and related accessories may not develop as quickly as we expect, or may not develop at all. Our dependence on our cellular carrier channel partners and their success in promoting Push to Talk over Cellular to their client base is key for the success of the business.

 

  Our future success is dependent on our ability to create independent brand awareness for our company and products with end customers, and our inability to achieve such brand awareness could limit our prospects.

 

  We are dependent on the continued services and performance of a concentrated group of senior management and other key personnel, the loss of any of whom could adversely impact our business.

 

  We compete in a rapidly evolving market, and the failure to respond quickly and effectively to changing market requirements could cause our business and operating results to decline.

 

  If we are unable to sell our solutions into new markets, our revenues may not grow.

 

  If we are unable to attract, integrate and retain additional qualified personnel, including top technical talent, our business could be adversely impacted.

 

  A security breach or other significant disruption of our information technology (“IT”) systems or those of our partners, suppliers or manufacturers, caused by cyberattacks or other means, could have a negative impact on our operations, sales, and operating results.

 

  We experience lengthy sales cycles for our products and the delay of an expected large order could result in a significant unexpected revenue shortfall.

 

2

 

 

  We have a limited history of contracting with third party manufacturers in Asia for the high-volume commercial production of our devices, and we may face manufacturing capacity constraints.

 

  Our financial condition and results of operations as well as those of potential customers could be adversely affected by the Russian invasion of Ukraine, which has caused a material adverse effect on the level of economic activity around the world, including in the markets we serve.

 

  We rely on industry data and projections which may prove to be inaccurate.

 

Risks Related to our Reliance on Third Parties

 

  As we work with multiple vendors for our components, if we fail to adequately forecast demand for our inventory and supply needs, we could incur additional costs or experience manufacturing delays, which could reduce our gross margin or cause us to delay or even lose sales.

 

  Our dependence on third-party suppliers for key components of our products could delay shipment of our products and reduce our sales.

 

  Because we rely on a small number of channel partners/customers for a large portion of our revenue, the loss of any of these customers would have a material adverse effect on our operating results and cash flows.
     
  The application development ecosystem supporting our devices and related accessories is new and evolving.

 

  Failure of our suppliers, subcontractors, distributors, resellers, and representatives to use acceptable legal or ethical business practices, or to fail for any other reason, could negatively impact our business.

 

  Our products are subject to risks associated with sourcing and manufacturing.

 

  The nature of our business may result in undesirable press coverage or other negative publicity, which would adversely impact our brand identity, future sales and results of operations.

 

  Changes in the availability of federal funding to support local public safety or other public sector efforts could impact our opportunities with public sector end customers.

 

  Economic uncertainties or downturns, or political changes, could limit the availability of funds available to our customers and potential customers, which could significantly adversely impact our business.

 

  Natural or man-made disasters and other similar events may significantly disrupt our business, and negatively impact our operating results and financial condition.

 

  We are exposed to risks associated with strategic acquisitions and investments.

 

  We could be adversely impacted by changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters.

 

3

 

 

Risks Related to Government Regulation

 

  We are subject to anti-corruption, anti-bribery, anti-money laundering, economic sanctions, export control, and similar laws. Non- compliance with such laws can subject us to criminal or civil liability and harm our business, revenues, financial condition and results of operations.

 

  We are subject to a wide range of product regulatory and safety, consumer, worker safety and environmental laws and regulations.

 

  Changes in laws and regulations concerning the use of telecommunication bandwidth could increase our costs and adversely impact our business.

 

  We are subject to a wide range of privacy and data security laws, regulations and other legal obligations.

 

Risks Related to Our Intellectual Property

 

  If we are unable to successfully protect our intellectual property, our competitive position may be harmed.

 

  Others may claim that we infringe on their intellectual property rights, which may result in costly and time-consuming litigation and could delay or otherwise impair the development and commercialization of our products.

 

  Our use of open source software could subject us to possible litigation or otherwise impair the development of our products.

  

  Our inability to obtain and maintain any third-party license required to develop new products and product enhancements could seriously harm our business, financial condition and results of operations.

 

Risks Related to our Locations in Israel and Canada and Our International Operations

 

  Conditions in Israel could materially and adversely affect our business.

 

  It may be difficult to enforce a U.S. judgment against us, our officers and directors named herein in Israel or the United States, or to assert U.S. securities laws claims in Israel or serve process on our officers and directors.

 

  Because we are a corporation incorporated in British Columbia and some of our directors and officers are resident in Canada, it may be difficult for investors in the United States to enforce civil liabilities against us based solely upon the federal securities laws of the United States. Similarly, it may be difficult for Canadian investors to enforce civil liabilities against our directors and officers residing outside of Canada.

 

  We have operations in China, which exposes us to risks inherent in doing business there.

 

  The impact of potential changes in customs, tariffs, and trade policies in the United States and the potential corresponding actions by other countries, in which we do business could adversely impact our financial performance.

 

  Operating outside of the United States presents specific risks to our business, and we have substantial operations outside of the United States.

 

  Foreign currency fluctuations may reduce our competitiveness and sales in foreign markets.

 

4

 

 

Risks Related to Ownership of Our Securities

 

  We may require additional capital to fund our business and support our growth, and our inability to generate and obtain such capital on acceptable terms, or at all, could harm our business, operating results, financial condition and prospects. In addition, such funding may dilute our existing shareholders.

 

  We expect that our stock price will fluctuate significantly, and you may not be able to resell your shares at or above the public offering price you paid for your shares.

 

  The conversion of the Lind Partner Note and the exercise of the Lind Partner Warrant or future sales of our Common Shares may further dilute the Common Shares and adversely impact the price of our Common Shares.

 

  If we are not able to comply with the applicable continued listing requirements or standards of Nasdaq, Nasdaq could delist our Common Shares and Warrants which could negatively impact the price of our securities and an investor’s ability to sell them. We have until August 21, 2023 to regain compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”), resulting from the fact that the closing bid price of the Company’s Common Shares, no par value per share, was below $1.00 per share for a period of 30 consecutive business days.

 

  If our Common Shares become subject to the penny stock rules, it may be more difficult to sell our Common Shares.

 

  If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis could be impaired.

 

  We will continue to incur significant increased costs as a result of operating as a public company in the United States, and our management will be required to devote substantial time to new compliance initiatives.

 

  Because we are a foreign private issuer and are exempt from certain Nasdaq corporate governance standards applicable to U.S. issuers, you will have less protection than you would have if we were a domestic issuer.

 

  We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.

 

  We will continue to incur significant increased costs as a result of operating as a public company in the United States, and our management will be required to devote substantial time to new compliance initiatives.

 

  Our executive officers and directors, and their affiliated entities, along with our two other largest stockholders, own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.

 

  The exercise of the outstanding warrants may further dilute the Common Shares and adversely impact the price of our Common Shares.

  

  The market for our Common Shares may not provide investors with adequate liquidity.

 

  Since we do not expect to pay any cash dividends for the foreseeable future, investors in our common shares may be forced to sell their stock in order to obtain a return on their investment.

 

5

 

 

  If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.

 

  A possible “short squeeze” due to a sudden increase in demand of our Common Shares that largely exceeds supply may lead to price volatility in our Common Shares.

 

  The Company was under a cease trading order with the British Columbia Securities Commission, for late filing of the Company’s three month ended March 31, 2023 financial statements which was rectified on May 24, 2023.

 

  The Company has received a notice from NASDAQ that the Company is in default of maintaining a minimum bid price of $1.00 per share. In the event this is not rectified by August 21, 2023, the Company will be de-listed from NASDAQ exchange. The Company has affected a 100-to-1 reverse stock split on August 10, 2023 at a price of __________ and if the price remains above $1.00 for ten consecutive days, then the default will have been rectified.

 

Risks Related to Our Financial Position and Capital Requirements

 

We have a history of operating losses and we may never achieve or maintain profitability.

 

We have a limited operating history and a history of losses from operations. As of June 30, 2023 accumulated deficit of $85,030,279. Our existing cash and cash equivalents will be insufficient to fully fund our business plan. Our ability to achieve profitability will depend on whether we can obtain additional capital when we need it, complete the development of our technology, obtain required regulatory approvals and continue to develop arrangements with channel partners. There can be no assurance that we will ever achieve profitability.

 

Our independent registered public accounting firm, in its report on our financial statements for the year ended December 31, 2022, concurs with management representation that raises substantial doubt about our ability to continue as a going concern.

 

We may require additional capital to fund our business and support our growth, and our inability to generate and obtain such capital on acceptable terms, or at all, could harm our business, operating results, financial condition and prospects.

 

We intend to continue to make substantial investments to fund our business and support our growth. In addition, we may require additional funds to respond to business challenges, including the need to develop new features or enhance our solutions, improve our operating infrastructure or acquire or develop complementary businesses and technologies. As a result, in addition to the revenues we generate from our business, we may need to engage in additional equity or debt financings to provide the funds required for these and other business endeavors. If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our Common Shares. Any debt financing that we may secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain such additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and to respond to business challenges could be significantly impaired, and our business may be adversely impacted. In addition, our inability to generate or obtain the financial resources needed may require us to delay, scale back, or eliminate some or all of our operations, which may have a significant adverse impact on our business, operating results and financial condition.

 

6

 

 

Our independent registered public accountants have noted that we may not survive as a going concern.

 

Our independent registered public accountants have included a “going concern” explanatory paragraph in its report on our consolidated financial statements for the fiscal year ended December 31, 2022, concurring with management representation of expressing substantial doubt about our ability to continue as an ongoing business for the next twelve months. Our consolidated financial statements do not include any adjustments that may result from the outcome of this uncertainty. If we cannot secure the financing needed to continue as a viable business, our shareholders may lose some or all of their investment in us. 

 

Our independent registered public accountants have identified material weaknesses in our internal controls over financial reporting in both 2022 and 2021. If we are unable to remediate these material weaknesses, we may not be able to report our financial results accurately, prevent fraud or file our periodic reports as a public company in a timely manner.

 

In connection with the audit of our consolidated financial statements for the years ended December 31, 2022 and 2021, our independent registered public accountants identified several material weaknesses in our internal control over financial reporting. A “material weakness” is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

 

In 2022, our independent registered public accountants identified the following material weaknesses in our internal control over financial reporting. The first material weakness related to our revenue recognition practices where we do not sufficiently review (i) product returns in relation to product sales and (ii) for title transfer terms to determine when revenue should be recorded. The second material weakness related to insufficient documentation of inventory controls relating to our inventory balances, advances to suppliers, and off-site inventory tracking is limited. The third material weakness related to internal control weaknesses in the capitalization and coordination of development costs to prevent excess payments and erroneously recorded invoices.

 

For the material weaknesses identified in our 2022 audit, we have taken steps to remediate these material weaknesses, and to further strengthen our accounting staff and internal controls, as detailed below:

 

  With respect to the revenue recognition practices, management will consistently apply of IFRS15 with respect to the five criterion for revenue recognition, In addition, management will institute peer review of North American sales by the Israeli subsidiary’s chief financial officer and peer review by Company’s Chief Financial Officer of Israeli sales recognition policy on a quarterly basis and engage in dialogue on new customers to ensure the revenue recognition policy and the customer contracts are consistently applied.

 

  With respect to the inventory control weaknesses, management will institute the following remediation procedures:

 

  Monthly comparison of inventory first and last cost in USD$ between periods to note any changes and to investigate the reason for these discrepancies to provide a more accurate quantum of write downs and consistent costing.

 

  The implementation of an IT system to track the inventory movements in North America;

 

  Monthly comparison of inventory units between periods to note any changes and to investigate the reason for any inconsistencies.

 

  Obtain confirmation of goods in transit with external vendors and consignment customers on a more timely basis.

 

7

 

 

  With respect to the development cost weaknesses, the research and development team will be required to approve all invoices from the R&D sub-contractor and ensure they fall within the budget to ensure the amounts capitalized are not in excess of the original budget with its discounted cash flows. Once the R&D team has approved the invoice based on the above criteria, the Company’s Chief Executive Officer will review the documentation and once approved, will forward said documentation to the Company’s Chief Financial Officer in Canada for wire initiation.

 

In 2021, our independent registered public accountants identified the following material weaknesses in our internal control over financial reporting. The first material weakness related to the insufficient review of inventory balances for products which are slow-moving. The second material weakness related to the insufficient review of advances to suppliers on products that are no longer selling, the third material weakness relates to insufficient controls surrounding off-site inventory tracking. The fourth material weakness related to insufficient review whether product returns relate to sales recorded in the fiscal year. The fifth material weakness relates to insufficient review of title transfer terms to determine the period in which revenue should be recorded.

 

For the material weaknesses identified in our 2021 audit, we have taken steps to remediate these material weaknesses, and to further strengthen our accounting staff and internal controls, as detailed below:

 

  On a quarterly basis, the Company now reviews inventory on hand for slow moving merchandise and reviews inventory on hand regularly. For the year ended 2021, it was determined that $4,659,648 (2020- $1,571,649) of the inventory was impaired due to slow movement. The accessories and spare parts related to these products amounted to $839,693 (2020 - $316,000), which was also impaired.

 

  The Company now reviews quantities on hand before approving purchase orders.

 

  As of April 1, 2022, the Company signed a lease for their own exclusive warehouse space so that outside contract warehouses will not be required.

 

  The Company now reviews product returns to compare and ensure that they occur in the same fiscal year.

 

  The Company’s controller scrutinizes all revenues earned in the period to ensure compliance with IFRS15.

 

  The Company’s controller and CFO in Canada coordinates full scheduling of the year end process to ensure timely close off of accounting periods.

 

To date, we have only partially remediated the material weaknesses identified in 2022 and 2021 above. We cannot be certain that other material weaknesses and control deficiencies will not be discovered in the future. If our efforts are not successful or other material weaknesses or control deficiencies occur in the future, we may be unable to report our financial results accurately on a timely basis or help prevent fraud, which could cause our reported financial results to be materially misstated and result in the loss of investor confidence or delisting and cause the market price of our Common Shares to decline.

 

We began to take steps to remediate these material weaknesses and strengthen our internal control over financial reporting, including the following:

 

  (i) documenting and formally assessing our accounting and financial reporting policies and procedures; and

 

  (ii) increasing the use of third-party consultants in assessing significant accounting transactions and other technical accounting and financial reporting issues, preparing accounting memoranda addressing these issues and maintaining these memoranda in our corporate records.

 

8

 

 

While we believe that these efforts will improve our internal control over financial reporting, the implementation of these measures is ongoing and will require validation and testing of the design and operating effectiveness of internal controls over a sustained period of financial reporting cycles. We cannot assure you that the measures we have taken to date, and are continuing to implement, will be sufficient to maintain effective internal control over financial reporting. Accordingly, there could continue to be a reasonable possibility that a misstatement of our accounts or disclosures that would result in a material misstatement of our financial statements that would not be prevented or detected on a timely basis.

 

Risks Related to Our Business and Industry

 

We rely on our channel partners to generate a substantial majority of our revenues. If these channel partners fail to perform or if we cannot enter into agreements with channel partners on favorable terms, our operating results could be significantly harmed.

 

More than 72% of our revenues for the six months ended June 30, 2023 (33% of our revenues for the six month period ended June 30, 2022), were generated through sales by our channel partners, which are primarily wireless carriers who sell our devices through their sales channels. To the extent our channel partners are unsuccessful in selling or do not promote our products, or we are unable to obtain and retain a sufficient number of high-quality channel partners, our business and operating results could be significantly harmed. Our channel partners are wireless carriers who have direct and indirect sales channels which we are leveraging to get to their customers. Our wireless carrier channel partners currently include:

 

  AT&T, in the United States;

 

  FirstNet, in the United States;

  

  Verizon, in the United States;

 

  T-Mobile, in the United States;

 

  Bell Mobility, in Canada;

 

  Rogers, in Canada; and

 

  a leading global land mobile radio, or LMR, vendor and distributor in North America and international markets.

 

While these arrangements are typically long term, they generally do not contain any firm purchase volume commitments. As a result, our channel partners are not contractually obligated to purchase from us any minimum number of products. We are generally required to satisfy any and all purchase orders delivered to us within specified delivery windows, with limited exceptions (such as orders significantly in excess of forecasts). If we are unable to efficiently manage our supply and satisfy purchase orders on a timely basis to our channel partners, we may be in breach of our sales arrangements and lose potential sales. If a technical issue with any of our covered products exceeds certain present failure thresholds for the relevant performance standard or standards, the channel partner typically has the right to cease selling the product, cancel open purchase orders and levy certain monetary penalties. If our products suffer technical issues or failures following sales to our channel partners, we may be subject to significant monetary penalties and our channel partners may cease making purchase orders, which would significantly harm our business and results of operations. In addition, our channel partners retain sole discretion in which of their stocked products to offer their customers. While we may offer limited customer incentives, we generally have limited to no control over which products our channel partners decide to offer or promote, which directly impacts the number of products that our partners will purchase from us.

 

9

 

 

In addition, our channel partners may be unsuccessful in marketing, selling and supporting our solutions. They may also market, sell and support solutions that are somewhat competitive with ours, and may devote more resources to the marketing, sales and support of such products. They may have incentives to promote our competitors’ products in lieu of our products, particularly for our bigger competitors with larger volumes of orders, more diverse product offerings and a longer relationship with our generally large-scale channel partners. As a result, our channel partners may stop selling our products completely. While we employ a small direct sales force, our channel partners have significantly larger sales teams who are not contractually obligated to promote any of our devices and often have multiple competing devices in stock to offer their customers. In addition, downstream sales by our channel partners often succeed due to attractive device prices and monthly rate plans, which we do not control. In certain cases, we may promote our own devices through customer incentives, however, there can be no assurance that any such incentives would contribute to increased purchases of our products. Further, given the impact of attractive pricing on ultimate sales, we generally must offer increased promotional funding or price reductions for our more expensive products. This promotional funding or price reductions operate to reduce our margins and significantly impact our profitability.

 

New sales channel partners may take several months or more to achieve significant sales. Our channel partner sales structure could subject us to lawsuits, potential liability and reputational harm if, for example, any of our channel partners misrepresents the functionality of our products or services to their customers, or violate laws or our corporate policies.

 

If we fail to effectively manage our existing or future sales channel partners, our channel partners fail to promote our products effectively, we are unable to meet our obligations under our sales arrangements or future agreements that we may enter into with wireless carrier customers have terms that are more favorable to the customer, our business and results of operations would be harmed.

 

We are materially dependent on the adoption of our solutions by both the industrial enterprise and public sector markets, and if end customers in those markets do not purchase our solutions, our revenues will be adversely impacted, and we may not be able to expand into other markets.

 

Our revenues have been primarily in the industrial enterprise market, and we are materially dependent on the adoption of our solutions by both the industrial enterprise and public sector markets. End customers in the public sector market may remain, for reasons outside our control, tied to LMR solutions or other competitive alternatives to our devices. Sales of our products to these buyers may also be delayed or limited by these competitive conditions. If our products are not widely accepted by buyers in those markets, we may not be able to expand sales of our products into new markets, and our business, results of operations and financial condition may be adversely impacted.

 

We participate in a competitive industry, which may become more competitive. Competitors with greater resources and significant experience in high-volume product manufacturing may be able to respond more quickly and cost-effectively than we can to new or emerging technologies and changes in customer requirements.

 

We face significant competition in developing and selling our solutions. Our primary competitors in the non-rugged mobile device market include LG Corporation, Apple Inc. and Samsung Electronics Co. Ltd. Our primary competitors in the rugged mobile device market include Sonim Technologies Inc., Bullitt Mobile Ltd., and Kyocera Corporation. We also face competition from large system integrators and manufacturers of private and public wireless network equipment and devices. Competitors in this space include Harris Corporation, JVC KENWOOD Corporation, Motorola, and Tait International Limited. Within the Cellular Booster category, we have several direct competitors, including Wilson Electronics, LLC, or Wilson Electronics, Nextivity, Inc. and SureCall Company.

 

We cannot assure you that we will be able to compete successfully against current or future competitors. Increased competition in mobile computing platforms, data capture products, or related accessories and software developments may result in price reductions, lower gross profit margins, and loss of market share, and could require increased spending on research and development, sales and marketing, and customer support. Some competitors may make strategic acquisitions or establish cooperative relationships with suppliers or companies that produce complementary products, which may create additional pressures on our competitive position in the marketplace.

 

10

 

 

Most of our competitors have longer operating histories, greater name recognition, larger customer bases and significantly greater financial, technical, sales, marketing and other resources and experience than we do. In addition, because of the higher volume of components that many of our competitors purchase from their suppliers, they are able to keep their supply costs relatively low and, as a result, may be able to recognize higher margins on their product sales than we do. Many of our competitors may also have existing relationships with the channel partners who we use to sell our products, or with our potential customers. This competition may result in reduced prices, reduced margins and longer sales cycles for our products. Our competitors may also be able to more quickly and cost-effectively respond to new or emerging technologies and changes in customer requirements. The combination of brand strength, extensive distribution channels and financial resources of the larger vendors could cause us to lose market share and could reduce our margins on our products. If any of our larger competitors were to commit greater technical, sales, marketing and other resources to our markets, our ability to compete would be adversely impacted. If we are unable to successfully compete with our competitors, our sales would suffer and as a result our financial condition will be adversely impacted.

 

Defects in our products could reduce demand for our products and result in a loss of sales, delay in market acceptance and injury to our reputation, which would adversely impact our business.

 

Complex software, as well as multiple components, displays, plastics and assemblies used in our products may contain undetected defects that are subsequently discovered at any point in the life of the product. Defects in our products may result in a loss of sales, product malfunction, delay in market acceptance and potential injuries to our customers which can bring to injury in our reputation and increased warranty costs.

 

Additionally, our software may contain undetected errors, defects or bugs. Although we have not suffered significant harm from any errors, defects or bugs to date, we may discover significant errors, defects, or bugs in the future that we may not be able to correct or correct in a timely manner. It is possible that errors, defects or bugs will be found in our existing or future software and/or hardware products and related services with the potential for delays in, or loss of market acceptance of, our products and services, diversion of our resources, injury to our reputation, increased service and warranty expenses, and payment of damages.

 

Further, errors, defects or bugs in our solutions could be exploited by hackers or could otherwise result in an actual or perceived breach of our information systems. Alleviating any of these problems could require significant expense and could cause interruptions, delays or cessation of our product licensing, which would reduce demand for our products and result in a loss of sales, delay in market acceptance and injure our reputation and could adversely impact our business, results of operations and financial condition.

   

If our business does not grow as we expect, or if we fail to manage our growth effectively, our operating results and business would suffer.

 

Our ability to successfully grow our business depends on a number of factors including our ability to:

 

  accelerate the adoption of our solutions by new end customers;

 

  expand into new vertical markets;

 

  develop and deliver new products and services;

 

  increase awareness of the benefits that our solutions offer; and

 

  expand our domestic and international footprint.

 

11

 

 

As usage of our solutions grows, we will need to continue to make investments to develop and implement new or updated solutions, software, technologies, security features and cloud-based infrastructure operations. In addition, we will need to appropriately scale our internal business systems and our services organization, including the suppliers of our products and customer support services, to serve our growing customer base. Any failure of, or delay in, these efforts could impair the performance of our solutions and reduce customer satisfaction.

 

Further, our growth could increase quickly and place a strain on our managerial, operational, financial and other resources, and our future operating results depend to a large extent on our ability to successfully manage our anticipated expansion and growth. To manage our growth successfully, we will need to continue to invest in sales and marketing, research and development, and general and administrative functions and other areas. We are likely to recognize the costs associated with these investments earlier than receiving some of the anticipated benefits, and the return on these investments may be lower, or may develop more slowly, than we expect, which could adversely impact our operating results.

 

If we are unable to manage our growth effectively, we may not be able to take advantage of market opportunities or develop new solutions or upgrades to our existing solutions, satisfy customer requirements, maintain the quality and security of our solutions or execute on our business plan, any of which could harm our business, operating results and financial condition.

 

We may not be able to continue to develop solutions to address user needs effectively in an industry characterized by ongoing change and rapid technological advances.

 

To be successful, we must adapt to rapidly changing technological and application needs by continually improving our products, as well as introducing new products and services, to address user demands.

 

Our industry is characterized by:

 

  evolving industry standards;

 

  frequent new product and service introductions;

 

  increasing demand for customized product and software solutions;

 

  rapid competitive developments;

  

  changing customer demands; and

 

  evolving distribution channels.

 

Future success will depend on our ability to effectively and economically adapt in this evolving environment. We could incur substantial costs if we must modify our business to adapt to these changes, and may even be unable to adapt to these changes.

 

The markets for our devices and related accessories may not develop as quickly as we expect, or may not develop at all. Our dependence on our cellular carrier channel partners and their success in promoting Push to Talk over Cellular to their client base is key for the success of the business.

 

Our future success is substantially dependent upon continued adoption of devices and related accessories in the industrial enterprise and public sector markets, including the transition from LMR to Push to Talk over Cellular and LTE networks. These market developments and transitions may take longer than we expect or may not occur at all, and may not be as widespread as we expect. If the market does not develop as we expect, our business, operating results and financial condition would be significantly harmed.

 

12

 

 

Our future success is dependent on our ability to create independent brand awareness for our company and products with end customers, and our inability to achieve such brand awareness could limit our prospects.

 

 We depend on wireless carriers to promote and distribute our products. While we intend to ramp up direct marketing and end-customer brand awareness initiatives in the future, our sales and marketing efforts have historically been predominantly focused on channel partners. To increase end-customer brand awareness, we intend to develop sales tools for key verticals within our target markets, increase usage of social media and expand product training efforts, among other things. As a result, we expect our sales and marketing expenses to increase in the future, primarily from increased sales personnel expenses, which will require us to cost-efficiently ramp up our sales and marketing capabilities and effectively target end customers. However, there can be no assurance that we will successfully increase our brand awareness or do so in a cost-efficient manner while maintaining market share within our existing sales channels. Our failure to establish stand-alone brand awareness with end customers of our products will leave us vulnerable to the marketing and selling success of others, including our channel partners, and these developments could have an adverse impact on our prospects. If we are unable to significantly increase the awareness of our brand and solutions with end customers in a cost-efficient manner, we will remain significantly dependent on our channel partners for sales of our products, and our business, financial condition and results of operations could be adversely impacted.

 

We are dependent on the continued services and performance of a concentrated group of senior management and other key personnel, the loss of any of whom could adversely impact our business.

 

Our future success depends in large part on the continued contributions of a concentrated group of senior management and other key personnel. In particular, the leadership of key management personnel is critical to the successful management of our company, the development of our solutions and our strategic direction. We also depend on the contributions of key technical personnel. Our senior management and key personnel are all employed on an at-will basis, which means that they could terminate their employment with us at any time, for any reason and without notice. The loss of any of our key personnel could significantly delay or prevent the achievement of our development and strategic objectives and harm our business.

 

We compete in a rapidly evolving market, and the failure to respond quickly and effectively to changing market requirements could cause our business and operating results to decline.

 

The mobile device market is characterized by rapidly changing technology, changing customer needs, evolving industry standards and frequent introductions of new products and services. In order to deliver a competitive mobile device, our solutions must be capable of operating in an increasingly complex network environment. As new wireless phones are introduced and standards in the mobile device market evolve, we may be required to modify our phones and services to make them compatible with these new products and standards. Likewise, if our competitors introduce new devices and services that compete with ours, we may be required to reposition our solutions or introduce new phones and solutions in response to such competitive pressure. We may not be successful in modifying our current devices or introducing new ones in a timely or appropriately responsive manner, or at all. If we fail to address these changes successfully, our business and operating results could be significantly harmed.

  

If we are unable to sell our solutions into new markets, our revenues may not grow.

 

Any new market into which we attempt to sell our solutions may not be receptive. Our ability to penetrate new markets depends on the quality of our solutions, the continued adoption of our public safety solution by first responders, the perceived value of our solutions as a risk management tool and our ability to design our solutions to meet the demands of our customers. If the markets for our solutions do not develop as we expect, our revenues may not grow.

 

13

 

 

Our ability to successfully face these challenges depends on several factors, including increasing the awareness of our solutions and their benefits, the effectiveness of our marketing programs, the costs of our solutions, our ability to attract, retain and effectively train sales and marketing personnel, and our ability to develop relationships with wireless carriers and other partners. If we are unsuccessful in developing and marketing our solutions into new markets, new markets for our solutions might not develop or might develop more slowly than we expect, either of which would harm our revenues and growth prospects.

  

If we are unable to attract, integrate and retain additional qualified personnel, including top technical talent, our business could be adversely impacted.

 

Our future success depends in part on our ability to identify, attract, integrate and retain highly skilled technical, managerial, sales and other personnel. We face intense competition for qualified individuals from numerous other companies, including other software and technology companies, many of whom have greater financial and other resources than we do. Some of these characteristics may be more appealing to high-quality candidates than those we have to offer. In addition, new hires often require significant training and, in many cases, take significant time before they achieve full productivity. We may incur significant costs to attract and retain qualified personnel, including significant expenditures related to salaries and benefits and compensation expenses related to equity awards, and we may lose new employees to our competitors or other companies before we realize the benefit of our investment in recruiting and training them. Moreover, new employees may not be or become as productive as we expect, as we may face challenges in adequately or appropriately integrating them into our workforce and culture. If we are unable to attract, integrate and retain suitably qualified individuals who are capable of meeting our growing technical, operational and managerial requirements on a timely basis or at all, our business will be adversely impacted.

 

Volatility or lack of positive performance in our stock price may also affect our ability to attract and retain our key employees. Many of our senior management personnel and other key employees have become, or will soon become, vested in a substantial amount of stock or stock options. Employees may be more likely to leave us if the shares they own or the shares underlying their vested options have significantly appreciated in value relative to the original purchase prices of the shares or the exercise prices of the options, or, conversely, if the exercise prices of the options that they hold are significantly above the market price of our Common Shares. If we are unable to appropriately incentivize and retain our employees through equity compensation, or if we need to increase our compensation expenses in order to appropriately incentivize and retain our employees, our business, operating results and financial condition would be adversely impacted.

 

A security breach or other significant disruption of our IT systems or those of our partners, suppliers or manufacturers, caused by cyberattacks or other means, could have a negative impact on our operations, sales, and operating results.

 

All IT systems are potentially vulnerable to damage, unauthorized access or interruption from a variety of sources, including but not limited to, cyberattacks, cyber intrusions, computer viruses, security breaches, energy blackouts, natural disasters, terrorism, sabotage, war, insider trading and telecommunication failures. A cyberattack or other significant disruption involving our IT systems or those of our outsource partners, suppliers or manufacturers could result in the unauthorized release of proprietary, confidential or sensitive information of ours or result in virus and malware installation on our devices. Such unauthorized access to, or release of, this information or other security breaches could: (i) allow others to unfairly compete with us, (ii) compromise safety or security, (iii) subject us to claims for breach of contract, tort, and other civil claims, and (iv) damage our reputation. Any or all of the foregoing could have a negative impact on our business, financial condition and results of operations.

  

14

 

 

We experience lengthy sales cycles for our products and the delay of an expected large order could result in a significant unexpected revenue shortfall.

 

The purchase of our products is often an enterprise-wide decision for prospective customers, which requires us to engage in sales efforts over an extended period of time and provide a significant level of education to prospective customers regarding the uses and benefits of such devices. Prospective customers, especially the wireless carriers that sell our products, often undertake a prolonged evaluation process that may take from several months to several years in certain cases. Consequently, if our forecasted sales from a specific customer are not realized, we may not be able to generate revenues from alternative sources in time to compensate for the shortfall. The loss or delay of an expected large order could also result in a significant unexpected revenue shortfall. Moreover, to the extent we enter into and deliver our products pursuant to significant contracts earlier than we expected, our operating results for subsequent periods may fall below expectations. We may spend substantial time, effort and money on our sales and marketing efforts without any assurance that our efforts will produce any sales. If we are unable to succeed in closing sales with new and existing customers, our business, operating results and financial condition will be harmed.

 

We have a limited history of contracting with third party manufacturers in Asia for the high-volume commercial production of our devices, and we may face manufacturing capacity constraints.

 

We have limited history and experience in contracting with third party manufacturers in Asia for the high-volume commercial production of our devices. Because of this limited production history, we face challenges in predicting our business and evaluating its prospects, which may result in breakdowns of our ability to timely supply our devices to our customers. Moreover, we face manufacturing capacity constraints that present further risks to our business. If overall demand of our devices increases in the future, we will need to expand our third party manufacturing capacity in a cost-efficient manner. Failing to meet customer demand due to our failure to successfully address these risks and challenges could adversely impact our reputation and future sales, which would significantly harm our business, results of operations and financial condition.

 

We face risks related to novel Coronavirus (COVID-19) which could significantly disrupt our research and development, operations, sales, supply chain and financial results.

 

Our business will be adversely impacted by the effects of the Novel Coronavirus (COVID-19). In addition to global macroeconomic effects, the novel Coronavirus (COVID-19) outbreak and any other related adverse public health developments will cause disruption to our operations, research and development, and sales activities. Our third-party manufacturers, third-party distributors, and our customers have been and will be disrupted by worker absenteeism, quarantines and restrictions on employees’ ability to work, office and factory closures, disruptions to ports and other shipping infrastructure, border closures, or other travel or health-related restrictions. Depending on the magnitude of such effects on our activities or the operations of our third-party manufacturers and third-party distributors, the supply of our products will be delayed, which could adversely affect our business, operations and customer relationships. In addition, the novel Coronavirus (COVID-19) or other disease outbreak will in the short-run, and may over the longer term, adversely affect the economies and financial markets of many countries, resulting in an economic downturn that will affect demand for our products and impact our operating results. There can be no assurance that any decrease in sales resulting from the novel Coronavirus (COVID-19) will be offset by increased sales in subsequent periods. Although the magnitude of the impact of the novel Coronavirus (COVID-19) outbreak on our business and operations remains uncertain, the continued spread of the novel Coronavirus (COVID-19) or the occurrence of other epidemics and the imposition of related public health measures and travel and business restrictions will adversely impact our business, financial condition, operating results and cash flows. In addition, we have experienced and will experience disruptions to our business operations resulting from quarantines, self-isolations, or other movement and restrictions on the ability of our employees to perform their jobs that may impact our ability to develop and design our products in a timely manner or meet required milestones or customer commitments.

 

Our business has not experienced any material impact from supply chain disruptions brought about by the novel Coronavirus (COVID-19) pandemic, however there is no certainty that this will continue into the future. Management is carefully monitoring the situation and is working with its partners, suppliers and manufacturers to ensure minimal impact on its business.

 

15

 

 

Our financial condition and results of operations as well as those of potential customers could be adversely affected by the Russian invasion of Ukraine, which has caused a material adverse effect on the level of economic activity around the world, including in the markets we serve.

 

In February 2022, the Russian Federation invaded Ukraine. As a result of the invasion, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus and certain of their citizens. While we currently have no customers or suppliers located in Belarus, the Russian Federation or Ukraine, nor have we experienced any supply disruptions directly related to the Russian invasion of Ukraine as we do not knowingly source any materials originating from Belarus, the Russian Federation or Ukraine, as the war in Ukraine continues or possibly escalates, this may lead to further disruption, instability and volatility in global markets and industries that could negatively impact our customers, operations and our supply chain. The impact of the conflict and related sanctions on the world economy are subject to rapid change and are difficult to predict. The war has created disruptions in the supply chain for certain of our products which, to date, has not had a substantive impact on our operations. None of our critical raw materials are sourced from, and none of our finished products are manufactured in, the sanctioned regions. We have no operations or other projects in that region.

 

We are monitoring any broader economic impact from Russia’s invasion of Ukraine and the ongoing war between the two nations, including heightened risk of cyberattacks, increased prices of fuel and other commodities, and potential impacts to our partners’ supply chains. Our financial condition, results of operations, and cash flows may be materially adversely affected, but the specific impact on our financial condition, results of operations, and cash flows is currently difficult to determine.

 

We rely on industry data and projections which may prove to be inaccurate.

 

We obtained statistical data, market data and other industry data and forecasts used in this prospectus from market research, publicly available information and industry publications. These industry data, including the vehicle communications industry, include projections that are based on a number of assumptions which have been derived from industry and government sources which we believe to be reasonable. The vehicle communications industry may not grow at the rate projected by industry data, or at all. The failure of the industry to grow as anticipated is likely to have a material adverse effect on our business and the market price of our Common Shares. In addition, the rapidly changing nature of the vehicle communications industry subjects any projections or estimates relating to the growth prospects or future condition of our industries to significant uncertainties. Furthermore, if any one or more of the assumptions underlying the industry data turns out to be incorrect, actual results may, and are likely to, differ from the projections based on these assumptions. While we believe that the statistical data, industry data and forecasts and market research are reliable, we have not independently verified the data.

 

16

 

 

Risks Related to our Reliance on Third Parties

 

As we work with multiple vendors for our components, if we fail to adequately forecast demand for our inventory and supply needs, we could incur additional costs or experience manufacturing delays, which could reduce our gross margin or cause us to delay or even lose sales.

 

Because our production volumes are based on a forecast of channel partner demand rather than purchase commitments from our major customers, there is a risk that our forecasts could be inaccurate and that we will be unable to sell our products at the volumes and prices we expect, which may result in excess inventory. We provide, and will continue to provide, forecasts of our demand to our third-party suppliers prior to the scheduled delivery of products to our channel partners. If we overestimate our requirements, our contract manufacturers may have excess component inventory, which could increase our costs. If we underestimate our requirements, our contract manufacturers may have inadequate component inventory, which could interrupt the manufacturing of our products and result in delays in shipments and revenues or even lost sales, or could incur unplanned overtime costs to meet our requirements, resulting in significant cost increases. For example, certain materials and components used to manufacture our products may reach end of life during any of our product’s life cycles, following which suppliers no longer provide such expired materials and components. This would require us to either source and qualify an alternative component, which could require a re-certification of the device by the wireless carriers and/or regulatory agencies, or forecast product demand for a final purchase of such materials and components that may reach end of life to ensure that we have sufficient product inventory through a product’s life cycle. If we overestimate forecasted demand, we would hold excess end-of-life materials and components resulting in increased costs. If we underestimate forecasted demand, we could experience delays in shipments and loss of revenues.

  

In addition, if we underestimate our requirements and the applicable supplier becomes insolvent or is no longer able to timely supply our needs in a cost-efficient manner or at all, we may be required to acquire components, which may need to be customized for our products, from alternative suppliers, including at significantly higher costs. If we cannot source alternative suppliers and/or alternative components, we may suffer delays in shipments or lost sales. Similarly, credit constraints at our suppliers could require us to accelerate payment of our accounts payable, impacting our cash flow. Further, lead times for materials and components that we order vary significantly and depend on factors such as the specific supplier, contract terms, customization needed for any particular component and demand for each component at a given time. Any such failure to accurately forecast demand and manufacturing and supply requirements, and any need to obtain alternative supply sources, could materially harm our business, results of operations and financial condition.

 

Our dependence on third-party suppliers for key components of our products could delay shipment of our products and reduce our sales.

 

We depend on certain suppliers for the delivery of components used in the assembly of our products. Our reliance on third-party suppliers creates risks related to our potential inability to obtain an adequate supply of components and reduced control over pricing and timing of delivery of components. In particular, we have little to no control over the prices at which our suppliers sell materials and components to us. Certain supplies of our components are available only from a single source or limited sources and we may not be able to diversify sources in a timely manner. We have experienced shortages in the past that have negatively impacted our results of operations and may experience such shortages in the future.

 

We also do not have long-term supply agreements with any of our suppliers. Our current contracts with certain suppliers may be cancelled or not extended by such suppliers and, therefore, do not afford us with sufficient protection against a reduction or interruption in supplies. Moreover, in the event any of these suppliers breach their contracts with us, our legal remedies associated with such a breach may be insufficient to compensate us for any damages we may suffer.

 

Any interruption of supply for any material components of our products, or inability to obtain required components from our third-party suppliers, could significantly delay the production and shipment of our products and harm our revenues, profitability and financial condition.

  

17

 

 

Because we rely on a small number of channel partners/customers for a large portion of our revenue, the loss of any of these customers would have a material adverse effect on our operating results and cash flows.

 

For our six month period ended June 30, 2023, we derived 67% of our revenue from five customers/channel partners. Any termination of a business relationship with, or a significant sustained reduction in business from, one or more of these channel partners/customers could have a material adverse effect on our operating results and cash flows.

 

If dedicated public safety LTE networks are not deployed at the rate we anticipate or at all, demand for our solutions may not grow as expected.

 

A key part of our strategy is to further expand the use of our solutions over dedicated LTE networks in the public safety market. If the deployment of dedicated LTE networks is delayed or such networks are not adopted at the rate we anticipate, demand for our solutions may not develop as we anticipate, which would have a negative effect on our revenues.

 

The application development ecosystem supporting our devices and related accessories is new and evolving.

 

The application development ecosystem supporting our devices and related accessories is new and evolving. Specifically, the number of application developers in the ecosystem supporting our devices and accessories is small. If the market or the application development ecosystem does not develop, timely or at all, demand for our products may be limited, and our business and results of operations will be significantly harmed.

 

Failure of our suppliers, subcontractors, distributors, resellers, and representatives to use acceptable legal or ethical business practices, or to fail for any other reason, could negatively impact our business.

 

We do not control the labor and other business practices of our suppliers, subcontractors, distributors, resellers and third-party sales representatives, or TPSRs, and cannot provide assurance that they will operate in compliance with applicable rules, and regulations regarding working conditions, employment practices, environmental compliance, anti-corruption, and trademark a copyright and patent licensing. If one of our suppliers, subcontractors, distributors, resellers, or TPSRs violates labor or other laws or implements labor or other business practices that are regarded as unethical, the shipment of finished products to us could be interrupted, orders could be cancelled, relationships could be terminated, and our reputation could be damaged. If one of our suppliers or subcontractors fails to procure the necessary license rights to trademarks, copyrights or patents, legal action could be taken against us that could impact the saleability of our products and expose us to financial obligations to a third party. Any of these events could have a negative impact on our sales and results of operations.

 

Moreover, any failure of our suppliers, subcontractors, distributors, resellers and TPSRs, for any reason, including bankruptcy or other business disruption, could disrupt our supply or distribution efforts and could have a negative impact on our sales and results of operations.

 

Our products are subject to risks associated with sourcing and manufacturing.

 

We do not own or operate any of the manufacturing facilities for our products and rely on a concentrated number of independent suppliers to manufacture all of the products we sell. For our business to be successful, our suppliers must provide us with quality products in substantial quantities, in compliance with regulatory requirements, at acceptable costs and on a timely basis. Our ability to obtain a sufficient selection or volume of merchandise on a timely basis at competitive prices could suffer as a result of any deterioration or change in our supplier relationships or events that adversely affect our suppliers.

 

18

 

 

There can be no assurance we will be able to detect, prevent or fix all defects that may affect our products manufactured by our suppliers. Failure to detect, prevent or fix defects, or the occurrence of real or perceived quality or safety problems or material defects in our current and future products, could result in a variety of consequences, including a greater number of product returns than expected from customers and our wholesale partners, litigation, product recalls and credit, warranty or other claims, among others, which could harm our brand, results of operations and financial condition. Such problems could hurt our brand image, which is critical to maintaining and expanding our business. Any negative publicity or lawsuits filed against us related to the perceived quality and safety of our products could harm our brand and decrease demand for our products.

 

If one or more of our significant suppliers were to sever their relationship with us or significantly alter the terms of our relationship, including due to changes in applicable trade policies, we may not be able to obtain replacement products in a timely manner, which could have a material adverse effect on our business, results of operations and financial condition.

 

In addition, if any of our primary suppliers fail to make timely shipments, do not meet our quality standards or otherwise fail to deliver us product in accordance with our plans, there could be a material adverse effect on our results of operations.

 

Our contractors and suppliers buy raw materials and are subject to wage rates that are oftentimes regulated by the governments of the countries in which our products are manufactured. The raw materials used to manufacture our products are subject to availability constraints and price volatility. There could be a significant disruption in the supply of raw materials from current sources or, in the event of a disruption, our suppliers might not be able to locate alternative suppliers of materials of comparable quality at an acceptable price or at all. Our business is dependent upon the ability of our unaffiliated suppliers to locate, train, employ and retain adequate personnel. Our unaffiliated suppliers have experienced, and may continue to experience in the future, unexpected increases in work wages, whether government-mandated or otherwise. Our suppliers may increase their pricing if their raw materials became more expensive. Our suppliers may pass the increase in sourcing costs to us through price increases, thereby impacting our margins. Material changes in the pricing practices of our suppliers could negatively impact our profitability.

 

In addition, we cannot be certain that our unaffiliated suppliers will be able to fill our orders in a timely manner. If we experience significant increases in demand, or reductions in the availability of materials, or need to replace an existing supplier, there can be no assurance additional supplies of raw materials or additional manufacturing capacity will be available when required on terms acceptable to us, or at all, or that any supplier would allocate sufficient capacity to us in order to meet our requirements. In addition, even if we are able to expand existing or find new manufacturing or sources of materials, we may encounter delays in production and added costs as a result of the time it takes to train suppliers in our methods, products, quality control standards and labor, health and safety standards. Any delays, interruption or increased costs in labor or wages, or the supply of materials or manufacture of our products, could have an adverse effect on our ability to meet wholesale partner and customer and consumer demand for our products and result in lower revenue and net income both in the short and long term.

 

Events that adversely impact our suppliers could impair our ability to obtain adequate and timely supplies. Such events include, among others, difficulties or problems associated with our suppliers’ business, the financial instability and labor problems of suppliers, merchandise quality and safety issues, natural or man-made disasters, inclement weather conditions, war, acts of terrorism and other political instability, economic conditions, transportation delays and shipment issues. Our suppliers may be forced to reduce their production, shut down their operations or file for bankruptcy. Our suppliers may consolidate, increasing their market power. The occurrence of one or more of these events could impact our ability to get products to our customers and/or wholesale partners, result in disruptions to our operations, increase our costs and decrease our profitability.

 

19

 

 

Global sourcing and foreign trade involve numerous factors and uncertainties beyond our control, including:

 

  increased shipping costs;

 

  the imposition of additional import or trade restrictions;

 

  legal or economic restrictions on overseas suppliers’ ability to produce and deliver products;

 

  increased custom duties and tariffs;

 

  unforeseen delays in customs clearance of goods;

 

  more restrictive quotas;

 

  loss of a most favored nation trading status;

 

  currency exchange rates;

 

  transportation delays;

 

  port of entry issues; and

 

  foreign government regulations, political instability and economic uncertainties in the countries from which we or our suppliers source our products.

  

Our sourcing operations may also be hurt by health concerns regarding the outbreak of viruses, widespread illness, infectious diseases, contagions and the occurrence of unforeseen epidemics (including the outbreak of the novel Coronavirus (Covid-19) and its potential impact on our financial results) in countries in which our merchandise is produced. Moreover, negative press or reports about internationally manufactured products may sway public opinion, and thus customer confidence, away from our products. Furthermore, changes in U.S. trade policies, including new restrictions, tariffs or other changes could lead to additional costs, delays in shipments, embargos and other uncertainties that could negatively impact our relationships with our international suppliers and materially adversely affect our business. These and other issues affecting our international suppliers or internationally manufactured merchandise could have a material adverse effect on our business, results of operations and financial condition.

  

In addition, some of our suppliers may not have the capacity to supply us with sufficient merchandise to keep pace with our growth plans, especially if we need significantly greater amounts of inventory. In such cases, our ability to pursue our growth strategy will depend in part upon our ability to develop new supplier relationships.

 

The nature of our business may result in undesirable press coverage or other negative publicity, which would adversely impact our brand identity, future sales and results of operations.

 

Our solutions are used to assist law enforcement and other public safety personnel in situations involving public safety. The incidents in which our solutions are deployed may involve injury, loss of life and other negative outcomes, and such events are likely to receive negative publicity. Such negative publicity could have an adverse impact on new sales or renewals or expansions of coverage areas by existing customers, which would adversely impact our financial results and business.

 

20

 

 

Changes in the availability of federal funding to support local public safety or other public sector efforts could impact our opportunities with public sector end customers.

 

Many of our public sector end customers rely to some extent on funds from the U.S. federal government in order to purchase and pay for our solutions. Any reduction in federal funding for local public safety or other public sector efforts could result in our end customers having less access to funds required to continue, renew, expand or pay for our solutions. For example, changes in policies with respect to “sanctuary cities” may result in a reduction in federal funds available to our current or potential end customers. Additionally, any future U.S. government shutdowns could result in delayed public safety spending or re-allocation of funding into other areas of public safety. If federal funding is reduced or eliminated and our end customers cannot find alternative sources of funding to purchase our solutions, our business will be harmed.

 

Economic uncertainties or downturns, or political changes, could limit the availability of funds available to our customers and potential customers, which could significantly adversely impact our business.

 

Current or future economic uncertainties or downturns could adversely impact our business and operating results. Negative conditions in the general economy both in the United States and abroad, including conditions resulting from changes in gross domestic product growth, inflation, changes in general interest rates, decisions of central banks, financial and credit market fluctuations, political deadlock, natural catastrophes, warfare and terrorist attacks in North America, Europe, the Asia Pacific region or elsewhere, could cause a decrease in funds available to our customers and potential customers and negatively affect the growth rate of our business.

 

These economic conditions may make it extremely difficult for our customers and us to forecast and plan future budgetary decisions or business activities accurately, and they could cause our customers to re-evaluate their decisions to purchase our solutions, which could delay and lengthen our sales cycles or result in cancellations of planned purchases. Furthermore, during challenging economic times or as a result of political changes, our customers may tighten their budgets and face constraints in gaining timely access to sufficient funding or other credit, which could result in an impairment of their ability to make timely payments to us. In turn, we may be required to increase our allowance for doubtful accounts, which would adversely impact our financial results.

 

We cannot predict the timing, strength or duration of any economic slowdown, instability or recovery, generally or within any particular industry, or the impact of political changes. If the economic conditions of the general economy or industries in which we operate worsen from present levels, or if recent political changes result in less funding being available to purchase our solutions, our business, operating results and financial condition could be adversely impacted. 

 

Natural or man-made disasters and other similar events may significantly disrupt our business, and negatively impact our operating results and financial condition.

 

Any of our facilities may be harmed or rendered inoperable by natural or man-made disasters, including earthquakes, tornadoes, hurricanes, wildfires, floods, nuclear disasters, acts of terrorism or other criminal activities, infectious disease outbreaks, and power outages, which may render it difficult or impossible for us to operate our business for some period of time. Our facilities would likely be costly to repair or replace, and any such efforts would likely require substantial time. Any disruptions in our operations could negatively impact our business and operating results, and harm our reputation. In addition, we may not carry business insurance or may not carry sufficient business insurance to compensate for losses that may occur. Any such losses or damages could have a significant adverse impact on our business, operating results and financial condition. In addition, the facilities of significant vendors may be harmed or rendered inoperable by such natural or man-made disasters, which may cause disruptions, difficulties or significant adverse impact on our business.

 

21

 

 

We are exposed to risks associated with strategic acquisitions and investments.

 

We may consider strategic acquisitions of companies with complementary technologies or intellectual property in the future. Acquisitions hold special challenges in terms of successful integration of technologies, products, services and employees. We may not realize the anticipated benefits of these acquisitions or the benefits of any other acquisitions we have completed or may complete in the future, and we may not be able to incorporate any acquired services, products or technologies with our existing operations, or integrate personnel from the acquired businesses, in which case our business could be harmed.

 

Acquisitions and other strategic decisions involve numerous risks, including:

 

  problems integrating and divesting the operations, technologies, personnel, services or products over geographically disparate locations;

 

  unanticipated costs, taxes, litigation and other contingent liabilities;

 

  continued liability for discontinued businesses and pre-closing activities of divested businesses or certain post-closing liabilities which we may agree to assume as part of the transaction in which a particular business is divested;

 

  adverse impacts on existing business relationships with suppliers and customers;

 

  cannibalization of revenues as customers may seek multi-product discounts;

 

  risks associated with entering into markets in which we have no, or limited, prior experience;

 

  incurrence of significant restructuring charges if acquired products or technologies are unsuccessful;

 

  significant diversion of management’s attention from our core business and diversion of key employees’ time and resources;

 

  licensing, indemnity or other conflicts between existing businesses and acquired businesses;

 

  inability to retain key customers, distributors, suppliers, vendors and other business relations of the acquired business; and

 

  potential loss of our key employees or the key employees of an acquired organization or as a result of discontinued businesses.

 

Financing for future acquisitions may not be available on favorable terms, or at all. If we identify an appropriate acquisition candidate for any of our businesses, we may not be able to negotiate the terms of the acquisition successfully, finance the acquisition or integrate the acquired business, products, service offerings, technologies or employees into our existing business and operations. Future acquisitions and divestitures may not be well-received by the investment community, which may cause the value of our stock to fall. We cannot ensure that we will be able to identify or complete any acquisition, divestiture or discontinued business in the future. Further, the terms of our indebtedness constrain our ability to make and finance additional acquisitions or divestitures.

 

22

 

 

If we acquire businesses, new products, service offerings or technologies in the future, we may incur significant acquisition-related costs. In addition, we may be required to amortize significant amounts of finite-lived intangible assets and we may record significant amounts of goodwill or indefinite-lived intangible assets that would be subject to testing for impairment. We have in the past and may in the future be required to write off all or part of the intangible assets or goodwill associated with these investments that could harm our operating results. If we consummate one or more significant future acquisitions in which the consideration consists of stock or other securities, our existing stockholders’ ownership could be significantly diluted. If we were to proceed with one or more significant future acquisitions in which the consideration included cash, we could be required to use a substantial portion of our cash and investments. Acquisitions could also cause operating margins to fall depending on the businesses acquired.

 

Our strategic investments may involve joint development, joint marketing, or entry into new business ventures, or new technology licensing. Any joint development efforts may not result in the successful introduction of any new products or services by us or a third party, and any joint marketing efforts may not result in increased demand for our products or services. Further, any current or future strategic acquisitions and investments by us may not allow us to enter and compete effectively in new markets or enhance our business in our existing markets and we may have to impair the carrying amount of our investments.

 

We could be adversely impacted by changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters.

 

International Financial Reporting Standards and related accounting pronouncements, implementation guidelines, and interpretations with regard to a wide range of matters that are relevant to our businesses, including, but not limited to, revenue recognition, asset impairment, inventories, customer rebates and other customer consideration, tax matters, and litigation and other contingent liabilities are highly complex and involve many subjective assumptions, estimates and judgments. Changes in these rules or their interpretation or changes in underlying assumptions, estimates or judgments could significantly change our reported or expected financial performance or financial condition. New accounting guidance may also require systems and other changes that could increase our operating costs and/or change our financial statements. For example, implementing future accounting guidance related to revenue, accounting for leases and other areas could require us to make significant changes to our accounting systems, impact existing debt agreements and result in adverse changes to our financial statements.

 

Risks Related to Government Regulation

 

The impact of potential changes in customs, tariffs, and trade policies in the United States and the potential corresponding actions by other countries, including recent trade initiatives announced by the U.S. presidential administration against China, in which we do business could adversely impact our financial performance.

 

The U.S. government has made proposals that are intended to address trade imbalances, which include encouraging increased production in the United States. These proposals could result in increased customs duties and tariffs, and the renegotiation of some U.S. trade agreements. We import a significant percentage of our products into the United States, and an increase in customs duties and tariffs with respect to these imports could negatively impact our financial performance. If such customs duties and tariffs are implemented, it also may cause U.S. trading partners to take actions with respect to U.S. imports or U.S. investment activities in their respective countries. Any potential changes in trade policies in the United States and the potential corresponding actions by other countries in which we do business could adversely impact our financial performance. Given the level of uncertainty over which provisions will be enacted, we cannot predict with certainty the impact of the proposals.

 

23

 

 

For example, in 2018, the U.S. presidential administration and Chinese government imposed significant tariffs on exports between the two countries. This evolving policy dispute between China and the United States is likely to have significant impact on the industries in which we participate, directly and indirectly, and no assurance can be given that any individual customer or significant groups of companies or a particular industry, will not be adversely impacted by any governmental actions taken by either China or the United States. In addition, we manufacture our mobile phones at our facility in Shenzhen, China, which could result in significant additional costs to us when shipping our products to various customers in the United States. It is not possible to predict with any certainty the outcome of the trade dispute between the United States and China, and prolonged or increased tariffs on imports from China to the United States would adversely impact our business, results of operations and financial condition.

 

In 2020, a Phase One trade agreement was signed imposing specific targets for Chinese purchases of various exports from the United States. These ambitious commitments specified numerical targets in U.S. goods and services exports to China for increases of $77 billion in 2020 and $123 billion in 2021 from the 2017 baseline. The Phase One agreement also imposed numerous tariffs on a variety of goods including but not limited to imports from China along with steel and aluminum imports from across the world, creating an upward pressure on prices in the United States. These tariffs currently impact over $350 billion of imports and exports and increase consumer costs by roughly $51 billion annually based on 2021 import levels. The uncertainty of the Phase One deal, unilaterally imposed in 2020 and substantially still in effect today, lie in their conditions. For instance, Section 301 enables the president to impose tariffs or quotas wherever the United States Trade Representative (USTR) finds that other nations are engaging in unfair trade practices and Section 232 allows the president to impose trade barriers if the Department of Commerce finds that imports threaten U.S. national security. The Company will be unable to pre-empt decisions of this nature, and as such, the risks and consequences which accompany them.

 

In 2021, the U.S. presidential administration signed Executive Order 14017 into order, assessing vulnerabilities in four priority product areas: semiconductors, large capacity batteries, critical minerals and materials, and pharmaceuticals and active pharmaceutical ingredients. Executive Order 14017 established an interagency Supply Chain Trade Task Force led by USTR. This task force was directed to identify foreign trade practices that the U.S. deemed unfair or otherwise determined to cause erosion to U.S. critical supply chains. The impact and decisions of this task force may cause consequential action from other trading partners, potentially impacting the Company’s financial performance.

 

Later in 2021 and into 2022, the U.S. Administration replaced the Section 232 tariffs on steel and aluminum imports from the EU with a tariff rate quota system (TRQ), replaced the Section 232 tariffs on steel imports from Japan with a TRQ (the Section 232 aluminum imports from Japan are still in effect) and, as of March 2022, replaced the Section 232 tariffs on steel and aluminum imports from the UK with a TRQ. To date, the US Administration has kept in place all of the Section 301 tariffs on Chinese imports, which might influence importers to shift away from China and reorganize supply chains or otherwise cause decreased trade altogether – both imports and exports – raising prices and reducing options for consumers and businesses in the U.S. While a number of exclusions and extensions to these tariffs exist and evolve within the current administration, retaliatory actions by other nations remain a possibility.

 

In 2022, five nations had levied retaliatory tariffs up to 70 percent on approximately $73.2 billion of U.S. exports. These tariffs do not include retaliation by Canada and Mexico; following the reversal of U.S. steel and aluminum tariffs, both Canada and Mexico withdrew their retaliatory tariffs of 7 percent to 25 percent on approximately $20 billion of U.S. exports. These tariffs also no longer include retaliation by the EU, as it cancelled its retaliatory tariffs in exchange for the United States replacing the aluminum and steel tariffs with a TRQ for EU imports.

 

24

 

 

The invasion of Ukraine by Russia has resulted increased sanctions on trade with Russia which could reverberate to other countries, other economies and other markets. On February 24, 2023, the United States, in coordination with allies and G7 partners, announced a new set of sanctions, export controls and tariffs targeting key, revenue-generating sectors of the Russian economy and restricting trade with over 200 persons, including both Russian and third-country actors across Europe, Asia and the Middle East. These new measures, taken by the U.S. Department of the Treasury’s Office of Foreign Assets Control, or OFAC, US Department of Commerce’s Bureau of Industry and Security, or BIS, Office of the US Trade Representative, or USTR and U.S. Department of State, mark the one-year anniversary of Russia’s war against Ukraine. These measures include the following:

 

  OFAC: (i) announced a new determination targeting the metals and mining sector of the Russian Federation economy under Executive Order 14024; (ii) added 83 entities and 22 individuals to the Specially Designated Nationals and Blocked Persons List, including over 30 third-country individuals and entities, resulting in the freezing of their assets within U.S. jurisdiction and prohibitions on transactions by U,S, persons or within the U.S. that involve such persons and their 50 percent or more owned entities; and (iii) made additions and revisions to several existing general licenses.

 

  BIS: (i) announced four new rules targeting Russia’s defense-industrial base and military and third countries supporting Russia; (ii) expanded export controls under the Export Administration Regulations, including licensing requirements on several commercial and industrial items; and (iii) added 86 entities to the Entity List determined to have engaged in sanctions evasion and backfill activities in support of Russia’s defense-industrial sector, prohibiting the targeted companies from purchasing items, such as semiconductors, whether made in the US or with certain US technology or software abroad.

 

  USTR announced additional tariff increases, primarily targeting metals, minerals and chemical products.

 

These sanctions, export controls and tariffs are part of the U.S.’s ongoing to impose economic costs on Russia in response to its actions in Ukraine.  

 

We are subject to anti-corruption, anti-bribery, anti-money laundering, economic sanctions, export control, and similar laws. Non-compliance with such laws can subject us to criminal or civil liability and harm our business, revenues, financial condition and results of operations.

 

We are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.S. domestic bribery statute contained in 18 U.S.C. Section 201, the U.S. Travel Act, and other anti-bribery and anti-money laundering laws in the countries in which we conduct activities. Anti-corruption and anti-bribery laws have been enforced aggressively in recent years and are interpreted broadly to generally prohibit companies and their employees and third-party intermediaries from authorizing, offering, or providing, directly or indirectly, improper payments or benefits to recipients in the public or private sector. As we increase our international presence, we may engage with distributors and third-party intermediaries to market our solutions and to obtain necessary permits, licenses, and other regulatory approvals. In addition, we or our third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities. We can be held liable for the corrupt or other illegal activities of these third-party intermediaries, our employees, representatives, contractors, partners and agents, even if we do not explicitly authorize such activities.

 

The United States has imposed economic sanctions that affect transactions with designated foreign countries, nationals and others. In particular, the United States prohibits U.S. persons from engaging with individuals and entities identified as “Specially Designated Nationals,” such as terrorists and narcotics traffickers. These prohibitions are administered by the U.S. Department of the Treasury’s Office of Foreign Assets Control. OFAC rules prohibit U.S. persons from engaging in, or facilitating a foreign person’s engagement in, transactions with or relating to the prohibited individual, entity or country, and require the blocking of assets in which the individual, entity or country has an interest. Blocked assets (e.g., property or bank deposits) cannot be paid out, withdrawn, set off or transferred in any manner without a license from OFAC. Other countries in which we operate, including Canada and the United Kingdom, also maintain economic and financial sanctions regimes.

 

25

 

 

Some of our solutions, including software updates and third-party accessories, may be subject to U.S. export control laws, including the Export Administration Regulations; however, the vast majority of our products are non-U.S.-origin items, developed and manufactured outside of the United States, and therefore not subject to these laws. For third-party accessories, we rely on manufactures to supply the appropriate export control classification numbers that determine our obligations under these laws.

 

We cannot assure you that our employees and agents will not take actions in violation of our policies and applicable law, for which we may be ultimately held responsible. As we increase our international presence, our risks under these laws, rules, and regulations may increase. Further, any change in the applicability or enforcement of these laws, rules, and regulations could adversely impact our business operations and financial results.

 

Detecting, investigating and resolving actual or alleged violations can require a significant diversion of time, resources, and attention from senior management. In addition, noncompliance with anti-corruption, anti-bribery, anti-money laundering, or economic sanctions laws, rules, and regulations could subject us to whistleblower complaints, investigations, sanctions, settlements, prosecution, other enforcement actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension and/or debarment from contracting with certain persons, the loss of export privileges, reputational harm, adverse media coverage, and other collateral consequences. If any subpoenas or investigations are launched, or governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal litigation, our business, revenues, financial condition, and results of operations would be significantly harmed. In addition, responding to any action will likely result in a significant diversion of management’s attention and resources and significant defense costs and other professional fees. Enforcement actions and sanctions could further harm our business, financial condition and results of operations.

  

We are subject to a wide range of product regulatory and safety, consumer, worker safety and environmental laws and regulations.

 

Our operations and the products we manufacture and/or sell are subject to a wide range of product regulatory and safety, consumer, worker safety and environmental laws and regulations. Compliance with such existing or future laws and regulations could subject us to future costs or liabilities, impact our production capabilities, constrict our ability to sell, expand or acquire facilities, restrict what solutions we can offer and generally impact our financial performance. Our products are designed for use in potentially explosive or hazardous environments. If our product design fails for any reason in such environments, we may be subject to product liabilities and future costs. In addition, some of these laws are environmental and relate to the use, disposal, remediation, emission and discharge of, and exposure to hazardous substances. These laws often impose liability and can require parties to fund remedial studies or actions regardless of fault. Environmental laws have tended to become more stringent over time and any new obligations under these laws could have a negative impact on our operations or financial performance. 

 

Laws focused on the energy efficiency of electronic products and accessories, recycling of both electronic products and packaging, reducing or eliminating certain hazardous substances in electronic products, and the transportation of batteries continue to expand significantly. Laws pertaining to accessibility features of electronic products, standardization of connectors and power supplies, the transportation of lithium-ion batteries, and other aspects are also proliferating. There are also demanding and rapidly changing laws around the globe related to issues such as product safety, radio interference, radio frequency radiation exposure, medical related functionality, and consumer and social mandates pertaining to use of wireless or electronic equipment. These laws, and changes to these laws, could have a substantial impact on whether we can offer certain products, solutions, and services, and on what capabilities and characteristics our products or services can or must include.

 

These laws and regulations impact our products and could negatively impact our ability to manufacture and sell products competitively. In addition, we anticipate that we will see increased demand to meet voluntary criteria related to reduction or elimination of certain constituents from products, increasing energy efficiency and providing additional accessibility.

 

26

 

 

Changes in laws and regulations concerning the use of telecommunication bandwidth could increase our costs and adversely impact our business.

 

Our business depends on our ability to sell devices that use telecommunication bandwidth allocated to licensed and unlicensed wireless services, and that use of that bandwidth is subject to laws and regulations that are subject to change over time. Changes in the permitted uses of telecommunication bandwidth, reallocation of such bandwidth to different uses, and new or increased regulation of the capabilities, manufacture, importation, and use of devices that depend on such bandwidth could increase our costs, require costly modifications to our products before they are sold, or limit our ability to sell those products into our target markets. In addition, we are subject to regulatory requirements for certification and testing of our products before they can be marketed or sold. Those requirements may be onerous and expensive. Changes to those requirements could result in significant additional costs and could adversely impact our ability to bring new products to market in a timely fashion.

 

We are subject to a wide range of privacy and data security laws, regulations and other legal obligations.

 

Personal privacy and information security are significant issues in the United States and the other jurisdictions in which we operate or make our products and applications available. The legislative and regulatory framework for privacy and security issues worldwide is rapidly evolving and is likely to remain uncertain for the foreseeable future. Our handling of data is subject to a variety of laws and regulations, including regulation by various government agencies, including the U.S. Federal Trade Commission, or FTC, and various state, local and foreign agencies. We may collect personally identifiable information, or PII, and other data from our customers. We use this information to provide services to our customers and to support, expand and improve our business. We may also share customers’ PII with third parties as allowed by applicable law and agreements and authorized by the customer or as described in our privacy policy.

  

The U.S. federal and various state and foreign governments have adopted or proposed limitations on the collection, distribution, transfer, use and storage of PII. In the United States, the FTC and many state attorneys general are applying federal and state consumer protection laws as imposing standards for the online collection, use and dissemination of data. Many foreign countries and governmental bodies, including Canada, the European Union and other relevant jurisdictions, have laws and regulations concerning the collection and use of PII obtained from their residents or by businesses operating within their jurisdiction. These laws and regulations often are more restrictive than those in the United States. Laws and regulations in these jurisdictions apply broadly to the collection, use, storage, disclosure and security of data that identifies or may be used to identify or locate an individual, such as names, email addresses and, in some jurisdictions, Internet Protocol, or IP, addresses. Within the European Union, legislators have adopted the General Data Protection Regulation, or GDPR, effective May 2018 which may impose additional obligations and risk upon our business, and which may increase substantially the penalties to which we could be subject in the event of any non-compliance. We may incur substantial expense in complying with the obligations imposed by the governments of the foreign jurisdictions in which we do business or seek to do business and we may be required to make significant changes in our business operations, all of which may adversely impact our revenues and our business overall. 

 

27

 

 

Although we are working to comply with those federal, state, and foreign laws and regulations, industry standards, contractual obligations and other legal obligations that apply to us, those laws, regulations, standards and obligations are evolving and may be modified, interpreted and applied in an inconsistent manner from one jurisdiction to another, and may conflict with one another, other requirements or legal obligations, our practices or the features of our products or applications. At state level, lawmakers continue to pass new laws concerning privacy and data security. Particularly notable in this regard is the California Consumer Privacy Act, or CCPA, which became effective on January 1, 2020. The CCPA will introduce significant new disclosure obligations and provide California consumers with significant new privacy rights. Any failure or perceived failure by us to comply with federal, state or foreign laws or regulations, industry standards, contractual obligations or other legal obligations, or any actual or suspected security incident, whether or not resulting in unauthorized access to, or acquisition, release or transfer of PII or other data, may result in governmental enforcement actions and prosecutions, private litigation, fines and penalties or adverse publicity and could cause our customers to lose trust in us, which could have an adverse impact on our reputation and business. Any inability to adequately address privacy and security concerns, even if unfounded, or comply with applicable laws, regulations, policies, industry standards, contractual obligations, or other legal obligations could result in additional cost and liability to us, damage our reputation, inhibit sales and adversely impact our business.

 

We also expect that there will continue to be new proposed laws, regulations and industry standards concerning privacy, data protection and information security in the United States, the European Union and other jurisdictions, and we cannot yet determine the impact such future laws, regulations and standards may have on our business. New laws, amendments to or re-interpretations of existing laws and regulations, industry standards, contractual obligations and other obligations may require us to incur additional costs and restrict our business operations. Such laws and regulations may require companies to implement privacy and security policies, permit users to access, correct and delete personal information stored or maintained by such companies, inform individuals of security breaches that affect their personal information, and, in some cases, obtain individuals’ consent to use PII for certain purposes. In addition, a foreign government could require that any PII collected in a country not be disseminated outside of that country, and we are not currently equipped to comply with such a requirement.

 

Risks Related to Our Intellectual Property

 

If we are unable to successfully protect our intellectual property, our competitive position may be harmed.

 

Our ability to compete is heavily affected by our ability to protect our intellectual property. We rely on a combination of patent licenses, confidentiality procedures and contractual provisions to protect our proprietary rights. We also enter, and plan to continue to enter, into confidentiality, invention assignment or license agreements with our employees, consultants and other parties with whom we contract, and control access to and distribution of our software, documentation and other proprietary information. The steps we take to protect our intellectual property may be inadequate, and it is possible that some or all of our confidentiality agreements will not be honored and certain contractual provisions may not be enforceable. Existing trade secret, trademark and copyright laws offer only limited protection. Unauthorized parties may attempt to copy aspects of our products or obtain and use information which we regard as proprietary. Policing unauthorized use of our products is difficult, time consuming and costly, particularly in foreign countries where the laws may not protect our proprietary rights as fully as in the United States. We cannot assure you that our means of protecting our proprietary rights will be adequate or that our competitors will not independently develop similar technology, the effect of either of which would harm our competitive position in the market. Furthermore, disputes can arise with our strategic partners, customers or others concerning the ownership of intellectual property.

 

28

 

 

Others may claim that we infringe on their intellectual property rights, which may result in costly and time-consuming litigation and could delay or otherwise impair the development and commercialization of our products.

 

In recent years, there has been a significant increase in litigation in the United States involving patents and other intellectual property rights, and because our products are comprised of complex technology, we are often involved in or impacted by assertions, including both requests to take licenses and litigation, regarding infringement of patent and other intellectual property rights of third parties. Third parties have asserted, and in the future may assert, intellectual property infringement claims against us and against our channel partners, end customers and suppliers. For example, we had been approached by Wilson Electronics about potential infringement of several of their patents involving cellphone boosters. As a result, the Company entered into a product technology licensing agreement with Wilson Electronics that resolved their claim whereby Wilson is entitled to a 4.5% licensing fee on the revenues earned by the Company for every booster product sold Many of these assertions are brought by non-practicing entities whose principal business model is to secure patent licensing revenues from product manufacturing companies. Claims for alleged infringement and any resulting lawsuit, if successful, could subject us to significant liability for damages and invalidation of our intellectual property rights. Defending any such claims, with or without merit, including pursuant to indemnity obligations, could be time consuming, expensive, cause product shipment delays or require us to enter into a royalty or licensing agreement, any of which could delay the development and commercialization of our products or reduce our margins. If we are unable to obtain a required license, our ability to sell or use certain products may be impaired. In addition, if we fail to obtain a license, or if the terms of the license are burdensome to us, our operations could be significantly harmed.

 

Our use of open source software could subject us to possible litigation or otherwise impair the development of our products.

 

A portion of our technologies incorporates open source software, including open source operating systems such as Android, and we expect to continue to incorporate open source software into our platform in the future. Few of the licenses applicable to open source software have been interpreted by courts, and their application to the open source software integrated into our proprietary technology platform may be uncertain. If we fail to comply with these licenses, then pursuant to the terms of these licenses, we may be subject to certain requirements, including requirements that we make available the source code for our software that incorporates the open source software. We cannot assure you that we have not incorporated open source software in our software in a manner that is inconsistent with the terms of the applicable licenses or our current policies and procedures. If an author or other third party that distributes such open source software were to allege that we had not complied with the conditions of one or more of these licenses, we could incur significant legal expenses defending against such allegations. Litigation could be costly for us to defend, have a negative effect on our operating results and financial condition or require us to devote additional research and development resources to change our technology platform.

 

With respect to open source operating systems, if third parties cease continued development of such operating systems or restrict our access to such operating system, our business and financial results could be adversely impacted. We are dependent on third parties’ continued development of operating systems, software application ecosystem infrastructures, and such third parties’ approval of our implementations of their operating and system and associated applications. If such parties cease to continue development or support of such operating systems or restrict our access to such operating systems, we would be required to change our strategy for our devices. As a result, our financial results could be negatively impacted because a resulting shift away from the operating systems we currently use, and the associated applications ecosystem could be costly and difficult.

 

29

 

 

Our inability to obtain and maintain any third-party license required to develop new products and product enhancements could seriously harm our business, financial condition and results of operations.

 

From time to time, we are required to license technology from third parties to develop new products or product enhancements. Third-party licenses may not be available to us on commercially reasonable terms, or at all. If we fail to renew any intellectual property license agreements on commercially reasonable terms, or any such license agreements otherwise expire or terminate, we may not be able to use the patents and technologies of these third parties in our products, which are critical to our success. We cannot assure you that we will be able to effectively control the level of licensing and royalty fees paid to third parties, and significant increase in such fees could have a significant and adverse impact on our future profitability. Seeking alternative patents and technologies may be difficult and time-consuming, and we may not be successful in finding alternative technologies or incorporating them into our products. Our inability to obtain any third-party license necessary to develop new products or product enhancements could require us to obtain substitute technology of lower quality or performance standards, or at greater cost, which could seriously harm our business, financial condition and results of operations.

 

Risks relating to our locations in Israel and Canada and our international operations

 

Conditions in Israel could materially and adversely affect our business.

 

A number of our officers and directors are residents of Israel. Accordingly, political, economic and military conditions in Israel and the surrounding region may directly affect our business and operations. Since the establishment of the State of Israel in 1948, a number of armed conflicts have taken place between Israel and its neighboring countries, as well as terrorist acts committed within Israel by hostile elements. Any hostilities involving Israel or the interruption or curtailment of trade between Israel and its trading partners could adversely affect our operations and results of operations. During the summer of 2006, Israel was engaged in an armed conflict with Hezbollah, a Lebanese Islamist Shiite militia group and political party. In December 2008 and January 2009 there was an escalation in violence among Israel, Hamas, the Palestinian Authority and other groups, as well as extensive hostilities along Israel’s border with the Gaza Strip, which resulted in missiles being fired from the Gaza Strip into Southern Israel. During November 2012 and from July through August 2014, Israel was engaged in an armed conflict with a militia group and political party who controls the Gaza Strip, which resulted in missiles being fired from the Gaza Strip into Southern Israel, as well as at areas more centrally located near Tel Aviv and at areas surrounding Jerusalem. These conflicts involved missile strikes against civilian targets in various parts of Israel, including areas in which our employees and some of our consultants are located, and negatively affected business conditions in Israel. This pattern of activity erupts from time to time with varying degrees of intensity and for varying periods of time and typically ends with a cease fire until hostilities flare up again.

 

Since February 2011, Egypt has experienced political turbulence and an increase in terrorist activity in the Sinai Peninsula. Such political turbulence and violence may damage peaceful and diplomatic relations between Israel and Egypt, and could affect the region as a whole. Similar civil unrest and political turbulence has occurred in other countries in the region, including Syria, which shares a common border with Israel, and is affecting the political stability of those countries. Since April 2011, internal conflict in Syria has escalated and chemical weapons have been used in the region. Foreign actors have intervened and may continue to intervene in Syria. This instability and any intervention may lead to deterioration of the political and economic relationships that exist between the State of Israel and some of these countries and may lead to additional conflicts in the region. In addition, Iran has threatened to attack Israel and may be developing nuclear weapons. Iran also has a strong influence among extremist groups in the region, including Hamas in Gaza, Hezbollah in Lebanon and various rebel militia groups in Syria. These situations have escalated at various points in recent years and may escalate in the future to more violent events, which may affect Israel and us. Any armed conflicts, terrorist activities or political instability in the region could adversely affect business conditions and could harm our results of operations and could make it more difficult for us to raise capital. Parties with whom we do business have sometimes declined to travel to Israel during periods of heightened unrest or tension, forcing us to make alternative arrangements when necessary in order to meet our business partners face to face. In addition, the political and security situation in Israel may result in parties with whom we have agreements involving performance in Israel claiming that they are not obligated to perform their commitments under those agreements pursuant to force majeure provisions in such agreements.

 

30

 

 

Further, in the past, the State of Israel and Israeli companies have been subjected to economic boycotts. Several countries still restrict business with the State of Israel and with Israeli companies. These restrictive laws and policies may have an adverse impact on our operating results, financial condition or the expansion of our business. A campaign of boycotts, divestment and sanctions has been undertaken against Israel, which could also adversely impact our business.

 

In addition, many Israeli citizens are obligated to perform several days, and in some cases more, of annual military reserve duty each year until they reach the age of 40 (or older, for reservists who are military officers or who have certain occupations) and, in the event of a military conflict, may be called to active duty. In response to increases in terrorist activity, there have been periods of significant call-ups of military reservists. It is possible that there will be military reserve duty call-ups in the future. Our operations could be disrupted by such call-ups, which may include the call-up of members of our management. Such disruption could materially adversely affect our business, prospects, financial condition and results of operations.

  

It may be difficult to enforce a U.S. judgment against us, our officers and directors named in this annual report on Form 20-F in Israel or the United States, or to assert U.S. securities laws claims in Israel or serve process on our officers and directors.

 

Not all of our directors or officers are residents of the United States and most of their and our assets are located outside the United States. Service of process upon us or our non-U.S. resident directors and officers may be difficult to obtain within the United States. We have been informed by our legal counsel in Israel that it may be difficult to assert claims under U.S. securities laws in original actions instituted in Israel or obtain a judgment based on the civil liability provisions of U.S. federal securities laws. Israeli courts may refuse to hear a claim based on a violation of U.S. securities laws against us or our non-U.S. officers and directors because Israel may not be the most appropriate forum to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proved as a fact, which can be a time-consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding case law in Israel addressing the matters described above. Additionally, Israeli courts might not enforce judgments obtained in the United States against us or our non-U.S. our directors and executive officers, which may make it difficult to collect on judgments rendered against us or our non-U.S. officers and directors.

 

Moreover, an Israeli court will not enforce a non-Israeli judgment if it was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases), if its enforcement is likely to prejudice the sovereignty or security of the State of Israel, if it was obtained by fraud or in the absence of due process, if it is at variance with another valid judgment that was given in the same matter between the same parties, or if a suit in the same matter between the same parties was pending before a court or tribunal in Israel at the time the foreign action was brought. For more information, see “Enforceability of Civil Liabilities.”

 

Because we are a corporation incorporated in British Columbia and some of our directors and officers are resident in Canada, it may be difficult for investors in the United States to enforce civil liabilities against us based solely upon the federal securities laws of the United States. Similarly, it may be difficult for Canadian investors to enforce civil liabilities against our directors and officers residing outside of Canada.

 

We are a corporation incorporated under the laws of British Columbia with our principal place of business in Montreal, Canada. Some of our directors and officers and the auditors or other experts named herein are residents of Canada and all or a substantial portion of our assets and those of such persons are located outside the United States. Consequently, it may be difficult for U.S. investors to effect service of process within the United States upon us or our directors or officers or such auditors who are not residents of the United States, or to realize in the United States upon judgments of courts of the United States predicated upon civil liabilities under the Securities Act. Investors should not assume that Canadian courts: (i) would enforce judgments of U.S. courts obtained in actions against us or such persons predicated upon the civil liability provisions of the U.S. federal securities laws or the securities or blue-sky laws of any state within the United States or (ii) would enforce, in original actions, liabilities against us or such persons predicated upon the U.S. federal securities laws or any such state securities or blue-sky laws.

 

31

 

 

Similarly, some of our directors and officers are residents of countries other than Canada and all or a substantial portion of the assets of such persons are located outside Canada. As a result, it may be difficult for Canadian investors to initiate a lawsuit within Canada against these non-Canadian residents. In addition, it may not be possible for Canadian investors to collect from these non-Canadian residents’ judgments obtained in courts in Canada predicated on the civil liability provisions of securities legislation of certain of the provinces and territories of Canada. It may also be difficult for Canadian investors to succeed in a lawsuit in the United States, based solely on violations of Canadian securities laws.

 

We have operations in China, which exposes us to risks inherent in doing business there.

 

We use multiple third-party suppliers and manufacturers based primarily in China. With the rapid development of the Chinese economy, the cost of labor has increased and may continue to increase in the future. Furthermore, pursuant to Chinese labor laws, employers in China are subject to various requirements when signing labor contracts, paying remuneration, determining the term of employees’ probation and unilaterally terminating labor contracts. Our results of operations will be materially and adversely affected if the labor costs of our third-party suppliers and manufacturers increase significantly. In addition, we and our manufacturers and suppliers may not be able to find a sufficient number of qualified workers due to the intensely competitive and fluid market for skilled labor in China.

 

Operating in China exposes us to political, legal and economic risks. In particular, the political, legal and economic climate in China, both nationally and regionally, is fluid and unpredictable. Our ability to utilize parties that operate in China may be adversely affected by changes in U.S. and Chinese laws and regulations such as those related to, among other things, taxation, import and export tariffs, environmental regulations, land use rights, intellectual property, currency controls, network security, employee benefits, hygiene supervision and other matters. In addition, we may not obtain or retain the requisite legal permits to continue utilizing third-parties that operate in China, and costs or operational limitations may be imposed in connection with obtaining and complying with such permits. In addition, Chinese trade regulations are in a state of flux, and we may potentially become subject to other forms of taxation, tariffs and duties in China. Furthermore, the third parties we rely on in China may disclose our confidential information or intellectual property to competitors or third parties, which could result in the illegal distribution and sale of counterfeit versions of our products. If any of these events occur, our business, financial condition and results of operations could be materially and adversely affected.

 

Operating outside of the United States presents specific risks to our business, and we have substantial operations outside of the United States.

 

Most of our employee base and operations are located outside the United States, primarily in Canada and Israel. Most of our software development, third-party contract manufacturing, and product assembly operations are conducted outside the United States.

 

Risks associated with operations outside the United States include:

 

  effectively managing and overseeing operations that are distant and remote from corporate headquarters may be difficult and may impose increased operating costs;

 

  fluctuating foreign currency rates could restrict sales, increase costs of purchasing, and impact collection of receivables outside of the United States;

  

  volatility in foreign credit markets may affect the financial well-being of our customers and suppliers;

 

  violations of anti-corruption laws, including the Foreign Corrupt Practices Act and the U.K. Bribery Act could result in large fines and penalties;

  

  violations of privacy and data security laws could result in large fines and penalties; and

 

  tax disputes with foreign taxing authorities, and any resultant taxation in foreign jurisdictions associated with operations in such jurisdictions, including with respect to transfer pricing practices associated with such operations.

 

32

 

  

Foreign currency fluctuations may reduce our competitiveness and sales in foreign markets.

 

The relative change in currency values creates fluctuations in product pricing for international customers. These changes in foreign end-customer costs may result in lost orders and reduce the competitiveness of our products in certain foreign markets. These changes may also negatively impact the financial condition of some foreign customers and reduce or eliminate their future orders of our products. We also face adverse changes in, or uncertainty of, local business laws or practices, including the following:

 

  foreign governments may impose burdensome tariffs, quotas, taxes, trade barriers, or capital flow restrictions;

 

  restrictions on the export or import of technology may reduce or eliminate the ability to sell in or purchase from certain markets;

 

  political and economic instability, including deterioration of political relations between the United States and other countries, may reduce demand for our solutions or put our non-U.S. assets at risk;

 

  potentially limited intellectual property protection in certain countries may limit recourse against infringing on our solutions or cause us to refrain from selling in certain geographic territories;

 

  staffing may be difficult along with higher turnover at international operations;

 

  a government-controlled exchange rate and limitations on the convertibility of currencies, including the Chinese yuan;

 

  transportation delays and customs related delays that may affect production and distribution of our products; and

 

  integration and enforcement of laws vary significantly among jurisdictions and may change significantly over time.

 

Our failure to manage any of these risks successfully could harm our international operations and adversely impact our business, operating results and financial condition.

 

Risks Related to Ownership of Our Securities

 

We do not know whether an active, liquid and orderly trading market will develop for our Common Shares or Warrants or what the market price of our Common Shares or Warrants will be and as a result it may be difficult for you to sell your Common Shares.

 

You may not be able to sell your shares or Warrants quickly or at the market price if trading in our Common Shares or Warrants is not active. The initial public offering price for our Common Shares and Warrants was determined through negotiations with the underwriters, and the negotiated price may not have been indicative of the market price of the Common Shares and Warrants after the offering. As a result of these and other factors, an investor may be unable to resell its Common Shares or Warrants at or above the initial public offering price. Further, an inactive market may also impair our ability to raise capital by selling our securities and may impair our ability to enter into strategic partnerships or acquire companies or products by using our Common Shares as consideration.

 

33

 

 

We expect that our stock price will fluctuate significantly, and you may not be able to resell your shares at or above the price at which you purchased our Common Shares.

 

The trading price of our Common Shares is likely to be volatile and subject to wide price fluctuations in response to various factors, including:

 

  market conditions in the broader stock market in general, or in our industry in particular;

 

  actual or anticipated fluctuations in our quarterly financial and operating results;

 

  introduction of new products and services by us or our competitors;

 

  sales, or anticipated sales, of large blocks of our stock;

 

  issuance of new or changed securities analysts’ reports or recommendations;

 

  failure of industry or securities analysts to maintain coverage of our company, changes in financial estimates by any industry or securities analysts that follow our company, or our failure to meet such estimates;

 

  additions or departures of key personnel;

 

  regulatory or political developments;

 

  changes in accounting principles or methodologies;

 

  acquisitions by us or by our competitors;

 

  litigation and governmental investigations; and

 

  economic, political and geopolitical conditions or events.

 

These and other factors may cause the market price and demand for our Common Shares to fluctuate substantially, which may limit or prevent investors from readily selling their Common Shares and may otherwise negatively affect the liquidity of our Common Shares. In addition, in the past, when the market price of a stock has been volatile, holders of that stock have often instituted securities class action litigation against the company that issued the stock. If any of our stockholders brought a lawsuit against us, we could incur substantial costs defending the lawsuit. Such a lawsuit could also divert the time and attention of our management from our business.

 

The market for our Common Shares may not provide investors with adequate liquidity.

 

Liquidity of the market for our Common Shares depends on a number of factors, including our financial condition and operating results, the number of holders of our Common Shares, the market for similar securities and the interest of securities dealers in making a market in the securities. We cannot predict the extent to which investor interest in the Company will maintain a trading market in our Common Shares, or how liquid that market will be. If an active market is not maintained, investors may have difficulty selling Common Shares that they hold.

 

34

 

 

Since we do not expect to pay any cash dividends for the foreseeable future, investors may be forced to sell their stock in order to obtain a return on their investment.

 

We do not anticipate declaring or paying in the foreseeable future any cash dividends on our capital stock. Instead, we plan to retain any earnings to finance our operations and growth plans discussed elsewhere or incorporated by reference in this prospectus. Accordingly, investors must rely on sales of their Common Shares after price appreciation, which may never occur, as the only way to realize any return on their investment. As a result, investors seeking cash dividends should not purchase our Common Shares.

 

Outstanding warrants and future sales of our Common Shares may further dilute the Common Shares and adversely impact the price of our Common Shares.

 

As of June 30, 2023, we had 133,943,404 Common Shares issued and outstanding. Subsequent to the period ended June 30, 2023, an additional 51,450,000 common shares had been issued in a direct offering for gross proceeds of $2,315,250 before offering expenses.

 

On August 9, 2023 the Company affected a 100-to-1 reverse stock split which resulted in the stock trading above $1.00.

 

A total of 13,100,084 Common Shares underlying outstanding warrants (pre-split) that have been registered with the SEC for resale are unrestricted and freely tradeable. We also have other outstanding unexercised agents’ options to purchase 931,507 (pre-split) Common Shares as of August 14, 2023 that expire between June 30, 2024 and March 8, 2027. If the holder of our free trading shares wanted to sell these shares, there might not be enough purchasers to maintain the market price of our Common Shares on the date of such sales. Any such sales, or the fear of such sales, could substantially decrease the market price of our Common Shares and the value of your investment.

 

If a substantial number of shares become available for sale and are sold in a short period of time, the market price of our Common Shares could decline.

 

We cannot predict whether future issuances of our Common Shares or the availability of shares for resale in the open market will decrease the market price per Common Share. We are not restricted from issuing additional Common Shares of, including any securities that are convertible into or exchangeable for, or that represent the right to receive Common Shares. Sales of a substantial number of our Common Shares in the public market or the perception that such sales might occur could materially adversely affect the market price of our Common Shares. Because our decision to issue securities in any future offering will depend on market conditions and other factors beyond our control, we cannot predict or estimate the amount, timing or nature of our future offerings. Thus, our shareholders bear the risk of any future stock issuances reducing the market price of our Common Shares and diluting their stock holdings in us.

 

If we are not able to comply with the applicable continued listing requirements or standards of Nasdaq, Nasdaq could delist our Common Shares

 

In order to maintain the listing of our Common Shares and Warrants on the Nasdaq Capital Market, we must satisfy minimum financial and other continued listing requirements and standards, including those regarding director independence and independent committee requirements, minimum stockholders’ equity, minimum share price, and certain corporate governance requirements. There can be no assurances that we will be able to comply with such applicable listing standards.

 

On August 26, 2022 we received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying us that we were not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”), resulting from the fact that the closing bid price of the Company’s Common Shares was below $1.00 per share for a period of 30 consecutive business days. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), we were given a period of 180 calendar days, or until February 22, 2023 (the “Compliance Period”), to regain compliance with Nasdaq’s minimum bid price requirement. We did not regain compliance by such date and submitted a written request to the Nasdaq to afford us an additional 180-day compliance period to cure the deficiency. On February 23, 2023, we received written notification from the Listing Qualifications Department of Nasdaq our request for a 180-day extension to regain compliance with Nasdaq’s minimum bid price requirement until August 21, 2023. If at any time prior to August 21, 2023, the bid price of the Common Shares closes at $1.00 per share or more for a minimum of 10 consecutive business days, we will regain compliance with the Bid Price Rule. As of August 4, 2023, the Company has affected a 100-to-1 reverse stock split in order to regain compliance with the share price trading above $1.00 for 10 consecutive business days. As of the date of this MD&A, the stock price is above $1.00 and if it remains above $1.00 for another 6 business days then the Company will be in compliance with the stock staying above $1.00.

 

35

 

 

If we do not regain compliance with the Bid Price Rule during the additional 180-day extension, Nasdaq will notify us that our Common Shares will be delisted. At that time, we may appeal the delisting determination to a hearings panel pursuant to the procedures set forth in the applicable Nasdaq Listing Rules. However, there can be no assurance that, if we do appeal the delisting determination by Nasdaq to the hearings panel, that such appeal would be successful. We intend to actively monitor the closing bid price of our Common Shares and may, if appropriate, consider implementing available options to regain compliance with the Bid Price Rule under the Nasdaq Listing Rules.

 

Nasdaq’s extension notice has no immediate effect on the listing or trading of the Common Shares, which will continue to trade on the Nasdaq Capital Market under the symbol “SYTA.”

 

If the Common Shares are not listed on Nasdaq at any time after this offering, we could face significant material adverse consequences, including: 

 

  a limited availability of market quotations for our securities;

  

  reduced liquidity;

 

  a determination that the Common Shares are a “penny stock” which will require brokers trading in our shares to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for the Common Shares;

 

  a limited amount of news and analyst coverage for our Company; and

 

  a decreased ability to issue additional securities or obtain additional financing in the future.

 

Upon delisting from the Nasdaq Capital Market, our Common Shares would be traded over-the-counter inter-dealer quotation system, more commonly known as the OTC. OTC transactions involve risks in addition to those associated with transactions in securities traded on the securities exchanges, such as the Nasdaq Capital Market, or Exchange-listed Stocks. Many OTC stocks trade less frequently and in smaller volumes than Exchange-listed Stocks. Accordingly, our stock would be less liquid than it would be otherwise. Also, the values of OTC stocks are often more volatile than Exchange-listed Stocks. Additionally, institutional investors are usually prohibited from investing in OTC stocks, and it might be more challenging to raise capital when needed.

 

In addition, if our Common Shares are delisted, your ability to transfer or sell your Common Shares may be limited and the value of those securities will be materially adversely affected.

 

If our Common Shares become subject to the penny stock rules, it may be more difficult to sell our Common Shares.

 

The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00 (other than securities registered on certain national securities exchanges or authorized for quotation on certain automated quotation systems, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or system). The OTC Bulletin Board does not meet such requirements and if the price of our Common Shares is less than $5.00 and our Common Shares are no longer listed on a national securities exchange such as Nasdaq, our stock may be deemed a penny stock. The penny stock rules require a broker-dealer, at least two business days prior to a transaction in a penny stock not otherwise exempt from those rules, to deliver to the customer a standardized risk disclosure document containing specified information and to obtain from the customer a signed and dated acknowledgment of receipt of that document. In addition, the penny stock rules require that prior to effecting any transaction in a penny stock not otherwise exempt from those rules, a broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive: (i) the purchaser’s written acknowledgment of the receipt of a risk disclosure statement; (ii) a written agreement to transactions involving penny stocks; and (iii) a signed and dated copy of a written suitability statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our Common Shares, and therefore shareholders may have difficulty selling their shares. 

 

36

 

 

Warrants are speculative in nature.

 

The Warrants do not confer any rights of Common Share ownership on their holders, such as voting rights or the right to receive dividends, but rather merely represent the right to acquire Common Shares at a fixed price for a limited period of time. Specifically, commencing on the date of issuance, holders of the Warrants may exercise their right to acquire the Common Shares and pay the Warrant exercise price per share, prior to five years from the date of issuance, after which date any unexercised Warrants will expire and have no further value.  

 

Because we are a foreign private issuer and are exempt from certain Nasdaq corporate governance standards applicable to U.S. issuers, you will have less protection than you would have if we were a domestic issuer.

 

Nasdaq Listing Rules require listed companies to have, among other things, a majority of its board members be independent. As a foreign private issuer, however, we are permitted to, and we may follow home country practice in lieu of the above requirements, or we may choose to comply with the above requirement within one year of listing. The corporate governance practice in our home country does not require a majority of our board to consist of independent directors. Thus, although a director must act in the best interests of the Company, it is possible that fewer board members will be exercising independent judgment and the level of board oversight on the management of our company may decrease as a result. In addition, Nasdaq Listing Rules also require foreign private issuers to have a compensation committee, a nominating/corporate governance committee composed entirely of independent directors, and an audit committee with a minimum of three members. We, as a foreign private issuer, are not subject to these requirements. Nasdaq Listing Rules may require shareholder approval for certain corporate matters, such as requiring that shareholders be given the opportunity to vote on all equity compensation plans and material revisions to those plans, and certain Common Share issuances. We intend to comply with the requirements of Nasdaq Listing Rules in determining whether shareholder approval is required on such matters and to appoint a nominating and corporate governance committee. We may, however, consider following home country practice in lieu of the requirements under Nasdaq Listing Rules with respect to certain corporate governance standards which may afford less protection to investors.

 

Our executive officers and directors, and their affiliated entities, along with our two other largest stockholders, own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.

 

Based on shares outstanding as of August 10, 2023, our executive officers and directors, together with entities affiliated with such individuals, along with our largest shareholder, will beneficially own approximately 10.0% of our Common Shares based on 185,393,404 Common Shares issued and outstanding on such date.

 

As of June 30, 2023, the Company had 133,943,404 (pre-split) Common Shares issued and outstanding.

 

General Risk Factors

 

The unfavorable outcome of any future litigation, arbitration or administrative action could have a significant adverse impact on our financial condition or results of operations.

 

From time to time, we are a party to litigation, arbitration, or administrative actions. Our financial results and reputation could be negatively impacted by unfavorable outcomes to any future litigation or administrative actions, including those related to the Foreign Corrupt Practices Act, the U.K. Bribery Act, or other anti-corruption laws. There can be no assurances as to the favorable outcome of any litigation or administrative proceedings. In addition, it can be very costly to defend litigation or administrative proceedings and these costs could negatively impact our financial results.

 

37

 

 

If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.

 

The trading market for our securities will depend in part on the research and reports that securities or industry analysts publish about us or our business. Securities and industry analysts do not currently, and may never, publish research on our company. If no securities or industry analysts commence coverage of our company, the trading price for our securities would likely be negatively impacted. In the event securities or industry analysts initiate coverage, if one or more of the analysts who covers us downgrades our stock or publishes inaccurate or unfavorable research about our business, our stock price may decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our securities could decrease, which might cause our stock price and trading volume to decline.

 

We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.

 

As discussed above, we are a foreign private issuer, and therefore, we are not required to comply with all of the periodic disclosure and current reporting requirements of the Securities Exchange Act of 1934, as amended, or the Exchange Act. In the future, we would lose our foreign private issuer status if (i) more than 50% of our outstanding voting securities are owned by U.S. residents and (ii) a majority of our directors or executive officers are U.S. citizens or residents, or we fail to meet additional requirements necessary to avoid loss of foreign private issuer status. If we lose our foreign private issuer status, we will be required to file with the SEC periodic reports and registration statements on U.S. domestic issuer forms, which are more detailed and extensive than the forms available to a foreign private issuer. We will also have to mandatorily comply with U.S. federal proxy requirements, and our officers, directors and principal shareholders will become subject to the short-swing profit disclosure and recovery provisions of Section 16 of the Exchange Act. In addition, we will lose our ability to rely upon exemptions from certain corporate governance requirements under the listing rules of the Nasdaq Capital Market. As a U.S. listed public company that is not a foreign private issuer, we will incur significant additional legal, accounting and other expenses that we will not incur as a foreign private issuer.

  

We incur significant increased costs as a result of operating as a public company in the United States, and our management is required to devote substantial time to new compliance initiatives.

 

As a public company in the United States, we incur significant legal, accounting and other expenses that we did not incur previously. We are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, which requires, among other things, that we file with the SEC annual, quarterly and current reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley Act, as well as rules subsequently adopted by the SEC and Nasdaq to implement provisions of the Sarbanes-Oxley Act, impose significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. Further, in July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, was enacted. There are significant corporate governance and executive-compensation-related provisions in the Dodd-Frank Act that require the SEC to adopt additional rules and regulations in these areas. Recent legislation permits emerging growth companies to implement many of these requirements over a longer period and up to five years from the pricing of their initial public offering. We intend to take advantage of this new legislation, but cannot assure you that we will not be required to implement these requirements sooner than planned and thereby incur unexpected expenses. Stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact the manner in which we operate our business in ways we cannot currently anticipate.

 

38

 

 

We expect the rules and regulations applicable to public companies to substantially increase our legal and financial compliance costs and to make some activities more time-consuming and costly. If these requirements divert the attention of our management and personnel from other business concerns, they could have a material adverse effect on our business, financial condition and results of operations. The increased costs will decrease our net income or increase our consolidated net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services. For example, we expect these rules and regulations to make it more difficult and more expensive for us to obtain director and officer liability insurance and we may be required to incur substantial costs to maintain the same or similar coverage. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers.

 

Although as a Foreign Private Issuer we are exempt from certain corporate governance standards applicable to US issuers, if we cannot satisfy, or continue to satisfy, the initial listing requirements and other rules of the Nasdaq Capital Market, our securities may not be listed or may be delisted, which could negatively impact the price of our securities and your ability to sell them.

 

In order to maintain our listing on the Nasdaq Capital Market, we will be required to comply with certain rules of the Nasdaq Capital Market, including those regarding minimum shareholders’ equity, minimum share price, minimum market value of publicly held shares, and various additional requirements. Even if we initially meet the listing requirements and other applicable rules of the Nasdaq Capital Market, we may not be able to continue to satisfy these requirements and applicable rules. If we are unable to satisfy the Nasdaq Capital Market criteria for maintaining our listing, our securities could be subject to delisting. In that regard, on May 18, 2021, we received a notice from Nasdaq indicating that, as a result of not having timely filed our Annual Report on Form 20-F for the fiscal year ended December 31, 2020, we were not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission. Nasdaq required that we submit a plan no later than July 16, 2021 to regain compliance and we have in fact regained compliance with Nasdaq’s listing requirements since then.

   

If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis could be impaired.

 

We are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, the Sarbanes-Oxley Act and the rules and regulations of Nasdaq. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal controls over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with International Financial Reporting Standards.

 

In connection with the audit of our consolidated financial statements for the years ended December 31, 2022, 2021 and 2020, our independent registered public accountants identified three, six and two material weaknesses, respectively, in our internal control over financial reporting.

  

We have taken steps to remediate these material weaknesses, and to further strengthen our accounting staff and internal controls, as described above. These measures have only partially remediated the material weaknesses identified in 2022 and 2021 as discussed above. We cannot be certain that other material weaknesses and control deficiencies will not be discovered in the future. Any failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition or results of operations. If our efforts are not successful or other material weaknesses or control deficiencies occur in the future, we may be unable to report our financial results accurately on a timely basis or help prevent fraud, which could cause our reported financial results to be materially misstated and result in the loss of investor confidence or delisting, cause the market price of our Common Shares to decline, and we could be subject to sanctions or investigations by Nasdaq, the Securities and Exchange Commission, or other regulatory authorities. Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets.

 

39

 

 

ITEM 4. INFORMATION ON THE COMPANY

 

A. History and Development of the Company

 

We were incorporated on October 15, 1986 as Big Rock Gold Ltd. as a corporation under the Company Act of British Columbia incorporation number BC 0316008. On April 5, 1988, we changed our name to International Cruiseshipcenters Corp. On June 24, 1991, we changed our name to Riley Resources Ltd. Effective January 23, 1998, we changed our name to International Riley Resources Ltd. Effective November 22, 2001, we changed our name to Wind River Resources Ltd. On January 3, 2008, we changed our name to Teslin River Resources Corp. In 1998, in connection with the name change to International Riley Resources Ltd., we consolidated our share capital on an eight to one basis and in 2001, in connection with the name change to Wind River Resources Ltd., we further consolidated our share capital on a five to one basis.

 

On July 24, 2015, Teslin River Resources Corp. completed a reverse acquisition by way of a three-cornered amalgamation, pursuant to which we acquired certain telecom operations of an Israel-based cellular technology company and changed our name to Siyata Mobile Inc.

  

On June 7, 2016, we acquired all of the issued and outstanding shares of Signifi Mobile Inc., or Signifi. In consideration for such acquisition, we paid cash in the amount of CAD$200,000 and issued 1,000,000 (6,897 shares after the 145/1 stock split) Common Shares at a value of CAD$360,000.

 

The Company’s common shares were previously listed on the TSX Venture Exchange (the “TSXV”) under the symbol “SIM” and the Company voluntarily delisted from the TSXV at the end of trading on October 19, 2020. Our shares traded on the OTCQX under the symbol “SYATF” from May 11, 2017 until September 25, 2020, at which time our shares were listed on the Nasdaq Capital Market.

  

On January 2, 2021, we announced the closing of a previously announced private placement led by Phoenix Fund of 129,450 units of the Company at a price of $100 per unit for aggregate gross proceeds of $12,945,000 USD. Each Unit consisted of ten Common Shares of the Company and ten Common Share purchase warrants. Each warrant entitles the holder thereof to acquire an additional Common Share of the Company at a price of $11.50 for a period of 42 months from the date of issuance.

 

On February 9, 2021, we announced that Peter Goldstein was appointed to serve as the Chairman of the Board of Directors, or the Board, of the Company. The Company further announced that Luisa Ingargiola was appointed as a director and a member of the Audit Committee, which took effect following the Company’s annual shareholders meeting held on February 23, 2021. Ms. Ingargiola replaced Brian Budd on the Board due to Mr. Budd not being re-nominated to serve on the Board at the upcoming shareholder’s meeting. Ms. Ingargiola resigned from the Board on October 29, 2021.

 

In March 2021, we acquired, through a wholly owned subsidiary formed by Signifi, all of the outstanding units of Clear RF LLC, or Clear RF. In exchange for 100% of the units of Clear RF, we agreed to pay a total of $700,000, comprised of approximately $389,970 in our Common Shares and $310,030 in cash. At closing we issued 23,949 Common Shares valued at $194,985 as the share consideration as well as $155,015 in cash and are required to pay an additional $155,015 in cash and an additional $194,985 of our Common Shares, subject to adjustment on March 31, 2022.

 

On April 8, 2021, we were informed by the British Columbia Securities Commission that it had issued a cease trading order due to the Company’s failure to timely file its annual audited financial statements for the year ended December 31, 2020, its annual management’s discussion and analysis for the year ended December 31, 2020, its annual information form for the year ended December 31, 2020 and its certification of annual filings for the year ended December 31, 2020. The Order did not impact the trading of our Common Shares and Warrants, trading under the symbols SYTA and SYTAW, respectively, on the Nasdaq Capital Market. The Order was revoked as of July 8, 2021.

 

40

 

 

On May 18, 2021, we received a notice from the Nasdaq indicating that, as a result of not having timely filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2020, the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission. We filed the Form 20-F on June 30, 2021 and believe that we regained compliance with the applicable Nasdaq rule.

 

On August 20, 2021, we were informed by the British Columbia Securities Commission that it had issued a cease trading order due to our failure to timely file its interim financial report for the period ended June 30, 2021, interim management’s discussion and analysis for the period ended June 30, 2021 and certification of interim filings for the period ended June 30, 2021. We filed our financial statements and other outstanding materials on October 14, 2021 and the cease trading order was revoked on October 15, 2021.

 

On October 27, 2021, we entered into a securities purchase agreement relating to the purchase and sale of a senior secured convertible note (the “Lind Note”) for gross proceeds of $6,000,000 with Lind Global Partners II, LP, or Lind, an investment fund managed by The Lind Partners, a New York based institutional fund manager (together “Lind”) which closed on November 3, 2021. The purchase agreement provided for, among other things, the issuance of a $7,200,000 Note with a 24-month maturity, 0% annual interest rate, and a fixed conversion price of $10.00 per share of the Company’s Common Shares. The Company is required to make principal payments in 18 equal monthly installments commencing 180 days after funding. At the discretion of the Company, the repayments can be made in: (i) cash; (ii) Common Shares (after Common Shares are registered) (the “Repayment Shares”); or a combination of both. Repayment Shares will be priced at 90% of the average of the five lowest daily VWAPs during the 20 trading days before the issuance of the Common Shares (the “Repayment Price”). The Company has the right to buy-back the outstanding face value of the Note at any time with no penalty (“Buy-Back Right”). Should the Company exercise its Buy-Back Right, Lind will have the option to convert up to 25% of the face value of the Note at the lesser of the conversion price of the Notes or the Repayment Price. Additionally, the Note ranks senior to other Company debt, excluding certain debt facilities, and is secured over Company assets, as more fully detailed in the Purchase Agreement and Note. Further, the purchase agreement provided that Lind will also receive a Common Shares purchase warrant to purchase up to 2,142,857 shares of the Company’s Common Shares (“Lind Warrant”). The Lind Warrant may be exercisable with cash payment for 60 months with an exercise price of $4.00 per Common Share (as later adjusted) and may be exercised on a cashless basis in the event that a registration statement covering the underlying Common Shares is not deemed effective. Both the Lind Note and the Lind Warrant contain certain anti-dilution protection in certain circumstances. The Company’s registration statement covering the Common Shares underlying the Note and Warrant was declared effective on December 3, 2021.

 

The Lind Note was repaid in full on November 14, 2022. Of the total repayment of principal and interest, the Company paid Lind $8,137,702 in cash and issued Lind 13,112,255 Common Shares. The Securities Purchase Agreement pursuant to which Lind Partners acquired the Lind Notes prohibits the Company from entering into any Prohibited Transactions without Lind’s prior written consent, until thirty days after such time as the Lind Note has been repaid in full and/or has been converted into Common Shares. That agreement also provides to Lind a 10 day right of first purchase if the Company makes a public offer of its Common Shares. On October 9, 2022, Lind entered into an agreement pursuant to which they waived such provisions in consideration of participating in the Company’s offering that closed on October 12, 2022 and receiving without payment therefor Common Share purchase warrants in the private placement to acquire up to 1,739,130 Common Shares at an exercise price of $0.23 per Common Share (the “Lind Waiver Warrants”). Lind did not exercise any of said Lind Waiver Warrants and did not participate in the Warrant Exercise Agreement discussed below.

 

Effective on October 29, 2021, the Board appointed Lourdes Felix as a director of the Board to fill the vacancy created by the resignation of Ms. Ingargiola. Ms. Felix will serve as a director until the Company’s next annual general meeting of shareholders and until her successor shall have been elected and qualified, subject to her earlier death, resignation, retirement, disqualification or removal. Ms. Felix was also appointed to serve as a member of the Company’s Audit Committee and Nominating and Corporate Governance Committee.

 

41

 

 

On November 15, 2021, Siyata announced the closing of a previously announced funding agreement for gross proceeds of $6,000,000 by Lind Global Partners II, LP, an investment fund managed by The Lind Partners. The proceeds were used to repay and terminate certain existing convertible notes.

 

On January 11, 2022, the Company closed its underwritten public offering of 8,695,652 Common Shares (or pre-funded warrants to purchase Common Shares in lieu thereof) and accompanying Warrants to purchase up to 8,695,652 Common Shares resulting in gross proceeds of approximately $20,000,000 and net proceeds of $18,358,028.

 

On May 24, 2022, we received a letter from Davidson & Company LLP (“Davidson”) that stated that Davidson did not wish to be reappointed as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Davidson ceased to serve as the Company’s independent registered accounting firm as of May 24, 2022. The Company requested that Davidson respond fully to the inquiries of Friedman, LLP, the Company’s successor independent registered public accounting firm, and Davidson agreed to cooperate with the Company and Friedman with respect to the transition. During the Company’s fiscal years ended December 31, 2021 and 2020 and the subsequent interim period through the filing of the Company’s Report of Foreign Private Issuer on Form 6-K on May 31, 2022, there were no “disagreements” (as defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions to Item 304 of Regulation S-K) with Davidson on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of Davidson, would have caused Davidson to make reference to the subject matter of such disagreements in connection with its report. Davidson’s report on the consolidated financial statements for the Company’s fiscal years ended December 31, 2021 and 2020 did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles, except that Davidson’s report for the years ended December 31, 2021 and 2020 contained an explanatory paragraph indicating that there was substantial doubt about the ability of the Company to continue as a going concern. In a separate correspondence, Davidson identified five material weaknesses in our internal controls over financial reporting. During the Company’s fiscal years ended December 31, 2021 and 2020 and the subsequent interim period through May 31, 2022, there had been no “reportable events” (as defined in Item 304(a)(1)(v) of Regulation S-K), except for certain material weaknesses in the Company’s internal control over financial reporting. 

 

On May 24, 2022, management of the Company notified Friedman LLP, or Friedman, that Friedman had been approved by the Company’s audit committee of the board of directors and the board of directors as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2022. Friedman LLP combined with Marcum LLP, or Marcum, effective September 1, 2022. During the fiscal years ended December 31, 2021 and 2020 and the subsequent interim period through May 31, 2022, the Company did not consult with Friedman or Marcum with respect to: (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered with respect to the Company’s financial statements, and no written report or oral advice was provided to the Company by Friedman or Marcum that was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue, or (ii) any matter that was subject to any disagreement, as defined in the United States Securities and Exchange Commission’s Regulation SK, Item 304(a)(1)(iv) and the related instructions thereto, or a reportable event within the meaning set forth in Item 304(a)(1)(v) of Regulation S-K.

 

42

 

 

As part of the Company’s normal quarterly reporting process for the six months ended June 30, 2022, management and the Audit Committee concluded that a material error was made related to the accounting for the warrants entered into on January 11, 2022 (the “January Warrants”) and therefore were misstated in the Company’s March 31, 2022 prior period financial statements, or Prior Period Financial Statements. There was no impact on any of the year end financial statements previously filed. On August 15, 2022, management and the Audit Committee determined that the Company’s condensed consolidated unaudited interim financial statements for the three month period ended March 31, 2022, filed with the SEC on Form 6-K on May 17, 2022 should no longer be relied upon due to an error in the accounting treatment for the classification of the Company’s January Warrants as equity rather than as a derivative liability. In addition, investors were advised that they should no longer rely upon any communications relating to these condensed consolidated unaudited interim financial statements. The Company determined that the January Warrants should be accounted for as a derivative liability in accordance with International Accounting Standards No. 32.6 and International Financial Reporting Standards No. 9 that deal with the measurement of financial assets and financial liabilities. As a result of this change, the January Warrants for 9,999,999 Common shares have been classified as liabilities rather than equity, the fair value of the January Warrants decreased by $2.9 million, transaction costs increased by $0.96 million and the fair value loss increased by $0.96 million for the three months ended March 31, 2022. The Company filed its restated condensed consolidated unaudited interim financial statements for the three month period ended March 31, 2022 as Exhibit 99.1 to its Form 6-K with the SEC on August 18, 2022 together with its restated Management’s Discussion and Analysis of Results of Operations and Financial Condition for the three months ended March 31, 2022.On July 1, 2022, the Company filed a “shelf” registration statement with the SEC covering $100 million aggregate amount of Common Shares, warrants to purchase Common Shares or debt securities, or any combination thereof, subscription rights evidencing the right to purchase Common Shares or debt securities, or any combination thererof, purchase contracts to purchase Common Shares, warrants, rights, debt securities, or any combination thererof, as well as units that include any of these securities. That registration statement was declared effective by the SEC on July 18, 2022.

 

On October 10, 2022, we entered into a Securities Purchase Agreement or the Purchase Agreement with certain institutional investors named therein (the “Purchasers”), pursuant to which we agreed to issue and sell, in a registered direct offering from the shelf: (i) 15,810,000 Common Shares, (ii) 1,590,000 pre-funded warrants, or the Pre-Funded Warrants and, (iii) in a private placement under Rule 506 of Regulation D, 17,400,000 warrants, or the Purchase Warrants at a combined purchase price of $0.23 per Common Share and Purchase Warrant if purchasing the Common Shares, or $0.22 per Pre-Funded Warrant and Purchase Warrant if purchasing the Pre-Funded Warrants. Each Purchase Warrant entitles the Purchaser to purchase one Common Share for a period of five years from the date of issuance for an exercise price of $0.23 per share. The Purchase Agreement contained customary representations and warranties and agreements of the Company and the Purchasers and customary indemnification rights and obligations of the parties. The offering closed on October 13, 2022 resulting in gross proceeds of approximately $4.0 million.

 

On November 22, 2022, the Company filed a registration statement with the SEC registering the resale, from time to time, by the selling shareholders named therein of up to 17,400,000 of our Common Shares issuable upon the exercise of the Common Share purchase warrants issued to the Selling Shareholders in a private placement pursuant to the Securities Purchase Agreements dated October 10, 2022 by and between the Selling Shareholders and the Company. That registration statement went effective on December 15, 2022.

 

On December 26, 2022, we were notified that there had occurred a significant infiltration of water into our warehouse premises located at 1751 Richardson, Suite 2207, Montreal, Quebec, Canada, due to a leaking water pipe in the floor above (which floor is not leased by the Company). Upon inspection of the premises, we believed that there could be substantial damage to our warehoused inventory of communication devices and signal boosters, the dollar value of which was presently not determinable. We are continuing to assess the potential damages, which will require a special inspection to determine the condition of the merchandise. Management believes that any damage is covered by its current property insurance policy and has filed a claim with our commercial property insurer whose policy covers the selling price of damaged inventory. Because we store similar inventory in another location, we did not believe that this event would result in any interruption of our sales activities, and thus future revenues should not be impacted by the water damage to the subject inventory. Only new, non-damaged, quality products will be shipped to our customers. From a balance sheet and income statement perspective, any damaged inventory will be considered impaired and written off (expensed) on the Company’s income statement as an impairment due to the water damage, and the inventory values will be reduced on the balance sheet by the amount of the damages in the fourth quarter of 2022. Any insurance proceeds receivable will be recorded as income in the quarter (likely in 2023) when it is at least virtually certain that the proceeds to be paid by the Company’s insurer have been agreed by both parties. Under international accounting standards, insurance proceeds are accounted for as “reimbursements” and would be recognized as a separate asset (with related income) when the recovery is virtually certain.

 

43

 

 

On January 18, 2023, we entered into warrant exercise agreements with fourteen existing accredited investors to exercise certain outstanding warrants, or Existing Warrants, to purchase up to an aggregate of 18,042,857 of the Company’s Common Shares. The gross proceeds to the Company from the exercise of the Existing Warrants totaled approximately $3,608,571, prior to deducting warrant inducement agent fees and estimated offering expenses. In consideration for the immediate exercise of the Existing Warrants for cash, the exercising holders received new unregistered warrants, or New Warrants, to purchase up to an aggregate of 18,042,857 Common Shares (equal to 100% of the Common Shares issued in connection with the exercise) in a private placement pursuant to Section 4(a)(2) of the Securities Act. In connection with the warrant exercise, the Company also agreed to reduce the exercise price of the Existing Warrants from $0.23 to $0.20 per share. The warrant exercise agreements and the New Warrants each include a beneficial ownership limitation that prevents the warrant holder from owning more than 4.99% (which may be increased to 9.99% in accordance with the terms of the New Warrants) of the Company’s outstanding Common Shares at any time. The New Warrants are exercisable immediately upon issuance at a cash exercise price of $0.20 per share and have a term of exercise equal to five years. However, the holder of the New Warrant may also effect an “alternative cashless exercise” on or after the earlier of: (i) one hundred and eighty (180) day anniversary of the initial exercise date (January 19, 2023) or (ii) the day after effectiveness of the registration statement of which this prospectus is a part. In such event, the aggregate number of Common Shares issuable in such alternative cashless exercise pursuant to any given notice of exercise electing to effect an alternative cashless exercise will equal the product of (x) the aggregate number of Common Shares that would be issuable upon exercise of the New Warrant in accordance with the terms of the New Warrant if such exercise were by means of a cash exercise rather than a cashless exercise and (y) 1.0, which would result in an effective exercise price of $0 at such time. In connection with the exercise of the Existing Warrants, the Company reduced the exercise price of 2,989,130 of certain of its remaining unexercised Common Share purchase warrants from $0.23 per Common Share to an exercise price of $0.20 per Common Share, which warrants may subsequently be repriced to $0 if the cashless exercise price of the New Warrants is triggered. However, previously issued warrants: (i) for 1,805,585 Common Shares that currently trade on the Nasdaq Capital Market under the symbol “SYTAW” that have an exercise price of $6.85 per share; (ii) for 1,294,500 Common Shares that were issued in a private transaction that have an exercise price of $11.50 per share; and (iii) for 9,999,999 Common Shares that were issued in a private transaction that have an exercise price of $2.30 per share are not required by their terms to be repriced.

 

On February 15, 2023, we filed a registration statement with the SEC registering for resale, from time to time, by the selling shareholders named therein up to 19,781,987 of our Common Shares issuable upon the exercise of: (i) the Common Share purchase warrants for 18,042,857 Common Shares (the “New Warrants”) issued to certain of the selling shareholders in a private placement pursuant to Warrant Exercise Agreements dated January 18, 2023 by and between those selling shareholders and the Company and (ii) upon the exercise of the Lind Waiver Warrants (defined therein) for 1,739,130 Common Shares issued to Lind under the securities purchase agreement dated October 27, 2021. That registration statement went effective on March 30, 2023.

 

Our auditor has agreed with management’s decision to include a “going concern” explanatory paragraph in its report on our consolidated financial statements for the fiscal year ended December 31, 2022, expressing substantial doubt about our ability to continue as an ongoing business for the next twelve months. Our consolidated financial statements do not include any adjustments that may result from the outcome of this uncertainty. If we cannot secure the financing needed to continue as a viable business, our shareholders may lose some or all of their investment in us. The Canadian registered office of the Company is located at 885 West Georgia Suite 2200, Vancouver, British Columbia V6C-3E8 and our warehouse and Canadian sales headquarters is located at 1751 Richardson Street, Suite #2207, Montreal, Quebec H3K-1G6, Canada. Our agent for U.S. federal securities law purposes is c/o Cogency Global Inc., 122 East 42nd Street, 18th Floor, New York, NY 10168.

 

44

 

44

 

 

The following diagram illustrates our corporate structure as of the date of this MD&A:

 

 

A picture containing text, businesscard, screenshot, font

Description automatically generated

 

Our website address is https://www.siyatamobile.com/. The information contained on our website or available through our website is not incorporated by reference into and should not be considered a part of this Annual Report, and the reference to our website in this Annual Report is an inactive textual reference only. The SEC also maintains an Internet website that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. Our filings with the SEC are also available to the public through the SEC’s website at www.sec.gov.

  

B.Business Overview

 

Siyata Mobile Inc. is a leading global developer of innovative cellular-based communications solutions over advanced mobile networks under the Uniden® Cellular and Siyata brands to global first responders and enterprise customers. Siyata’s three complementary product categories include rugged handheld mobile devices and in-vehicle communications solutions which are sold to first responders, enterprise customers, commercial fleet vehicles and industrial workers, and cellular amplifiers to boost the cellular signal inside homes, and buildings and vehicles.

 

Our customer base includes cellular network operators and their dealers, as well as commercial vehicle technology distributors for fleets of all sizes in the United States, Canada, Europe, Australia and the Middle East.

 

45

 

 

Products

 

The Company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (“PoC”) smartphone devices. These rugged business-to-business (“B2B”) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries.

 

Prior to 2021, Siyata sold rugged handsets, such as the Uniden UR5 and Uniden UR7 only in international markets. In Q2 2022, Siyata unveiled its next generation rugged device, the SD7. The SD7 is Siyata’s first mission critical push-to-talk device (“MCPTT”) and is also the first rugged handset that Siyata announced in North America in the fourth quarter of 2021, and is now shipping in North America, Europe, The Middle East and Australia. The wireless carriers who have certified and are selling SD7 Handset include AT&T, FirstNet, Verizon, T-Mobile, US Cellular, Bell Mobility, Telstra, and KPN. The SD7 Rugged PTT Handset is targeting first responders and enterprise customers who have previously used traditional legacy two-way Land Mobile Radios (“LMR”) but who would prefer a solution that provides wide-area coverage like a cellular device, and also one that provides the same core functionality of Push-to-Talk that they used with their previous older technology.

 

A close-up of a black radio

Description automatically generated with low confidence

 

46

 

 

SD7 Handset

 

Siyata has also announced the SD7+ with Body Camera, which is similar to the SD7 Handset, but it incorporates body camera functionality. The SD7+ can replace both an LMR two-way radio and a dedicated body camera device for police, security, or any customer who requires PTT and body camera functionality. The SD7+ is expected to begin shipping in the coming months.

 

A close-up of a phone

Description automatically generated with medium confidence

 

SD7+ Body Cam

 

Our second product category is purpose built In-Vehicle communication devices. In Q4 2021, Siyata launched the VK7, a first-of-its-kind, patent-pending vehicle kit with an integrated 10-watt speaker, a simple slide-in connection sleeve for the SD7 Handset, and an external antenna connection for connecting an antenna to allow for an in-vehicle experience for the user that is similar to that from a traditional land mobile radio (“LMR”) device. The VK7 has been uniquely designed to be used with the SD7 Handset, while connecting directly into the vehicle’s power and can also connect to a Uniden cellular amplifier for better cellular connectivity. The pending patent for the VK7 Vehicle Kit provides temperature control by heating the VK7 in cold environments, and cooling the VK7 in hot environments. The VK7 can also be equipped with an external remote speaker microphone (“RSM”) to ensure compliance with hands-free communication legislation.

 

47

 

 

A picture containing electronics, electronic device, gadget, video game console

Description automatically generated

 

VK7 Vehicle Kit

 

The Uniden® UV350 4G/LTE, is a purpose built In-Vehicle communication device designed specifically for professional vehicles such as trucks, vans, buses, emergency service vehicles and other enterprise vehicles. This platform is designed to facilitate replacement of the current in-vehicle, multi-device status-quo with a single device that incorporates voice, PoC, data, fleet management solutions and other Android based professional applications. The UV350 also supports Band 14 for the First Responder Network Authority, or FirstNet®, compatibility which is the U.S. First Responders 4G/LTE network with PoC capabilities that aims to replace aging two-way radio systems currently in use.

 

A close-up of a cell phone

Description automatically generated with medium confidence

 

UV350 In-Vehicle Device

 

The aforementioned portfolio of solutions offers the benefits of PoC without any of the difficulties managing the current generation of rugged smart/feature phones and is ideally suited as a perfect upgrade from Land Mobile Radios (“LMR”). Used for generations, LMR has a significant number of limitations, including network incompatibility, limited coverage areas, and restricted functionality that leave a huge need for a unified network and platform. Siyata’s innovative PoC product lines are helping to service the generational shift from LMR to PoC. According to VDC Research, the LMR market is growing at a 5.9% compound annual growth rate, while the PoC market is growing at 13.6% CAGR and annual PoC shipments are expected to grow to 2.7 million in 2023.  

 

48

 

  

Siyata’s customer base includes cellular network operators and their dealers, as well as commercial vehicle technology distributors for fleets of all sizes in the U.S., Canada, Europe, Australia, The Middle East and other international markets.

 

Cellular boosters are our third product category with approximately 30 million of these devices sold globally every year. Siyata manufactures and sells Uniden® Cellular boosters and accessories for enterprise, first responder and consumer customers with a focus on the North America markets. Cellular communication provides a robust, secure environment not just for remote workers, in-home and in-vehicles; but also for restaurant patrons who wish to download menus; for patients at pharmacies who need to verify identity and download scripts; for remote workers who require strong clear cellular signals; and for first responders where connectivity literally means the difference between life and death - just to name a few examples. The vehicle vertical in this portfolio complements Siyata’s in-vehicle and rugged handheld smartphones as these sales can be bundled through the Company’s existing sales channels.

 

A picture containing text, electronics, meter, smartphone

Description automatically generated A close-up of a device

Description automatically generated with low confidence A black electronic device with red text

Description automatically generated with low confidence
Uniden U70P In-Building Booster Uniden UM50 In-Vehicle Booster Uniden UM2M In-Vehicle Booster

 

We offer a full line of cellular boosters, to boost cellular reception, under the brand name Uniden®. We have entered into a partnership whereby Uniden America Corporation, the North American subsidiary of Japan-based Uniden Corporation, has granted the exclusive license to us to market cellular signal boosters under the Uniden® brand name within the U.S. and Canada, on a rolling three year contract term, with the current extension expiring December 31, 2031 unless sooner terminated pursuant to the terms of this Agreement. As a world-wide leader in wireless communications, Uniden America Corporation manufactures and markets wireless consumer electronic products. Based in Fort Worth, Texas, Uniden sells its products through dealers and distributors throughout North, Central and South America. Uniden Cellular booster kits solve issues of poor reception, dropped calls, lost data and transmission quality issues that users routinely experience on every cellular network. These easy-to-install cellular booster kits are designed for homes, cabins, offices, and buildings to improve the cellular signal reception indoors, allowing people to use their cellular phones indoors where they previously could not do so. We also offer models designed for vehicles, both wired and wireless boosters, to improve the cellular reception inside a vehicle that is driving in a weak cellular signal area. Uniden cellular signal boosters offer kits designed to offer cellphone coverage for difference distances, including kits for a small area of 1 or 2 rooms, and more expansive solutions that will cover over 100,000 sq. ft. Our cellular signal boosters are carrier agnostic to ensure the best signal integrity, supporting 2G, 3G, 4G and soon 5G (in development) technologies on all carriers operating in North America.

 

49

 

 

Customers and Channels

 

Certifications for the SD7 Handset with North American carriers include Bell Mobility, AT&T (as well as at its first responder cellular network FirstNet®), Verizon Wireless, T-Mobile, US Cellular, and internationally with Telstra and KPN. These wireless carriers also sell the innovative VK7 Vehicle Kit that works with the SD7 Handset. These are major milestones for the Company following Siyata’s years of experience perfecting in-vehicle cellular based technology, vehicle installations, software integration with various Push-to-Talk (“PTT”) solutions and intensive carrier certifications.

 

Siyata’s customer base includes cellular network operators and their dealers, as well as commercial vehicle technology distributors for fleets of all sizes in the U.S., Canada, Europe, Australia, the Middle East and other international markets.

 

Our rugged handsets are targeted to approximately 47 million enterprise task and public sector workers across North America including construction, transport& logistics, manufacturing, energy & utility, public safety and federal government. As of December 31, 2022, Siyata had secured North American wireless carrier approvals of the SD7 Handset for use on their networks from AT&T, FirstNet, Verizon, and Bell Mobility. During 2023, Siyata has since added T-Mobile and US Cellular to its list of North American wireless carriers who have approved SD7 for use on their networks. Internationally, Telstra from Australia and KPN from the Netherlands has also approved SD7 for use on their network during 2023.

 

The North American Tier 1 cellular carriers that Siyata is working with have large scale distribution and sales channels. With an estimated 25 million commercial vehicles including 7.0 million first responder vehicles, the Company sees the North American market as its largest opportunity with a total addressable market over $19 billion. These Tier 1 cellular carriers have a keen interest in selling the VK7 Vehicle Kit with the SD7 Handset and the UV350 In-Vehicle Device as they allow for new SIM card activations in commercial vehicles and increased ARPU from existing customers with corporate and first responder fleets while targeting new customers with a unique, dedicated, PTT solution.

 

Our Pricing

 

For wireless carriers, they are free to price the device how they choose. In most cases for significant sales opportunities the carriers are willing to subsidize the cost of the device in order to secure the new activations with the associated monthly Average Revenue Per User, or ARPU.

 

Even our unsubsidized full price are competitive compared to other hardware solutions, but when our device is subsidized, the capital and operational expense benefits to customers compared to other solutions are even greater.

 

Competition

 

Rugged Handsets Category

 

Our direct competitors include Sonim Technologies, Kyocera, and one ruggedized model from Samsung. These competitors also target sales of Push-to-Talk over Cellular (PoC) solutions through wireless carriers in North America and internationally. None of these competitors offer a unique solution like our SD7 Handset which focuses on a simple upgrade from two-way radios, nor do they offer an equivalent to our VK7 Vehicle Kit. These direct competitors focus on more expensive ruggedized Smartphones.

 

Indirectly, we compete with low-cost Push-to-Talk over Cellular devices designed and developed by various Chinese companies including Telo, Inrico, and others. These products are not approved for sale by North America wireless carriers due to lower overall device specifications which do not meet requirements of North American wireless carriers. These devices are mostly sold in international markets to highly price sensitive customers.

 

50

 

 

Indirectly, we also compete with traditional two-way LMR radios, also known as “portables” that are carried or worn on a belt and used for PTT communications. These are sold by a small number of large LMR vendors who sell directly to large first responder organizations and to large enterprise customers. They also sell through dealers and distributors to small and medium-sized commercial customers. These products are generally not sold through wireless carriers in North America or internationally. The government and enterprise customers that they target are now often considering the alternative of Push-to-Talk over Cellular since customers do not need to purchase repeaters and towers nor any government licensing for the frequencies that they use. Also, Push-to-Talk over Cellular provides much wider-area coverage, and these PoC solutions tend to be less expensive than traditional LMR radios both to purchase the PoC hardware such as the Siyata SD7 Handset, as well as to subscribe to monthly PoC service from a wireless carrier.

 

In-Vehicle Category

 

We do not believe that we have any direct competitors within the in-vehicle market category in North America that provide a dedicated cellular based device for commercial and first responder vehicles, and we believe that no other company offers an In-Vehicle IoT device that is approved for sale in North America by wireless carriers.

 

We have several indirect competitors. Firstly, customers could choose a handheld phone along with a professionally installed third party car kit. There are car kit providers who attempt to make their car kits compatible with popular handheld phone models. By comparison, the UV350 device offers enhanced audio quality, safety, and reception. Furthermore, the UV350 is always active and can be used in temperature extremes. Furthermore, the UV350 kit is one complete solution from one supplier, as opposed to buying separately from two different companies and assembling a phone and a car kit that offers no proven compatibility.

 

Our second group of indirect competitors are rugged tablets that can be placed in a mount. The UV350 device offers better audio quality, better safety, better cellular reception, and it is always on and ready to be used. Also, compared to a tablet, the UV350 can also make cellular calls including emergency 911 calls whereas the tablet cannot as it is a data only device.

 

Our third group of indirect competitors are In-Vehicle Two-way LMR Radios also knows as “mobiles”. Not only can the UV350 make phone calls which the LMR radio cannot, but the UV350 offers much better coverage due to using the cellular network as opposed to a limited two-way radio network. And the UV350 can support downloadable Android apps and can serve as a modem for IoT devices and as a Wi-Fi hotspot for further connectivity options and more.

 

Our fourth group of indirect competition is a leading global LMR vendor who offers an In-Vehicle device which is a Push to Talk over Cellular device, compatible only with its own OEM’s PTT application, and as it is not a smartphone based device so it does not offer any downloadable apps (fleet management, GPS tracking, live video feed, etc.) nor the ability to make a phone call over the wireless network. This LMR vendor sells the In-Vehicle device directly to customers and through its dealer channel, but not through wireless carriers.

 

Cellular Boosters Category

 

Within the Cellular Booster category, we have several direct competitors, including Wilson Electronics, LLC, Nextivity Inc., and SureCall Company.

 

Intellectual Property

 

We own two patents that we acquired from ClearRF, as discussed below, and we have entered into several licensing agreements for the use of a trademark and certain patents.

 

51

 

 

Uniden America Corporation

 

In December 2012, Signifi Mobile, the Company’s wholly-owned subsidiary entered into a license agreement with Uniden America Corporation, as amended (the “Uniden Agreement”). The Uniden Agreement provides for the Company to use the trademark “Uniden®”, along with associated designs and trade dress to distribute, market and sell its In-Vehicle device, cellular signal booster and accessories during its term in North America. The agreement includes renewal options up to December 31, 2031 and is subject to certain minimum royalties.

 

Wilson Electronics LLC

 

Effective January 1, 2018, Signifi Mobile Inc., the Company’s wholly-owned subsidiary, entered into an agreement with Wilson Electronics, LLC to permit the Company to utilize several of Wilson Electronics’ patents related to cellphone boosters (the “Wilson Agreement”). The Wilson Agreement grants the Company an indefinite right to utilize its cellphone booster-related patents in exchange for paying Wilson Electronics, LLC a royalty fee for boosters sold by the Company. The Wilson Agreement remains in force until the Wilson patents on the Booster products expire.

 

Via Licensing Corporation

 

Effective June 8, 2018, the Company entered into two separate licensing agreements with Via Licensing Corporation to utilize worldwide patents related to the coding and decoding of “android” software as well as access and download within the “LTE/ 4G” network. This patent is for an initial period of 5 years and can be extended for a further 5-year term. The Company has the right at any time during the term on any extension hereof, to terminate these agreements upon providing 60 days advanced notice of termination. The quarterly royalty fees are based solely on product sales and is a percentage formula based upon the number of units sold, the country manufactured and the country location of the end customer. There are no minimum royalty fees payable according to the agreement.

 

eWave Mobile Ltd.

 

Effective October 1, 2017, we entered into an Asset Purchase Agreement with eWave Mobile Ltd., or eWave, for the purchase of certain distribution rights and contracts in connection with the right to sell and distribute in Israel certain cellular devices for the push to talk market, or the eWave Supplies, in exchange for $700,000 in cash and issued shares of common stock of the Company equal to $700,000. Additionally, we shall pay eWave 50% of up to $1,500,000 in net profit that we earn from sales related to the eWave Suppliers, and 25% thereafter of the net profit exceeding $1,500,000.

 

 Clear RF, LLC

 

On March 31, 2021, the Company’s indirectly and wholly-owned subsidiary ClearRF Nevada Inc. acquired all of the issued and outstanding interests of Clear RF, LLC, or ClearRF, a Washington State limited liability company, for a total purchase price of US$700,000 in a combination of cash and Common Shares. ClearRF produces M2M (machine-to-machine) cellular amplifiers for commercial and industrial M2M applications and offers patented direct connect cellular amplifiers and patented auto gain & oscillation control designed for M2M and “internet-of-things.” Or IoT, applications. Two patents (described below) held by ClearRF were subsequently transferred and assigned to ClearRF Nevada following the closing of this acquisition.

 

  i. RF Passive Bypass technology enables tethered devices to communicate through the amplifier network, even if the amplifier loses power, or when the signal is not required, a key differentiator amongst competitors, in particular for mission-critical applications and first responder vehicles that require constant clear cellular coverage and connectivity.

 

  ii. Auto Gain & Oscillation Control detects the level of incoming signal strength and self-adjusts output power to ensure maximum signal strength. This feature is vital for telematics (mobile) M2M applications because the amplifier will be in constant motion and will require periodic self-adjustment based on changing incoming signal environment.

 

52

 

 

Seasonality

 

We do not experience any effects of seasonality it our business. Our products are designed to function at full capacity under all weather conditions and therefore, we do not experience any shifts in our sales patterns.

  

C. Organizational Structure

 

Our subsidiaries as of December 31, 2022 are as follows:

 

Name of Subsidiary   Principal Activities   Place of Incorporation   Ownership  
Queensgate Resources Corp.   Inactive   British Columbia, Canada     100 %
Queensgate Resources US Corp.   Inactive   Nevada, USA     100 %
Siyata Mobile (Canada) Inc.   Inactive   British Columbia, Canada     100 %
Siyata Mobile Israel Ltd.   R&D and wholesale distribution   Israel     100 %
Signifi Mobile Inc.   Wholesale distribution   Quebec, Canada     100 %
ClearRF Nevada Ltd.   Inactive   Nevada, USA     100 %
ClearRF LLC   Inactive holding patents   Washington, USA     100 %

  

D. Property, Plant and Equipment

 

Our warehouse and Canadian sales headquarters are located at 1751 Richardson Street, Suite #2207, Montreal, Quebec H3K-1G6, Canada, with approximately 5,616 square feet of space. We entered into a lease agreement for its property for a 20-month term, beginning on October 1, 2022, and expiring on May 31, 2024. Under this Lease, we pay net rent of $2.00 per square foot per annum, approximately $11,232 annum, payable in monthly equal installments. Additional warehouse space was leased at 250 Ford Boulevard, town of Chateauguay, Quebec, J6J-4Z2 with approximately 2,837 square feet of space. We entered into a lease agreement for its property for a 26 month term, beginning on April 1, 2022 and expiring on May 31, 2024. Under this Lease, we pay net rent of $11.50 per square foot per annum, approximately $32,625 annum, payable in monthly equal installments.

 

We believe that our existing facilities are adequate to meet current requirements and that suitable additional or substitute space will be available as needed to accommodate any further physical expansion of operations and for any additional offices.

 

ITEM 4A. UNRESOLVED STAFF COMMENTS

 

None.

 

ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS

 

A. Operating Results

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes included elsewhere in this Annual Report. The discussion below contains forward-looking statements that are based upon our current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from these expectations due to inaccurate assumptions and known or unknown risks and uncertainties, including those identified in “Cautionary Note Regarding Forward-Looking Statements” and under “Risk Factors” elsewhere in this Annual Report.

 

53

 

 

Overview

 

Siyata Mobile Inc. is a leading global developer of innovative cellular-based communications solutions over advanced mobile networks under the Uniden® Cellular and Siyata brands to global first responders and enterprise customers. Siyata’s three complementary product categories include rugged handheld mobile devices and in-vehicle communications solutions which are sold to first responders, enterprise customers, commercial fleet vehicles and industrial workers, and cellular amplifiers which are sold to boost the cellular signal inside homes, buildings and vehicles.

  

On September 25, 2020 the Company listed on the Nasdaq Capital Markets (“Nasdaq”) under the symbol SYTA for its Common Shares, and the Company’s warrants issued on September 29, 2020 at $6.85 are traded under the symbol SYTAW, and expire in five (5) years from the date of issue.

 

The registered and records office is located at 2200 - 885 West Georgia Street, Vancouver, BC V6C 3E8, Canada.

 

Significant Highlights

 

The following highlights and developments until the date of this MD&A are as follows:

 

On May 16, 2023, Siyata announced its Q4 2022 and full year 2022 financial results.

 

On May 17, 2023, Siyata announced that KPN Royal Dutch Telecom (“KPN”) in the Netherlands are now selling the Siyata SD7 Handset.

 

On May 22, 2023, Siyata announced its participation in Critical Communications World tradeshow, held in Helsinki, Finland on May 23 to 25, 2023.

 

On May 24, 2023, Siyata announced its Q1, 2023 financial results.

 

On May 31, 2023, Siyata announced that it is presenting at the 13th annual LD Micro Invitational conference in Los Angeles, California from June 6 to 8, 2023.

 

On June 1, 2023, Siyata announced it had received an order from an Emergency Medical Services (“EMS”) organization for $1.2 million for In-Vehicle devices and for a new product called Siyata Real Time View, an in-fleet video monitoring solution.

 

On June 5, 2023, Siyata announced aggregate orders of $400,000 for its SD7 Handset and VK7 Vehicle Kit from the verticals of healthcare, education, and construction.

 

On June 12, 2023, Siyata announced that Minnesota Coaches, Inc, a privately held motor coach and school bus transportation company, has taken delivery of its first order of SD7 Handsets and VK7 Vehicle Kits.

 

On June 14, 2023, Siyata announced a new product called the Siyata Mobile Command Center for in-field communications for EMS organizations.

 

On June 15, 2023, Siyata announced its participation to showcase its SD7 Handset and VK7 Vehicle Kit in the Minnesota School Bus Operators Association’s Annual Summer Conference in Alexandria, Minnesota on June 19 to 21, 2023.

 

On June 20, 2023, Siyata announced that Mobile Tornado Group Plc will offer its robust PTT application on the Siyata SD7 Handset.

 

On June 21, 2023, Siyata announced its participation with CrisisGo to show its Mission Critical PTT and Emergency Response Management capabilities at NASRO 2023, a National School Safety Conference in Indianapolis, Indiana on June 28 to 29, 2023.

 

54

 

 

On June 22, 2023, Siyata announced new aggregate orders of approximately $600,000 for its Siyata SD7 Handset and VK7 Vehicle Kit in the vertical markets of education, construction, and logistics.

 

On June 27, 2023, Siyata announced the pricing of a new public offering of 50 million common shares at $0.045 per share. The gross proceeds to Siyata before fees, commissions, and expenses are expected to be $2.25 million, closing on or about June 28, 2023.

 

On July 6, 2023, Siyata announced the receipt of its single largest order for SD7 Handsets of $1.4 million, to be delivered in the second half of 2023.

 

On July 11, 2023, Siyata announced that it had entered into a securities purchase agreement with certain institutional investors to purchase 51.45 million common shares at a price of $0.045 per share. The gross proceeds to Siyata before fees, commissions, and expenses are expected to be $2.3 million, closing on or about July 13, 2023.

 

On July 12, 2023, Siyata announced that its 2023 Annual General Meeting of its stockholders will be held on Thursday August 3, 2023 at 1 pm ET.

 

On July 18, 2023, Siyata announced it had received orders from two large North American waste management companies for its SD7 Handset and VK7 Vehicle Kit, and for its UV350 In-Vehicle Device.

 

On July 20, 2023, Siyata announced its participation in APCO 2023, which is APCO’s International Annual Conference and Expo for public safety communications officials to be held on August 6 to 9, 2023, in Nashville, Tennessee.

 

On July 25, 2023, Siyata names public safety advocate and Business Development executive Doug Clark, formerly from AT&T FirstNet, as its new Assistant Vice President, Sales and Marketing.

 

On August 10, 2023, the Company affected a 100-to-1 reverse stock split resulting in 185,393,404 shares converted with rounding into 1,853,955 shares.

 

Outlook

 

Siyata has laid the foundation for greater distribution with expanded partnerships, key new sale hires, and expanded product offerings into North America. Management is hopeful that this momentum will continue throughout 2023, in particular, as it leverages its key sales channels, and with its expanded and refreshed product offerings.

 

55

 

 

Uniden® UV350 | Active engagements including several customer trials and several repeat orders from existing UV350 customers in 2023 should translate into growth in this product line.

 

Rugged Handsets | Siyata’s rugged handsets are targeted to the approximately 47 million enterprise task and public sector workers across North America including construction, transport and logistics, manufacturing, energy and utility, public safety, and federal government. Prior to launching SD7 Handset in North America, Siyata sold its rugged handsets only in international markets. Siyata expanded its footprint in this product category with the launch of the SD7 device, in the fourth quarter of 2021 in North America. The SD7 is a next-generation device and Siyata’s first mission-critical push-to-talk handset. [Source: U.S. Department of Transportation, VDC Research.]

 

Cellular Boosters | The pandemic has helped fuel strong demand for Siyata’s boosters in 2020 and 2021. This momentum slowed in 2022 but we anticipate consistent sales in 2023.

 

Summary Of Quarterly Results

 

The following unaudited table sets out selected financial information for the Company on a consolidated basis for the last eight most recently completed quarters based on a pre 100-1 common shares reverse stock split.

 

   June 30,
2023
   Mar 31,
2023
restated
   Dec 31,
2022
   Sep 30,
2022
   Jun 30,
2022
   Mar 31,
2022
(restated)
   Dec 31,
2021
   Sep 30,
2021
 
Income/(loss)  $(2,333,617)  $(4,877,999)  $(6,588,309   $(527,948)  $(4,304,088)  $(3,878,909)  $(4,979,661)  $(5,667,937)
Comprehensive income/(loss) for the period  $(2,333,617)  $(4,877,999)  $(6,589,329)  $(390,838)  $(4,278,102)  $(3,903,377)  $(4,833,795)  $(5,677,274)
Loss per share  $(0.03)  $(0.08)  $(0.17)  $(0.03)  $(0.29)  $(0.30)  $(0.99)  $(1.18)

 

56

 

 

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2023

 

The following is an analysis of the Company’s operating results for the three months ended June 30, 2023, and includes a comparison against the three months ended June 30, 2022.

 

Operations:

 

Revenues for the three months ended June 30, 2023, were $2,710,717 compared to $969,528 for the three months ended June 30, 2022. This increase of $1,741,189 (180%) is due mainly to the increase in the sale of rugged devices as a result of the launching of the SD7 in 2022 of $1,916,000 or 871% increase, offset by a $174,811 decrease (negative 23%) in sales of boosters in the same period.  

 

Cost of sales for the three months ended June 30, 2023, were $1,906,227 compared to $860,855 for the three months ended June 30, 2022. The gross margin dollars for the three months ended June 30, 2023 and June 30, 2022 was $804,490 (29.7% of sales) and $108,673 (11.2% of sales), respectively, a positive variance in gross margin by $695,817 (18.5% increase in gross margin percentage). This relates to the increase in sales of our new suite of rugged and in-vehicle cellular devices at higher margins compared to the margins sold on the legacy rugged devices.

  

Amortization and depreciation costs for the three months ended June 30, 2023, were $453,499 compared to $335,419 for the three months ended June 30, 2022, respectively, a negative variance of $118,080. This negative variance is due to the increased intangible asset amortization that began for the VK7 in 2023 of $101,133 and an increase in the amortization of the SD7 of $16,947.

 

Development expenses for the three months ended June 30, 2023, were $31,465 compared to $140,054 for the three months ended June 30, 2022, respectively. This positive variance of $108,589 is due to the decrease of the development costs incurred on the company’s rugged device development program that did not meet the criteria for capitalization was lower in 2022 due to more focused development activities on capitalizable products.

 

Selling and marketing costs for the three months ended June 30, 2023, were $1,037,803 compared to $1,163,675 for the three months ended June 30, 2022 respectively. This positive variance of $125,872 is due mainly to the decrease in promotional costs of $88,000, decrease in our U.S. sales team headcount of $32,000 and decreased travel expense of $5,872.

 

General and administrative costs for the three months ended June 30, 2023, were $1,703,382 compared to $1,851,582 for the three months ended June 30, 2022, respectively. This positive variance of $148,200 (8%) relates mainly to the, decreases in insurance included in office and general of $258,000, decrease consulting and director’s fees of $56,000 due to no bonuses paid in 2023, decrease in shareholder relations costs of $135,000, the decrease of $29,000 in travel costs, offset by an increase in professional services costs of $197,000 related to both the increase in fees for U.S. securities attorney and the additional costs for the annual PCAOB audit, increase of $120,000 in salaries expense related to additional employees, in 2023, and a $12,800 increase in regulatory and filing fees.

 

Inventory Impairment costs for the three months ended June 30, 2023, were $NIL compared to $238,980 for the three months ended June 30, 2022, respectively.

 

Bad debts for the three months ended June 30, 2023, were $10,148 compared to $70,643 for the three months ended June 30, 2022, respectively.

 

Share-based compensation costs for the three months ended June 30, 2023, were $260,705 compared to $1,126,300 for the three months ended June 30, 2022, respectively. The decrease in share-based compensation relates to the valuation of stock options vested during the prior year period due to the issuance in Q1 2022 of 600,000 RSU’s to directors and officers that vested immediately.

 

57

 

 

Finance expenses for the three months ended June 30, 2023, were $41,251 compared to $18,739 for the three months ended June 30, 2022, respectively. This negative variance of $22,512 consists of negative variance in the interest on the factoring of $16,951 and negative variance interest on lease obligations of $5,561.

 

Foreign exchange loss for the three months ended June 30, 2023, was income of $78,762 compared to an expenses of $106,828 for the three months ended June 30, 2022, respectively This variance resulted from foreign currency fluctuations in the period.

 

Change in fair value of the convertible promissory note for the three months ended June 30, 2023, were $NIL compared to $570,391 for the three months ended June 30, 2022, respectively. In 2022, this resulted from both the repricing of the convertible feature of the promissory note when other capital raises reduced the convertible price and due to the full repayment of the promissory note via the issuance of share capital whose formula in the agreement between the parties required between 80%-90% of the lowest 5 day VWAP in a thirty day period which resulted in a significant fair value loss in the year.

 

Change in fair value of the warrant liability for the three months ended June 30, 2023, was a gain of $321,384 compared to a gain of $1,209,850 for the three months ended June 30, 2022, respectively. The three months ended June 2023 amount relates to only to the revaluation of the 9,999,9999 warrants issued January 2022.

 

Net loss for the period

 

The Company experienced a net loss for the three months ended June 30, 2023, were $2,333,617 compared to a net loss of $4,304,088 for the three months ended June 30, 2022 respectively, a positive variance of, ($1,970,471). This positive variance was due mainly to an increase in gross margin of $695,817, decrease in share-based payments of $865,595, decrease in development expense of $108,589, decrease in foreign exchange of $185,590, decrease in bad debt expense by $60,495, decreases in inventory impairment of $238,980, a decrease in selling expenses of $125,872 and a decrease in G&A expenses of $148,200, decrease in the fair value gain on financial derivatives of $318,075 offset by an increase in finance expenses of $22,512, an increase in amortization of $118,080.

 

Loss and comprehensive loss for the period

 

As a result of the activities discussed above, the Company experienced a comprehensive loss for the three months ended June 30, 2023, were $2,333,617 versus $4,278,102 for the three months ended June 30, 2022, respectively, representing a positive variance of $1,944,485.

 

Adjusted EBITDA

 

For the three months ended June 30, 2023, the adjusted EBITDA is negative ($1,978,308) versus negative ($3,356,261) in the prior year period, a positive variance of $1,377,953. Adjusted EBITDA is defined as the net operating loss excluding depreciation and amortization, intangible impairment, goodwill impairment and share-based compensation expense. It is a non-IFRS calculation that should be compared to our audited financial information included elsewhere in this Annual Report.

 

58

 

 

RESULTS OF OPERATIONS FOR THE SIX MONTHS ENDED JUNE 30, 2023

 

The following is an analysis of the Company’s operating results for the six months ended June 30, 2023, and includes a comparison against the six months ended June 30, 2022.

 

Operations:

 

Revenues for the six months ended June 30, 2023, were $4,513,354 compared to $1,802,502 for the six months ended June 30, 2022. This increase of $2,710,852 (150%) is due mainly to the increase in the sale of rugged devices of $2,911,000 or 494% increase due to the launching of the SD7 in Q3 2022 offset by a $200,148 decrease in sales of boosters in the same period.  

 

Cost of sales for the six months ended June 30, 2023, were $3,212,347 compared to $1,438,778 for the six months ended June 30, 2022. The gross margin dollars for the six months ended June 30, 2023 and June 30, 2022 was $1,301,007 (28.8% of sales) and $363,724 (20.2% of sales), respectively, a positive variance in gross margin by $937,283 (8.6% decrease in gross margin percentage). This relates to the increase in sales of our new suite of rugged and in-vehicle cellular devices at higher margins compared to the margins sold on the legacy rugged devices.

  

Amortization and depreciation costs for the six months ended June 30, 2023, were $855,139 compared to $459,924 for the six months ended June 30, 2022, respectively, a negative variance of $395,215. This negative variance is due to the increased intangible asset amortization that began for the VK7 in 2023 of $202,265, the increase in amortization of the SD7 in 2023, due to the 2022 amortization only beginning in Q2 2022, of $236,875 offset by the decrease in the right of use amortization in the period by $43,925.

 

Development expenses for the six months ended June 30, 2023, were $85,450 compared to $263,370 for the six months ended June 30, 2022, respectively. This positive variance is due to the decrease of the development costs incurred on the company’s rugged device development program that did not meet the criteria for capitalization was lower in 2022 due to more focused development activities on capitalizable products.

 

Selling and marketing costs for the six months ended June 30, 2023, were $2,041,168 compared to $2,208,726 for the six months ended June 30, 2022 respectively. This positive variance of $167,558 is due mainly to the decrease in promotional costs of $237,000, offset by both an increase in our U.S. sales team headcount of $55,000 and increased travel expense of $14,442.

 

General and administrative costs for the six months ended June 30, 2023, were $3,095,812 compared to $3,510,661 for the six months ended June 30, 2022, respectively. This positive variance of $414,849 (12%) relates mainly to the decrease consulting and director’s fees of $212,000 due to no bonuses paid in 2023, decreases in insurance included in office and general of $374,000, decrease in investor relations costs of $328,000, the decrease of $51,000 in travel costs, offset by an increase in professional services costs of $385,000 related to both the increase in fees for U.S. securities attorney and the additional costs for the annual PCAOB audit, increase of $146,000 in salaries expense related to additional employees, in 2023, an $19,151 increase in regulatory and filing fees.

 

Inventory Impairment costs for the six months ended June 30, 2023, were $NIL compared to $303,316 for the six months ended June 30, 2022, respectively.

 

Bad debts for the six months ended June 30, 2023, were $10,148 compared to $63,285 for the six months ended June 30, 2022, respectively.

 

Share-based compensation costs for the six months ended June 30, 2023, were $571,533 compared to $1,939,035 for the six months ended June 30, 2022, respectively. The decrease in share-based compensation relates to the valuation of stock options vested during the prior year period due to the issuance in Q1 2022 of 600,0000 RSU’s to directors and officers that vested immediately.

 

59

 

 

Finance expenses for the six months ended June 30, 2023, were $75,349 compared to $45,726 for the six months ended June 30, 2022, respectively. This negative variance of $29,623 consists of negative variance in interest on the factoring of the North American receivables of $16,951and a negative variance interest on lease obligations of $12,672.

 

Foreign exchange loss for the six months ended June 30, 2023, was a gain of $78,599 compared to a loss of $19,168 for the six months ended June 30, 2022, respectively This variance resulted from foreign currency fluctuations in the period.

 

Transaction costs for the six months ended June 30, 2023, were $NIL compared to $965,247 for the six months ended June 30, 2022, respectively In 2022, transaction cost related to share issuance costs incurred on the two equity raises undertaken in the year, which were allocated to the warrant liability and expensed when incurred.

 

Change in fair value of the convertible promissory note for the six months ended June 30, 2023, were $NIL compared to $3,250,848 for the six months ended June 30, 2022, respectively. In 2022, this resulted from both the repricing of the convertible feature of the promissory note when other capital raises reduced the convertible price and due to the full repayment of the promissory note via the issuance of share capital whose formula in the agreement between the parties required between 80%-90% of the lowest 5 day VWAP in a thirty day period which resulted in a significant fair value loss in the year.

 

Change in fair value of the opening warrant liability for the six months ended June 30, 2023, was $NIL compared to a gain of $962.350 for the six months ended June 30, 2022, respectively. The six months ended 2022 relates to the adjustment of fair value of the opening balance of a warrant liability due to a capital raise.

 

Change in fair value of the warrant liability for the six months ended June 30, 2023, was a loss of $1,856,623 compared to a gain of $5,444,935 for the six months ended June 30, 2022, respectively. The six months ended 2023 amount relates to the inducement warrant fair value loss of $2,875,580 plus the transaction costs for the warrant exercise and re-issuance of $309,000 included in change in fair value plus the actual change in fair value gain of for the period of $1,327,957. As well, resulting of certain warrants becoming cashless, their was a significant reduction in the number of warrants outstanding that required fair value valuation as of June 30, 2023.

 

Net loss for the period

 

The Company experienced a net loss for the six months ended June 30, 2023, were $7,211,616 compared to a net loss of $8,182,997 for the six months ended June 30, 2022, respectively, a positive variance of, $971,381. This variance was due mainly to a decreases in inventory impairment of $303,316, decrease in development expense of $177,920, decrease in share-based payments of $1,367,502, a decrease in selling expenses of $167,558, increase in gross margin of $937,283, a decrease in G&A expenses of $414,849, a decrease in foreign exchange of $97,767, a decrease in bad debt expense by $53,137 and a decrease in transaction costs of $965,247. offset by an increase in the fair value loss on financial derivatives of $3,088,360, increase in finance expenses of $29,623, and an increase in amortization of $395,215.

 

Loss and comprehensive loss for the period

 

As a result of the activities discussed above, the Company experienced a comprehensive loss for the six months ended June 30, 2023, were $7,211,616 versus $8,181,479 for the six months ended June 30, 2022, respectively, representing a positive variance of $969,863.

 

Adjusted EBITDA

 

For the six months ended June 30, 2023, the adjusted EBITDA is negative ($3,931,571) versus negative ($5,985,634) in the prior year period, a positive variance of $2,054,063. Adjusted EBITDA is defined as the net operating loss excluding depreciation and amortization, intangible impairment, goodwill impairment and share-based compensation expense. It is a non-IFRS calculation that should be compared to our audited financial information included elsewhere in this Annual Report.

 

60

 

 

B. Liquidity and Capital Resources

 

The Company’s objective in managing liquidity risk is to maintain sufficient liquidity in order to meet operational and investing requirements at any point in time. The Company has historically financed its operations primarily through a combination of demand loans and the sale of share capital by way of private placements.

 

As at June 30, 2023, the Company had a cash balance $2,026,640 (Dec 31, 2022-$1,913,742). The Company had an accumulated deficit of $85,030,279 (Dec 31, 2022-$77,818,663) and working capital of $3,740,713 (December 31, 2022-$1,643,434).

 

Net cash flows related to operating activities used in the six month period ended June 30, 2023 and six months ended June 30, 2022 were negative ($4,223,380) and negative ($11,174,413), respectively. The decrease in cash used for operating activities of $6,951,033 was primarily due to the decrease in the change in non-cash working capital items of $4,222,270, and a decrease of net loss including addbacks of $2,728,763.

 

The non-cash working capital variances consisting of increase in the change of trade and other receivables of $966,547, decrease in the change of prepaids of $188,170, decrease in the change of inventory of $4,177,104, an decrease in the change of advances to suppliers of $380,658, an increase in in the change of accounts payable and accrued liabilities of $592,485 and a decrease in the change of deferred revenue of $149,600.

  

Net cash flows used in investing activities in six month period ended June 30, 2023 and six months ended June 30, 2022 were negative ($1,332,911) and negative ($1,546,475), respectively. A positive variance of $213,564. This positive variance relates primarily to the acquisition in Q1 2022 of ClearRF of $155,014 that did not recur in 2023, offset by an increase in intangible asset additions of $60,445, and the increase in fixed asset additions of $1,895.

 

Net cash flows used in financing activities in the six month period ended June 30, 2023 and six months ended June 30, 2022 were $5,669,189 and $15,141,656, respectively. A negative variance of $9,472,467 relates to increase in 2022 net proceeds of share capital raises after share issuance costs of $13,427,813, a $5,740 increase in the lease payments, and an increase in cash transaction costs of $748,600, offset by the $4,000,000 reduction in the convertible promissory note, and a $709,686 increase in bank loan.

 

The future success of the Company is dependent on the continued success of its vehicle mounted communications products, its mobile rugged phones and its booster products together with the ability to finance the necessary working capital, at agreeable terms, to support the growth of the business.  

 

The Company’s unaudited condensed interim consolidated financial statements have been prepared in accordance with IFRS under the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business rather than a process of forced liquidation. The consolidated audited financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.

 

SHARE CAPITAL

 

  (a) Authorized Unlimited number of Common Shares without par value

 

Issued and Outstanding:

 

As at June 30, 2023, the Company had 133,943,404 common shares issued and outstanding (December 31, 2022 – 44,868,560).

 

As of the date of issuance of these financial statements total outstanding common shares is 185,193,404.

 

As of August 9, 2023 the Company affected a 100-1 reverse stock split so that the outstanding number of shares will be 1,853,955.

 

61

 

 

Transactions for the six months ended June 30, 2023 are as follows:

 

  The Company issued 18,042,857 common shares on the exercise of various warrants for gross proceeds of $3,608,571. Additionally, the Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 30, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,987 common shares were issued for cashless warrants in Q2 2023.

 

Subsequent Events:

 

Subsequent to the period end, the Company issued 51,450,000 common shares at $0.45 for total gross proceeds of $2,315,250.

 

On August 9, 2023 the Company affected a 100-1 reverse stock split so that the outstanding number of common shares will be 1,853,955 (pre-split 185,393,404),

 

  (b) Common share transactions

 

Transactions for the six months ended June 30, 2022 are as follows:

 

 

On January 11, 2022, the Company completed an underwritten public offering in the United States, raising a total of $20,013,043 in gross proceeds. The Company allocated the gross proceeds firstly to the warrant liabilities, with the remainder to the common shares. Direct costs have been allocated based on the percentage allocation of the proceeds. The underwritten public offering resulted in the sale to the public of 7,215,652 Units at $2.30 per Unit, with each Unit being comprised of one common share and one warrant (the “Unit Warrants”) exercisable at $2.30 per share. The Unit warrants are exercisable immediately and have a term of 5 years. Gross proceeds of $10,936,974 were allocated to the common shares, and $5,395,878 to the unit warrants liability.

 

In addition, the Company issued 1,480,000 pre-funded units (“Pre-Funded Units”) at $2.29 per Pre-Funded Unit. Each Pre-Funded Unit is comprised of a one-pre-funded warrant (a “Pre-Funded Warrant”) to purchase one common share, and one warrant to purchase one common share. The Pre-Funded Warrant allows the holder to acquire one common share of the Company at an exercise price of $0.01 per common share, and a warrant to purchase a common share at an exercise price of $2.30 per share. The warrants are exercisable immediately and have a term of 5 years. Each Pre-Funded Warrant is exercisable immediately and is exercisable until all Pre-Funded Warrants are exercised. Proceeds of $2,560,400 were allocated to the pre-funded warrants and $1,106,747 to the unit warrants in the warrant liability.

 

The Company determined that the pre-funded warrants within the Pre-funded Units are common shares in substance, as they require only a minimal exercise price of $0.01. In addition, the underwriting agreement includes both the Units and Pe-funded Units and were negotiated together in the equity raise. Given that the purpose of the Prefunded Unit is in substance the same as that of the Unit (i.e., resulting in the ownership of both common shares and common share warrants) and that the terms of the warrants in both the Units and Prefunded Units are the same (i.e., the obligations of the Company for the units are the same), the Company determined that the Units and Pre-funded Units are closely related and should be combined into one unit of account for the purposes of allocating proceeds.

 

Therefore, the proceeds from the sale of the Units and Pre-funded Units are combined and allocated among the common shares, pre-funded warrants, and the common share warrants using the residual method, with the warrant liability being initially recognized at fair value as of the registration date and the residual amount being allocated to the common shares (i.e., equity).

 

62

 

 

  (b) Common share transactions (cont’d)

 

The Company concurrently sold an additional 1,304,347 warrants to purchase 1,304,347 common shares exercisable at $2.30 per share (the “Option Warrants”) pursuant to an over-allotment option exercised by the underwriter. The exercise price of the warrants issued in connection with the exercise of the over-allotment option was $0.0097 per warrant. Each Option Warrant is exercisable immediately and has a term of five years from the issue date. Proceeds of $975,393 were allocated to the option warrant liability. As the fair value of the warrant liability exceeded the proceeds received on the warrants of $13,043, a fair value loss of $962,350 was recognized in the statement of profit and loss as a fair value change in the opening warrant liability.

 

The fair value of the common shares and pre-funded units was determined by reference to the market price on the day of the offering, which was $1.73 per share. The Unit Warrants, Warrants, and Option Warrants were valued using the Black-Scholes model using the following assumptions: initial stock price $1.73, strike rate $2.30, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company also issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company assessed that the warrants issued under the public offering, excluding the Placement Agent Warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. The Placement Agent Warrants were assessed under IFRS 2 Share Based Payments, as equity-settled share-based payments and have been recorded in equity.

 

The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued. 

  

The fair value of the common shares and pre-funded units was determined by reference to the market price on the day of the offering, which was $1.73 per share. The Unit Warrants, Warrants, and Option Warrants were valued using the Black-Scholes model using the following assumptions: initial stock price $1.73, strike rate $2.30, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

 

On March 31, 2022, as part of the ClearRF acquisition (Note 3), the Company issued 138,958 shares to the vendor with a fair value of $190,094.

 

The Company issued 854,219 common shares with a fair value of $1,002,461 as combined payments of the monthly principal repayment of $400,000 for the months of May and June 2022 payable in shares per the terms of the promissory note.

 

The Company issued 155,000 common shares, with a fair value of $170,500 ($1.10 per share) to consultants as part of their compensation for services rendered.

 

63

 

 

Stock Options:

 

The Company has a shareholder-approved “rolling” stock option plan (the “Plan”) in compliance with Nasdaq policies. Under the Plan the maximum number of shares reserved for issuance may not exceed 15% of the total number of issued and outstanding Common Shares on a fully diluted basis at the time of granting. The exercise price of each stock option shall not be less than the market price of the Company’s stock at the date of grant, less a discount of up to 25%. Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted.

 

A summary of the Company’s stock option activity at June 30, 2023 and the date of the MD&A are as follows:

 

   Number of
stock
options
   Weighted
Average
Exercise
Price
 
Outstanding options, December 31, 2021   414,568   $13.88 
Granted   1,145,000   $1.15 
Expired/Cancelled   (53,430)  $30.90 
Outstanding options, December 31, 2022, June 30, 2023 and the date of the MD&A   1,506,138   $3.53 

Outstanding options after the 100-1 reverse stock split), December 31, 2022, June 30, 2023
and the date of the MD&A

   

15,061

   $353.00 

  

Transactions for the six months ended June 30, 2022 are as follows:

 

On January 1, 2022, the Company granted 20,000 stock options at $4.00 per share that vest in 8 equal quarterly periods with the first vesting occurring on the grant date. The fair value on the date of the grant was $54,480 ($2.724 per option).

 

On April 13, 2022, the Company granted 795,000 stock options to executives and employees at an exercise price of $1.10 per share. These options vest quarterly over three years period with the first vesting taking place at the date of the grant. The fair value of these options on the date of the grant is $678,520 ($0.8535 per share).

 

64

 

 

As of June 30, 2023 stock options outstanding are as follows:

 

Grant Date  Number of
options
outstanding
   Number of
options
exercisable
   Weighted
Average
Exercise
Price
   Expiry date  Remaining contractual
life (years)
24-Dec-18   12,896    12,896    54.00   24-Dec-23  0.48
15-Jan-19   828    828    54.00   15-Jan-24  0.55
21-Mar-19   12,345    12,345    59.00   21-Mar-24  0.73
1-Jan-20   2,069    2,069    54.00   1-Jan-24  0.51
15-Nov-20   95,000    95,000    6.00   15-Nov-30  7.38
15-Nov-20   161,500    161,500    6.00   15-Nov-25  2.38
2-Jan-21   57,000    49,875    11.50   2-Jan-26  2.51
2-Jan-21   5,000    4,375    11.50   2-Jan-31  7.52
18-Jan-21   14,500    12,688    11.50   18-Jan-26  2.56
1-Jan-22   20,000    10,000    4.00   29-Oct-26  3.33
13-Apr-22   795,000    331,250    1.10   13-Apr-27  3.79
12-Jul-22   330,000    110,000    1.10   12-Jul-25  2.04
Total (before the 100-1 reverse stock split)   1,506,138    802,826   $3.53      3.37

Total (after the 100-1 reverse stock split)

   15,061    8,283   $353.0      3.37

 

Restricted Share Units (“RSUs”)

 

The Company approved on February 14, 2022, an amended and restated equity incentive plan which permits the issuance of restricted share units in addition to stock options.

 

A summary of the Company’s restricted share unit activity during the year ended December 31, 2022 and for the interim period of June 30, 2023 and the date of this MD&A are as follows:

 

    Number of
RSU’s
    Weighted
Average
Issue
Price
 
Outstanding RSU, December 31, 2021     -     $                  -  
Granted     3,195,000     $ 1.05  
Exercised     (30,000 )   $ 1.10  
Outstanding RSU, December 31, 2022, June 30, 2023 and the date of this MD&A before the 100-1 reverse stock split     3,165,000     $ 1.05  
Outstanding RSU, December 31, 2022, June 30, 2023 and the date of this MD&A after the 100-1 reverse
stock split
    31,650     $ 105.00  

 

As at June 30, 2023 restricted share units outstanding are as follows:

 

Grant Date   Number of
RSU’s
outstanding
    Number of
RSU’s
exercisable
    Weighted
Average
Issue Price
 
09-Mar-22     2,250,000       1,050,000     $ 1.03  
13-Apr-22     825,000       513,750     $ 1.10  
12-Jul-22     90,000       30,000     $ 1.10  
Outstanding RSU, June 30, 2023 (before 100-1 reverse stock split)     3,165,000       1,893,750     $ 1.05  
Outstanding RSU, June 30, 2023 (after the 100-1 reverse stock split)     31,650       18,938     $ 105.00  

 

 

65

 

 

Transactions for the six months ended June 30, 2022, are as follows:

 

On March 9, 2022, the Company granted 450,000 RSU’s to Directors that vest immediately. On the date of granting, the fair value and stock price was $1.03/share.

 

On March 9, 2022, the Company granted 1,800,000 RSU’s to a Director that vest quarterly over 12 periods with the first vesting of 150,000 RSU’s occurring on the date of the granted and another 150,000 vest every six months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.03/share.  

 

On April 13, 2022, the Company granted 240,000 RSU’s to consultants that vest immediately. On the date of granting, the fair value and the stock price was $1.10/share.

 

On April 13, 2022, the Company granted 585,000 RSU’s to employees of the Company that vest quarterly over 12 periods with the first vesting of 48,750 RSU’s occurring on the date of the granted and another 48,750 RSU’s vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.10/share.

 

66

 

 

Agent’s options

 

A summary of the Company’s agents’ options activity for the six month period ended June 30, 2023 is as follows:

 

    Number of     Weighted
average
exercise
 
    options     price  
Outstanding agent options, December 31, 2021     445,926     $ 7.51  
Granted     487,283       2.51  
Expired     (1,702 )     20.49  
Outstanding agent options, December 31, 2022, June 30, 2023 and date of the MD&A (before the 100-1 reverse stock split)     931,507     $ 4.87  
Outstanding agent options, December 31, 2022, June 30, 2023 and date of the MD&A (after the 100-1 reverse stock split)     9,315     $ 487.00  

 

As at June 30, 2023, agent’s options outstanding and exercisable are as follows:

 

Grant Date   Number of
options
outstanding
    Number of
options
exercisable
    Weighted
Average
Exercise
Price
    Expiry date   Remaining
contractual life
(years)
 
                             
29-Sep-20     113,500       113,500     $ 6.60     28-Sep-25     2.00  
29-Sep-20     266,000       266,000     $ 6.85     28-Sep-25     2.00  
31-Dec-20     64,724       64,724     $ 11.50     30-Jun-24     1.00  
11-Jan-22     434,783       434,783     $ 2.53     11-Jan-27     4.00  
01-Apr-22     52,500       52,500     $ 2.30     08-Mar-27     4.00  
Total (before the 100-1 reverse stock split)     931,507       931,507     $ 4.87           2.98  
Total (after the 100-1 reverse stock split)     9,315       9,315     $ 487.00           2.98  

 

Transactions for the six months ended June 30, 2022 are as follows:

 

  The Company issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%. The Company also issued 52,500 agent’s options with a fair value of $61,950 with an exercise price of $2.30.

 

67

 

 

Share Purchase Warrants:

 

A summary of the Company’s warrant activity for the period ended at June 30, 2023 is as follows:

 

    Number of
Warrants
    Weighted
average
exercise
price
 
Outstanding, December 31, 2021     5,121,328     $ 7.64  
Granted     29,139,129     $ 0.94  
Expired     (128,386 )   $ 33.47  
Outstanding, December 31, 2022     34,132,071     $ 1.76  
Granted     18,042,857       0.20  
Exercised     (39,074,844 )     0.09  
Outstanding, June 30, 2023 and the date of the MD&A (before the 100-1 reverse stock split)     13,100,084     $ 3.84  
Outstanding, June 30, 2023 and the date of the MD&A (after the 100-1 reverse stock split)     131,001     $ 384.00  

 

As of June 30, 2023, share purchase warrants outstanding and exercisable are as follows:

 

Grant Date   Number of
Warrants
outstanding and
exercisable
    Exercise
Price
    Expiry date
29-Sep-20     1,805,585     $ 6.85     28-Sep-25
31-Dec-20     1,294,500     $ 11.50     30-Jun-24
11-Jan-22     9,999,999     $ 2.30     11-Jan-27
Total (before the 100-1 reverse stock split)     13,100,084     $ 3.84      
Total (before the 100-1 reverse stock split)     131,001     $ 384.00      

 

Transactions for the six months ended June 30, 2023 are as follows:

 

  18,042,857 warrants were exercised on January 19, 2023. The Company on the same day, issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 31, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,987 cashless warrants were exercised in Q23 2023.

 

Transactions for the six months ended June 30, 2022 are as follows:

 

  128,386 share purchase warrant expired in 2022.

 

  On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exercisable at $2.30 per warrant and with a term of five years.

 

68

 

 

FINANCIAL INSTRUMENTS

 

The fair values of the Company’s cash, trade and other receivables, accounts payable and accrued liabilities and long-term debt, approximate carrying value, which is the amount recorded on the consolidated statement of financial position.

 

Credit risk

 

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company places its cash with institutions of high creditworthiness. Management has assessed there to be a low level of credit risk associated with its cash balances.

 

The Company's exposure to credit risk is influenced mainly by the individual characteristics of each customer. However, management also considers the demographics of the Company's customer base, including the default risk of the industry and country in which customers operate, as these factors may have an influence on credit risk. Approximately 34% of the Company's revenue for the six months ended June 30, 2023 (June 30, 2022 -23%) is attributable to sales transactions with a single customer.

 

The Company has established a credit policy under which each new customer is analyzed individually for creditworthiness before the Company's standard payment and delivery terms and conditions are offered. The Company's review includes external ratings, when available, and in some cases bank references. Purchase limits are established for each customer, which represents the maximum open amount without requiring approval from the Risk Management Committee; these limits are reviewed quarterly. In prior years, certain key customers were offered extended payment terms on their purchases due to slow down from Covid-19 and budget approvals for government tenders.

 

More than 40% (2022 – 18%) of the Company's customers have been active with the Company for over four years, and the allowance for doubtful accounts of $1,091,026 (2022 - $1,056,393) has been recognized against these customers. In monitoring customer credit risk, customers are grouped according to their credit characteristics, including whether they are an individual or legal entity, whether they are a wholesale, retail or end-user customer, geographic location, industry, aging profile, maturity, and the existence of previous financial difficulties. Trade and other receivables relate mainly to the Company's wholesale customers. Customers that are graded as “high risk” are placed on a restricted customer list and monitored by the Company.

 

The carrying amount of financial assets represents the maximum credit exposure, notwithstanding the carrying amount of security or any other credit enhancements.

 

Liquidity risk

 

Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities that are settled by delivering cash or another financial asset. The Company’s approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company’s reputation.

 

69

 

 

The Company examines current forecasts of its liquidity requirements so as to make certain that there is sufficient cash for its operating needs, and it is careful at all times to have enough unused credit facilities so that the Company does not exceed its credit limits and is in compliance with its financial covenants (if any). These forecasts take into consideration matters such as the Company’s plan to use debt for financing its activity, compliance with required financial covenants, compliance with certain liquidity ratios, and compliance with external requirements such as laws or regulation.

 

The Company uses activity-based costing to cost its products and services, which assists it in monitoring cash flow requirements and optimizing its cash return on investments. Typically, the Company ensures that it has sufficient cash on demand to meet expected operational expenses for a period of 90 days, including the servicing of financial obligations; this excludes the potential impact of extreme circumstances that cannot reasonably be predicted, such as natural disasters.

 

With the exception of employee benefits, the Company’s accounts payable and accrued liabilities have contractual terms of 90 days. The employment benefits included in accrued liabilities have variable maturities within the coming year.

 

Market risk

 

  a) Currency Risk

 

Currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates.

  

  a) Interest Rate Risk

 

Interest rate risk is the risk that the fair value of future cash flows will fluctuate as a result of changes in interest rates. The Company’s sensitively to interest rates is currently immaterial as the Company’s debt bears interest at fixed rates.

 

  b) Price Risk

 

The Company is exposed to price risk with respect to equity prices. Equity price risk is defined as the potential adverse impact on the Company’s earnings due to movements in individual equity prices or general movements in the level of the stock market. The Company closely monitors individual equity movements, and the stock market to determine the appropriate course of action to be taken by the Company.

 

C. Research and development, patents and licenses, etc.

 

Research and development 

 

The Company undertakes research activities that present the prospect of gaining new scientific or technical knowledge and understanding, and the Company’s development activities involve a plan or design for the production of new or substantially improved products and processes. The Company conducts its own research and development with its internal engineering teams in Israel and complements that effort with subcontractors for both its hardware and software development. The Company analyzes market trends, evaluates emerging wireless technologies, and innovates to address anticipated customer needs.

 

Patents

 

The Company owns two patents that it acquired from Clear RF and the Corporation has entered into several licensing agreements for the use of a trademark and certain patents.

 

70

 

 

In March 2021, the Corporation, through a wholly-owned subsidiary of Signifi Mobile Inc., the Corporation’s wholly-owned subsidiary, also acquired all of the outstanding units of Clear RF LLC (“ClearRF”), a Washington State limited liability company, for a total purchase price of $700,000. The purchase price which was satisfied by the issuance of approximately $389,970 in Common Shares and a payment of $310,030 in cash. ClearRF produces M2M (machine-to-machine) cellular amplifiers for commercial and industrial M2M applications, and offers patented direct connect cellular amplifiers and patented auto gain & oscillation control designed for M2M and “internet-of-things” (“IoT”) applications. ClearRF’s flagship product is a 4G LTE direct connect cellular amplifier designed specifically for fixed and mobile M2M and IoT applications, used to connect directly to any cellular router, modem, embedded module, or alarm panel.

 

Licensing Agreements

 

Licensing Agreement with Uniden® America Corp

 

In December 2012, Signifi Mobile Inc., the Corporation’s wholly-owned subsidiary, entered into a license agreement (as amended, the “Uniden Agreement”) with Uniden America Corporation (“Uniden”). The Uniden Agreement includes renewal options up to December 31,2022, and has been successively renewed to date.

 

The Uniden Agreement, as in effect currently, provides the Corporation with the exclusive right to use the trademark “Uniden®” (along with associated designs and trade dress) and distribute, market, and sell its in-vehicle device, cellular signal booster and accessories under the Uniden® brand in the categories of cellular amplifiers, connected vehicle cellular devices, and rugged cellular products, during its term in North America. The Uniden® brand brings strong brand recognition for the Corporation’s devices and introduces a more unified brand to the current dealers, operators, and future customers in North America. 

 

The current Uniden Agreement which commenced on January 1, 2020, and expires on December 31, 2031. Minimum annual payments under the Uniden Agreement are $200,000 in 2023-2025 and $250,000 in each of 2026-2028 and $300,000 from 2029-2031 (collectively, the “Minimum Royalty Payments”). At the end of each fiscal year, Siyata has agreed to pay Uniden 3% of any sales from the licensed products under the Uniden Agreement that exceeds the Minimum Royalty Payments for such fiscal year.

 

Licensing Agreement with Via Licensing Corporation

 

Effective June 8, 2018, the Corporation entered into two separate patent licensing agreements (together, the “Via Licensing Agreements”) with Via Licensing Corporation to utilize worldwide patents related to the coding and decoding of Android software as well as access and download within the LTE/ 4G network. This patent license is for an initial period of five years and can be extended for a further five-year term. Management is completing the extension prior to the expiry date. Under the Via Licensing Agreements, the Corporation has the right, at any time during the term or any extension thereof, to terminate the agreements upon providing 60 days advanced notice of termination. The Via Licensing Agreements provide for the payment, to Via Licensing Corporation, of quarterly royalty fees that are based solely on product sales and is expressed as a percentage formula based upon the number of units sold, the country in which the units were manufactured, and the country location of the end customer. There are no minimum royalty fees payable under the Via Licensing Agreements.

 

Licensing Agreement with Wilson Electronics, LLC

 

Siyata, through its wholly-owned subsidiary, Signifi Mobile Inc., entered into a royalty agreement (the “Wilson Agreement”) with Wilson Electronics, LLC on November 30, 2017, with an effective date of January 1, 2018. The Wilson Agreement permits the Corporation to utilize several of Wilson Electronics’ LLC’s patents related to cellphone boosters. Specifically, under the Wilson Agreement, the Corporation has licensed a patent for its cellular booster portfolio of products, for the rights to the stand-alone cell phone radio signal booster on a worldwide basis. The Wilson Agreement is expected to remain in force until the expiration of all of the patents licensed under the Wilson Agreement expire, which is estimated to occur in December 2027. The Wilson Agreement requires Siyata to pay a royalty to Wilson Electronics, LLC of 4.5% of the sales of booster products, payable quarterly.

 

71

 

 

D. Trend Information

 

See Item 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS, Subsection A. “Outlook” for trend information.

 

E. Critical Accounting Estimates

 

The preparation of the consolidated financial statements in conformity with IFRS requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates:

  

  i) Critical accounting estimates

 

Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised and in any future periods affected. Information about critical estimates in applying accounting policies that have the most significant effect on the amounts recognized in the consolidated financial statements are, but not limited to the following:

 

  Income taxes - Tax provisions are based on enacted or substantively enacted laws. Changes in those laws could affect amounts recognized in profit or loss both in the period of change, which would include any impact on cumulative provisions, and future periods. Deferred tax assets, if any, are recognized to the extent it is considered probable that those assets will be recoverable. This involves an assessment of when those deferred tax assets are likely to reverse.

 

  Fair value of stock options and warrants - Determining the fair value of warrants and stock options requires judgments related to the choice of a pricing model, the estimation of stock price volatility, the expected forfeiture rate and the expected term of the underlying instruments. Any changes in the estimates or inputs utilized to determine fair value could have a significant impact on the Company’s future operating results or on other components of shareholders’ equity.

 

  Capitalization of development costs and their amortization rate – Development costs are capitalized in accordance with the accounting policy. To determine the amounts earmarked for capitalization, management estimates the cash flows which are expected to be derived from the asset for which the development is carried out and the expected benefit period.

 

  Inventory - Inventory is valued at the lower of cost and net realizable value. Cost of inventory includes cost of purchase (purchase price, import duties, transport, handling, and other costs directly attributable to the acquisition of inventories), cost of conversion, and other costs incurred in bringing the inventories to their present location and condition. Net realizable value for inventories is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Provisions are made in profit or loss of the current period on any difference between book value and net realizable value.

 

72

 

 

  Estimated product returns - Revenue from product sales is recognized net of estimated sales discounts, credits, returns, rebates and allowances. The return allowance is determined based on an analysis of the historical rate of returns, industry return data, and current market conditions, which is applied directly against sales.

 

  Impairment of non-financial assets - The Company assesses impairment at each reporting date by evaluating conditions specific to the Company that may lead to asset impairment. The recoverable amount of an asset or a cash-generating unit (“CGU”) is determined using the greater of fair value less costs to sell and value in use which requires the use of various judgments, estimates, and assumptions.

 

  Useful life of intangible assets – The Company estimates the useful life used to amortize intangible assets which relates to the expected future performance of the assets acquired based on management estimate of the sales forecast.

 

  Future purchase consideration - In a business combination, the Company recognizes a contingent consideration at fair value at the acquisition date. Contingent consideration classified as an asset or liability that is a financial instrument and within the scope of IAS 39 Financial Instruments: Recognition and Measurement, is measured at fair value with changes in fair value recognized either in profit or loss, or as a change to other comprehensive income (“OCI”). If the contingent consideration is not within the scope of IAS 39, it is measured at fair value in accordance with the appropriate IFRS. Contingent consideration that is classified as equity is not re-measured and subsequent settlement is accounted for within equity.

 

  Contingent consideration from an asset acquisition is recognized when: the conditions associated with the contingency are met; the Company has a present legal or constructive obligation that can be estimated reliably; and it is probably that an outflow of economic benefits will be required to settle the obligation.

  

  ii) Critical accounting judgments

 

Information about critical judgments in applying accounting policies that have the most significant effect on the amounts recognized in the consolidated financial statements are, but are not limited to, the following:

 

  Deferred income taxes – judgments are made by management to determine the likelihood of whether deferred income tax assets at the end of the reporting period will be realized from future taxable earnings. To the extent that assumptions regarding future profitability change, there can be an increase or decrease in the amounts recognized in respect of deferred tax assets as well as the amounts recognized in profit or loss in the period in which the change occurs.

 

  Functional currency - The functional currency for the Company and each of the Company’s subsidiaries is the currency of the primary economic environment in which the respective entity operates. The Company has determined the functional currency of each entity to be the Canadian dollar with the exception of Siyata Israel which has the functional currency of the US dollar. Such determination involves certain judgments to identify the primary economic environment. The Company reconsiders the functional currency of its subsidiaries if there is a change in events and/or conditions that determine the primary economic environment.

 

  Going concern – As disclosed in Note 1 to the consolidated financial statements.

 

73

 

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

None than specifically apply to the Company as evaluated by management.

 

RELATED PARTY TRANSACTIONS

 

Key Personnel Compensation

 

Key Personnel Compensation

 

Key management personnel includes those persons having authority and responsibility for planning, directing, and controlling the activities of the Company as a whole. The Company has determined that key management personnel consists of executive and non-executive members of the Company’s Board of Directors and corporate officers. The remuneration of directors and key management personnel for the six months ended June 30 31, 2023 and 2022 are as follows:

 

   2023   2022 
Payments to key management personnel:        
Salaries, consulting and directors’ fees  $667,582   $851,262 
Share-based payments   438,008    1,792,129 
Total  $1,105,590   $2,643,391 

 

Other related party transactions are as follows: 

 

      (in thousands) 
Type of Service  Nature of Relationship  2023   2022 
Selling and marketing expenses  VP Technology/VP Sales International  $182   $152 
General and administrative expense  Companies controlled by the CEO, CFO and Directors  $486   $699 

 

C. Off-Balance Sheet Arrangements

 

The Company currently has no off-balance sheet arrangements.

 

Additional Information

 

Additional information relating to the Company can be found on SEDAR at www.sedar.com.

 

 

74

 

 

EX-99.5 6 ea183026ex99-5_siyata.htm PRESS RELEASE DATED AUGUST 14, 2023

Exhibit 99.5

 

 

 

 

N  E  W  S       R  E  L  E  A  S  E

 

 

 

Siyata Mobile Announces 180% Increase in Revenue for Second Quarter 2023

 

Revenue of $2.7 million, up 180% year-over-year and 50% sequentially

 

Company to host conference call at 9 a.m. ET on Tuesday, August 15

 

Vancouver, BC – August 14, 2023 -- Siyata Mobile Inc. (Nasdaq: SYTA, SYTAW) (“Siyata” or the “Company”), a global vendor of Push-to-Talk over Cellular (PoC) devices and cellular signal booster systems, announced its financial results for the three months ended June 30, 2023.

 

“Growth continued to accelerate in the second quarter with a 180% year-over-year increase in revenue on strengthening sales of our mission-critical PoC (MCPTT) SD7 solution,” said Marc Seelenfreund, Founder and CEO of Siyata. “Adoption of our critical communications devices is expanding. We have received purchase orders for SD7 handset and its accessories of more than $5 million since the start of 2023, and our resellers also anticipate an increase in demand. Just as important, the increase in orders reaches beyond emergency services to include education, healthcare, industrial and enterprise use cases among others. Given our performance in the first half of the year and our expanding sales pipeline, we are increasingly optimistic that 2023 will be a strong growth sales year for Siyata.”

 

Key financial highlights for the three months ended June 30, 2023:

 

Revenues were $2.7 million compared to $970,000 for the three months ended June 30, 2022. This increase of $1.7 million, or 180%, was due mainly to sales of the SD7 in Q2 2023 of $1.9 million.

 

Gross profit of $804,000, or 29.7% of revenues, compared to $109,000, or 11.2% of revenues for the three months ended June 30, 2022. The increase in gross profit dollars and margin was mainly due to selling more SD7 Handsets which are at a higher gross margin compared to fewer low gross margin legacy devices last year.

 

Net loss was ($2.3) million as compared to a net loss of ($4.3) million in the same period in the prior year.

 

Adjusted EBITDA was ($2.0) million compared to ($3.4) million in the same period in the prior year, an improvement of $1.4 million. (See reconciliation with IFRS below).

  

Liquidity and Capital Resources

 

As of June 30, 2023, the Company had a cash balance of $2.0 million and working capital of $3.7 million compared to $1.9 million and $1.6 million, respectively, as of December 31, 2022.

 

In June 2022, the Company issued 50.0 million common shares at a purchase price of $0.045 per share in a public offering for gross proceeds of $2.25 million. Subsequent to June 30, 2023, the Company issued an additional 51.45 million common shares at a purchase price of $0.045 per share in a registered direct offering for gross proceeds of $2.3 million. Also subsequent to the end of the second quarter, the Company effected a 1-for-100 reverse stock split.

 

 

 

 

Conference Call Details

 

The Company will host a conference call at 9 a.m. ET on Tuesday, August 15, 2023 to discuss its second quarter 2023 financial results. Following management’s formal remarks there will be a question-and-answer session.

 

Date: Tuesday, August 15, 2023

Time: 9 a.m. Eastern Time/6 a.m. Pacific Time

North America dial-in number: +1 (888) 506-0062

International toll-free dial-in number: +1 (973) 528-0011

Access Code: 642415

 

A replay will be available until August 29, 2023. To access the replay, dial +1 (877) 481-4010 or +1 (919) 882-2331. When prompted, enter Passcode 48862.

 

The call will also be available over the Internet and accessible at: https://www.webcaster4.com/Webcast/Page/2988/48862.

 

About Siyata Mobile

 

Siyata Mobile Inc. is a B2B global vendor of next generation Push-To-Talk over Cellular devices and cellular booster systems. Its portfolio of in-vehicle and rugged devices enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to increase situational awareness and save lives.

 

Its portfolio of enterprise grade and consumer cellular booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for the maximum cellular signal strength possible.

 

Siyata’s common shares trade on the Nasdaq under the symbol “SYTA” and its previously issued warrants trade on the Nasdaq under the symbol “SYTAW.”

 

Visit siyatamobile.com and unidencellular.com to learn more.

 

Investor Relations (Canada):

 

Kin Communications

1-866-684-6730

SYTA@kincommunications.com

 

Investor Relations (United States):

 

Brett Maas

Hayden IR

SYTA@Haydenir.com

646-536-7331

 

Siyata Mobile Corporate:

 

Glenn Kennedy, VP of International Sales

Siyata Mobile Inc.

glenn@siyata.net

 

Forward Looking Statements

 

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Siyata’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Siyata could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Siyata’s filings with the Securities and Exchange Commission (“SEC”), and in any subsequent filings with the SEC. Except as otherwise required by law, Siyata undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites and social media have been provided as a convenience, and the information contained on such websites or social media is not incorporated by reference into this press release.

 

-- Tables Follow --

2

 

 

Siyata Mobile Inc.
Unaudited Condensed Interim Consolidated Statements of Financial Position
(Expressed in US dollars)

 

   June 30,
2023
   December 31,
2022
 
ASSETS        
Current        
Cash  $2,026,640   $1,913,742 
Trade and other receivables   2,455,711    1,574,628 
Prepaid expenses   262,481    173,504 
Inventory   2,505,957    4,092,550 
Advance to suppliers   588,970    155,852 
    7,839,759    7,910,276 
Long term receivable   142,838    150,185 
Right of use assets   770,840    887,137 
Equipment   190,706    207,402 
Intangible assets   7,633,427    6,987,531 
Total assets  $16,577,570   $16,142,531 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current          
Bank loan  $719,623   $- 
Accounts payable and accrued liabilities   2,742,429    3,078,650 
Deferred revenue   -    149,600 
Lease obligations   329,433    303,788 
Warrant liability   307,381    2,734,804 
    4,098,866    6,266,842 
Lease obligation   484,298    635,217 
Total liabilities   4,583,164    6,902,059 
Shareholders’ equity          
Share capital   82,706,883    73,312,866 
Reserves   14,218,932    13,647,399 
Accumulated other comprehensive loss   98,870    98,870 
Deficit   (85,030,279)   (77,818,663)
    11,994,406    9,240,472 
Total liabilities and shareholders’ equity  $16,577,570   $16,142,531 

 

3

 

 

Siyata Mobile Inc.
Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss
(Expressed in US dollars)
For the three and six months ended June 30

 

   6 months ended
June 30, 2023
   3 months ended
June 30, 2023
 
   USD   USD   USD   USD 
   2023   2022   2023   2022 
                 
Revenue  $4,513,354   $1,802,502   $2,710,717   $969,528 
Cost of sales   (3,212,347)   (1,438,778)   (1,906,227)   (860,855)
Gross Profit   1,301,007    363,724    804,490    108,673 
                     
EXPENSES                    
Amortization and depreciation   855,139    459,924    453,499    335,419 
Development expenses   85,450    263,370    31,465    140,054 
Selling and marketing   2,041,168    2,208,726    1,037,803    1,163,675 
General and administrative   3,095,812    3,510,661    1,703,382    1,851,582 
Inventory impairment   -    303,316    -    238,980 
Bad debts   10,148    63,285    10,148    70,643 
Share-based payments   571,533    1,939,035    260,705    1,126,300 
Total operating expenses   6,659,250    8,748,317    3,497,002    4,926,653 
                     
Net operating loss   (5,358,243)   (8,384,593)   (2,692,512)   (4,817,980)
                     
OTHER EXPENSES                    
Finance expense   75,349    45,726    41,251    18,739 
Foreign exchange   (78,599)   19,168    (78,762)   106,828 
Change in fair value of convertible promissory note   -    3,250,848    -    570,391 
Change in fair value of opening warrant liability   -    962,350    -    - 
Change in fair value of warrant liability   1,856,623    (5,444,935)   (321,384)   (1,209,850)
Transaction costs   -    965,247    -    - 
Total other expenses   1,853,373    (201,596)   (358,895)   (513,892)
Net loss for the year   (7,211,616)   (8,182,997)   (2,333,617)   (4,304,088)
                     
Other comprehensive income                    
Translation adjustment   -    1,518    -    25,986 
                     
Comprehensive loss for the year  $(7,211,616)  $(8,181,479)  $(2,333,617)  $(4,278,102)
                     
Weighted average shares (before the 100-1 reverse split)   68,257,292    13,805,757    77,394,214    14,635,152 
Basic and diluted loss per share (before the 100-1 reverse split)  $(0.11)  $(0.59)  $(0.03)  $(0.29)
                     
Weighted average shares (after the 100-1 reverse split)   682,573    138,058    773,942    146,352 
Basic and diluted loss per share (after the 100-1 reverse split)  $(10.57)  $(59.27)  $(3.02)  $(29.41)

 

4

 

 

Siyata Mobile Inc.
Reconciliation to Adjusted EBITDA
(Expressed in US dollars)
For the three months ended June 30, 2023 and 2022

 

   6 months ended
June 30, 2023
   3 months ended
June 30, 2023
 
   USD   USD   USD   USD 
EBITDA  2023   2022   2023   2022 
Net operating loss   (5,358,243)   (8,384,593)   (2,692,512)   (4,817,980)
addback                    
Amortization and depreciation   855,139    459,924    453,499    335,419 
Share based payments   571,533    1,939,035    260,705    1,126,300 
                     
Adjusted EBITDA   (3,931,571)   (5,985,634)   (1,978,308)   (3,356,261)

 

- END -

 

 

5

 

 

GRAPHIC 7 ex99-2_001.jpg GRAPHIC begin 644 ex99-2_001.jpg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end GRAPHIC 8 ex99-2_002.jpg GRAPHIC begin 644 ex99-2_002.jpg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end GRAPHIC 9 ex99-2_003.jpg GRAPHIC begin 644 ex99-2_003.jpg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end GRAPHIC 10 ex99-2_004.jpg GRAPHIC begin 644 ex99-2_004.jpg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ex99-2_005.jpg GRAPHIC begin 644 ex99-2_005.jpg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end GRAPHIC 12 ex99-2_006.jpg GRAPHIC begin 644 ex99-2_006.jpg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end GRAPHIC 13 ex99-2_007.jpg GRAPHIC begin 644 ex99-2_007.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHK-U75ETV6UC,9=KA]H]!T_QH TJ*Y:Q\5/,DC31Q';>- M;@(PS@=^M=30 4444 %%%% !1110 4444 %%%% !1110 4444 %,,L8ZR*/Q MKSCXRZA=VF@64%M.T23S$2[3C< .!].:\,DDE;[TA/UII ?6YNK<=;B(?5Q2 M?;;3_GZA_P"_@KXSOV8S*I[#.:J@$]Z+ ?:OVZS_ .?N#_OX*RM9O]!E\J&\ MNK%Y0RLBR.IQR,GVZ?I7Q\5..OZ4PIG_ /518#ZLM+CPY;RRO>3:<,7\SH69 M"0">"/:NJ&J:>0"+^U(/(/G+_C7Q1Y8IVWWHL!]J_P!J:?\ \_\ :_\ ?Y?\ M:3^U]-_Z"-I_W^7_ !KXKVGUHPP.\%7-UIWC72'MYFC+74<;;3CU7B\_X *HYH 0^E)BE-)0 F*,4M)F@!:0] M*,TA/% &Y"/W"?[HK7\,K_Q5NC_]?L/_ *&*R81^XC_W16QX77_BK-'_ .OV M'_T,4Q'U51116904444 %%%% !1110 4444 >9_&09TC3?\ KNW\A7CF*]C^ M,IQI&FG_ *;M_P"@UX\.:N.Q+,#5_P#C]_X *SS6AK/_ !_?\ %9^"3@ D^E M Q#3M->&9" \,JDG #(1D^E #,T9ITEO/$0)()4 M+' #H1D^@S2BUN?E/V>;YCA?W9Y/H..30!'0>E2FUN1&TAMY@BCYF,9P/J:A M)XH Z" ?N(_]T5M>%_\ D:](_P"OR'_T,5C0?\>\7^Z/Y5L>%_\ D;-(_P"O MV'_T,4Q'U11116904444 %%%% !1110 4444 >9_&49T;3?^N[?^@UX]T%>Q M?&3_ ) VG?\ 7=O_ $&O'1TJX["9@:Q_Q_?\ %4[225+V!H&59A(NQFQ@-GC M.>,5M?\?W_ !74^ M'YHX-(5YI$C0'[SL *QK; ;N!1@4UI$6,R%U"8SN)XQZYIJR))&)(W5D/(93 MD'\:Y0).*4"HX98IEW12(Z@XRK C-+'-%*[+'(C%3A@K D?6@![*-IKRW5!B M_E^I_F:]0,T1=HA(GF 9*;ANQ]*\QU8?\3&7ZG^9K>CN,U;?_CWB_P!P?RK; M\+?\C9I'_7Y%_P"ABL:W'^C1?[@K:\,#_BJM)_Z_(O\ T,5U"/J6BBBLR@HH MHH **** "BBB@ HHHH \V^,7_(%T[_KNW_H->.'H*]C^,7_(%T[_ *[M_P"@ MUXZ:N.PF<[K7_']_P 4]WM+O2;>)[B-987+>7,K%&R.^*9K0_P!.'^X*S34R M5P.GDN].;P_%IXU &2-@V=C!6Y)V^PYX^@IEM>:=%HEU8&_V-<;L%$;$>0!@ M<>W/U-T7^X/Y5L^&/\ D:])_P"ON+_T,5BVQ_T:+_<% M;'AD_P#%5:3_ -?<7_H8K01]34445F4%%%% !1110 4444 %%%% 'FWQB_Y MVG?]=V_]!KQW->P_&/\ Y NG?]=V_P#0:\: /3CH/@1+_'VRW"BU+G-W MN3S.5VX_)OK[5%>:#X'CLD(G#/%/)%MMKQ6DDBW2;)6R<=D_ GBO-"!CI32! MZ4AG6Z[IWAZV9H=*DADS%/AC<;SN6;:F"?5!N_$U4:/1UNI(VCMF5YBL3+(? ME4+GYCG !; _.N<_"EK6-3E6QA.DY.]S=OTT:'3W$2(URY(7RF+;&^7/.?N_ M>'O6%2"EI3GS.]BJ<.16O&_\ MD9]*_P"ON+_T,5BVY_T:+_=%;7AG_D:=*_Z^XO\ T(51)]5T445F4%%%% !1 M110 4444 %%%% 'F?QGXT33O^OAO_0:\9%>R_&CC1--_Z^&_]!KQ<-5K81C: MQ_Q^C_<%9QK0U8_Z9_P 5G4 (:8:>:8:0QM%!I* %H!I** .@MS_ *-%_NBM MGPTQ7Q1I1!_Y>XO_ $(5B6Y_T>+_ '16OX=;'B72S_T]Q?\ H0JA'UE11168 MPHHHH **** "BBB@ HHHH \Q^-)QHFF_]?#?^@UXKFO:/C6<:'IO_7PW_H-> M* U2$9.J_P#'V/\ <%4#5[5#_I?_ 50-,!#332DYI#2&---IQ%)B@!,T4M M)0!MP'_1X_\ =%:V@-CQ%IA_Z>HO_0Q6/ ?]'C_W16IH)_XJ#3?^OJ+_ -"% M,1]=T445 PHHHH **** "BBB@ HHHH \N^-W_("TS_KX;_T&O$5->V?' XT/ M2^?^7AO_ $&O#]X!ZBJ0C/U,_P"E_P# 15$U;U!LW.>ORCFJ1- P)HIN?:DS M[4 .(I*3)]#1N/H: #%)BEW>QHS[&@#4A.((_P#=%:>A'_BH-._Z^HO_ $(5 ME1-^Y0'^[6GH)+>(M,5>2;J( #_>%,1]@T445 PHHHH **** "BBB@ HHHH MR/$7AK3?%&G"RU*)F16W(Z'#(?4&N+;X)>'#TO-1'_ T_P#B:]+HH \JG^ _ MA^<@G4M1&.F"G_Q-0?\ #/WA[_H*:E^:?_$UZY10!Y%_PS[X?_Z"NI?FG_Q- M9VJ_ +3((UEM=9NDC! ?S45CR<#& /45[=7->+9M01;"*T9DBDE_>LL0<\8* MC!^A_*@#R&U^"-I>3W$46LSJ8;QK4;XQ\VU0Q/Y$UTR_L^>'0@W:GJ1;')#) MC/\ WS6A'>:LGVV6T=EF74V<*+<'S"5 YST^E>FCI0!Y%_PSYX=_Z"FI_FG_ M ,32C]GSPX.NIZF?^!)_\37KE% 'EJ_ GPX/O7^I-_P-!_[+6KH?PC\-:%JL M&HQ_:KB:!M\8G<%5;L< #)%=[11< HHHH **** "BBB@ HHHH **** "BBB@ M HHHH *" >HS110 Q(8HRQ2-%+'<2% R?6GT44 %%%% !1110 4444 %%%% '!1110!__V0$! end GRAPHIC 14 ex99-2_008.jpg GRAPHIC begin 644 ex99-2_008.jpg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end GRAPHIC 15 ex99-2_009.jpg GRAPHIC begin 644 ex99-2_009.jpg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end GRAPHIC 16 ex99-4_001.jpg GRAPHIC begin 644 ex99-4_001.jpg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ex99-4_002.jpg GRAPHIC begin 644 ex99-4_002.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# $! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_ MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P 1" &7 ?D# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#^_BBBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\I^,_Q< M\"_ /X8>-OC#\2M1GT;P'X TB37O%&IVUC=:E>WH>.O 8>.+ MQ^!PLY.,,1C<+0G*/Q*-:O3I2<=]4JC:NGJEN'Q4,/6K)=&Z5 M.517\O=U\CQ./_@N9_P3W91(GCGXBLCHCJP^$GC4@K(H=&!&G'(92&''((QF ME_X?D?\ !/;_ *'SXC?^&C\;_P#RJ_'_ .OQ7\L&FLW]EZ7D8VZ=IX)!&7/V M*'DX7''O@CI5W=[^O<=CCLO?M[5_3E+P&X>G3C)9EFDW*\Y.,H4XJ4U&5ES4 M_>WUDM.ED?@TO%C/.:?^PX&"4YQ7/3G4E*,)2BI/EG[J:5U?XMT?U)?\/R/^ M">W_ $/?Q'_\-'XW_P#E51_P_(_X)[?]#Y\1O_#1^-__ )5?YQ],_P MN[_: M_P _]\4;O]K_ #_WQ5_\0%X?6^89K_X/I?\ R O^(LYW_P! N7?^$]3_ .3/ MZDO^'Y'_ 3V_P"A\^(W_AH_&_\ \JO\Y^N#_A^1_P $]O\ H>_B/_X:/QO_ M /*JOY;=W^U_G_OBC=_M?Y_[XH_X@-P]_P!#'-/_ ?2_P#D _XBSG?_ $"Y M=_X3U/\ Y,_J2_X?D?\ !/;_ *'SXC?^&C\;_P#RJ_'_ .OQ1_P_(_X)[?\ M0]_$?_PT?C?T_P"P5^'U]N:_EMW>_P#G_OBDW^Y_,?\ Q-/_ (@'D'_0?FO_ M (.I?_(#_P"(KYY_T"9?_P"$]3_Y,_J3_P"'Y'_!/;_H?/B-_P"&C\;_ /RJ M_'_Z_%'_ _(_P"">W_0]_$?_P -'XW_ /E57\MF_P!S^GK_ +GX_3WXI=WO MVSU'Y?I_\ )G]27_#\ MC_@GM_T/GQ&_\-'XW_\ E5_G'TR?\/R/^">W_0^?$;_PT?C?_P"57^<_7'\M MN[W_ %!_DE&[_:_S_P!\4O\ B O#_P#T,,U_\'TO_D!?\19SO_H%R[_PGJ?_ M "9_4E_P_(_X)[?]#W\1_P#PT?C?_P"55'_#\C_@GM_T/GQ&_P##1^-__E5^ M/_U^*_EMW?[7^?\ OBC=_M?Y_P"^*'X"\/K?,,U7_<>E_P#(!_Q%G._^@7+O M_">I_P#)G]2/_#\G_@GN.?\ A._B/^'PC\;@\^_]E#Z=>M?0G[,?_!2K]E#] MKGXBW_PM^"_B[Q+JGC/3/#-UXPGTWQ!X)\0^%XYM L[VVTVZN;2YU:U@AG>W MN[RV1H5;>(Y/,PP(-?QU;O1B#TR,$C/&>4QQ7Z2?\$9LM_P4-U(_+EOV8_%Q M;"XRW_"9^$<$8( 8CJV.?QKYCC'P?R;A[AS-,XPV/QU2K@J,*D:-:<9QJ/VL M%:\8*R5]KIW2>I[O#?B+FN#_/_P#54E-48SSG)/3M_P#7IU?SVM;NUKN_WI;^?<_95UUO=M_\ M-Y!1113&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%?G1_P %:3C_ ()R_M:?]DT0_EXET#_&OT7K\Y_^"M&&_P""<_[6HZ?\6S7G MZ>)= _PKT\E5\YRA+=YGE_\ ZF8;_,X,T_Y%F9=O[/QM_P#PFJG\>VG#&EZ9 MDCG3]._6R@ZU9/&W.<,"RD MD*VUPN/O,A(W*N3@Y&1DCN?@MX"/Q4\<_"[X M;C7+#PTWCC5?#GAS^WM3P;/2_M\$*_:GC+Q">1XP5LH#+"MU>206S2Q>;O'L MFK?"3P%>_$Z^^&OP^T[XYZMK6BZ)\1F\0>&?&GASPIX.\7Z;KO@K2[S4]-U5 M+=K^?3I/#+6EC=ZEK%I.D&LI81%+&:]NY(G']W5L^P&!JT-6.'=2I6]VE&/M$U=RT2YGRQM)_P CPRS%8N,\31BY4XXB-!1BU*3J M34JD;TT^=1:T]HTH*34;\SL?,9&,>AR 1@@LOWE!&067*[QU!8 \YPE>G'X. M?$E=?L/"[>&'.NZG\/;?XJVT*ZEI[65U\/I/#[^)?^$GBU#[0UM)I\.E)+<2 M;YA=PRN+&:(76R-NIU;]FOXRZ%I>AZYJOA;3(-(USQ!X?\,_;X?&'A6_C\/: MSXI"OH-GXU2PU:X?P8^J0,T]I)XA%C!(D;1F59V2-M9Y_DT%3MF6#BJL%.G& M5>,IU$X5*BE!7RW M3=]$G>]M3PBC_P#6!W..I ZD#NWW0>"<\5];?$_]CKXG_#[XM>(_A9I]QX3\ M2_V#9IJH\3R^-_!/A[2AH^VRADO-=;4_$:P^&9_[2OH]/M=/U2Y2\O0%OH(V MLY4E/@FM?#KQ7X1^(47PV\;:/=>&?$D?B#0]!U73[H0SR6IUN]L(+>^AEADD MM=0L9[*_BO\ 3;F*22TO(GAFB=XI5-&%S_*\;357"X_#UD\&\P4(MJM]45-U M75]C)1JV5--APY/1328/RY!^8E5P-P8]1@KD?,OS#G MD# RV%/V3\>?V2;KX7_'GP=\'_A_X@O/B!I/Q"U1=!\(^*-1L8+"YEU_3-=N M?"OC72=9M+(^1#)X.U:SEU&>5)59=$>*]D$2/DP_%K]E#4]"^+Z?#7X(:AJ7 MQ5TB3X7^%/BE/XKU1=(\*:?IOA[Q"ERL^JZYJMW>P:)HFC1W5O')875Y>KYB MS)"BLV2.&CQCP_76#<,9[N/PM7&8>4Y3I1>'H3C3J2JK8I?3D$$D!LKM.W(;!)'0JP]\$KDK>#)='O; MR^74[34(["/[/+<7-VJ02*/.;WX!^/\ PU=?$O0O%_@OQ GB'PA\'[OXMZ6- M"UCPS?: /"\-UIT:^+]0U9;N:S\1>"3:W$MM%+X6N;C4)-2> H1 EP:UCQ3D MLJV*H4\52J5<-"A4]E&O&4JD,1[/V4Z*4FJT/WT%5E3O[-W4TK-A+(\R5*C. M6'K0C4SE>-F].[2/!^^.X)!!X(Y^4D'G#KAU)&"K#.# MD!"0,Y. !DG!.!G!)P#@#C<>@R"3CFOK'XB_LT:K:?$K0O /PFL=1\0Q77P1 M^&7Q8\07_B'6-'TG2O#8\8^&-/U36[W6?$&JSZ9H^A:!;ZI>0VEE+?W"OON; M>W$TTKJJ^(ZE\-_$WA;XDZ3\-?'.E7WA;7+GQ'X7T>^@D:UNWMK+Q/J&GVUI MKFGW%M-B;T?1]G;Q&OTI_P"",?\ RD-U'_LV3Q;_ .IEX2K\W+BWFM+FYL[J*6VN M[2>:UN+6XC,4\-U;2O#O[, M7BYL_3QIX17'XYS_ $KYKQ0E&7 F?2C)2B\-3Y9Q?-&7[ZG\,EHUJG==&GLT M?1OSI_P""M/\ RCF_:T_[ M)HB_@?$N@Y'ZUZF2.VL:QX4L(-6\0:5 =.B-O>Z=IUQ%M1N#>2:KK]Y)+I\NH7$-ONMH M<5^9VG+_ +'<(QNK M>[TJXNE\!0ZM(?+:VOWM[191;%1T'Q;_ &@O@!J?P0^+'PS^%=O)IECX[UWX M,Z[X*\#V?PCT?P/:^#-*\"ZE%>Z]X>\7>.[>ZNM6^(^MW5R]W?P^(-6DGLYF M<) +>XFF6/\ .HRN553)(0@(1#(YBC!M7Q4*D<=B,92AAJ]:&'P]*K-NC@Z-*)GRSBE5JJ: ME)*ZYH1?,]6?HOK?QA_9AUWXQ_&#XI_VC??VW\6?">@ZAX5USQ?\%;'QWIWP M=\<:<-&L-=TV]\#:MJ+:+\09M;T>RN;?1?$YBEM="F>%/LKF::6+Q7]H_P", M7@WXJ_M)VWQ7\*?VNOA&(?!^)QJVDP:+J8'@31_"UAK0?1;%I;.QW7&D700>0=W!Y^]G68#%PQD<3F%2<,$\K]G6KPJ4/J"PJPT%&FJ<'&:4() MIO5OZKXM\,>%O&O[.'[.OPX MNO'.G^&'UB_\.>/_ ('_ &R>:RU;PT+FVN_$'@?69+WRKF2WN!+-=+!=>1*( M"Q_/[)]?X2ON02"'*X7C-UZE2,_''BSQ1!XI;5+[1EN+F7PMX1BNI+O3]/@NY[B>SLK97EB268QI\% M;B6+'[Q)8GN6XPQQU9",QL>8R24*Y.3)_GUYY(P3SW/4GKGYNI)HI\ Y+3G* M:GCHI\DE"&*2OB$H^UQDJCH^T5:LXMNG%JA'GERTT[6*G$V/FJ:4,-'E]HKQ MIS4XQJ3E.2IR]HXJ"TBHN#E9O]YW_2VR_:Q^&A\2>-].%SM3K=VGFPNT\!CL=1A@+# M8/E;XH?%:+QI\;O"'C:_\6W7C?0O"5U\-K"VU]O FF_#ISX>\':GI]V^GZ-X M(TF1[;3=.TZ&&ZAT*"5TGNH5@,JP^8B+\] D'(X]<< X8/R!@'Y@#SG. #P, M4>O^UDM[YSU]>O?IAU6 M]]C[B^,WQ^^'GCS0/B5INB2ZZ9O&'[;I_:!TY;[3)K6";X?C2FM4?4 )&A77 M8KHJT>BSB1XWR8W# ,.F^*/QK^ ?QT3XJ>%O%_B3QYX#\/W/[2>M?'CP/XET M;P2?$ESXHTOQ#X8TSP_?^&][[MQYRQS2=#D?+Q@;?E ^;?P!@*0_S C!5B2I M!)SS+@/)82A4I/&4ZE.=*4*D<5%3BJ*](UK18M/@T&*'6'C\-)IVLP75R/$-QJFE%KW6Y_+MUTW4&:R/F!@X^ M_/\ @C)_RD/U#_LV#QAVQ_S.W@_MV^E?FKZGN223D\YP:<[ MOS5MV?UVK_%_O'^E.IJ_Q?[Q_I3J_B6.WS_1']1+9?/\V%%%%4,**** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH#_ (8*_.G_ (*T_P#* M.7]K3_LFL?\ ZDF@'^7-?HF[* 02 3T!(R?7 ^AK\_/VWM$?]H_P1XE_8@\' MW97Q=\:?#BOXX\20P_;K/X0?#6+5+:YG\8ZY;AQ#<:EK5]IZ:/X-\-RSQ3:W M=O?7DA33=/N6'H91.-/,\!7EI1PV,PV)KU'HH4A1@Y6YYUJ,X)7:ZF_]@_3_ /TB MAJU7[AQ_\$ /%T4,,$7[;/B01P0I#%_Q:?PT=L<> ?^)E@D@8VG&0?3BG?\ M. _&0Y'[;7B//_9(_# _4:CFOZTI>-' T:<(/%XQ]>"ZMKJ^Y^'5%?N-_PX$\:'_F]KQ%_X:;PV/Y:E M1_PX$\:#_F]KQ'^/PF\-G^>I5I_Q&G@3_H,QO_A'/_,G_B&/%7_0/AO_ IA M_F?AS17[B_\ #@3QH?\ F]KQ'_X:;PV/Y:E1_P . _&7?]MKQ'_X:3PR?U.H MY/XT?\1IX$Z8S&?^$<_\P_XACQ5_T#X?_P *(?YGX=45^XP_X("^,^,?MM>( MB.G_ "23PU_34N/3C''UKS[QS_P0^\7>#+WX?6;?ME^(+QO'GC[3_!(9OA5X M?B%B+[1]=UC[=&J:CM:6%M&\A ^%9;E@3BJAXS<$5)0A3Q6,DY*3;^J32BHJ M4GZZ1?\ 5D9S\->)Z<92GAZ"2<4OW\'S.4HQ6SNM9+^KGX]45^XP_P"" ?C3 M/_)[7B+\?A/X;Q^?]IC^=!_X(!^,^_[;/B(?3X3>&F_1M3(_'&?SJ?\ B-/ MG_09C/\ PCG_ )E_\0RXJ_Z!\/\ ^%,/\S\.:*_<7_AP'XS'3]MKQ'_X:7PT MO_H.I<_C1_PX$\9_]'M>(_\ PTWAS_Y94?\ $:>!.N,QGRPD_P#,?_$,>*O^ M@?#_ /A1#_,_#JBOW&_X<"^-/^CVO$7_ (:7PW_\L:7_ ( M]>N?L_?\$Z?%/_!-WXJC]JV[^+>L_M ^'[#PEJ/@#XDZ.?!=GX>UWPA\/];O M].U+4/'VA1:9>79U_P#X174-,M[[7M+:$WLOAU]2N;!Y;FPCMY?E>-?$[A/B M/AK,\FRS%8F>.QU.%+#0J89TX.I&I&HHSG*24/:*+A3>O-4M%VNF>]PQP/G^ M29W@LSQE"DL-A)RJ5W"M&;5*4900>A!_&OY@491O&2M*,FI+M):-/1.Z:LTTK.Y^[1:<8N+4HM M)J47=-/5-/JK,6BBBF4%%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(2 " M20 !DD] *6D;H?H>^.WKQCZY% ";UZY[D'KP0<$'TQWSTZG@TC2QKRSJ, DY M/0 9)/T')K\S?V@/VW_BE\&_VU_V1OV9;+]G>>Z^%/[2?Q \0_#K4?C[XB\9 MZ3IL$'B/2OA+XO\ B@=,\ ^ ]/2^U[Q FGQ>%DT[Q-X@\2'P_I4%UJ$5II$6 MKRPW+P_-G[0'_!4[XT> O$W[7GCGX,?LU^$_B;^RS_P3X\7:-X,_:M\=^(?B M3J7A+XG:UK:Z+X?\8?$YO@/X/M?"VMZ!X@MO@WX,\2Z9JGB1O%NO:%)XEU*& M_P!$T%!<6'FS '[B"5,9+8''W@5(R0!D'&#DC@\X(/0@T&6,#);C.!P3D@$G M&!S@ DXZ '/2OPF^,_\ P5H^*OAV?]ISXR_ _P#9W\(_%;]C#]A[Q%X0\._M M'_$S6_B/J7A;XG^)I]:\,^$_''C[5/@9X(M/"FJ:#KNE_"/P3XXT+5O$*>,- M=T6]\27BZGH^B0I<69E?L9_^"R/PQT'XW^//#?Q"\%V7A']GSPCJ'QJ\*6?Q MB7QU:ZGXSD\1? KP%X9^(NO:EXE^$,6DV^I^'? _Q%TOQ+9:)\&]636M3UCQ MSXI?1]*MM#AD\3:4HF7PNV]M/7I^.X;_ *>O0_3?XY_%U?A7X>L#HNDGQ;\1 M/&6JP^%OACX#MY5@O?%_BVYC,L$3S_,^G^'M%A676?%VM.GD:/H5E)9T 6PTR)E633_" M7AFW(T3PCI"OY=AI5M',ZF\O+V2;PG]DOP_\3OB?;0?M6?M&^"!X!^*OQ%TN M^7X;?":]DFN[WX!_!;4[PWGAGPGKAEVQ1?%CQ1I:V&M_%N\M0GV+6I_^$2LI M#IN@9N?NY>@P !CCGGCCG@>E=4ZD(THT*+?+.*E7;TYY7O&'1\D'9V?Q5+R? MNQ@CDITISJ2JU[-Q;C22VA_>6K:DUH];>7T45S M6[OF?=I7\EHNFR.JU]VW\_\ *P4444679?.O0@GT!!/!%?.WQX. M=>_9YP>?^%]Z 3C) _XH_P <'.>A.#D+U//'!Q\A?!/]OGQOX_\ VPOVL?V> MOBU\ 9O@-X._9X^"?@;X[Z!XK\1^-]*\2>+_ !AX%\3Z_P"/M"G\1>(_#7A[ M[;I/@FTEA\":GJ>E:%+K.HZU_9K6]QK"6=Q.;"U^1O!'_!2_XB?$O7?V,OC' M^T/^SAX=^%/['/[5WC[Q9KW[+WQ/T?XG:EK'Q4\&ZMX2\ >.?&'P^U/]H+P- M+X6L_#&F:3\8/ .A>)=8T.'PEXHUN3PY<2Z7I^N"2XFDFBTH5%1KJ#A2Z#JPQC.>P')R3T X/6OP>^&O\ P5O^,=Q_PSS\:?CA^RUI M/P\_9&_;2M?B3-^S=XK\-^/M2\3_ !OTNZ\'> _$WQ-^'UA\9?A[/X:T[P]I ME[\+HAUS[+&-5 M.BKJ#R7ZZ1]O%Q_9BWTCW@LO)^TLTQ=CMT679?01_+_Z]5KB$2Q2Q/''+%+&Z2)*H>-T92KQRQGB2-U)61""' M0L"#N(JU2')'&.W7GC/(_$<9[=<'I1;JM'W6CWNK-6::>J:=T]59B<;JUW;M M>Z=U9IIWNFFTUM9GPWX?:3]DWQ[9^!;Z5H/V;/B=X@:V^&^H3DM9?!;XBZW= M-+)\-K^Y+$VO@/QKJ,LMSX&NI7BM] UVY?PP3';7NE!/MN.6-Q.!C)Q7+>.O!/AOXA>$==\%>,M,MM9\->)M.GTC6M.N@62XL[D M,-T_;4^-FG?MV>+O^"=_Q[^% MI\&Z%X-_9[\3_&CX&_'#QUXVT.?XB_'GX?\ A+XHV_PZBU+5? NBRW<.B/IM MC]KGO+O4=0_MW7;+2K?Q->:7IBZA+%'V59QQ-/VR5L3145B[?\OX:*.*2ZU5 MI'$I:-1C7LOWG-C2INC)TXVCAUK3C_S[O=NG'72G%_ GJKN.J4;?LKYB\X.< M$C !)R 3C@=>#QU)XZD4>8@ 8L,$;@?;&<_3_P"N.H-?A1\/O^"LGQ;\6:K\ M"/CIXA_9M\+>&/V ?VH?VD-2_9E^$?Q;D^)5_+\;M*UR;7?%'A+P%\6?B'\. MI/#4/A72OA?\3/%WA#4-/T.#2?&-_P"(]!T_5-#U76K<1W ?^"LGQ>\ M1ZE\!_CMXO\ V:/#WA7]@G]J'X_ZY^SI\'/BG;?$34=4^.VE^((]3\6>'?AW M\1?B%\,5\+)X MC_K_ (#3ZII]3H/W3\Q.N<#<%&01ECV&0,]"#CH00>AI0ZGOCDCD$=#CO]01 MZ@@C@YK\*/A]_P %FH?&_@GQMJMW\!);?X@:]X%^$_C3]E?X=>#?B'IOC_7/ MC-JWQ\\1^+_!GPL^$_C46.E:0/AI\6+36O!UWKGQ/\+2'6[;P1X!&K^)KC4I M4T&\C?\ :#P"_C:7P;X4E^)4'ANU^(LV@:-+XXL?!KW\WA2R\52Z?;2ZY:>' M)M5;^U;C1+34&N8--N]0*7=Q:10S3JC2>0H!W-%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4C %6!Z$$'ITQSUX_/BEI" 00>A!!^AXH _$G_@H!X+_ &W/B!^U M]^Q!X\^!?['D7Q8^&/[(7Q@U[XN:OXSNOV@?A5X N/',?CGX.>,OAC?^&M \ M,>*KJ/6=,U'PK?\ B>WU.XO]65-.U:SLI8M.D::5 /G/XU?L2_MW0#_@H_\ MLV_!KX9?#KQ%\#_^"GWQ'L_B3>_M >)OBKHNA:A^S(WQ2\"^#/ 'Q]\/^+/A ML^G3Z_\ $.;2K#PM>ZA\,+_P5<7$&I7NKP6VN?V3!9?:)/Z/O)CR" 1C< > M,-C=]G]=]/NUU\KG\T_Q2_X)^?MH^#/!/[??[$WP.\!?#WQ1^S+^WYXVT+Q- M9_M,>+?BII'AS4OV=/#GBGX;_#[X=?''3_&'PSNK&3Q1XXU&RTGP#=ZS\.+C MPM=RVMS>:Y'#K]QH]KIS3OZMKG[(.N_MD?&'6/B#\/\ P/X$^&?P,^ /PB@T M3]GKXL:KX>\/W7BW]KS]J?PCX*O_ G\(_C5\0WM89]7U#X%_LSZSI^DZOX" MT+Q'YT?C?Q\ECXL:"\T3PGH$5?IA\3M1O_VA?'NI?L\^%+N\M?AGX5>UD_:/ M\9Z3,\:7B3K'=6/P*T+4+:02QZSX@LY8;WXA7]BRW&@^%98M(,D6H:VT=O\ M8>D:1I^D:;I^E:98V>F:;I%I!INE:=IUO':6&G6%C$MM96EE:1*L%O;6L$<< M4$,*"*-(T100BFNAQC2I1E)7K5E&<8-V>'I)^[*2_P"?E;2\9?!#WDDYQMSQ MG*I6<8N]*BVG425JM9I7C%_\^Z/246^:5XMM1=_R]_X)@? 7]J#X%>'/BO;_ M +1-WXGT?3/%EW\+[CP=\/\ QK\8I?COXET;QOH7@6/2?CI\17\>O=Z@D6@? M&7Q\(O&&A>%A>I+H*1W3W.F:-<:BUA%^JZ#"J/84PPH1A@6Y!^8[CE0 ""P. M,8SC[N23C/-2C@ >E8=_/!FK-1M&K-N)8'V. >, =4^+-U-\2+KP= MI=P^I7UGXJL?'6G0:3H=DLNLZ5<1%M5C2(2+'XQ\*/V OVW/B!X(_8._8U_: M)\!?#[X<_L]_L#7OB^;6?CUX1^)FE^+-5_:0AT/X7>//@Y\%D\ _#^UL8?$/ MPZG31?&Z^*_B"_C658HK[1VTG18]1@O?.A_I,9%P62A<(2J5(0CU4V]M>6,I=NT7M;8B=3V4)3?1PBO+G<8]+=9 M>9^(_P"SQ^Q?^W)J\W_!-_\ 9_\ VB?AO\./ 'P5_P""9/BF]\97'QJ\-_$O M2_&5]^T_J/@'P)XH^%GP3MO!/P^TVTMO$'P[M)=$\1_\)1\1H_'#LQO+)=!T M5-22ZENXE\9_\$^_CMXN\-?$CXX^%/A#X?\ A3XPU?XV^']"\'?LH?"CQ1X6 M^$=]IG[&>F_$2/5?C-X4T3XH>&KG2=#\-_'C]K V=KXP^(/C!=9TPVO@_3?# M/PIAUW3K&QN[B7^B$0H.['''S$-QN+8.0<@$G&?NCA<#BE,*$;26(P >>H!S M@X R/;IVQBD6?*/[#GPY^-'PF_9<^%7P_P#V@O%5SXP^*7AS3=8MM7U*^UR3 MQ5J.FZ+<>)=:O?!OA/5?%\P\_P 8:OX,\'7.A>%=6\4REWUW4-(N-0\ZX$PN M)?K.HTB2/.W/(4_LN^#OC MCI?[0OPBOO&O@#5U^-$_Q'L/VA]*\$I<)K%UX;ET)WT76/AW+OUS6+:\GT[4 M+22UED,?]!I 88(_R01_(U&85SNRV>,'(R!U(SC)#-\S YR>/N\54*LJ,X5( MK6+OW79IK:46M'&2<6M))Q;3B<(U(RC*ZVLU=:Z]4UL?RK?LM_LJ?ML>-_AW M^S+_ ,$VOC)\/?AIX+^&?_!/[]K+3/B[\4OCY9_$?2;W6OBY\./!?B?QGX^^ M"^E^ OA/8VD?BCPSJ?CN[\4Z6VK>+==N6\-V.G^'=:M;*XU#4YI+&U]C^$O[ M"7[/M3\03OH%I8>'=1ETBXU&?58(;?] MJ_CQ\+O$]UJ>B?&GX.QVD/QI^'EEG74PM--^*?@JYD-SKGPJ\47.0%M- M2,7]H>%-5D$K>%_$]M:7\*"UGO8Y/2_A5\3_ U\7O!&C^-_##7<-KJ2W-GJ M&D:G#);Z[X7\0Z;,]KKWA;Q'I\FR?3/$'A_4HIK#4[2;#K+"LT3&WFBF?>O! M3@L52=ZC6E=^RY=>6E-1VC M?1KS][E=NREU=OQ1^+?[ _QS^)=S^TE\=/A[\+_"/P4\;VWCZV\+?LZ?!7P! MJWA;X(/ _ACQA<7$-_\ M+_A[-;:0FH:;JGB_Q1?1?IE^P;\+?C!\'OV>-(\$_&C4=3EUVU\;?$K5?"'A MG6_%\OQ#\1_#;X3Z_P".=9UCX7_"OQ)\1))[V7QYKOP\\(7>F>&]1\3F_OH[ MZ6S:&'4+Z"WCN9?LN.-"JMSD@,"6W$''8@D8Y[$@]3DY-*T*L5.7!5@W#8S@ MDA6'0IDD[2,9P<9 (YON^6J^3[=O*QU$M%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4'H>]%(QP">>G;K1:^G?3[P]-^@UF(4MD ;0*FM+2)FL[;4W@[GXS_%[3?A#X/.M2:==^(O$NM7UOX9\ >"- M,8-K?CKQMJ@DBT7PWI2.5"K+*OVK5=1D*6FCZ5!?:G=NL%HYKG_@/\(]1\"6 M>N^,?'VJ6_BCXT_$NY@USXE>*(D9[2":%"ND^"/"^\ V7@?P3:R'2- M%$;7 MDB7FMWJ-J.I7+#>C"-)?6:VJ5X8>G*S52HFK2G%[QCO*_P 4E&"T=1KDJRG5 M;HTI.,E95Y1TE3A):N+3T;M9?W9-]K]W\)_ACX9^$O@G2? _AB&=K'31-3QD\G'>E "C 'T&*6L93G4G.I/64Y-MO5R?5M]>G9=DDDEO3 MA&G"$(6481Y4DDE9=K>=_P"KW****1H%%%% !1110 4444 ,?I]3C^O]*^>/ MCQ_R'OV>1V_X7YX?_3PAXZ(_4"OH=^F1Z_\ U_Y@5\\?'C_D/?L\_P#9?/#_ M /ZB'CNNC W^LT_^O6)^_P"KUSEQO^[RT37M*%[_ /7ZF?15%%%ZN1/&';)' 7ANI'T'/.>>F,<9[5\7_ !2TC5?V?/'6 MJ?M#^"M/N]2^'_B#[,O[2'@;2[:2XF-A:1);VGQN\-:=%@OXC\)6J1P^.+&U MB9_$OA*-[W8VKZ/;O-]IDC< 6EU$TD<]K=0,)(9TPZD\#)I!(A&0OO^7M_D?7VYI@.HIN] M?\C_ #]?_K\4;U]_RH =13=Z_P"1_G_(^F3>O^1_G_)^N !U%-WK[_E1O7_( M_P _7_Z_% #J*;O7W_+V_P CZ^W-&]?\C_/U_P#K\4 .HIN]??\ *C>O^1_G M_(^F0!U%-WK_ )'^?\GZX-Z^_P"5 #JYCQ?XM\.^!_#>N^+_ !5JUGH?ASP[ MIEUJ^M:M>RB.VM-/LXC)-*Q)R[GY8H((PTMSK/NN/V:/A7XG9M$AE399?''XI^' M[J2(Z^X+*-1^&?PYU&)X=&0@V/BCQA;-J0-U8:/://M1A&HW*;M2@TIS6J4K M_ F].>5K1BWO=O2+9A6JR@E&"O5G\,-Y6U7-;?E7Q-]$N[1TWP7\)^)OB7XQ M?]I3XJ:7=:1J%YI]UI7P1^'>I1F.?X7_ ]U'RS+K6K6;?+!\2/B##';7WB) MRIE\/Z.MAX8MYE$>H^=]?J, 9ZXY_//]?K].E0)$RG(4+CD#@_-C:?IVV@?* M /0U8&<#/7O^OIWZ9[5E5JRK57-KEIP_=TJ:O[L5LU?IO[SUDVY-WDQTJ4: M*Y%K.?[RK4M\4GOJOE9=$ET2%HHI"0.I[9_#.*7ZZ&PM%,:1%^\P'.T>[8SM M'JV.W6EWKZYZ'(Y'-)-.UFG=76NZ3LVOGIZ@.HIN]??\O;_(^OMS1O7_ "/\ M_7_Z_%,!U%-WK[_E1O7_ "/\_P"1],@#J*;O7_(_S_D_7!O7W_*@ ?[I_#^8 MKYW^/'_(>_9Y_P"R^>'_ /U$/'=?0S."".?\GZU\\?'A@=>_9YZ_\E\\/9X/ M /@_QUR?;) )Z!F4$@LH/3@]<3"VO[O$;6_Z!Z_FGIOZ M'T711G_.#]/\_GTI"0!D_P C_G_/-1[$#OQDC&1CD=<8/0BE=7:OJE=KK9]0>F^E] MKCJ*0,#G':EI@<7XX\%^&_B'X8U_P1XPTB'6_#'B;3KC2]:TRY7,-U:70V[A M(,O%$'(."<-QR.F<]/7I^'7&*\6^,WP=L?B[X5CTK[?=>%O%F@:K!XL^'_CO2 MS&=9\$^-]-5CI.O6!./M-H>;'7='F*VFN:+F7>^.7-M]%7@OBA4VY7&/-[-O[2B MG=2:/:E?<."N3TYX/N._3TI]?.WP(^+U_P"/[37/!_CS3;?PO\:OAM=6VB_$ MKPI%N%H;B:*5M)\:>%FE)DOO OC6UB;5?#NHY=XG-WH]Z8]0TZY4_0J.#U(Y MY'./3V X[^_:LZM.5&HX3:[Q>Z=U=.,MG%K6,D[---/MI1J0JPYX6722TO%K M[,ENFNJ>J[$E%)D>H_,49'J/S%1==U]Z_P S2Z[BT4F1ZC\Q1D>H_,477=?> MO\PNNXM%)D>H_,49'J/S%%UW7WK_ #"Z[BT4F1ZC\Q1D>H_,477=?>O\PNNX MM%)D>H_,49'J/S%%UW7WK_,+KN+129'J/S%&1ZC\Q1==U]Z_S"Z[BT4F1ZC\ MQ064=Q^'/\LT77=?>A[["T4WNH69 M%,!PQQA0>N>^3E<=&RH^;&<=".<_Q%>-O^"XG_!0JP\<^.=-TOQG\,M-TK2? M&WBS2=*L%^&&C7?V+3-+UZ_T_3[9KNYF-Q=2Q6EO$LMS*0\TH:0JNX*/[=I0 M#P<_-[<=_P##I^M?YC'C_P#Y*)\1S_U47QW_ .I5JU?J_A1DF59UCLWIYI@Z M>,A1PV&J485(QE:I*K*#2YM%SK\B:/S_ $G\@"3^ )K]O? _"3N_["RQ+>SPK;2WL[5;-K M;3330_+WQ1G]],RK6ONZDTK=W=Z::N^Q^NW_ _/_P""C7_0_?#'_P -/H/_ M ,>H_P"'Y_\ P4:_Z'[X8_\ AI]!_P#CU?D2!D@!E(8@+R1N!(&\$\;0?O9P MRX)90!FCOCD9567<"K,"6&X+R54%>"^TL""H(&:(\#<)RER+(LK3Y/:>]A7% M_D+_ %HS^]O[2K7;LOWL_P#P+?X/[_PZK75'Z[?\/S_^"C7_ M $/WPQ_\-/H/_P >H_X?G_\ !1K_ *'[X8_^>'_P"/5^1-%'^HW"?_ $(L MK?33"M_=:L[K3=*WGJ@_UIS[3_A3JZM)?OI6ULUU_O+[S]=O^'Y__!1K_H?O MAC_X:?0?_CU'_#\__@HU_P!#]\,?_#3Z#_\ 'J_(KC\3TY4Y;. N K\BN,9Y [Y7Y@.@&T')=FPJJNX'>C;MA9E3/L?4$\9&<94'#%S]I*W MYGZ[?\/S_P#@HU_T/WPQ_P##3Z#_ /'J/^'Y_P#P4:_Z'[X8_P#AI]!_^/5^ M1-%'^H_"?_0BRSH_]T?5)_\ /[LQ?ZT9_P#]#&M_X,G_ )G[5_#'_@KE^W3\ M?OBI\*_@9\0_B%X0_P"$ ^,'Q(\%_#CQNGA;P#I7AKQ%<>%/%NOV>DZ_::3X MBLY&O=&NKS3+B>U%]9JMQ'%<3)$48I-'_:;X>\-Z+X3T32/#'AS3;'1?#WA_ M3[/2-%T?3H%M[+3M-T^%+>PLK6 K'#;V\<<:@')93(QRQK_ #B_V11G]K/] MEP_]7!?"?Z_\CCI0X/KS7^DB5^;.>X..V!C/X\\?_7K\,\5,JRW*,SR[#Y7A M:>"PV(PDL55H4HJ-/VRJ*ES]_U/@+'XW'X+&UL;7EB:U&O" ME2JS;V5?P:>?7.?IQR#GC^9>OZ.\.^% MN'LRX5P.+QV4X3%XF=3$1G5K4E)N,:LHQ5^:+NDK:W5OO/Q/C#/LWP6?8G"X M3&5:5&G"FU&,Y))R4962371MGZ[?\/S_ /@HU_T/WPQ_\-/H/_QZC_A^?_P4 M:_Z'[X8_^>'_X]7Y$T5]Q_J/PF_P#F0Y9'UPSE^54^8_UHX@_Z&-?_ ,&3 M_P S]=O^'Y__ 4:_P"A^^&/_AI]!_\ CU'_ _/_P""C7_0_?#'_P -/H/_ M ,>K\B:"< G!/'08R3V R0#],Y/8'DA_ZC<)WBO["RM.5^6^%:YK:/EO62;7 M5)W74?\ K/Q!R\W]HUFDW&RJ3^A^NW_#\__@HU_P!# M]\,?_#3Z#_\ 'J/^'Y__ 4:_P"A^^&/_AI]!_\ CU?D2.@]<#..1D]AT.1T M((!!]00:*7^I'"/_ $))[GP MU=:SXW^'$T_A'Q#;^*M$:'X7Z% (=93Y<.INTU**ORU7NI6\K[K<4^)\]J)4Y9C6E M:TD^=MIIJ2:N[-Q:35WNE?8_7G_A^E_P4;_Z'[X9?^&H\/\ _P 6M]KE/BG/TG?.,9)=I2IJ+]7%\R7IJ?KM_P /S_\ @HU_T/WPQ_\ #3Z# M_P#'J/\ A^?_ ,%&O^A^^&/_ (:?0?\ X]7Y$Y'3//8?S_G1SW&/3Z>M5'@? MA.5[9%EETTK/"23N]M'63:[NUEU:$^*,_5O^%*KJN;2K)Z>=I:/7;?R/UV_X M?G_\%&O^A^^&/_AI]!_^/4?\/S_^"C7_ $/WPQ_\-/H/_P >K\B:*/\ 4?A. M[7]A99H[/_9);_\ @T'Q/Q DG_:-:S5U^\GMZ7T^9^NW_#\__@HU_P!#]\,? M_#3Z#_\ 'J/^'Y__ 4:_P"A^^&/_AI]!_\ CU?D311_J/PG_P!"+*__ D? M_P N%_K1Q!_T,:__ (,G_F?L[X&_X+@_\%#M6\>> M&U/QO\,KK2M<\<^$-# MU6U'PMT6W:YTW6-?L-.O84N(9Q-;R/;7,GES1$21N RGBO[=8P%).?O $DDG MCC R3R!GC/(SMR0!7^8_\-AGXG_"WV^)WP]/Y>+]'K_3C*\ =,D GKG"_AW' M]:_#?%?)LKR?,,JI99A*&!A6P]:I6CAZ?LX3=.I!)N/-)MI-IZ]?(_3N ,SQ M^8X?,YXZO/$RHU,/"ESRYS_G_]0I:_*EJK M_P!>7WJQ^B_._G_7G<*1ONM]#_*EI#T/T-,#\$_^"UG[0_Q2_9 ;]FGXX_ 7 M4M&\+_$G5_$OCOP!K>LZCH=MK<.N^"Y= M-73P]K-E=,L&HZ?9:OMU;38[H2 MOINHEI[%X#+<"?\ $=?^"Z?_ 4:!R/B!\,SD=_A-X>[X/:4>G^>*_4W_@Y& M&?A-^RQZGXJ>-QG_ +E&R_QK^3?_ #_G\A7[[P%D&2YGPW@<7F678?&8AU
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end GRAPHIC 25 ex99-5_001.jpg GRAPHIC begin 644 ex99-5_001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# @&!@<&!0@'!P<)"0@*#!0-# L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#W^BBB@ HH MHH **** "BBB@ HHILDB0QM)*ZI&@+,S' '=ZI\9/#]M.]MHUIJ. MO3H<'^S;\,^-_ M#_BZ)CI%^LDT8S);R I+']4//X]*Z&@ HHHH **** "BBB@ HHHH ***K7^H MV6EVK75_=P6L"]9)I BC\30!9HKA;GXQ^ K5]C>((G/K%$[C\PM/M?B]X#NR M GB*W0G_ )ZHZ?S% ';T56L=0L]3M$N["ZANK=_NRPN'4_B*Y?5OB?X6T7Q5 M%X B*% _ 5)0!P^CZKX)\?W27=EY7]K6K;_F0P7<)_1L>O45W M%9E_X>TK4[F&ZN;*(W<#!XKE!LE0^SCG\,X-:= !1110 4444 %%%% !1110 M 5\IW1U7XS?%>739+YH+&.23R@>5@A0XR%[L>/Q/H*^K*^9/%OP_\7^ /&DW MB3PK%<3VC2O-%+;)YC1!CRCIW'..A!'O0!Z+:_L]^"X856=M1N) .7:X"Y/T M %0WG[._A"="+:YU.V;U$RN/R*UPUO\ M$>*;("+4M%L99%X8E7B;\1D_P J MV=._:5B:0#4O#CHG=K:XW$?@P'\Z /8?"/AJW\(>&+/0[65IH[8-^\90"Y9B MQ) ^M<5XE^'O@;4OB!#K.J:LEOJ#R1E[$W**)W& F5/S7^O2O!?B1_R<7IW_ %]6'\TH ^B;W7M'TV<07VJV M5M,<'RYIU1N>G!-:->#_ +1OAD2V6F^)8(_GA;[+<$#^$\H3]#N'_ A7I?PT M\1?\)/\ #_2M09]TZQ>1/Z^8GRDGZX!_&@#H[[4K'2[?S]0O(+6'.WS)Y BY M],FBPU&RU6U%UI]W!=6Y)42P2!U)'49%?/\ ^T-K(M(\+6F7:$"5T7^* M60[4'UQ_Z%7HNLZA#\(_A% ENB/=N2Q]L[F_"@#M=4UW2=#B$N MJZE:62'H;B94S],GFLRQ\?>$=2G$%IXCTV24]$^T*"?IGK7@?@KX7ZS\41+X MF\0ZQ-%;32$)(1OEF(.#MSPJ@\?ATKL[K]FS0VAQ::YJ,4N/O2HCK^0 _G0! MZ]<:SI=G=16USJ-I#/, T<4DRJS@G (!//-5==\4Z+X<@=]4U*UMI/*:5(I9 M55Y H_A!.3Z5\IZOX9O_ A\3M(T74+\7S0W%LT4@+8"%P0 #T[\5[A\8_A[ M:>)--N?$4]_<12Z782&.%%!5\9;G/- &/\(?B6-1@UNX\5^(K>*1KA3;QW+_#>HW<=I9:]IMSO>$/@CI/A#Q-:ZW!JMWHUSVH>._">E3F"]\0Z=#,.L9G4L/J!TKR7XV>.-6N-?@\#>'Y)$DEV+5W^[&#V&""?7-2:+^S=9_8HWUS6[DW3#+QV:JJH?3RZ7XAT;6T MWZ7JMG> =?(F5R/J >*EL-8TS5"XT_4+6[,?WQ!,K[?K@\5X7KW[/S:/97&I M^'_$<\/2H/V:>=3\0D]?)A_\ 0FH ^B**** "BBO MO%"?&;3/%.HWVE"[DT^:X9H(H'2=%3.%&TY(XQV'- 'NT]G:W0Q<6T,P_P"F MB!OYU@ZQ\/\ PGKEL\-]H5B=P(\R.(1NON&7!!KQ$_$CXQV_R2Z+.S>K:4W] M!3+B\^-7C6$V+6EY:VTPVOB%;52#URQP-<[2?Q"U9^)/\ R<7IW_7U8?S2O4/A5\*X_ <$M]?31W.L7"!':,?)"G7: MN>3DXR?:N#\?^&M36*7%DS7$<+% %*[CGIQ@T >V^+=!B\3^ M%-2T:4#_ $J!E0G^%^JG\& ->)_L^^(#I5[KOAO47\GRP;H*YQL9/ED'Y8/_ M $U]"U\L?&?1+WPC\0;C5]/\R"UU>)V$B<#^)+E2UK:RM>8/0<[85_#@_\!KM_VC+::7P-83H"8H;]?,QVRC '\_YUH_ ? MPU_8G@!+^5-MSJK^><]?+'"#\LG_ (%7?^(-"LO$NA7>D:A'OMKE-K8ZJ>H8 M>X."/I0!R_P>O+:\^%FB?9V4^3&T,BC^%PQR#^>?QKNJ^9F\&?$WX7:E._AE MYKW3Y&SNME$BN!TWQ')!]Q^=6%\>!/'\7CC1M0UZTO-0N99X9I M9T)F\M1(/E9AP, =!P!7U+?V4.I:=W,47R(9;3[0 !P '7.1^- 'T-XA_Y%K5?^O.;_ - ->$_LT_\ M(2\0_P#7&'^;579OC7XYC:UD2XT^SD4JY9%M4*GJ"?O'Z"MO]G_P[K.A:EKW M]J:9=6:O'$J-/$4#D%LXSUH ]UHHHH **** "BBB@ HHHH *^8/B-J$OQ(^, M=GX=LI-UI;3"S0J<@'.97_#!'_ :^GZS[;0M(L[K[5:Z790W'/[V.!5?GKR! MGF@"W:VT-E:0VMN@2&%%CC4=E P!4M%% !1110 4444 %%%% !1110 4444 '%%%% '__V0$! end EX-101.SCH 26 syta-20230630.xsd XBRL SCHEMA FILE 001 - Statement - Restated Unaudited Condensed Interim Consolidated Statements of Financial Position link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Restated Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders’ Equity link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Restated Unaudited Condensed Interim Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Unaudited Condensed Interim Consolidated Statements of Financial Position link:presentationLink link:definitionLink link:calculationLink 007 - Statement - Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss link:presentationLink link:definitionLink link:calculationLink 008 - Statement - Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 009 - Statement - Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders’ Equity link:presentationLink link:definitionLink link:calculationLink 010 - Statement - Unaudited Condensed Interim Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Nature of Operations and Going Concern link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Basis of Preparation link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Trade and Other Receivables link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Inventory link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Convertible Debentures link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Warrant Liability link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Share Capital link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Cost of Sales link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Selling and Marketing Expenses link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - General and Administrative Expenses link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Transaction Costs link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Financial Instruments link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Segmented Information link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Supplemental Information with Respect to Cash Flows link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Restatement of Financial Statements link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Bank Loan link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Basis of Preparation (Tables) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Trade and Other Receivables (Tables) link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Inventory (Tables) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Warrant Liability (Tables) link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Share Capital (Tables) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Cost of Sales (Tables) link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Selling and Marketing Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - General and Administrative Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Segmented Information (Tables) link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Supplemental Information with Respect to Cash Flows (Tables) link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Restatement of Financial Statements (Tables) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Nature of Operations and Going Concern (Details) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Basis of Preparation (Details) - Schedule of Consolidated Financial Statements link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Trade and Other Receivables (Details) - Schedule of Trade and Other Receivables link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - Inventory (Details) - Schedule of Inventory link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - Convertible Debentures (Details) link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - Warrant Liability (Details) link:presentationLink link:definitionLink link:calculationLink 048 - Disclosure - Warrant Liability (Details) - Schedule of the Warrant Liability link:presentationLink link:definitionLink link:calculationLink 049 - Disclosure - Share Capital (Details) link:presentationLink link:definitionLink link:calculationLink 050 - Disclosure - Share Capital (Details) - Schedule of Stock Option Activity link:presentationLink link:definitionLink link:calculationLink 051 - Disclosure - Share Capital (Details) - Schedule Stock Options Outstanding link:presentationLink link:definitionLink link:calculationLink 052 - Disclosure - Cost of Sales (Details) - Schedule of Cost of Sales link:presentationLink link:definitionLink link:calculationLink 053 - Disclosure - Selling and Marketing Expenses (Details) - Schedule of Selling and Marketing Expenses link:presentationLink link:definitionLink link:calculationLink 054 - Disclosure - General and Administrative Expenses (Details) - Schedule of General and Administrative Eexpenses link:presentationLink link:definitionLink link:calculationLink 055 - Disclosure - Transaction Costs (Details) link:presentationLink link:definitionLink link:calculationLink 056 - Disclosure - Financial Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 057 - Disclosure - Related Party Transactions (Details) - Schedule of Remuneration of Directors and Key Management Personnel link:presentationLink link:definitionLink link:calculationLink 058 - Disclosure - Related Party Transactions (Details) - Schedule of Classified within Profit and Loss link:presentationLink link:definitionLink link:calculationLink 059 - Disclosure - Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers link:presentationLink link:definitionLink link:calculationLink 060 - Disclosure - Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information link:presentationLink link:definitionLink link:calculationLink 061 - Disclosure - Segmented Information (Details) - Schedule of Product Information link:presentationLink link:definitionLink link:calculationLink 062 - Disclosure - Supplemental Information with Respect to Cash Flows (Details) link:presentationLink link:definitionLink link:calculationLink 063 - Disclosure - Supplemental Information with Respect to Cash Flows (Details) - Schedule of Supplemental Information with Respect to Cash Flows link:presentationLink link:definitionLink link:calculationLink 064 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 065 - Disclosure - Restatement of Financial Statements (Details) link:presentationLink link:definitionLink link:calculationLink 066 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Financial Position link:presentationLink link:definitionLink link:calculationLink 067 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Loss and Comprehensive Loss link:presentationLink link:definitionLink link:calculationLink 068 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 069 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Changes in Shareholder’s Equity link:presentationLink link:definitionLink link:calculationLink 070 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 071 - Disclosure - Basis of Preparation (Details) - Schedule of Consolidated Financial Statements link:presentationLink link:definitionLink link:calculationLink 072 - Disclosure - Bank Loan (Details) link:presentationLink link:definitionLink link:calculationLink 073 - Disclosure - Warrant Liability (Details) - Schedule of the warrant liability link:presentationLink link:definitionLink link:calculationLink 074 - Disclosure - Warrant Liability (Details) - Schedule of Change in Warrant Fair Value link:presentationLink link:definitionLink link:calculationLink 075 - Disclosure - Share Capital (Details) - Schedule of Stock Option Activity link:presentationLink link:definitionLink link:calculationLink 076 - Disclosure - Share Capital (Details) - Schedule Stock Options Outstanding link:presentationLink link:definitionLink link:calculationLink 077 - Disclosure - Related Party Transactions (Details) - Schedule of Remuneration of Directors and Key Management Personnel link:presentationLink link:definitionLink link:calculationLink 078 - Disclosure - Related Party Transactions (Details) - Schedule of Classified Within Profit and Loss link:presentationLink link:definitionLink link:calculationLink 079 - Disclosure - Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers link:presentationLink link:definitionLink link:calculationLink 080 - Disclosure - Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information link:presentationLink link:definitionLink link:calculationLink 081 - Disclosure - Segmented Information (Details) - Schedule of Product Information link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 27 syta-20230630_cal.xml XBRL CALCULATION FILE EX-101.DEF 28 syta-20230630_def.xml XBRL DEFINITION FILE EX-101.LAB 29 syta-20230630_lab.xml XBRL LABEL FILE EX-101.PRE 30 syta-20230630_pre.xml XBRL PRESENTATION FILE XML 31 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document And Entity Information
6 Months Ended
Jun. 30, 2023
Document Information Line Items  
Entity Registrant Name Siyata Mobile Inc.
Document Type 6-K
Current Fiscal Year End Date --12-31
Amendment Flag false
Entity Central Index Key 0001649009
Document Period End Date Jun. 30, 2023
Document Fiscal Year Focus 2023
Document Fiscal Period Focus Q2
Entity File Number 001-39557
XML 32 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Restated Unaudited Condensed Interim Consolidated Statements of Financial Position - USD ($)
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Current            
Cash $ 2,026,640 $ 1,179,694 $ 1,913,742      
Trade and other receivables (Note 3) 2,455,711 1,111,123 1,574,628      
Prepaid expenses 262,481 665,446 173,504      
Inventory (Note 4) 2,505,957 3,564,040 4,092,550      
Advance to suppliers 588,970 675,561 155,852      
Total current assets 7,839,759 7,195,864 7,910,276      
Long term receivable 142,838 146,196 150,185      
Right of use assets 770,840 811,966 887,137      
Equipment 190,706 199,743 207,402      
Intangible assets 7,633,427 7,481,391 6,987,531      
Total assets 16,577,570 15,835,160 16,142,531      
Current            
Accounts payable and accrued liabilities 2,742,429 2,111,174 3,078,650      
Deferred revenue 149,600      
Lease obligations 329,433 294,359 303,788      
Warrant liability (Note 6) 307,381 628,765 2,734,804      
Total current liabilities 4,098,866 3,034,298 6,266,842      
Lease obligations 484,298 543,944 635,217      
Total liabilities 4,583,164 3,578,242 6,902,059      
Shareholders’ equity            
Share capital (Note 7) 82,706,883 76,921,437 73,312,866      
Reserves (Note 7) 14,218,932 17,933,273 13,647,399      
Accumulated other comprehensive loss 98,870 98,870 98,870      
Deficit (85,030,279) (82,696,662) (77,818,663)      
Shareholders’ equity 11,994,406 12,256,918 9,240,472 $ 10,374,976 $ 12,402,753 $ 2,486,648
Total liabilities and shareholders’ equity $ 16,577,570 $ 15,835,160 $ 16,142,531      
XML 33 R3.htm IDEA: XBRL DOCUMENT v3.23.2
Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Profit or loss [abstract]    
Revenue $ 1,802,637 $ 832,974
Cost of sales (Note 8) (1,306,120) (577,923)
Gross profit 496,517 255,051
EXPENSES    
Amortization and depreciation 401,640 124,505
Development expenses 53,985 123,316
Selling and marketing (Note 9) 1,003,365 1,045,051
General and administrative (Note 10) 1,392,430 1,659,079
Inventory impairment (Note 4) 64,336
Bad debts (recovered) (Note 3) (7,358)
Share-based payments (Note 7) 310,828 812,735
Total operating expenses 3,162,248 3,821,664
Net operating loss (2,665,731) (3,566,613)
OTHER EXPENSES    
Finance expense 34,098 26,987
Foreign exchange 163 (87,660)
Change in fair value of convertible promissory note (Note 5) 2,680,457
Change in fair value of warrant liability (Note 6) 2,178,007 (3,272,735)
Transaction costs (Note 11) 965,247
Total other expenses (income) 2,212,268 312,296
Net loss for the year (4,877,999) (3,878,909)
Other comprehensive income    
Translation adjustment (24,468)
Comprehensive loss for the year $ (4,877,999) $ (3,903,377)
Weighted average shares (in Shares) 59,102,369 12,976,363
Basic and diluted loss per share (in Dollars per share) $ (0.08) $ (0.3)
XML 34 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) - $ / shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Profit or loss [abstract]    
Diluted loss per share $ (0.08) $ (0.30)
XML 35 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Restated Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders’ Equity - USD ($)
Share Capital
Reserves
Accumulated other comprehensive Income (loss)
Deficit
Total
Balance at Dec. 31, 2021 $ 54,655,244 $ 10,389,555 $ (38,739) $ (62,519,412) $ 2,486,648
Balance (in Shares) at Dec. 31, 2021 5,276,695        
Shares issued on acquisition of ClearRF $ 190,095 190,095
Shares issued on acquisition of ClearRF (in Shares) 138,958        
Shares issued on capital raise $ 10,936,974 10,936,974
Shares issued on capital raise (in Shares) 7,215,652        
Share issuance costs on capital raise $ (1,051,647) 307,189 (744,458)
Pre-funded warrants exercised $ 2,575,200 2,575,200
Pre-funded warrants exercised (in Shares) 1,480,000        
Share based payments 812,735 812,735
Translation adjustment 24,468 24,468
Net loss (3,878,909) (3,878,909)
Balance at Mar. 31, 2022 $ 67,305,866 11,509,479 (14,271) (66,398,321) 12,402,753
Balance (in Shares) at Mar. 31, 2022 14,111,305        
Balance at Dec. 31, 2021 $ 54,655,244 10,389,555 (38,739) (62,519,412) 2,486,648
Balance (in Shares) at Dec. 31, 2021 5,276,695        
Shares issued on acquisition of ClearRF $ 190,095       190,095
Shares issued on acquisition of ClearRF (in Shares) 138,958        
Shares issued on capital raise $ 10,936,974 307,189     11,244,163
Shares issued on capital raise (in Shares) 7,215,652        
Share issuance costs on capital raise $ (1,051,647)       (1,051,647)
Pre-funded warrants exercised $ 2,575,200       2,575,200
Pre-funded warrants exercised (in Shares) 1,480,000        
Share based payments   1,939,035     1,939,035
Translation adjustment     1,518   1,518
Net loss       (8,182,997) (8,182,997)
Balance at Jun. 30, 2022 $ 68,478,827 12,635,779 (37,221) (70,702,409) 10,374,976
Balance at Mar. 31, 2022 $ 67,305,866 11,509,479 (14,271) (66,398,321) 12,402,753
Balance (in Shares) at Mar. 31, 2022 14,111,305        
Net loss         (4,304,088)
Balance at Jun. 30, 2022 $ 68,478,827 12,635,779 (37,221) (70,702,409) 10,374,976
Balance at Dec. 31, 2022 $ 73,312,866 13,647,399 98,870 (77,818,663) 9,240,472
Balance (in Shares) at Dec. 31, 2022 44,868,560        
Issue of common shares for warrants $ 3,608,571 3,608,571
Issue of common shares for warrants (in Shares) 18,042,857        
Warrants reclassified from warrant liability 3,975,046 3,975,046
Share based payments 310,828 310,828
Net loss (4,877,999) (4,877,999)
Balance at Mar. 31, 2023 $ 76,921,437 17,933,273 98,870 (82,696,662) 12,256,918
Balance (in Shares) at Mar. 31, 2023 62,911,417        
Balance at Dec. 31, 2022 $ 73,312,866 13,647,399 98,870 (77,818,663) 9,240,472
Balance (in Shares) at Dec. 31, 2022 44,868,560        
Shares issued on capital raise $ 2,250,000       2,250,000
Shares issued on capital raise (in Shares) 50,000,000        
Share issuance costs on capital raise $ (439,600)       (439,600)
Share based payments   571,533     571,533
Net loss       (7,211,616) (7,211,616)
Balance at Jun. 30, 2023 82,706,883 14,218,932 98,870 (85,030,279) 11,994,406
Balance at Mar. 31, 2023 $ 76,921,437 17,933,273 98,870 (82,696,662) 12,256,918
Balance (in Shares) at Mar. 31, 2023 62,911,417        
Net loss         (2,333,617)
Balance at Jun. 30, 2023 $ 82,706,883 $ 14,218,932 $ 98,870 $ (85,030,279) $ 11,994,406
XML 36 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Restated Unaudited Condensed Interim Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating activities        
Net loss for the year $ (4,877,999) $ (3,878,909) $ (7,211,616) $ (8,182,997)
Items not affecting cash:        
Amortization and depreciation 401,640 124,505 855,139 459,924
Bad debt expense (recovered)   (7,358) 10,148 63,285
Impairment of inventory 64,336 303,316
Fair value changes on derivatives 2,178,007 (592,278)    
Interest expense, net of repayments   (4,651) 962,350
Foreign exchange 11,666   7,347
Share based payments 310,828 812,735 571,533 1,939,035
Change in non-cash working capital (Note 15) (1,136,712) (3,225,654)
Net cash used in operating activities (3,112,570) (6,707,274) (4,223,380) (11,174,413)
Investing activities        
Intangible asset additions (817,849) (739,579) (1,329,175) (1,389,620)
Equipment additions (2,498)   (3,736) (1,841)
Acquisition of ClearRF   (155,014)    
Net cash used in investing activities (820,347) (894,593) (1,332,911) (1,546,475)
Financing activities        
Lease payments (100,702) (78,731) (160,405) (154,665)
Bank loan   (27,159) 719,623 9,937
Convertible debt issued, net of repayments (4,000,000) (4,000,000)
Proceeds on share issuance, net of share issuance costs   16,711,184 2,250,000 16,711,184
Transaction costs (309)   (748,600)
Exercise of warrants 3,608,571 2,575,200 3,608,571 2,575,200
Net cash from financing activities 3,198,869 15,180,494 5,669,189 15,141,656
Effect of foreign exchange on cash   22,680 13,910
Change in cash for the year (734,048) 7,601,307 112,898 2,434,678
Cash, beginning of year 1,913,742 1,619,742 $ 1,913,742 $ 1,619,742
Cash, end of year $ 1,179,694 $ 9,221,049    
XML 37 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Condensed Interim Consolidated Statements of Financial Position - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current    
Cash $ 2,026,640 $ 1,913,742
Trade and other receivables 2,455,711 1,574,628
Prepaid expenses 262,481 173,504
Inventory 2,505,957 4,092,550
Advance to suppliers 588,970 155,852
Total current assets 7,839,759 7,910,276
Long term receivable 142,838 150,185
Right of use assets 770,840 887,137
Equipment 190,706 207,402
Intangible assets 7,633,427 6,987,531
Total assets 16,577,570 16,142,531
Current    
Bank loan 719,623
Accounts payable and accrued liabilities 2,742,429 3,078,650
Deferred revenue 149,600
Lease obligations 329,433 303,788
Warrant liability 307,381 2,734,804
Total current liabilities 4,098,866 6,266,842
Lease obligation 484,298 635,217
Total liabilities 4,583,164 6,902,059
Shareholders’ equity    
Share capital 82,706,883 73,312,866
Reserves 14,218,932 13,647,399
Accumulated other comprehensive loss 98,870 98,870
Deficit (85,030,279) (77,818,663)
Shareholders’ equity 11,994,406 9,240,472
Total liabilities and shareholders’ equity $ 16,577,570 $ 16,142,531
XML 38 R8.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue $ 2,710,717 $ 969,528 $ 4,513,354 $ 1,802,502
Cost of sales (1,906,227) (860,855) (3,212,347) (1,438,778)
Gross Profit 804,490 108,673 1,301,007 363,724
EXPENSES        
Amortization and depreciation 453,499 335,419 855,139 459,924
Development expenses 31,465 140,054 85,450 263,370
Selling and marketing 1,037,803 1,163,675 2,041,168 2,208,726
General and administrative 1,703,382 1,851,582 3,095,812 3,510,661
Inventory impairment 238,980 303,316
Bad debts 10,148 70,643 10,148 63,285
Share-based payments 260,705 1,126,300 571,533 1,939,035
Total operating expenses 3,497,002 4,926,653 6,659,250 8,748,317
Net operating loss (2,692,512) (4,817,980) (5,358,243) (8,384,593)
OTHER EXPENSES        
Finance expense 41,251 18,739 75,349 45,726
Foreign exchange (78,762) 106,828 (78,599) 19,168
Change in fair value of convertible promissory note 570,391 3,250,848
Change in fair value of opening warrant liability 962,350
Change in fair value of warrant liability (321,384) (1,209,850) 1,856,623 (5,444,935)
Transaction costs 965,247
Total other expenses (358,895) (513,892) 1,853,373 (201,596)
Net loss for the year (2,333,617) (4,304,088) (7,211,616) (8,182,997)
Other comprehensive income        
Translation adjustment 25,986 1,518
Comprehensive loss for the year $ (2,333,617) $ (4,278,102) $ (7,211,616) $ (8,181,479)
before the 100-1 reverse split [Member]        
Other comprehensive income        
Weighted average shares (in Shares) 77,394,214 14,635,152 68,257,292 13,805,757
Basic loss per share (in Dollars per share) $ (0.03) $ (0.29) $ (0.11) $ (0.59)
Weighted average shares (after the 100-1 reverse split) (in Shares) 77,394,214 14,635,152 68,257,292 13,805,757
Basic and diluted loss per share (after the 100-1 reverse split) (in Dollars per share) $ (0.03) $ (0.29) $ (0.11) $ (0.59)
after the 100-1 reverse split [Member]        
Other comprehensive income        
Weighted average shares (in Shares) 773,942 146,352 682,573 138,058
Basic loss per share (in Dollars per share) $ (3.02) $ (29.41) $ (10.57) $ (59.27)
Weighted average shares (after the 100-1 reverse split) (in Shares) 773,942 146,352 682,573 138,058
Basic and diluted loss per share (after the 100-1 reverse split) (in Dollars per share) $ (3.02) $ (29.41) $ (10.57) $ (59.27)
XML 39 R9.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) - $ / shares
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
before the 100-1 reverse split [Member]        
Diluted loss per share $ (0.03) $ (0.29) $ (0.11) $ (0.59)
after the 100-1 reverse split [Member]        
Diluted loss per share $ (3.02) $ (29.41) $ (10.57) $ (59.27)
XML 40 R10.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders’ Equity - USD ($)
Share capital
Reserves
Accumulated other comprehensive income (loss)
Deficit
Total
Balance at Dec. 31, 2021 $ 54,655,244 $ 10,389,555 $ (38,739) $ (62,519,412) $ 2,486,648
Balance (in Shares) at Dec. 31, 2021 5,276,695        
Shares issued on acquisition of ClearRF $ 190,095 190,095
Shares issued on acquisition of ClearRF (in Shares) 138,958        
Share issued on capital raise $ 10,936,974 10,936,974
Share issued on capital raise (in Shares) 7,215,652        
Share issuance costs on capital raise $ (1,051,647) 307,189 (744,458)
Pre-funded warrants exercised $ 2,575,200 2,575,200
Pre-funded warrants exercised (in Shares) 1,480,000        
Share based payments 812,735 812,735
Translation adjustment 24,468 24,468
Net loss (3,878,909) (3,878,909)
Balance at Mar. 31, 2022 67,305,866 11,509,479 (14,271) (66,398,321) 12,402,753
Balance at Dec. 31, 2021 $ 54,655,244 10,389,555 (38,739) (62,519,412) 2,486,648
Balance (in Shares) at Dec. 31, 2021 5,276,695        
Shares issued on acquisition of ClearRF $ 190,095       190,095
Shares issued on acquisition of ClearRF (in Shares) 138,958        
Share issued on capital raise $ 10,936,974 307,189     11,244,163
Share issued on capital raise (in Shares) 7,215,652        
Share issuance costs on capital raise $ (1,051,647)       (1,051,647)
Pre-funded warrants exercised $ 2,575,200       2,575,200
Pre-funded warrants exercised (in Shares) 1,480,000        
Shares issued for debt $ 1,172,961       1,172,961
Shares issued for debt (in Shares) 1,009,219        
Share based payments   1,939,035     1,939,035
Translation adjustment     1,518   1,518
Net loss       (8,182,997) (8,182,997)
Balance at Jun. 30, 2022 $ 68,478,827 12,635,779 (37,221) (70,702,409) 10,374,976
Balance (in Shares) at Jun. 30, 2022 15,120,524        
Balance at Mar. 31, 2022 $ 67,305,866 11,509,479 (14,271) (66,398,321) 12,402,753
Net loss         (4,304,088)
Balance at Jun. 30, 2022 $ 68,478,827 12,635,779 (37,221) (70,702,409) 10,374,976
Balance (in Shares) at Jun. 30, 2022 15,120,524        
Balance at Dec. 31, 2022 $ 73,312,866 13,647,399 98,870 (77,818,663) 9,240,472
Balance (in Shares) at Dec. 31, 2022 44,868,560        
Share based payments 310,828 310,828
Net loss (4,877,999) (4,877,999)
Balance at Mar. 31, 2023 76,921,437 17,933,273 98,870 (82,696,662) 12,256,918
Balance at Dec. 31, 2022 $ 73,312,866 13,647,399 98,870 (77,818,663) 9,240,472
Balance (in Shares) at Dec. 31, 2022 44,868,560        
Warrants exercised $ 7,583,617 (3,975,046)     3,608,571
Warrants exercised (in Shares) 39,074,844        
Warrants transferred from liability   3,975,046     3,975,046
Share issued on capital raise $ 2,250,000       2,250,000
Share issued on capital raise (in Shares) 50,000,000        
Share issuance costs on capital raise $ (439,600)       (439,600)
Share based payments   571,533     571,533
Net loss       (7,211,616) (7,211,616)
Balance at Jun. 30, 2023 $ 82,706,883 14,218,932 98,870 (85,030,279) 11,994,406
Balance (in Shares) at Jun. 30, 2023 133,943,404        
Balance at Mar. 31, 2023 $ 76,921,437 17,933,273 98,870 (82,696,662) 12,256,918
Net loss         (2,333,617)
Balance at Jun. 30, 2023 $ 82,706,883 $ 14,218,932 $ 98,870 $ (85,030,279) $ 11,994,406
Balance (in Shares) at Jun. 30, 2023 133,943,404        
XML 41 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Condensed Interim Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating activities        
Net loss for the year $ (4,877,999) $ (3,878,909) $ (7,211,616) $ (8,182,997)
Items not affecting cash:        
Amortization and depreciation 401,640 124,505 855,139 459,924
Bad debt expense   (7,358) 10,148 63,285
Impairment of inventory 64,336 303,316
Fair value changes on convertible debenture     3,250,848
Fair value changes on opening warrant liability   (4,651) 962,350
Fair value changes on warrant liability     1,856,623 (5,444,936)
Interest expense, net of repayments     9,586
Foreign exchange 11,666   7,347
Share based payments 310,828 812,735 571,533 1,939,035
Net Change in non-cash working capital 1,136,712 3,225,654
Trade receivables     (891,231) 75,316
Prepaids (491,942) (731,566) (88,977) (277,147)
Inventory 528,510 (1,060,581) 1,586,593 (2,590,511)
Advances to suppliers (967,476) (836,698) (433,118) (813,776)
Accounts payable and accrued liabilities     (336,221) (928,706)
Deferred revenues     (149,600)
Net cash used in operating activities (3,112,570) (6,707,274) (4,223,380) (11,174,413)
Investing activities        
Intangible asset additions (817,849) (739,579) (1,329,175) (1,389,620)
Equipment additions (2,498)   (3,736) (1,841)
Acquisition of ClearRF     (155,014)
Net cash used in investing activities (820,347) (894,593) (1,332,911) (1,546,475)
Financing activities        
Lease payments (100,702) (78,731) (160,405) (154,665)
Bank loan   (27,159) 719,623 9,937
Convertible debt issued, net of repayments (4,000,000) (4,000,000)
Proceeds on share issuance, net of share issuance costs   16,711,184 2,250,000 16,711,184
Transaction costs (309)   (748,600)
Exercise of warrants 3,608,571 2,575,200 3,608,571 2,575,200
Net cash from financing activities 3,198,869 15,180,494 5,669,189 15,141,656
Effect of foreign exchange on cash   22,680 13,910
Change in cash and restricted cash for the period (734,048) 7,601,307 112,898 2,434,678
Cash and restricted cash, beginning of the period $ 1,913,742 $ 1,619,742 1,913,742 1,619,742
Cash and restricted cash, end of period     $ 2,026,640 $ 4,054,420
XML 42 R12.htm IDEA: XBRL DOCUMENT v3.23.2
Nature of Operations and Going Concern
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Nature of Operations and Going Concern [Abstract]    
NATURE OF OPERATIONS AND GOING CONCERN
1.NATURE OF OPERATIONS AND GOING CONCERN

 

Siyata Mobile Inc. (“Siyata” or the “Company”) was incorporated under the Business Corporations Act, British Columbia on October 15, 1986. The Company’s shares are listed on NASDAQ under the symbol SYTA and warrants issued on September 29, 2020, are traded under the symbol SYTAW. The Company’s principal activity is the sale of vehicle-mounted, cellular-based communications platforms over advanced mobile networks and cellular booster systems. The registered and records office is located at 2200 - 885 West Georgia Street, Vancouver, BC V6C 3E8.

 

These restated unaudited condensed interim consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) IAS 34 Interim Financial Reporting, with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business rather than a process of forced liquidation. These restated unaudited condensed interim consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

The Company incurred a net loss of $4,877,999 during the three month period ended March 31, 2023 (March 31, 2022- three month period net loss of $3,879,909), and, as of that date, the Company’s total deficit was $82,696,662 (December 31, 2022 - $77,818,663). The Company’s continuation as a going concern is dependent upon the success of the Company’s sale of inventory, the existing cash flows, and the ability of the Company to obtain additional debt or equity financing, all of which are uncertain. These material uncertainties raise substantial doubt on the Company’s ability to continue as a going concern.

1. NATURE OF OPERATIONS AND GOING CONCERN

 

Siyata Mobile Inc. (“Siyata” or the “Company”) was incorporated under the Business Corporations Act, British Columbia on October 15, 1986. The Company’s shares are listed on NASDAQ under the symbol SYTA and warrants issued on September 29, 2020, are traded under the symbol SYTAW. The Company’s principal activity is the sale of vehicle-mounted, cellular-based communications platforms over advanced mobile networks and cellular booster systems. The registered and records office is located at 2200 - 885 West Georgia Street, Vancouver, BC V6C 3E8.

 

These unaudited condensed interim consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) IAS 34 Interim Financial Reporting, with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business rather than a process of forced liquidation. These unaudited condensed interim consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

The Company incurred a net loss of $7,211,616 during the six month period ended June 30, 2023 (June 30, 2022- six month period net loss of $8,182,997), and, as of that date, the Company’s total deficit was $85,030,279 (December 31, 2022 - $77,818,663). The Company’s continuation as a going concern is dependent upon the success of the Company’s sale of inventory, the existing cash flows, and the ability of the Company to obtain additional debt or equity financing, all of which are uncertain. These material uncertainties raise substantial doubt on the Company’s ability to continue as a going concern.

XML 43 R13.htm IDEA: XBRL DOCUMENT v3.23.2
Basis of Preparation
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Basis Of Preparation Of Financial Statements Text Block [Abstract]    
BASIS OF PREPARATION
2.BASIS OF PREPARATION

 

Statement of compliance

 

These restated unaudited condensed interim consolidated financial statements, including comparatives, have been prepared in accordance with International Accounting Standards (IAS) 34 Interim Financial Reporting. Omitted from these restated financial statements are certain information and note disclosures normally included in the annual financial statements. These financial statements and notes presented should be read in conjunction with the annual financial statements for the year ended December 31, 2022.

 

The accounting methods and principles of computation adopted in these restated financial statements are the same as those in annual consolidated financial statements for the year ended December 31, 2022.

 

The preparation of these restated unaudited condensed interim consolidated financial statements requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The significant judgements made by management when applying the Company’s accounting policies and the key sources of estimation uncertainty were the same as those that applied to the Company’s December 31, 2022 annual consolidated financial statements.

 

Basis of consolidation and presentation

 

These restated unaudited condensed interim consolidated financial statements of the Company have been prepared on a historical cost basis, except for financial instruments classified as financial instruments at fair value through profit and loss, which are stated at their fair value. In addition, the restated condensed interim consolidated financial statements have been prepared using the accrual basis of accounting, except for the statement of cash flows.

 

These restated unaudited condensed interim consolidated financial statements incorporate the financial statements of the Company and its wholly controlled subsidiaries. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. These restated condensed interim consolidated financial statements include the accounts of the Company and its direct wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.

 

The restated unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:

 

Name of Subsidiary   Place of Incorporation   Ownership  
Queensgate Resources Corp.   British Columbia, Canada     100 %
Queensgate Resources US Corp.   Nevada, USA     100 %
Siyata Mobile (Canada) Inc.   British Columbia, Canada     100 %
Siyata Mobile Israel Ltd.   Israel     100 %
Signifi Mobile Inc.   Quebec, Canada     100 %
ClearRF Nevada Ltd.   Nevada, USA     100 %

 

Recent adoptions of accounting pronouncements

 

The following amendments became effective on January 1, 2023, and did not have a material impact on the Company’s condensed interim consolidated financial statements:

 

  In February 2021, the IASB issued Definition of Accounting Estimates (Amendments to IAS 8). The amendments define accounting estimates and clarify the distinction between changes in accounting estimates and changes in accounting policies.

 

  In February 2021, the IASB issued Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2). The amendments provide guidance to help entities disclose their material (previously “significant”) accounting policies.

 

  In May 2021, the IASB issued Deferred Tax related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12). The amendments narrow the scope of the recognition exemption so that companies would be required to recognize deferred tax for transactions that give rise to equal amounts of taxable and deductible temporary differences, such as leases.

 

Future accounting pronouncements

 

The standards, amendments, and interpretations issued before 2023 but not yet adopted by the Company have been disclosed in Note 3 of the Company’s December 31, 2022 annual consolidated financial statements. The Company is currently considering the impact of adopting these standards, amendments and interpretations on its consolidated financial statement.

2. BASIS OF PREPARATION

 

Statement of compliance

 

These unaudited condensed interim consolidated financial statements, including comparatives, have been prepared in accordance with International Accounting Standards (IAS) 34 Interim Financial Reporting. Omitted from these financial statements are certain information and note disclosures normally included in the annual financial statements. These financial statements and notes presented should be read in conjunction with the annual financial statements for the year ended December 31, 2022.

 

The accounting methods and principles of computation adopted in these financial statements are the same as those in annual consolidated financial statements for the year ended December 31, 2022, except that the functional currency of Signifi Mobile Inc. is the $USD (formerly $CDN) as of January 1, 2023, and therefore all of the entities in the consolidated group of Siyata Mobile Inc. are all using the USD$ as the functional currency.

 

The preparation of these unaudited condensed interim consolidated financial statements requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The significant judgements made by management when applying the Company’s accounting policies and the key sources of estimation uncertainty were the same as those that applied to the Company’s December 31, 2022 annual consolidated financial statements.

 

Basis of consolidation and presentation

 

These unaudited condensed interim consolidated financial statements of the Company have been prepared on a historical cost basis, except for financial instruments classified as financial instruments at fair value through profit and loss, which are stated at their fair value. In addition, the condensed interim consolidated financial statements have been prepared using the accrual basis of accounting, except for the statement of cash flows.

 

These unaudited condensed interim consolidated financial statements incorporate the financial statements of the Company and its wholly controlled subsidiaries. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. These condensed interim consolidated financial statements include the accounts of the Company and its direct wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.

 

The unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:

 

Name of Subsidiary  Place of Incorporation  Ownership 
Queensgate Resources Corp.  British Columbia, Canada   100%
Queensgate Resources US Corp.  Nevada, USA   100%
Siyata Mobile (Canada) Inc.  British Columbia, Canada   100%
Siyata Mobile Israel Ltd.  Israel   100%
Signifi Mobile Inc.  Quebec, Canada   100%
ClearRF Nevada Ltd.  Nevada, USA   100%

 

Recent adoptions of accounting pronouncements

 

The following amendments became effective on January 1, 2023, and did not have a material impact on the Company’s condensed interim consolidated financial statements:

 

In February 2021, the IASB issued Definition of Accounting Estimates (Amendments to IAS 8). The amendments define accounting estimates and clarify the distinction between changes in accounting estimates and changes in accounting policies.

 

In February 2021, the IASB issued Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2). The amendments provide guidance to help entities disclose their material (previously “significant”) accounting policies.

 

In May 2021, the IASB issued Deferred Tax related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12). The amendments narrow the scope of the recognition exemption so that companies would be required to recognize deferred tax for transactions that give rise to equal amounts of taxable and deductible temporary differences, such as leases.

 

Future accounting pronouncements

 

The standards, amendments, and interpretations issued before 2023 but not yet adopted by the Company have been disclosed in Note 3 of the Company’s December 31, 2022 annual consolidated financial statements. The Company is currently considering the impact of adopting these standards, amendments and interpretations on its consolidated financial statement. 

XML 44 R14.htm IDEA: XBRL DOCUMENT v3.23.2
Trade and Other Receivables
3 Months Ended
Mar. 31, 2023
Trade and Other Receivables [Abstract]  
TRADE AND OTHER RECEIVABLES
3.TRADE AND OTHER RECEIVABLES

 

   March 31,
2023
   December 31,
2022
 
Trade receivables  $1,645,627   $2,015,291 
Allowance for doubtful accounts   (1,062,052)   (1,056,393)
Taxes receivable   527,548    615,730 
Total  $1,111,123   $1,574,628 
XML 45 R15.htm IDEA: XBRL DOCUMENT v3.23.2
Inventory
3 Months Ended
Mar. 31, 2023
Inventory [Abstract]  
INVENTORY
4.INVENTORY

 

   March 31,
2023
   December 31,
2022
 
Finished products  $6,874,848   $7,392,002 
Impairment of finished products   (3,555,683)   (3,555,683)
Accessories and spare parts   663,645    675,001 
Impairment of accessories and spare parts   (418,770)   (418,770)
Total  $3,564,040   $4,092,550 
XML 46 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Convertible Debentures
3 Months Ended
Mar. 31, 2023
Convertible Debentures [Abstract]  
CONVERTIBLE DEBENTURES
5.CONVERTIBLE DEBENTURES

 

On November 3, 2021, the Company issued a US$7,200,000 convertible promissory note (the “Promissory Note”) and 2,142,857 warrants for gross proceeds of US$6,000,000. The Company elected to measure the promissory note (hybrid contract) at fair value through profit or loss (“FVTPL”) on initial recognition and, as such, the embedded conversion feature was not separated. The warrants were recorded as a liability.

 

During the three months ended March 31, 2022, the Company completed a secondary offering of its common shares, and as a result of the terms of the convertible promissory note, the Company was required to direct 20% of the gross proceed of the offering to the lender. A total of US$4,000,000 was repaid to the lender on January 13, 2022. Commencing in May 2022, the Company made monthly payments of $400,000 through issuance of common shares towards the principal balance of the promissory note, resulting the promissory note being fully repaid by December 31, 2022. The Company issued 13,112,255 common shares, with a total market value of $4,138,002. The difference between the fair value of the shares issued, and the value of the principal repaid of $938,002 was included in profit and loss in the change in fair value of convertible promissory note.

 

For the three months ended March 31, 2022 the Company recorded a fair value loss of $2,023,751 on the Convertible debenture.

XML 47 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Warrant Liability
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Warrant Liability [Abstract]    
WARRANT LIABILITY
6.WARRANT LIABILITY

 

The balance of the warrant liability is as follows:

 

   November 3,
2021
   January 11,
2022
   October 12,
2022
   January 19,
2023
   Total 
Balance December 31, 2022  $197,733   $501,330   $2,035,741   $
-
   $2,734,804 
Exercise of warrants   (197,733)   
-
    (1,717,801)   
-
    (1,915,534)
Warrants issued   
-
    
-
    
-
    2,875,580    2,875,580 
Transfer to equity   
-
    
-
    (564,946)   (3,410,100)   (3,975,046)
Change in fair value        127,435    247,006    534,520    908,961 
Balance March 31, 2023  $
-
   $628,765   $
-
   $
-
   $628,765 

 

January 19, 2023 warrants

 

On January 19, 2023, the Company entered into warrant exercise agreements with fourteen existing accredited investors to exercise certain outstanding warrants to purchase up to an aggregate of 18,042,857 of the Company’s common shares. In consideration for the immediate exercise of the outstanding warrants for cash, the Company agreed to reduce the exercise price from $0.23 to $0.20 per share and issue new unregistered warrants to purchase up to an aggregate of 18,042,857 common shares with an exercise price of $0.20 per share. The gross proceeds to the Company from the exercise totaled approximately $3,608,571, prior to deducting warrant inducement agent fees and offering expenses.

 

The new warrants are exercisable immediately upon issuance at an exercise price of $0.20 per share and have a term of exercise equal to five years. In connection with the exercise, the Company will be required pursuant to the terms of 2,989,130 of its remaining unexercised common share purchase warrants, to reduce the exercise price of such warrants from $0.23 per common share to an exercise price of $0.20 per common share.

 

On March 30, 2023, the SEC accepted the registration statement of the Company to the effect that all of the 21,031,987 outstanding $0.20 warrants become immediately a cashless exercise and their underlying shares become immediately tradeable. Subsequent to the quarter ended March 31, 2023, 21,031,987 warrants were exercised cashless in exchange for 21,031,987 common shares of the Company. All of the warrants that became cashless exercise were transferred to equity at March 30, 2023, as they no longer met the definition of a liability.

 

The fair value of the warrants issued at January 19, 2023 was $2,875,580 and was determined using the stock price at the date of issue, with a 15% discount for lack of marketability. This method was used as the warrants contained an alternative cashless exercise feature.

 

The fair value of the warrants on March 30, 2023 was $3,410,100 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.

 

November 3, 2021 warrants

 

The warrants allowed for the purchase of 1,892,857 common shares of the Company at an exercise price of US 4.00 per common share and expired 5 years from the issue date of the related promissory note. Under the terms of the warrants, the exercise price of the warrant was adjusted to $2.30 when an offering was closed on January 3, 2022 that issued shares at a price lower than the exercise price. On January 19, 2023 the warrant holders entered into the agreement noted above to exercise the warrants, and receive new warrants in exchange.

 

At December 31, 2022 the fair value of the warrants was $197,733 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.15, strike rate $0.23 dividend yield 0%, term 3.84 years, volatility 110% and risk-free rate 4.08%.

 

At January 19, 2023 prior to exercise, the fair value of the warrants was $NIL and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.19, strike rate $0.20 dividend yield 0%, term 0 years, volatility 130% and risk-free rate 3.62%.

 

January 11, 2022 warrants

 

The Company assessed that the 8,519,999 warrants, and 1,480,000 pre-funded warrants issued in the January 2022 equity offering did not meet the “fixed for fixed” test and are therefore recorded as liabilities at fair value through profit and loss, and revalued at the end of each period.

 

At December 31, 2022 the fair value of the warrants was $501,330 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.15, strike rate $2.30, dividend yield 0%, term 4.03 years, volatility 110% and risk-free rate 4.08%.

 

At March 31, 2023 the fair value of the warrants was $628,765 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.19, strike rate $2.30, dividend yield 0%, term 3.79 years, volatility 125% and risk-free rate 3.69%.

 

October 12, 2022 warrants

 

The Company assessed that the 17,400,000 warrants and 1,590,000 pre-funded warrants issued as part of the October 2022 equity offering did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. On January 19, 2023 the warrant holders entered into the agreement noted above to exercise 16,150,000 of the 17,400,000 warrants, and receive new warrants in exchange. The remaining 1,250,000 warrants that were outstanding at January 19, 2023 were converted to cashless exercise warrants on March 30, 2023 as described above.

 

The fair value of the warrants as at December 31, 2022 was $1,850,758 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.15; exercise price $0.23; expected volatility: 100%; dividend yield 0%; risk free rate: 3.98%.

 

The fair value of the 1,250,000 unexercised warrants on January 19, 2023 was $132,957 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.19; exercise price $0.20; term 4.73 years; expected volatility: 115%; dividend yield 0%; risk free rate: 3.49%.

 

The fair value of the 16,150,000 exercised warrants immediately prior to exercise on January 19, 2023 was $NIL and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.19; exercise price $0.20; term 0 years; expected volatility: 115%; dividend yield 0%; risk free rate: 3.49%.

 

The fair value of the 2,989,130 (1,739,130 waiver warrants plus 1,250,000 unexercised warrants) outstanding warrants on March 30, 2023 prior to the transfer to equity was $564,946 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.

 

In connection with the October 2022 equity offering, the Company issued 1,739,130 waiver warrants exercisable at $0.23 per share which expire, if unexercised, on October 12, 2027, to entice the holder of the convertible promissory note to waive their right to block the equity offering. The waiver warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss and revalued at the end of each period. On March 30, 2023, the waiver warrants were modified to cashless exercise as described above, and therefore met the “fixed for fixed” test and were reclassified to equity.

 

The fair value of the waiver warrants as at December 31, 2022 was $184,983 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.15; exercise price $0.23; expected volatility: 100%; dividend yield 0%; risk free rate: 3.10%.

 

The fair value of the waiver warrants as at March 30, 2023 prior to transfer to equity was $328,696 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.

4. WARRANT LIABILITY

 

The balance of the warrant liability is as follows:

 

   November 3,
2021
   January 11,
2022
   October 12,
2022
   January 19,
2023
   Total 
Balance December 31, 2022  $197,733   $501,330   $2,035,741   $
-
   $2,734,804 

Change in fair value of warrants exercised

   (197,733)   
-
    (1,717,801)   
-
    (1,915,534)
Warrants issued   
-
    
-
    
-
    2,875,580    2,875,580 
Proceeds from Inducement warrants issued   
-
    
-
    
-
    
-
    
-
 
Transfer to equity   
-
    
-
    (564,946)   (3,410,100)   (3,975,046)
Change in fair value   
-
    (193,949)   247,006    534,520    587,577 
Balance June 30, 2023  $
-
   $307,381   $
-
   $
-
   $307,381 

 

Change in warrant fair value January 1, 2023-June 30, 2023    
Change in fair value of warrants exercised   (1,915,534)
Fair value of warrants issued as inducement   2,875,580 
Other changes in fair value of warrants   587,577 
Day 1 Loss - FV Change in Warrant Liability   309,000 
Total change in warrant fair value January 1, 2023-June 30, 2023   1,856,623 

 

January 19, 2023 warrants

 

On January 19, 2023, the Company entered into warrant exercise agreements with fourteen existing accredited investors to exercise certain outstanding warrants to purchase up to an aggregate of 18,042,857 of the Company’s common shares. In consideration for the immediate exercise of the outstanding warrants for cash, the Company agreed to reduce the exercise price from $0.23 to $0.20 per share and issue new unregistered warrants to purchase up to an aggregate of 18,042,857 common shares with an exercise price of $0.20 per share. The gross proceeds to the Company from the exercise totaled approximately $3,608,571, prior to deducting warrant inducement agent fees and offering expenses.

 

The new warrants are exercisable immediately upon issuance at an exercise price of $0.20 per share and have a term of exercise equal to five years. In connection with the exercise, the Company will be required pursuant to the terms of 2,989,130 of its remaining unexercised common share purchase warrants, to reduce the exercise price of such warrants from $0.23 per common share to an exercise price of $0.20 per common share.

 

On March 30, 2023, the SEC accepted the registration statement of the Company to the effect that all of the 21,031,987 outstanding $0.20 warrants become immediately a cashless exercise and their underlying shares become immediately tradeable. Subsequent to the quarter ended March 31, 2023, 21,031,987 warrants were exercised cashless in exchange for 21,031,987 common shares of the Company. All of the warrants that became cashless exercise were transferred to equity at March 30, 2023, as they no longer met the definition of a liability.

 

The fair value of the warrants issued at January 19, 2023 was $2,875,580 and was determined using the stock price at the date of issue, with a 15% discount for lack of marketability. This method was used as the warrants contained an alternative cashless exercise feature.

 

The fair value of the warrants on March 30, 2023 that was transferred to equity was $3,410,100 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.

November 3, 2021 warrants

 

The warrants allowed for the purchase of 1,892,857 common shares of the Company at an exercise price of US 4.00 per common share and expired 5 years from the issue date of the related promissory note. Under the terms of these warrants, the exercise price of the warrant was adjusted to $2.30 when an offering was closed on January 3, 2022 that issued shares at a price lower than the exercise price. On January 19, 2023 the warrant holders entered into the agreement noted above to exercise the warrants, and receive new warrants in exchange.

 

At December 31, 2022 the fair value of the warrants was $197,733 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.15, strike rate $0.23 dividend yield 0%, term 3.84 years, volatility 110% and risk-free rate 4.08%.

 

At January 19, 2023 prior to exercise, the fair value of the warrants was $NIL and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.19, strike rate $0.20 dividend yield 0%, term 0.0 years, volatility 130% and risk-free rate 3.62%.

 

January 11, 2022 warrants

 

The Company assessed that the 8,519,999 warrants, and 1,480,000 pre-funded warrants issued in the January 2022 equity offering did not meet the “fixed for fixed” test and are therefore recorded as liabilities at fair value through profit and loss, and revalued at the end of each period.

 

At December 31, 2022 the fair value of the warrants was $501,330 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.15, strike rate $2.30, dividend yield 0%, term 4.03 years, volatility 110% and risk-free rate 4.08%.

 

At June 30, 2023 the fair value of the warrants was $307,381 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.05, strike rate $2.30, dividend yield 0%, term 3.54 years, volatility 170% and risk-free rate 4.35%. This is based on a level 3 output calculated as follows:

 

The expected volatility was based on the historical daily stock price volatility over a look-back period that was consistent with the balance-remaining term corresponding to each Instrument as of the Valuation Date(s). The historical volatility was then adjusted for:
   
The actual implied-to-historical volatility ratio observed for the Company’s publicly-traded warrants. This approach incorporated the differences between the implied volatility and the historical volatility for the publicly-traded warrant. The ratio was used to determine the volatility if the Instruments were publicly traded.

 

A 25% volatility haircut1 given that the Instruments were not publicly traded and were expected to have lower volatilities than the comparable publicly-traded instruments. The 25% volatility haircut is amortised over the balance-remaining term of the Instruments. As of the Valuation Date, the volatility haircut was 18% for the warrants issued on January 11, 2022. This adjustment informed the expected equity volatility for a privately-issued instrument

 

October 12, 2022 warrants

 

The Company assessed that the 17,400,000 warrants and 1,590,000 pre-funded warrants issued as part of the October 2022 equity offering did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. On January 19, 2023 the warrant holders entered into the agreement noted above to exercise 16,150,000 of the 17,400,000 warrants, and receive new warrants in exchange. The remaining 1,250,000 warrants that were outstanding at January 19, 2023 were converted to cashless exercise warrants on March 30, 2023 as described above.

 

The fair value of the warrants as at December 31, 2022 was $1,850,758 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.15; exercise price $0.23; expected volatility: 100%; dividend yield 0%; risk free rate: 3.98%.

 

The fair value of the 1,250,000 unexercised warrants on January 19, 2023 was $132,957 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.19; exercise price $0.20; term 4.73 years; expected volatility: 115%; dividend yield 0%; risk free rate: 3.49%.

 

The fair value of the 16,150,000 exercised warrants immediately prior to exercise on January 19, 2023 was $NIL and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.19; exercise price $0.20; term 0 years; expected volatility: 115%; dividend yield 0%; risk free rate: 3.49%.

 

The fair value of the 2,989,130 (1,739,130 waiver warrants plus 1,250,000 unexercised warrants) outstanding warrants on March 30, 2023 prior to the transfer to equity was $564,946 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.

 

In connection with the October 2022 equity offering, the Company issued 1,739,130 waiver warrants exercisable at $0.23 per share which expire, if unexercised, on October 12, 2027, to entice the holder of the convertible promissory note to waive their right to block the equity offering. The waiver warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss and revalued at the end of each period. On March 30, 2023, the waiver warrants were modified to cashless exercise as described above, and therefore met the “fixed for fixed” test and were reclassified to equity.

 

The fair value of the waiver warrants as at December 31, 2022 was $184,983 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.15; exercise price $0.23; expected volatility: 100%; dividend yield 0%; risk free rate: 3.10%.

 

The fair value of the waiver warrants as at March 30, 2023 prior to transfer to equity was $328,696 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.

XML 48 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Share Capital
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Share Capital [Abstract]    
SHARE CAPITAL
7.SHARE CAPITAL

 

(a)Authorized Unlimited number of common shares without par value

 

As at March 31, 2023, the Company had 62,911,417 common shares issued and outstanding (December 31, 2022 – 44,868,560).

 

As of the date of issuance of these restated financial statements total outstanding common shares is 1,853,955 post 100-to-1 reverse split that was effective as of August 3, 2023, (185,393,404 pre-split).

 

  (b) Common share transactions

 

Transaction subsequent to the quarter ended March 31, 2023 is as follows:

 

Subsequent to the period end, a total of 21,031,987 cashless warrants were exercised in exchange for common shares of the Company.

 

On June 28, 2023 the Company issued 50,000,000 at $0.045 per share for gross proceeds of $2,250,000 before offering expenses and other expenses included in share issuance costs.

 

On July 13, 2023, the Company issued 51,450,000 shares at $0.045 per share for gross proceeds of $2,315,250.

 

On August 3, 2023, the Company affected a 100-to-1 reverse stock split resulting in 185,393,404 shares converted with rounding into 1,853,955 shares.

 

Transactions for the three months ended March 31, 2023 are as follows:

 

  The Company issued 18,042,857 common shares on the exercise of various warrants for gross proceeds of $3,608,571. Additionally, the Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 30, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,987 common shares were issued for cashless warrants subsequent to March 31, 2023 as described in Note 16.

 

Transactions for the three months ended March 31, 2022 are as follows:

 

  On January 11, 2022, the Company completed an underwritten public offering in the United States, raising a total of $20,013,043 in gross proceeds. The Company allocated the gross proceeds firstly to the warrant liabilities, with the remainder to the common shares. Direct costs have been allocated based on the percentage allocation of the proceeds. The underwritten public offering resulted in the sale to the public of 7,215,652 Units at $2.30 per Unit, with each Unit being comprised of one common share and one warrant (the “Unit Warrants”) exercisable at $2.30 per share. The Unit warrants are exercisable immediately and have a term of 5 years. Gross proceeds of $10,936,974 were allocated to the common shares, and $5,395,878 to the unit warrants liability.

 

In addition, the Company issued 1,480,000 pre-funded units (“Pre-Funded Units”) at $2.29 per Pre-Funded Unit. Each Pre-Funded Unit is comprised of a one-pre-funded warrant (a “Pre-Funded Warrant”) to purchase one common share, and one warrant to purchase one common share. The Pre-Funded Warrant allows the holder to acquire one common share of the Company at an exercise price of $0.01 per common share, and a warrant to purchase a common share at an exercise price of $2.30 per share. The warrants are exercisable immediately and have a term of 5 years. Each Pre-Funded Warrant is exercisable immediately and is exercisable until all Pre-Funded Warrants are exercised. Proceeds of $2,560,400 were allocated to the pre-funded warrants and $1,106,747 to the unit warrants in the warrant liability.

 

The Company determined that the pre-funded warrants within the Pre-funded Units are common shares in substance, as they require only a minimal exercise price of $0.01. In addition, the underwriting agreement includes both the Units and Pe-funded Units and were negotiated together in the equity raise. Given that the purpose of the Prefunded Unit is in substance the same as that of the Unit (i.e., resulting in the ownership of both common shares and common share warrants) and that the terms of the warrants in both the Units and Prefunded Units are the same (i.e., the obligations of the Company for the units are the same), the Company determined that the Units and Pre-funded Units are closely related and should be combined into one unit of account for the purposes of allocating proceeds.

 

Therefore, the proceeds from the sale of the Units and Pre-funded Units are combined and allocated among the common shares, pre-funded warrants, and the common share warrants using the residual method, with the warrant liability being initially recognized at fair value as of the registration date and the residual amount being allocated to the common shares (i.e., equity).

 

The Company concurrently sold an additional 1,304,347 warrants to purchase 1,304,347 common shares exercisable at $2.30 per share (the “Option Warrants”) pursuant to an over-allotment option exercised by the underwriter. The exercise price of the warrants issued in connection with the exercise of the over-allotment option was $0.0097 per warrant. Each Option Warrant is exercisable immediately and has a term of five years from the issue date. Proceeds of $975,393 were allocated to the option warrant liability. As the fair value of the warrant liability exceeded the proceeds received on the warrants of $13,043, a fair value loss of $962,350 was recognized in the statement of profit and loss as a fair value change in the opening warrant liability.

 

The fair value of the common shares and pre-funded units was determined by reference to the market price on the day of the offering, which was $1.73 per share. The Unit Warrants, Warrants, and Option Warrants were valued using the Black-Scholes model using the following assumptions: initial stock price $1.73, strike rate $2.30, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company also issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company assessed that the warrants issued under the public offering, excluding the Placement Agent Warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. The Placement Agent Warrants were assessed under IFRS 2 Share Based Payments, as equity-settled share-based payments and have been recorded in equity.

 

The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued.

 

  On March 31, 2022, as part of the ClearRF acquisition (Note 3), the Company issued 138,958 shares to the vendor with a fair value of $190,094.

 

  (c) Stock options

 

The Company has a shareholder-approved “rolling” stock option plan (the “Plan”) in compliance with Nasdaq policies. Under the Plan the maximum number of shares reserved for issuance may not exceed 15% of the total number of issued and outstanding common shares at the time of granting. The exercise price of each stock option shall not be less than the market price of the Company’s stock at the date of grant, less a discount of up to 25%. Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted.

 

A summary of the Company’s stock option activity is as follows:

 

   Number of
stock
options
  

Weighted
Average

Exercise
Price

 
Outstanding options, December 31, 2021   414,568   $13.88 
Granted   1,145,000   $1.15 
Expired/Cancelled   (53,430)  $30.90 
Outstanding options, December 31, 2022 and March 31, 2023   1,506,138   $3.53 

 

As at March 31, 2023 stock options outstanding are as follows:

 

Grant Date  Number of
options
outstanding
   Number of
options
exercisable
   Weighted
Average
Exercise
Price
   Expiry date  Remaining
contractual
life (years)
 
24-Dec-18   12,896    12,896   $54.00   24-Dec-23   0.63 
15-Jan-19   828    828   $54.00   15-Jan-24   0.69 
21-Mar-19   12,345    12,345   $59.00   21-Mar-24   0.87 
01-Jan-20   2,069    2,069   $54.00   01-Jan-24   0.65 
15-Nov-20   95,000    95,000   $6.00   15-Nov-30   7.53 
15-Nov-20   161,500    161,500   $6.00   15-Nov-25   2.52 
02-Jan-21   57,000    57,000   $11.50   02-Jan-26   2.65 
02-Jan-21   5,000    5,000   $11.50   02-Jan-31   7.66 
18-Jan-21   14,500    14,500   $11.50   18-Jan-26   2.70 
01-Jan-22   20,000    12,500   $4.00   29-Oct-26   3.48 
13-Apr-22   795,000    265,000   $1.10   13-Apr-27   3.93 
12-Jul-22   330,000    110,000   $1.10   12-Jul-25   2.18 
Total   1,506,138    748,638   $3.53       3.51 

 

Transactions for the three months ended March 31, 2022 are as follows:

 

  On January 1, 2022, the Company granted 20,000 stock options at $4.00 per share that vest in 8 equal quarterly periods with the first vesting occurring on the grant date. The fair value on the date of the grant was $54,480 ($2.724 per option).

 

  (d) Restricted share units

 

The Company approved on February 14, 2022, the addition of the issuance of restricted share units to the existing executive stock option plan.

 

A summary of the Company’s restricted share unit activity is as follows:

 

   Number of RSU’s   Weighted Average
Issue
Price
 
Outstanding RSU, December 31, 2021   
-
   $
-
 
Granted   3,195,000   $1.05 
Exercised   (30,000)  $1.10 
Outstanding RSU, December 31, 2022 and March 31, 2023   3,165,000   $1.05 

 

As at March 31, 2023 restricted share units outstanding are as follows:

 

Grant Date  Number of
RSU’s
outstanding
   Number of
RSU’s
exercisable
   Weighted
Average
Issue Price
 
09-Mar-22   2,250,000    1,200,000   $1.03 
13-Apr-22   825,000    513,750   $1.10 
12-Jul-22   90,000    37,500   $1.10 
Outstanding RSU, March 31, 2023   3,165,000    1,751,250   $1.05 

 

Transactions for the three months ended March 31, 2022, are as follows:

 

  On March 9, 2022, the Company granted 450,000 RSU’s to Directors that vest immediately. On the date of granting, the fair value and stock price was $1.03/share.

 

  On March 9, 2022, the Company granted 1,800,000 RSU’s to a Director that vest quarterly over 12 periods with the first vesting of 150,000 RSU’s occurring on the date of the granted and another 150,000 vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.03/share.

 

  (e) Agents’ options

 

A summary of the Company’s agent options activity is as follows:

 

   Number of
options
   Weighted
average
exercise price
 
Outstanding agent options, December 31, 2021   445,926   $7.51 
Granted   487,283   $2.51 
Expired   (1,702)  $20.49 
Outstanding agent options, December 31, 2022 and March 31, 2023   931,507   $4.12 

 

As at March 31, 2023 agent options outstanding are as follows:

 

Grant Date  Number of
options
outstanding
   Number of
options
exercisable
   Weighted
Average
Exercise Price
   Expiry date  Remaining
contractual life (years)
 
                    
29-Sep-20   113,500    113,500   $6.60   28-Sep-25   2.00 
29-Sep-20   266,000    266,000   $6.85   28-Sep-25   2.00 
31-Dec-20   64,724    64,724   $11.50   30-Jun-24   1.00 
11-Jan-22   434,783    434,783   $2.53   11-Jan-27   4.00 
01-Apr-22   52,500    52,500   $2.30   08-Mar-27   4.00 
Total   931,507    931,507   $4.12       2.98 

 

Transactions for the three months ended March 31, 2022 are as follows:

 

  The Company issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%. The Company also issued 52,500 agent’s options with a fair value of $61,950 with an exercise price of $2.30.

 

  (f) Share purchase warrants

 

A summary of the Company’s share purchase warrant activity is as follows:

 

   Number of Warrants   Weighted average exercise price 
Outstanding, December 31, 2021   5,121,328   $7.64 
Granted   29,139,129   $0.94 
Expired   (128,386)  $33.47 
Outstanding, December 31, 2022   34,132,071   $1.76 
Granted   18,042,857    0.20 
Exercised   (18,042,857)   0.20 
Outstanding, March 31, 2023   34,132,071   $1.47 

 

As at March 31, 2023 the share purchase warrants outstanding are as follows:

 

Grant Date  Number of
Warrants
outstanding and
exercisable
   Exercise
Price
   Expiry date
29-Sep-20   1,805,585   $6.85   28-Sep-25
31-Dec-20   1,294,500   $11.50   30-Jun-24
11-Jan-22   9,999,999   $2.30   11-Jan-27
12-Oct-22   1,250,000    Cashless   11-Jan-27
12-Oct-22   1,739,130    Cashless   11-Jan-27
19-Jan-23   18,042,857    Cashless   18-Jan-28
Total   34,132,071   $1.47    

 

Transactions for the three months ended March 31, 2023 are as follows:

 

  18,042,857 warrants were exercised. The Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 31, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 17,116,987 cashless warrants were exercised subsequent to March 31, 2023.

 

Transactions for the three months ended March 31, 2022 are as follows:

 

  128,386 share purchase warrant expired in 2022.

 

  On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exercisable at $2.30 per warrant and with a term of five years.
5. SHARE CAPITAL

 

  (a) Authorized Unlimited number of common shares without par value

 

As at June 30, 2023, the Company had 133,943,404 common shares issued and outstanding (December 31, 2022 – 44,868,560).

 

As of the date of issuance of these unaudited condensed interim consolidated financial statements total outstanding common shares is 1,853,955 post 100-to-1 reverse split that was effective as of August 9, 2023, (185,393,404 pre-split) as described in Subsequent Events Note 10.

  (b) Common share transactions

 

Transactions for the six months ended June 30, 2023 are as follows:

 

The Company issued 18,042,857 common shares on the exercise of various warrants for gross proceeds of $3,608,571. Additionally, the Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 30, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,857 common shares were issued for cashless warrants in Q2 2023.

 

On June 28, 2023 the Company issued 50,000,000 at $0.045 per share for gross proceeds of $2,250,000 before offering expenses and other expenses included in share issuance costs.

 

Subsequent to June 30, 2023, the Company issued 51,250,000 shares at $0.045 per share for gross proceeds of $2,306,250 as described in Subsequent Events Note 10.

 

Transactions for the six months ended June 30, 2022 are as follows:

 

  On January 11, 2022, the Company completed an underwritten public offering in the United States, raising a total of $20,013,043 in gross proceeds. The Company allocated the gross proceeds firstly to the warrant liabilities, with the remainder to the common shares. Direct costs have been allocated based on the percentage allocation of the proceeds. The underwritten public offering resulted in the sale to the public of 7,215,652 Units at $2.30 per Unit, with each Unit being comprised of one common share and one warrant (the “Unit Warrants”) exercisable at $2.30 per share. The Unit warrants are exercisable immediately and have a term of 5 years. Gross proceeds of $10,936,974 were allocated to the common shares, and $5,395,878 to the unit warrants liability.

 

In addition, the Company issued 1,480,000 pre-funded units (“Pre-Funded Units”) at $2.29 per Pre-Funded Unit. Each Pre-Funded Unit is comprised of a one-pre-funded warrant (a “Pre-Funded Warrant”) to purchase one common share, and one warrant to purchase one common share. The Pre-Funded Warrant allows the holder to acquire one common share of the Company at an exercise price of $0.01 per common share, and a warrant to purchase a common share at an exercise price of $2.30 per share. The warrants are exercisable immediately and have a term of 5 years. Each Pre-Funded Warrant is exercisable immediately and is exercisable until all Pre-Funded Warrants are exercised. Proceeds of $2,560,400 were allocated to the pre-funded warrants and $1,106,747 to the unit warrants in the warrant liability.

 

The Company determined that the pre-funded warrants within the Pre-funded Units are common shares in substance, as they require only a minimal exercise price of $0.01. In addition, the underwriting agreement includes both the Units and Pe-funded Units and were negotiated together in the equity raise. Given that the purpose of the Prefunded Unit is in substance the same as that of the Unit (i.e., resulting in the ownership of both common shares and common share warrants) and that the terms of the warrants in both the Units and Prefunded Units are the same (i.e., the obligations of the Company for the units are the same), the Company determined that the Units and Pre-funded Units are closely related and should be combined into one unit of account for the purposes of allocating proceeds.

 

  b) Common share transactions (cont’d)

 

Therefore, the proceeds from the sale of the Units and Pre-funded Units are combined and allocated among the common shares, pre-funded warrants, and the common share warrants using the residual method, with the warrant liability being initially recognized at fair value as of the registration date and the residual amount being allocated to the common shares (i.e., equity).

 

The Company concurrently sold an additional 1,304,347 warrants to purchase 1,304,347 common shares exercisable at $2.30 per share (the “Option Warrants”) pursuant to an over-allotment option exercised by the underwriter. The exercise price of the warrants issued in connection with the exercise of the over-allotment option was $0.0097 per warrant. Each Option Warrant is exercisable immediately and has a term of five years from the issue date. Proceeds of $975,393 were allocated to the option warrant liability. As the fair value of the warrant liability exceeded the proceeds received on the warrants of $13,043, a fair value loss of $962,350 was recognized in the statement of profit and loss as a fair value change in the opening warrant liability.

 

The fair value of the common shares and pre-funded units was determined by reference to the market price on the day of the offering, which was $1.73 per share. The Unit Warrants, Warrants, and Option Warrants were valued using the Black-Scholes model using the following assumptions: initial stock price $1.73, strike rate $2.30, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company also issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.

 

The Company assessed that the warrants issued under the public offering, excluding the Placement Agent Warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. The Placement Agent Warrants were assessed under IFRS 2 Share Based Payments, as equity-settled share-based payments and have been recorded in equity.

 

The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued.

 

  (b) Common share transactions (cont’d)

 

On March 31, 2022, as part of the ClearRF acquisition, the Company issued 138,958 shares to the vendor with a fair value of $190,094.

 

The Company issued 155,000 common shares, with a fair value of $170,500 ($1.10 per share) to consultants as part of their compensation for services rendered.

 

The Company issued 854,219 common shares with a fair value of $1,002,461 as combined payments of the monthly principal repayment of $400,000 for the months of May and June 2022 payable in shares per the terms of the promissory note.

 

  (c) Stock options

 

The Company has a shareholder-approved “rolling” stock option plan (the “Plan”) in compliance with Nasdaq policies. Under the Plan the maximum number of shares reserved for issuance may not exceed 15% of the total number of issued and outstanding common shares at the time of granting. The exercise price of each stock option shall not be less than the market price of the Company’s stock at the date of grant, less a discount of up to 25%. Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted.

 

A summary of the Company’s stock option activity is as follows:

 

   Number of
Stock
Options
   Weighted
Average
Exercise
Price
 
Outstanding options, December 31, 2021   414,568   $13.88 
Granted   1,145,000    1.15 
Expired/Cancelled   (53,430)   30.90 
Outstanding options, December 31, 2022   1,506,138   $3.53 
Granted   
-
    
-
 
Expired/Cancelled   
-
    
-
 
Outstanding options, June 30, 2023 and date of MD&A (before the 100-1 reverse stock split)  1,506,138   $3.53 
Outstanding options, June 30, 2023 and date of MD&A (after the 100-1 reverse stock split)   15,061   $353.00 

 

As at June 30, 2023 stock options outstanding are as follows:

 

Grant Date  Number of
options
outstanding
   Number of
options exercisable
   Weighted
Average
Exercise
Price
   Expiry date  Remaining
contractual
life (years)
 
24-Dec-18   12,896    12,896    54.00   24-Dec-23   0.48 
15-Jan-19   828    828    54.00   15-Jan-24   0.55 
21-Mar-19   12,345    12,345    59.00   21-Mar-24   0.73 
1-Jan-20   2,069    2,069    54.00   1-Jan-24   0.51 
15-Nov-20   95,000    95,000    6.00   15-Nov-30   7.38 
15-Nov-20   161,500    161,500    6.00   15-Nov-25   2.38 
2-Jan-21   57,000    57,000    11.50   2-Jan-26   2.51 
2-Jan-21   5,000    5,000    11.50   2-Jan-31   7.52 
18-Jan-21   14,500    14,500    11.50   18-Jan-26   2.56 
1-Jan-22   20,000    12,500    4.00   29-Oct-26   3.33 
13-Apr-22   795,000    331,250    1.10   13-Apr-27   3.79 
12-Jul-22   330,000    110,000    1.10   12-Jul-25   2.04 
Total (before the 100-1 reverse stock split)   1,506,138    794, 888   $3.53       3.67 
Total (after the 100-1 reverse stock split)   15,061    7,949   $353.00       3.67 

 

Transactions for the six months ended June 30, 2022 are as follows:

 

 

On January 1, 2022, the Company granted 20,000 stock options at $4.00 per share that vest in 8 equal quarterly periods with the first vesting occurring on the grant date. The fair value on the date of the grant was $54,480 ($2.724 per option).

 

On April 13, 2022, the Company granted 795,000 stock options to executives and employees at an exercise price of $1.10 per share. These options vest quarterly over three years period with the first vesting taking place at the date of the grant. The fair value of these options on the date of the grant is $678,520 ($0.8535 per share).

 

  (d) Restricted share units

 

The Company approved on February 14, 2022, the addition of the issuance of restricted share units to the existing executive stock option plan.

 

A summary of the Company’s restricted share unit activity is as follows:

 

    Number of RSU’s     Weighted
Average
Issue Price
 
             
Outstanding RSU, December 31, 2021     0     $ -  
Granted     3,195,000       1.05  
Exercised     (30,000 )     1.10  
Outstanding RSU, December 31, 2022     3,165,000     $ 1.05  
Granted     -       -  
Exercised     -       -  
Outstanding RSU, June 30, 2023 and date of MD&A (before 100-1 reverse stock split)     3,165,000     $ 1.05  
Outstanding RSU, June 30, 2023 and date of MD&A  (after 100-1 reverse stock split)     31,650     $ 105.00  

 

As at June 30, 2023 restricted share units outstanding are as follows:

 

Grant Date   Number of
RSU’s
outstanding
    Number of
RSU’s
exercisable
    Weighted
Average
Issue Price
 
9-Mar-22     2,250,000       1,350,000       1.03  
13-Apr-22     825,000       513,750       1.10  
12-Jul-22     90,000       30,000       1.10  
Outstanding RSU, June 30, 2023 and date of MD&A (before 100-1 reverse stock split)     3,165,000       1,893,750     $ 1.05  
Outstanding RSU, June 30, 2023 and date of MD&A (after 100-1 reverse stock split)     31,650       18,938     $ 105.00  

 

Transactions for the six month period ended June 30, 2022, are as follows:

 

  On March 9, 2022, the Company granted 450,000 RSU’s to Directors that vest immediately. On the date of granting, the fair value and stock price was $1.03/share.

 

 

On March 9, 2022, the Company granted 1,800,000 RSU’s to a Director that vest quarterly over 12 periods with the first vesting of 150,000 RSU’s occurring on the date of the granted and another 150,000 vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.03/share.

 

On April 13, 2022, the Company granted 240,000 RSU’s to consultants that vest immediately. On the date of granting, the fair value and the stock price was $1.10/share.

 

On April 13, 2022, the Company granted 585,000 RSU’s to employees of the Company that vest quarterly over 12 periods with the first vesting of 48,750 RSU’s occurring on the date of the granted and another 48,750 RSU’s vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.10/share.

 

  (e) Agents’ options

 

A summary of the Company’s agent options activity is as follows:

 

    Number of
options
    Weighted
average
exercise price
 
             
Outstanding agent options, December 31, 2020     452,523     $ 8.02  
Expired     (6,597 )     52,68  
Outstanding agent options, December 31, 2021     445,926     $ 7.51  
Granted     487,283       2.51  
Expired     (1,702 )     20.49  
Outstanding agent options, December 31, 2022     931,507     $ 4.12  
Granted     -       -  
Expired     -       -  
Outstanding agent options, June 30, 2023 and date of MD&A (before the 100-1 reverse stock split)     931,507     $ 4.87  
Outstanding agent options, June 30, 2023 and date of MD&A (after the 100-1 reverse stock split)     9,315     $ 487.00  

 

As at June 30, 2023 agent options outstanding are as follows:

 

Grant Date   Number of
options
outstanding
    Number of
options
exercisable
    Weighted
Average
Exercise
Price
    Expiry date   Remaining
contractual
life (years)
 
                             
29-Sep-20     113,500       113,500     $ 6.60     28-Sep-25     2.00  
29-Sep-20     266,000       266,000     $ 6.85     28-Sep-25     2.00  
31-Dec-20     64,724       64,724     $ 11.50     30-Jun-24     1.00  
11-Jan-22     434,783       434,783     $ 2.53     11-Jan-27     4.00  
1-Apr-22     52,500       52,500     $ 2.30     8-Mar-27     4.00  
Total (before the 100-1 reverse stock split)     931,507       931,507     $ 4.87           2.98  
Total (after the 100-1 reverse stock split)     9,315       9,315     $ 487.00           2.98  

 

Transactions for the six month period ended June 30, 2022 are as follows:

 

  The Company issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%. The Company also issued 52,500 agent’s options with a fair value of $61,950 with an exercise price of $2.30.

 

  (f) Share purchase warrants

 

A summary of the Company’s share purchase warrant activity is as follows:

 

As at June 30, 2023 the share purchase warrants outstanding are as follows:

 

Grant Date   Number of Warrants outstanding and exercisable     Exercise Price     Expiry date
29-Sep-20     1,805,585       6.85     28-Sep-25
31-Dec-20     1,294,500       11.50     30-Jun-24
11-Jan-22     9,999,999       2.30     10-Jan-27
Total (before the 100-1 reverse stock split)     13,100,084     $ 3.84      
Total (before the 100-1 reverse stock split)     131,001     $ 384.00      

 

Transactions for the six months ended June 30, 2023 are as follows:

 

  18,042,857 warrants were exercised on January 12, 2023. The Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 31, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,857 cashless warrants were exercised in Q2 2023.

 

Transactions for the six month period ended June 30, 2022 are as follows:

 

 

On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exercisable at $2.30 per warrant and with a term of five years. 

XML 49 R19.htm IDEA: XBRL DOCUMENT v3.23.2
Cost of Sales
3 Months Ended
Mar. 31, 2023
Cost Of Sales Text Block [Abstract]  
COST OF SALES
8.COST OF SALES

 

(in thousands)  March 31,
2023
   March 31,
2022
 
         
Inventory expensed  $971   $359 
Royalties   106    54 
Other expenses   229    165 
Total  $1,306   $578 
XML 50 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Selling and Marketing Expenses
3 Months Ended
Mar. 31, 2023
Selling and Marketing Expenses [Abstract]  
SELLING AND MARKETING EXPENSES
9.SELLING AND MARKETING EXPENSES

 

(in thousands)  March 31,
2023
   March 31,
2022
 
         
Salaries and related expenses  $705   $618 
Advertising and marketing   249    398 
Travel and conferences   49    29 
Total  $1,003   $1,045 
XML 51 R21.htm IDEA: XBRL DOCUMENT v3.23.2
General and Administrative Expenses
6 Months Ended
Jun. 30, 2023
General and Administrative Expenses [Abstract]  
GENERAL AND ADMINISTRATIVE EXPENSES
10.GENERAL AND ADMINISTRATIVE EXPENSES

 

(in thousands)  March 31,
2023
   March 31,
2022
 
Salaries and related expenses  $151   $125 
Professional services   565    377 
Consulting and director fees   263    419 
Travel   14    36 
Office and general   326    442 
Regulatory and filing fees   27    21 
Shareholder relations   46    239 
Total  $1,392   $1,659 
XML 52 R22.htm IDEA: XBRL DOCUMENT v3.23.2
Transaction Costs
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Transaction Costs [Abstract]    
TRANSACTION COSTS
11.TRANSACTION COSTS

 

Transaction costs incurred in relation to the January 2023 warrant raise and issuance described in Note 7 were $309,000 and were included in the change in fair value of warrant liability on the statement of operations.

 

Transaction costs incurred in the three months ended March 31, 2022 were $965,247, which are costs incurred for the January 11, 2022 capital raise that were allocated to the warrant liability and expensed through the statement of operations.

6. TRANSACTION COSTS

 

Transaction costs incurred in relation to the January 2023 warrant raise and issuance described in Note 5 were $439,600 and were included in the change in fair value of warrant liability on the statement of operations.

 

Transaction costs incurred in the six months ended June 30, 2022 were $965,247, which are costs incurred for the January 11, 2022 capital raise that were allocated to the warrant liability and expensed through the statement of operations.

XML 53 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Financial Instruments
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Derivative Financial Instruments Text Block [Abstract]    
FINANCIAL INSTRUMENTS
12.FINANCIAL INSTRUMENTS

 

The fair values of the Company’s cash, trade and other receivables, accounts payable and accrued liabilities and long-term debt, approximate carrying value, which is the amount recorded on the consolidated statement of financial position.

 

Credit risk

 

Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company places its cash with institutions of high creditworthiness. Management has assessed there to be a low level of credit risk associated with its cash balances.

 

The Company’s exposure to credit risk is influenced mainly by the individual characteristics of each customer. However, management also considers the demographics of the Company’s customer base, including the default risk of the industry and country in which customers operate, as these factors may have an influence on credit risk. Approximately 34% of the Company’s revenue for the three months ended March 31, 2023 (March 31, 2022 -23%) is attributable to sales transactions with a single customer.

 

The Company has established a credit policy under which each new customer is analyzed individually for creditworthiness before the Company’s standard payment and delivery terms and conditions are offered. The Company’s review includes external ratings, when available, and in some cases bank references. Purchase limits are established for each customer, which represents the maximum open amount without requiring approval from the Risk Management Committee; these limits are reviewed quarterly. In prior years, certain key customers were offered extended payment terms on their purchases due to slow down from Covid-19 and budget approvals for government tenders.

 

As a result, the Company had customers with overdue receivables on their books which resulted in the Company taking a bad debt provision on these overdue receivables which amounted to $1,062,052 at March 31, 2023 (March 31, 2022 - $1,056,393).

 

More than 50% (2022 – 18%) of the Company’s customers have been active with the Company for over four years, and the allowance for doubtful accounts of $1,062,052 (2022 - $1,056,393) has been recognized against these customers. In monitoring customer credit risk, customers are grouped according to their credit characteristics, including whether they are an individual or legal entity, whether they are a wholesale, retail or end-user customer, geographic location, industry, aging profile, maturity, and the existence of previous financial difficulties. Trade and other receivables relate mainly to the Company’s wholesale customers. Customers that are graded as “high risk” are placed on a restricted customer list and monitored by the Company.

 

The carrying amount of financial assets represents the maximum credit exposure, notwithstanding the carrying amount of security or any other credit enhancements.

 

Liquidity risk

 

Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities that are settled by delivering cash or another financial asset. The Company’s approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company’s reputation.

 

The Company examines current forecasts of its liquidity requirements so as to make certain that there is sufficient cash for its operating needs, and it is careful at all times to have enough unused credit facilities so that the Company does not exceed its credit limits and is in compliance with its financial covenants (if any). These forecasts take into consideration matters such as the Company’s plan to use debt for financing its activity, compliance with required financial covenants, compliance with certain liquidity ratios, and compliance with external requirements such as laws or regulation.

 

The Company uses activity-based costing to cost its products and services, which assists it in monitoring cash flow requirements and optimizing its cash return on investments. Typically, the Company ensures that it has sufficient cash on demand to meet expected operational expenses for a period of 90 days, including the servicing of financial obligations; this excludes the potential impact of extreme circumstances that cannot reasonably be predicted, such as natural disasters.

 

With the exception of employee benefits, the Company’s accounts payable and accrued liabilities have contractual terms of 90 days. The employment benefits included in accrued liabilities have variable maturities within the coming year.

 

Market risk

 

  a) Currency Risk

 

Currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates.

 

  b) Interest Rate Risk

 

Interest rate risk is the risk that the fair value of future cash flows will fluctuate as a result of changes in interest rates. The Company’s sensitivity to interest rates is inherently involved in the calculation of the fair value of the warranty liability which are revalued based on changes parameters which include the prevailing interest rate.

 

  c) Price Risk

 

The Company is exposed to price risk with respect to equity prices. Equity price risk is defined as the potential adverse impact on the Company’s earnings due to movements in individual equity prices or general movements in the level of the stock market. The Company closely monitors individual equity movements, and the stock market to determine the appropriate course of action to be taken by the Company.

7. FINANCIAL INSTRUMENTS

 

The fair values of the Company’s cash, trade and other receivables, accounts payable and accrued liabilities and long-term debt, approximate carrying value, which is the amount recorded on the unaudited condensed interim consolidated statement of financial position.

XML 54 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Related Party Text Block [Abstract]    
RELATED PARTY TRANSACTIONS
13.RELATED PARTY TRANSACTIONS

 

Key Personnel Compensation

 

Key management personnel includes those persons having authority and responsibility for planning, directing, and controlling the activities of the Company as a whole. The Company has determined that key management personnel consists of executive and non-executive members of the Company’s Board of Directors and corporate officers. The remuneration of directors and key management personnel for the three months ended March 31, 2023 and 2022 are as follows:

 

   2023   2022 
Payments to key management personnel:        
Salaries, consulting and directors’ fees  $285,413   $491,889 
Share-based payments   243,323    767,436 
Total  $528,736   $1,259,325 

  

Salaries, consulting and directors’ fees shown above are classified within profit and loss as shown below:

 

      (in thousands) 
Type of Service  Nature of Relationship  2023   2022 
Selling and marketing expenses  VP Technology/VP Sales International  $46   $84 
General and administrative expense  Companies controlled by the CEO, CFO and Directors  $239   $408 
8. RELATED PARTY TRANSACTIONS

 

Key Personnel Compensation

 

Key management personnel includes those persons having authority and responsibility for planning, directing, and controlling the activities of the Company as a whole. The Company has determined that key management personnel consists of executive and non-executive members of the Company’s Board of Directors and corporate officers. The remuneration of directors and key management personnel for the three and six month period ended June 30, 2023 and 2022 are as follows:

 

   2023   2022 
Payments to key management personnel:        
Salaries, consulting and directors’ fees  $667,582   $851,262 
Share-based payments   438,008    1,792,129 
Total  $1,105,590   $2,643,391 

 

Salaries, consulting and directors’ fees shown above are classified within profit and loss as shown below:

 

      (in thousands) 
Type of Service  Nature of Relationship  2023   2022 
Selling and marketing expenses  VP Technology/VP Sales International  $182   $152 
General and administrative expense  Companies controlled by the CEO, CFO and Directors  $486   $699 
XML 55 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Segmented Information
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Segmented Information Disclosure [Abstract]    
SEGMENTED INFORMATION
14.SEGMENTED INFORMATION

 

The Company is domiciled in Canada, and it operates and produces its income primarily in Israel, Europe and North America. The Company operates as a single segment being the sale of cellular-based communications products.

 

The Company’s entity-wide disclosures include disaggregated information about product sales, geographical areas, and major customers.

 

Geographical area information is shown below:

 

External revenues by Geography for the three months ended March 31    
(in thousands)  2023   2022 
         
USA  $1,073   $245 
Canada   219    249 
EMEA   511    326 
Australia   
-
    13 
Total  $1,803   $833 

 

Non-current asset geographic area information is shown below:

 

(in thousands)  March 31,
2023
   December 31,
2022
 
         
Long-term receivable total  $146   $150 
Canada   
-
    
-
 
EMEA   146    150 
           
Right of use asset total  $812   $887 
Canada   118    177 
EMEA   694    710 
           
Equipment total  $200   $207 
Canada   
-
    
-
 
EMEA   200    207 
           
Intangibles total  $7,481   $6,988 
Canada   
-
    
-
 
EMEA   7,481    6,988 

 

Product information is shown below:

 

Revenue by product line for the three months ended March 31        
(in thousands)  2023   2022 
Cellular boosters and related accessories  $438   $463 
Rugged devices and related accessories   1,365    370 
Total  $1,803   $833 
9. SEGMENTED INFORMATION

 

The Company is domiciled in Canada, and it operates and produces its income primarily in Israel, Europe and North America. The Company operates as a single segment being the sale of cellular-based communications products.

 

The Company’s entity-wide disclosures include disaggregated information about product sales, geographical areas, and major customers.

 

Geographical area information is shown below:

 

External revenues by Geography for the three and six month period ended June 30  6 months ended
June 30
   3 months ended
June 30
 
(in thousands)  2023   2022   2023   2022 
USA  $3,342   $722   $2,270   $477 
Canada   521    625    302    376 
EMEA   650    443    139    104 
Australia   
-
    

13

    
-
    13 
Total  $4,513   $1,803   $2,711   $970 

 

Non-current asset geographic area information is shown below:

 

(in thousands)  June 30,
2023
   December 31,
2022
 
         
Long-term receivable total  $143   $150 
Canada   
-
    
-
 
EMEA   143    150 
           
Right of use asset total  $771   $887 
Canada   126    177 
EMEA   645    710 
           
Equipment total  $191   $207 
Canada   
-
    
-
 
EMEA   191    207 
           
Intangibles total  $7,633   $6,988 
Canada   70    
-
 
EMEA   7,563    6,988 

 

Product information is shown below:

 

Revenue by product line for the three and six month period ended June 30  6 months ended   3 months ended 
(in thousands)  2023   2022   2023   2022 
Cellular boosters and related accessories  $1,012    1,213   $575    750 
Rugged devices and related accessories  $3,501    590   $2,136    220 
Total  $4,513    1,803   $2,711    970 
XML 56 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Supplemental Information with Respect to Cash Flows
3 Months Ended
Mar. 31, 2023
Supplemental Information with Respect to Cash Flows [Abstract]  
SUPPLEMENTAL INFORMATION WITH RESPECT TO CASH FLOWS
15.SUPPLEMENTAL INFORMATION WITH RESPECT TO CASH FLOWS

 

   Three months ended
March 31
 
   2023   2022 
Change in non-cash working capital:        
Trade and other receivables  $463,505   $(6,303)
Prepaids   (491,942)   (731,566)
Inventory   528,510    (1,060,581)
Advances to suppliers   (519,709)   (590,506)
Accounts payable and accrued liabilities   (967,476)   (836,698)
Deferred revenue   (149,600)   
-
 
   $(1,136,712)  $(3,225,654)

 

During the three months ended March 31, 2023, the Company paid $nil (March 31, 2022 - $2,659) in interest and $Nil (March 31, 2022 - $nil) in income taxes.

XML 57 R27.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent Events
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Subsequent Events [Abstract]    
SUBSEQUENT EVENTS
16.SUBSEQUENT EVENTS

 

Subsequent to the period end, a total of 21,031,987 cashless warrants were exercised in exchange for common shares of the Company.

 

On June 28, 2023 the Company issued 50,000,000 at $0.045 per share for gross proceeds of $2,250,000 before offering expenses and other expenses included in share issuance costs.

 

On July 13, 2023, the Company issued 51,450,000 shares at $0.045 per share for gross proceeds of $2,315,250.

 

On August 3, 2023, the Company affected a 100-to-1 reverse stock split resulting in 185,393,404 shares converted with rounding into 1,853,955 shares.

 

The Company was issued a cease trading order by the British Columbia Securities Exchange for late filing of these Q1 2023 financial statements that were due on May 15, 2023. The cease trading order was lifted upon filing of the Q1 2023 financial statements on May 24, 2023.

 

The Company entered into a factoring agreement for their receivables in North America.

10. SUBSEQUENT EVENTS

 

Subsequent to the period end, the Company issued 51,250,000 common shares at $0.45 for total gross proceeds of $2,306,250.

 

On August 9, 2023, the Company affected a 100-to-1 reverse stock split resulting in 185,393,404 common shares converted with rounding into 1,853,955 new common shares.

XML 58 R28.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement of Financial Statements
6 Months Ended
Jun. 30, 2023
Disclosure Of Separate Financial Statements Text Block Abstract  
RESTATEMENT OF FINANCIAL STATEMENTS
17.RESTATEMENT OF FINANCIAL STATEMENTS

 

In conjunction with preparation of the Company’s financial statements for the three month period ended March 31, 2023 and as part of a continuous disclosure review by the Staff of Company’s principal securities regulator in relation to the accounting for warrant liability and share capital, the Company identified an error in how the fair value has been accounted for in the previously issued financial statements.

 

The Company evaluated the significance of the corrections and determined the adjustments were material to the unaudited condensed interim consolidated financial statements for the three month period ended March 31, 2023. The impact of these changes have been restated in these financial statements.

 

The above restatement reflects the impact of an error in the calculation of the fair value of warrant liability on January 19, 2023 due to an incorrect input parameter for the term to maturity of those warrants resulting in an overstatement of the change in fair value expense for the period of $2,705,253 and a resulting decrease in the same amount to share capital.

 

The above restatement did not impact the total assets nor liabilities and did not impact the net equity as the share capital decreased by $2,705,253 and the deficit was reduced by the same amount.

 

   As originally filed   Adjustment   As Restated 
ASSETS            
Current            
Cash  $1,179,694    
 
   $1,179,694 
Trade and other receivables (Note 3)   1,111,123    
 
    1,111,123 
Prepaid expenses   665,446    
 
    665,446 
Inventory (Note 4)   3,564,040    
 
    3,564,040 
Advance to suppliers   675,561    
 
    675,561 
    7,195,864    
 
    7,195,864 
Long term receivable   146,196    
 
    146,196 
Right of use assets   811,966    
 
    811,966 
Equipment   199,743    
 
    199,743 
Intangible assets   7,481,391    
 
    7,481,391 
Total assets  $15,835,160    
 
   $15,835,160 
                
LIABILITIES AND SHAREHOLDERS' EQUITY               
Current               
Accounts payable and accrued liabilities  $2,111,174    
 
   $2,111,174 
Deferred revenue   
-
    
 
    
-
 
Lease obligations   294,359    
 
    294,359 
Warrant liability (Note 6)   628,765    
 
    628,765 
    3,034,298    
 
    3,034,298 
Lease obligation   543,944    
 
    543,944 
Total liabilities   3,578,242    
 
    3,578,242 
Shareholders' equity               
Share capital (Note 7)   79,626,690    (2,705,253)   76,921,437 
Reserves (Note 7)   17,933,273    
 
    17,933,273 
Accumulated other comprehensive loss   98,870    
 
    98,870 
Deficit   (85,401,915)   2,705,253    (82,696,662)
    12,256,918    
-
    12,256,918 
Total liabilities and shareholders' equity  $15,835,160   $
-
   $15,835,160 

 

   As originally filed   Adjustment   As Restated 
Revenue  $1,802,637    
 
   $1,802,637 
Cost of sales (Note 8)   (1,306,120)   
 
    (1,306,120)
Gross profit   496,517    
 
    496,517 
                
EXPENSES               
Amortization and depreciation   401,640    
 
    401,640 
Development expenses   53,985    
 
    53,985 
Selling and marketing (Note 9)   1,003,365    
 
    1,003,365 
General and administrative (Note 10)   1,392,430    
 
    1,392,430 
Share-based payments (Note 7)   310,828    
 
    310,828 
Total operating expenses   3,162,248    
 
    3,162,248 
                
Net operating loss   (2,665,731)   
 
    (2,665,731)
                
OTHER EXPENSES               
Finance expense (Note 11)   34,098    
 
    34,098 
Foreign exchange   163    
 
    163 
Change in fair value of convertible promissory note (Note 5)   
-
    
 
    
-
 
Change in fair value of warrant liability (Note 6)   4,883,260    (2,705,253)   2,178,007 
Transaction costs (Note 12)   -    
 
    
-
 
Total other expenses   4,917,521    (2,705,253)   2,212,268 
Net loss for the year   (7,583,252)   (2,705,253)   (4,877,999)
                
Other comprehensive income               
Translation adjustment   
-
    
 
    
-
 
                
Comprehensive loss for the year  $(7,583,252)  $(2,705,253)  $(4,877,999)
                
Weighted average shares   59,102,369    59,102,369    59,102,369 
Basic and diluted loss per share
  $(0.13)  $0.05   $(0.08)

 

Selected line items restated in the Consolidated Statements of Changes in Shareholder’s Equity:

 

Deficit  As originally filed   Adjustment   As Restated 
Deficit-Beginning of period   (77,818,663)   
 
    (77,818,663)
loss for the period   (7,583,252)   2,705,253    (4,877,999)
Deficit-end of period   (85,401,915)   2,705,253    (82,696,662)

 

Share Capital  As originally filed   Adjustment   As Restated 
Share capital-Beginning of period   73,312,866    
 
    73,312,866 
warrants exercised   6,313,824    (2,705,253)   3,608,571 
Share capital-end of period   79,626,690    (2,705,253)   76,921,437 

 

Selected line items restated in the Consolidated Statements of Cash Flows:

 

   As originally filed   Adjustment   As Restated 
Operating activities               
Net loss for the year  $(7,583,252)  $2,705,253   $(4,877,999)
Items not affecting cash:               
Amortization and depreciation   401,640    
 
    401,640 
Bad debt expense   
-
    
 
    
-
 
Fair value changes on derivatives   4,883,260    (2,705,253)   2,178,007 
Interest expense, net of repayments   
-
    
 
    
-
 
Foreign exchange   11,666    
 
    11,666 
Transaction costs   
-
    
 
    
-
 
Share based payments   310,828    
 
    310,828 
Change in non-cash working capital   (1,136,712)   
 
    (1,136,712)
Net cash used in operating activities   (3,112,570)   
-
    (3,112,570)
                
Investing activities               
Intangible asset additions   (817,849)   
 
    (817,849)
Equipment additions   (2,498)   
 
    (2,498)
Acquisition of ClearRF   
-
    
 
    
-
 
Net cash used in investing activities   (820,347)   
 
    (820,347)
                
Financing activities               
Lease payments   (100,702)   
 
    (100,702)
Bank loan   
-
    
 
    
-
 
Convertible debt issued, net of repayments   
-
    
 
    
-
 
Proceeds on share issuance, net of share issuance costs   
-
    
 
    
-
 
Transaction costs   (309,000)   
 
    (309,000)
Exercise of warrants   3,608,571    
 
    3,608,571 
Net cash from financing activities   3,198,869    
-
    3,198,869 
                
Effect of foreign exchange on cash   
-
    
 
    
-
 
                
Change in cash and restricted cash for the year   (734,048)   
 
    (734,048)
Cash and restricted cash, beginning of year   1,913,742    
 
    1,913,742 
Cash and restricted cash, end of year  $1,179,694   $
-
   $1,179,694 
XML 59 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Bank Loan
6 Months Ended
Jun. 30, 2023
Bank Loan [Abstract]  
BANK LOAN
3.BANK LOAN

 

The Company has obtained in April 2023, a $2,000,0000 line of credit factoring for its North American receivables with an 85% advance rate with interest of 1.8% for the first 30 days, then 0.5% every 10 days thereafter of the face value.

 

This loan is collateralized by the North American receivables, inventory and equipment. As at June 30, 2023 the loan balance is 719,623.

XML 60 R30.htm IDEA: XBRL DOCUMENT v3.23.2
Accounting Policies, by Policy (Policies)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Accounting Policies [Abstract]    
Basis of consolidation and presentation

Basis of consolidation and presentation

These restated unaudited condensed interim consolidated financial statements of the Company have been prepared on a historical cost basis, except for financial instruments classified as financial instruments at fair value through profit and loss, which are stated at their fair value. In addition, the restated condensed interim consolidated financial statements have been prepared using the accrual basis of accounting, except for the statement of cash flows.

These restated unaudited condensed interim consolidated financial statements incorporate the financial statements of the Company and its wholly controlled subsidiaries. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. These restated condensed interim consolidated financial statements include the accounts of the Company and its direct wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.

The restated unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:

Name of Subsidiary   Place of Incorporation   Ownership  
Queensgate Resources Corp.   British Columbia, Canada     100 %
Queensgate Resources US Corp.   Nevada, USA     100 %
Siyata Mobile (Canada) Inc.   British Columbia, Canada     100 %
Siyata Mobile Israel Ltd.   Israel     100 %
Signifi Mobile Inc.   Quebec, Canada     100 %
ClearRF Nevada Ltd.   Nevada, USA     100 %

Basis of consolidation and presentation

These unaudited condensed interim consolidated financial statements of the Company have been prepared on a historical cost basis, except for financial instruments classified as financial instruments at fair value through profit and loss, which are stated at their fair value. In addition, the condensed interim consolidated financial statements have been prepared using the accrual basis of accounting, except for the statement of cash flows.

These unaudited condensed interim consolidated financial statements incorporate the financial statements of the Company and its wholly controlled subsidiaries. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. These condensed interim consolidated financial statements include the accounts of the Company and its direct wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.

The unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:

Name of Subsidiary  Place of Incorporation  Ownership 
Queensgate Resources Corp.  British Columbia, Canada   100%
Queensgate Resources US Corp.  Nevada, USA   100%
Siyata Mobile (Canada) Inc.  British Columbia, Canada   100%
Siyata Mobile Israel Ltd.  Israel   100%
Signifi Mobile Inc.  Quebec, Canada   100%
ClearRF Nevada Ltd.  Nevada, USA   100%
Recent adoptions of accounting pronouncements

Recent adoptions of accounting pronouncements

The following amendments became effective on January 1, 2023, and did not have a material impact on the Company’s condensed interim consolidated financial statements:

  In February 2021, the IASB issued Definition of Accounting Estimates (Amendments to IAS 8). The amendments define accounting estimates and clarify the distinction between changes in accounting estimates and changes in accounting policies.
  In February 2021, the IASB issued Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2). The amendments provide guidance to help entities disclose their material (previously “significant”) accounting policies.
  In May 2021, the IASB issued Deferred Tax related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12). The amendments narrow the scope of the recognition exemption so that companies would be required to recognize deferred tax for transactions that give rise to equal amounts of taxable and deductible temporary differences, such as leases.

 

Recent adoptions of accounting pronouncements

The following amendments became effective on January 1, 2023, and did not have a material impact on the Company’s condensed interim consolidated financial statements:

In February 2021, the IASB issued Definition of Accounting Estimates (Amendments to IAS 8). The amendments define accounting estimates and clarify the distinction between changes in accounting estimates and changes in accounting policies.
In February 2021, the IASB issued Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2). The amendments provide guidance to help entities disclose their material (previously “significant”) accounting policies.
In May 2021, the IASB issued Deferred Tax related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12). The amendments narrow the scope of the recognition exemption so that companies would be required to recognize deferred tax for transactions that give rise to equal amounts of taxable and deductible temporary differences, such as leases.

 

Future accounting pronouncements

Future accounting pronouncements

The standards, amendments, and interpretations issued before 2023 but not yet adopted by the Company have been disclosed in Note 3 of the Company’s December 31, 2022 annual consolidated financial statements. The Company is currently considering the impact of adopting these standards, amendments and interpretations on its consolidated financial statement.

Future accounting pronouncements

The standards, amendments, and interpretations issued before 2023 but not yet adopted by the Company have been disclosed in Note 3 of the Company’s December 31, 2022 annual consolidated financial statements. The Company is currently considering the impact of adopting these standards, amendments and interpretations on its consolidated financial statement. 

XML 61 R31.htm IDEA: XBRL DOCUMENT v3.23.2
Basis of Preparation (Tables)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Basis Of Preparation Of Financial Statements Text Block [Abstract]    
Schedule of Consolidated Financial Statements The restated unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:
Name of Subsidiary   Place of Incorporation   Ownership  
Queensgate Resources Corp.   British Columbia, Canada     100 %
Queensgate Resources US Corp.   Nevada, USA     100 %
Siyata Mobile (Canada) Inc.   British Columbia, Canada     100 %
Siyata Mobile Israel Ltd.   Israel     100 %
Signifi Mobile Inc.   Quebec, Canada     100 %
ClearRF Nevada Ltd.   Nevada, USA     100 %
The unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:
Name of Subsidiary  Place of Incorporation  Ownership 
Queensgate Resources Corp.  British Columbia, Canada   100%
Queensgate Resources US Corp.  Nevada, USA   100%
Siyata Mobile (Canada) Inc.  British Columbia, Canada   100%
Siyata Mobile Israel Ltd.  Israel   100%
Signifi Mobile Inc.  Quebec, Canada   100%
ClearRF Nevada Ltd.  Nevada, USA   100%
XML 62 R32.htm IDEA: XBRL DOCUMENT v3.23.2
Trade and Other Receivables (Tables)
3 Months Ended
Mar. 31, 2023
Trade and Other Receivables [Abstract]  
Schedule of Trade and Other Receivables
   March 31,
2023
   December 31,
2022
 
Trade receivables  $1,645,627   $2,015,291 
Allowance for doubtful accounts   (1,062,052)   (1,056,393)
Taxes receivable   527,548    615,730 
Total  $1,111,123   $1,574,628 
XML 63 R33.htm IDEA: XBRL DOCUMENT v3.23.2
Inventory (Tables)
3 Months Ended
Mar. 31, 2023
Inventory [Abstract]  
Schedule of Inventory
   March 31,
2023
   December 31,
2022
 
Finished products  $6,874,848   $7,392,002 
Impairment of finished products   (3,555,683)   (3,555,683)
Accessories and spare parts   663,645    675,001 
Impairment of accessories and spare parts   (418,770)   (418,770)
Total  $3,564,040   $4,092,550 
XML 64 R34.htm IDEA: XBRL DOCUMENT v3.23.2
Warrant Liability (Tables)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Warrant Liability [Abstract]    
Schedule of the Warrant Liability The balance of the warrant liability is as follows:
   November 3,
2021
   January 11,
2022
   October 12,
2022
   January 19,
2023
   Total 
Balance December 31, 2022  $197,733   $501,330   $2,035,741   $
-
   $2,734,804 
Exercise of warrants   (197,733)   
-
    (1,717,801)   
-
    (1,915,534)
Warrants issued   
-
    
-
    
-
    2,875,580    2,875,580 
Transfer to equity   
-
    
-
    (564,946)   (3,410,100)   (3,975,046)
Change in fair value        127,435    247,006    534,520    908,961 
Balance March 31, 2023  $
-
   $628,765   $
-
   $
-
   $628,765 
Selected line items restated in the Consolidated Statements of Cash Flows:
   As originally filed   Adjustment   As Restated 
Operating activities               
Net loss for the year  $(7,583,252)  $2,705,253   $(4,877,999)
Items not affecting cash:               
Amortization and depreciation   401,640    
 
    401,640 
Bad debt expense   
-
    
 
    
-
 
Fair value changes on derivatives   4,883,260    (2,705,253)   2,178,007 
Interest expense, net of repayments   
-
    
 
    
-
 
Foreign exchange   11,666    
 
    11,666 
Transaction costs   
-
    
 
    
-
 
Share based payments   310,828    
 
    310,828 
Change in non-cash working capital   (1,136,712)   
 
    (1,136,712)
Net cash used in operating activities   (3,112,570)   
-
    (3,112,570)
                
Investing activities               
Intangible asset additions   (817,849)   
 
    (817,849)
Equipment additions   (2,498)   
 
    (2,498)
Acquisition of ClearRF   
-
    
 
    
-
 
Net cash used in investing activities   (820,347)   
 
    (820,347)
                
Financing activities               
Lease payments   (100,702)   
 
    (100,702)
Bank loan   
-
    
 
    
-
 
Convertible debt issued, net of repayments   
-
    
 
    
-
 
Proceeds on share issuance, net of share issuance costs   
-
    
 
    
-
 
Transaction costs   (309,000)   
 
    (309,000)
Exercise of warrants   3,608,571    
 
    3,608,571 
Net cash from financing activities   3,198,869    
-
    3,198,869 
                
Effect of foreign exchange on cash   
-
    
 
    
-
 
                
Change in cash and restricted cash for the year   (734,048)   
 
    (734,048)
Cash and restricted cash, beginning of year   1,913,742    
 
    1,913,742 
Cash and restricted cash, end of year  $1,179,694   $
-
   $1,179,694 
Schedule of Change in Warrant Fair Value   The balance of the warrant liability is as follows:
   November 3,
2021
   January 11,
2022
   October 12,
2022
   January 19,
2023
   Total 
Balance December 31, 2022  $197,733   $501,330   $2,035,741   $
-
   $2,734,804 

Change in fair value of warrants exercised

   (197,733)   
-
    (1,717,801)   
-
    (1,915,534)
Warrants issued   
-
    
-
    
-
    2,875,580    2,875,580 
Proceeds from Inducement warrants issued   
-
    
-
    
-
    
-
    
-
 
Transfer to equity   
-
    
-
    (564,946)   (3,410,100)   (3,975,046)
Change in fair value   
-
    (193,949)   247,006    534,520    587,577 
Balance June 30, 2023  $
-
   $307,381   $
-
   $
-
   $307,381 
Schedule of Change in Warrant Fair Value  
Change in warrant fair value January 1, 2023-June 30, 2023    
Change in fair value of warrants exercised   (1,915,534)
Fair value of warrants issued as inducement   2,875,580 
Other changes in fair value of warrants   587,577 
Day 1 Loss - FV Change in Warrant Liability   309,000 
Total change in warrant fair value January 1, 2023-June 30, 2023   1,856,623 
XML 65 R35.htm IDEA: XBRL DOCUMENT v3.23.2
Share Capital (Tables)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Share Capital [Abstract]    
Schedule of Stock Option Activity A summary of the Company’s stock option activity is as follows:
   Number of
stock
options
  

Weighted
Average

Exercise
Price

 
Outstanding options, December 31, 2021   414,568   $13.88 
Granted   1,145,000   $1.15 
Expired/Cancelled   (53,430)  $30.90 
Outstanding options, December 31, 2022 and March 31, 2023   1,506,138   $3.53 

 

   Number of RSU’s   Weighted Average
Issue
Price
 
Outstanding RSU, December 31, 2021   
-
   $
-
 
Granted   3,195,000   $1.05 
Exercised   (30,000)  $1.10 
Outstanding RSU, December 31, 2022 and March 31, 2023   3,165,000   $1.05 
   Number of
options
   Weighted
average
exercise price
 
Outstanding agent options, December 31, 2021   445,926   $7.51 
Granted   487,283   $2.51 
Expired   (1,702)  $20.49 
Outstanding agent options, December 31, 2022 and March 31, 2023   931,507   $4.12 
   Number of Warrants   Weighted average exercise price 
Outstanding, December 31, 2021   5,121,328   $7.64 
Granted   29,139,129   $0.94 
Expired   (128,386)  $33.47 
Outstanding, December 31, 2022   34,132,071   $1.76 
Granted   18,042,857    0.20 
Exercised   (18,042,857)   0.20 
Outstanding, March 31, 2023   34,132,071   $1.47 
A summary of the Company’s stock option activity is as follows:
   Number of
Stock
Options
   Weighted
Average
Exercise
Price
 
Outstanding options, December 31, 2021   414,568   $13.88 
Granted   1,145,000    1.15 
Expired/Cancelled   (53,430)   30.90 
Outstanding options, December 31, 2022   1,506,138   $3.53 
Granted   
-
    
-
 
Expired/Cancelled   
-
    
-
 
Outstanding options, June 30, 2023 and date of MD&A (before the 100-1 reverse stock split)  1,506,138   $3.53 
Outstanding options, June 30, 2023 and date of MD&A (after the 100-1 reverse stock split)   15,061   $353.00 

 

    Number of RSU’s     Weighted
Average
Issue Price
 
             
Outstanding RSU, December 31, 2021     0     $ -  
Granted     3,195,000       1.05  
Exercised     (30,000 )     1.10  
Outstanding RSU, December 31, 2022     3,165,000     $ 1.05  
Granted     -       -  
Exercised     -       -  
Outstanding RSU, June 30, 2023 and date of MD&A (before 100-1 reverse stock split)     3,165,000     $ 1.05  
Outstanding RSU, June 30, 2023 and date of MD&A  (after 100-1 reverse stock split)     31,650     $ 105.00  
    Number of
options
    Weighted
average
exercise price
 
             
Outstanding agent options, December 31, 2020     452,523     $ 8.02  
Expired     (6,597 )     52,68  
Outstanding agent options, December 31, 2021     445,926     $ 7.51  
Granted     487,283       2.51  
Expired     (1,702 )     20.49  
Outstanding agent options, December 31, 2022     931,507     $ 4.12  
Granted     -       -  
Expired     -       -  
Outstanding agent options, June 30, 2023 and date of MD&A (before the 100-1 reverse stock split)     931,507     $ 4.87  
Outstanding agent options, June 30, 2023 and date of MD&A (after the 100-1 reverse stock split)     9,315     $ 487.00  
Schedule Stock Options Outstanding As at March 31, 2023 stock options outstanding are as follows:
Grant Date  Number of
options
outstanding
   Number of
options
exercisable
   Weighted
Average
Exercise
Price
   Expiry date  Remaining
contractual
life (years)
 
24-Dec-18   12,896    12,896   $54.00   24-Dec-23   0.63 
15-Jan-19   828    828   $54.00   15-Jan-24   0.69 
21-Mar-19   12,345    12,345   $59.00   21-Mar-24   0.87 
01-Jan-20   2,069    2,069   $54.00   01-Jan-24   0.65 
15-Nov-20   95,000    95,000   $6.00   15-Nov-30   7.53 
15-Nov-20   161,500    161,500   $6.00   15-Nov-25   2.52 
02-Jan-21   57,000    57,000   $11.50   02-Jan-26   2.65 
02-Jan-21   5,000    5,000   $11.50   02-Jan-31   7.66 
18-Jan-21   14,500    14,500   $11.50   18-Jan-26   2.70 
01-Jan-22   20,000    12,500   $4.00   29-Oct-26   3.48 
13-Apr-22   795,000    265,000   $1.10   13-Apr-27   3.93 
12-Jul-22   330,000    110,000   $1.10   12-Jul-25   2.18 
Total   1,506,138    748,638   $3.53       3.51 
Grant Date  Number of
RSU’s
outstanding
   Number of
RSU’s
exercisable
   Weighted
Average
Issue Price
 
09-Mar-22   2,250,000    1,200,000   $1.03 
13-Apr-22   825,000    513,750   $1.10 
12-Jul-22   90,000    37,500   $1.10 
Outstanding RSU, March 31, 2023   3,165,000    1,751,250   $1.05 
Grant Date  Number of
options
outstanding
   Number of
options
exercisable
   Weighted
Average
Exercise Price
   Expiry date  Remaining
contractual life (years)
 
                    
29-Sep-20   113,500    113,500   $6.60   28-Sep-25   2.00 
29-Sep-20   266,000    266,000   $6.85   28-Sep-25   2.00 
31-Dec-20   64,724    64,724   $11.50   30-Jun-24   1.00 
11-Jan-22   434,783    434,783   $2.53   11-Jan-27   4.00 
01-Apr-22   52,500    52,500   $2.30   08-Mar-27   4.00 
Total   931,507    931,507   $4.12       2.98 
Grant Date  Number of
Warrants
outstanding and
exercisable
   Exercise
Price
   Expiry date
29-Sep-20   1,805,585   $6.85   28-Sep-25
31-Dec-20   1,294,500   $11.50   30-Jun-24
11-Jan-22   9,999,999   $2.30   11-Jan-27
12-Oct-22   1,250,000    Cashless   11-Jan-27
12-Oct-22   1,739,130    Cashless   11-Jan-27
19-Jan-23   18,042,857    Cashless   18-Jan-28
Total   34,132,071   $1.47    
As at June 30, 2023 stock options outstanding are as follows:
Grant Date  Number of
options
outstanding
   Number of
options exercisable
   Weighted
Average
Exercise
Price
   Expiry date  Remaining
contractual
life (years)
 
24-Dec-18   12,896    12,896    54.00   24-Dec-23   0.48 
15-Jan-19   828    828    54.00   15-Jan-24   0.55 
21-Mar-19   12,345    12,345    59.00   21-Mar-24   0.73 
1-Jan-20   2,069    2,069    54.00   1-Jan-24   0.51 
15-Nov-20   95,000    95,000    6.00   15-Nov-30   7.38 
15-Nov-20   161,500    161,500    6.00   15-Nov-25   2.38 
2-Jan-21   57,000    57,000    11.50   2-Jan-26   2.51 
2-Jan-21   5,000    5,000    11.50   2-Jan-31   7.52 
18-Jan-21   14,500    14,500    11.50   18-Jan-26   2.56 
1-Jan-22   20,000    12,500    4.00   29-Oct-26   3.33 
13-Apr-22   795,000    331,250    1.10   13-Apr-27   3.79 
12-Jul-22   330,000    110,000    1.10   12-Jul-25   2.04 
Total (before the 100-1 reverse stock split)   1,506,138    794, 888   $3.53       3.67 
Total (after the 100-1 reverse stock split)   15,061    7,949   $353.00       3.67 
Grant Date   Number of
RSU’s
outstanding
    Number of
RSU’s
exercisable
    Weighted
Average
Issue Price
 
9-Mar-22     2,250,000       1,350,000       1.03  
13-Apr-22     825,000       513,750       1.10  
12-Jul-22     90,000       30,000       1.10  
Outstanding RSU, June 30, 2023 and date of MD&A (before 100-1 reverse stock split)     3,165,000       1,893,750     $ 1.05  
Outstanding RSU, June 30, 2023 and date of MD&A (after 100-1 reverse stock split)     31,650       18,938     $ 105.00  
Grant Date   Number of
options
outstanding
    Number of
options
exercisable
    Weighted
Average
Exercise
Price
    Expiry date   Remaining
contractual
life (years)
 
                             
29-Sep-20     113,500       113,500     $ 6.60     28-Sep-25     2.00  
29-Sep-20     266,000       266,000     $ 6.85     28-Sep-25     2.00  
31-Dec-20     64,724       64,724     $ 11.50     30-Jun-24     1.00  
11-Jan-22     434,783       434,783     $ 2.53     11-Jan-27     4.00  
1-Apr-22     52,500       52,500     $ 2.30     8-Mar-27     4.00  
Total (before the 100-1 reverse stock split)     931,507       931,507     $ 4.87           2.98  
Total (after the 100-1 reverse stock split)     9,315       9,315     $ 487.00           2.98  
Grant Date   Number of Warrants outstanding and exercisable     Exercise Price     Expiry date
29-Sep-20     1,805,585       6.85     28-Sep-25
31-Dec-20     1,294,500       11.50     30-Jun-24
11-Jan-22     9,999,999       2.30     10-Jan-27
Total (before the 100-1 reverse stock split)     13,100,084     $ 3.84      
Total (before the 100-1 reverse stock split)     131,001     $ 384.00      
XML 66 R36.htm IDEA: XBRL DOCUMENT v3.23.2
Cost of Sales (Tables)
3 Months Ended
Mar. 31, 2023
Cost Of Sales Text Block [Abstract]  
Schedule of Cost of Sales
(in thousands)  March 31,
2023
   March 31,
2022
 
         
Inventory expensed  $971   $359 
Royalties   106    54 
Other expenses   229    165 
Total  $1,306   $578 
XML 67 R37.htm IDEA: XBRL DOCUMENT v3.23.2
Selling and Marketing Expenses (Tables)
3 Months Ended
Mar. 31, 2023
Disclosure Of General And Administrative Expense Text Block Abstract  
Schedule of Selling and Marketing Expenses SELLING AND MARKETING EXPENSES
(in thousands)  March 31,
2023
   March 31,
2022
 
         
Salaries and related expenses  $705   $618 
Advertising and marketing   249    398 
Travel and conferences   49    29 
Total  $1,003   $1,045 
XML 68 R38.htm IDEA: XBRL DOCUMENT v3.23.2
General and Administrative Expenses (Tables)
6 Months Ended
Jun. 30, 2023
General and Administrative Expenses [Abstract]  
Schedule of General and Administrative Eexpenses GENERAL AND ADMINISTRATIVE EXPENSES
(in thousands)  March 31,
2023
   March 31,
2022
 
Salaries and related expenses  $151   $125 
Professional services   565    377 
Consulting and director fees   263    419 
Travel   14    36 
Office and general   326    442 
Regulatory and filing fees   27    21 
Shareholder relations   46    239 
Total  $1,392   $1,659 
XML 69 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions (Tables)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Related Party Text Block [Abstract]    
Schedule of Remuneration of Directors and Key Management Personnel The remuneration of directors and key management personnel for the three months ended March 31, 2023 and 2022 are as follows:
   2023   2022 
Payments to key management personnel:        
Salaries, consulting and directors’ fees  $285,413   $491,889 
Share-based payments   243,323    767,436 
Total  $528,736   $1,259,325 

  

The remuneration of directors and key management personnel for the three and six month period ended June 30, 2023 and 2022 are as follows
   2023   2022 
Payments to key management personnel:        
Salaries, consulting and directors’ fees  $667,582   $851,262 
Share-based payments   438,008    1,792,129 
Total  $1,105,590   $2,643,391 

 

Schedule of Classified within Profit and Loss Salaries, consulting and directors’ fees shown above are classified within profit and loss as shown below:
      (in thousands) 
Type of Service  Nature of Relationship  2023   2022 
Selling and marketing expenses  VP Technology/VP Sales International  $46   $84 
General and administrative expense  Companies controlled by the CEO, CFO and Directors  $239   $408 
Salaries, consulting and directors’ fees shown above are classified within profit and loss as shown below:
      (in thousands) 
Type of Service  Nature of Relationship  2023   2022 
Selling and marketing expenses  VP Technology/VP Sales International  $182   $152 
General and administrative expense  Companies controlled by the CEO, CFO and Directors  $486   $699 
XML 70 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Segmented Information (Tables)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Segmented Information Disclosure [Abstract]    
Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers Geographical area information is shown below:
External revenues by Geography for the three months ended March 31    
(in thousands)  2023   2022 
         
USA  $1,073   $245 
Canada   219    249 
EMEA   511    326 
Australia   
-
    13 
Total  $1,803   $833 

 

Geographical area information is shown below:
External revenues by Geography for the three and six month period ended June 30  6 months ended
June 30
   3 months ended
June 30
 
(in thousands)  2023   2022   2023   2022 
USA  $3,342   $722   $2,270   $477 
Canada   521    625    302    376 
EMEA   650    443    139    104 
Australia   
-
    

13

    
-
    13 
Total  $4,513   $1,803   $2,711   $970 

 

Schedule of Non Current Asset Geographic Area Information Non-current asset geographic area information is shown below:
(in thousands)  March 31,
2023
   December 31,
2022
 
         
Long-term receivable total  $146   $150 
Canada   
-
    
-
 
EMEA   146    150 
           
Right of use asset total  $812   $887 
Canada   118    177 
EMEA   694    710 
           
Equipment total  $200   $207 
Canada   
-
    
-
 
EMEA   200    207 
           
Intangibles total  $7,481   $6,988 
Canada   
-
    
-
 
EMEA   7,481    6,988 
Non-current asset geographic area information is shown below:
(in thousands)  June 30,
2023
   December 31,
2022
 
         
Long-term receivable total  $143   $150 
Canada   
-
    
-
 
EMEA   143    150 
           
Right of use asset total  $771   $887 
Canada   126    177 
EMEA   645    710 
           
Equipment total  $191   $207 
Canada   
-
    
-
 
EMEA   191    207 
           
Intangibles total  $7,633   $6,988 
Canada   70    
-
 
EMEA   7,563    6,988 
Schedule of Product Information Product information is shown below:
Revenue by product line for the three months ended March 31        
(in thousands)  2023   2022 
Cellular boosters and related accessories  $438   $463 
Rugged devices and related accessories   1,365    370 
Total  $1,803   $833 
Revenue by product line for the three and six month period ended June 30  6 months ended   3 months ended 
(in thousands)  2023   2022   2023   2022 
Cellular boosters and related accessories  $1,012    1,213   $575    750 
Rugged devices and related accessories  $3,501    590   $2,136    220 
Total  $4,513    1,803   $2,711    970 
XML 71 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Supplemental Information with Respect to Cash Flows (Tables)
3 Months Ended
Mar. 31, 2023
Supplemental Information with Respect to Cash Flows [Abstract]  
Schedule of Supplemental Information with Respect to Cash Flows
   Three months ended
March 31
 
   2023   2022 
Change in non-cash working capital:        
Trade and other receivables  $463,505   $(6,303)
Prepaids   (491,942)   (731,566)
Inventory   528,510    (1,060,581)
Advances to suppliers   (519,709)   (590,506)
Accounts payable and accrued liabilities   (967,476)   (836,698)
Deferred revenue   (149,600)   
-
 
   $(1,136,712)  $(3,225,654)
XML 72 R42.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement of Financial Statements (Tables)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Disclosure Of Separate Financial Statements Text Block Abstract    
Schedule of restated in the Consolidated Statements of Financial Position   The above restatement did not impact the total assets nor liabilities and did not impact the net equity as the share capital decreased by $2,705,253 and the deficit was reduced by the same amount.
   As originally filed   Adjustment   As Restated 
ASSETS            
Current            
Cash  $1,179,694    
 
   $1,179,694 
Trade and other receivables (Note 3)   1,111,123    
 
    1,111,123 
Prepaid expenses   665,446    
 
    665,446 
Inventory (Note 4)   3,564,040    
 
    3,564,040 
Advance to suppliers   675,561    
 
    675,561 
    7,195,864    
 
    7,195,864 
Long term receivable   146,196    
 
    146,196 
Right of use assets   811,966    
 
    811,966 
Equipment   199,743    
 
    199,743 
Intangible assets   7,481,391    
 
    7,481,391 
Total assets  $15,835,160    
 
   $15,835,160 
                
LIABILITIES AND SHAREHOLDERS' EQUITY               
Current               
Accounts payable and accrued liabilities  $2,111,174    
 
   $2,111,174 
Deferred revenue   
-
    
 
    
-
 
Lease obligations   294,359    
 
    294,359 
Warrant liability (Note 6)   628,765    
 
    628,765 
    3,034,298    
 
    3,034,298 
Lease obligation   543,944    
 
    543,944 
Total liabilities   3,578,242    
 
    3,578,242 
Shareholders' equity               
Share capital (Note 7)   79,626,690    (2,705,253)   76,921,437 
Reserves (Note 7)   17,933,273    
 
    17,933,273 
Accumulated other comprehensive loss   98,870    
 
    98,870 
Deficit   (85,401,915)   2,705,253    (82,696,662)
    12,256,918    
-
    12,256,918 
Total liabilities and shareholders' equity  $15,835,160   $
-
   $15,835,160 

 

Schedule of restated in the Consolidated Statements of Changes in Shareholder’s Equity  
   As originally filed   Adjustment   As Restated 
Revenue  $1,802,637    
 
   $1,802,637 
Cost of sales (Note 8)   (1,306,120)   
 
    (1,306,120)
Gross profit   496,517    
 
    496,517 
                
EXPENSES               
Amortization and depreciation   401,640    
 
    401,640 
Development expenses   53,985    
 
    53,985 
Selling and marketing (Note 9)   1,003,365    
 
    1,003,365 
General and administrative (Note 10)   1,392,430    
 
    1,392,430 
Share-based payments (Note 7)   310,828    
 
    310,828 
Total operating expenses   3,162,248    
 
    3,162,248 
                
Net operating loss   (2,665,731)   
 
    (2,665,731)
                
OTHER EXPENSES               
Finance expense (Note 11)   34,098    
 
    34,098 
Foreign exchange   163    
 
    163 
Change in fair value of convertible promissory note (Note 5)   
-
    
 
    
-
 
Change in fair value of warrant liability (Note 6)   4,883,260    (2,705,253)   2,178,007 
Transaction costs (Note 12)   -    
 
    
-
 
Total other expenses   4,917,521    (2,705,253)   2,212,268 
Net loss for the year   (7,583,252)   (2,705,253)   (4,877,999)
                
Other comprehensive income               
Translation adjustment   
-
    
 
    
-
 
                
Comprehensive loss for the year  $(7,583,252)  $(2,705,253)  $(4,877,999)
                
Weighted average shares   59,102,369    59,102,369    59,102,369 
Basic and diluted loss per share
  $(0.13)  $0.05   $(0.08)

 

Schedule of restated in the Consolidated Statements of Changes in Shareholder’s Equity   Selected line items restated in the Consolidated Statements of Changes in Shareholder’s Equity:
Deficit  As originally filed   Adjustment   As Restated 
Deficit-Beginning of period   (77,818,663)   
 
    (77,818,663)
loss for the period   (7,583,252)   2,705,253    (4,877,999)
Deficit-end of period   (85,401,915)   2,705,253    (82,696,662)
Share Capital  As originally filed   Adjustment   As Restated 
Share capital-Beginning of period   73,312,866    
 
    73,312,866 
warrants exercised   6,313,824    (2,705,253)   3,608,571 
Share capital-end of period   79,626,690    (2,705,253)   76,921,437 
Schedule of restated in the Consolidated Statements of Cash Flows The balance of the warrant liability is as follows:
   November 3,
2021
   January 11,
2022
   October 12,
2022
   January 19,
2023
   Total 
Balance December 31, 2022  $197,733   $501,330   $2,035,741   $
-
   $2,734,804 
Exercise of warrants   (197,733)   
-
    (1,717,801)   
-
    (1,915,534)
Warrants issued   
-
    
-
    
-
    2,875,580    2,875,580 
Transfer to equity   
-
    
-
    (564,946)   (3,410,100)   (3,975,046)
Change in fair value        127,435    247,006    534,520    908,961 
Balance March 31, 2023  $
-
   $628,765   $
-
   $
-
   $628,765 
Selected line items restated in the Consolidated Statements of Cash Flows:
   As originally filed   Adjustment   As Restated 
Operating activities               
Net loss for the year  $(7,583,252)  $2,705,253   $(4,877,999)
Items not affecting cash:               
Amortization and depreciation   401,640    
 
    401,640 
Bad debt expense   
-
    
 
    
-
 
Fair value changes on derivatives   4,883,260    (2,705,253)   2,178,007 
Interest expense, net of repayments   
-
    
 
    
-
 
Foreign exchange   11,666    
 
    11,666 
Transaction costs   
-
    
 
    
-
 
Share based payments   310,828    
 
    310,828 
Change in non-cash working capital   (1,136,712)   
 
    (1,136,712)
Net cash used in operating activities   (3,112,570)   
-
    (3,112,570)
                
Investing activities               
Intangible asset additions   (817,849)   
 
    (817,849)
Equipment additions   (2,498)   
 
    (2,498)
Acquisition of ClearRF   
-
    
 
    
-
 
Net cash used in investing activities   (820,347)   
 
    (820,347)
                
Financing activities               
Lease payments   (100,702)   
 
    (100,702)
Bank loan   
-
    
 
    
-
 
Convertible debt issued, net of repayments   
-
    
 
    
-
 
Proceeds on share issuance, net of share issuance costs   
-
    
 
    
-
 
Transaction costs   (309,000)   
 
    (309,000)
Exercise of warrants   3,608,571    
 
    3,608,571 
Net cash from financing activities   3,198,869    
-
    3,198,869 
                
Effect of foreign exchange on cash   
-
    
 
    
-
 
                
Change in cash and restricted cash for the year   (734,048)   
 
    (734,048)
Cash and restricted cash, beginning of year   1,913,742    
 
    1,913,742 
Cash and restricted cash, end of year  $1,179,694   $
-
   $1,179,694 
XML 73 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Nature of Operations and Going Concern (Details) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Nature Of Operations And Going Concern Abstract          
Net loss $ (4,877,999) $ 3,879,909 $ 7,211,616 $ 8,182,997  
Total deficit   $ 82,696,662 $ 85,030,279 $ 77,818,663 $ 77,818,663
XML 74 R44.htm IDEA: XBRL DOCUMENT v3.23.2
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Queensgate Resources Corp. [Member]    
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]    
Name of Subsidiary Queensgate Resources Corp. Queensgate Resources Corp.
Place of Incorporation British Columbia, Canada British Columbia, Canada
Ownership 100.00% 100.00%
Queensgate Resources US Corp. [Member]    
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]    
Name of Subsidiary Queensgate Resources US Corp. Queensgate Resources US Corp.
Place of Incorporation Nevada, USA Nevada, USA
Ownership 100.00% 100.00%
Siyata Mobile (Canada) Inc. [Member]    
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]    
Name of Subsidiary Siyata Mobile (Canada) Inc. Siyata Mobile (Canada) Inc.
Place of Incorporation British Columbia, Canada British Columbia, Canada
Ownership 100.00% 100.00%
Siyata Mobile Israel Ltd. [Member]    
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]    
Name of Subsidiary Siyata Mobile Israel Ltd. Siyata Mobile Israel Ltd.
Place of Incorporation Israel Israel
Ownership 100.00% 100.00%
Signifi Mobile Inc. [Member]    
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]    
Name of Subsidiary Signifi Mobile Inc. Signifi Mobile Inc.
Place of Incorporation Quebec, Canada Quebec, Canada
Ownership 100.00% 100.00%
ClearRF Nevada Ltd. [Member]    
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]    
Name of Subsidiary ClearRF Nevada Ltd. ClearRF Nevada Ltd.
Place of Incorporation Nevada, USA Nevada, USA
Ownership 100.00% 100.00%
XML 75 R45.htm IDEA: XBRL DOCUMENT v3.23.2
Trade and Other Receivables (Details) - Schedule of Trade and Other Receivables - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Schedule Of Trade And Other Receivables Abstract    
Trade receivables $ 1,645,627 $ 2,015,291
Allowance for doubtful accounts (1,062,052) (1,056,393)
Taxes receivable 527,548 615,730
Total $ 1,111,123 $ 1,574,628
XML 76 R46.htm IDEA: XBRL DOCUMENT v3.23.2
Inventory (Details) - Schedule of Inventory - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Schedule of inventory [Abstract]    
Finished products $ 6,874,848 $ 7,392,002
Impairment of finished products (3,555,683) (3,555,683)
Accessories and spare parts 663,645 675,001
Impairment of accessories and spare parts (418,770) (418,770)
Total $ 3,564,040 $ 4,092,550
XML 77 R47.htm IDEA: XBRL DOCUMENT v3.23.2
Convertible Debentures (Details) - USD ($)
1 Months Ended 3 Months Ended
Jan. 13, 2022
Nov. 03, 2021
May 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Convertible Debentures [Abstract]          
Convertible promissory note issued   $ 7,200,000      
Warrants issued (in Shares)   2,142,857      
Gross proceeds   $ 6,000,000      
Percentage of gross proceeds         20.00%
Total amount repaid $ 4,000,000        
Monthly payment     $ 400,000    
Common shares issued (in Shares)       13,112,255  
Market value       $ 4,138,002  
Principal amount       $ 938,002  
Convertible debenture         $ 2,023,751
XML 78 R48.htm IDEA: XBRL DOCUMENT v3.23.2
Warrant Liability (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Oct. 12, 2022
Jan. 11, 2022
Nov. 03, 2021
Jan. 19, 2023
Oct. 31, 2022
Mar. 31, 2023
Mar. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Warrant Liability (Details) [Line Items]                  
Purchase of aggregate shares (in Shares)       18,042,857          
Exercise price (in Dollars per share)     $ 2.3 $ 0.2          
Aggregate common shares (in Shares)       18,042,857          
Gross proceeds amount (in Dollars)       $ 3,608,571          
Exercise warrants term       5 years          
Outstanding warrants (in Shares)             21,031,987    
Outstanding warrants per share (in Dollars per share)             $ 0.2    
Warrants exercised (in Shares)       17,400,000     21,031,987    
Exchange of common shares (in Shares)             21,031,987    
Fair value of the warrants amount (in Dollars)         $ 628,765 $ 3,410,100 $ 307,381  
Common shares (in Shares)     1,892,857            
Initial stock price (in Dollars per share)       $ 0.19   $ 0.19   $ 0.05  
Strike rate (in Dollars per share)       $ 0.2   $ 2.3   $ 2.3  
Dividend yield percentage       0.00%   0.00%   0.00% 0.00%
Warrants term       0 years   3 years 9 months 14 days   3 years 6 months 14 days  
Volatility percentage       130.00%   125.00%   170.00%  
Risk-free rate percentage       3.62%   3.69%   4.35% 3.10%
Warrants (in Shares) 17,400,000 8,519,999   1,250,000          
Pre-funded warrants (in Shares) 1,590,000 1,480,000              
Share price (in Dollars per share)                 $ 0.15
Exercise price (in Dollars per share)           $ 2.3   $ 2.3 $ 0.23
Expected volatility percentage                 100.00%
Warrants issued (in Dollars)         $ 1,739,130 $ 1,739,130      
Exercisable per share (in Dollars per share)         $ 0.23 $ 0.23      
Fair value of the waiver warrants (in Dollars)             328,696 $ 328,696 $ 184,983
Warrant term     5 years            
Expired term         Oct. 12, 2027        
Common Shares [Member]                  
Warrant Liability (Details) [Line Items]                  
Exercise price (in Dollars per share)       $ 0.2          
Holder exercised warrants (in Shares)       0.23          
Warrants [Member]                  
Warrant Liability (Details) [Line Items]                  
Exercise price (in Dollars per share)       $ 0.2          
Holder exercised warrants (in Shares)       2,989,130          
Warrants exercised (in Shares)       16,150,000          
January 19, 2023 Warrants [Member]                  
Warrant Liability (Details) [Line Items]                  
Fair value of the warrants amount (in Dollars)       $ 2,875,580          
Discount for lack of marketability percentage       15.00%          
November 3, 2021 Warrants [Member]                  
Warrant Liability (Details) [Line Items]                  
Fair value of the warrants amount (in Dollars)                 $ 197,733
Initial stock price (in Dollars per share)                 $ 0.15
Strike rate (in Dollars per share)                 $ 0.23
Dividend yield percentage                 0.00%
Warrants term                 3 years 10 months 2 days
Volatility percentage                 110.00%
Risk-free rate percentage                 4.08%
Black Scholes Option Pricing Model [Member]                  
Warrant Liability (Details) [Line Items]                  
Fair value of the warrants amount (in Dollars)       $ 132,957         $ 501,330
Initial stock price (in Dollars per share)                 $ 0.15
Strike rate (in Dollars per share)                 $ 2.3
Dividend yield percentage                 0.00%
Warrants term                 4 years 10 days
Volatility percentage                 110.00%
Risk-free rate percentage                 4.08%
October 12, 2022 Warrants [Member]                  
Warrant Liability (Details) [Line Items]                  
Fair value of the warrants amount (in Dollars)       $ 1,250,000   $ 2,989,130     $ 1,850,758
Dividend yield percentage       0.00%         0.00%
Warrants term       4 years 8 months 23 days          
Volatility percentage       115.00%          
Risk-free rate percentage       3.49%         3.98%
Share price (in Dollars per share)       $ 0.19         $ 0.15
Exercise price (in Dollars per share)       $ 0.2         $ 0.23
Expected volatility percentage                 100.00%
Warrants issued (in Dollars)           $ 1,739,130      
Unexercised warrants (in Shares)           1,250,000      
Fair value of the outstanding warrants (in Dollars)             $ 564,946    
Prior to Exercise [Member] | Black Scholes Option Pricing Model [Member]                  
Warrant Liability (Details) [Line Items]                  
Fair value of the warrants amount (in Dollars)                
Prior to Exercise [Member] | October 12, 2022 Warrants [Member]                  
Warrant Liability (Details) [Line Items]                  
Fair value of the warrants amount (in Dollars)       $ 16,150,000          
Dividend yield percentage       0.00%          
Warrants term       0 years          
Volatility percentage       115.00%          
Risk-free rate percentage       3.49%          
Share price (in Dollars per share)       $ 0.19          
Exercise price (in Dollars per share)       0.2          
Top of range [Member]                  
Warrant Liability (Details) [Line Items]                  
Exercise price (in Dollars per share)       0.23          
Volatility percentage   25.00%              
Bottom of range [Member]                  
Warrant Liability (Details) [Line Items]                  
Exercise price (in Dollars per share)       $ 0.2          
Volatility percentage   18.00%              
Warrants [Member]                  
Warrant Liability (Details) [Line Items]                  
Exercise price (in Dollars per share)     $ 4            
XML 79 R49.htm IDEA: XBRL DOCUMENT v3.23.2
Warrant Liability (Details) - Schedule of the Warrant Liability - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Condensed Financial Statements, Captions [Line Items]    
Balance-beginning of period $ 2,734,804 $ 2,734,804
Exercise of warrants (1,915,534) (1,915,534)
Warrants issued 2,875,580 2,875,580
Transfer to equity (3,975,046) (3,975,046)
Change in fair value 908,961 587,577
Balance-Ending of period 628,765 307,381
Warrants Nov 3, 2021 [Member]    
Condensed Financial Statements, Captions [Line Items]    
Balance-beginning of period 197,733 197,733
Exercise of warrants (197,733)  
Warrants issued  
Transfer to equity  
Balance-Ending of period  
Warrants Jan 11, 2022 [Member]    
Condensed Financial Statements, Captions [Line Items]    
Balance-beginning of period 501,330 501,330
Exercise of warrants
Warrants issued
Transfer to equity
Change in fair value 127,435 (193,949)
Balance-Ending of period 628,765 307,381
October 12, 2022 [Member]    
Condensed Financial Statements, Captions [Line Items]    
Balance-beginning of period 2,035,741 2,035,741
Exercise of warrants (1,717,801) (1,717,801)
Warrants issued
Transfer to equity (564,946) (564,946)
Change in fair value 247,006 247,006
Balance-Ending of period
January 19, 2023 [Member]    
Condensed Financial Statements, Captions [Line Items]    
Balance-beginning of period
Exercise of warrants
Warrants issued 2,875,580 2,875,580
Transfer to equity (3,410,100) (3,410,100)
Change in fair value 534,520 534,520
Balance-Ending of period
XML 80 R50.htm IDEA: XBRL DOCUMENT v3.23.2
Share Capital (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Aug. 03, 2023
Aug. 03, 2023
Jul. 13, 2023
Jul. 13, 2023
Jan. 12, 2023
Apr. 13, 2022
Jan. 11, 2022
Jan. 01, 2022
Aug. 09, 2023
Jun. 28, 2023
Jun. 23, 2023
Mar. 30, 2023
Mar. 31, 2022
Mar. 31, 2023
Jun. 30, 2023
Dec. 31, 2022
Share Capital (Details) [Line Items]                                
Number of shares issued                   50,000,000     854,219 21,031,987 51,250,000  
Total outstanding common shares   185,393,404                       1,853,955    
Cashless Remaining Warrant Unexercised                           21,031,987 51,250,000  
Company issued per share (in Dollars per share)                   $ 0.045         $ 0.045  
Proceeds from exercise of options (in Dollars)                   $ 2,250,000         $ 2,306,250  
EXercise warrants issued                           18,042,857    
Warrants price (in Dollars per share)                           $ 0.23 $ 0.23  
Gross proceeds (in Dollars)             $ 20,013,043               $ 3,608,571  
Sale to public share units                           7,215,652 7,215,652  
Public shares per unit (in Dollars per share)                           $ 2.3 $ 2.3  
Exercisable per share (in Dollars per share)                           $ 2.3 $ 2.3  
Exercisable term                           5 years 5 years  
Gross proceeds (in Dollars)                           $ 10,936,974 $ 2,306,250  
Unit warrants (in Dollars)                           $ 5,395,878 $ 5,395,878  
Shares issued pre-funded units                           1,480,000 1,480,000  
Pre-funded per unit (in Dollars per share)                           $ 2.29 $ 2.29  
Value, per share (in Dollars per share)                           0.01 0.01  
Exercise price per share (in Dollars per share)                           $ 2.3 $ 2.3 $ 0.23
Warrant term years                           5 years 5 years  
Issued pre-funded units (in Dollars)                           $ 2,560,400 $ 2,560,400  
Minimal exercise price (in Dollars per share)                           $ 0.01 $ 0.01  
Over-allotment option per share (in Dollars per share)                           $ 0.0097 $ 0.0097  
Proceeds received on warrants (in Dollars)                           $ 13,043 $ 13,043  
Fair value loss (in Dollars)                           $ 962,350 $ 962,350  
Initial stock price (in Dollars per share)             $ 1.73                  
Strike rate (in Dollars per share)             $ 2.53                  
Dividend yield percentage             0.00%                  
Volatility percentage             60.00%                  
Risk free rate             0.50%                  
Shares reserved percentage                           15.00% 15.00%  
Stock discount rate                           25.00% 25.00%  
Stock option issued           795,000   20,000                
Stock option exercise price (in Dollars per share)           $ 1.1   $ 4                
Fair value granted (in Dollars)           $ 678,520   $ 54,480           $ 54,480    
Fair value options (in Dollars)           $ 0.8535   $ 2.724           $ 2.724    
RSU's transactions description                           On March 9, 2022, the Company granted 450,000 RSU’s to Directors that vest immediately. On the date of granting, the fair value and stock price was $1.03/share.   ● On March 9, 2022, the Company granted 1,800,000 RSU’s to a Director that vest quarterly over 12 periods with the first vesting of 150,000 RSU’s occurring on the date of the granted and another 150,000 vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.03/share.   ●On March 9, 2022, the Company granted 450,000 RSU’s to Directors that vest immediately. On the date of granting, the fair value and stock price was $1.03/share.   ● On March 9, 2022, the Company granted 1,800,000 RSU’s to a Director that vest quarterly over 12 periods with the first vesting of 150,000 RSU’s occurring on the date of the granted and another 150,000 vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.03/share.   On April 13, 2022, the Company granted 240,000 RSU’s to consultants that vest immediately. On the date of granting, the fair value and the stock price was $1.10/share.   On April 13, 2022, the Company granted 585,000 RSU’s to employees of the Company that vest quarterly over 12 periods with the first vesting of 48,750 RSU’s occurring on the date of the granted and another 48,750 RSU’s vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.10/share.    
Agents options, description                           ●The Company issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%. The Company also issued 52,500 agent’s options with a fair value of $61,950 with an exercise price of $2.30. ●The Company issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%. The Company also issued 52,500 agent’s options with a fair value of $61,950 with an exercise price of $2.30.  
Share issued                           18,042,857 18,042,857  
Warrants issued                           18,042,857 18,042,857  
Exercise warrants         18,042,857             18,042,857   18,042,857    
Cashless warrants exercised                           17,116,987 21,031,857  
Transactions during the year, description                           ●128,386 share purchase warrant expired in 2022.   ● On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exercisable at $2.30 per warrant and with a term of five years. On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exercisable at $2.30 per warrant and with a term of five years.  
Fair value (in Dollars)                         $ 1,002,461      
Principal repayment (in Dollars)                         $ 400,000      
Non adjusting Events [Member]                                
Share Capital (Details) [Line Items]                                
Number of shares issued     51,450,000 51,450,000             50,000,000          
Total outstanding common shares                 1,853,955              
Company issued per share (in Dollars per share)     $ 0.045 $ 0.045             $ 0.045          
Proceeds from exercise of options (in Dollars)     $ 2,315,250 $ 2,315,250             $ 2,250,000          
Reverse Stock Split Shares 185,393,404 185,393,404             185,393,404              
Stock Shares Converted 1,853,955 1,853,955                            
Option Warrants [Member]                                
Share Capital (Details) [Line Items]                                
Number of shares issued                           62,911,417 133,943,404 44,868,560
Number of shares outstanding                           62,911,417 133,943,404 44,868,560
Warrants [Member]                                
Share Capital (Details) [Line Items]                                
Number of shares issued                           18,042,857    
Proceeds from exercise of options (in Dollars)                           $ 3,608,571    
Pre-Funded Units [member]                                
Share Capital (Details) [Line Items]                                
Warrant term years                           5 years 5 years  
Pre-funded warrants issued (in Dollars)                           $ 1,106,747 $ 1,106,747  
Over-Allotment Option [Member]                                
Share Capital (Details) [Line Items]                                
Warrant term years                           5 years 5 years  
Additional warrants purchased                           1,304,347 1,304,347  
Warrants to purchase shares                           1,304,347 1,304,347  
Common shares exercisable per share (in Dollars per share)                           $ 2.3 $ 2.3  
Option warrant exercisable term description                           Each Option Warrant is exercisable immediately and has a term of five years from the issue date. Each Option Warrant is exercisable immediately and has a term of five years from the issue date.  
Option warrants issued (in Dollars)                           $ 975,393 $ 975,393  
Market price per share (in Dollars per share)                           $ 1.73 $ 1.73  
Initial stock price (in Dollars per share)                           1.73 1.73  
Strike rate (in Dollars per share)                           $ 2.3 $ 2.3  
Dividend yield percentage                           0.00% 0.00%  
Volatility percentage                           60.00% 60.00%  
Risk free rate                           0.50% 0.50%  
Placement Agent Warrants [member]                                
Share Capital (Details) [Line Items]                                
Exercisable term             5 years                  
Warrant term years             5 years                  
Warrants issued                           434,783 434,783  
Exercise price per share (in Dollars per share)                           $ 2.53 $ 2.53  
Fair value of placement agent warrants (in Dollars)             $ 307,189                  
Common share transactions, description                           The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued. The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued.  
Stock Options [member]                                
Share Capital (Details) [Line Items]                                
Option warrant exercisable term description                           Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted. Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted.  
Warrants Liability [Member]                                
Share Capital (Details) [Line Items]                                
Gross proceeds (in Dollars)                             $ 10,936,974  
Warrants [Member]                                
Share Capital (Details) [Line Items]                                
Warrants price (in Dollars per share)                           $ 0.23 $ 0.23  
Cashless warrants exercised                             21,031,857  
Common Share Transactions [Member] | Option Warrants [Member]                                
Share Capital (Details) [Line Items]                                
Number of shares issued                           18,042,857    
ClearRF Acquisition [Member]                                
Share Capital (Details) [Line Items]                                
Number of shares issued                         155,000      
Value, per share (in Dollars per share)                         $ 1.1      
Shares issued to vendor                         138,958      
Fair value amount (in Dollars)                         $ 190,094      
Fair value (in Dollars)                         $ 170,500      
XML 81 R51.htm IDEA: XBRL DOCUMENT v3.23.2
Share Capital (Details) - Schedule of Stock Option Activity - $ / shares
3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Stock Options [Member]        
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]        
Number of options, Outstanding at beginning 1,506,138 1,506,138 414,568  
Weighted average exercise price, Outstanding at beginning $ 3.53 $ 3.53 $ 13.88  
Number of options, Granted   1,145,000  
Weighted average exercise price, Granted   $ 1.15  
Number of options, Expired/Cancelled   (53,430)  
Weighted average exercise price, Expired/Cancelled   $ 30.9  
Number of options, Outstanding at ending     1,506,138 414,568
Weighted average exercise price, Outstanding at ending     $ 3.53 $ 13.88
Restricted Share Units [Member]        
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]        
Number of options, Outstanding at beginning 3,165,000 3,165,000  
Weighted average exercise price, Outstanding at beginning $ 1.05 $ 1.05  
Number of options, Granted   3,195,000  
Weighted average exercise price, Granted     $ 1.05  
Number of options, Exercised     (30,000)  
Weighted average exercise price, Exercised   $ 1.1  
Number of options, Outstanding at ending     3,165,000
Weighted average exercise price, Outstanding at ending     $ 1.05
Agents’ Options [Member]        
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]        
Number of options, Outstanding at beginning 931,507 931,507 445,926  
Weighted average exercise price, Outstanding at beginning $ 4.12 $ 4.12 $ 7.51  
Number of options, Granted   487,283  
Weighted average exercise price, Granted     $ 2.51  
Number of options, Expired/Cancelled     (1,702) (6,597)
Weighted average exercise price, Expired/Cancelled   $ 20.49 $ 5,268
Number of options, Outstanding at ending     931,507 445,926
Weighted average exercise price, Outstanding at ending     $ 4.12 $ 7.51
Share Purchase Warrants [Member]        
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]        
Number of options, Outstanding at beginning 34,132,071 34,132,071 5,121,328  
Weighted average exercise price, Outstanding at beginning $ 1.76 $ 1.76 $ 7.64  
Number of options, Granted 18,042,857   29,139,129  
Weighted average exercise price, Granted $ 0.2   $ 0.94  
Number of options, Exercised (18,042,857)      
Weighted average exercise price, Exercised $ 0.2      
Number of options, Expired/Cancelled     (128,386)  
Weighted average exercise price, Expired/Cancelled     $ 33.47  
Number of options, Outstanding at ending 34,132,071   34,132,071 5,121,328
Weighted average exercise price, Outstanding at ending $ 1.47   $ 1.76 $ 7.64
XML 82 R52.htm IDEA: XBRL DOCUMENT v3.23.2
Share Capital (Details) - Schedule Stock Options Outstanding - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 1,506,138  
Number of options exercisable 748,638  
Weighted Average Exercise Price (in Dollars per share) $ 3.53  
Remaining contractual life (years) 3 years 6 months 3 days  
Restricted Share Units [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 3,165,000  
Number of options exercisable 1,751,250  
Weighted Average Exercise Price (in Dollars per share) $ 1.05  
Agents’ Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 931,507  
Number of options exercisable 931,507  
Weighted Average Exercise Price (in Dollars per share) $ 4.12  
Remaining contractual life (years) 2 years 11 months 23 days  
Share Purchase Warrants [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable 34,132,071  
Weighted Average Exercise Price (in Dollars per share) $ 1.47  
24-Dec-18 [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 12,896 12,896
Number of options exercisable 12,896 12,896
Weighted Average Exercise Price (in Dollars per share) $ 54 $ 54
Expiry date 24-Dec-23 24-Dec-23
Remaining contractual life (years) 7 months 17 days 5 months 23 days
15-Jan-19 [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 828 828
Number of options exercisable 828 828
Weighted Average Exercise Price (in Dollars per share) $ 54 $ 54
Expiry date 15-Jan-24 15-Jan-24
Remaining contractual life (years) 8 months 8 days 6 months 18 days
21-Mar-19 [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 12,345 12,345
Number of options exercisable 12,345 12,345
Weighted Average Exercise Price (in Dollars per share) $ 59 $ 59
Expiry date 21-Mar-24 21-Mar-24
Remaining contractual life (years) 10 months 13 days 8 months 23 days
01-Jan-20 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 2,069 2,069
Number of options exercisable 2,069 2,069
Weighted Average Exercise Price (in Dollars per share) $ 54 $ 54
Expiry date 01-Jan-24 1-Jan-24
Remaining contractual life (years) 7 months 24 days 6 months 3 days
15-Nov-20 [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 95,000 95,000
Number of options exercisable 95,000 95,000
Weighted Average Exercise Price (in Dollars per share) $ 6 $ 6
Expiry date 15-Nov-30 15-Nov-30
Remaining contractual life (years) 7 years 6 months 10 days 7 years 4 months 17 days
15-Nov-20 [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 161,500 161,500
Number of options exercisable 161,500 161,500
Weighted Average Exercise Price (in Dollars per share) $ 6 $ 6
Expiry date 15-Nov-25 15-Nov-25
Remaining contractual life (years) 2 years 6 months 7 days 2 years 4 months 17 days
02-Jan-21 [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 57,000 57,000
Number of options exercisable 57,000 57,000
Weighted Average Exercise Price (in Dollars per share) $ 11.5 $ 11.5
Expiry date 02-Jan-26 2-Jan-26
Remaining contractual life (years) 2 years 7 months 24 days 2 years 6 months 3 days
02-Jan-21 [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 5,000 5,000
Number of options exercisable 5,000 5,000
Weighted Average Exercise Price (in Dollars per share) $ 11.5 $ 11.5
Expiry date 02-Jan-31 2-Jan-31
Remaining contractual life (years) 7 years 7 months 28 days 7 years 6 months 7 days
18-Jan-21 [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 14,500 14,500
Number of options exercisable 14,500 14,500
Weighted Average Exercise Price (in Dollars per share) $ 11.5 $ 11.5
Expiry date 18-Jan-26 18-Jan-26
Remaining contractual life (years) 2 years 8 months 12 days 2 years 6 months 21 days
01-Jan-22 [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 20,000 20,000
Number of options exercisable 12,500 12,500
Weighted Average Exercise Price (in Dollars per share) $ 4 $ 4
Expiry date 29-Oct-26 29-Oct-26
Remaining contractual life (years) 3 years 5 months 23 days 3 years 3 months 29 days
13-Apr-22 [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 795,000 795,000
Number of options exercisable 265,000 331,250
Weighted Average Exercise Price (in Dollars per share) $ 1.1 $ 1.1
Expiry date 13-Apr-27 13-Apr-27
Remaining contractual life (years) 3 years 11 months 4 days 3 years 9 months 14 days
13-Apr-22 [Member] | Restricted Share Units [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 825,000 825,000
Number of options exercisable 513,750 513,750
Weighted Average Exercise Price (in Dollars per share) $ 1.1 $ 1.1
12-Jul-22 [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 330,000 330,000
Number of options exercisable 110,000 110,000
Weighted Average Exercise Price (in Dollars per share) $ 1.1 $ 1.1
Expiry date 12-Jul-25 12-Jul-25
Remaining contractual life (years) 2 years 2 months 4 days 2 years 14 days
12-Jul-22 [Member] | Restricted Share Units [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 90,000 90,000
Number of options exercisable 37,500 30,000
Weighted Average Exercise Price (in Dollars per share) $ 1.1 $ 1.1
09-Mar-22 [Member] | Restricted Share Units [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 2,250,000 2,250,000
Number of options exercisable 1,200,000 1,350,000
Weighted Average Exercise Price (in Dollars per share) $ 1.03 $ 1.03
29-Sep-20 [Member] | Agents’ Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 113,500 113,500
Number of options exercisable 113,500 113,500
Weighted Average Exercise Price (in Dollars per share) $ 6.6 $ 6.6
Expiry date 28-Sep-25 28-Sep-25
Remaining contractual life (years) 2 years 2 years
29-Sep-20 [Member] | Share Purchase Warrants [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable 1,805,585 1,805,585
Weighted Average Exercise Price (in Dollars per share) $ 6.85 $ 6.85
Expiry date 28-Sep-25 28-Sep-25
29-Sep-20 [Member] | Agents’ Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 266,000 266,000
Number of options exercisable 266,000 266,000
Weighted Average Exercise Price (in Dollars per share) $ 6.85 $ 6.85
Expiry date 28-Sep-25 28-Sep-25
Remaining contractual life (years) 2 years 2 years
31-Dec-20 [Member] | Agents’ Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 64,724 64,724
Number of options exercisable 64,724 64,724
Weighted Average Exercise Price (in Dollars per share) $ 11.5 $ 11.5
Expiry date 30-Jun-24 30-Jun-24
Remaining contractual life (years) 1 year 1 year
31-Dec-20 [Member] | Share Purchase Warrants [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable 1,294,500 1,294,500
Weighted Average Exercise Price (in Dollars per share) $ 11.5 $ 11.5
Expiry date 30-Jun-24 30-Jun-24
11-Jan-22 [Member] | Agents’ Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 434,783 434,783
Number of options exercisable 434,783 434,783
Weighted Average Exercise Price (in Dollars per share) $ 2.53 $ 2.53
Expiry date 11-Jan-27 11-Jan-27
Remaining contractual life (years) 4 years 4 years
11-Jan-22 [Member] | Share Purchase Warrants [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable 9,999,999 9,999,999
Weighted Average Exercise Price (in Dollars per share) $ 2.3 $ 2.3
Expiry date 11-Jan-27 10-Jan-27
01-Apr-22 [Member] | Agents’ Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 52,500 52,500
Number of options exercisable 52,500 52,500
Weighted Average Exercise Price (in Dollars per share) $ 2.3 $ 2.3
Expiry date 08-Mar-27 8-Mar-27
Remaining contractual life (years) 4 years 4 years
12-Oct-22 [Member] | Share Purchase Warrants [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable 1,250,000  
Weighted Average Exercise Price (in Dollars per share)  
Expiry date 11-Jan-27  
12-Oct-22 [Member] | Share Purchase Warrants [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable 1,739,130  
Weighted Average Exercise Price (in Dollars per share)  
Expiry date 11-Jan-27  
19-Jan-23 [Member] | Share Purchase Warrants [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable 18,042,857  
Weighted Average Exercise Price (in Dollars per share)  
Expiry date 18-Jan-28  
XML 83 R53.htm IDEA: XBRL DOCUMENT v3.23.2
Cost of Sales (Details) - Schedule of Cost of Sales - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Schedule of Cost of Sales [Abstract]    
Inventory expensed $ 971 $ 359
Royalties 106 54
Other expenses 229 165
Total $ 1,306 $ 578
XML 84 R54.htm IDEA: XBRL DOCUMENT v3.23.2
Selling and Marketing Expenses (Details) - Schedule of Selling and Marketing Expenses - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Schedule of selling and marketing expenses [Abstract]    
Salaries and related expenses $ 705 $ 618
Advertising and marketing 249 398
Travel and conferences 49 29
Total $ 1,003 $ 1,045
XML 85 R55.htm IDEA: XBRL DOCUMENT v3.23.2
General and Administrative Expenses (Details) - Schedule of General and Administrative Eexpenses - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Schedule Of General And Administrative Eexpenses Abstract    
Salaries and related expenses $ 151 $ 125
Professional services 565 377
Consulting and director fees 263 419
Travel 14 36
Office and general 326 442
Regulatory and filing fees 27 21
Shareholder relations 46 239
Total $ 1,392 $ 1,659
XML 86 R56.htm IDEA: XBRL DOCUMENT v3.23.2
Transaction Costs (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2023
Jan. 31, 2023
Transaction Costs (Details) [Line Items]              
Warrant liability           $ 309,000 $ 439,600
Transaction costs $ 965,247 $ 965,247    
Warrant Liability [Member]              
Transaction Costs (Details) [Line Items]              
Transaction costs         $ 965,247    
XML 87 R57.htm IDEA: XBRL DOCUMENT v3.23.2
Financial Instruments (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Financial Instruments (Details) [Line Items]    
Overdue receivables $ 1,062,052 $ 1,056,393
Active customers, description More than 50% (2022 – 18%) of the Company’s customers have been active with the Company for over four years  
Allowance for doubtful accounts $ 1,062,052 $ 1,056,393
Customer One [Member]    
Financial Instruments (Details) [Line Items]    
Revenue percentage 34.00% 23.00%
XML 88 R58.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions (Details) - Schedule of Remuneration of Directors and Key Management Personnel - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Payments to key management personnel:        
Salaries, consulting and directors’ fees $ 285,413 $ 491,889 $ 667,582 $ 851,262
Share-based payments 243,323 767,436 438,008 1,792,129
Total $ 528,736 $ 1,259,325 $ 1,105,590 $ 2,643,391
XML 89 R59.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions (Details) - Schedule of Classified within Profit and Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
VP Technology/VP Sales International [Member]        
Related Party Transactions (Details) - Schedule of Classified within Profit and Loss [Line Items]        
Selling and marketing expenses $ 46 $ 84 $ 182 $ 152
Companies controlled by the CEO, CFO and Directors [Member]        
Related Party Transactions (Details) - Schedule of Classified within Profit and Loss [Line Items]        
General and administrative expense $ 239 $ 408    
XML 90 R60.htm IDEA: XBRL DOCUMENT v3.23.2
Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers [Line Items]    
Revenue $ 1,803 $ 833
USA [Member]    
Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers [Line Items]    
Revenue 1,073 245
Canada [Member]    
Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers [Line Items]    
Revenue 219 249
EMEA [Member]    
Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers [Line Items]    
Revenue 511 326
Australia [Member]    
Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers [Line Items]    
Revenue $ 13
XML 91 R61.htm IDEA: XBRL DOCUMENT v3.23.2
Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information - USD ($)
$ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information [Line Items]      
Long-term receivable total $ 143 $ 146 $ 150
Right of use asset total 771 812 887
Equipment total 191 200 207
Intangibles total $ 7,633 7,481 6,988
Canada [Member]      
Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information [Line Items]      
Long-term receivable total  
Right of use asset total   118 177
Equipment total  
Intangibles total  
EMEA [Member]      
Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information [Line Items]      
Long-term receivable total   146 150
Right of use asset total   694 710
Equipment total   200 207
Intangibles total   $ 7,481 $ 6,988
XML 92 R62.htm IDEA: XBRL DOCUMENT v3.23.2
Segmented Information (Details) - Schedule of Product Information - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Segmented Information (Details) - Schedule of Product Information [Line Items]            
Revenue by product $ 2,711 $ 1,803 $ 970 $ 833 $ 4,513 $ 1,803
Cellular boosters and related accessories [Member]            
Segmented Information (Details) - Schedule of Product Information [Line Items]            
Revenue by product   438   463    
Rugged devices and related accessories [Member]            
Segmented Information (Details) - Schedule of Product Information [Line Items]            
Revenue by product   $ 1,365   $ 370    
XML 93 R63.htm IDEA: XBRL DOCUMENT v3.23.2
Supplemental Information with Respect to Cash Flows (Details) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Supplemental Information with Respect to Cash Flows [Abstract]    
Interest amount paid $ 2,659
Income tax
XML 94 R64.htm IDEA: XBRL DOCUMENT v3.23.2
Supplemental Information with Respect to Cash Flows (Details) - Schedule of Supplemental Information with Respect to Cash Flows - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Change in non-cash working capital:        
Trade and other receivables $ 463,505 $ (6,303)    
Prepaids (491,942) (731,566) $ (88,977) $ (277,147)
Inventory 528,510 (1,060,581) 1,586,593 (2,590,511)
Advances to suppliers (519,709) (590,506)    
Accounts payable and accrued liabilities (967,476) (836,698) $ (433,118) $ (813,776)
Deferred revenue (149,600)    
Total $ (1,136,712) $ (3,225,654)    
XML 95 R65.htm IDEA: XBRL DOCUMENT v3.23.2
Subsequent Events (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Aug. 03, 2023
Aug. 03, 2023
Jul. 13, 2023
Jul. 13, 2023
Aug. 09, 2023
Jun. 28, 2023
Jun. 23, 2023
Mar. 31, 2023
Jun. 30, 2023
Mar. 31, 2022
Subsequent Events (Details) [Line Items]                    
Cashless warrants               21,031,987 51,250,000  
Company shares issued           50,000,000   21,031,987 51,250,000 854,219
Company issued per share (in Dollars per share)           $ 0.045     $ 0.045  
Gross proceeds (in Dollars)           $ 2,250,000     $ 2,306,250  
Common shares price (in Dollars per share)                 $ 0.45  
Gross proceeds (in Dollars)               $ 10,936,974 $ 2,306,250  
Non-Adjusting Events After Reporting Period [Member]                    
Subsequent Events (Details) [Line Items]                    
Company shares issued     51,450,000 51,450,000     50,000,000      
Company issued per share (in Dollars per share)     $ 0.045 $ 0.045     $ 0.045      
Gross proceeds (in Dollars)     $ 2,315,250 $ 2,315,250     $ 2,250,000      
Reverse stock split shares 185,393,404 185,393,404     185,393,404          
Stock shares converted 1,853,955 1,853,955                
XML 96 R66.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement of Financial Statements (Details)
6 Months Ended
Jun. 30, 2023
USD ($)
Disclosure Of Separate Financial Statements Text Block Abstract  
Change in fair value expense $ 2,705,253
Share capital $ 2,705,253
XML 97 R67.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Financial Position - USD ($)
Jun. 30, 2023
Dec. 31, 2022
As originally filed [Member]    
Current    
Cash $ 1,179,694  
Trade and other receivables (Note 3) 1,111,123  
Prepaid expenses 665,446  
Inventory (Note 4) 3,564,040  
Advance to suppliers 675,561  
Current total 7,195,864  
Long term receivable 146,196  
Right of use assets 811,966  
Equipment 199,743  
Intangible assets 7,481,391  
Total assets 15,835,160  
Current    
Accounts payable and accrued liabilities 2,111,174  
Deferred revenue  
Lease obligations 294,359  
Warrant liability (Note 6) 628,765  
Current liabilities 3,034,298  
Lease obligation 543,944  
Total liabilities 3,578,242  
Shareholders' equity    
Share capital (Note 7) 79,626,690 $ 73,312,866
Reserves (Note 7) 17,933,273  
Accumulated other comprehensive loss 98,870  
Deficit (85,401,915) (77,818,663)
Total Shareholders' equity 12,256,918  
Total liabilities and shareholders' equity 15,835,160  
Adjustment [Member]    
Current    
Cash  
Trade and other receivables (Note 3)  
Prepaid expenses  
Inventory (Note 4)  
Advance to suppliers  
Current total  
Long term receivable  
Right of use assets  
Equipment  
Intangible assets  
Total assets  
Current    
Accounts payable and accrued liabilities  
Deferred revenue  
Lease obligations  
Warrant liability (Note 6)  
Current liabilities  
Lease obligation  
Total liabilities  
Shareholders' equity    
Share capital (Note 7) (2,705,253)
Reserves (Note 7)  
Accumulated other comprehensive loss  
Deficit 2,705,253
Total Shareholders' equity  
Total liabilities and shareholders' equity  
As Restated [Member]    
Current    
Cash 1,179,694  
Trade and other receivables (Note 3) 1,111,123  
Prepaid expenses 665,446  
Inventory (Note 4) 3,564,040  
Advance to suppliers 675,561  
Current total 7,195,864  
Long term receivable 146,196  
Right of use assets 811,966  
Equipment 199,743  
Intangible assets 7,481,391  
Total assets 15,835,160  
Current    
Accounts payable and accrued liabilities 2,111,174  
Deferred revenue  
Lease obligations 294,359  
Warrant liability (Note 6) 628,765  
Current liabilities 3,034,298  
Lease obligation 543,944  
Total liabilities 3,578,242  
Shareholders' equity    
Share capital (Note 7) 76,921,437 73,312,866
Reserves (Note 7) 17,933,273  
Accumulated other comprehensive loss 98,870  
Deficit (82,696,662) $ (77,818,663)
Total Shareholders' equity 12,256,918  
Total liabilities and shareholders' equity $ 15,835,160  
XML 98 R68.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Loss and Comprehensive Loss
6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
As originally filed [Member]  
Condensed Statement of Income Captions [Line Items]  
Revenue $ 1,802,637
Cost of sales (Note 8) (1,306,120)
Gross profit 496,517
EXPENSES  
Amortization and depreciation 401,640
Development expenses 53,985
Selling and marketing (Note 9) 1,003,365
General and administrative (Note 10) 1,392,430
Share-based payments (Note 7) 310,828
Total operating expenses 3,162,248
Net operating loss (2,665,731)
OTHER EXPENSES  
Finance expense (Note 11) 34,098
Foreign exchange 163
Change in fair value of convertible promissory note (Note 5)
Change in fair value of warrant liability (Note 6) 4,883,260
Total other expenses 4,917,521
Net loss for the year (7,583,252)
Other comprehensive income  
Translation adjustment
Comprehensive loss for the year $ (7,583,252)
Weighted average shares (in Shares) | shares 59,102,369
Basic and diluted loss per share (in Dollars per share) | $ / shares $ (0.13)
Adjustment [Member]  
Condensed Statement of Income Captions [Line Items]  
Revenue
Cost of sales (Note 8)
Gross profit
EXPENSES  
Amortization and depreciation
Development expenses
Selling and marketing (Note 9)
General and administrative (Note 10)
Share-based payments (Note 7)
Total operating expenses
Net operating loss
OTHER EXPENSES  
Finance expense (Note 11)
Foreign exchange
Change in fair value of convertible promissory note (Note 5)
Change in fair value of warrant liability (Note 6) (2,705,253)
Transaction costs (Note 12)
Total other expenses (2,705,253)
Net loss for the year (2,705,253)
Other comprehensive income  
Translation adjustment
Comprehensive loss for the year $ (2,705,253)
Weighted average shares (in Shares) | shares 59,102,369
Basic and diluted loss per share (in Dollars per share) | $ / shares $ 0.05
As Restated [Member]  
Condensed Statement of Income Captions [Line Items]  
Revenue $ 1,802,637
Cost of sales (Note 8) (1,306,120)
Gross profit 496,517
EXPENSES  
Amortization and depreciation 401,640
Development expenses 53,985
Selling and marketing (Note 9) 1,003,365
General and administrative (Note 10) 1,392,430
Share-based payments (Note 7) 310,828
Total operating expenses 3,162,248
Net operating loss (2,665,731)
OTHER EXPENSES  
Finance expense (Note 11) 34,098
Foreign exchange 163
Change in fair value of convertible promissory note (Note 5)
Change in fair value of warrant liability (Note 6) 2,178,007
Transaction costs (Note 12)
Total other expenses 2,212,268
Net loss for the year (4,877,999)
Other comprehensive income  
Translation adjustment
Comprehensive loss for the year $ (4,877,999)
Weighted average shares (in Shares) | shares 59,102,369
Basic and diluted loss per share (in Dollars per share) | $ / shares $ (0.08)
XML 99 R69.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Loss and Comprehensive Loss (Parentheticals)
6 Months Ended
Jun. 30, 2023
$ / shares
As originally filed [Member]  
Condensed Statement of Income Captions [Line Items]  
Diluted loss per share $ (0.13)
Adjustment [Member]  
Condensed Statement of Income Captions [Line Items]  
Diluted loss per share 0.05
As Restated [Member]  
Condensed Statement of Income Captions [Line Items]  
Diluted loss per share $ (0.08)
XML 100 R70.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Changes in Shareholder’s Equity
6 Months Ended
Jun. 30, 2023
USD ($)
Previously Reported [Member]  
Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Changes in Shareholder’s Equity [Line Items]  
Deficit-Beginning of period $ (77,818,663)
loss for the period (7,583,252)
Deficit-end of period (85,401,915)
Share capital-Beginning of period 73,312,866
warrants exercised 6,313,824
Share capital-end of period 79,626,690
Revision of Prior Period, Adjustment [Member]  
Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Changes in Shareholder’s Equity [Line Items]  
Deficit-Beginning of period
loss for the period 2,705,253
Deficit-end of period 2,705,253
Share capital-Beginning of period
warrants exercised (2,705,253)
Share capital-end of period (2,705,253)
As Restated [Member]  
Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Changes in Shareholder’s Equity [Line Items]  
Deficit-Beginning of period (77,818,663)
loss for the period (4,877,999)
Deficit-end of period (82,696,662)
Share capital-Beginning of period 73,312,866
warrants exercised 3,608,571
Share capital-end of period $ 76,921,437
XML 101 R71.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Cash Flows
6 Months Ended
Jun. 30, 2023
USD ($)
As originally filed [Member]  
Operating activities  
Net loss for the year $ (7,583,252)
Items not affecting cash:  
Amortization and depreciation 401,640
Bad debt expense
Fair value changes on derivatives 4,883,260
Interest expense, net of repayments
Foreign exchange 11,666
Transaction costs
Share based payments 310,828
Change in non-cash working capital (1,136,712)
Net cash used in operating activities (3,112,570)
Investing activities  
Intangible asset additions (817,849)
Equipment additions (2,498)
Acquisition of ClearRF
Net cash used in investing activities (820,347)
Financing activities  
Lease payments (100,702)
Bank loan
Convertible debt issued, net of repayments
Proceeds on share issuance, net of share issuance costs
Transaction costs (309,000)
Exercise of warrants 3,608,571
Net cash from financing activities 3,198,869
Effect of foreign exchange on cash
Change in cash and restricted cash for the year (734,048)
Cash and restricted cash, beginning of year 1,913,742
Cash and restricted cash, end of year 1,179,694
Adjustment [Member]  
Operating activities  
Net loss for the year 2,705,253
Items not affecting cash:  
Amortization and depreciation
Bad debt expense
Fair value changes on derivatives (2,705,253)
Interest expense, net of repayments
Foreign exchange
Transaction costs
Share based payments
Change in non-cash working capital
Net cash used in operating activities
Investing activities  
Intangible asset additions
Equipment additions
Acquisition of ClearRF
Net cash used in investing activities
Financing activities  
Lease payments
Bank loan
Convertible debt issued, net of repayments
Proceeds on share issuance, net of share issuance costs
Transaction costs
Exercise of warrants
Net cash from financing activities
Effect of foreign exchange on cash
Change in cash and restricted cash for the year
Cash and restricted cash, beginning of year
Cash and restricted cash, end of year
As Restated [Member]  
Operating activities  
Net loss for the year (4,877,999)
Items not affecting cash:  
Amortization and depreciation 401,640
Bad debt expense
Fair value changes on derivatives 2,178,007
Interest expense, net of repayments
Foreign exchange 11,666
Transaction costs
Share based payments 310,828
Change in non-cash working capital (1,136,712)
Net cash used in operating activities (3,112,570)
Investing activities  
Intangible asset additions (817,849)
Equipment additions (2,498)
Acquisition of ClearRF
Net cash used in investing activities (820,347)
Financing activities  
Lease payments (100,702)
Bank loan
Convertible debt issued, net of repayments
Proceeds on share issuance, net of share issuance costs
Transaction costs (309,000)
Exercise of warrants 3,608,571
Net cash from financing activities 3,198,869
Effect of foreign exchange on cash
Change in cash and restricted cash for the year (734,048)
Cash and restricted cash, beginning of year 1,913,742
Cash and restricted cash, end of year $ 1,179,694
XML 102 R72.htm IDEA: XBRL DOCUMENT v3.23.2
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Queensgate Resources Corp. [Member]    
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]    
Name of Subsidiary Queensgate Resources Corp. Queensgate Resources Corp.
Place of Incorporation British Columbia, Canada British Columbia, Canada
Ownership 100.00% 100.00%
Queensgate Resources US Corp. [Member]    
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]    
Name of Subsidiary Queensgate Resources US Corp. Queensgate Resources US Corp.
Place of Incorporation Nevada, USA Nevada, USA
Ownership 100.00% 100.00%
Siyata Mobile (Canada) Inc. [Member]    
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]    
Name of Subsidiary Siyata Mobile (Canada) Inc. Siyata Mobile (Canada) Inc.
Place of Incorporation British Columbia, Canada British Columbia, Canada
Ownership 100.00% 100.00%
Siyata Mobile Israel Ltd. [Member]    
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]    
Name of Subsidiary Siyata Mobile Israel Ltd. Siyata Mobile Israel Ltd.
Place of Incorporation Israel Israel
Ownership 100.00% 100.00%
Signifi Mobile Inc. [Member]    
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]    
Name of Subsidiary Signifi Mobile Inc. Signifi Mobile Inc.
Place of Incorporation Quebec, Canada Quebec, Canada
Ownership 100.00% 100.00%
ClearRF Nevada Ltd. [Member]    
Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]    
Name of Subsidiary ClearRF Nevada Ltd. ClearRF Nevada Ltd.
Place of Incorporation Nevada, USA Nevada, USA
Ownership 100.00% 100.00%
XML 103 R73.htm IDEA: XBRL DOCUMENT v3.23.2
Bank Loan (Details) - USD ($)
1 Months Ended
Apr. 30, 2023
Jun. 30, 2023
Bank Loan (Details) [Line Items]    
Advance rate 85.00%  
Interest rate 1.80%  
Face value.rate 0.50%  
Loan balance (in Dollars)   $ 719,623
North America [Member]    
Bank Loan (Details) [Line Items]    
Credit factoring (in Dollars) $ 20,000,000  
XML 104 R74.htm IDEA: XBRL DOCUMENT v3.23.2
Warrant Liability (Details) - Schedule of the warrant liability - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Jun. 30, 2023
Warrant Liability (Details) - Schedule of the warrant liability [Line Items]    
Balance-beginning of period $ 2,734,804 $ 2,734,804
Balance-Ending of period 628,765 307,381
Change in fair value of warrants exercised (1,915,534) (1,915,534)
Warrants issued 2,875,580 2,875,580
Proceeds from Inducement warrants issued  
Transfer to equity (3,975,046) (3,975,046)
Change in fair value 908,961 587,577
Warrants Nov 3, 2021 [Member]    
Warrant Liability (Details) - Schedule of the warrant liability [Line Items]    
Balance-beginning of period 197,733 197,733
Balance-Ending of period  
Change in fair value of warrants exercised   (197,733)
Warrants issued  
Proceeds from Inducement warrants issued  
Transfer to equity  
Change in fair value  
January 11, 2022 [Member]    
Warrant Liability (Details) - Schedule of the warrant liability [Line Items]    
Balance-beginning of period 501,330 501,330
Balance-Ending of period 628,765 307,381
Change in fair value of warrants exercised
Warrants issued
Proceeds from Inducement warrants issued  
Transfer to equity
Change in fair value 127,435 (193,949)
October 12, 2022 [Member]    
Warrant Liability (Details) - Schedule of the warrant liability [Line Items]    
Balance-beginning of period 2,035,741 2,035,741
Balance-Ending of period
Change in fair value of warrants exercised (1,717,801) (1,717,801)
Warrants issued
Proceeds from Inducement warrants issued  
Transfer to equity (564,946) (564,946)
Change in fair value 247,006 247,006
January 19, 2023 [Member]    
Warrant Liability (Details) - Schedule of the warrant liability [Line Items]    
Balance-beginning of period
Balance-Ending of period
Change in fair value of warrants exercised
Warrants issued 2,875,580 2,875,580
Proceeds from Inducement warrants issued  
Transfer to equity (3,410,100) (3,410,100)
Change in fair value $ 534,520 $ 534,520
XML 105 R75.htm IDEA: XBRL DOCUMENT v3.23.2
Warrant Liability (Details) - Schedule of Change in Warrant Fair Value
6 Months Ended
Jun. 30, 2023
USD ($)
Schedule Of Change In Warrant Fair Value Abstract  
Change in fair value of warrants exercised $ (1,915,534)
Fair value of warrants issued as inducement 2,875,580
other changes in fair value of warrants 587,577
Day 1 Loss - FV Change in Warrant Liability 309,000
Total change in warrant fair value January 1, 2023-June 30, 2023 $ 1,856,623
XML 106 R76.htm IDEA: XBRL DOCUMENT v3.23.2
Share Capital (Details) - Schedule of Stock Option Activity - $ / shares
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Stock Options [Member]      
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]      
Number of options, Outstanding at beginning 1,506,138 414,568  
Weighted average exercise price, Outstanding at beginning $ 3.53 $ 13.88  
Number of options, Outstanding at ending   1,506,138 414,568
Weighted average exercise price, Outstanding at ending   $ 3.53 $ 13.88
Number of options, Granted 1,145,000  
Weighted average exercise price, Granted $ 1.15  
Number of options, Expired/Cancelled (53,430)  
Weighted average exercise price, Expired/Cancelled $ 30.9  
Restricted Share Units [Member]      
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]      
Number of options, Outstanding at beginning 3,165,000  
Weighted average exercise price, Outstanding at beginning $ 1.05  
Number of options, Outstanding at ending   3,165,000
Weighted average exercise price, Outstanding at ending   $ 1.05
Number of options, Granted 3,195,000  
Weighted average exercise price, Granted   $ 1.05  
Number of options, Expired/Cancelled   (30,000)  
Weighted average exercise price, Expired/Cancelled $ 1.1  
Agents’ Options [Member]      
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]      
Number of options, Outstanding at beginning 931,507 445,926 452,523
Weighted average exercise price, Outstanding at beginning $ 4.12 $ 7.51 $ 8.02
Number of options, Outstanding at ending   931,507 445,926
Weighted average exercise price, Outstanding at ending   $ 4.12 $ 7.51
Number of options, Granted 487,283  
Weighted average exercise price, Granted   $ 2.51  
Number of options, Expired/Cancelled   (1,702) (6,597)
Weighted average exercise price, Expired/Cancelled $ 20.49 $ 5,268
before the 100-1 reverse stock split [Member] | Stock Options [Member]      
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]      
Number of options, Outstanding at ending 1,506,138    
Weighted average exercise price, Outstanding at ending $ 3.53    
before the 100-1 reverse stock split [Member] | Restricted Share Units [Member]      
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]      
Number of options, Outstanding at ending 3,165,000    
Weighted average exercise price, Outstanding at ending $ 1.05    
before the 100-1 reverse stock split [Member] | Agents’ Options [Member]      
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]      
Number of options, Outstanding at ending 931,507    
Weighted average exercise price, Outstanding at ending $ 4.87    
after the 100-1 reverse stock split [Member] | Stock Options [Member]      
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]      
Number of options, Outstanding at ending 15,061    
Weighted average exercise price, Outstanding at ending $ 353    
after the 100-1 reverse stock split [Member] | Restricted Share Units [Member]      
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]      
Number of options, Outstanding at ending 31,650    
Weighted average exercise price, Outstanding at ending $ 105    
after the 100-1 reverse stock split [Member] | Agents’ Options [Member]      
Share Capital (Details) - Schedule of Stock Option Activity [Line Items]      
Number of options, Outstanding at ending 9,315    
Weighted average exercise price, Outstanding at ending $ 487    
XML 107 R77.htm IDEA: XBRL DOCUMENT v3.23.2
Share Capital (Details) - Schedule Stock Options Outstanding - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2023
Jun. 30, 2023
01-Jan-20 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 2,069 2,069
Number of options exercisable 2,069 2,069
Weighted Average Exercise Price (in Dollars per share) $ 54 $ 54
Expiry date 01-Jan-24 1-Jan-24
Remaining contractual life (years) 7 months 24 days 6 months 3 days
Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 1,506,138  
Number of options exercisable 748,638  
Weighted Average Exercise Price (in Dollars per share) $ 3.53  
Remaining contractual life (years) 3 years 6 months 3 days  
Stock Options [Member] | 24-Dec-18 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 12,896 12,896
Number of options exercisable 12,896 12,896
Weighted Average Exercise Price (in Dollars per share) $ 54 $ 54
Expiry date 24-Dec-23 24-Dec-23
Remaining contractual life (years) 7 months 17 days 5 months 23 days
Stock Options [Member] | 15-Jan-19 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 828 828
Number of options exercisable 828 828
Weighted Average Exercise Price (in Dollars per share) $ 54 $ 54
Expiry date 15-Jan-24 15-Jan-24
Remaining contractual life (years) 8 months 8 days 6 months 18 days
Stock Options [Member] | 21-Mar-19 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 12,345 12,345
Number of options exercisable 12,345 12,345
Weighted Average Exercise Price (in Dollars per share) $ 59 $ 59
Expiry date 21-Mar-24 21-Mar-24
Remaining contractual life (years) 10 months 13 days 8 months 23 days
Stock Options [Member] | 15-Nov-20 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 95,000 95,000
Number of options exercisable 95,000 95,000
Weighted Average Exercise Price (in Dollars per share) $ 6 $ 6
Expiry date 15-Nov-30 15-Nov-30
Remaining contractual life (years) 7 years 6 months 10 days 7 years 4 months 17 days
Stock Options [Member] | 15-Nov-20 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 161,500 161,500
Number of options exercisable 161,500 161,500
Weighted Average Exercise Price (in Dollars per share) $ 6 $ 6
Expiry date 15-Nov-25 15-Nov-25
Remaining contractual life (years) 2 years 6 months 7 days 2 years 4 months 17 days
Stock Options [Member] | 02-Jan-21 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 57,000 57,000
Number of options exercisable 57,000 57,000
Weighted Average Exercise Price (in Dollars per share) $ 11.5 $ 11.5
Expiry date 02-Jan-26 2-Jan-26
Remaining contractual life (years) 2 years 7 months 24 days 2 years 6 months 3 days
Stock Options [Member] | 02-Jan-21 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 5,000 5,000
Number of options exercisable 5,000 5,000
Weighted Average Exercise Price (in Dollars per share) $ 11.5 $ 11.5
Expiry date 02-Jan-31 2-Jan-31
Remaining contractual life (years) 7 years 7 months 28 days 7 years 6 months 7 days
Stock Options [Member] | 18-Jan-21 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 14,500 14,500
Number of options exercisable 14,500 14,500
Weighted Average Exercise Price (in Dollars per share) $ 11.5 $ 11.5
Expiry date 18-Jan-26 18-Jan-26
Remaining contractual life (years) 2 years 8 months 12 days 2 years 6 months 21 days
Stock Options [Member] | 01-Jan-22 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 20,000 20,000
Number of options exercisable 12,500 12,500
Weighted Average Exercise Price (in Dollars per share) $ 4 $ 4
Expiry date 29-Oct-26 29-Oct-26
Remaining contractual life (years) 3 years 5 months 23 days 3 years 3 months 29 days
Stock Options [Member] | 13-Apr-22 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 795,000 795,000
Number of options exercisable 265,000 331,250
Weighted Average Exercise Price (in Dollars per share) $ 1.1 $ 1.1
Expiry date 13-Apr-27 13-Apr-27
Remaining contractual life (years) 3 years 11 months 4 days 3 years 9 months 14 days
Stock Options [Member] | 12-Jul-22 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 330,000 330,000
Number of options exercisable 110,000 110,000
Weighted Average Exercise Price (in Dollars per share) $ 1.1 $ 1.1
Expiry date 12-Jul-25 12-Jul-25
Remaining contractual life (years) 2 years 2 months 4 days 2 years 14 days
Restricted Share Units [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 3,165,000  
Number of options exercisable 1,751,250  
Weighted Average Exercise Price (in Dollars per share) $ 1.05  
Restricted Share Units [Member] | 13-Apr-22 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 825,000 825,000
Number of options exercisable 513,750 513,750
Weighted Average Exercise Price (in Dollars per share) $ 1.1 $ 1.1
Restricted Share Units [Member] | 12-Jul-22 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 90,000 90,000
Number of options exercisable 37,500 30,000
Weighted Average Exercise Price (in Dollars per share) $ 1.1 $ 1.1
Restricted Share Units [Member] | 09-Mar-22 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 2,250,000 2,250,000
Number of options exercisable 1,200,000 1,350,000
Weighted Average Exercise Price (in Dollars per share) $ 1.03 $ 1.03
Agents’ Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 931,507  
Number of options exercisable 931,507  
Weighted Average Exercise Price (in Dollars per share) $ 4.12  
Remaining contractual life (years) 2 years 11 months 23 days  
Agents’ Options [Member] | 29-Sep-20 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 113,500 113,500
Number of options exercisable 113,500 113,500
Weighted Average Exercise Price (in Dollars per share) $ 6.6 $ 6.6
Expiry date 28-Sep-25 28-Sep-25
Remaining contractual life (years) 2 years 2 years
Agents’ Options [Member] | 29-Sep-20 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 266,000 266,000
Number of options exercisable 266,000 266,000
Weighted Average Exercise Price (in Dollars per share) $ 6.85 $ 6.85
Expiry date 28-Sep-25 28-Sep-25
Remaining contractual life (years) 2 years 2 years
Agents’ Options [Member] | 31-Dec-20 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 64,724 64,724
Number of options exercisable 64,724 64,724
Weighted Average Exercise Price (in Dollars per share) $ 11.5 $ 11.5
Expiry date 30-Jun-24 30-Jun-24
Remaining contractual life (years) 1 year 1 year
Agents’ Options [Member] | 11-Jan-22 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 434,783 434,783
Number of options exercisable 434,783 434,783
Weighted Average Exercise Price (in Dollars per share) $ 2.53 $ 2.53
Expiry date 11-Jan-27 11-Jan-27
Remaining contractual life (years) 4 years 4 years
Agents’ Options [Member] | 01-Apr-22 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding 52,500 52,500
Number of options exercisable 52,500 52,500
Weighted Average Exercise Price (in Dollars per share) $ 2.3 $ 2.3
Expiry date 08-Mar-27 8-Mar-27
Remaining contractual life (years) 4 years 4 years
Share Purchase Warrants [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable 34,132,071  
Weighted Average Exercise Price (in Dollars per share) $ 1.47  
Share Purchase Warrants [Member] | 29-Sep-20 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable 1,805,585 1,805,585
Weighted Average Exercise Price (in Dollars per share) $ 6.85 $ 6.85
Expiry date 28-Sep-25 28-Sep-25
Share Purchase Warrants [Member] | 31-Dec-20 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable 1,294,500 1,294,500
Weighted Average Exercise Price (in Dollars per share) $ 11.5 $ 11.5
Expiry date 30-Jun-24 30-Jun-24
Share Purchase Warrants [Member] | 11-Jan-22 [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable 9,999,999 9,999,999
Weighted Average Exercise Price (in Dollars per share) $ 2.3 $ 2.3
Expiry date 11-Jan-27 10-Jan-27
before the 100-1 reverse stock split [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding   1,506,138
Number of options exercisable   794,888
Weighted Average Exercise Price (in Dollars per share)   $ 3.53
Remaining contractual life (years)   3 years 8 months 1 day
before the 100-1 reverse stock split [Member] | Restricted Share Units [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding   3,165,000
Number of options exercisable   1,893,750
Weighted Average Exercise Price (in Dollars per share)   $ 1.05
before the 100-1 reverse stock split [Member] | Agents’ Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding   931,507
Number of options exercisable   931,507
Weighted Average Exercise Price (in Dollars per share)   $ 4.87
Remaining contractual life (years)   2 years 11 months 23 days
before the 100-1 reverse stock split [Member] | Share Purchase Warrants [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable   13,100,084
Weighted Average Exercise Price (in Dollars per share)   $ 3.84
after the 100-1 reverse stock split [Member] | Agents’ Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding   9,315
Number of options exercisable   9,315
Weighted Average Exercise Price (in Dollars per share)   $ 487
Remaining contractual life (years)   2 years 11 months 23 days
after the 100-1 reverse stock split [Member] | Stock Options [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding   15,061
Number of options exercisable   7,949
Weighted Average Exercise Price (in Dollars per share)   $ 353
Remaining contractual life (years)   3 years 8 months 1 day
after the 100-1 reverse stock split [Member] | Restricted Share Units [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options outstanding   31,650
Number of options exercisable   18,938
Weighted Average Exercise Price (in Dollars per share)   $ 105
after the 100-1 reverse stock split [Member] | Share Purchase Warrants [Member]    
Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]    
Number of options exercisable   131,001
Weighted Average Exercise Price (in Dollars per share)   $ 384
XML 108 R78.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions (Details) - Schedule of Remuneration of Directors and Key Management Personnel - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Payments to key management personnel:        
Salaries, consulting and directors’ fees $ 285,413 $ 491,889 $ 667,582 $ 851,262
Share-based payments 243,323 767,436 438,008 1,792,129
Total $ 528,736 $ 1,259,325 $ 1,105,590 $ 2,643,391
XML 109 R79.htm IDEA: XBRL DOCUMENT v3.23.2
Related Party Transactions (Details) - Schedule of Classified Within Profit and Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
VP Technology/VP Sales International [Member]        
Related Party Transactions (Details) - Schedule of Classified Within Profit and Loss [Line Items]        
Selling and marketing expenses $ 46 $ 84 $ 182 $ 152
Companies controlled by the CEO, CFO and Directors [Member]        
Related Party Transactions (Details) - Schedule of Classified Within Profit and Loss [Line Items]        
General and administrative expense     $ 486 $ 699
XML 110 R80.htm IDEA: XBRL DOCUMENT v3.23.2
Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers [Line Items]        
Revenue $ 2,711 $ 970 $ 4,513 $ 1,803
USA [Member]        
Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers [Line Items]        
Revenue 2,270 477 3,342 722
Canada [Member]        
Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers [Line Items]        
Revenue 302 376 521 625
EMEA [Member]        
Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers [Line Items]        
Revenue 139 104 650 443
Australia [Member]        
Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers [Line Items]        
Revenue $ 13 $ 13
XML 111 R81.htm IDEA: XBRL DOCUMENT v3.23.2
Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information - USD ($)
$ in Thousands
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information [Line Items]      
Long-term receivable total $ 143 $ 146 $ 150
Right of use asset total 771 812 887
Equipment total 191 200 207
Intangibles total 7,633 $ 7,481 6,988
CANADA      
Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information [Line Items]      
Long-term receivable total  
Right of use asset total 126   177
Equipment total  
Intangibles total 70  
EMEA [Member]      
Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information [Line Items]      
Right of use asset total 645   710
Equipment total 191   207
Intangibles total $ 7,563   $ 6,988
XML 112 R82.htm IDEA: XBRL DOCUMENT v3.23.2
Segmented Information (Details) - Schedule of Product Information - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Segmented Information (Details) - Schedule of Product Information [Line Items]            
Revenue by product $ 2,711 $ 1,803 $ 970 $ 833 $ 4,513 $ 1,803
Cellular boosters and related accessories [Member]            
Segmented Information (Details) - Schedule of Product Information [Line Items]            
Revenue by product 575   750   1,012 1,213
Rugged devices and related accessories [Member]            
Segmented Information (Details) - Schedule of Product Information [Line Items]            
Revenue by product $ 2,136   $ 220   $ 3,501 $ 590
XML 113 ea183026-6k_siyata_htm.xml IDEA: XBRL DOCUMENT 0001649009 2023-01-01 2023-06-30 0001649009 2023-03-31 0001649009 2022-12-31 0001649009 2023-01-01 2023-03-31 0001649009 2022-01-01 2022-03-31 0001649009 ifrs-full:ClassesOfShareCapitalMember 2021-12-31 0001649009 syta:ReservesMember 2021-12-31 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001649009 ifrs-full:RetainedEarningsMember 2021-12-31 0001649009 2021-12-31 0001649009 ifrs-full:ClassesOfShareCapitalMember 2022-01-01 2022-03-31 0001649009 syta:ReservesMember 2022-01-01 2022-03-31 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001649009 ifrs-full:RetainedEarningsMember 2022-01-01 2022-03-31 0001649009 ifrs-full:ClassesOfShareCapitalMember 2022-03-31 0001649009 syta:ReservesMember 2022-03-31 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001649009 ifrs-full:RetainedEarningsMember 2022-03-31 0001649009 2022-03-31 0001649009 ifrs-full:ClassesOfShareCapitalMember 2022-12-31 0001649009 syta:ReservesMember 2022-12-31 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001649009 ifrs-full:RetainedEarningsMember 2022-12-31 0001649009 ifrs-full:ClassesOfShareCapitalMember 2023-01-01 2023-03-31 0001649009 syta:ReservesMember 2023-01-01 2023-03-31 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001649009 ifrs-full:RetainedEarningsMember 2023-01-01 2023-03-31 0001649009 ifrs-full:ClassesOfShareCapitalMember 2023-03-31 0001649009 syta:ReservesMember 2023-03-31 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001649009 ifrs-full:RetainedEarningsMember 2023-03-31 0001649009 2023-06-30 0001649009 2022-01-01 2022-06-30 0001649009 2023-04-01 2023-06-30 0001649009 2022-04-01 2022-06-30 0001649009 syta:beforeThe1001ReverseSplitMember 2023-01-01 2023-06-30 0001649009 syta:beforeThe1001ReverseSplitMember 2022-01-01 2022-06-30 0001649009 syta:beforeThe1001ReverseSplitMember 2023-04-01 2023-06-30 0001649009 syta:beforeThe1001ReverseSplitMember 2022-04-01 2022-06-30 0001649009 syta:afterThe1001ReverseSplitMember 2023-01-01 2023-06-30 0001649009 syta:afterThe1001ReverseSplitMember 2022-01-01 2022-06-30 0001649009 syta:afterThe1001ReverseSplitMember 2023-04-01 2023-06-30 0001649009 syta:afterThe1001ReverseSplitMember 2022-04-01 2022-06-30 0001649009 ifrs-full:ClassesOfShareCapitalMember 2022-01-01 2022-06-30 0001649009 syta:ReservesMember 2022-01-01 2022-06-30 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-06-30 0001649009 ifrs-full:RetainedEarningsMember 2022-01-01 2022-06-30 0001649009 ifrs-full:ClassesOfShareCapitalMember 2022-06-30 0001649009 syta:ReservesMember 2022-06-30 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001649009 ifrs-full:RetainedEarningsMember 2022-06-30 0001649009 2022-06-30 0001649009 ifrs-full:ClassesOfShareCapitalMember 2023-01-01 2023-06-30 0001649009 syta:ReservesMember 2023-01-01 2023-06-30 0001649009 ifrs-full:RetainedEarningsMember 2023-01-01 2023-06-30 0001649009 ifrs-full:ClassesOfShareCapitalMember 2023-06-30 0001649009 syta:ReservesMember 2023-06-30 0001649009 ifrs-full:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001649009 ifrs-full:RetainedEarningsMember 2023-06-30 0001649009 syta:QueensgateResourcesCorpMember 2023-01-01 2023-03-31 0001649009 syta:QueensgateResourcesCorpMember 2023-03-31 0001649009 syta:QueensgateResourcesUSCorpMember 2023-01-01 2023-03-31 0001649009 syta:QueensgateResourcesUSCorpMember 2023-03-31 0001649009 syta:SiyataMobileCanadaIncMember 2023-01-01 2023-03-31 0001649009 syta:SiyataMobileCanadaIncMember 2023-03-31 0001649009 syta:SiyataMobileIsraelLtdMember 2023-01-01 2023-03-31 0001649009 syta:SiyataMobileIsraelLtdMember 2023-03-31 0001649009 syta:SignifiMobileIncMember 2023-01-01 2023-03-31 0001649009 syta:SignifiMobileIncMember 2023-03-31 0001649009 syta:ClearRFNevadaLtdMember 2023-01-01 2023-03-31 0001649009 syta:ClearRFNevadaLtdMember 2023-03-31 0001649009 2021-11-03 2021-11-03 0001649009 2022-01-01 2022-01-13 0001649009 2022-05-01 2022-05-31 0001649009 2023-01-01 2023-01-19 0001649009 ifrs-full:TopOfRangeMember 2023-01-01 2023-01-19 0001649009 ifrs-full:BottomOfRangeMember 2023-01-01 2023-01-19 0001649009 syta:CommonSharesMember 2023-01-01 2023-01-19 0001649009 syta:WarrantsMember 2023-01-01 2023-01-19 0001649009 syta:WarrantsMember 2023-01-19 0001649009 syta:CommonSharesMember 2023-01-19 0001649009 2023-01-01 2023-03-30 0001649009 syta:January192023WarrantsMember 2023-01-01 2023-01-19 0001649009 2021-11-01 2021-11-03 0001649009 syta:WarrantsMember 2021-11-01 2021-11-03 0001649009 syta:November32021WarrantsMember 2022-01-01 2022-12-31 0001649009 2022-01-01 2022-01-11 0001649009 syta:BlackScholesOptionPricingModelMember 2022-01-01 2022-12-31 0001649009 2022-10-01 2022-10-12 0001649009 syta:October122022WarrantsMember 2022-01-01 2022-12-31 0001649009 syta:October122022WarrantsMember 2022-12-31 0001649009 syta:October122022WarrantsMember 2023-01-01 2023-01-19 0001649009 syta:BlackScholesOptionPricingModelMember 2023-01-01 2023-01-19 0001649009 syta:October122022WarrantsMember 2023-01-19 0001649009 syta:October122022WarrantsMember syta:PriorToExerciseMember 2023-01-01 2023-01-19 0001649009 syta:BlackScholesOptionPricingModelMember syta:PriorToExerciseMember 2023-01-01 2023-01-19 0001649009 syta:October122022WarrantsMember syta:PriorToExerciseMember 2023-01-19 0001649009 syta:October122022WarrantsMember 2023-01-01 2023-03-31 0001649009 syta:October122022WarrantsMember 2023-01-01 2023-03-30 0001649009 2022-01-01 2022-12-31 0001649009 syta:November32021Member 2022-12-31 0001649009 syta:January112022Member 2022-12-31 0001649009 syta:October122022Member 2022-12-31 0001649009 syta:January192023Member 2022-12-31 0001649009 syta:November32021Member 2023-01-01 2023-03-31 0001649009 syta:January112022Member 2023-01-01 2023-03-31 0001649009 syta:October122022Member 2023-01-01 2023-03-31 0001649009 syta:January192023Member 2023-01-01 2023-03-31 0001649009 syta:November32021Member 2023-03-31 0001649009 syta:January112022Member 2023-03-31 0001649009 syta:October122022Member 2023-03-31 0001649009 syta:January192023Member 2023-03-31 0001649009 ifrs-full:OrdinarySharesMember 2023-03-31 0001649009 ifrs-full:OrdinarySharesMember 2022-12-31 0001649009 2023-07-25 2023-08-03 0001649009 2023-06-28 0001649009 2023-06-01 2023-06-28 0001649009 syta:NonAdjustingEventMember 2023-07-13 0001649009 syta:NonAdjustingEventMember 2023-07-13 2023-07-13 0001649009 syta:NonAdjustingEventMember 2023-07-25 2023-08-03 0001649009 syta:CommonShareTransactionsMember ifrs-full:OrdinarySharesMember 2023-03-31 0001649009 syta:WarrantsMember 2023-01-01 2023-03-31 0001649009 syta:WarrantsMember 2023-03-31 0001649009 syta:WarrantsMember 2023-01-01 2023-03-31 0001649009 2022-01-11 0001649009 syta:PreFundedUnitsMember 2023-01-01 2023-03-31 0001649009 syta:OptionWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:OptionWarrantsMember 2023-03-31 0001649009 syta:PlacementAgentWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:PlacementAgentWarrantsMember 2023-03-31 0001649009 syta:PlacementAgentWarrantsMember 2022-01-11 2022-01-11 0001649009 2022-01-11 2022-01-11 0001649009 syta:ClearRFAcquisitionMember 2022-03-01 2022-03-31 0001649009 syta:ClearRFAcquisitionMember 2022-03-31 0001649009 syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 2022-01-01 2022-01-01 0001649009 2022-01-01 0001649009 syta:StockOptionsMember 2021-12-31 0001649009 syta:StockOptionsMember 2022-01-01 2022-12-31 0001649009 syta:StockOptionsMember 2022-12-31 0001649009 syta:RestrictedShareUnitsMember 2021-12-31 0001649009 syta:RestrictedShareUnitsMember 2022-01-01 2022-12-31 0001649009 syta:RestrictedShareUnitsMember 2022-12-31 0001649009 syta:AgentsOptionsMember 2021-12-31 0001649009 syta:AgentsOptionsMember 2022-01-01 2022-12-31 0001649009 syta:AgentsOptionsMember 2022-12-31 0001649009 syta:SharePurchaseWarrantsMember 2021-12-31 0001649009 syta:SharePurchaseWarrantsMember 2022-01-01 2022-12-31 0001649009 syta:SharePurchaseWarrantsMember 2022-12-31 0001649009 syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:TwentyFourDecemberTwoThousandEighteenMember syta:StockOptionsMember 2023-03-31 0001649009 syta:TwentyFourDecemberTwoThousandEighteenMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:FifteenJanuaryTwoThousandNineteenMember syta:StockOptionsMember 2023-03-31 0001649009 syta:FifteenJanuaryTwoThousandNineteenMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:TwentyOneMarchTwoThousandNineteenMember syta:StockOptionsMember 2023-03-31 0001649009 syta:TwentyOneMarchTwoThousandNineteenMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:OneJanuaryTwoThousandAndTwentyMember 2023-03-31 0001649009 syta:OneJanuaryTwoThousandAndTwentyMember 2023-01-01 2023-03-31 0001649009 syta:FifteenNovemberTwoThousandTwentyMember syta:StockOptionsMember 2023-03-31 0001649009 syta:FifteenNovemberTwoThousandTwentyMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:FifteenNovemberThousandTwentyOneMember syta:StockOptionsMember 2023-03-31 0001649009 syta:FifteenNovemberThousandTwentyOneMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:SecondJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2023-03-31 0001649009 syta:SecondJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:SecondJanuaryTwoThousandTwentyOneOneMember syta:StockOptionsMember 2023-03-31 0001649009 syta:SecondJanuaryTwoThousandTwentyOneOneMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:EighteenthJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2023-03-31 0001649009 syta:EighteenthJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:OneJanuaryTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-03-31 0001649009 syta:OneJanuaryTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-03-31 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-03-31 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:StockOptionsMember 2023-03-31 0001649009 syta:StockOptionsMember 2023-01-01 2023-03-31 0001649009 syta:NineMarchTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-03-31 0001649009 syta:NineMarchTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-01-01 2023-03-31 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-03-31 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-01-01 2023-03-31 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-03-31 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-01-01 2023-03-31 0001649009 syta:RestrictedShareUnitsMember 2023-03-31 0001649009 syta:RestrictedShareUnitsMember 2023-01-01 2023-03-31 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:AgentsOptionsMember 2023-03-31 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:AgentsOptionsMember 2023-01-01 2023-03-31 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyOneMember syta:AgentsOptionsMember 2023-03-31 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyOneMember syta:AgentsOptionsMember 2023-01-01 2023-03-31 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:AgentsOptionsMember 2023-03-31 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:AgentsOptionsMember 2023-01-01 2023-03-31 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:AgentsOptionsMember 2023-03-31 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:AgentsOptionsMember 2023-01-01 2023-03-31 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoOneMember syta:AgentsOptionsMember 2023-03-31 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoOneMember syta:AgentsOptionsMember 2023-01-01 2023-03-31 0001649009 syta:AgentsOptionsMember 2023-03-31 0001649009 syta:AgentsOptionsMember 2023-01-01 2023-03-31 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:TwelveOctoberTwoThousandAndTwentyTwoMember syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:TwelveOctoberTwoThousandAndTwentyTwoMember syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:TwelveOctoberTwoThousandAndTwentyTwoTwoMember syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:TwelveOctoberTwoThousandAndTwentyTwoTwoMember syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:NineteenJanuaryTwoThousandAndTwentyThreeMember syta:SharePurchaseWarrantsMember 2023-01-01 2023-03-31 0001649009 syta:NineteenJanuaryTwoThousandAndTwentyThreeMember syta:SharePurchaseWarrantsMember 2023-03-31 0001649009 syta:CustomerOneMember 2023-01-01 2023-03-31 0001649009 syta:CustomerOneMember 2022-01-01 2022-03-31 0001649009 syta:VPTechnologyMember 2023-01-01 2023-03-31 0001649009 syta:VPTechnologyMember 2022-01-01 2022-03-31 0001649009 syta:CEOCFOAndDirectorsMember 2023-01-01 2023-03-31 0001649009 syta:CEOCFOAndDirectorsMember 2022-01-01 2022-03-31 0001649009 country:US 2023-01-01 2023-03-31 0001649009 country:US 2022-01-01 2022-03-31 0001649009 country:CA 2023-01-01 2023-03-31 0001649009 country:CA 2022-01-01 2022-03-31 0001649009 syta:EMEAOneMember 2023-01-01 2023-03-31 0001649009 syta:EMEAOneMember 2022-01-01 2022-03-31 0001649009 country:AU 2023-01-01 2023-03-31 0001649009 country:AU 2022-01-01 2022-03-31 0001649009 country:CA 2023-03-31 0001649009 country:CA 2022-12-31 0001649009 syta:EuropeTheMiddleEastAndAfricaMember 2023-03-31 0001649009 syta:EuropeTheMiddleEastAndAfricaMember 2022-12-31 0001649009 syta:CellularBoostersAndRelatedAccessoriesMember 2023-01-01 2023-03-31 0001649009 syta:CellularBoostersAndRelatedAccessoriesMember 2022-01-01 2022-03-31 0001649009 syta:RuggedDevicesAndRelatedAccessoriesMember 2023-01-01 2023-03-31 0001649009 syta:RuggedDevicesAndRelatedAccessoriesMember 2022-01-01 2022-03-31 0001649009 syta:NonAdjustingEventMember 2023-06-23 0001649009 syta:NonAdjustingEventMember 2023-06-01 2023-06-23 0001649009 syta:NonAdjustingEventMember 2023-07-01 2023-07-13 0001649009 syta:NonAdjustingEventMember 2023-07-29 2023-08-03 0001649009 srt:ScenarioPreviouslyReportedMember 2023-06-30 0001649009 srt:RestatementAdjustmentMember 2023-06-30 0001649009 syta:AsRestatedMember 2023-06-30 0001649009 srt:ScenarioPreviouslyReportedMember 2023-01-01 2023-06-30 0001649009 srt:RestatementAdjustmentMember 2023-01-01 2023-06-30 0001649009 syta:AsRestatedMember 2023-01-01 2023-06-30 0001649009 srt:ScenarioPreviouslyReportedMember 2022-12-31 0001649009 srt:RestatementAdjustmentMember 2022-12-31 0001649009 syta:AsRestatedMember 2022-12-31 0001649009 syta:QueensgateResourcesCorpMember 2023-01-01 2023-06-30 0001649009 syta:QueensgateResourcesCorpMember 2023-06-30 0001649009 syta:QueensgateResourcesUSCorpMember 2023-01-01 2023-06-30 0001649009 syta:QueensgateResourcesUSCorpMember 2023-06-30 0001649009 syta:SiyataMobileCanadaIncMember 2023-01-01 2023-06-30 0001649009 syta:SiyataMobileCanadaIncMember 2023-06-30 0001649009 syta:SiyataMobileIsraelLtdMember 2023-01-01 2023-06-30 0001649009 syta:SiyataMobileIsraelLtdMember 2023-06-30 0001649009 syta:SignifiMobileIncMember 2023-01-01 2023-06-30 0001649009 syta:SignifiMobileIncMember 2023-06-30 0001649009 syta:ClearRFNevadaLtdMember 2023-01-01 2023-06-30 0001649009 syta:ClearRFNevadaLtdMember 2023-06-30 0001649009 srt:NorthAmericaMember 2023-04-01 2023-04-30 0001649009 2023-04-30 0001649009 2023-04-01 2023-04-30 0001649009 ifrs-full:TopOfRangeMember 2022-01-01 2022-01-11 0001649009 ifrs-full:BottomOfRangeMember 2022-01-01 2022-01-11 0001649009 2022-10-01 2022-10-31 0001649009 syta:WarrantsNov32021Member 2022-12-31 0001649009 syta:WarrantsNov32021Member 2023-01-01 2023-06-30 0001649009 syta:January112022Member 2023-01-01 2023-06-30 0001649009 syta:October122022Member 2023-01-01 2023-06-30 0001649009 syta:January192023Member 2023-01-01 2023-06-30 0001649009 syta:WarrantsNov32021Member 2023-06-30 0001649009 syta:January112022Member 2023-06-30 0001649009 syta:October122022Member 2023-06-30 0001649009 syta:January192023Member 2023-06-30 0001649009 ifrs-full:OrdinarySharesMember 2023-06-30 0001649009 syta:NonAdjustingEventMember 2023-07-25 2023-08-09 0001649009 2023-03-01 2023-03-30 0001649009 syta:WarrantsMember 2023-01-01 2023-06-30 0001649009 syta:WarrantsLiabilityMember 2023-06-30 0001649009 syta:PreFundedUnitsMember 2023-01-01 2023-06-30 0001649009 syta:OptionWarrantsMember 2023-01-01 2023-06-30 0001649009 syta:OptionWarrantsMember 2023-06-30 0001649009 syta:PlacementAgentWarrantsMember 2023-01-01 2023-06-30 0001649009 syta:PlacementAgentWarrantsMember 2023-06-30 0001649009 2022-03-01 2022-03-31 0001649009 syta:StockOptionsMember 2023-01-01 2023-06-30 0001649009 2022-04-01 2022-04-13 0001649009 2022-04-13 0001649009 2023-01-01 2023-01-12 0001649009 syta:StockOptionsMember 2023-01-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:StockOptionsMember 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:StockOptionsMember 2023-06-30 0001649009 syta:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:RestrictedShareUnitsMember 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:RestrictedShareUnitsMember 2023-06-30 0001649009 syta:AgentsOptionsMember 2020-12-31 0001649009 syta:AgentsOptionsMember 2021-01-01 2021-12-31 0001649009 syta:AgentsOptionsMember 2023-01-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:TwentyFourDecemberTwoThousandEighteenMember syta:StockOptionsMember 2023-06-30 0001649009 syta:TwentyFourDecemberTwoThousandEighteenMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:FifteenJanuaryTwoThousandNineteenMember syta:StockOptionsMember 2023-06-30 0001649009 syta:FifteenJanuaryTwoThousandNineteenMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:TwentyOneMarchTwoThousandNineteenMember syta:StockOptionsMember 2023-06-30 0001649009 syta:TwentyOneMarchTwoThousandNineteenMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:OneJanuaryTwoThousandAndTwentyMember 2023-06-30 0001649009 syta:OneJanuaryTwoThousandAndTwentyMember 2022-07-01 2023-06-30 0001649009 syta:FifteenNovemberTwoThousandTwentyMember syta:StockOptionsMember 2023-06-30 0001649009 syta:FifteenNovemberTwoThousandTwentyMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:FifteenNovemberThousandTwentyOneMember syta:StockOptionsMember 2023-06-30 0001649009 syta:FifteenNovemberThousandTwentyOneMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:SecondJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2023-06-30 0001649009 syta:SecondJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:SecondJanuaryTwoThousandTwentyOneOneMember syta:StockOptionsMember 2023-06-30 0001649009 syta:SecondJanuaryTwoThousandTwentyOneOneMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:EighteenthJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2023-06-30 0001649009 syta:EighteenthJanuaryTwoThousandAndTwentyOneMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:OneJanuaryTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-06-30 0001649009 syta:OneJanuaryTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-06-30 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2023-06-30 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:StockOptionsMember 2022-07-01 2023-06-30 0001649009 syta:NineMarchTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-06-30 0001649009 syta:NineMarchTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2022-07-01 2023-06-30 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-06-30 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2022-07-01 2023-06-30 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2023-06-30 0001649009 syta:twelveJulyTwoThousandAndTwentyTwoMember syta:RestrictedShareUnitsMember 2022-07-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:RestrictedShareUnitsMember 2022-07-01 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:RestrictedShareUnitsMember 2022-07-01 2023-06-30 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:AgentsOptionsMember 2022-07-01 2023-06-30 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyOneMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyOneMember syta:AgentsOptionsMember 2022-07-01 2023-06-30 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:AgentsOptionsMember 2022-07-01 2023-06-30 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:AgentsOptionsMember 2022-07-01 2023-06-30 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoOneMember syta:AgentsOptionsMember 2023-06-30 0001649009 syta:ThirteenthAprilTwoThousandAndTwentyTwoOneMember syta:AgentsOptionsMember 2022-07-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:AgentsOptionsMember 2022-07-01 2023-06-30 0001649009 syta:AgentsOptionsMember syta:afterThe1001ReverseStockSplitMember 2023-06-30 0001649009 syta:AgentsOptionsMember syta:afterThe1001ReverseStockSplitMember 2022-07-01 2023-06-30 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2022-07-01 2023-06-30 0001649009 syta:TwentyNineSeptemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2023-06-30 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2022-07-01 2023-06-30 0001649009 syta:ThirtyfirstDecemberTwoThousandTwentyMember syta:SharePurchaseWarrantsMember 2023-06-30 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:SharePurchaseWarrantsMember 2022-07-01 2023-06-30 0001649009 syta:ElevenJanuaryTwoThousandAndTwentyTwoMember syta:SharePurchaseWarrantsMember 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:SharePurchaseWarrantsMember 2022-07-01 2023-06-30 0001649009 syta:beforeThe1001ReverseStockSplitMember syta:SharePurchaseWarrantsMember 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:SharePurchaseWarrantsMember 2022-07-01 2023-06-30 0001649009 syta:afterThe1001ReverseStockSplitMember syta:SharePurchaseWarrantsMember 2023-06-30 0001649009 2023-01-31 0001649009 syta:WarrantLiabilityMember 2022-01-01 2022-06-30 0001649009 syta:VPTechnologyMember 2023-01-01 2023-06-30 0001649009 syta:VPTechnologyMember 2022-01-01 2022-06-30 0001649009 syta:CEOCFOAndDirectorsMember 2023-01-01 2023-06-30 0001649009 syta:CEOCFOAndDirectorsMember 2022-01-01 2022-06-30 0001649009 country:US 2023-01-01 2023-06-30 0001649009 country:US 2022-01-01 2022-06-30 0001649009 country:US 2023-04-01 2023-06-30 0001649009 country:US 2022-04-01 2022-06-30 0001649009 country:CA 2023-01-01 2023-06-30 0001649009 country:CA 2022-01-01 2022-06-30 0001649009 country:CA 2023-04-01 2023-06-30 0001649009 country:CA 2022-04-01 2022-06-30 0001649009 syta:EMEAOneMember 2023-01-01 2023-06-30 0001649009 syta:EMEAOneMember 2022-01-01 2022-06-30 0001649009 syta:EMEAOneMember 2023-04-01 2023-06-30 0001649009 syta:EMEAOneMember 2022-04-01 2022-06-30 0001649009 country:AU 2023-01-01 2023-06-30 0001649009 country:AU 2022-01-01 2022-06-30 0001649009 country:AU 2023-04-01 2023-06-30 0001649009 country:AU 2022-04-01 2022-06-30 0001649009 country:CA 2023-06-30 0001649009 country:CA 2022-12-31 0001649009 syta:EMEAOneMember 2023-06-30 0001649009 syta:EMEAOneMember 2022-12-31 0001649009 syta:CellularBoostersAndRelatedAccessoriesMember 2023-01-01 2023-06-30 0001649009 syta:CellularBoostersAndRelatedAccessoriesMember 2022-01-01 2022-06-30 0001649009 syta:CellularBoostersAndRelatedAccessoriesMember 2023-04-01 2023-06-30 0001649009 syta:CellularBoostersAndRelatedAccessoriesMember 2022-04-01 2022-06-30 0001649009 syta:RuggedDevicesAndRelatedAccessoriesMember 2023-01-01 2023-06-30 0001649009 syta:RuggedDevicesAndRelatedAccessoriesMember 2022-01-01 2022-06-30 0001649009 syta:RuggedDevicesAndRelatedAccessoriesMember 2023-04-01 2023-06-30 0001649009 syta:RuggedDevicesAndRelatedAccessoriesMember 2022-04-01 2022-06-30 iso4217:USD shares iso4217:USD shares pure 6-K 2023 001-39557 Siyata Mobile Inc. 2023-06-30 1179694 1913742 1111123 1574628 665446 173504 3564040 4092550 675561 155852 7195864 7910276 146196 150185 811966 887137 199743 207402 7481391 6987531 15835160 16142531 2111174 3078650 149600 294359 303788 628765 2734804 3034298 6266842 543944 635217 3578242 6902059 76921437 73312866 17933273 13647399 98870 98870 -82696662 -77818663 12256918 9240472 15835160 16142531 1802637 832974 1306120 577923 496517 255051 401640 124505 53985 123316 1003365 1045051 1392430 1659079 64336 -7358 310828 812735 3162248 3821664 -2665731 -3566613 34098 26987 163 -87660 2680457 2178007 -3272735 965247 -2212268 -312296 -4877999 -3878909 24468 -4877999 -3903377 59102369 12976363 -0.08 -0.3 5276695 54655244 10389555 -38739 -62519412 2486648 138958 190095 190095 7215652 10936974 10936974 -1051647 307189 -744458 1480000 2575200 2575200 812735 812735 24468 24468 -3878909 -3878909 14111305 67305866 11509479 -14271 -66398321 12402753 44868560 73312866 13647399 98870 -77818663 9240472 18042857 3608571 3608571 3975046 3975046 310828 310828 -4877999 -4877999 62911417 76921437 17933273 98870 -82696662 12256918 -4877999 -3878909 401640 124505 -7358 64336 2178007 -592278 -4651 11666 310828 812735 1136712 3225654 -3112570 -6707274 817849 739579 2498 155014 -820347 -894593 100702 78731 -27159 -4000000 16711184 -309 3608571 2575200 3198869 15180494 22680 -734048 7601307 1913742 1619742 1179694 9221049 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NATURE OF OPERATIONS AND GOING CONCERN</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Siyata Mobile Inc. (“Siyata” or the “Company”) was incorporated under the Business Corporations Act, British Columbia on October 15, 1986. The Company’s shares are listed on NASDAQ under the symbol SYTA and warrants issued on September 29, 2020, are traded under the symbol SYTAW. The Company’s principal activity is the sale of vehicle-mounted, cellular-based communications platforms over advanced mobile networks and cellular booster systems. The registered and records office is located at 2200 - 885 West Georgia Street, Vancouver, BC V6C 3E8.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These restated unaudited condensed interim consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) IAS 34 <i>Interim Financial Reporting</i>, with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business rather than a process of forced liquidation. These restated unaudited condensed interim consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company incurred a net loss of $4,877,999 during the three month period ended March 31, 2023 (March 31, 2022- three month period net loss of $3,879,909), and, as of that date, the Company’s total deficit was $82,696,662 (December 31, 2022 - $77,818,663). The Company’s continuation as a going concern is dependent upon the success of the Company’s sale of inventory, the existing cash flows, and the ability of the Company to obtain additional debt or equity financing, all of which are uncertain. These material uncertainties raise substantial doubt on the Company’s ability to continue as a going concern.</p> -4877999 3879909 82696662 77818663 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BASIS OF PREPARATION</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Statement of compliance </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These restated unaudited condensed interim consolidated financial statements, including comparatives, have been prepared in accordance with International Accounting Standards (IAS) 34 <i>Interim Financial Reporting. </i>Omitted from these restated financial statements are certain information and note disclosures normally included in the annual financial statements. These financial statements and notes presented should be read in conjunction with the annual financial statements for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The accounting methods and principles of computation adopted in these restated financial statements are the same as those in annual consolidated financial statements for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The preparation of these restated unaudited condensed interim consolidated financial statements requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The significant judgements made by management when applying the Company’s accounting policies and the key sources of estimation uncertainty were the same as those that applied to the Company’s December 31, 2022 annual consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Basis of consolidation and presentation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These restated unaudited condensed interim consolidated financial statements of the Company have been prepared on a historical cost basis, except for financial instruments classified as financial instruments at fair value through profit and loss, which are stated at their fair value. In addition, the restated condensed interim consolidated financial statements have been prepared using the accrual basis of accounting, except for the statement of cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These restated unaudited condensed interim consolidated financial statements incorporate the financial statements of the Company and its wholly controlled subsidiaries. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. These restated condensed interim consolidated financial statements include the accounts of the Company and its direct wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The restated unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Subsidiary</b></span></td> <td> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place of Incorporation</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 46%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Queensgate Resources Corp.</span></td> <td style="width: 1%"> </td> <td style="width: 42%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">British Columbia, Canada</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Queensgate Resources US Corp.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada, USA</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siyata Mobile (Canada) Inc.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">British Columbia, Canada</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siyata Mobile Israel Ltd.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signifi Mobile Inc.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quebec, Canada</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ClearRF Nevada Ltd.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada, USA</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.8pt"><b>Recent adoptions of accounting pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The following amendments became effective on January 1, 2023, and did not have a material impact on the Company’s condensed interim consolidated financial statements:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2021, the IASB issued Definition of Accounting Estimates (Amendments to IAS 8). The amendments define accounting estimates and clarify the distinction between changes in accounting estimates and changes in accounting policies. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2021, the IASB issued Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2). The amendments provide guidance to help entities disclose their material (previously “significant”) accounting policies. </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the IASB issued Deferred Tax related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12). The amendments narrow the scope of the recognition exemption so that companies would be required to recognize deferred tax for transactions that give rise to equal amounts of taxable and deductible temporary differences, such as leases.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Future accounting pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The standards, amendments, and interpretations issued before 2023 but not yet adopted by the Company have been disclosed in Note 3 of the Company’s December 31, 2022 annual consolidated financial statements. The Company is currently considering the impact of adopting these standards, amendments and interpretations on its consolidated financial statement.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Basis of consolidation and presentation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These restated unaudited condensed interim consolidated financial statements of the Company have been prepared on a historical cost basis, except for financial instruments classified as financial instruments at fair value through profit and loss, which are stated at their fair value. In addition, the restated condensed interim consolidated financial statements have been prepared using the accrual basis of accounting, except for the statement of cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These restated unaudited condensed interim consolidated financial statements incorporate the financial statements of the Company and its wholly controlled subsidiaries. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. These restated condensed interim consolidated financial statements include the accounts of the Company and its direct wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The restated unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Subsidiary</b></span></td> <td> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place of Incorporation</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 46%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Queensgate Resources Corp.</span></td> <td style="width: 1%"> </td> <td style="width: 42%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">British Columbia, Canada</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Queensgate Resources US Corp.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada, USA</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siyata Mobile (Canada) Inc.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">British Columbia, Canada</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siyata Mobile Israel Ltd.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signifi Mobile Inc.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quebec, Canada</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ClearRF Nevada Ltd.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada, USA</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> The restated unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Subsidiary</b></span></td> <td> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Place of Incorporation</b></span></td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ownership</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 46%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Queensgate Resources Corp.</span></td> <td style="width: 1%"> </td> <td style="width: 42%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">British Columbia, Canada</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Queensgate Resources US Corp.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada, USA</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siyata Mobile (Canada) Inc.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">British Columbia, Canada</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Siyata Mobile Israel Ltd.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signifi Mobile Inc.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quebec, Canada</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ClearRF Nevada Ltd.</span></td> <td> </td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nevada, USA</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> Queensgate Resources Corp. British Columbia, Canada 1 Queensgate Resources US Corp. Nevada, USA 1 Siyata Mobile (Canada) Inc. British Columbia, Canada 1 Siyata Mobile Israel Ltd. Israel 1 Signifi Mobile Inc. Quebec, Canada 1 ClearRF Nevada Ltd. Nevada, USA 1 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.8pt"><b>Recent adoptions of accounting pronouncements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The following amendments became effective on January 1, 2023, and did not have a material impact on the Company’s condensed interim consolidated financial statements:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2021, the IASB issued Definition of Accounting Estimates (Amendments to IAS 8). The amendments define accounting estimates and clarify the distinction between changes in accounting estimates and changes in accounting policies. </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2021, the IASB issued Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2). The amendments provide guidance to help entities disclose their material (previously “significant”) accounting policies. </span></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the IASB issued Deferred Tax related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12). The amendments narrow the scope of the recognition exemption so that companies would be required to recognize deferred tax for transactions that give rise to equal amounts of taxable and deductible temporary differences, such as leases.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Future accounting pronouncements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The standards, amendments, and interpretations issued before 2023 but not yet adopted by the Company have been disclosed in Note 3 of the Company’s December 31, 2022 annual consolidated financial statements. The Company is currently considering the impact of adopting these standards, amendments and interpretations on its consolidated financial statement.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRADE AND OTHER RECEIVABLES</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 28.35pt; text-align: justify; text-indent: -13.5pt"><b> </b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Trade receivables</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">1,645,627</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">2,015,291</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Allowance for doubtful accounts</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(1,062,052</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(1,056,393</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Taxes receivable</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">527,548</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">615,730</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,111,123</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,574,628</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Trade receivables</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">1,645,627</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">2,015,291</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Allowance for doubtful accounts</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(1,062,052</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(1,056,393</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Taxes receivable</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">527,548</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">615,730</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,111,123</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,574,628</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> 1645627 2015291 1062052 1056393 527548 615730 1111123 1574628 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INVENTORY</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Finished products</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">6,874,848</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">7,392,002</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Impairment of finished products</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(3,555,683</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(3,555,683</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accessories and spare parts</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">663,645</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">675,001</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Impairment of accessories and spare parts</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(418,770</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(418,770</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,564,040</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4,092,550</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Finished products</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">6,874,848</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">7,392,002</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Impairment of finished products</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(3,555,683</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(3,555,683</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accessories and spare parts</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">663,645</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">675,001</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Impairment of accessories and spare parts</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(418,770</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(418,770</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,564,040</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4,092,550</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> 6874848 7392002 -3555683 -3555683 663645 675001 -418770 -418770 3564040 4092550 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CONVERTIBLE DEBENTURES</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On November 3, 2021, the Company issued a US$7,200,000 convertible promissory note (the “Promissory Note”) and 2,142,857 warrants for gross proceeds of US$6,000,000. The Company elected to measure the promissory note (hybrid contract) at fair value through profit or loss (“FVTPL”) on initial recognition and, as such, the embedded conversion feature was not separated. The warrants were recorded as a liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">During the three months ended March 31, 2022, the Company completed a secondary offering of its common shares, and as a result of the terms of the convertible promissory note, the Company was required to direct 20% of the gross proceed of the offering to the lender. A total of US$4,000,000 was repaid to the lender on January 13, 2022. Commencing in May 2022, the Company made monthly payments of $400,000 through issuance of common shares towards the principal balance of the promissory note, resulting the promissory note being fully repaid by December 31, 2022. The Company issued 13,112,255 common shares, with a total market value of $4,138,002. The difference between the fair value of the shares issued, and the value of the principal repaid of $938,002 was included in profit and loss in the change in fair value of convertible promissory note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 56.7pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">For the three months ended March 31, 2022 the Company recorded a fair value loss of $2,023,751 on the Convertible debenture.</p> 7200000 2142857 6000000 0.20 4000000 400000 13112255 4138002 938002 2023751 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WARRANT LIABILITY</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The balance of the warrant liability is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">November 3,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">January 11,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">October 12, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">January 19,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-weight: bold">Balance December 31, 2022</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">197,733</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">501,330</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">2,035,741</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">2,734,804</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Exercise of warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(197,733</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,717,801</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,915,534</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrants issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,580</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Transfer to equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(564,946</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,410,100</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,975,046</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in fair value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127,435</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">247,006</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">534,520</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">908,961</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold">Balance March 31, 2023</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">-</div></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">628,765</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">-</div></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">628,765</td><td style="font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="text-decoration:underline">January 19, 2023 warrants</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On January 19, 2023, the Company entered into warrant exercise agreements with fourteen existing accredited investors to exercise certain outstanding warrants to purchase up to an aggregate of 18,042,857 of the Company’s common shares. In consideration for the immediate exercise of the outstanding warrants for cash, the Company agreed to reduce the exercise price from $0.23 to $0.20 per share and issue new unregistered warrants to purchase up to an aggregate of 18,042,857 common shares with an exercise price of $0.20 per share. The gross proceeds to the Company from the exercise totaled approximately $3,608,571, prior to deducting warrant inducement agent fees and offering expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The new warrants are exercisable immediately upon issuance at an exercise price of $0.20 per share and have a term of exercise equal to five years. In connection with the exercise, the Company will be required pursuant to the terms of 2,989,130 of its remaining unexercised common share purchase warrants, to reduce the exercise price of such warrants from $0.23 per common share to an exercise price of $0.20 per common share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On March 30, 2023, the SEC accepted the registration statement of the Company to the effect that all of the 21,031,987 outstanding $0.20 warrants become immediately a cashless exercise and their underlying shares become immediately tradeable. Subsequent to the quarter ended March 31, 2023, 21,031,987 warrants were exercised cashless in exchange for 21,031,987 common shares of the Company. All of the warrants that became cashless exercise were transferred to equity at March 30, 2023, as they no longer met the definition of a liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the warrants issued at January 19, 2023 was $2,875,580 and was determined using the stock price at the date of issue, with a 15% discount for lack of marketability. This method was used as the warrants contained an alternative cashless exercise feature.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the warrants on March 30, 2023 was $3,410,100 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="text-decoration:underline">November 3, 2021 warrants</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The warrants allowed for the purchase of 1,892,857 common shares of the Company at an exercise price of US 4.00 per common share and expired 5 years from the issue date of the related promissory note. Under the terms of the warrants, the exercise price of the warrant was adjusted to $2.30 when an offering was closed on January 3, 2022 that issued shares at a price lower than the exercise price. On January 19, 2023 the warrant holders entered into the agreement noted above to exercise the warrants, and receive new warrants in exchange.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">At December 31, 2022 the fair value of the warrants was $197,733 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.15, strike rate $0.23 dividend yield 0%, term 3.84 years, volatility 110% and risk-free rate 4.08%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">At January 19, 2023 prior to exercise, the fair value of the warrants was $<span style="-sec-ix-hidden: hidden-fact-127">NIL</span> and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.19, strike rate $0.20 dividend yield 0%, term 0 years, volatility 130% and risk-free rate 3.62%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="text-decoration:underline">January 11, 2022 warrants</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company assessed that the 8,519,999 warrants, and 1,480,000 pre-funded warrants issued in the January 2022 equity offering did not meet the “fixed for fixed” test and are therefore recorded as liabilities at fair value through profit and loss, and revalued at the end of each period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">At December 31, 2022 the fair value of the warrants was $501,330 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.15, strike rate $2.30, dividend yield 0%, term 4.03 years, volatility 110% and risk-free rate 4.08%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">At March 31, 2023 the fair value of the warrants was $628,765 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.19, strike rate $2.30, dividend yield 0%, term 3.79 years, volatility 125% and risk-free rate 3.69%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="text-decoration:underline">October 12, 2022 warrants</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -6.55pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company assessed that the 17,400,000 warrants and 1,590,000 pre-funded warrants issued as part of the October 2022 equity offering did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. On January 19, 2023 the warrant holders entered into the agreement noted above to exercise 16,150,000 of the 17,400,000 warrants, and receive new warrants in exchange. The remaining 1,250,000 warrants that were outstanding at January 19, 2023 were converted to cashless exercise warrants on March 30, 2023 as described above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the warrants as at December 31, 2022 was $1,850,758 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.15; exercise price $0.23; expected volatility: 100%; dividend yield 0%; risk free rate: 3.98%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the 1,250,000 unexercised warrants on January 19, 2023 was $132,957 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.19; exercise price $0.20; term 4.73 years; expected volatility: 115%; dividend yield 0%; risk free rate: 3.49%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the 16,150,000 exercised warrants immediately prior to exercise on January 19, 2023 was $<span style="-sec-ix-hidden: hidden-fact-128">NIL</span> and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.19; exercise price $0.20; term 0 years; expected volatility: 115%; dividend yield 0%; risk free rate: 3.49%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the 2,989,130 (1,739,130 waiver warrants plus 1,250,000 unexercised warrants) outstanding warrants on March 30, 2023 prior to the transfer to equity was $564,946 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In connection with the October 2022 equity offering, the Company issued 1,739,130 waiver warrants exercisable at $0.23 per share which expire, if unexercised, on October 12, 2027, to entice the holder of the convertible promissory note to waive their right to block the equity offering. The waiver warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss and revalued at the end of each period. On March 30, 2023, the waiver warrants were modified to cashless exercise as described above, and therefore met the “fixed for fixed” test and were reclassified to equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the waiver warrants as at December 31, 2022 was $184,983 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.15; exercise price $0.23; expected volatility: 100%; dividend yield 0%; risk free rate: 3.10%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the waiver warrants as at March 30, 2023 prior to transfer to equity was $328,696 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.</p> The balance of the warrant liability is as follows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">November 3,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">January 11,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">October 12, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">January 19,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-weight: bold">Balance December 31, 2022</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">197,733</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">501,330</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">2,035,741</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-116">-</div></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">2,734,804</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Exercise of warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(197,733</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-117">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,717,801</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-118">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,915,534</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrants issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-119">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-120">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-121">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,580</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Transfer to equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-122">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-123">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(564,946</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,410,100</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,975,046</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in fair value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">127,435</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">247,006</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">534,520</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">908,961</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold">Balance March 31, 2023</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-124">-</div></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">628,765</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-125">-</div></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-126">-</div></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">628,765</td><td style="font-weight: bold; text-align: left"> </td></tr> </table> 197733 501330 2035741 2734804 -197733 -1717801 -1915534 2875580 2875580 -564946 -3410100 -3975046 127435 247006 534520 908961 628765 628765 18042857 0.23 0.2 18042857 0.2 3608571 0.2 P5Y 2989130 0.23 0.2 21031987 0.2 21031987 21031987 2875580 0.15 3410100 1892857 4 2.3 197733 0.15 0.23 0 P3Y10M2D 1.10 0.0408 0.19 0.2 0 P0Y 1.30 0.0362 8519999 1480000 501330 0.15 2.3 0 P4Y10D 1.10 0.0408 628765 0.19 2.3 0 P3Y9M14D 1.25 0.0369 17400000 1590000 16150000 17400000 1250000 1850758 0.15 0.23 1 0 0.0398 1250000 132957 0.19 0.2 P4Y8M23D 1.15 0 0.0349 16150000 0.19 0.2 P0Y 1.15 0 0.0349 2989130 1739130 1250000 564946 1739130 0.23 184983 0.15 0.23 1 0 0.031 328696 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARE CAPITAL</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized </b>Unlimited number of common shares without par value</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As at March 31, 2023, the Company had 62,911,417 common shares issued and outstanding (December 31, 2022 – 44,868,560).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As of the date of issuance of these restated financial statements total outstanding common shares is 1,853,955 post 100-to-1 reverse split that was effective as of August 3, 2023, (185,393,404 pre-split).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common share transactions</b></span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">●</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Transaction subsequent to the quarter ended March 31, 2023 is as follows:</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">●</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Subsequent to the period end, a total of 21,031,987 cashless warrants were exercised in exchange for common shares of the Company.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">●</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On June 28, 2023 the Company issued 50,000,000 at $0.045 per share for gross proceeds of $2,250,000 before offering expenses and other expenses included in share issuance costs.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">●</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On July 13, 2023, the Company issued 51,450,000 shares at $0.045 per share for gross proceeds of $2,315,250.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.25in">●</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">On August 3, 2023, the Company affected a 100-to-1 reverse stock split resulting in 185,393,404 shares converted with rounding into 1,853,955 shares.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Transactions for the three months ended March 31, 2023 are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued 18,042,857 common shares on the exercise of various warrants for gross proceeds of $3,608,571. Additionally, the Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 30, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,987 common shares were issued for cashless warrants subsequent to March 31, 2023 as described in Note 16.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Transactions for the three months ended March 31, 2022 are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 71px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 11, 2022, the Company completed an underwritten public offering in the United States, raising a total of $20,013,043 in gross proceeds. The Company allocated the gross proceeds firstly to the warrant liabilities, with the remainder to the common shares. Direct costs have been allocated based on the percentage allocation of the proceeds. The underwritten public offering resulted in the sale to the public of 7,215,652 Units at $2.30 per Unit, with each Unit being comprised of one common share and one warrant (the “Unit Warrants”) exercisable at $2.30 per share. The Unit warrants are exercisable immediately and have a term of 5 years. Gross proceeds of $10,936,974 were allocated to the common shares, and $5,395,878 to the unit warrants liability.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0.55pt">In addition, the Company issued 1,480,000 pre-funded units (“Pre-Funded Units”) at $2.29 per Pre-Funded Unit. Each Pre-Funded Unit is comprised of a one-pre-funded warrant (a “Pre-Funded Warrant”) to purchase one common share, and one warrant to purchase one common share. The Pre-Funded Warrant allows the holder to acquire one common share of the Company at an exercise price of $0.01 per common share, and a warrant to purchase a common share at an exercise price of $2.30 per share. The warrants are exercisable immediately and have a term of 5 years. Each Pre-Funded Warrant is exercisable immediately and is exercisable until all Pre-Funded Warrants are exercised. Proceeds of $2,560,400 were allocated to the pre-funded warrants and $1,106,747 to the unit warrants in the warrant liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0.55pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The Company determined that the pre-funded warrants within the Pre-funded Units are common shares in substance, as they require only a minimal exercise price of $0.01. In addition, the underwriting agreement includes both the Units and Pe-funded Units and were negotiated together in the equity raise. Given that the purpose of the Prefunded Unit is in substance the same as that of the Unit (i.e., resulting in the ownership of both common shares and common share warrants) and that the terms of the warrants in both the Units and Prefunded Units are the same (i.e., the obligations of the Company for the units are the same), the Company determined that the Units and Pre-funded Units are closely related and should be combined into one unit of account for the purposes of allocating proceeds.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Therefore, the proceeds from the sale of the Units and Pre-funded Units are combined and allocated among the common shares, pre-funded warrants, and the common share warrants using the residual method, with the warrant liability being initially recognized at fair value as of the registration date and the residual amount being allocated to the common shares (i.e., equity).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company concurrently sold an additional 1,304,347 warrants to purchase 1,304,347 common shares exercisable at $2.30 per share (the “Option Warrants”) pursuant to an over-allotment option exercised by the underwriter. The exercise price of the warrants issued in connection with the exercise of the over-allotment option was $0.0097 per warrant. Each Option Warrant is exercisable immediately and has a term of five years from the issue date. Proceeds of $975,393 were allocated to the option warrant liability. As the fair value of the warrant liability exceeded the proceeds received on the warrants of $13,043, a fair value loss of $962,350 was recognized in the statement of profit and loss as a fair value change in the opening warrant liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the common shares and pre-funded units was determined by reference to the market price on the day of the offering, which was $1.73 per share. The Unit Warrants, Warrants, and Option Warrants were valued using the Black-Scholes model using the following assumptions: initial stock price $1.73, strike rate $2.30, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company also issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company assessed that the warrants issued under the public offering, excluding the Placement Agent Warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. The Placement Agent Warrants were assessed under IFRS 2 <i>Share Based Payments, </i>as equity-settled share-based payments and have been recorded in equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 48px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 31, 2022, as part of the ClearRF acquisition (Note 3), the Company issued 138,958 shares to the vendor with a fair value of $190,094.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock options</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has a shareholder-approved “rolling” stock option plan (the “Plan”) in compliance with Nasdaq policies. Under the Plan the maximum number of shares reserved for issuance may not exceed 15% of the total number of issued and outstanding common shares at the time of granting. The exercise price of each stock option shall not be less than the market price of the Company’s stock at the date of grant, less a discount of up to 25%. Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of the Company’s stock option activity is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> stock<br/> options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted<br/> Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise<br/> Price</b></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold; padding-bottom: 1.5pt">Outstanding options, December 31, 2021</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">414,568</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">13.88</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,145,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(53,430</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30.90</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 1.5pt">Outstanding options, December 31, 2022 and March 31, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,506,138</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3.53</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As at March 31, 2023 stock options outstanding are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Grant Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> options<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> options<br/> exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiry date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Remaining<br/> contractual <br/> life (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">24-Dec-18</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">12,896</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">12,896</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">54.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">24-Dec-23</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0.63</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>15-Jan-19</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">828</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">828</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">54.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">15-Jan-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.69</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>21-Mar-19</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">59.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">21-Mar-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.87</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>01-Jan-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">54.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">01-Jan-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.65</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>15-Nov-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">15-Nov-30</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.53</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>15-Nov-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">161,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">161,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">15-Nov-25</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.52</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>02-Jan-21</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">02-Jan-26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.65</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>02-Jan-21</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">02-Jan-31</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.66</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>18-Jan-21</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">18-Jan-26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.70</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>01-Jan-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">29-Oct-26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.48</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>13-Apr-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">795,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">265,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">13-Apr-27</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.93</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">12-Jul-22</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">330,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">110,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.10</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">12-Jul-25</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.18</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,506,138</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">748,638</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3.53</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3.51</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Transactions for the three months ended March 31, 2022 are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2022, the Company granted 20,000 stock options at $4.00 per share that vest in 8 equal quarterly periods with the first vesting occurring on the grant date. The fair value on the date of the grant was $54,480 ($2.724 per option).</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted share units</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company approved on February 14, 2022, the addition of the issuance of restricted share units to the existing executive stock option plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">A summary of the Company’s restricted share unit activity is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of RSU’s</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average<br/> Issue <br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding RSU, December 31, 2021</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">-</div></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 76%">Granted</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">3,195,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.05</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(30,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.10</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Outstanding RSU, December 31, 2022 and March 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,165,000</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1.05</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As at March 31, 2023 restricted share units outstanding are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Grant Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> RSU’s <br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> RSU’s <br/> exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted <br/> Average <br/> Issue Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">09-Mar-22</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2,250,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,200,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.03</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>13-Apr-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">825,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">513,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.10</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">12-Jul-22</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">90,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.10</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Outstanding RSU, March 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,165,000</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,751,250</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1.05</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Transactions for the three months ended March 31, 2022, are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 9, 2022, the Company granted 450,000 RSU’s to Directors that vest immediately. On the date of granting, the fair value and stock price was $1.03/share.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 9, 2022, the Company granted 1,800,000 RSU’s to a Director that vest quarterly over 12 periods with the first vesting of 150,000 RSU’s occurring on the date of the granted and another 150,000 vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.03/share.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71.45pt; text-align: justify; text-indent: -0.25in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Agents’ options</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -0.25in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of the Company’s agent options activity is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted <br/> average <br/> exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold">Outstanding agent options, December 31, 2021</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 9%; font-weight: bold; text-align: right">445,926</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">7.51</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">487,283</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2.51</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,702</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20.49</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Outstanding agent options, December 31, 2022 and March 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">931,507</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4.12</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As at March 31, 2023 agent options outstanding are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Grant Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> options <br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> options <br/> exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiry date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Remaining<br/> contractual life (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">29-Sep-20</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">113,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">113,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6.60</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">28-Sep-25</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>29-Sep-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">266,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">266,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6.85</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">28-Sep-25</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>31-Dec-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,724</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,724</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">30-Jun-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>11-Jan-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">434,783</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">434,783</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2.53</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">11-Jan-27</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">01-Apr-22</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.30</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">08-Mar-27</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">931,507</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">931,507</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4.12</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2.98</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Transactions for the three months ended March 31, 2022 are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%. The Company also issued 52,500 agent’s options with a fair value of $61,950 with an exercise price of $2.30.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.25in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(f)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share purchase warrants</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of the Company’s share purchase warrant activity is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Number of Warrants</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Weighted average exercise price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold">Outstanding, December 31, 2021</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 9%; font-weight: bold; text-align: right">5,121,328</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">7.64</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29,139,129</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.94</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(128,386</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">33.47</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold">Outstanding, December 31, 2022</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">34,132,071</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">1.76</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,042,857</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.20</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,042,857</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.20</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Outstanding, March 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">34,132,071</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1.47</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As at March 31, 2023 the share purchase warrants outstanding are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Grant Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> Warrants <br/> outstanding and <br/> exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiry date</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">29-Sep-20</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,805,585</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6.85</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">28-Sep-25</td></tr> <tr style="vertical-align: bottom; "> <td>31-Dec-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,294,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">30-Jun-24</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>11-Jan-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,999,999</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2.30</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">11-Jan-27</td></tr> <tr style="vertical-align: bottom; "> <td>12-Oct-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-131; font-family: Times New Roman, Times, Serif; font-size: 10pt">Cashless</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">11-Jan-27</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>12-Oct-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,739,130</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-132; font-family: Times New Roman, Times, Serif; font-size: 10pt">Cashless</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">11-Jan-27</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">19-Jan-23</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,042,857</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-133; font-family: Times New Roman, Times, Serif; font-size: 10pt">Cashless</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">18-Jan-28</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">34,132,071</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1.47</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Transactions for the three months ended March 31, 2023 are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,042,857 warrants were exercised. The Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 31, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 17,116,987 cashless warrants were exercised subsequent to March 31, 2023.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Transactions for the three months ended March 31, 2022 are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">128,386 share purchase warrant expired in 2022.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exercisable at $2.30 per warrant and with a term of five years.</span></td></tr> </table> 62911417 62911417 44868560 44868560 1853955 185393404 21031987 50000000 0.045 2250000 51450000 0.045 2315250 185393404 1853955 18042857 3608571 18042857 18042857 0.23 21031987 20013043 7215652 2.3 2.3 P5Y 10936974 5395878 1480000 2.29 0.01 2.3 P5Y 2560400 1106747 0.01 1304347 1304347 2.3 0.0097 Each Option Warrant is exercisable immediately and has a term of five years from the issue date. P5Y 975393 13043 962350 1.73 1.73 2.3 0 P5Y 0.60 0.005 434783 2.53 P5Y 307189 1.73 2.53 0 P5Y 0.60 0.005 The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued. 138958 190094 0.15 0.25 Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted. A summary of the Company’s stock option activity is as follows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> stock<br/> options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Weighted<br/> Average</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exercise<br/> Price</b></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold; padding-bottom: 1.5pt">Outstanding options, December 31, 2021</td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">414,568</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">13.88</td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,145,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(53,430</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">30.90</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 1.5pt">Outstanding options, December 31, 2022 and March 31, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,506,138</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3.53</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of RSU’s</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted Average<br/> Issue <br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Outstanding RSU, December 31, 2021</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-129">-</div></td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-130">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 76%">Granted</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">3,195,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.05</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(30,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.10</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Outstanding RSU, December 31, 2022 and March 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,165,000</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1.05</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> options</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted <br/> average <br/> exercise price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold">Outstanding agent options, December 31, 2021</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 9%; font-weight: bold; text-align: right">445,926</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">7.51</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">487,283</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2.51</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,702</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">20.49</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Outstanding agent options, December 31, 2022 and March 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">931,507</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4.12</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Number of Warrants</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Weighted average exercise price</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; font-weight: bold">Outstanding, December 31, 2021</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 9%; font-weight: bold; text-align: right">5,121,328</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">7.64</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">29,139,129</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.94</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(128,386</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">33.47</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold">Outstanding, December 31, 2022</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">34,132,071</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">1.76</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,042,857</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.20</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(18,042,857</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">0.20</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Outstanding, March 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">34,132,071</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1.47</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> 414568 13.88 1145000 1.15 -53430 30.9 1506138 3.53 As at March 31, 2023 stock options outstanding are as follows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Grant Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> options<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> options<br/> exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiry date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Remaining<br/> contractual <br/> life (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">24-Dec-18</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">12,896</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">12,896</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">54.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">24-Dec-23</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0.63</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>15-Jan-19</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">828</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">828</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">54.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">15-Jan-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.69</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>21-Mar-19</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">59.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">21-Mar-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.87</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>01-Jan-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">54.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">01-Jan-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.65</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>15-Nov-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">15-Nov-30</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.53</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>15-Nov-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">161,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">161,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">15-Nov-25</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.52</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>02-Jan-21</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">02-Jan-26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.65</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>02-Jan-21</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">02-Jan-31</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.66</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>18-Jan-21</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">18-Jan-26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.70</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>01-Jan-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">4.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">29-Oct-26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.48</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>13-Apr-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">795,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">265,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">13-Apr-27</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.93</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">12-Jul-22</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">330,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">110,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.10</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">12-Jul-25</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.18</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,506,138</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">748,638</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3.53</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3.51</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Grant Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> RSU’s <br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> RSU’s <br/> exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted <br/> Average <br/> Issue Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">09-Mar-22</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2,250,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,200,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1.03</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>13-Apr-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">825,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">513,750</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1.10</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">12-Jul-22</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">90,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">37,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.10</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Outstanding RSU, March 31, 2023</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,165,000</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,751,250</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1.05</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Grant Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> options <br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> options <br/> exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiry date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Remaining<br/> contractual life (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%">29-Sep-20</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">113,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">113,500</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6.60</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">28-Sep-25</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">2.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>29-Sep-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">266,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">266,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">6.85</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">28-Sep-25</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>31-Dec-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,724</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">64,724</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">30-Jun-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>11-Jan-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">434,783</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">434,783</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2.53</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">11-Jan-27</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.00</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">01-Apr-22</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.30</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">08-Mar-27</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4.00</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">931,507</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">931,507</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4.12</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2.98</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Grant Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of <br/> Warrants <br/> outstanding and <br/> exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiry date</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">29-Sep-20</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,805,585</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">6.85</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">28-Sep-25</td></tr> <tr style="vertical-align: bottom; "> <td>31-Dec-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,294,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">30-Jun-24</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>11-Jan-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,999,999</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">2.30</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">11-Jan-27</td></tr> <tr style="vertical-align: bottom; "> <td>12-Oct-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,250,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-131; font-family: Times New Roman, Times, Serif; font-size: 10pt">Cashless</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">11-Jan-27</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>12-Oct-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,739,130</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-132; font-family: Times New Roman, Times, Serif; font-size: 10pt">Cashless</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">11-Jan-27</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">19-Jan-23</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,042,857</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-133; font-family: Times New Roman, Times, Serif; font-size: 10pt">Cashless</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">18-Jan-28</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">34,132,071</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1.47</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="text-align: center; padding-bottom: 4pt"> </td></tr> </table> 12896 12896 54 24-Dec-23 P0Y7M17D 828 828 54 15-Jan-24 P0Y8M8D 12345 12345 59 21-Mar-24 P0Y10M13D 2069 2069 54 01-Jan-24 P0Y7M24D 95000 95000 6 15-Nov-30 P7Y6M10D 161500 161500 6 15-Nov-25 P2Y6M7D 57000 57000 11.5 02-Jan-26 P2Y7M24D 5000 5000 11.5 02-Jan-31 P7Y7M28D 14500 14500 11.5 18-Jan-26 P2Y8M12D 20000 12500 4 29-Oct-26 P3Y5M23D 795000 265000 1.1 13-Apr-27 P3Y11M4D 330000 110000 1.1 12-Jul-25 P2Y2M4D 1506138 748638 3.53 P3Y6M3D 20000 4 54480 2.724 3195000 1.05 -30000 1.1 3165000 1.05 2250000 1200000 1.03 825000 513750 1.1 90000 37500 1.1 3165000 1751250 1.05 On March 9, 2022, the Company granted 450,000 RSU’s to Directors that vest immediately. On the date of granting, the fair value and stock price was $1.03/share.   ● On March 9, 2022, the Company granted 1,800,000 RSU’s to a Director that vest quarterly over 12 periods with the first vesting of 150,000 RSU’s occurring on the date of the granted and another 150,000 vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.03/share.   445926 7.51 487283 2.51 -1702 20.49 931507 4.12 113500 113500 6.6 28-Sep-25 P2Y 266000 266000 6.85 28-Sep-25 P2Y 64724 64724 11.5 30-Jun-24 P1Y 434783 434783 2.53 11-Jan-27 P4Y 52500 52500 2.3 08-Mar-27 P4Y 931507 931507 4.12 P2Y11M23D ●The Company issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%. The Company also issued 52,500 agent’s options with a fair value of $61,950 with an exercise price of $2.30. 5121328 7.64 29139129 0.94 -128386 33.47 34132071 1.76 18042857 0.2 -18042857 0.2 34132071 1.47 1805585 6.85 28-Sep-25 1294500 11.5 30-Jun-24 9999999 2.3 11-Jan-27 1250000 11-Jan-27 1739130 11-Jan-27 18042857 18-Jan-28 34132071 1.47 18042857 18042857 18042857 0.23 17116987 ●128,386 share purchase warrant expired in 2022.   ● On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exercisable at $2.30 per warrant and with a term of five years. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>COST OF SALES</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Inventory expensed</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">971</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">359</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Royalties</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">106</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">54</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other expenses</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">229</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">165</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,306</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">578</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Inventory expensed</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">971</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">359</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Royalties</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">106</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">54</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Other expenses</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">229</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">165</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,306</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">578</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 971000 359000 106000 54000 229000 165000 1306000 578000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SELLING AND MARKETING EXPENSES</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Salaries and related expenses</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">705</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">618</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Advertising and marketing</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">249</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">398</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Travel and conferences</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">49</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">29</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,003</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,045</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SELLING AND MARKETING EXPENSES</b></span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Salaries and related expenses</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">705</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">618</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Advertising and marketing</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">249</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">398</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Travel and conferences</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">49</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">29</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,003</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,045</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 705000 618000 249000 398000 49000 29000 1003000 1045000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GENERAL AND ADMINISTRATIVE EXPENSES</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><b> </b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Salaries and related expenses</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">151</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">125</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Professional services</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">565</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">377</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Consulting and director fees</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">263</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">419</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Travel</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">14</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office and general</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">326</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">442</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Regulatory and filing fees</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">27</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Shareholder relations</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">46</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">239</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,392</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,659</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GENERAL AND ADMINISTRATIVE EXPENSES</b></span><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Salaries and related expenses</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">151</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">125</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Professional services</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">565</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">377</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Consulting and director fees</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">263</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">419</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Travel</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">14</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">36</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office and general</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">326</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">442</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Regulatory and filing fees</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">27</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">21</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Shareholder relations</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">46</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">239</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt">Total</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,392</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,659</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 151000 125000 565000 377000 263000 419000 14000 36000 326000 442000 27000 21000 46000 239000 1392000 1659000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>11.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSACTION COSTS</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Transaction costs incurred in relation to the January 2023 warrant raise and issuance described in Note 7 were $309,000 and were included in the change in fair value of warrant liability on the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Transaction costs incurred in the three months ended March 31, 2022 were $965,247, which are costs incurred for the January 11, 2022 capital raise that were allocated to the warrant liability and expensed through the statement of operations.</p> 309000 965247 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>12.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL INSTRUMENTS</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair values of the Company’s cash, trade and other receivables, accounts payable and accrued liabilities and long-term debt, approximate carrying value, which is the amount recorded on the consolidated statement of financial position.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><i>Credit risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Credit risk is the risk of an unexpected loss if a customer or third party to a financial instrument fails to meet its contractual obligations. The Company places its cash with institutions of high creditworthiness. Management has assessed there to be a low level of credit risk associated with its cash balances.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company’s exposure to credit risk is influenced mainly by the individual characteristics of each customer. However, management also considers the demographics of the Company’s customer base, including the default risk of the industry and country in which customers operate, as these factors may have an influence on credit risk. Approximately 34% of the Company’s revenue for the three months ended March 31, 2023 (March 31, 2022 -23%) is attributable to sales transactions with a single customer.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company has established a credit policy under which each new customer is analyzed individually for creditworthiness before the Company’s standard payment and delivery terms and conditions are offered. The Company’s review includes external ratings, when available, and in some cases bank references. Purchase limits are established for each customer, which represents the maximum open amount without requiring approval from the Risk Management Committee; these limits are reviewed quarterly. In prior years, certain key customers were offered extended payment terms on their purchases due to slow down from Covid-19 and budget approvals for government tenders.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As a result, the Company had customers with overdue receivables on their books which resulted in the Company taking a bad debt provision on these overdue receivables which amounted to $1,062,052 at March 31, 2023 (March 31, 2022 - $1,056,393).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">More than 50% (2022 – 18%) of the Company’s customers have been active with the Company for over four years, and the allowance for doubtful accounts of $1,062,052 (2022 - $1,056,393) has been recognized against these customers. In monitoring customer credit risk, customers are grouped according to their credit characteristics, including whether they are an individual or legal entity, whether they are a wholesale, retail or end-user customer, geographic location, industry, aging profile, maturity, and the existence of previous financial difficulties. Trade and other receivables relate mainly to the Company’s wholesale customers. Customers that are graded as “high risk” are placed on a restricted customer list and monitored by the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The carrying amount of financial assets represents the maximum credit exposure, notwithstanding the carrying amount of security or any other credit enhancements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><i>Liquidity risk </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Liquidity risk is the risk that the Company will encounter difficulty in meeting the obligations associated with its financial liabilities that are settled by delivering cash or another financial asset. The Company’s approach to managing liquidity is to ensure, as far as possible, that it will always have sufficient liquidity to meet its liabilities when due, under both normal and stressed conditions, without incurring unacceptable losses or risking damage to the Company’s reputation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company examines current forecasts of its liquidity requirements so as to make certain that there is sufficient cash for its operating needs, and it is careful at all times to have enough unused credit facilities so that the Company does not exceed its credit limits and is in compliance with its financial covenants (if any). These forecasts take into consideration matters such as the Company’s plan to use debt for financing its activity, compliance with required financial covenants, compliance with certain liquidity ratios, and compliance with external requirements such as laws or regulation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company uses activity-based costing to cost its products and services, which assists it in monitoring cash flow requirements and optimizing its cash return on investments. Typically, the Company ensures that it has sufficient cash on demand to meet expected operational expenses for a period of 90 days, including the servicing of financial obligations; this excludes the potential impact of extreme circumstances that cannot reasonably be predicted, such as natural disasters.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">With the exception of employee benefits, the Company’s accounts payable and accrued liabilities have contractual terms of 90 days. The employment benefits included in accrued liabilities have variable maturities within the coming year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -0.25in; text-align: justify; text-indent: 0.5in"><i>Market risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>a)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Currency Risk</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Currency risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>b)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Interest Rate Risk</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Interest rate risk is the risk that the fair value of future cash flows will fluctuate as a result of changes in interest rates. The Company’s sensitivity to interest rates is inherently involved in the calculation of the fair value of the warranty liability which are revalued based on changes parameters which include the prevailing interest rate.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>c)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Price Risk</i></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company is exposed to price risk with respect to equity prices. Equity price risk is defined as the potential adverse impact on the Company’s earnings due to movements in individual equity prices or general movements in the level of the stock market. The Company closely monitors individual equity movements, and the stock market to determine the appropriate course of action to be taken by the Company.</p> 0.34 0.23 1062052 1056393 More than 50% (2022 – 18%) of the Company’s customers have been active with the Company for over four years 1062052 1056393 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RELATED PARTY TRANSACTIONS</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="text-decoration:underline">Key Personnel Compensation</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Key management personnel includes those persons having authority and responsibility for planning, directing, and controlling the activities of the Company as a whole. The Company has determined that key management personnel consists of executive and non-executive members of the Company’s Board of Directors and corporate officers. The remuneration of directors and key management personnel for the three months ended March 31, 2023 and 2022 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Payments to key management personnel:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify; padding-left: 9pt">Salaries, consulting and directors’ fees</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">285,413</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">491,889</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt">Share-based payments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">243,323</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">767,436</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">528,736</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,259,325</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Salaries, consulting and directors’ fees shown above are classified within profit and loss as shown below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Type of Service</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nature of Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 38%; text-align: center; padding-bottom: 1.5pt">Selling and marketing expenses</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 37%; text-align: center; padding-bottom: 1.5pt">VP Technology/VP Sales International</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">46</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">84</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center; padding-bottom: 1.5pt">General and administrative expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">Companies controlled by the CEO, CFO and Directors</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">239</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">408</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> The remuneration of directors and key management personnel for the three months ended March 31, 2023 and 2022 are as follows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Payments to key management personnel:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify; padding-left: 9pt">Salaries, consulting and directors’ fees</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">285,413</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">491,889</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt">Share-based payments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">243,323</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">767,436</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">528,736</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,259,325</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">  </p> 285413 491889 243323 767436 528736 1259325 Salaries, consulting and directors’ fees shown above are classified within profit and loss as shown below:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Type of Service</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nature of Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 38%; text-align: center; padding-bottom: 1.5pt">Selling and marketing expenses</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 37%; text-align: center; padding-bottom: 1.5pt">VP Technology/VP Sales International</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">46</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">84</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center; padding-bottom: 1.5pt">General and administrative expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">Companies controlled by the CEO, CFO and Directors</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">239</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">408</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 46000 84000 239000 408000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>14.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEGMENTED INFORMATION</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company is domiciled in Canada, and it operates and produces its income primarily in Israel, Europe and North America. The Company operates as a single segment being the sale of cellular-based communications products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company’s entity-wide disclosures include disaggregated information about product sales, geographical areas, and major customers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Geographical area information is shown below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="5" style="font-weight: bold">External revenues by Geography for the three months ended March 31</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">USA</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">245</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">219</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">249</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">511</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">326</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Australia</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">13</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,803</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">833</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Non-current asset geographic area information is shown below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Long-term receivable total</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">146</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">150</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-135">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-136">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">146</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Right of use asset total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">812</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">887</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">118</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">177</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">694</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">710</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Equipment total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">207</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-137">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-138">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">207</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Intangibles total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,481</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,988</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-139">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-140">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,481</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,988</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Product information is shown below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Revenue by product line for the three months ended March 31</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Cellular boosters and related accessories</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">438</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">463</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Rugged devices and related accessories</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,365</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">370</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,803</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">833</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> Geographical area information is shown below:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="5" style="font-weight: bold">External revenues by Geography for the three months ended March 31</td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">USA</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,073</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">245</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">219</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">249</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">511</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">326</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Australia</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-134">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">13</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,803</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">833</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 1073000 245000 219000 249000 511000 326000 13000 1803000 833000 Non-current asset geographic area information is shown below:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Long-term receivable total</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">146</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">150</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-135">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-136">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">146</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Right of use asset total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">812</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">887</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">118</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">177</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">694</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">710</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Equipment total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">200</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">207</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-137">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-138">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">207</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Intangibles total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,481</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,988</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-139">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-140">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,481</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,988</td><td style="text-align: left"> </td></tr> </table> 146000 150000 146000 150000 812000 887000 118000 177000 694000 710000 200000 207000 200000 207000 7481000 6988000 7481000 6988000 Product information is shown below:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Revenue by product line for the three months ended March 31</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Cellular boosters and related accessories</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">438</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">463</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Rugged devices and related accessories</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,365</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">370</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,803</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">833</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 438000 463000 1365000 370000 1803000 833000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>15.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUPPLEMENTAL INFORMATION WITH RESPECT TO CASH FLOWS</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> March 31</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Change in non-cash working capital:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 9pt">Trade and other receivables</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">463,505</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(6,303</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Prepaids</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(491,942</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(731,566</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">Inventory</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">528,510</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,060,581</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 9pt">Advances to suppliers</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(519,709</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(590,506</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 9pt">Accounts payable and accrued liabilities</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(967,476</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(836,698</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Deferred revenue</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(149,600</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-141">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,136,712</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,225,654</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">During the three months ended March 31, 2023, the Company paid $<span style="-sec-ix-hidden: hidden-fact-142">nil</span> (March 31, 2022 - $2,659) in interest and $<span style="-sec-ix-hidden: hidden-fact-143">Nil</span> (March 31, 2022 - $<span style="-sec-ix-hidden: hidden-fact-144">nil</span>) in income taxes.</p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> March 31</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Change in non-cash working capital:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-left: 9pt">Trade and other receivables</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">463,505</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(6,303</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Prepaids</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(491,942</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(731,566</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">Inventory</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">528,510</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,060,581</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-left: 9pt">Advances to suppliers</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(519,709</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(590,506</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 9pt">Accounts payable and accrued liabilities</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(967,476</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(836,698</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Deferred revenue</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(149,600</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-141">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(1,136,712</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,225,654</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table> 463505 -6303 -491942 -731566 528510 -1060581 -519709 -590506 -967476 -836698 -149600 -1136712 -3225654 2659 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>16.</b></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUBSEQUENT EVENTS</b></span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Subsequent to the period end, a total of 21,031,987 cashless warrants were exercised in exchange for common shares of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On June 28, 2023 the Company issued 50,000,000 at $0.045 per share for gross proceeds of $2,250,000 before offering expenses and other expenses included in share issuance costs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On July 13, 2023, the Company issued 51,450,000 shares at $0.045 per share for gross proceeds of $2,315,250.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On August 3, 2023, the Company affected a 100-to-1 reverse stock split resulting in 185,393,404 shares converted with rounding into 1,853,955 shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company was issued a cease trading order by the British Columbia Securities Exchange for late filing of these Q1 2023 financial statements that were due on May 15, 2023. The cease trading order was lifted upon filing of the Q1 2023 financial statements on May 24, 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company entered into a factoring agreement for their receivables in North America.</p> 21031987 50000000 0.045 2250000 51450000 0.045 2315250 185393404 1853955 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left"><b>17.</b></td><td style="text-align: justify"><b>RESTATEMENT OF FINANCIAL STATEMENTS</b></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In conjunction with preparation of the Company’s financial statements for the three month period ended March 31, 2023 and as part of a continuous disclosure review by the Staff of Company’s principal securities regulator in relation to the accounting for warrant liability and share capital, the Company identified an error in how the fair value has been accounted for in the previously issued financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company evaluated the significance of the corrections and determined the adjustments were material to the unaudited condensed interim consolidated financial statements for the three month period ended March 31, 2023. The impact of these changes have been restated in these financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The above restatement reflects the impact of an error in the calculation of the fair value of warrant liability on January 19, 2023 due to an incorrect input parameter for the term to maturity of those warrants resulting in an overstatement of the change in fair value expense for the period of $2,705,253 and a resulting decrease in the same amount to share capital.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The above restatement did not impact the total assets nor liabilities and did not impact the net equity as the share capital decreased by $2,705,253 and the deficit was reduced by the same amount.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As originally filed</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">ASSETS</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Current</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-indent: 0in; padding-left: -0.125in">Cash</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">1,179,694</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-145"> </div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">1,179,694</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Trade and other receivables (Note 3)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,111,123</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-146"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,111,123</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Prepaid expenses</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">665,446</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-147"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">665,446</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Inventory (Note 4)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,564,040</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-148"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,564,040</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Advance to suppliers</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">675,561</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-149"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">675,561</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 0in; padding-left: -0.125in"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">7,195,864</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-150"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">7,195,864</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Long term receivable</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">146,196</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-151"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">146,196</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Right of use assets</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">811,966</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-152"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">811,966</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 0in; padding-left: -0.125in">Equipment</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">199,743</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-153"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">199,743</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Intangible assets</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,481,391</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-154"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,481,391</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Total assets</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">15,835,160</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-155"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">15,835,160</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 0in; padding-left: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: 0in; padding-left: -0.125in">LIABILITIES AND SHAREHOLDERS' EQUITY</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-indent: 0in; padding-left: -0.125in">Current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Accounts payable and accrued liabilities</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,111,174</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-156"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,111,174</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Deferred revenue</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-157">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-158"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-159">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Lease obligations</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">294,359</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-160"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">294,359</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Warrant liability (Note 6)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">628,765</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">628,765</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,034,298</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-162"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,034,298</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Lease obligation</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">543,944</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-163"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">543,944</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Total liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,578,242</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-164"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,578,242</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; text-indent: 0in; padding-left: -0.125in">Shareholders' equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 0in; padding-left: -0.125in">Share capital (Note 7)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">79,626,690</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2,705,253</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">76,921,437</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Reserves (Note 7)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">17,933,273</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-165"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">17,933,273</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Accumulated other comprehensive loss</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">98,870</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-166"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">98,870</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Deficit</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(85,401,915</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,705,253</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(82,696,662</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,256,918</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-167">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,256,918</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Total liabilities and shareholders' equity</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">15,835,160</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">15,835,160</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As originally filed</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-indent: -0.125in; padding-left: 0.125in">Revenue</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">1,802,637</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-169"> </div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">1,802,637</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Cost of sales (Note 8)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,306,120</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-170"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,306,120</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Gross profit</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">496,517</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-171"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">496,517</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">EXPENSES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Amortization and depreciation</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">401,640</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-172"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">401,640</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Development expenses</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">53,985</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">53,985</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Selling and marketing (Note 9)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,003,365</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-174"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,003,365</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">General and administrative (Note 10)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,392,430</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-175"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,392,430</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Share-based payments (Note 7)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">310,828</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">310,828</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Total operating expenses</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,162,248</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-177"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,162,248</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net operating loss</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,665,731</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-178"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,665,731</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">OTHER EXPENSES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Finance expense (Note 11)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">34,098</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-179"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">34,098</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Foreign exchange</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">163</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-180"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">163</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Change in fair value of convertible promissory note (Note 5)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Change in fair value of warrant liability (Note 6)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">4,883,260</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2,705,253</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">2,178,007</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Transaction costs (Note 12)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-184"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total other expenses</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,917,521</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,705,253</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,212,268</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net loss for the year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(7,583,252</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,705,253</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(4,877,999</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Other comprehensive income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Translation adjustment</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-186">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-187"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Comprehensive loss for the year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(7,583,252</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,705,253</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(4,877,999</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">Weighted average shares</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">59,102,369</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">59,102,369</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">59,102,369</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><div style="-sec-ix-hidden: hidden-fact-191; -sec-ix-hidden: hidden-fact-190; -sec-ix-hidden: hidden-fact-189">Basic and diluted loss per share</div></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(0.13</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">0.05</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(0.08</td><td style="font-weight: bold; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Selected line items restated in the Consolidated Statements of Changes in Shareholder’s Equity:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Deficit</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As originally filed</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-indent: -0.125in; padding-left: 0.125in">Deficit-Beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(77,818,663</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-192"> </div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(77,818,663</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">loss for the period</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,583,252</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,705,253</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,877,999</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Deficit-end of period</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(85,401,915</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,705,253</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(82,696,662</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> </table> <p style="margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Share Capital</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As originally filed</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-indent: -0.125in; padding-left: 0.125in">Share capital-Beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">73,312,866</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-193"> </div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">73,312,866</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">warrants exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,313,824</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,705,253</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,608,571</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Share capital-end of period</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">79,626,690</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,705,253</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">76,921,437</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Selected line items restated in the Consolidated Statements of Cash Flows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As originally filed</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Operating activities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 64%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net loss for the year</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">(7,583,252</td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,705,253</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">(4,877,999</td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Items not affecting cash:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Amortization and depreciation</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">401,640</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-194"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">401,640</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Bad debt expense</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-196"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Fair value changes on derivatives</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">4,883,260</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,705,253</td><td style="text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">2,178,007</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Interest expense, net of repayments</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-198">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-199"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Foreign exchange</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">11,666</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-201"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">11,666</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Transaction costs</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-203"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-204">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in">Share based payments</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">310,828</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-205"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">310,828</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Change in non-cash working capital</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,136,712</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-206"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,136,712</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net cash used in operating activities</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(3,112,570</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-207">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(3,112,570</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Investing activities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Intangible asset additions</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(817,849</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-208"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(817,849</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Equipment additions</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2,498</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-209"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2,498</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Acquisition of ClearRF</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-210">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-211"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-212">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net cash used in investing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(820,347</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-213"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(820,347</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Financing activities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Lease payments</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(100,702</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-214"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(100,702</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Bank loan</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-215">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-216"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-217">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Convertible debt issued, net of repayments</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-218">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-219"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-220">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Proceeds on share issuance, net of share issuance costs</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-221">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-222"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-223">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Transaction costs</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(309,000</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-224"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(309,000</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Exercise of warrants</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,608,571</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-225"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,608,571</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net cash from financing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,198,869</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-226">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,198,869</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Effect of foreign exchange on cash</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-227">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-228"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-229">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Change in cash and restricted cash for the year</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(734,048</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-230"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(734,048</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Cash and restricted cash, beginning of year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,913,742</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-231"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,913,742</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Cash and restricted cash, end of year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,179,694</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,179,694</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 2705253 2705253 1179694 1179694 1111123 1111123 665446 665446 3564040 3564040 675561 675561 7195864 7195864 146196 146196 811966 811966 199743 199743 7481391 7481391 15835160 15835160 2111174 2111174 294359 294359 628765 628765 3034298 3034298 543944 543944 3578242 3578242 79626690 -2705253 76921437 17933273 17933273 98870 98870 -85401915 2705253 -82696662 12256918 12256918 15835160 15835160 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As originally filed</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-indent: -0.125in; padding-left: 0.125in">Revenue</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">1,802,637</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-169"> </div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">1,802,637</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Cost of sales (Note 8)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,306,120</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-170"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,306,120</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Gross profit</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">496,517</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-171"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">496,517</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">EXPENSES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Amortization and depreciation</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">401,640</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-172"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">401,640</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Development expenses</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">53,985</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">53,985</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Selling and marketing (Note 9)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,003,365</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-174"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,003,365</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">General and administrative (Note 10)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,392,430</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-175"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,392,430</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Share-based payments (Note 7)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">310,828</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-176"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">310,828</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Total operating expenses</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,162,248</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-177"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,162,248</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net operating loss</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,665,731</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-178"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,665,731</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">OTHER EXPENSES</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Finance expense (Note 11)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">34,098</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-179"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">34,098</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Foreign exchange</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">163</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-180"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">163</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Change in fair value of convertible promissory note (Note 5)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Change in fair value of warrant liability (Note 6)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">4,883,260</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2,705,253</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">2,178,007</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Transaction costs (Note 12)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-184"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Total other expenses</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">4,917,521</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,705,253</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,212,268</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net loss for the year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(7,583,252</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,705,253</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(4,877,999</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Other comprehensive income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Translation adjustment</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-186">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-187"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-188">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Comprehensive loss for the year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(7,583,252</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,705,253</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(4,877,999</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -0.125in; padding-left: 0.125in">Weighted average shares</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">59,102,369</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">59,102,369</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">59,102,369</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in"><div style="-sec-ix-hidden: hidden-fact-191; -sec-ix-hidden: hidden-fact-190; -sec-ix-hidden: hidden-fact-189">Basic and diluted loss per share</div></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(0.13</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">0.05</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(0.08</td><td style="font-weight: bold; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> 1802637 1802637 1306120 1306120 496517 496517 401640 401640 53985 53985 1003365 1003365 1392430 1392430 310828 310828 3162248 3162248 -2665731 -2665731 34098 34098 163 163 4883260 -2705253 2178007 4917521 -2705253 2212268 -7583252 -2705253 -4877999 -7583252 -2705253 -4877999 59102369 59102369 59102369 -0.13 0.05 -0.08 Selected line items restated in the Consolidated Statements of Changes in Shareholder’s Equity:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Deficit</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As originally filed</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-indent: -0.125in; padding-left: 0.125in">Deficit-Beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(77,818,663</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-192"> </div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(77,818,663</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">loss for the period</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,583,252</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,705,253</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(4,877,999</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Deficit-end of period</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(85,401,915</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,705,253</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(82,696,662</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Share Capital</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As originally filed</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-indent: -0.125in; padding-left: 0.125in">Share capital-Beginning of period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">73,312,866</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-193"> </div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">73,312,866</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">warrants exercised</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,313,824</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,705,253</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,608,571</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Share capital-end of period</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">79,626,690</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(2,705,253</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">76,921,437</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> -77818663 -77818663 7583252 -2705253 4877999 -85401915 2705253 -82696662 73312866 73312866 6313824 -2705253 3608571 79626690 -2705253 76921437 Selected line items restated in the Consolidated Statements of Cash Flows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As originally filed</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Operating activities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="width: 64%; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Net loss for the year</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">(7,583,252</td><td style="width: 1%; font-weight: bold; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,705,253</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">(4,877,999</td><td style="width: 1%; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Items not affecting cash:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Amortization and depreciation</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">401,640</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-194"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">401,640</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Bad debt expense</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-195">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-196"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-197">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Fair value changes on derivatives</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">4,883,260</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2,705,253</td><td style="text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">2,178,007</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Interest expense, net of repayments</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-198">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-199"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-200">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Foreign exchange</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">11,666</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-201"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">11,666</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Transaction costs</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-202">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-203"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-204">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in">Share based payments</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">310,828</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-205"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">310,828</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Change in non-cash working capital</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,136,712</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-206"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(1,136,712</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net cash used in operating activities</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(3,112,570</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-207">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(3,112,570</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Investing activities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Intangible asset additions</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(817,849</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-208"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(817,849</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Equipment additions</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2,498</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-209"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2,498</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Acquisition of ClearRF</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-210">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-211"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-212">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net cash used in investing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(820,347</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-213"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(820,347</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; text-indent: -0.125in; padding-left: 0.125in">Financing activities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Lease payments</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(100,702</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-214"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(100,702</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Bank loan</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-215">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-216"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-217">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Convertible debt issued, net of repayments</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-218">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-219"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-220">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Proceeds on share issuance, net of share issuance costs</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-221">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-222"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-223">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.25in">Transaction costs</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(309,000</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-224"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(309,000</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in">Exercise of warrants</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,608,571</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-225"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,608,571</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Net cash from financing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,198,869</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-226">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,198,869</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Effect of foreign exchange on cash</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-227">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-228"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-229">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.125in; padding-left: 0.125in">Change in cash and restricted cash for the year</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(734,048</td><td style="font-weight: bold; text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-230"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(734,048</td><td style="font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Cash and restricted cash, beginning of year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,913,742</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-231"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,913,742</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in">Cash and restricted cash, end of year</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,179,694</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-232">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,179,694</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> -7583252 2705253 -4877999 401640 401640 4883260 -2705253 2178007 11666 11666 310828 310828 1136712 1136712 -3112570 -3112570 817849 817849 2498 2498 -820347 -820347 100702 100702 -309000 -309000 3608571 3608571 3198869 3198869 -734048 -734048 1913742 1913742 1179694 1179694 -0.08 -0.30 The above restatement did not impact the total assets nor liabilities and did not impact the net equity as the share capital decreased by $2,705,253 and the deficit was reduced by the same amount.<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As originally filed</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Adjustment</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As Restated</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">ASSETS</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold">Current</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-indent: 0in; padding-left: -0.125in">Cash</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">1,179,694</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-145"> </div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">1,179,694</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Trade and other receivables (Note 3)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,111,123</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-146"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,111,123</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Prepaid expenses</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">665,446</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-147"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">665,446</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Inventory (Note 4)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,564,040</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-148"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3,564,040</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Advance to suppliers</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">675,561</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-149"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">675,561</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 0in; padding-left: -0.125in"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">7,195,864</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-150"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">7,195,864</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Long term receivable</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">146,196</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-151"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">146,196</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Right of use assets</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">811,966</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-152"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">811,966</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 0in; padding-left: -0.125in">Equipment</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">199,743</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-153"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">199,743</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Intangible assets</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,481,391</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-154"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,481,391</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Total assets</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">15,835,160</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-155"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">15,835,160</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: 0in; padding-left: -0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; text-indent: 0in; padding-left: -0.125in">LIABILITIES AND SHAREHOLDERS' EQUITY</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-indent: 0in; padding-left: -0.125in">Current</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Accounts payable and accrued liabilities</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,111,174</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-156"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">2,111,174</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Deferred revenue</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-157">-</div></td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-158"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-159">-</div></td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Lease obligations</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">294,359</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-160"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">294,359</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Warrant liability (Note 6)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">628,765</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">628,765</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,034,298</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-162"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,034,298</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Lease obligation</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">543,944</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-163"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">543,944</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Total liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,578,242</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-164"> </div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3,578,242</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; text-indent: 0in; padding-left: -0.125in">Shareholders' equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: 0in; padding-left: -0.125in">Share capital (Note 7)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">79,626,690</td><td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2,705,253</td><td style="font-weight: bold; text-align: left">)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">76,921,437</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Reserves (Note 7)</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">17,933,273</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-165"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">17,933,273</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 0in; padding-left: -0.125in">Accumulated other comprehensive loss</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">98,870</td><td style="font-weight: bold; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-166"> </div></td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">98,870</td><td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Deficit</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(85,401,915</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">2,705,253</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(82,696,662</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,256,918</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-167">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">12,256,918</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt; text-indent: 0in; padding-left: -0.125in">Total liabilities and shareholders' equity</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">15,835,160</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">15,835,160</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 0.05 -0.08 -0.13 false --12-31 Q2 0001649009 2026640 1913742 2455711 1574628 262481 173504 2505957 4092550 588970 155852 7839759 7910276 142838 150185 770840 887137 190706 207402 7633427 6987531 16577570 16142531 719623 2742429 3078650 149600 329433 303788 307381 2734804 4098866 6266842 484298 635217 4583164 6902059 82706883 73312866 14218932 13647399 98870 98870 -85030279 -77818663 11994406 9240472 16577570 16142531 4513354 1802502 2710717 969528 3212347 1438778 1906227 860855 1301007 363724 804490 108673 855139 459924 453499 335419 85450 263370 31465 140054 2041168 2208726 1037803 1163675 3095812 3510661 1703382 1851582 303316 238980 10148 63285 10148 70643 571533 1939035 260705 1126300 6659250 8748317 3497002 4926653 -5358243 -8384593 -2692512 -4817980 75349 45726 41251 18739 78599 -19168 78762 -106828 3250848 570391 962350 -1856623 5444935 321384 1209850 965247 -1853373 201596 358895 513892 -7211616 -8182997 -2333617 -4304088 -1518 -25986 -7211616 -8181479 -2333617 -4278102 68257292 13805757 77394214 14635152 -0.11 -0.59 -0.03 -0.29 682573 138058 773942 146352 -10.57 -59.27 -3.02 -29.41 5276695 54655244 10389555 -38739 -62519412 2486648 138958 190095 190095 7215652 10936974 307189 11244163 -1051647 -1051647 1480000 2575200 2575200 1009219 1172961 1172961 1939035 1939035 1518 1518 -8182997 -8182997 15120524 68478827 12635779 -37221 -70702409 10374976 44868560 73312866 13647399 98870 -77818663 9240472 39074844 7583617 -3975046 3608571 3975046 3975046 50000000 2250000 2250000 -439600 -439600 571533 571533 -7211616 -7211616 133943404 82706883 14218932 98870 -85030279 11994406 -7211616 -8182997 855139 459924 10148 63285 303316 3250848 962350 1856623 -5444936 9586 7347 571533 1939035 -891231 75316 -88977 -277147 1586593 -2590511 -433118 -813776 -336221 -928706 -149600 -4223380 -11174413 1329175 1389620 3736 1841 -155014 -1332911 -1546475 160405 154665 719623 9937 -4000000 2250000 16711184 -748600 3608571 2575200 5669189 15141656 13910 112898 2434678 1913742 1619742 2026640 4054420 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NATURE OF OPERATIONS AND GOING CONCERN</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Siyata Mobile Inc. (“Siyata” or the “Company”) was incorporated under the Business Corporations Act, British Columbia on October 15, 1986. The Company’s shares are listed on NASDAQ under the symbol SYTA and warrants issued on September 29, 2020, are traded under the symbol SYTAW. The Company’s principal activity is the sale of vehicle-mounted, cellular-based communications platforms over advanced mobile networks and cellular booster systems. The registered and records office is located at 2200 - 885 West Georgia Street, Vancouver, BC V6C 3E8.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These unaudited condensed interim consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) IAS 34 <i>Interim Financial Reporting</i>, with the assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business rather than a process of forced liquidation. These unaudited condensed interim consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company incurred a net loss of $7,211,616 during the six month period ended June 30, 2023 (June 30, 2022- six month period net loss of $8,182,997), and, as of that date, the Company’s total deficit was $85,030,279 (December 31, 2022 - $77,818,663). The Company’s continuation as a going concern is dependent upon the success of the Company’s sale of inventory, the existing cash flows, and the ability of the Company to obtain additional debt or equity financing, all of which are uncertain. These material uncertainties raise substantial doubt on the Company’s ability to continue as a going concern.</p> 7211616 8182997 85030279 77818663 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.</b></span></td> <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BASIS OF PREPARATION </b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Statement of compliance </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These unaudited condensed interim consolidated financial statements, including comparatives, have been prepared in accordance with International Accounting Standards (IAS) 34 <i>Interim Financial Reporting. </i>Omitted from these financial statements are certain information and note disclosures normally included in the annual financial statements. These financial statements and notes presented should be read in conjunction with the annual financial statements for the year ended December 31, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The accounting methods and principles of computation adopted in these financial statements are the same as those in annual consolidated financial statements for the year ended December 31, 2022, except that the functional currency of Signifi Mobile Inc. is the $USD (formerly $CDN) as of January 1, 2023, and therefore all of the entities in the consolidated group of Siyata Mobile Inc. are all using the USD$ as the functional currency.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The preparation of these unaudited condensed interim consolidated financial statements requires management to make estimates, judgments and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income and expenses. The significant judgements made by management when applying the Company’s accounting policies and the key sources of estimation uncertainty were the same as those that applied to the Company’s December 31, 2022 annual consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Basis of consolidation and presentation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These unaudited condensed interim consolidated financial statements of the Company have been prepared on a historical cost basis, except for financial instruments classified as financial instruments at fair value through profit and loss, which are stated at their fair value. In addition, the condensed interim consolidated financial statements have been prepared using the accrual basis of accounting, except for the statement of cash flows.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These unaudited condensed interim consolidated financial statements incorporate the financial statements of the Company and its wholly controlled subsidiaries. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. These condensed interim consolidated financial statements include the accounts of the Company and its direct wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Name of Subsidiary</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Place of Incorporation</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Ownership</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 47%; text-align: justify">Queensgate Resources Corp.</td><td style="width: 1%"> </td> <td style="width: 40%; text-align: justify">British Columbia, Canada</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Queensgate Resources US Corp.</td><td> </td> <td style="text-align: justify">Nevada, USA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Siyata Mobile (Canada) Inc.</td><td> </td> <td style="text-align: justify">British Columbia, Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Siyata Mobile Israel Ltd.</td><td> </td> <td style="text-align: justify">Israel</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Signifi Mobile Inc.</td><td> </td> <td style="text-align: justify">Quebec, Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">ClearRF Nevada Ltd.</td><td> </td> <td style="text-align: justify">Nevada, USA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.8pt"><b>Recent adoptions of accounting pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The following amendments became effective on January 1, 2023, and did not have a material impact on the Company’s condensed interim consolidated financial statements:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 40pt"></td><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2021, the IASB issued Definition of Accounting Estimates (Amendments to IAS 8). The amendments define accounting estimates and clarify the distinction between changes in accounting estimates and changes in accounting policies.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 40pt"></td><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2021, the IASB issued Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2). The amendments provide guidance to help entities disclose their material (previously “significant”) accounting policies.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 40pt"></td><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the IASB issued Deferred Tax related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12). The amendments narrow the scope of the recognition exemption so that companies would be required to recognize deferred tax for transactions that give rise to equal amounts of taxable and deductible temporary differences, such as leases.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Future accounting pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The standards, amendments, and interpretations issued before 2023 but not yet adopted by the Company have been disclosed in Note 3 of the Company’s December 31, 2022 annual consolidated financial statements. The Company is currently considering the impact of adopting these standards, amendments and interpretations on its consolidated financial statement. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Basis of consolidation and presentation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These unaudited condensed interim consolidated financial statements of the Company have been prepared on a historical cost basis, except for financial instruments classified as financial instruments at fair value through profit and loss, which are stated at their fair value. In addition, the condensed interim consolidated financial statements have been prepared using the accrual basis of accounting, except for the statement of cash flows.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">These unaudited condensed interim consolidated financial statements incorporate the financial statements of the Company and its wholly controlled subsidiaries. Control exists when the Company has the power, directly or indirectly, to govern the financial and operating policies of an entity so as to obtain benefits from its activities. These condensed interim consolidated financial statements include the accounts of the Company and its direct wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Name of Subsidiary</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Place of Incorporation</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Ownership</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 47%; text-align: justify">Queensgate Resources Corp.</td><td style="width: 1%"> </td> <td style="width: 40%; text-align: justify">British Columbia, Canada</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Queensgate Resources US Corp.</td><td> </td> <td style="text-align: justify">Nevada, USA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Siyata Mobile (Canada) Inc.</td><td> </td> <td style="text-align: justify">British Columbia, Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Siyata Mobile Israel Ltd.</td><td> </td> <td style="text-align: justify">Israel</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Signifi Mobile Inc.</td><td> </td> <td style="text-align: justify">Quebec, Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">ClearRF Nevada Ltd.</td><td> </td> <td style="text-align: justify">Nevada, USA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> </table> The unaudited condensed interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Name of Subsidiary</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Place of Incorporation</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Ownership</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 47%; text-align: justify">Queensgate Resources Corp.</td><td style="width: 1%"> </td> <td style="width: 40%; text-align: justify">British Columbia, Canada</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Queensgate Resources US Corp.</td><td> </td> <td style="text-align: justify">Nevada, USA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Siyata Mobile (Canada) Inc.</td><td> </td> <td style="text-align: justify">British Columbia, Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">Siyata Mobile Israel Ltd.</td><td> </td> <td style="text-align: justify">Israel</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify">Signifi Mobile Inc.</td><td> </td> <td style="text-align: justify">Quebec, Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">ClearRF Nevada Ltd.</td><td> </td> <td style="text-align: justify">Nevada, USA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">100</td><td style="text-align: left">%</td></tr> </table> Queensgate Resources Corp. British Columbia, Canada 1 Queensgate Resources US Corp. Nevada, USA 1 Siyata Mobile (Canada) Inc. British Columbia, Canada 1 Siyata Mobile Israel Ltd. Israel 1 Signifi Mobile Inc. Quebec, Canada 1 ClearRF Nevada Ltd. Nevada, USA 1 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.8pt"><b>Recent adoptions of accounting pronouncements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The following amendments became effective on January 1, 2023, and did not have a material impact on the Company’s condensed interim consolidated financial statements:</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 40pt"></td><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2021, the IASB issued Definition of Accounting Estimates (Amendments to IAS 8). The amendments define accounting estimates and clarify the distinction between changes in accounting estimates and changes in accounting policies.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 40pt"></td><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2021, the IASB issued Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2). The amendments provide guidance to help entities disclose their material (previously “significant”) accounting policies.</span></td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 40pt"></td><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2021, the IASB issued Deferred Tax related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12). The amendments narrow the scope of the recognition exemption so that companies would be required to recognize deferred tax for transactions that give rise to equal amounts of taxable and deductible temporary differences, such as leases.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><b>Future accounting pronouncements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The standards, amendments, and interpretations issued before 2023 but not yet adopted by the Company have been disclosed in Note 3 of the Company’s December 31, 2022 annual consolidated financial statements. The Company is currently considering the impact of adopting these standards, amendments and interpretations on its consolidated financial statement. </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 24px; text-align: left"><b>3.</b></td><td style="text-align: justify"><b>BANK LOAN</b></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company has obtained in April 2023, a $<span style="-sec-ix-hidden: hidden-fact-34">2,000,0000</span> line of credit factoring for its North American receivables with an 85% advance rate with interest of </span>1.8% for the first 30 days, then 0.5% every 10 days thereafter of the face value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">This loan is collateralized by the North American receivables, inventory and equipment. As at June 30, 2023 the loan balance is 719,623.</p> 0.85 0.018 0.005 719623 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WARRANT LIABILITY</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The balance of the warrant liability is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">November 3,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">January 11,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">October 12, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">January 19,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-weight: bold">Balance December 31, 2022</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">197,733</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">501,330</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">2,035,741</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">-</div></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">2,734,804</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Change in fair value of warrants exercised</p></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(197,733</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,717,801</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,915,534</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrants issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,580</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Proceeds from Inducement warrants issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Transfer to equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(564,946</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,410,100</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,975,046</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(193,949</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">247,006</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">534,520</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">587,577</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Balance June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">307,381</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">307,381</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><b>Change in warrant fair value January 1, 2023-June 30, 2023</b></td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Change in fair value of warrants exercised</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(1,915,534</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td>Fair value of warrants issued as inducement</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,580</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other changes in fair value of warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">587,577</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Day 1 Loss - FV Change in Warrant Liability</td><td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">309,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Total change in warrant fair value January 1, 2023-June 30, 2023</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,856,623</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="text-decoration:underline">January 19, 2023 warrants</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On January 19, 2023, the Company entered into warrant exercise agreements with fourteen existing accredited investors to exercise certain outstanding warrants to purchase up to an aggregate of 18,042,857 of the Company’s common shares. In consideration for the immediate exercise of the outstanding warrants for cash, the Company agreed to reduce the exercise price from $0.23 to $0.20 per share and issue new unregistered warrants to purchase up to an aggregate of 18,042,857 common shares with an exercise price of $0.20 per share. The gross proceeds to the Company from the exercise totaled approximately $3,608,571, prior to deducting warrant inducement agent fees and offering expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The new warrants are exercisable immediately upon issuance at an exercise price of $0.20 per share and have a term of exercise equal to five years. In connection with the exercise, the Company will be required pursuant to the terms of 2,989,130 of its remaining unexercised common share purchase warrants, to reduce the exercise price of such warrants from $0.23 per common share to an exercise price of $0.20 per common share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On March 30, 2023, the SEC accepted the registration statement of the Company to the effect that all of the 21,031,987 outstanding $0.20 warrants become immediately a cashless exercise and their underlying shares become immediately tradeable. Subsequent to the quarter ended March 31, 2023, 21,031,987 warrants were exercised cashless in exchange for 21,031,987 common shares of the Company. All of the warrants that became cashless exercise were transferred to equity at March 30, 2023, as they no longer met the definition of a liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the warrants issued at January 19, 2023 was $2,875,580 and was determined using the stock price at the date of issue, with a 15% discount for lack of marketability. This method was used as the warrants contained an alternative cashless exercise feature.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 18pt; text-align: justify">The fair value of the warrants on March 30, 2023 that was transferred to equity was $3,410,100 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="text-decoration:underline">November 3, 2021 warrants</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The warrants allowed for the purchase of 1,892,857 common shares of the Company at an exercise price of US 4.00 per common share and expired 5 years from the issue date of the related promissory note. Under the terms of these warrants, the exercise price of the warrant was adjusted to $2.30 when an offering was closed on January 3, 2022 that issued shares at a price lower than the exercise price. On January 19, 2023 the warrant holders entered into the agreement noted above to exercise the warrants, and receive new warrants in exchange.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">At December 31, 2022 the fair value of the warrants was $197,733 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.15, strike rate $0.23 dividend yield 0%, term 3.84 years, volatility 110% and risk-free rate 4.08%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">At January 19, 2023 prior to exercise, the fair value of the warrants was $<span style="-sec-ix-hidden: hidden-fact-52">NIL</span> and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.19, strike rate $0.20 dividend yield 0%, term 0.0 years, volatility 130% and risk-free rate 3.62%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="text-decoration:underline">January 11, 2022 warrants</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company assessed that the 8,519,999 warrants, and 1,480,000 pre-funded warrants issued in the January 2022 equity offering did not meet the “fixed for fixed” test and are therefore recorded as liabilities at fair value through profit and loss, and revalued at the end of each period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">At December 31, 2022 the fair value of the warrants was $501,330 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.15, strike rate $2.30, dividend yield 0%, term 4.03 years, volatility 110% and risk-free rate 4.08%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">At June 30, 2023 t<span style="font-family: Times New Roman, Times, Serif">he fair value of the warrants was $307,381 and was determined using a Black-Scholes option pricing model with the following assumptions: initial stock price $0.05, strike rate $2.30, dividend yield 0%, term 3.54 years, volatility 170% and risk-free rate 4.35%. This is based on a level 3 output calculated as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"></td><td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td><td style="text-align: justify; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">The expected volatility was based on the historical daily stock price volatility over a look-back period that was consistent with the balance-remaining term corresponding to each Instrument as of the Valuation Date(s). The historical volatility was then adjusted for:</span></td></tr><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: justify; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top"> <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"></td><td style="font-family: Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif">●</span></td><td style="text-align: justify; font-family: Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">The actual implied-to-historical volatility ratio observed for the Company’s publicly-traded warrants. This approach incorporated the differences between the implied volatility and the historical volatility for the publicly-traded warrant. The ratio was used to determine the volatility if the Instruments were publicly traded.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="font-family: Times New Roman, Times, Serif; vertical-align: top; text-align: justify"> <td style="font-family: Times New Roman, Times, Serif; width: 0.25in"></td><td style="font-family: Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif">●</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">A 25% volatility haircut1 given that the Instruments were not publicly traded and were expected to have lower volatilities than the comparable publicly-traded instruments. The 25% volatility haircut is amortised over the balance-remaining term of the Instruments. As of the Valuation Date, the volatility haircut was 18% for the warrants issued on January 11, 2022. This adjustment informed the expected equity volatility for a privately-issued instrument</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span style="text-decoration:underline">October 12, 2022 warrants</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -6.55pt"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company assessed that the 17,400,000 warrants and 1,590,000 pre-funded warrants issued as part of the October 2022 equity offering did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each pe</span>riod. On January 19, 2023 the warrant holders entered into the agreement noted above to exercise 16,150,000 of the 17,400,000 warrants, and receive new warrants in exchange. The remaining 1,250,000 warrants that were outstanding at January 19, 2023 were converted to cashless exercise warrants on March 30, 2023 as described above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the warrants as at December 31, 2022 was $1,850,758 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.15; exercise price $0.23; expected volatility: 100%; dividend yield 0%; risk free rate: 3.98%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the 1,250,000 unexercised warrants on January 19, 2023 was $132,957 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.19; exercise price $0.20; term 4.73 years; expected volatility: 115%; dividend yield 0%; risk free rate: 3.49%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the 16,150,000 exercised warrants immediately prior to exercise on January 19, 2023 was $<span style="-sec-ix-hidden: hidden-fact-53">NIL</span> and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.19; exercise price $0.20; term 0 years; expected volatility: 115%; dividend yield 0%; risk free rate: 3.49%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the 2,989,130 (1,739,130 waiver warrants plus 1,250,000 unexercised warrants) outstanding warrants on March 30, 2023 prior to the transfer to equity was $564,946 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In connection with the October 2022 equity offering, the Company issued 1,739,130 waiver warrants exercisable at $0.23 per share which expire, if unexercised, on October 12, 2027, to entice the holder of the convertible promissory note to waive their right to block the equity offering. The waiver warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss and revalued at the end of each period. On March 30, 2023, the waiver warrants were modified to cashless exercise as described above, and therefore met the “fixed for fixed” test and were reclassified to equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the waiver warrants as at December 31, 2022 was $184,983 and was determined using the Black-Scholes Option Pricing Model with the following assumptions: share price: $0.15; exercise price $0.23; expected volatility: 100%; dividend yield 0%; risk free rate: 3.10%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair value of the waiver warrants as at March 30, 2023 prior to transfer to equity was $328,696 and was determined using the stock price on the date, as the warrants were cashless exercise at that date.</p> The balance of the warrant liability is as follows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">November 3,<br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">January 11,<br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">October 12, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">January 19,<br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; font-weight: bold">Balance December 31, 2022</td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">197,733</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">501,330</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">2,035,741</td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-35">-</div></td><td style="width: 1%; font-weight: bold; text-align: left"> </td><td style="width: 1%; font-weight: bold"> </td> <td style="width: 1%; font-weight: bold; text-align: left">$</td><td style="width: 9%; font-weight: bold; text-align: right">2,734,804</td><td style="width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Change in fair value of warrants exercised</p></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(197,733</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-36">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,717,801</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-37">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,915,534</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Warrants issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-38">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-39">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-40">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,580</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,580</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Proceeds from Inducement warrants issued</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-41">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-42">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-43">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-44">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-45">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Transfer to equity</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-46">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-47">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(564,946</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,410,100</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(3,975,046</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-48">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(193,949</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">247,006</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">534,520</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">587,577</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Balance June 30, 2023</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-49">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">307,381</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-50">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><div style="-sec-ix-hidden: hidden-fact-51">-</div></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">307,381</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 197733 501330 2035741 2734804 -197733 -1717801 -1915534 2875580 2875580 -564946 -3410100 -3975046 -193949 247006 534520 587577 307381 307381 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><b>Change in warrant fair value January 1, 2023-June 30, 2023</b></td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Change in fair value of warrants exercised</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">(1,915,534</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td>Fair value of warrants issued as inducement</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,875,580</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other changes in fair value of warrants</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">587,577</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Day 1 Loss - FV Change in Warrant Liability</td><td style="border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">309,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1.5pt">Total change in warrant fair value January 1, 2023-June 30, 2023</td><td style="font-weight: bold; border-bottom: Black 1.5pt solid"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,856,623</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> 1915534 2875580 587577 309000 1856623 18042857 0.23 0.2 18042857 0.2 3608571 0.2 P5Y 2989130 0.23 0.2 21031987 0.2 21031987 21031987 2875580 0.15 3410100 1892857 4 P5Y 2.3 197733 0.15 0.23 0 P3Y10M2D 1.10 0.0408 0.19 0.2 0 P0Y 1.30 0.0362 8519999 1480000 501330 0.15 2.3 0 P4Y10D 1.10 0.0408 307381 0.05 2.3 0 P3Y6M14D 1.70 0.0435 0.25 0.18 17400000 1590000 16150000 17400000 1250000 1850758 0.15 0.23 1 0 0.0398 1250000 132957 0.19 0.2 P4Y8M23D 1.15 0 0.0349 16150000 0.19 0.2 P0Y 1.15 0 0.0349 2989130 1739130 1250000 564946 1739130 0.23 2027-10-12 184983 0.15 0.23 1 0 0.031 328696 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SHARE CAPITAL</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Authorized </b>Unlimited number of common shares without par value</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">As at June 30, 2023, the Company had 133,943,404 common shares issued and outstanding (December 31, 2022 – 44,868,560).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36pt; text-align: justify">As of the date of issuance of these unaudited condensed interim consolidated financial statements total outstanding common shares is 1,853,955 post 100-to-1 reverse split that was effective as of August 9, 2023, (185,393,404 pre-split) as described in Subsequent Events Note 10.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common share transactions</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Transactions for the six months ended June 30, 2023 are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 71px"></td><td style="width: 24px; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify">The Company issued 18,042,857 common shares on the exercise of various warrants for gross proceeds of $3,608,571. Additionally, the Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 30, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,857 common shares were issued for cashless warrants in Q2 2023.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0.55pt">On June 28, 2023 the Company issued 50,000,000 at $0.045 per share for gross proceeds of $2,250,000 before offering expenses and other expenses included in share issuance costs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0.55pt">Subsequent to June 30, 2023, the Company issued 51,250,000 shares at $0.045 per share for gross proceeds of $2,306,250 as described in Subsequent Events Note 10.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Transactions for the six months ended June 30, 2022 are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 71px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 11, 2022, the Company completed an underwritten public offering in the United States, raising a total of $20,013,043 in gross proceeds. The Company allocated the gross proceeds firstly to the warrant liabilities, with the remainder to the common shares. Direct costs have been allocated based on the percentage allocation of the proceeds. The underwritten public offering resulted in the sale to the public of 7,215,652 Units at $2.30 per Unit, with each Unit being comprised of one common share and one warrant (the “Unit Warrants”) exercisable at $2.30 per share. The Unit warrants are exercisable immediately and have a term of 5 years. Gross proceeds of $10,936,974 were allocated to the common shares, and $5,395,878 to the unit warrants liability.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0.55pt">In addition, the Company issued 1,480,000 pre-funded units (“Pre-Funded Units”) at $2.29 per Pre-Funded Unit. Each Pre-Funded Unit is comprised of a one-pre-funded warrant (a “Pre-Funded Warrant”) to purchase one common share, and one warrant to purchase one common share. The Pre-Funded Warrant allows the holder to acquire one common share of the Company at an exercise price of $0.01 per common share, and a warrant to purchase a common share at an exercise price of $2.30 per share. The warrants are exercisable immediately and have a term of 5 years. Each Pre-Funded Warrant is exercisable immediately and is exercisable until all Pre-Funded Warrants are exercised. Proceeds of $2,560,400 were allocated to the pre-funded warrants and $1,106,747 to the unit warrants in the warrant liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: 0.55pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify">The Company determined that the pre-funded warrants within the Pre-funded Units are common shares in substance, as they require only a minimal exercise price of $0.01. In addition, the underwriting agreement includes both the Units and Pe-funded Units and were negotiated together in the equity raise. Given that the purpose of the Prefunded Unit is in substance the same as that of the Unit (i.e., resulting in the ownership of both common shares and common share warrants) and that the terms of the warrants in both the Units and Prefunded Units are the same (i.e., the obligations of the Company for the units are the same), the Company determined that the Units and Pre-funded Units are closely related and should be combined into one unit of account for the purposes of allocating proceeds.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common share transactions </b>(cont’d)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Therefore, the proceeds from the sale of the Units and Pre-funded Units are combined and allocated among the common shares, pre-funded warrants, and the common share warrants using the residual method, with the warrant liability being initially recognized at fair value as of the registration date and the residual amount being allocated to the common shares (i.e., equity).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company concurrently sold an additional 1,304,347 warrants to purchase 1,304,347 common shares exercisable at $2.30 per share (the “Option Warrants”) pursuant to an over-allotment option exercised by the underwriter. The exercise price of the warrants issued in connection with the exercise of the over-allotment option was $0.0097 per warrant. Each Option Warrant is exercisable immediately and has a term of five years from the issue date. Proceeds of $975,393 were allocated to the option warrant liability. As the fair value of the warrant liability exceeded the proceeds received on the warrants of $13,043, a fair value loss of $962,350 was recognized in the statement of profit and loss as a fair value change in the opening warrant liability.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The fair value of the common shares and pre-funded units was determined by reference to the market price on the day of the offering, which was $1.73 per share. The Unit Warrants, Warrants, and Option Warrants were valued using the Black-Scholes model using the following assumptions: initial stock price $1.73, strike rate $2.30, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company also issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company assessed that the warrants issued under the public offering, excluding the Placement Agent Warrants did not meet the “fixed for fixed” test and are therefore reported as liabilities at fair value through profit and loss, and revalued at the end of each period. The Placement Agent Warrants were assessed under IFRS 2 <i>Share Based Payments, </i>as equity-settled share-based payments and have been recorded in equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Common share transactions </b>(cont’d)</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 48px"></td><td style="width: 20pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="text-align: justify">On March 31, 2022, as part of the ClearRF acquisition, the Company issued 138,958 shares to the vendor with a fair value of $190,094.</td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.55pt">The Company issued 155,000 common shares, with a fair value of $170,500 ($1.10 per share) to consultants as part of their compensation for services rendered.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.55pt">The Company issued 854,219 common shares with a fair value of $1,002,461 as combined payments of the monthly principal repayment of $400,000 for the months of May and June 2022 payable in shares per the terms of the promissory note.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock options</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company has a shareholder-approved “rolling” stock option plan (the “Plan”) in compliance with Nasdaq policies. Under the Plan the maximum number of shares reserved for issuance may not exceed 15% of the total number of issued and outstanding common shares at the time of granting. The exercise price of each stock option shall not be less than the market price of the Company’s stock at the date of grant, less a discount of up to 25%. Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of the Company’s stock option activity is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of<br/> Stock<br/> Options</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 76%; font-weight: bold">Outstanding options, December 31, 2021</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">414,568</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">13.88</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,145,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(53,430</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">30.90</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Outstanding options, December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,506,138</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3.53</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Expired/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold">Outstanding options, June 30, 2023 and date of MD&amp;A (before the 100-1 reverse stock split)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"></td><td style="font-weight: bold; text-align: right">1,506,138</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">3.53</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; font-weight: bold">Outstanding options, June 30, 2023 and date of MD&amp;A (after the 100-1 reverse stock split)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">15,061</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">353.00</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As at June 30, 2023 stock options outstanding are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Grant Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> options<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> options exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiry date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Remaining<br/> contractual <br/> life (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: center">24-Dec-18</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">12,896</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">12,896</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">54.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">24-Dec-23</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0.48</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">15-Jan-19</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">828</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">828</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">54.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">15-Jan-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.55</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">21-Mar-19</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">59.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">21-Mar-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.73</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">1-Jan-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">54.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">1-Jan-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.51</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">15-Nov-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">15-Nov-30</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.38</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">15-Nov-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">161,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">161,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">15-Nov-25</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.38</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2-Jan-21</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">2-Jan-26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.51</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">2-Jan-21</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">2-Jan-31</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.52</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">18-Jan-21</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">18-Jan-26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.56</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">1-Jan-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">29-Oct-26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.33</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">13-Apr-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">795,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">331,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">13-Apr-27</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.79</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center; padding-bottom: 1.5pt">12-Jul-22</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">330,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">110,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.10</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">12-Jul-25</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.04</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">Total (before the 100-1 reverse stock split)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,506,138</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>794, 888</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">3.53</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3.67</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">Total (after the 100-1 reverse stock split)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">15,061</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,949</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">353.00</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3.67</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Transactions for the six months ended June 30, 2022 are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 1, 2022, the Company granted 20,000 stock options at $4.00 per share that vest in 8 equal quarterly periods with the first vesting occurring on the grant date. The fair value on the date of the grant was $54,480 ($2.724 per option).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 13, 2022, the Company granted 795,000 stock options to executives and employees at an exercise price of $1.10 per share. These options vest quarterly over three years period with the first vesting taking place at the date of the grant. The fair value of these options on the date of the grant is $678,520 ($0.8535 per share).</p></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted share units</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company approved on February 14, 2022, the addition of the issuance of restricted share units to the existing executive stock option plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">A summary of the Company’s restricted share unit activity is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of RSU’s</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Issue Price</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding RSU, December 31, 2021</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid"> </td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-58; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>0</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-59; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,195,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.05</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding RSU, December 31, 2022</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3,165,000</b></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.05</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-60; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-61; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding RSU, June 30, 2023 and date of MD&amp;A (before 100-1 reverse stock split)</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3,165,000</b></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.05</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding RSU, June 30, 2023 and date of MD&amp;A  (after 100-1 reverse stock split)</b></span></td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31,650</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>105.00</b></span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As at June 30, 2023 restricted share units outstanding are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant Date</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br/> RSU’s<br/> outstanding</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br/> RSU’s<br/> exercisable</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Issue Price</b></span></td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9-Mar-22</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,250,000</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,350,000</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13-Apr-22</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">825,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">513,750</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12-Jul-22</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90,000</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding RSU, June 30, 2023 and date of MD&amp;A (before 100-1 reverse stock split)</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3,165,000</b></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,893,750</b></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.05</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding RSU, June 30, 2023 and date of MD&amp;A (after 100-1 reverse stock split)</b></span></td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31,650</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18,938</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>105.00</b></span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Transactions for the six month period ended June 30, 2022, are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 9, 2022, the Company granted 450,000 RSU’s to Directors that vest immediately. On the date of granting, the fair value and stock price was $1.03/share.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 9, 2022, the Company granted 1,800,000 RSU’s to a Director that vest quarterly over 12 periods with the first vesting of 150,000 RSU’s occurring on the date of the granted and another 150,000 vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.03/share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 13, 2022, the Company granted 240,000 RSU’s to consultants that vest immediately. On the date of granting, the fair value and the stock price was $1.10/share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 13, 2022, the Company granted 585,000 RSU’s to employees of the Company that vest quarterly over 12 periods with the first vesting of 48,750 RSU’s occurring on the date of the granted and another 48,750 RSU’s vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.10/share.</p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"> </p></td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Agents’ options</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 49.65pt; text-align: justify; text-indent: -0.25in"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of the Company’s agent options activity is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br/> options</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> average<br/> exercise price</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding agent options, December 31, 2020</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid"> </td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>452,523</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.02</b></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,597</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-62; font-family: Times New Roman, Times, Serif; font-size: 10pt">52,68</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding agent options, December 31, 2021</b></span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>445,926</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.51</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">487,283</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.51</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,702</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.49</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding agent options, December 31, 2022</b></span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">931,507</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding agent options, June 30, 2023 and date of MD&amp;A (before the 100-1 reverse stock split)</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>931,507</b></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.87</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding agent options, June 30, 2023 and date of MD&amp;A (after the 100-1 reverse stock split)</b></span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9,315</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>487.00</b></span></td> <td> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As at June 30, 2023 agent options outstanding are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant Date</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br/> options<br/> outstanding</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br/> options<br/> exercisable</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Exercise<br/> Price</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiry date</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining<br/> contractual<br/> life (years)</b></span></td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29-Sep-20</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">113,500</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">113,500</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.60</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28-Sep-25</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.00</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29-Sep-20</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">266,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">266,000</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.85</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28-Sep-25</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.00</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31-Dec-20</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,724</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,724</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.50</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30-Jun-24</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11-Jan-22</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">434,783</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">434,783</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.53</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11-Jan-27</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-Apr-22</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,500</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,500</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.30</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-Mar-27</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total (before the 100-1 reverse stock split)</b></span></td> <td><b> </b></td> <td><b> </b></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>931,507</b></span></td> <td><b> </b></td> <td><b> </b></td> <td><b> </b></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>931,507</b></span></td> <td><b> </b></td> <td><b> </b></td> <td><b>$</b></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.87</b></span></td> <td><b> </b></td> <td><b> </b></td> <td style="text-align: center"><b> </b></td> <td><b> </b></td> <td><b> </b></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.98</b></span></td> <td><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total (after the 100-1 reverse stock split)</b></span></td> <td><b> </b></td> <td style="border-bottom: black 4.5pt double"><b> </b></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9,315</b></span></td> <td><b> </b></td> <td><b> </b></td> <td style="border-bottom: black 4.5pt double"><b> </b></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9,315</b></span></td> <td><b> </b></td> <td><b> </b></td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><b>487.00</b></td> <td><b> </b></td> <td><b> </b></td> <td style="text-align: center"><b> </b></td> <td><b> </b></td> <td style="border-bottom: black 4.5pt double"><b> </b></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.98</b></span></td> <td><b> </b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i>Transactions for the six month period ended June 30, 2022 are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%. The Company also issued 52,500 agent’s options with a fair value of $61,950 with an exercise price of $2.30.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 70.9pt; text-align: justify; text-indent: -0.25in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(f)</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Share purchase warrants</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A summary of the Company’s share purchase warrant activity is as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As at June 30, 2023 the share purchase warrants outstanding are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant Date</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Warrants outstanding and exercisable</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiry date</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29-Sep-20</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,805,585</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.85</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28-Sep-25</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31-Dec-20</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,294,500</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.50</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30-Jun-24</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11-Jan-22</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,999,999</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.30</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Jan-27</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total (before the 100-1 reverse stock split)</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13,100,084</b></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.84</b></span></td> <td> </td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total (before the 100-1 reverse stock split)</b></span></td> <td><b> </b></td> <td style="border-bottom: black 4.5pt double"><b> </b></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>131,001</b></span></td> <td><b> </b></td> <td><b> </b></td> <td style="border-bottom: black 4.5pt double"><b>$</b></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>384.00</b></span></td> <td><b> </b></td> <td><b> </b></td> <td style="text-align: center"><b> </b></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Transactions for the six months ended June 30, 2023 are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 72px"> </td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,042,857 warrants were exercised on January 12, 2023. The Company issued 18,042,857 warrants to replace those warrants that were exercised. As an incentive to investors to exercise the 18,042,857 warrants, the Company issued cashless warrants to those investors that were exercisable as of March 31, 2023. As well, any holders of the $0.23 warrants that had a ratchet provision also became cashless. As a result, 21,031,857 cashless warrants were exercised in Q2 2023.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Transactions for the six month period ended June 30, 2022 are as follows:</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify">On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exercisable at $2.30 per warrant and with a term of five years. </p> 133943404 133943404 44868560 44868560 1853955 185393404 18042857 3608571 18042857 18042857 0.23 21031857 50000000 0.045 2250000 51250000 0.045 2306250 20013043 7215652 2.3 2.3 P5Y 10936974 5395878 1480000 2.29 0.01 2.3 P5Y 2560400 1106747 0.01 1304347 1304347 2.3 0.0097 Each Option Warrant is exercisable immediately and has a term of five years from the issue date. P5Y 975393 13043 962350 1.73 1.73 2.3 0 P5Y 0.60 0.005 434783 2.53 P5Y 307189 1.73 2.53 0 P5Y 0.60 0.005 The direct costs related to the issuance of the common shares and warrants issued in the January 2022 underwritten public offering were $2,016,895, including the value of the Placement Agent Warrants. Direct costs of $965,248 were allocated to the warrant liability and expensed immediately in profit and loss. During the period, 1,480,000 Pre-Funded Warrants were exercised for gross proceeds of $14,800, converting into 1,480,000 common shares that were fully issued. 138958 190094 155000 170500 1.1 854219 1002461 400000 0.15 0.25 Options can have a maximum term of ten years and typically terminate 90 days following the termination of the optionee’s employment or engagement, except in the case of retirement or death. Vesting of options is at the discretion of the Board of Directors at the time the options are granted. A summary of the Company’s stock option activity is as follows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Number of<br/> Stock<br/> Options</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; width: 76%; font-weight: bold">Outstanding options, December 31, 2021</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">414,568</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; font-weight: bold; text-align: right">13.88</td><td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,145,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.15</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Expired/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(53,430</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">30.90</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">Outstanding options, December 31, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">1,506,138</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3.53</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-54">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-55">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Expired/Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-56">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-57">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; font-weight: bold">Outstanding options, June 30, 2023 and date of MD&amp;A (before the 100-1 reverse stock split)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"></td><td style="font-weight: bold; text-align: right">1,506,138</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">3.53</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; font-weight: bold">Outstanding options, June 30, 2023 and date of MD&amp;A (after the 100-1 reverse stock split)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">15,061</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">353.00</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of RSU’s</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Issue Price</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding RSU, December 31, 2021</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid"> </td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-58; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>0</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-59; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>-</b></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,195,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.05</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(30,000</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding RSU, December 31, 2022</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3,165,000</b></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.05</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-60; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-61; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding RSU, June 30, 2023 and date of MD&amp;A (before 100-1 reverse stock split)</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3,165,000</b></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.05</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding RSU, June 30, 2023 and date of MD&amp;A  (after 100-1 reverse stock split)</b></span></td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31,650</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>105.00</b></span></td> <td> </td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br/> options</b></span></td> <td> </td> <td> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> average<br/> exercise price</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in"> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 76%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding agent options, December 31, 2020</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid"> </td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>452,523</b></span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="width: 9%; border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.02</b></span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,597</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-62; font-family: Times New Roman, Times, Serif; font-size: 10pt">52,68</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding agent options, December 31, 2021</b></span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>445,926</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.51</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">487,283</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.51</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,702</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.49</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding agent options, December 31, 2022</b></span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">931,507</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-63; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expired</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: hidden-fact-64; font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding agent options, June 30, 2023 and date of MD&amp;A (before the 100-1 reverse stock split)</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>931,507</b></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.87</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding agent options, June 30, 2023 and date of MD&amp;A (after the 100-1 reverse stock split)</b></span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9,315</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>487.00</b></span></td> <td> </td></tr> </table> 414568 13.88 1145000 1.15 -53430 30.9 1506138 3.53 1506138 3.53 15061 353 As at June 30, 2023 stock options outstanding are as follows:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Grant Date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> options<br/> outstanding</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> options exercisable</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Expiry date</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Remaining<br/> contractual <br/> life (years)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: center">24-Dec-18</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">12,896</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">12,896</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">54.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">24-Dec-23</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">0.48</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">15-Jan-19</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">828</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">828</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">54.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">15-Jan-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.55</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">21-Mar-19</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,345</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">59.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">21-Mar-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.73</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">1-Jan-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">54.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">1-Jan-24</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0.51</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">15-Nov-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">95,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">15-Nov-30</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.38</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">15-Nov-20</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">161,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">161,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">15-Nov-25</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.38</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2-Jan-21</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">57,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">2-Jan-26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.51</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">2-Jan-21</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">2-Jan-31</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7.52</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">18-Jan-21</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">14,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11.50</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">18-Jan-26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.56</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center">1-Jan-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">20,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">12,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4.00</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">29-Oct-26</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.33</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">13-Apr-22</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">795,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">331,250</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: center">13-Apr-27</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.79</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center; padding-bottom: 1.5pt">12-Jul-22</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">330,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">110,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1.10</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">12-Jul-25</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2.04</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">Total (before the 100-1 reverse stock split)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">1,506,138</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden: hidden-fact-65; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>794, 888</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">3.53</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">3.67</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">Total (after the 100-1 reverse stock split)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">15,061</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">7,949</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">353.00</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">3.67</td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in; text-indent: -0.125in; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant Date</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br/> RSU’s<br/> outstanding</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br/> RSU’s<br/> exercisable</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Issue Price</b></span></td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9-Mar-22</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,250,000</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,350,000</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.03</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13-Apr-22</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">825,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">513,750</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12-Jul-22</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">90,000</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.10</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding RSU, June 30, 2023 and date of MD&amp;A (before 100-1 reverse stock split)</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3,165,000</b></span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1,893,750</b></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.05</b></span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-indent: -0.125in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding RSU, June 30, 2023 and date of MD&amp;A (after 100-1 reverse stock split)</b></span></td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>31,650</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"> </td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>18,938</b></span></td> <td> </td> <td> </td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>105.00</b></span></td> <td> </td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant Date</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br/> options<br/> outstanding</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of<br/> options<br/> exercisable</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted<br/> Average<br/> Exercise<br/> Price</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiry date</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining<br/> contractual<br/> life (years)</b></span></td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td style="text-align: center"> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29-Sep-20</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">113,500</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">113,500</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.60</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28-Sep-25</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.00</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29-Sep-20</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">266,000</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">266,000</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.85</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28-Sep-25</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.00</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31-Dec-20</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,724</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,724</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.50</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30-Jun-24</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.00</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11-Jan-22</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">434,783</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">434,783</span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.53</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11-Jan-27</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-Apr-22</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,500</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52,500</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.30</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-Mar-27</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.00</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total (before the 100-1 reverse stock split)</b></span></td> <td><b> </b></td> <td><b> </b></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>931,507</b></span></td> <td><b> </b></td> <td><b> </b></td> <td><b> </b></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>931,507</b></span></td> <td><b> </b></td> <td><b> </b></td> <td><b>$</b></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.87</b></span></td> <td><b> </b></td> <td><b> </b></td> <td style="text-align: center"><b> </b></td> <td><b> </b></td> <td><b> </b></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.98</b></span></td> <td><b> </b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total (after the 100-1 reverse stock split)</b></span></td> <td><b> </b></td> <td style="border-bottom: black 4.5pt double"><b> </b></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9,315</b></span></td> <td><b> </b></td> <td><b> </b></td> <td style="border-bottom: black 4.5pt double"><b> </b></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9,315</b></span></td> <td><b> </b></td> <td><b> </b></td> <td style="border-bottom: black 4.5pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><b>487.00</b></td> <td><b> </b></td> <td><b> </b></td> <td style="text-align: center"><b> </b></td> <td><b> </b></td> <td style="border-bottom: black 4.5pt double"><b> </b></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.98</b></span></td> <td><b> </b></td></tr> </table><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant Date</b></span></td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Warrants outstanding and exercisable</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise Price</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiry date</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29-Sep-20</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,805,585</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 9%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.85</span></td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28-Sep-25</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31-Dec-20</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,294,500</span></td> <td> </td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.50</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30-Jun-24</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11-Jan-22</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,999,999</span></td> <td> </td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.30</span></td> <td> </td> <td> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Jan-27</span></td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total (before the 100-1 reverse stock split)</b></span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>13,100,084</b></span></td> <td> </td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$</b></span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.84</b></span></td> <td> </td> <td> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total (before the 100-1 reverse stock split)</b></span></td> <td><b> </b></td> <td style="border-bottom: black 4.5pt double"><b> </b></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>131,001</b></span></td> <td><b> </b></td> <td><b> </b></td> <td style="border-bottom: black 4.5pt double"><b>$</b></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>384.00</b></span></td> <td><b> </b></td> <td><b> </b></td> <td style="text-align: center"><b> </b></td></tr> </table> 12896 12896 54 24-Dec-23 P0Y5M23D 828 828 54 15-Jan-24 P0Y6M18D 12345 12345 59 21-Mar-24 P0Y8M23D 2069 2069 54 1-Jan-24 P0Y6M3D 95000 95000 6 15-Nov-30 P7Y4M17D 161500 161500 6 15-Nov-25 P2Y4M17D 57000 57000 11.5 2-Jan-26 P2Y6M3D 5000 5000 11.5 2-Jan-31 P7Y6M7D 14500 14500 11.5 18-Jan-26 P2Y6M21D 20000 12500 4 29-Oct-26 P3Y3M29D 795000 331250 1.1 13-Apr-27 P3Y9M14D 330000 110000 1.1 12-Jul-25 P2Y14D 1506138 3.53 P3Y8M1D 15061 7949 353 P3Y8M1D 20000 4 54480 2.724 795000 1.1 678520 0.8535 3195000 1.05 -30000 1.1 3165000 1.05 3165000 1.05 31650 105 2250000 1350000 1.03 825000 513750 1.1 90000 30000 1.1 3165000 1893750 1.05 31650 18938 105 ●On March 9, 2022, the Company granted 450,000 RSU’s to Directors that vest immediately. On the date of granting, the fair value and stock price was $1.03/share.   ● On March 9, 2022, the Company granted 1,800,000 RSU’s to a Director that vest quarterly over 12 periods with the first vesting of 150,000 RSU’s occurring on the date of the granted and another 150,000 vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.03/share.   On April 13, 2022, the Company granted 240,000 RSU’s to consultants that vest immediately. On the date of granting, the fair value and the stock price was $1.10/share.   On April 13, 2022, the Company granted 585,000 RSU’s to employees of the Company that vest quarterly over 12 periods with the first vesting of 48,750 RSU’s occurring on the date of the granted and another 48,750 RSU’s vest every three months until all of the granted RSU’s have vested. On the date of granting, the fair value and the stock price was $1.10/share.   452523 8.02 -6597 445926 7.51 487283 2.51 -1702 20.49 931507 4.12 931507 4.87 9315 487 113500 113500 6.6 28-Sep-25 P2Y 266000 266000 6.85 28-Sep-25 P2Y 64724 64724 11.5 30-Jun-24 P1Y 434783 434783 2.53 11-Jan-27 P4Y 52500 52500 2.3 8-Mar-27 P4Y 931507 931507 4.87 P2Y11M23D 9315 9315 487 P2Y11M23D ●The Company issued warrants to the placement agents to purchase 434,783 common shares at an exercise price of $2.53 per share (the “Placement Agent Warrants”), which are exercisable 180 days from January 11, 2022, with a term of five years. The fair value of the Placement Agent Warrants was determined to be $307,189 using the Black-Scholes model with the following assumptions: initial stock price $1.73, strike rate $2.53, dividend yield 0%, term 5 years, volatility 60.0% and risk-free rate 0.50%. The Company also issued 52,500 agent’s options with a fair value of $61,950 with an exercise price of $2.30. 1805585 6.85 28-Sep-25 1294500 11.5 30-Jun-24 9999999 2.3 10-Jan-27 13100084 3.84 131001 384 18042857 18042857 18042857 0.23 21031857 On January 11, 2022 as part of an underwritten public offering, the Company issued a total of 9,999,999 share purchase warrants, exercisable at $2.30 per warrant and with a term of five years. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSACTION COSTS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Transaction costs incurred in relation to the January 2023 warrant raise and issuance described in Note 5 were $439,600 and were included in the change in fair value of warrant liability on the statement of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Transaction costs incurred in the six months ended June 30, 2022 were $965,247, which are costs incurred for the January 11, 2022 capital raise that were allocated to the warrant liability and expensed through the statement of operations.</p> 439600 965247 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FINANCIAL INSTRUMENTS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The fair values of the Company’s cash, trade and other receivables, accounts payable and accrued liabilities and long-term debt, approximate carrying value, which is the amount recorded on the unaudited condensed interim consolidated statement of financial position.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RELATED PARTY TRANSACTIONS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><span style="text-decoration:underline">Key Personnel Compensation</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Key management personnel includes those persons having authority and responsibility for planning, directing, and controlling the activities of the Company as a whole. The Company has determined that key management personnel consists of executive and non-executive members of the Company’s Board of Directors and corporate officers. The remuneration of directors and key management personnel for the three and six month period ended June 30, 2023 and 2022 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Payments to key management personnel:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify; padding-left: 9pt">Salaries, consulting and directors’ fees</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">667,582</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">851,262</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt">Share-based payments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">438,008</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,792,129</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,105,590</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,643,391</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Salaries, consulting and directors’ fees shown above are classified within profit and loss as shown below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Type of Service</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nature of Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: center; padding-bottom: 1.5pt">Selling and marketing expenses</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 35%; text-align: center; padding-bottom: 1.5pt">VP Technology/VP Sales International</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">182</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">152</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt">General and administrative expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">Companies controlled by the CEO, CFO and Directors</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">486</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">699</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> The remuneration of directors and key management personnel for the three and six month period ended June 30, 2023 and 2022 are as follows<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify">Payments to key management personnel:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: justify; padding-left: 9pt">Salaries, consulting and directors’ fees</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">667,582</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">851,262</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt; padding-left: 9pt">Share-based payments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">438,008</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,792,129</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,105,590</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,643,391</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> 667582 851262 438008 1792129 1105590 2643391 Salaries, consulting and directors’ fees shown above are classified within profit and loss as shown below:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Type of Service</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Nature of Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: center; padding-bottom: 1.5pt">Selling and marketing expenses</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 35%; text-align: center; padding-bottom: 1.5pt">VP Technology/VP Sales International</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">182</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">152</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt">General and administrative expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">Companies controlled by the CEO, CFO and Directors</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">486</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">699</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 182000 152000 486000 699000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SEGMENTED INFORMATION</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company is domiciled in Canada, and it operates and produces its income primarily in Israel, Europe and North America. The Company operates as a single segment being the sale of cellular-based communications products.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">The Company’s entity-wide disclosures include disaggregated information about product sales, geographical areas, and major customers.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Geographical area information is shown below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold">External revenues by Geography for the three and six month period ended June 30</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">6 months ended <br/> June 30</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">3 months ended<br/> June 30</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">(in thousands)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">USA</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,342</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">722</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,270</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">477</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">521</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">625</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">302</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">376</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">650</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">443</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">139</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">104</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Australia</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">13</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">13</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,513</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,803</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,711</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">970</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Non-current asset geographic area information is shown below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Long-term receivable total</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">143</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">150</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Right of use asset total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">771</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">887</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">126</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">177</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">645</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">710</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Equipment total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">191</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">207</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">191</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">207</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Intangibles total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,633</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,988</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,563</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,988</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Product information is shown below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold">Revenue by product line for the three and six month period ended June 30</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">6 months ended</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">3 months ended</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Cellular boosters and related accessories</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,012</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,213</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">575</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">750</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Rugged devices and related accessories</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,501</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">590</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,136</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">220</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,513</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,803</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,711</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">970</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> Geographical area information is shown below:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold">External revenues by Geography for the three and six month period ended June 30</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">6 months ended <br/> June 30</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">3 months ended<br/> June 30</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">(in thousands)</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2023</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">USA</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">3,342</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">722</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,270</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">477</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">521</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">625</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">302</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">376</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">650</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">443</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">139</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">104</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Australia</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-66">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">13</p></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-67">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">13</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,513</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,803</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,711</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">970</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.5in"> </p> 3342000 722000 2270000 477000 521000 625000 302000 376000 650000 443000 139000 104000 13000 13000 4513000 1803000 2711000 970000 Non-current asset geographic area information is shown below:<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">(in thousands)</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, <br/> 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 1.5pt">Long-term receivable total</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">143</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">150</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-68">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-69">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">143</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">150</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Right of use asset total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">771</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">887</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">126</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">177</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">645</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">710</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Equipment total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">191</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">207</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-70">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-71">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">191</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">207</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Intangibles total</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,633</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">6,988</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 9pt">Canada</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">70</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-72">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt">EMEA</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,563</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,988</td><td style="text-align: left"> </td></tr> </table> 143000 150000 143000 150000 771000 887000 126000 177000 645000 710000 191000 207000 191000 207000 7633000 6988000 70000 7563000 6988000 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: left; font-weight: bold">Revenue by product line for the three and six month period ended June 30</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">6 months ended</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">3 months ended</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">(in thousands)</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">Cellular boosters and related accessories</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,012</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1,213</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">575</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">750</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-align: left">Rugged devices and related accessories</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,501</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">590</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,136</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">220</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">4,513</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,803</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,711</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">970</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 1012000 1213000 575000 750000 3501000 590000 2136000 220000 4513000 1803000 2711000 970000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SUBSEQUENT EVENTS</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.3pt; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Subsequent to the period end, the Company issued 51,250,000 common shares at $0.45 for total gross proceeds of $2,306,250.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">On August 9, 2023, the Company affected a 100-to-1 reverse stock split resulting in 185,393,404 common shares converted with rounding into 1,853,955 new common shares.</p> 51250000 0.45 2306250 185393404 1853955 -0.03 -0.11 -0.29 -0.59 -10.57 -29.41 -59.27 -3.02 20000000 5268 794888 EXCEL 114 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$" M% ,4 " "CBPY7$@%B4"$" @+P $P @ %X$@( 6T-O F;G1E;G1?5'EP97-=+GAM;%!+!08 6@!: *T8 #*% ( ! end XML 115 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 116 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 117 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 388 347 1 false 85 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.siyata.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Restated Unaudited Condensed Interim Consolidated Statements of Financial Position Sheet http://www.siyata.com/role/ConsolidatedBalanceSheet Restated Unaudited Condensed Interim Consolidated Statements of Financial Position Statements 2 false false R3.htm 002 - Statement - Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss Sheet http://www.siyata.com/role/ConsolidatedIncomeStatement Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss Statements 3 false false R4.htm 003 - Statement - Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) Sheet http://www.siyata.com/role/ConsolidatedIncomeStatement_Parentheticals Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) Statements 4 false false R5.htm 004 - Statement - Restated Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders??? Equity Sheet http://www.siyata.com/role/ShareholdersEquityType2or3 Restated Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders??? Equity Statements 5 false false R6.htm 005 - Statement - Restated Unaudited Condensed Interim Consolidated Statements of Cash Flows Sheet http://www.siyata.com/role/ConsolidatedCashFlow Restated Unaudited Condensed Interim Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Statement - Unaudited Condensed Interim Consolidated Statements of Financial Position Sheet http://www.siyata.com/role/ConsolidatedBalanceSheet0 Unaudited Condensed Interim Consolidated Statements of Financial Position Statements 7 false false R8.htm 007 - Statement - Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss Sheet http://www.siyata.com/role/ConsolidatedIncomeStatement0 Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss Statements 8 false false R9.htm 008 - Statement - Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) Sheet http://www.siyata.com/role/ConsolidatedIncomeStatement_Parentheticals0 Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) Statements 9 false false R10.htm 009 - Statement - Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders??? Equity Sheet http://www.siyata.com/role/ShareholdersEquityType2or30 Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders??? Equity Statements 10 false false R11.htm 010 - Statement - Unaudited Condensed Interim Consolidated Statements of Cash Flows Sheet http://www.siyata.com/role/ConsolidatedCashFlow0 Unaudited Condensed Interim Consolidated Statements of Cash Flows Statements 11 false false R12.htm 011 - Disclosure - Nature of Operations and Going Concern Sheet http://www.siyata.com/role/NatureofOperationsandGoingConcern Nature of Operations and Going Concern Notes 12 false false R13.htm 012 - Disclosure - Basis of Preparation Sheet http://www.siyata.com/role/BasisofPreparation Basis of Preparation Notes 13 false false R14.htm 013 - Disclosure - Trade and Other Receivables Sheet http://www.siyata.com/role/TradeandOtherReceivables Trade and Other Receivables Notes 14 false false R15.htm 014 - Disclosure - Inventory Sheet http://www.siyata.com/role/Inventory Inventory Notes 15 false false R16.htm 015 - Disclosure - Convertible Debentures Sheet http://www.siyata.com/role/ConvertibleDebentures Convertible Debentures Notes 16 false false R17.htm 016 - Disclosure - Warrant Liability Sheet http://www.siyata.com/role/WarrantLiability Warrant Liability Notes 17 false false R18.htm 017 - Disclosure - Share Capital Sheet http://www.siyata.com/role/ShareCapital Share Capital Notes 18 false false R19.htm 018 - Disclosure - Cost of Sales Sheet http://www.siyata.com/role/CostofSales Cost of Sales Notes 19 false false R20.htm 019 - Disclosure - Selling and Marketing Expenses Sheet http://www.siyata.com/role/SellingandMarketingExpenses Selling and Marketing Expenses Notes 20 false false R21.htm 020 - Disclosure - General and Administrative Expenses Sheet http://www.siyata.com/role/GeneralandAdministrativeExpenses General and Administrative Expenses Notes 21 false false R22.htm 021 - Disclosure - Transaction Costs Sheet http://www.siyata.com/role/TransactionCosts Transaction Costs Notes 22 false false R23.htm 022 - Disclosure - Financial Instruments Sheet http://www.siyata.com/role/FinancialInstruments Financial Instruments Notes 23 false false R24.htm 023 - Disclosure - Related Party Transactions Sheet http://www.siyata.com/role/RelatedPartyTransactions Related Party Transactions Notes 24 false false R25.htm 024 - Disclosure - Segmented Information Sheet http://www.siyata.com/role/SegmentedInformation Segmented Information Notes 25 false false R26.htm 025 - Disclosure - Supplemental Information with Respect to Cash Flows Sheet http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlows Supplemental Information with Respect to Cash Flows Notes 26 false false R27.htm 026 - Disclosure - Subsequent Events Sheet http://www.siyata.com/role/SubsequentEvents Subsequent Events Notes 27 false false R28.htm 027 - Disclosure - Restatement of Financial Statements Sheet http://www.siyata.com/role/RestatementofFinancialStatements Restatement of Financial Statements Notes 28 false false R29.htm 028 - Disclosure - Bank Loan Sheet http://www.siyata.com/role/BankLoan Bank Loan Notes 29 false false R30.htm 029 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.siyata.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies 30 false false R31.htm 030 - Disclosure - Basis of Preparation (Tables) Sheet http://www.siyata.com/role/BasisofPreparationTables Basis of Preparation (Tables) Tables http://www.siyata.com/role/BasisofPreparation 31 false false R32.htm 031 - Disclosure - Trade and Other Receivables (Tables) Sheet http://www.siyata.com/role/TradeandOtherReceivablesTables Trade and Other Receivables (Tables) Tables http://www.siyata.com/role/TradeandOtherReceivables 32 false false R33.htm 032 - Disclosure - Inventory (Tables) Sheet http://www.siyata.com/role/InventoryTables Inventory (Tables) Tables http://www.siyata.com/role/Inventory 33 false false R34.htm 033 - Disclosure - Warrant Liability (Tables) Sheet http://www.siyata.com/role/WarrantLiabilityTables Warrant Liability (Tables) Tables http://www.siyata.com/role/WarrantLiability 34 false false R35.htm 034 - Disclosure - Share Capital (Tables) Sheet http://www.siyata.com/role/ShareCapitalTables Share Capital (Tables) Tables http://www.siyata.com/role/ShareCapital 35 false false R36.htm 035 - Disclosure - Cost of Sales (Tables) Sheet http://www.siyata.com/role/CostofSalesTables Cost of Sales (Tables) Tables http://www.siyata.com/role/CostofSales 36 false false R37.htm 036 - Disclosure - Selling and Marketing Expenses (Tables) Sheet http://www.siyata.com/role/SellingandMarketingExpensesTables Selling and Marketing Expenses (Tables) Tables http://www.siyata.com/role/SellingandMarketingExpenses 37 false false R38.htm 037 - Disclosure - General and Administrative Expenses (Tables) Sheet http://www.siyata.com/role/GeneralandAdministrativeExpensesTables General and Administrative Expenses (Tables) Tables http://www.siyata.com/role/GeneralandAdministrativeExpenses 38 false false R39.htm 038 - Disclosure - Related Party Transactions (Tables) Sheet http://www.siyata.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://www.siyata.com/role/RelatedPartyTransactions 39 false false R40.htm 039 - Disclosure - Segmented Information (Tables) Sheet http://www.siyata.com/role/SegmentedInformationTables Segmented Information (Tables) Tables http://www.siyata.com/role/SegmentedInformation 40 false false R41.htm 040 - Disclosure - Supplemental Information with Respect to Cash Flows (Tables) Sheet http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlowsTables Supplemental Information with Respect to Cash Flows (Tables) Tables http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlows 41 false false R42.htm 041 - Disclosure - Restatement of Financial Statements (Tables) Sheet http://www.siyata.com/role/RestatementofFinancialStatementsTables Restatement of Financial Statements (Tables) Tables http://www.siyata.com/role/RestatementofFinancialStatements 42 false false R43.htm 042 - Disclosure - Nature of Operations and Going Concern (Details) Sheet http://www.siyata.com/role/NatureofOperationsandGoingConcernDetails Nature of Operations and Going Concern (Details) Details http://www.siyata.com/role/NatureofOperationsandGoingConcern 43 false false R44.htm 043 - Disclosure - Basis of Preparation (Details) - Schedule of Consolidated Financial Statements Sheet http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable Basis of Preparation (Details) - Schedule of Consolidated Financial Statements Details http://www.siyata.com/role/BasisofPreparationTables 44 false false R45.htm 044 - Disclosure - Trade and Other Receivables (Details) - Schedule of Trade and Other Receivables Sheet http://www.siyata.com/role/ScheduleofTradeandOtherReceivablesTable Trade and Other Receivables (Details) - Schedule of Trade and Other Receivables Details http://www.siyata.com/role/TradeandOtherReceivablesTables 45 false false R46.htm 045 - Disclosure - Inventory (Details) - Schedule of Inventory Sheet http://www.siyata.com/role/ScheduleofInventoryTable Inventory (Details) - Schedule of Inventory Details http://www.siyata.com/role/InventoryTables 46 false false R47.htm 046 - Disclosure - Convertible Debentures (Details) Sheet http://www.siyata.com/role/ConvertibleDebenturesDetails Convertible Debentures (Details) Details http://www.siyata.com/role/ConvertibleDebentures 47 false false R48.htm 047 - Disclosure - Warrant Liability (Details) Sheet http://www.siyata.com/role/WarrantLiabilityDetails Warrant Liability (Details) Details http://www.siyata.com/role/WarrantLiabilityTables 48 false false R49.htm 048 - Disclosure - Warrant Liability (Details) - Schedule of the Warrant Liability Sheet http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable Warrant Liability (Details) - Schedule of the Warrant Liability Details http://www.siyata.com/role/WarrantLiabilityTables 49 false false R50.htm 049 - Disclosure - Share Capital (Details) Sheet http://www.siyata.com/role/ShareCapitalDetails Share Capital (Details) Details http://www.siyata.com/role/ShareCapitalTables 50 false false R51.htm 050 - Disclosure - Share Capital (Details) - Schedule of Stock Option Activity Sheet http://www.siyata.com/role/ScheduleofStockOptionActivityTable Share Capital (Details) - Schedule of Stock Option Activity Details http://www.siyata.com/role/ShareCapitalTables 51 false false R52.htm 051 - Disclosure - Share Capital (Details) - Schedule Stock Options Outstanding Sheet http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable Share Capital (Details) - Schedule Stock Options Outstanding Details http://www.siyata.com/role/ShareCapitalTables 52 false false R53.htm 052 - Disclosure - Cost of Sales (Details) - Schedule of Cost of Sales Sheet http://www.siyata.com/role/ScheduleofCostofSalesTable Cost of Sales (Details) - Schedule of Cost of Sales Details http://www.siyata.com/role/CostofSalesTables 53 false false R54.htm 053 - Disclosure - Selling and Marketing Expenses (Details) - Schedule of Selling and Marketing Expenses Sheet http://www.siyata.com/role/ScheduleofSellingandMarketingExpensesTable Selling and Marketing Expenses (Details) - Schedule of Selling and Marketing Expenses Details http://www.siyata.com/role/SellingandMarketingExpensesTables 54 false false R55.htm 054 - Disclosure - General and Administrative Expenses (Details) - Schedule of General and Administrative Eexpenses Sheet http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable General and Administrative Expenses (Details) - Schedule of General and Administrative Eexpenses Details http://www.siyata.com/role/GeneralandAdministrativeExpensesTables 55 false false R56.htm 055 - Disclosure - Transaction Costs (Details) Sheet http://www.siyata.com/role/TransactionCostsDetails Transaction Costs (Details) Details http://www.siyata.com/role/TransactionCosts 56 false false R57.htm 056 - Disclosure - Financial Instruments (Details) Sheet http://www.siyata.com/role/FinancialInstrumentsDetails Financial Instruments (Details) Details http://www.siyata.com/role/FinancialInstruments 57 false false R58.htm 057 - Disclosure - Related Party Transactions (Details) - Schedule of Remuneration of Directors and Key Management Personnel Sheet http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable Related Party Transactions (Details) - Schedule of Remuneration of Directors and Key Management Personnel Details http://www.siyata.com/role/RelatedPartyTransactionsTables 58 false false R59.htm 058 - Disclosure - Related Party Transactions (Details) - Schedule of Classified within Profit and Loss Sheet http://www.siyata.com/role/ScheduleofClassifiedwithinProfitandLossTable Related Party Transactions (Details) - Schedule of Classified within Profit and Loss Details http://www.siyata.com/role/RelatedPartyTransactionsTables 59 false false R60.htm 059 - Disclosure - Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers Sheet http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers Details http://www.siyata.com/role/SegmentedInformationTables 60 false false R61.htm 060 - Disclosure - Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information Sheet http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information Details http://www.siyata.com/role/SegmentedInformationTables 61 false false R62.htm 061 - Disclosure - Segmented Information (Details) - Schedule of Product Information Sheet http://www.siyata.com/role/ScheduleofProductInformationTable Segmented Information (Details) - Schedule of Product Information Details http://www.siyata.com/role/SegmentedInformationTables 62 false false R63.htm 062 - Disclosure - Supplemental Information with Respect to Cash Flows (Details) Sheet http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlowsDetails Supplemental Information with Respect to Cash Flows (Details) Details http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlowsTables 63 false false R64.htm 063 - Disclosure - Supplemental Information with Respect to Cash Flows (Details) - Schedule of Supplemental Information with Respect to Cash Flows Sheet http://www.siyata.com/role/ScheduleofSupplementalInformationwithRespecttoCashFlowsTable Supplemental Information with Respect to Cash Flows (Details) - Schedule of Supplemental Information with Respect to Cash Flows Details http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlowsTables 64 false false R65.htm 064 - Disclosure - Subsequent Events (Details) Sheet http://www.siyata.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.siyata.com/role/SubsequentEvents 65 false false R66.htm 065 - Disclosure - Restatement of Financial Statements (Details) Sheet http://www.siyata.com/role/RestatementofFinancialStatementsDetails Restatement of Financial Statements (Details) Details http://www.siyata.com/role/RestatementofFinancialStatementsTables 66 false false R67.htm 066 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Financial Position Sheet http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Financial Position Details http://www.siyata.com/role/RestatementofFinancialStatementsTables 67 false false R68.htm 067 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Loss and Comprehensive Loss Sheet http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Loss and Comprehensive Loss Details http://www.siyata.com/role/RestatementofFinancialStatementsTables 68 false false R69.htm 068 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) Sheet http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable_Parentheticals Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Loss and Comprehensive Loss (Parentheticals) Details http://www.siyata.com/role/RestatementofFinancialStatementsTables 69 false false R70.htm 069 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Changes in Shareholder???s Equity Sheet http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Changes in Shareholder???s Equity Details http://www.siyata.com/role/RestatementofFinancialStatementsTables 70 false false R71.htm 070 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Cash Flows Sheet http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Cash Flows Details http://www.siyata.com/role/RestatementofFinancialStatementsTables 71 false false R72.htm 071 - Disclosure - Basis of Preparation (Details) - Schedule of Consolidated Financial Statements Sheet http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0 Basis of Preparation (Details) - Schedule of Consolidated Financial Statements Details http://www.siyata.com/role/BasisofPreparationTables 72 false false R73.htm 072 - Disclosure - Bank Loan (Details) Sheet http://www.siyata.com/role/BankLoanDetails Bank Loan (Details) Details http://www.siyata.com/role/BankLoan 73 false false R74.htm 073 - Disclosure - Warrant Liability (Details) - Schedule of the warrant liability Sheet http://www.siyata.com/role/ScheduleofthewarrantliabilityTable Warrant Liability (Details) - Schedule of the warrant liability Details http://www.siyata.com/role/WarrantLiabilityTables 74 false false R75.htm 074 - Disclosure - Warrant Liability (Details) - Schedule of Change in Warrant Fair Value Sheet http://www.siyata.com/role/ScheduleofChangeinWarrantFairValueTable Warrant Liability (Details) - Schedule of Change in Warrant Fair Value Details http://www.siyata.com/role/WarrantLiabilityTables 75 false false R76.htm 075 - Disclosure - Share Capital (Details) - Schedule of Stock Option Activity Sheet http://www.siyata.com/role/ScheduleofStockOptionActivityTable0 Share Capital (Details) - Schedule of Stock Option Activity Details http://www.siyata.com/role/ShareCapitalTables 76 false false R77.htm 076 - Disclosure - Share Capital (Details) - Schedule Stock Options Outstanding Sheet http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0 Share Capital (Details) - Schedule Stock Options Outstanding Details http://www.siyata.com/role/ShareCapitalTables 77 false false R78.htm 077 - Disclosure - Related Party Transactions (Details) - Schedule of Remuneration of Directors and Key Management Personnel Sheet http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable0 Related Party Transactions (Details) - Schedule of Remuneration of Directors and Key Management Personnel Details http://www.siyata.com/role/RelatedPartyTransactionsTables 78 false false R79.htm 078 - Disclosure - Related Party Transactions (Details) - Schedule of Classified Within Profit and Loss Sheet http://www.siyata.com/role/ScheduleofClassifiedWithinProfitandLossTable Related Party Transactions (Details) - Schedule of Classified Within Profit and Loss Details http://www.siyata.com/role/RelatedPartyTransactionsTables 79 false false R80.htm 079 - Disclosure - Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers Sheet http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable0 Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers Details http://www.siyata.com/role/SegmentedInformationTables 80 false false R81.htm 080 - Disclosure - Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information Sheet http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable0 Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information Details http://www.siyata.com/role/SegmentedInformationTables 81 false false R82.htm 081 - Disclosure - Segmented Information (Details) - Schedule of Product Information Sheet http://www.siyata.com/role/ScheduleofProductInformationTable0 Segmented Information (Details) - Schedule of Product Information Details http://www.siyata.com/role/SegmentedInformationTables 82 false false All Reports Book All Reports ea183026-6k_siyata.htm ea183026ex99-1_siyata.htm ea183026ex99-3_siyata.htm ea183026ex99-2_siyata.htm ea183026ex99-4_siyata.htm ea183026ex99-5_siyata.htm syta-20230630.xsd syta-20230630_cal.xml syta-20230630_def.xml syta-20230630_lab.xml syta-20230630_pre.xml http://fasb.org/srt/2022 http://xbrl.sec.gov/dei/2022 https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full true true JSON 120 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ea183026-6k_siyata.htm ea183026ex99-1_siyata.htm ea183026ex99-3_siyata.htm": { "axisCustom": 1, "axisStandard": 17, "baseTaxonomies": { "http://fasb.org/srt/2022": 4, "http://xbrl.sec.gov/dei/2022": 9, "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 988 }, "contextCount": 388, "dts": { "calculationLink": { "local": [ "syta-20230630_cal.xml" ] }, "definitionLink": { "local": [ "syta-20230630_def.xml" ] }, "inline": { "local": [ "ea183026-6k_siyata.htm", "ea183026ex99-1_siyata.htm", "ea183026ex99-3_siyata.htm" ] }, "labelLink": { "local": [ "syta-20230630_lab.xml" ] }, "presentationLink": { "local": [ "syta-20230630_pre.xml" ] }, "schema": { "local": [ "syta-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 585, "entityCount": 1, "hidden": { "http://fasb.org/srt/2022": 1, "http://www.siyata.com/20230630": 124, "http://xbrl.sec.gov/dei/2022": 5, "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full": 108, "total": 238 }, "keyCustom": 190, "keyStandard": 157, "memberCustom": 64, "memberStandard": 12, "nsprefix": "syta", "nsuri": "http://www.siyata.com/20230630", "report": { "R1": { "firstAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "ea183026-6k_siyata.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.siyata.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "b", "p", "div", "body", "html" ], "baseRef": "ea183026-6k_siyata.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c5", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "009 - Statement - Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders\u2019 Equity", "menuCat": "Statements", "order": "10", "role": "http://www.siyata.com/role/ShareholdersEquityType2or30", "shortName": "Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c43", "decimals": "0", "lang": null, "name": "syta:SharesIssuedForDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "010 - Statement - Unaudited Condensed Interim Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "11", "role": "http://www.siyata.com/role/ConsolidatedCashFlow0", "shortName": "Unaudited Condensed Interim Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c32", "decimals": "0", "lang": null, "name": "syta:FairValueChangesOnConvertibleDebenture", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:NatureOfOperationsAndGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Nature of Operations and Going Concern", "menuCat": "Notes", "order": "12", "role": "http://www.siyata.com/role/NatureofOperationsandGoingConcern", "shortName": "Nature of Operations and Going Concern", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:NatureOfOperationsAndGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Basis of Preparation", "menuCat": "Notes", "order": "13", "role": "http://www.siyata.com/role/BasisofPreparation", "shortName": "Basis of Preparation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Trade and Other Receivables", "menuCat": "Notes", "order": "14", "role": "http://www.siyata.com/role/TradeandOtherReceivables", "shortName": "Trade and Other Receivables", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Inventory", "menuCat": "Notes", "order": "15", "role": "http://www.siyata.com/role/Inventory", "shortName": "Inventory", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:ConvertibleDebenturesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Convertible Debentures", "menuCat": "Notes", "order": "16", "role": "http://www.siyata.com/role/ConvertibleDebentures", "shortName": "Convertible Debentures", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:ConvertibleDebenturesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Warrant Liability", "menuCat": "Notes", "order": "17", "role": "http://www.siyata.com/role/WarrantLiability", "shortName": "Warrant Liability", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Share Capital", "menuCat": "Notes", "order": "18", "role": "http://www.siyata.com/role/ShareCapital", "shortName": "Share Capital", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCostOfSalesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Cost of Sales", "menuCat": "Notes", "order": "19", "role": "http://www.siyata.com/role/CostofSales", "shortName": "Cost of Sales", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCostOfSalesExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Cash", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Restated Unaudited Condensed Interim Consolidated Statements of Financial Position", "menuCat": "Statements", "order": "2", "role": "http://www.siyata.com/role/ConsolidatedBalanceSheet", "shortName": "Restated Unaudited Condensed Interim Consolidated Statements of Financial Position", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c1", "decimals": "0", "lang": null, "name": "ifrs-full:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Selling and Marketing Expenses", "menuCat": "Notes", "order": "20", "role": "http://www.siyata.com/role/SellingandMarketingExpenses", "shortName": "Selling and Marketing Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "syta:DisclosureOfGeneralAndAdministrativeExpensesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - General and Administrative Expenses", "menuCat": "Notes", "order": "21", "role": "http://www.siyata.com/role/GeneralandAdministrativeExpenses", "shortName": "General and Administrative Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "syta:DisclosureOfGeneralAndAdministrativeExpensesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Transaction Costs", "menuCat": "Notes", "order": "22", "role": "http://www.siyata.com/role/TransactionCosts", "shortName": "Transaction Costs", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Financial Instruments", "menuCat": "Notes", "order": "23", "role": "http://www.siyata.com/role/FinancialInstruments", "shortName": "Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "24", "role": "http://www.siyata.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:SegmentedInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Segmented Information", "menuCat": "Notes", "order": "25", "role": "http://www.siyata.com/role/SegmentedInformation", "shortName": "Segmented Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:SegmentedInformationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Supplemental Information with Respect to Cash Flows", "menuCat": "Notes", "order": "26", "role": "http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlows", "shortName": "Supplemental Information with Respect to Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "27", "role": "http://www.siyata.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Restatement of Financial Statements", "menuCat": "Notes", "order": "28", "role": "http://www.siyata.com/role/RestatementofFinancialStatements", "shortName": "Restatement of Financial Statements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Bank Loan", "menuCat": "Notes", "order": "29", "role": "http://www.siyata.com/role/BankLoan", "shortName": "Bank Loan", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss", "menuCat": "Statements", "order": "3", "role": "http://www.siyata.com/role/ConsolidatedIncomeStatement", "shortName": "Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:DescriptionOfAccountingPolicyForBasisOfConsolidationAndPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Accounting Policies, by Policy (Policies)", "menuCat": "Policies", "order": "30", "role": "http://www.siyata.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:DescriptionOfAccountingPolicyForBasisOfConsolidationAndPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:DisclosureOfConsolidatedFinancialStatementsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Basis of Preparation (Tables)", "menuCat": "Tables", "order": "31", "role": "http://www.siyata.com/role/BasisofPreparationTables", "shortName": "Basis of Preparation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:DisclosureOfConsolidatedFinancialStatementsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Trade and Other Receivables (Tables)", "menuCat": "Tables", "order": "32", "role": "http://www.siyata.com/role/TradeandOtherReceivablesTables", "shortName": "Trade and Other Receivables (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:DisclosureOfDetailedInformationAboutInventories", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Inventory (Tables)", "menuCat": "Tables", "order": "33", "role": "http://www.siyata.com/role/InventoryTables", "shortName": "Inventory (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:DisclosureOfDetailedInformationAboutInventories", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedFinancialStatementsTableTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Warrant Liability (Tables)", "menuCat": "Tables", "order": "34", "role": "http://www.siyata.com/role/WarrantLiabilityTables", "shortName": "Warrant Liability (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c0", "decimals": null, "lang": "en-US", "name": "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:ScheduleOfTheCompanysStockOptionActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Share Capital (Tables)", "menuCat": "Tables", "order": "35", "role": "http://www.siyata.com/role/ShareCapitalTables", "shortName": "Share Capital (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:ScheduleOfTheCompanysStockOptionActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCostOfSalesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:ScheduleOfCostOfSalesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Cost of Sales (Tables)", "menuCat": "Tables", "order": "36", "role": "http://www.siyata.com/role/CostofSalesTables", "shortName": "Cost of Sales (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCostOfSalesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:ScheduleOfCostOfSalesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:ScheduleOfSellingAndMarketingExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Selling and Marketing Expenses (Tables)", "menuCat": "Tables", "order": "37", "role": "http://www.siyata.com/role/SellingandMarketingExpensesTables", "shortName": "Selling and Marketing Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:ScheduleOfSellingAndMarketingExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "syta:DisclosureOfGeneralAndAdministrativeExpensesTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "syta:DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - General and Administrative Expenses (Tables)", "menuCat": "Tables", "order": "38", "role": "http://www.siyata.com/role/GeneralandAdministrativeExpensesTables", "shortName": "General and Administrative Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "syta:DisclosureOfGeneralAndAdministrativeExpensesTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "syta:DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Related Party Transactions (Tables)", "menuCat": "Tables", "order": "39", "role": "http://www.siyata.com/role/RelatedPartyTransactionsTables", "shortName": "Related Party Transactions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Parentheticals)", "menuCat": "Statements", "order": "4", "role": "http://www.siyata.com/role/ConsolidatedIncomeStatement_Parentheticals", "shortName": "Restated Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R40": { "firstAnchor": { "ancestors": [ "p", "syta:SegmentedInformationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:DisclosureOfGeographicalSegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Segmented Information (Tables)", "menuCat": "Tables", "order": "40", "role": "http://www.siyata.com/role/SegmentedInformationTables", "shortName": "Segmented Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "syta:SegmentedInformationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:DisclosureOfGeographicalSegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:ScheduleOfSupplementalInformationWithRespectToCashFlowsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Supplemental Information with Respect to Cash Flows (Tables)", "menuCat": "Tables", "order": "41", "role": "http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlowsTables", "shortName": "Supplemental Information with Respect to Cash Flows (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": null, "first": true, "lang": "en-US", "name": "syta:ScheduleOfSupplementalInformationWithRespectToCashFlowsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Restatement of Financial Statements (Tables)", "menuCat": "Tables", "order": "42", "role": "http://www.siyata.com/role/RestatementofFinancialStatementsTables", "shortName": "Restatement of Financial Statements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "syta:NatureOfOperationsAndGoingConcernTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ProfitLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Nature of Operations and Going Concern (Details)", "menuCat": "Details", "order": "43", "role": "http://www.siyata.com/role/NatureofOperationsandGoingConcernDetails", "shortName": "Nature of Operations and Going Concern (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "syta:NatureOfOperationsAndGoingConcernTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ProfitLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c59", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:NameOfSubsidiary", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - Basis of Preparation (Details) - Schedule of Consolidated Financial Statements", "menuCat": "Details", "order": "44", "role": "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "shortName": "Basis of Preparation (Details) - Schedule of Consolidated Financial Statements", "subGroupType": "details", "uniqueAnchor": null }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CurrentTradeReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - Trade and Other Receivables (Details) - Schedule of Trade and Other Receivables", "menuCat": "Details", "order": "45", "role": "http://www.siyata.com/role/ScheduleofTradeandOtherReceivablesTable", "shortName": "Trade and Other Receivables (Details) - Schedule of Trade and Other Receivables", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfLoansAndAdvancesToCustomersExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:CurrentTradeReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "syta:DisclosureOfDetailedInformationAboutInventories", "ifrs-full:DisclosureOfInventoriesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:FinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - Inventory (Details) - Schedule of Inventory", "menuCat": "Details", "order": "46", "role": "http://www.siyata.com/role/ScheduleofInventoryTable", "shortName": "Inventory (Details) - Schedule of Inventory", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "syta:DisclosureOfDetailedInformationAboutInventories", "ifrs-full:DisclosureOfInventoriesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:FinishedGoods", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "syta:ConvertibleDebenturesTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c71", "decimals": "0", "first": true, "lang": null, "name": "syta:ConvertiblePromissoryNoteIssued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - Convertible Debentures (Details)", "menuCat": "Details", "order": "47", "role": "http://www.siyata.com/role/ConvertibleDebenturesDetails", "shortName": "Convertible Debentures (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "syta:ConvertibleDebenturesTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c71", "decimals": "0", "first": true, "lang": null, "name": "syta:ConvertiblePromissoryNoteIssued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c74", "decimals": "0", "first": true, "lang": null, "name": "syta:AggregateShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - Warrant Liability (Details)", "menuCat": "Details", "order": "48", "role": "http://www.siyata.com/role/WarrantLiabilityDetails", "shortName": "Warrant Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c74", "decimals": "0", "first": true, "lang": null, "name": "syta:AggregateShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "syta:BalanceWarrantLiability", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "048 - Disclosure - Warrant Liability (Details) - Schedule of the Warrant Liability", "menuCat": "Details", "order": "49", "role": "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable", "shortName": "Warrant Liability (Details) - Schedule of the Warrant Liability", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c104", "decimals": "0", "lang": null, "name": "syta:ExerciseOfThePrefundedWarrants", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c5", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Equity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Restated Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders\u2019 Equity", "menuCat": "Statements", "order": "5", "role": "http://www.siyata.com/role/ShareholdersEquityType2or3", "shortName": "Restated Unaudited Condensed Interim Consolidated Statement of Changes in Shareholders\u2019 Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c23", "decimals": "0", "lang": null, "name": "syta:StockIssuedDuringPeriodValueIssuedOnWarrantExercises", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c115", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesIssued", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "049 - Disclosure - Share Capital (Details)", "menuCat": "Details", "order": "50", "role": "http://www.siyata.com/role/ShareCapitalDetails", "shortName": "Share Capital (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c114", "decimals": "0", "lang": null, "name": "ifrs-full:IncreaseDecreaseInNumberOfSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c139", "decimals": "0", "first": true, "lang": null, "name": "syta:NumberOfOptionsOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "050 - Disclosure - Share Capital (Details) - Schedule of Stock Option Activity", "menuCat": "Details", "order": "51", "role": "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "shortName": "Share Capital (Details) - Schedule of Stock Option Activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c149", "decimals": "0", "lang": null, "name": "syta:NumberOfOptionsGranted", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c175", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "051 - Disclosure - Share Capital (Details) - Schedule Stock Options Outstanding", "menuCat": "Details", "order": "52", "role": "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "shortName": "Share Capital (Details) - Schedule Stock Options Outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c203", "decimals": "INF", "lang": null, "name": "ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "syta:ScheduleOfCostOfSalesTableTextBlock", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "syta:InventoryExpensed", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "052 - Disclosure - Cost of Sales (Details) - Schedule of Cost of Sales", "menuCat": "Details", "order": "53", "role": "http://www.siyata.com/role/ScheduleofCostofSalesTable", "shortName": "Cost of Sales (Details) - Schedule of Cost of Sales", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "syta:ScheduleOfCostOfSalesTableTextBlock", "ifrs-full:DisclosureOfCostOfSalesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "syta:InventoryExpensed", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "syta:SalariesAndRelatedExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "053 - Disclosure - Selling and Marketing Expenses (Details) - Schedule of Selling and Marketing Expenses", "menuCat": "Details", "order": "54", "role": "http://www.siyata.com/role/ScheduleofSellingandMarketingExpensesTable", "shortName": "Selling and Marketing Expenses (Details) - Schedule of Selling and Marketing Expenses", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "syta:SalariesAndRelatedExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "syta:DisclosureOfGeneralAndAdministrativeExpensesTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:WagesAndSalaries", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "054 - Disclosure - General and Administrative Expenses (Details) - Schedule of General and Administrative Eexpenses", "menuCat": "Details", "order": "55", "role": "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable", "shortName": "General and Administrative Expenses (Details) - Schedule of General and Administrative Eexpenses", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "syta:DisclosureOfGeneralAndAdministrativeExpensesTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:WagesAndSalaries", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NoncurrentWarrantLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "055 - Disclosure - Transaction Costs (Details)", "menuCat": "Details", "order": "56", "role": "http://www.siyata.com/role/TransactionCostsDetails", "shortName": "Transaction Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:NoncurrentWarrantLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "syta:OverdueReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "056 - Disclosure - Financial Instruments (Details)", "menuCat": "Details", "order": "57", "role": "http://www.siyata.com/role/FinancialInstrumentsDetails", "shortName": "Financial Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "syta:OverdueReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "057 - Disclosure - Related Party Transactions (Details) - Schedule of Remuneration of Directors and Key Management Personnel", "menuCat": "Details", "order": "58", "role": "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable", "shortName": "Related Party Transactions (Details) - Schedule of Remuneration of Directors and Key Management Personnel", "subGroupType": "details", "uniqueAnchor": null }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c211", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:SalesAndMarketingExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "058 - Disclosure - Related Party Transactions (Details) - Schedule of Classified within Profit and Loss", "menuCat": "Details", "order": "59", "role": "http://www.siyata.com/role/ScheduleofClassifiedwithinProfitandLossTable", "shortName": "Related Party Transactions (Details) - Schedule of Classified within Profit and Loss", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c213", "decimals": "-3", "lang": null, "name": "ifrs-full:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Restated Unaudited Condensed Interim Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://www.siyata.com/role/ConsolidatedCashFlow", "shortName": "Restated Unaudited Condensed Interim Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "0", "lang": null, "name": "syta:FairValueChangesOnDerivatives", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "syta:SegmentedInformationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "syta:ExternalRevenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "059 - Disclosure - Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers", "menuCat": "Details", "order": "60", "role": "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable", "shortName": "Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "syta:SegmentedInformationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "-3", "first": true, "lang": null, "name": "syta:ExternalRevenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c31", "decimals": "-3", "first": true, "lang": null, "name": "syta:LongtermReceivableTotal", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060 - Disclosure - Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information", "menuCat": "Details", "order": "61", "role": "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable", "shortName": "Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c223", "decimals": "-3", "lang": null, "name": "syta:RightOfUseAssetTotal", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "syta:ScheduleOfProductTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c33", "decimals": "-3", "first": true, "lang": null, "name": "syta:RevenueByProduct", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "061 - Disclosure - Segmented Information (Details) - Schedule of Product Information", "menuCat": "Details", "order": "62", "role": "http://www.siyata.com/role/ScheduleofProductInformationTable", "shortName": "Segmented Information (Details) - Schedule of Product Information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c227", "decimals": "-3", "lang": null, "name": "syta:RevenueByProduct", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c18", "decimals": "0", "first": true, "lang": null, "name": "syta:InterestAmountPaid", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "062 - Disclosure - Supplemental Information with Respect to Cash Flows (Details)", "menuCat": "Details", "order": "63", "role": "http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlowsDetails", "shortName": "Supplemental Information with Respect to Cash Flows (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c18", "decimals": "0", "first": true, "lang": null, "name": "syta:InterestAmountPaid", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "syta:ScheduleOfSupplementalInformationWithRespectToCashFlowsTableTextBlock", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "syta:TradeAndOtherReceivablesNonCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "063 - Disclosure - Supplemental Information with Respect to Cash Flows (Details) - Schedule of Supplemental Information with Respect to Cash Flows", "menuCat": "Details", "order": "64", "role": "http://www.siyata.com/role/ScheduleofSupplementalInformationwithRespecttoCashFlowsTable", "shortName": "Supplemental Information with Respect to Cash Flows (Details) - Schedule of Supplemental Information with Respect to Cash Flows", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "syta:ScheduleOfSupplementalInformationWithRespectToCashFlowsTableTextBlock", "ifrs-full:DisclosureOfCashFlowStatementExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c1", "decimals": "0", "first": true, "lang": null, "name": "syta:TradeAndOtherReceivablesNonCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "syta:CashlessRemainingWarrantUnexercised", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "064 - Disclosure - Subsequent Events (Details)", "menuCat": "Details", "order": "65", "role": "http://www.siyata.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c0", "decimals": "2", "lang": null, "name": "syta:CommonSharesPrice", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "syta:ChangeInFairValueExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "065 - Disclosure - Restatement of Financial Statements (Details)", "menuCat": "Details", "order": "66", "role": "http://www.siyata.com/role/RestatementofFinancialStatementsDetails", "shortName": "Restatement of Financial Statements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ifrs-full:DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "syta:ChangeInFairValueExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c235", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "066 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Financial Position", "menuCat": "Details", "order": "67", "role": "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable", "shortName": "Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Financial Position", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c235", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c238", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "067 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Loss and Comprehensive Loss", "menuCat": "Details", "order": "68", "role": "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable", "shortName": "Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Loss and Comprehensive Loss", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "srt:CondensedStatementOfComprehensiveIncomeTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c238", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "068 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Loss and Comprehensive Loss (Parentheticals)", "menuCat": "Details", "order": "69", "role": "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable_Parentheticals", "shortName": "Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Loss and Comprehensive Loss (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c31", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Cash", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "006 - Statement - Unaudited Condensed Interim Consolidated Statements of Financial Position", "menuCat": "Statements", "order": "7", "role": "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "shortName": "Unaudited Condensed Interim Consolidated Statements of Financial Position", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c31", "decimals": "0", "lang": null, "name": "ifrs-full:BankAcceptanceLiabilities", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c241", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:RetainedEarnings", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "069 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Changes in Shareholder\u2019s Equity", "menuCat": "Details", "order": "70", "role": "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable", "shortName": "Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Changes in Shareholder\u2019s Equity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c235", "decimals": "0", "lang": null, "name": "ifrs-full:NoncurrentWarrantLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c238", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ProfitLossFromContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "070 - Disclosure - Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Cash Flows", "menuCat": "Details", "order": "71", "role": "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable", "shortName": "Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Cash Flows", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c238", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:ProfitLossFromContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c59", "decimals": null, "first": true, "lang": "en-US", "name": "ifrs-full:NameOfSubsidiary", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "071 - Disclosure - Basis of Preparation (Details) - Schedule of Consolidated Financial Statements", "menuCat": "Details", "order": "72", "role": "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0", "shortName": "Basis of Preparation (Details) - Schedule of Consolidated Financial Statements", "subGroupType": "details", "uniqueAnchor": null }, "R73": { "firstAnchor": { "ancestors": [ "span", "p", "ifrs-full:DisclosureOfBorrowingsExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c257", "decimals": "2", "first": true, "lang": null, "name": "syta:AdvanceRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "072 - Disclosure - Bank Loan (Details)", "menuCat": "Details", "order": "73", "role": "http://www.siyata.com/role/BankLoanDetails", "shortName": "Bank Loan (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ifrs-full:DisclosureOfBorrowingsExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c257", "decimals": "2", "first": true, "lang": null, "name": "syta:AdvanceRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "syta:BalanceWarrantLiability", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "073 - Disclosure - Warrant Liability (Details) - Schedule of the warrant liability", "menuCat": "Details", "order": "74", "role": "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable", "shortName": "Warrant Liability (Details) - Schedule of the warrant liability", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c263", "decimals": "0", "lang": null, "name": "syta:ExerciseOfThePrefundedWarrants", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:LossesOnChangeInFairValueOfDerivatives", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "074 - Disclosure - Warrant Liability (Details) - Schedule of Change in Warrant Fair Value", "menuCat": "Details", "order": "75", "role": "http://www.siyata.com/role/ScheduleofChangeinWarrantFairValueTable", "shortName": "Warrant Liability (Details) - Schedule of Change in Warrant Fair Value", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "ifrs-full:DisclosureOfFinancialLiabilitiesExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:LossesOnChangeInFairValueOfDerivatives", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c139", "decimals": "0", "first": true, "lang": null, "name": "syta:NumberOfOptionsOutstandingAtBeginning", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "075 - Disclosure - Share Capital (Details) - Schedule of Stock Option Activity", "menuCat": "Details", "order": "76", "role": "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0", "shortName": "Share Capital (Details) - Schedule of Stock Option Activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "b", "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c292", "decimals": "0", "lang": null, "name": "syta:NumberOfOptionsOutstandingAtBeginning", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c157", "decimals": "INF", "first": true, "lang": null, "name": "ifrs-full:NumberOfSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "076 - Disclosure - Share Capital (Details) - Schedule Stock Options Outstanding", "menuCat": "Details", "order": "77", "role": "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0", "shortName": "Share Capital (Details) - Schedule Stock Options Outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c287", "decimals": "INF", "lang": null, "name": "ifrs-full:NumberOfSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "077 - Disclosure - Related Party Transactions (Details) - Schedule of Remuneration of Directors and Key Management Personnel", "menuCat": "Details", "order": "78", "role": "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable0", "shortName": "Related Party Transactions (Details) - Schedule of Remuneration of Directors and Key Management Personnel", "subGroupType": "details", "uniqueAnchor": null }, "R79": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-1_siyata.htm", "contextRef": "c211", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:SalesAndMarketingExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "078 - Disclosure - Related Party Transactions (Details) - Schedule of Classified Within Profit and Loss", "menuCat": "Details", "order": "79", "role": "http://www.siyata.com/role/ScheduleofClassifiedWithinProfitandLossTable", "shortName": "Related Party Transactions (Details) - Schedule of Classified Within Profit and Loss", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c358", "decimals": "-3", "lang": null, "name": "ifrs-full:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c33", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "007 - Statement - Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss", "menuCat": "Statements", "order": "8", "role": "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "shortName": "Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c33", "decimals": "0", "first": true, "lang": null, "name": "ifrs-full:Revenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "syta:SegmentedInformationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c33", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:OtherRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "079 - Disclosure - Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers", "menuCat": "Details", "order": "80", "role": "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable0", "shortName": "Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "syta:SegmentedInformationDisclosureTextBlock", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c33", "decimals": "-3", "first": true, "lang": null, "name": "ifrs-full:OtherRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c31", "decimals": "-3", "first": true, "lang": null, "name": "syta:LongtermReceivableTotal", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080 - Disclosure - Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information", "menuCat": "Details", "order": "81", "role": "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable0", "shortName": "Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c376", "decimals": "-3", "lang": null, "name": "syta:RightOfUseAssetTotal", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "syta:ScheduleOfProductTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c33", "decimals": "-3", "first": true, "lang": null, "name": "syta:RevenueByProduct", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "081 - Disclosure - Segmented Information (Details) - Schedule of Product Information", "menuCat": "Details", "order": "82", "role": "http://www.siyata.com/role/ScheduleofProductInformationTable0", "shortName": "Segmented Information (Details) - Schedule of Product Information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "syta:ScheduleOfProductTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "ea183026ex99-3_siyata.htm", "contextRef": "c382", "decimals": "-3", "lang": null, "name": "syta:RevenueByProduct", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "008 - Statement - Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Parentheticals)", "menuCat": "Statements", "order": "9", "role": "http://www.siyata.com/role/ConsolidatedIncomeStatement_Parentheticals0", "shortName": "Unaudited Condensed Interim Consolidated Statements of Loss and Comprehensive Loss (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": null } }, "segmentCount": 85, "tag": { "country_AU": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AUSTRALIA", "terseLabel": "Australia [Member]" } } }, "localname": "AU", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable", "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable0" ], "xbrltype": "domainItemType" }, "country_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CANADA", "terseLabel": "Canada [Member]", "verboseLabel": "CANADA" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable", "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable0", "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable", "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable0" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "USA\t[Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable", "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable0" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.siyata.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.siyata.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.siyata.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.siyata.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.siyata.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.siyata.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.siyata.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.siyata.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.siyata.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.siyata.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.siyata.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "ifrs-full_AccumulatedOtherComprehensiveIncome": { "auth_ref": [ "r176" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 3.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of accumulated items of income and expense (including reclassification adjustments) that are not recognised in profit or loss as required or permitted by other IFRSs. [Refer: IFRSs [member]; Other comprehensive income]" } }, "en-us": { "role": { "label": "Accumulated other comprehensive income", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r174" ], "lang": { "en": { "role": { "documentation": "This member stands for accumulated other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Accumulated other comprehensive income [member]", "terseLabel": "Accumulated other comprehensive Income (loss)", "verboseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "domainItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "auth_ref": [ "r186" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 14.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for decrease (increase) in inventories", "terseLabel": "Inventory" } } }, "localname": "AdjustmentsForDecreaseIncreaseInInventories", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofSupplementalInformationwithRespecttoCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses": { "auth_ref": [ "r188" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 13.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for decrease (increase) in prepaid expenses", "terseLabel": "Prepaids" } } }, "localname": "AdjustmentsForDecreaseIncreaseInPrepaidExpenses", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofSupplementalInformationwithRespecttoCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": { "auth_ref": [ "r188" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 12.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for decrease (increase) in trade and other receivables", "terseLabel": "Trade receivables" } } }, "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDeferredTaxExpense": { "auth_ref": [ "r188" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 17.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for deferred tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred tax expense (income); Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for deferred tax expense", "terseLabel": "Deferred revenues" } } }, "localname": "AdjustmentsForDeferredTaxExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "auth_ref": [ "r187" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for depreciation and amortisation expense", "terseLabel": "Amortization and depreciation" } } }, "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": { "auth_ref": [ "r186" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 16.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for increase (decrease) in trade accounts payable", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": { "auth_ref": [ "r188" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 15.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for increase (decrease) in trade and other payables", "terseLabel": "Advances to suppliers", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofSupplementalInformationwithRespecttoCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForInterestExpense": { "auth_ref": [ "r188" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 8.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for interest expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Interest expense; Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for interest expense", "terseLabel": "Interest expense, net of repayments" } } }, "localname": "AdjustmentsForInterestExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForSharebasedPayments": { "auth_ref": [ "r187" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 10.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for share-based payments", "terseLabel": "Share based payments" } } }, "localname": "AdjustmentsForSharebasedPayments", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": { "auth_ref": [ "r156", "r187" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 9.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Adjustments for unrealised foreign exchange losses (gains)", "terseLabel": "Foreign exchange" } } }, "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_AdvertisingExpense": { "auth_ref": [ "r175" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from advertising." } }, "en-us": { "role": { "label": "Advertising expense", "terseLabel": "Advertising and marketing" } } }, "localname": "AdvertisingExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofSellingandMarketingExpensesTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Assets": { "auth_ref": [ "r14", "r89", "r90", "r91", "r114", "r117" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BankAcceptanceLiabilities": { "auth_ref": [ "r176" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 1.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of bank acceptances recognised as liabilities." } }, "en-us": { "role": { "label": "Bank acceptance liabilities", "terseLabel": "Bank loan" } } }, "localname": "BankAcceptanceLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_BasicEarningsLossPerShare": { "auth_ref": [ "r50", "r51" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } }, "en-us": { "role": { "label": "Basic earnings (loss) per share", "netLabel": "Basic and diluted loss per share (after the 100-1 reverse split) (in Dollars per share)", "terseLabel": "Basic and diluted loss per share (in Dollars per share)", "verboseLabel": "Basic loss per share (in Dollars per share)" } } }, "localname": "BasicEarningsLossPerShare", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "perShareItemType" }, "ifrs-full_BorrowingsInterestRate": { "auth_ref": [ "r190" ], "lang": { "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Borrowings, interest rate", "terseLabel": "Interest rate" } } }, "localname": "BorrowingsInterestRate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/BankLoanDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_BottomOfRangeMember": { "auth_ref": [ "r93", "r103", "r125", "r158", "r159", "r190" ], "lang": { "en": { "role": { "documentation": "This member stands for the bottom of a range." } }, "en-us": { "role": { "label": "Bottom of range [member]", "terseLabel": "Bottom of range [Member]" } } }, "localname": "BottomOfRangeMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Cash": { "auth_ref": [ "r189" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 1.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } }, "en-us": { "role": { "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashAndCashEquivalents": { "auth_ref": [ "r12", "r64", "r85" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } }, "en-us": { "role": { "label": "Cash and cash equivalents", "periodEndLabel": "Cash, end of year", "periodStartLabel": "Cash, beginning of year" } } }, "localname": "CashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "auth_ref": [ "r59", "r65" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } }, "en-us": { "role": { "label": "Cash flows from (used in) financing activities", "terseLabel": "Net cash from financing activities", "totalLabel": "Net cash from financing activities" } } }, "localname": "CashFlowsFromUsedInFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "auth_ref": [ "r59", "r65" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } }, "en-us": { "role": { "label": "Cash flows from (used in) investing activities", "terseLabel": "Net cash used in investing activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "CashFlowsFromUsedInInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "auth_ref": [ "r59", "r65" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Cash flows from (used in) operating activities", "terseLabel": "Net cash used in operating activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "CashFlowsFromUsedInOperatingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "auth_ref": [ "r40" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Categories of related parties [axis]" } } }, "localname": "CategoriesOfRelatedPartiesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofClassifiedWithinProfitandLossTable", "http://www.siyata.com/role/ScheduleofClassifiedwithinProfitandLossTable", "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfOrdinarySharesAxis": { "auth_ref": [ "r50" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of ordinary shares [axis]" } } }, "localname": "ClassesOfOrdinarySharesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/TransactionCostsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfShareCapitalAxis": { "auth_ref": [ "r22" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Classes of share capital [axis]" } } }, "localname": "ClassesOfShareCapitalAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_ClassesOfShareCapitalMember": { "auth_ref": [ "r22" ], "lang": { "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } }, "en-us": { "role": { "label": "Share capital [member]", "terseLabel": "Share Capital", "verboseLabel": "Share capital" } } }, "localname": "ClassesOfShareCapitalMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30", "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ComponentsOfEquityAxis": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Components of equity [axis]" } } }, "localname": "ComponentsOfEquityAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "stringItemType" }, "ifrs-full_ComprehensiveIncome": { "auth_ref": [ "r2", "r26", "r71", "r74", "r81", "r157" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } }, "en-us": { "role": { "label": "Comprehensive income", "totalLabel": "Comprehensive loss for the year" } } }, "localname": "ComprehensiveIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CostOfSales": { "auth_ref": [ "r0", "r29" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "ifrs-full_GrossProfit", "weight": -1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 2.0, "parentTag": "ifrs-full_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } }, "en-us": { "role": { "label": "Cost of sales", "negatedLabel": "Cost of sales (Note 8)", "negatedNetLabel": "Cost of sales (Note 8)", "negatedTerseLabel": "Cost of sales" } } }, "localname": "CostOfSales", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": { "auth_ref": [ "r44", "r47", "r76", "r78" ], "lang": { "en": { "role": { "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Country of incorporation of subsidiary", "terseLabel": "Place of Incorporation" } } }, "localname": "CountryOfIncorporationOrResidenceOfSubsidiary", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0" ], "xbrltype": "stringItemType" }, "ifrs-full_CreationDateAxis": { "auth_ref": [ "r67", "r68", "r69" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Creation date [axis]" } } }, "localname": "CreationDateAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentAdvancesToSuppliers": { "auth_ref": [ "r175" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 5.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current advances made to suppliers before goods or services are received." } }, "en-us": { "role": { "label": "Current advances to suppliers", "terseLabel": "Advance to suppliers" } } }, "localname": "CurrentAdvancesToSuppliers", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssets": { "auth_ref": [ "r15", "r79", "r157" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 1.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } }, "en-us": { "role": { "label": "Current assets", "terseLabel": "Current total", "totalLabel": "Total current assets" } } }, "localname": "CurrentAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets [abstract]", "terseLabel": "Current" } } }, "localname": "CurrentAssetsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentLeaseLiabilities": { "auth_ref": [ "r95" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 4.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Current lease liabilities", "terseLabel": "Lease obligations" } } }, "localname": "CurrentLeaseLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilities": { "auth_ref": [ "r16", "r80", "r157" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 1.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } }, "en-us": { "role": { "label": "Current liabilities", "terseLabel": "Current liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "CurrentLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities [abstract]", "terseLabel": "Current" } } }, "localname": "CurrentLiabilitiesAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "ifrs-full_CurrentPrepaidExpenses": { "auth_ref": [ "r175" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 3.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } }, "en-us": { "role": { "label": "Current prepaid expenses", "terseLabel": "Prepaid expenses" } } }, "localname": "CurrentPrepaidExpenses", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentTradeReceivables": { "auth_ref": [ "r145", "r146" ], "calculation": { "http://www.siyata.com/role/ScheduleofTradeandOtherReceivablesTable": { "order": 1.0, "parentTag": "ifrs-full_NoncurrentReceivables", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } }, "en-us": { "role": { "label": "Current trade receivables", "terseLabel": "Trade receivables" } } }, "localname": "CurrentTradeReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofTradeandOtherReceivablesTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_CurrentWarrantLiability": { "auth_ref": [ "r176" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 5.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current warrant liabilities. [Refer: Warrant liability]" } }, "en-us": { "role": { "label": "Current warrant liability", "terseLabel": "Warrant liability (Note 6)", "verboseLabel": "Warrant liability" } } }, "localname": "CurrentWarrantLiability", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DefaultFinancialStatementsDateMember": { "auth_ref": [ "r67", "r68", "r69" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Creation date' axis if no other member is used." } }, "en-us": { "role": { "label": "Default financial statements date [member]" } } }, "localname": "DefaultFinancialStatementsDateMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "ifrs-full_DeferredTaxLiabilityAsset": { "auth_ref": [ "r32" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]" } }, "en-us": { "role": { "label": "Deferred tax liability (asset)", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredTaxLiabilityAsset", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofSupplementalInformationwithRespecttoCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DepreciationAndAmortisationExpense": { "auth_ref": [ "r1", "r29", "r86", "r113", "r119", "r142" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 1.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives." } }, "en-us": { "role": { "label": "Depreciation and amortisation expense", "terseLabel": "Amortization and depreciation" } } }, "localname": "DepreciationAndAmortisationExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_DescriptionOfAnyRetirementBenefitPlanTerminationTerms": { "auth_ref": [ "r42" ], "lang": { "en": { "role": { "documentation": "The description of the termination terms of a retirement benefit plan." } }, "en-us": { "role": { "label": "Description of any retirement benefit plan termination terms", "terseLabel": "Option warrant exercisable term description" } } }, "localname": "DescriptionOfAnyRetirementBenefitPlanTerminationTerms", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "auth_ref": [ "r105" ], "lang": { "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } }, "en-us": { "role": { "label": "Expected volatility, share options granted", "terseLabel": "Volatility percentage" } } }, "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfRedesignatedFinancialLiabilities": { "auth_ref": [ "r72", "r126" ], "lang": { "en": { "role": { "documentation": "The description of financial liabilities that have been redesignated on transition to IFRSs. [Refer: IFRSs [member]; Financial liabilities]" } }, "en-us": { "role": { "label": "Description of redesignated financial liabilities", "terseLabel": "Common share transactions, description" } } }, "localname": "DescriptionOfRedesignatedFinancialLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "auth_ref": [ "r105" ], "lang": { "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } }, "en-us": { "role": { "label": "Risk free interest rate, share options granted", "terseLabel": "Risk free rate" } } }, "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_DescriptionOfSignificantEventsAndTransactions": { "auth_ref": [ "r53" ], "lang": { "en": { "role": { "documentation": "The description, in the entity's interim financial report, of events and transactions that are significant to an understanding of the changes in the financial position and performance of the entity since the end of the last annual reporting period. Information disclosed in relation to those events and transactions shall update the relevant information presented in the most recent annual financial report." } }, "en-us": { "role": { "label": "Description of significant events and transactions", "terseLabel": "RSU's transactions description" } } }, "localname": "DescriptionOfSignificantEventsAndTransactions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_DilutedEarningsLossPerShare": { "auth_ref": [ "r50", "r51" ], "lang": { "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } }, "en-us": { "role": { "label": "Diluted earnings (loss) per share", "terseLabel": "Diluted loss per share" } } }, "localname": "DilutedEarningsLossPerShare", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement_Parentheticals", "http://www.siyata.com/role/ConsolidatedIncomeStatement_Parentheticals0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable_Parentheticals" ], "xbrltype": "perShareItemType" }, "ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares": { "auth_ref": [ "r184" ], "lang": { "en": { "role": { "documentation": "The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options." } }, "en-us": { "role": { "label": "Dilutive effect of share options on number of ordinary shares", "terseLabel": "Number of options exercisable" } } }, "localname": "DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "sharesItemType" }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } }, "en-us": { "role": { "label": "Disclosure of basis of preparation of financial statements [text block]", "terseLabel": "BASIS OF PREPARATION" } } }, "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/BasisofPreparation" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfBorrowingsExplanatory": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "The disclosure of borrowings. [Refer: Borrowings]" } }, "en-us": { "role": { "label": "Disclosure of borrowings [text block]", "terseLabel": "BANK LOAN" } } }, "localname": "DisclosureOfBorrowingsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/BankLoan" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfCashFlowStatementExplanatory": { "auth_ref": [ "r66" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for a statement of cash flows." } }, "en-us": { "role": { "label": "Disclosure of cash flow statement [text block]", "terseLabel": "SUPPLEMENTAL INFORMATION WITH RESPECT TO CASH FLOWS" } } }, "localname": "DisclosureOfCashFlowStatementExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlows" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "auth_ref": [ "r22" ], "lang": { "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]" } }, "en-us": { "role": { "label": "Disclosure of classes of share capital [text block]", "terseLabel": "SHARE CAPITAL" } } }, "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapital" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory": { "auth_ref": [ "r49", "r88" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for separate financial statements." } }, "en-us": { "role": { "label": "Disclosure of separate financial statements [text block]", "terseLabel": "RESTATEMENT OF FINANCIAL STATEMENTS" } } }, "localname": "DisclosureOfConsolidatedAndSeparateFinancialStatementsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/RestatementofFinancialStatements" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfCostOfSalesExplanatory": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "The disclosure of the cost of sales. [Refer: Cost of sales]" } }, "en-us": { "role": { "label": "Disclosure of cost of sales [text block]", "terseLabel": "COST OF SALES" } } }, "localname": "DisclosureOfCostOfSalesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/CostofSales" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "The disclosure of derivative financial instruments. [Refer: Derivatives [member]]" } }, "en-us": { "role": { "label": "Disclosure of derivative financial instruments [text block]", "terseLabel": "FINANCIAL INSTRUMENTS" } } }, "localname": "DisclosureOfDerivativeFinancialInstrumentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/FinancialInstruments" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "auth_ref": [ "r31" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } }, "en-us": { "role": { "label": "Disclosure of events after reporting period [text block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory": { "auth_ref": [ "r92" ], "lang": { "en": { "role": { "documentation": "The disclosure of the fair value measurement of liabilities." } }, "en-us": { "role": { "label": "Disclosure of fair value measurement of liabilities [text block]", "terseLabel": "Schedule of Change in Warrant Fair Value" } } }, "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]]" } }, "en-us": { "role": { "label": "Disclosure of fair value of financial instruments [text block]", "terseLabel": "Schedule of Change in Warrant Fair Value" } } }, "localname": "DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]" } }, "en-us": { "role": { "label": "Disclosure of finance income (cost) [text block]", "terseLabel": "TRANSACTION COSTS" } } }, "localname": "DisclosureOfFinanceIncomeExpenseExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/TransactionCosts" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfFinancialLiabilitiesExplanatory": { "auth_ref": [ "r110" ], "lang": { "en": { "role": { "documentation": "The disclosure of financial liabilities. [Refer: Financial liabilities]" } }, "en-us": { "role": { "label": "Disclosure of financial liabilities [text block]", "terseLabel": "WARRANT LIABILITY" } } }, "localname": "DisclosureOfFinancialLiabilitiesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/WarrantLiability" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "The disclosure of general and administrative expenses. [Refer: Administrative expenses]" } }, "en-us": { "role": { "label": "Disclosure of general and administrative expense [text block]", "terseLabel": "SELLING AND MARKETING EXPENSES" } } }, "localname": "DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/SellingandMarketingExpenses" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfInventoriesExplanatory": { "auth_ref": [ "r35" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for inventories." } }, "en-us": { "role": { "label": "Disclosure of inventories [text block]", "terseLabel": "INVENTORY" } } }, "localname": "DisclosureOfInventoriesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/Inventory" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfLoansAndAdvancesToCustomersExplanatory": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "The disclosure of loans and advances to customers. [Refer: Loans and advances to customers]" } }, "en-us": { "role": { "label": "Disclosure of loans and advances to customers [text block]", "terseLabel": "Schedule of Trade and Other Receivables" } } }, "localname": "DisclosureOfLoansAndAdvancesToCustomersExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/TradeandOtherReceivablesTables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "auth_ref": [ "r41" ], "lang": { "en": { "role": { "documentation": "The entire disclosure for related parties." } }, "en-us": { "role": { "label": "Disclosure of related party [text block]", "terseLabel": "RELATED PARTY TRANSACTIONS" } } }, "localname": "DisclosureOfRelatedPartyExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": { "auth_ref": [ "r172" ], "lang": { "en": { "role": { "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]" } }, "en-us": { "role": { "label": "Disclosure of trade and other receivables [text block]", "terseLabel": "TRADE AND OTHER RECEIVABLES" } } }, "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/TradeandOtherReceivables" ], "xbrltype": "textBlockItemType" }, "ifrs-full_DiscountRateUsedInPreviousMeasurementOfFairValueLessCostsOfDisposal": { "auth_ref": [ "r56" ], "lang": { "en": { "role": { "documentation": "The discount rate used in the previous measurement of fair value less costs of disposal." } }, "en-us": { "role": { "label": "Discount rate used in previous measurement of fair value less costs of disposal", "terseLabel": "Stock discount rate" } } }, "localname": "DiscountRateUsedInPreviousMeasurementOfFairValueLessCostsOfDisposal", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_DividendsPaidOtherSharesPerShare": { "auth_ref": [ "r54" ], "lang": { "en": { "role": { "documentation": "The amount of dividends paid per other share." } }, "en-us": { "role": { "label": "Dividends paid, other shares per share", "terseLabel": "Public shares per unit (in Dollars per share)" } } }, "localname": "DividendsPaidOtherSharesPerShare", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "auth_ref": [ "r61", "r62" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Effect of exchange rate changes on cash and cash equivalents", "terseLabel": "Effect of foreign exchange on cash" } } }, "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "auth_ref": [ "r40" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } }, "en-us": { "role": { "label": "Entity's total for related parties [member]" } } }, "localname": "EntitysTotalForRelatedPartiesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_Equity": { "auth_ref": [ "r14", "r18", "r70", "r73", "r89", "r90", "r91" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 2.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } }, "en-us": { "role": { "label": "Equity", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "terseLabel": "Total Shareholders' equity", "totalLabel": "Shareholders\u2019 equity" } } }, "localname": "Equity", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable", "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [abstract]", "terseLabel": "Shareholders\u2019 equity" } } }, "localname": "EquityAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "ifrs-full_EquityAndLiabilities": { "auth_ref": [ "r14" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } }, "en-us": { "role": { "label": "Equity and liabilities", "terseLabel": "Total liabilities and shareholders' equity", "totalLabel": "Total liabilities and shareholders\u2019 equity" } } }, "localname": "EquityAndLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_EquityMember": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } }, "en-us": { "role": { "label": "Equity [member]" } } }, "localname": "EquityMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "domainItemType" }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "auth_ref": [ "r103" ], "lang": { "en": { "role": { "documentation": "The exercise price of outstanding share options." } }, "en-us": { "role": { "label": "Exercise price of outstanding share options", "terseLabel": "Common shares exercisable per share (in Dollars per share)" } } }, "localname": "ExercisePriceOfOutstandingShareOptions2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "auth_ref": [ "r105" ], "lang": { "en": { "role": { "documentation": "The exercise price of share options granted." } }, "en-us": { "role": { "label": "Exercise price, share options granted", "terseLabel": "Exercise price (in Dollars per share)" } } }, "localname": "ExercisePriceShareOptionsGranted2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_ExpectedCreditLossRate": { "auth_ref": [ "r162", "r164" ], "lang": { "en": { "role": { "documentation": "The rate of expected credit losses, calculated as percentage of the gross carrying amount. Expected credit losses are the weighted average of credit losses with the respective risks of a default occurring as the weights." } }, "en-us": { "role": { "label": "Expected credit loss rate", "terseLabel": "Shares reserved percentage" } } }, "localname": "ExpectedCreditLossRate", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "auth_ref": [ "r105" ], "lang": { "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } }, "en-us": { "role": { "label": "Expected dividend as percentage, share options granted", "terseLabel": "Dividend yield percentage" } } }, "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_ExpenseByNatureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses by nature [abstract]", "terseLabel": "EXPENSES" } } }, "localname": "ExpenseByNatureAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "stringItemType" }, "ifrs-full_FairValueOfAcquiredReceivables": { "auth_ref": [ "r107" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The fair value of receivables acquired in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Fair value of acquired receivables", "terseLabel": "Fair value (in Dollars)" } } }, "localname": "FairValueOfAcquiredReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss": { "auth_ref": [ "r111" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]" } }, "en-us": { "role": { "label": "Financial assets at fair value through profit or loss", "terseLabel": "Fair value loss (in Dollars)" } } }, "localname": "FinancialAssetsAtFairValueThroughProfitOrLoss", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinancialLiabilitiesAtFairValue": { "auth_ref": [ "r109" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]" } }, "en-us": { "role": { "label": "Financial liabilities, at fair value", "terseLabel": "Convertible debenture" } } }, "localname": "FinancialLiabilitiesAtFairValue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConvertibleDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_FinishedGoods": { "auth_ref": [ "r147", "r183" ], "calculation": { "http://www.siyata.com/role/ScheduleofInventoryTable": { "order": 1.0, "parentTag": "syta_TotalInventories", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Current finished goods", "terseLabel": "Finished products" } } }, "localname": "FinishedGoods", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives": { "auth_ref": [ "r179" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 2.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } }, "en-us": { "role": { "label": "Gains (losses) on change in fair value of derivatives", "negatedLabel": "Change in fair value of warrant liability" } } }, "localname": "GainsLossesOnChangeInFairValueOfDerivatives", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": { "auth_ref": [ "r7", "r36" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 1.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]" } }, "en-us": { "role": { "label": "Foreign exchange gain (loss)", "negatedLabel": "Foreign exchange" } } }, "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GeneralAndAdministrativeExpense": { "auth_ref": [ "r175" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 4.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to general and administrative activities of the entity." } }, "en-us": { "role": { "label": "General and administrative expense", "netLabel": "General and administrative expense", "terseLabel": "General and administrative (Note 10)", "verboseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofClassifiedwithinProfitandLossTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GeographicalAreasAxis": { "auth_ref": [ "r123", "r150", "r161", "r168" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Geographical areas [axis]" } } }, "localname": "GeographicalAreasAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable0" ], "xbrltype": "stringItemType" }, "ifrs-full_GeographicalAreasMember": { "auth_ref": [ "r123", "r150", "r161", "r168" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } }, "en-us": { "role": { "label": "Geographical areas [member]" } } }, "localname": "GeographicalAreasMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable0" ], "xbrltype": "domainItemType" }, "ifrs-full_GrossLoanCommitments": { "auth_ref": [ "r163" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of contractual undiscounted cash flows for gross commitments to receive a loan." } }, "en-us": { "role": { "label": "Gross loan commitments", "terseLabel": "Loan balance (in Dollars)" } } }, "localname": "GrossLoanCommitments", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/BankLoanDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_GrossProfit": { "auth_ref": [ "r143" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 1.0, "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } }, "en-us": { "role": { "label": "Gross profit", "terseLabel": "Gross Profit", "totalLabel": "Gross profit", "verboseLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_IncomeTaxesPaidRefund": { "auth_ref": [ "r63" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash flows from income taxes paid or refunded." } }, "en-us": { "role": { "label": "Income taxes paid (refund)", "terseLabel": "Income tax" } } }, "localname": "IncomeTaxesPaidRefund", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "auth_ref": [ "r64" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } }, "en-us": { "role": { "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes", "terseLabel": "Change in cash and restricted cash for the period", "totalLabel": "Change in cash for the year", "verboseLabel": "Change in cash and restricted cash for the year" } } }, "localname": "IncreaseDecreaseInCashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in the fair value measurement of the entity's own equity instruments. [Refer: At fair value [member]; Entity's own equity instruments [member]]" } }, "en-us": { "role": { "label": "Increase (decrease) in fair value measurement, entity's own equity instruments", "terseLabel": "Change in fair value" } } }, "localname": "IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable", "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding": { "auth_ref": [ "r21" ], "lang": { "en": { "role": { "documentation": "The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]" } }, "en-us": { "role": { "label": "Increase (decrease) in number of shares outstanding", "terseLabel": "Total outstanding common shares" } } }, "localname": "IncreaseDecreaseInNumberOfSharesOutstanding", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl": { "auth_ref": [ "r5" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity through changes in ownership interests in subsidiaries that do not result in loss of control. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity", "terseLabel": "Shares issued on capital raise", "verboseLabel": "Share issued on capital raise" } } }, "localname": "IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "auth_ref": [ "r5" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } }, "en-us": { "role": { "label": "Increase (decrease) through share-based payment transactions, equity", "terseLabel": "Share based payments" } } }, "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners": { "auth_ref": [ "r173" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase (decrease) in equity resulting from transactions with owners." } }, "en-us": { "role": { "label": "Increase (decrease) through transactions with owners, equity", "terseLabel": "Translation adjustment" } } }, "localname": "IncreaseDecreaseThroughTransactionsWithOwners", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InformationAboutMajorCustomers": { "auth_ref": [ "r124" ], "lang": { "en": { "role": { "documentation": "Information about the entity's major customers and the extent of the entity's reliance on them." } }, "en-us": { "role": { "label": "Information about major customers", "terseLabel": "Active customers, description" } } }, "localname": "InformationAboutMajorCustomers", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r9", "r57" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 5.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } }, "en-us": { "role": { "label": "Intangible assets other than goodwill", "terseLabel": "Intangible assets" } } }, "localname": "IntangibleAssetsOtherThanGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InterestExpenseOnFinancialLiabilitiesDesignatedAtFairValueThroughProfitOrLoss": { "auth_ref": [ "r175" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of interest expense on financial liabilities designated at fair value through profit or loss. [Refer: Interest expense; Financial liabilities at fair value through profit or loss, designated upon initial recognition or subsequently]" } }, "en-us": { "role": { "label": "Interest expense on financial liabilities designated at fair value through profit or loss", "terseLabel": "Fair value changes on derivatives" } } }, "localname": "InterestExpenseOnFinancialLiabilitiesDesignatedAtFairValueThroughProfitOrLoss", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Inventories": { "auth_ref": [ "r10", "r34", "r145" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 4.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Current inventories", "terseLabel": "Inventory (Note 4)", "verboseLabel": "Inventory" } } }, "localname": "Inventories", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_InventoriesTotal": { "auth_ref": [ "r10" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets: (a) held for sale in the ordinary course of business; (b) in the process of production for such sale; or (c) in the form of materials or supplies to be consumed in the production process or in the rendering of services. Inventories encompass goods purchased and held for resale including, for example, merchandise purchased by a retailer and held for resale, or land and other property held for resale. Inventories also encompass finished goods produced, or work in progress being produced, by the entity and include materials and supplies awaiting use in the production process. [Refer: Current finished goods; Current merchandise; Current work in progress; Land]" } }, "en-us": { "role": { "label": "Inventories", "terseLabel": "Inventory (Note 4)" } } }, "localname": "InventoriesTotal", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssueOfEquity": { "auth_ref": [ "r5" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The increase in equity through the issue of equity instruments." } }, "en-us": { "role": { "label": "Issue of equity", "terseLabel": "Warrants reclassified from warrant liability" } } }, "localname": "IssueOfEquity", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapital": { "auth_ref": [ "r148" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 1.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The nominal value of capital issued." } }, "en-us": { "role": { "label": "Issued capital", "periodEndLabel": "Share capital-end of period", "periodStartLabel": "Share capital-Beginning of period", "terseLabel": "Share capital (Note 7)", "verboseLabel": "Share capital" } } }, "localname": "IssuedCapital", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_IssuedCapitalOrdinaryShares": { "auth_ref": [ "r177" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital]" } }, "en-us": { "role": { "label": "Issued capital, ordinary shares", "terseLabel": "Share capital" } } }, "localname": "IssuedCapitalOrdinaryShares", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/RestatementofFinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensation": { "auth_ref": [ "r39" ], "calculation": { "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable0": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation", "totalLabel": "Total" } } }, "localname": "KeyManagementPersonnelCompensation", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable", "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": { "auth_ref": [ "r37" ], "calculation": { "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable": { "order": 1.0, "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0 }, "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable0": { "order": 1.0, "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of post-employment benefits. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation, post-employment benefits", "terseLabel": "Salaries, consulting and directors\u2019 fees" } } }, "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable", "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "auth_ref": [ "r38" ], "calculation": { "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable": { "order": 2.0, "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0 }, "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable0": { "order": 2.0, "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } }, "en-us": { "role": { "label": "Key management personnel compensation, share-based payment", "terseLabel": "Share-based payments" } } }, "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable", "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_Liabilities": { "auth_ref": [ "r14", "r89", "r90", "r91", "r114", "r118" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 1.0, "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } }, "en-us": { "role": { "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_LossesOnChangeInFairValueOfDerivatives": { "auth_ref": [ "r179" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The losses resulting from changes in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } }, "en-us": { "role": { "label": "Losses on change in fair value of derivatives", "negatedLabel": "Change in fair value of warrants exercised" } } }, "localname": "LossesOnChangeInFairValueOfDerivatives", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofChangeinWarrantFairValueTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_MajorCustomersAxis": { "auth_ref": [ "r124" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Major customers [axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_MajorCustomersMember": { "auth_ref": [ "r124" ], "lang": { "en": { "role": { "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used." } }, "en-us": { "role": { "label": "Customers [member]" } } }, "localname": "MajorCustomersMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_NameOfSubsidiary": { "auth_ref": [ "r43", "r46", "r75", "r77" ], "lang": { "en": { "role": { "documentation": "The name of a subsidiary. [Refer: Subsidiaries [member]]" } }, "en-us": { "role": { "label": "Name of subsidiary", "terseLabel": "Name of Subsidiary" } } }, "localname": "NameOfSubsidiary", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0" ], "xbrltype": "stringItemType" }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "auth_ref": [ "r30" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]" } } }, "localname": "NonadjustingEventsAfterReportingPeriodAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_NonadjustingEventsMember": { "auth_ref": [ "r30" ], "lang": { "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } }, "en-us": { "role": { "label": "Non-adjusting events after reporting period [member]" } } }, "localname": "NonadjustingEventsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_NoncurrentLeaseLiabilities": { "auth_ref": [ "r95" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 2.0, "parentTag": "ifrs-full_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Non-current lease liabilities", "terseLabel": "Lease obligations", "verboseLabel": "Lease obligation" } } }, "localname": "NoncurrentLeaseLiabilities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentReceivables": { "auth_ref": [ "r11", "r17" ], "calculation": { "http://www.siyata.com/role/ScheduleofTradeandOtherReceivablesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of non-current trade receivables and non-current other receivables. [Refer: Non-current trade receivables; Other non-current receivables]" } }, "en-us": { "role": { "label": "Trade and other non-current receivables", "totalLabel": "Total" } } }, "localname": "NoncurrentReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofTradeandOtherReceivablesTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NoncurrentWarrantLiability": { "auth_ref": [ "r176" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of non-current warrant liabilities. [Refer: Warrant liability]" } }, "en-us": { "role": { "label": "Non-current warrant liability", "negatedLabel": "loss for the period", "terseLabel": "Warrant liability" } } }, "localname": "NoncurrentWarrantLiability", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable", "http://www.siyata.com/role/TransactionCostsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_NumberOfSharesAuthorised": { "auth_ref": [ "r19" ], "lang": { "en": { "role": { "documentation": "The number of shares authorised." } }, "en-us": { "role": { "label": "Number of shares authorised", "terseLabel": "Warrants to purchase shares" } } }, "localname": "NumberOfSharesAuthorised", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_NumberOfSharesIssued": { "auth_ref": [ "r173" ], "lang": { "en": { "role": { "documentation": "The number of shares issued by the entity." } }, "en-us": { "role": { "label": "Number of shares issued", "terseLabel": "Number of shares issued", "verboseLabel": "Company shares issued" } } }, "localname": "NumberOfSharesIssued", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "ifrs-full_NumberOfSharesOutstanding": { "auth_ref": [ "r21" ], "lang": { "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } }, "en-us": { "role": { "label": "Number of shares outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)", "terseLabel": "Number of options outstanding", "verboseLabel": "Number of shares outstanding" } } }, "localname": "NumberOfSharesOutstanding", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0", "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "ifrs-full_OperatingExpense": { "auth_ref": [ "r179" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 2.0, "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of all operating expenses." } }, "en-us": { "role": { "label": "Operating expense", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OrdinarySharesMember": { "auth_ref": [ "r50", "r178" ], "lang": { "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } }, "en-us": { "role": { "label": "Ordinary shares [member]", "terseLabel": "Option Warrants [Member]", "verboseLabel": "Ordinary shares [member]" } } }, "localname": "OrdinarySharesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/TransactionCostsDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_OtherComprehensiveIncome": { "auth_ref": [ "r4", "r25", "r28", "r84" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } }, "en-us": { "role": { "label": "Other comprehensive income", "terseLabel": "Comprehensive loss for the year", "totalLabel": "Comprehensive loss for the year" } } }, "localname": "OtherComprehensiveIncome", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other comprehensive income [abstract]", "terseLabel": "Other comprehensive income" } } }, "localname": "OtherComprehensiveIncomeAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "stringItemType" }, "ifrs-full_OtherExpenseByNature": { "auth_ref": [ "r29", "r142" ], "calculation": { "http://www.siyata.com/role/ScheduleofCostofSalesTable": { "order": 3.0, "parentTag": "syta_CostOfSalesTotal", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]" } }, "en-us": { "role": { "label": "Other expenses, by nature", "terseLabel": "Other expenses" } } }, "localname": "OtherExpenseByNature", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofCostofSalesTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherOperatingIncomeExpense": { "auth_ref": [ "r179" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 2.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note." } }, "en-us": { "role": { "label": "Other operating income (expense)", "negatedLabel": "Total other expenses", "negatedTotalLabel": "Total other expenses (income)", "totalLabel": "Total other expenses" } } }, "localname": "OtherOperatingIncomeExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherReserves": { "auth_ref": [ "r148" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 2.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]" } }, "en-us": { "role": { "label": "Other reserves", "terseLabel": "Reserves (Note 7)", "verboseLabel": "Reserves" } } }, "localname": "OtherReserves", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_OtherReservesMember": { "auth_ref": [ "r6", "r23" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing reserves within equity, not including retained earnings. It also represents the standard value for the 'Reserves within equity' axis if no other member is used. [Refer: Retained earnings]" } }, "en-us": { "role": { "label": "Other reserves [member]" } } }, "localname": "OtherReservesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "domainItemType" }, "ifrs-full_OtherRevenue": { "auth_ref": [ "r175" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Other revenue", "terseLabel": "Revenue" } } }, "localname": "OtherRevenue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ParValuePerShare": { "auth_ref": [ "r20" ], "lang": { "en": { "role": { "documentation": "The nominal value per share." } }, "en-us": { "role": { "label": "Par value per share", "terseLabel": "Value, per share (in Dollars per share)" } } }, "localname": "ParValuePerShare", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "auth_ref": [ "r155" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } }, "en-us": { "role": { "label": "Payments of lease liabilities, classified as financing activities", "negatedLabel": "Lease payments", "negatedTerseLabel": "Lease payments" } } }, "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PercentageOfEntitysRevenue": { "auth_ref": [ "r191" ], "lang": { "en": { "role": { "documentation": "The percentage of the entity's revenue. [Refer: Revenue]" } }, "en-us": { "role": { "label": "Percentage of entity's revenue", "terseLabel": "Revenue percentage" } } }, "localname": "PercentageOfEntitysRevenue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/FinancialInstrumentsDetails" ], "xbrltype": "percentItemType" }, "ifrs-full_PercentageOfVotingEquityInterestsAcquired": { "auth_ref": [ "r106" ], "lang": { "en": { "role": { "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]" } }, "en-us": { "role": { "label": "Percentage of voting equity interests acquired", "terseLabel": "Ownership" } } }, "localname": "PercentageOfVotingEquityInterestsAcquired", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0" ], "xbrltype": "percentItemType" }, "ifrs-full_PlanAssetsAtFairValue": { "auth_ref": [ "r181" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]" } }, "en-us": { "role": { "label": "Plan assets, at fair value", "terseLabel": "Fair value amount (in Dollars)" } } }, "localname": "PlanAssetsAtFairValue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromExerciseOfOptions": { "auth_ref": [ "r185" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the exercise of options." } }, "en-us": { "role": { "label": "Proceeds from exercise of options", "netLabel": "Gross proceeds (in Dollars)", "terseLabel": "warrants exercised", "verboseLabel": "Proceeds from exercise of options (in Dollars)" } } }, "localname": "ProceedsFromExerciseOfOptions", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable", "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromExerciseOfWarrants": { "auth_ref": [ "r185" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the exercise of share purchase warrants." } }, "en-us": { "role": { "label": "Proceeds from exercise of warrants", "terseLabel": "Exercise of warrants" } } }, "localname": "ProceedsFromExerciseOfWarrants", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromIssueOfOrdinaryShares": { "auth_ref": [ "r185" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]" } }, "en-us": { "role": { "label": "Proceeds from issue of ordinary shares", "terseLabel": "Total amount repaid" } } }, "localname": "ProceedsFromIssueOfOrdinaryShares", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConvertibleDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProceedsFromIssuingShares": { "auth_ref": [ "r154" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The cash inflow from issuing shares." } }, "en-us": { "role": { "label": "Proceeds from issuing shares", "terseLabel": "Proceeds on share issuance, net of share issuance costs" } } }, "localname": "ProceedsFromIssuingShares", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProductsAndServicesAxis": { "auth_ref": [ "r121", "r160" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Products and services [axis]" } } }, "localname": "ProductsAndServicesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofProductInformationTable0" ], "xbrltype": "stringItemType" }, "ifrs-full_ProductsAndServicesMember": { "auth_ref": [ "r121", "r160" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } }, "en-us": { "role": { "label": "Products and services [member]" } } }, "localname": "ProductsAndServicesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofProductInformationTable0" ], "xbrltype": "domainItemType" }, "ifrs-full_ProfessionalFeesExpense": { "auth_ref": [ "r175" ], "calculation": { "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable": { "order": 2.0, "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } }, "en-us": { "role": { "label": "Professional fees expense", "terseLabel": "Professional services" } } }, "localname": "ProfessionalFeesExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLoss": { "auth_ref": [ "r3", "r24", "r60", "r71", "r74", "r114", "r116", "r157", "r167", "r170" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 1.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } }, "en-us": { "role": { "label": "Profit (loss)", "terseLabel": "Net loss", "totalLabel": "Net loss for the year", "verboseLabel": "Net loss for the year" } } }, "localname": "ProfitLoss", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable", "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossBeforeTax": { "auth_ref": [ "r108", "r142", "r143", "r165", "r166" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss) before tax", "terseLabel": "Net loss" } } }, "localname": "ProfitLossBeforeTax", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/NatureofOperationsandGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossFromContinuingOperations": { "auth_ref": [ "r24", "r83", "r114", "r116" ], "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss) from continuing operations", "terseLabel": "Net loss for the year" } } }, "localname": "ProfitLossFromContinuingOperations", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ProfitLossFromOperatingActivities": { "auth_ref": [ "r152", "r179" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 1.0, "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } }, "en-us": { "role": { "label": "Profit (loss) from operating activities", "terseLabel": "Net operating loss", "totalLabel": "Net operating loss" } } }, "localname": "ProfitLossFromOperatingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PropertyPlantAndEquipment": { "auth_ref": [ "r8", "r33" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 4.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period." } }, "en-us": { "role": { "label": "Property, plant and equipment", "terseLabel": "Equipment" } } }, "localname": "PropertyPlantAndEquipment", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": { "auth_ref": [ "r153" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]" } }, "en-us": { "role": { "label": "Purchase of intangible assets, classified as investing activities", "negatedLabel": "Intangible asset additions", "negatedTerseLabel": "Intangible asset additions" } } }, "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "auth_ref": [ "r153" ], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } }, "en-us": { "role": { "label": "Purchase of property, plant and equipment, classified as investing activities", "negatedLabel": "Equipment additions", "negatedTerseLabel": "Equipment additions" } } }, "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RangeAxis": { "auth_ref": [ "r93", "r103", "r125", "r158", "r159", "r190" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Range [axis]" } } }, "localname": "RangeAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesMember": { "auth_ref": [ "r93", "r103", "r125", "r158", "r159", "r190" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } }, "en-us": { "role": { "label": "Ranges [member]" } } }, "localname": "RangesMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": { "auth_ref": [ "r103" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [axis]" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": { "auth_ref": [ "r103" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]" } }, "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [member]" } } }, "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_ResearchAndDevelopmentExpense": { "auth_ref": [ "r58" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 2.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } }, "en-us": { "role": { "label": "Research and development expense", "terseLabel": "Development expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_ReservesWithinEquityAxis": { "auth_ref": [ "r23" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Reserves within equity [axis]" } } }, "localname": "ReservesWithinEquityAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ConsolidatedIncomeStatement_Parentheticals0", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "stringItemType" }, "ifrs-full_RestrictedCashAndCashEquivalents": { "auth_ref": [ "r176" ], "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]" } }, "en-us": { "role": { "label": "Restricted cash and cash equivalents", "periodEndLabel": "Cash and restricted cash, end of period", "periodStartLabel": "Cash and restricted cash, beginning of the period" } } }, "localname": "RestrictedCashAndCashEquivalents", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarnings": { "auth_ref": [ "r148", "r149" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 4.0, "parentTag": "ifrs-full_Equity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Retained earnings", "periodEndLabel": "Deficit-end of period", "periodStartLabel": "Deficit-Beginning of period", "terseLabel": "Deficit" } } }, "localname": "RetainedEarnings", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RetainedEarningsMember": { "auth_ref": [ "r6", "r144" ], "lang": { "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } }, "en-us": { "role": { "label": "Retained earnings [member]", "terseLabel": "Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "domainItemType" }, "ifrs-full_Revenue": { "auth_ref": [ "r27", "r82", "r108", "r112", "r115", "r121", "r122", "r124", "r142", "r143", "r157" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "ifrs-full_GrossProfit", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 1.0, "parentTag": "ifrs-full_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } }, "en-us": { "role": { "label": "Revenue", "terseLabel": "Revenue" } } }, "localname": "Revenue", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RightofuseAssets": { "auth_ref": [ "r96" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 3.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } }, "en-us": { "role": { "label": "Right-of-use assets", "terseLabel": "Right of use assets" } } }, "localname": "RightofuseAssets", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_RoyaltyExpense": { "auth_ref": [ "r179" ], "calculation": { "http://www.siyata.com/role/ScheduleofCostofSalesTable": { "order": 2.0, "parentTag": "syta_CostOfSalesTotal", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense arising from royalties." } }, "en-us": { "role": { "label": "Royalty expense", "terseLabel": "Royalties" } } }, "localname": "RoyaltyExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofCostofSalesTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SalesAndMarketingExpense": { "auth_ref": [ "r179" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 3.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to the marketing and selling of goods or services." } }, "en-us": { "role": { "label": "Sales and marketing expense", "netLabel": "Selling and marketing expenses", "terseLabel": "Selling and marketing (Note 9)", "verboseLabel": "Selling and marketing" } } }, "localname": "SalesAndMarketingExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofClassifiedWithinProfitandLossTable", "http://www.siyata.com/role/ScheduleofClassifiedwithinProfitandLossTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SegmentsAxis": { "auth_ref": [ "r55", "r94", "r114", "r151", "r169" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "localname": "SegmentsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofCostofSalesTable", "http://www.siyata.com/role/ScheduleofSellingandMarketingExpensesTable" ], "xbrltype": "stringItemType" }, "ifrs-full_SegmentsMember": { "auth_ref": [ "r55", "r94", "r120", "r151", "r169" ], "lang": { "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } } }, "localname": "SegmentsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofCostofSalesTable", "http://www.siyata.com/role/ScheduleofSellingandMarketingExpensesTable" ], "xbrltype": "domainItemType" }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r179" ], "calculation": { "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of expense relating to selling, general and administrative activities of the entity." } }, "en-us": { "role": { "label": "Selling, general and administrative expense", "terseLabel": "General and administrative expense", "totalLabel": "Total" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofClassifiedWithinProfitandLossTable", "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_SharebasedPaymentArrangementsMember": { "auth_ref": [ "r104" ], "lang": { "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } }, "en-us": { "role": { "label": "Share-based payment arrangements [member]" } } }, "localname": "SharebasedPaymentArrangementsMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0", "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "auth_ref": [ "r45", "r48", "r87" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Subsidiaries [axis]" } } }, "localname": "SignificantInvestmentsInSubsidiariesAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0" ], "xbrltype": "stringItemType" }, "ifrs-full_SpareParts": { "auth_ref": [ "r183" ], "calculation": { "http://www.siyata.com/role/ScheduleofInventoryTable": { "order": 3.0, "parentTag": "syta_TotalInventories", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "A classification of current inventory representing the amount of interchangeable parts that are kept in an inventory and are used for the repair or replacement of failed parts. [Refer: Inventories]" } }, "en-us": { "role": { "label": "Current spare parts", "terseLabel": "Accessories and spare parts" } } }, "localname": "SpareParts", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityLineItems": { "auth_ref": [], "lang": { "en": { "role": { "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table." } }, "en-us": { "role": { "label": "Statement of changes in equity [line items]" } } }, "localname": "StatementOfChangesInEquityLineItems", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfChangesInEquityTable": { "auth_ref": [ "r6" ], "lang": { "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } }, "en-us": { "role": { "label": "Statement of changes in equity [table]" } } }, "localname": "StatementOfChangesInEquityTable", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "stringItemType" }, "ifrs-full_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "xbrltype": "stringItemType" }, "ifrs-full_TaxEffectOfImpairmentOfGoodwill": { "auth_ref": [ "r180" ], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 5.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount representing the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to impairment of goodwill. [Refer: Accounting profit; Goodwill]" } }, "en-us": { "role": { "label": "Tax effect of impairment of goodwill", "terseLabel": "Inventory impairment" } } }, "localname": "TaxEffectOfImpairmentOfGoodwill", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TopOfRangeMember": { "auth_ref": [ "r93", "r103", "r125", "r158", "r159", "r190" ], "lang": { "en": { "role": { "documentation": "This member stands for top of a range." } }, "en-us": { "role": { "label": "Top of range [member]", "terseLabel": "Top of range [Member]" } } }, "localname": "TopOfRangeMember", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "ifrs-full_TradeAndOtherCurrentPayables": { "auth_ref": [ "r13" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 2.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } }, "en-us": { "role": { "label": "Trade and other current payables", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "TradeAndOtherCurrentPayables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeAndOtherCurrentReceivables": { "auth_ref": [ "r11", "r17" ], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 2.0, "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } }, "en-us": { "role": { "label": "Trade and other current receivables", "terseLabel": "Trade and other receivables (Note 3)", "verboseLabel": "Trade and other receivables" } } }, "localname": "TradeAndOtherCurrentReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TradeReceivables": { "auth_ref": [ "r146" ], "calculation": { "http://www.siyata.com/role/ScheduleofTradeandOtherReceivablesTable": { "order": 2.0, "parentTag": "ifrs-full_NoncurrentReceivables", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "The amount due from customers for goods and services sold." } }, "en-us": { "role": { "label": "Trade receivables", "terseLabel": "Taxes receivable" } } }, "localname": "TradeReceivables", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofTradeandOtherReceivablesTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "auth_ref": [ "r104" ], "lang": { "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } }, "en-us": { "role": { "label": "Types of share-based payment arrangements [axis]" } } }, "localname": "TypesOfSharebasedPaymentArrangementsAxis", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0", "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "ifrs-full_WagesAndSalaries": { "auth_ref": [ "r182" ], "calculation": { "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable": { "order": 1.0, "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en": { "role": { "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]" } }, "en-us": { "role": { "label": "Wages and salaries", "terseLabel": "Salaries and related expenses" } } }, "localname": "WagesAndSalaries", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable" ], "xbrltype": "monetaryItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": { "auth_ref": [ "r102" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement", "terseLabel": "Weighted Average Exercise Price (in Dollars per share)" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r99" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options exercised in share-based payment arrangement", "terseLabel": "Weighted average exercise price, Exercised", "verboseLabel": "Weighted average exercise price, Expired/Cancelled" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": { "auth_ref": [ "r100" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options expired in share-based payment arrangement", "terseLabel": "Weighted average exercise price, Expired/Cancelled" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "auth_ref": [ "r98" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options granted in share-based payment arrangement", "terseLabel": "Weighted average exercise price, Granted" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "auth_ref": [ "r97", "r101" ], "lang": { "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } }, "en-us": { "role": { "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement", "periodEndLabel": "Weighted average exercise price, Outstanding at ending", "periodStartLabel": "Weighted average exercise price, Outstanding at beginning" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ScheduleofStockOptionActivityTable" ], "xbrltype": "perShareItemType" }, "ifrs-full_WeightedAverageShares": { "auth_ref": [ "r52" ], "lang": { "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } }, "en-us": { "role": { "label": "Weighted average number of ordinary shares used in calculating basic earnings per share", "terseLabel": "Weighted average shares (in Shares)", "verboseLabel": "Weighted average shares (after the 100-1 reverse split) (in Shares)" } } }, "localname": "WeightedAverageShares", "nsuri": "https://xbrl.ifrs.org/taxonomy/2022-03-24/ifrs-full", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "sharesItemType" }, "srt_CondensedBalanceSheetStatementTable": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.", "label": "Condensed Balance Sheet Statement [Table]" } } }, "localname": "CondensedBalanceSheetStatementTable", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "stringItemType" }, "srt_CondensedBalanceSheetStatementsCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Balance Sheet Statements, Captions [Line Items]" } } }, "localname": "CondensedBalanceSheetStatementsCaptionsLineItems", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "stringItemType" }, "srt_CondensedFinancialStatementsCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Financial Statements, Captions [Line Items]" } } }, "localname": "CondensedFinancialStatementsCaptionsLineItems", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable", "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable" ], "xbrltype": "stringItemType" }, "srt_CondensedStatementOfComprehensiveIncomeTable": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.", "label": "Condensed Statement of Comprehensive Income [Table]" } } }, "localname": "CondensedStatementOfComprehensiveIncomeTable", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable_Parentheticals" ], "xbrltype": "stringItemType" }, "srt_CondensedStatementOfComprehensiveIncomeTableTextBlock": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed statement of comprehensive income (loss) including, but not limited to, statements of comprehensive income (loss) of consolidated entities and consolidation eliminations.", "label": "Condensed Statement of Comprehensive Income [Table Text Block]", "terseLabel": "Schedule of restated in the Consolidated Statements of Changes in Shareholder\u2019s Equity" } } }, "localname": "CondensedStatementOfComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/RestatementofFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "srt_CondensedStatementOfIncomeCaptionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Condensed Statement of Income Captions [Line Items]" } } }, "localname": "CondensedStatementOfIncomeCaptionsLineItems", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable_Parentheticals" ], "xbrltype": "stringItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Continent of North America.", "label": "North America [Member]", "terseLabel": "North America [Member]" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/BankLoanDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofProductInformationTable" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofProductInformationTable" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period, Adjustment [Member]", "terseLabel": "Adjustment [Member]", "verboseLabel": "Revision of Prior Period, Adjustment [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable_Parentheticals" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable_Parentheticals" ], "xbrltype": "stringItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision.", "label": "Previously Reported [Member]", "terseLabel": "As originally filed [Member]", "verboseLabel": "Previously Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable_Parentheticals" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.", "label": "Condensed Balance Sheet [Table Text Block]", "terseLabel": "Schedule of restated in the Consolidated Statements of Financial Position" } } }, "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/RestatementofFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "srt_ScheduleOfCondensedFinancialStatementsTable": { "auth_ref": [ "r138", "r139", "r140", "r141" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.", "label": "Condensed Financial Statements [Table]" } } }, "localname": "ScheduleOfCondensedFinancialStatementsTable", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable", "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable" ], "xbrltype": "stringItemType" }, "srt_ScheduleOfCondensedFinancialStatementsTableTextBlock": { "auth_ref": [ "r192" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows.", "label": "Condensed Financial Statements [Table Text Block]", "terseLabel": "Schedule of the Warrant Liability", "verboseLabel": "Schedule of restated in the Consolidated Statements of Cash Flows" } } }, "localname": "ScheduleOfCondensedFinancialStatementsTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/RestatementofFinancialStatementsTables", "http://www.siyata.com/role/WarrantLiabilityTables" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r127", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r137" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/BankLoanDetails", "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable", "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable0", "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r127", "r128" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.siyata.com/role/BankLoanDetails", "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable", "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable0", "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable" ], "xbrltype": "stringItemType" }, "syta_AcquisitionPurchasedValue": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Business combinations [member]]", "label": "Acquisition Purchased Value", "terseLabel": "Acquisition of ClearRF" } } }, "localname": "AcquisitionPurchasedValue", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "syta_AdvanceRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of advance rate.", "label": "Advance Rate", "terseLabel": "Advance rate" } } }, "localname": "AdvanceRate", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/BankLoanDetails" ], "xbrltype": "percentItemType" }, "syta_AdvancesToSuppliersNonCurrents": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Advances to suppliers.", "label": "Advances To Suppliers Non Currents", "terseLabel": "Advances to suppliers" } } }, "localname": "AdvancesToSuppliersNonCurrents", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofSupplementalInformationwithRespecttoCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "syta_AgentsOptionsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agents options, description.", "label": "Agents Options Description", "terseLabel": "Agents options, description" } } }, "localname": "AgentsOptionsDescription", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "syta_AgentsOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agents Options Member", "terseLabel": "Agents\u2019 Options [Member]" } } }, "localname": "AgentsOptionsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "domainItemType" }, "syta_AggregateCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Aggregate Common Shares", "terseLabel": "Aggregate common shares (in Shares)" } } }, "localname": "AggregateCommonShares", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "syta_AggregateShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Aggregate Shares", "terseLabel": "Purchase of aggregate shares (in Shares)" } } }, "localname": "AggregateShares", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "syta_AllowanceForDoubtfulAccounts": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ScheduleofTradeandOtherReceivablesTable": { "order": 3.0, "parentTag": "ifrs-full_NoncurrentReceivables", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allowance for doubtful accounts.", "label": "Allowance For Doubtful Accounts", "negatedLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccounts", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofTradeandOtherReceivablesTable" ], "xbrltype": "monetaryItemType" }, "syta_AllowanceForDoubtfulAccountsAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Allowance for doubtful accounts.", "label": "Allowance For Doubtful Accounts Amount", "terseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsAmount", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "syta_AsRestatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "As Restated Member", "terseLabel": "As Restated [Member]" } } }, "localname": "AsRestatedMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable_Parentheticals" ], "xbrltype": "domainItemType" }, "syta_BadDebtExpense": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Bad Debt Expense", "terseLabel": "Bad debt expense (recovered)", "verboseLabel": "Bad debt expense" } } }, "localname": "BadDebtExpense", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "syta_BadDebtrecovered": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 6.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 6.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of Bad debts (recovered).", "label": "Bad Debtrecovered", "terseLabel": "Bad debts (recovered) (Note 3)", "verboseLabel": "Bad debts" } } }, "localname": "BadDebtrecovered", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "syta_BalanceWarrantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of warrant liabilities.", "label": "Balance Warrant Liability", "periodEndLabel": "Balance-Ending of period", "periodStartLabel": "Balance-beginning of period" } } }, "localname": "BalanceWarrantLiability", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable", "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable" ], "xbrltype": "monetaryItemType" }, "syta_BankLoanDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Bank Loan (Details) [Line Items]" } } }, "localname": "BankLoanDetailsLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/BankLoanDetails" ], "xbrltype": "stringItemType" }, "syta_BankLoanDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Bank Loan (Details) [Table]" } } }, "localname": "BankLoanDetailsTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/BankLoanDetails" ], "xbrltype": "stringItemType" }, "syta_BasisofPreparationDetailsScheduleofConsolidatedFinancialStatementsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Line Items]" } } }, "localname": "BasisofPreparationDetailsScheduleofConsolidatedFinancialStatementsLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0" ], "xbrltype": "stringItemType" }, "syta_BasisofPreparationDetailsScheduleofConsolidatedFinancialStatementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis of Preparation (Details) - Schedule of Consolidated Financial Statements [Table]" } } }, "localname": "BasisofPreparationDetailsScheduleofConsolidatedFinancialStatementsTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0" ], "xbrltype": "stringItemType" }, "syta_BlackScholesOptionPricingModelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Black Scholes Option Pricing Model Member", "terseLabel": "Black Scholes Option Pricing Model [Member]" } } }, "localname": "BlackScholesOptionPricingModelMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "syta_BlackScholesValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of black scholes value.", "label": "Black Scholes Value", "terseLabel": "Fair value of placement agent warrants (in Dollars)" } } }, "localname": "BlackScholesValue", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "syta_CEOCFOAndDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CEOCFOAnd Directors Member", "terseLabel": "Companies controlled by the CEO, CFO and Directors [Member]" } } }, "localname": "CEOCFOAndDirectorsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofClassifiedWithinProfitandLossTable", "http://www.siyata.com/role/ScheduleofClassifiedwithinProfitandLossTable" ], "xbrltype": "domainItemType" }, "syta_CashAndRestrictedCashBeginningOfYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash and restricted cash, beginning of year.", "label": "Cash And Restricted Cash Beginning Of Year", "periodStartLabel": "Cash and restricted cash, beginning of year" } } }, "localname": "CashAndRestrictedCashBeginningOfYear", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "syta_CashAndRestrictedCashEndOfYear": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]", "label": "Cash And Restricted Cash End Of Year", "periodEndLabel": "Cash and restricted cash, end of year" } } }, "localname": "CashAndRestrictedCashEndOfYear", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "syta_CashlessRemainingWarrantUnexercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of cashless remaining warrant unexercised.", "label": "Cashless Remaining Warrant Unexercised", "terseLabel": "Cashless Remaining Warrant Unexercised", "verboseLabel": "Cashless warrants" } } }, "localname": "CashlessRemainingWarrantUnexercised", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "syta_CashlessWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cashless warrants exercised.", "label": "Cashless Warrants Exercised", "terseLabel": "Cashless warrants exercised" } } }, "localname": "CashlessWarrantsExercised", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "syta_CellularBoostersAndRelatedAccessoriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cellular Boosters And Related Accessories Member", "terseLabel": "Cellular boosters and related accessories [Member]" } } }, "localname": "CellularBoostersAndRelatedAccessoriesMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofProductInformationTable", "http://www.siyata.com/role/ScheduleofProductInformationTable0" ], "xbrltype": "domainItemType" }, "syta_ChangeInFairValueExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of change in fair value expense.", "label": "Change In Fair Value Expense", "terseLabel": "Change in fair value expense" } } }, "localname": "ChangeInFairValueExpense", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/RestatementofFinancialStatementsDetails" ], "xbrltype": "monetaryItemType" }, "syta_ChangeInFairValueOfConvertibleDebentures": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": -1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 4.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of change in fair value of convertible debenture.", "label": "Change In Fair Value Of Convertible Debentures", "terseLabel": "Change in fair value of convertible promissory note (Note 5)", "verboseLabel": "Change in fair value of convertible promissory note" } } }, "localname": "ChangeInFairValueOfConvertibleDebentures", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "syta_ChangeInFairValueOfOpeningWarrantLiability": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 5.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of opening warrant liability.", "label": "Change In Fair Value Of Opening Warrant Liability", "terseLabel": "Change in fair value of opening warrant liability" } } }, "localname": "ChangeInFairValueOfOpeningWarrantLiability", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "syta_ChangeInFairValueOfWarrantLiability": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of warrant liability.", "label": "Change In Fair Value Of Warrant Liability", "terseLabel": "Change in fair value of warrant liability (Note 6)" } } }, "localname": "ChangeInFairValueOfWarrantLiability", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "syta_ChangeInNonCashWorkingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change In Non Cash Working Capital Abstract", "terseLabel": "Change in non-cash working capital:" } } }, "localname": "ChangeInNonCashWorkingCapitalAbstract", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofSupplementalInformationwithRespecttoCashFlowsTable" ], "xbrltype": "stringItemType" }, "syta_ChangeInNoncashWorkingCapital": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 11.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of change in non-cash working capital.", "label": "Change In Noncash Working Capital", "negatedLabel": "Change in non-cash working capital (Note 15)", "negatedTerseLabel": "Change in non-cash working capital", "terseLabel": "Net Change in non-cash working capital" } } }, "localname": "ChangeInNoncashWorkingCapital", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "syta_ClassOfWarrantOrRightIssuedDuringThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or right issued during the period.", "label": "Class Of Warrant Or Right Issued During The Period", "terseLabel": "Warrants issued (in Shares)" } } }, "localname": "ClassOfWarrantOrRightIssuedDuringThePeriod", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConvertibleDebenturesDetails" ], "xbrltype": "sharesItemType" }, "syta_ClassOfWarrantOrRightissuedDuringThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class Of Warrant Or Rightissued During The Period", "terseLabel": "Holder exercised warrants (in Shares)" } } }, "localname": "ClassOfWarrantOrRightissuedDuringThePeriod", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "syta_ClassOfWarrantOrRightsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class Of Warrant Or Rights Axis", "terseLabel": "Class Of Warrant Or Rights [Axis]" } } }, "localname": "ClassOfWarrantOrRightsAxis", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable", "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable", "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "syta_ClassOfWarrantOrRightsDomainDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ClassOfWarrantOrRightsDomain [Domain]" } } }, "localname": "ClassOfWarrantOrRightsDomainDomain", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable", "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable", "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "syta_ClearRFAcquisitionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Clear RFAcquisition Member", "terseLabel": "ClearRF Acquisition [Member]" } } }, "localname": "ClearRFAcquisitionMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "syta_ClearRFNevadaLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Clear RFNevada Ltd Member", "terseLabel": "ClearRF Nevada Ltd. [Member]" } } }, "localname": "ClearRFNevadaLtdMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0" ], "xbrltype": "domainItemType" }, "syta_CommonShareIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common share issued.", "label": "Common Share Issued", "terseLabel": "Common shares issued (in Shares)" } } }, "localname": "CommonShareIssued", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConvertibleDebenturesDetails" ], "xbrltype": "sharesItemType" }, "syta_CommonSharePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common share per share.", "label": "Common Share Per Share", "terseLabel": "Market price per share (in Dollars per share)" } } }, "localname": "CommonSharePerShare", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "syta_CommonShareTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Share Transactions Member", "terseLabel": "Common Share Transactions [Member]" } } }, "localname": "CommonShareTransactionsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "syta_CommonShareUnitOfWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Common share, unit of warrants.", "label": "Common Share Unit Of Warrants", "terseLabel": "Unit warrants (in Dollars)" } } }, "localname": "CommonShareUnitOfWarrants", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "syta_CommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Shares", "terseLabel": "Common shares (in Shares)" } } }, "localname": "CommonShares", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "syta_CommonSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Shares Member", "terseLabel": "common Shares [Member]", "verboseLabel": "Common Shares [Member]" } } }, "localname": "CommonSharesMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "syta_CommonSharesPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares price.", "label": "Common Shares Price", "terseLabel": "Common shares price (in Dollars per share)" } } }, "localname": "CommonSharesPrice", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "syta_CompanyIssuedPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "he amount of company issued per share.", "label": "Company Issued Per Share", "terseLabel": "Company issued per share (in Dollars per share)" } } }, "localname": "CompanyIssuedPerShare", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "syta_ConsultingAndDirectorFees": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable": { "order": 3.0, "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Consulting and director fees.", "label": "Consulting And Director Fees", "terseLabel": "Consulting and director fees" } } }, "localname": "ConsultingAndDirectorFees", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable" ], "xbrltype": "monetaryItemType" }, "syta_ConvertibleDebenturesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Debentures Text Block", "terseLabel": "CONVERTIBLE DEBENTURES" } } }, "localname": "ConvertibleDebenturesTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConvertibleDebentures" ], "xbrltype": "textBlockItemType" }, "syta_ConvertibleDebtIssuedNetOfRepayments": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 2.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Convertible debt issued, net of repayments.", "label": "Convertible Debt Issued Net Of Repayments", "terseLabel": "Convertible debt issued, net of repayments" } } }, "localname": "ConvertibleDebtIssuedNetOfRepayments", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "syta_ConvertiblePromissoryNoteIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of convertible promissory note issued.", "label": "Convertible Promissory Note Issued", "terseLabel": "Convertible promissory note issued" } } }, "localname": "ConvertiblePromissoryNoteIssued", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConvertibleDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "syta_CostOfSalesTotal": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ScheduleofCostofSalesTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.", "label": "Cost Of Sales Total", "totalLabel": "Total" } } }, "localname": "CostOfSalesTotal", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofCostofSalesTable" ], "xbrltype": "monetaryItemType" }, "syta_CostofSalesDetailsScheduleofCostofSalesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Cost of Sales [Abstract]" } } }, "localname": "CostofSalesDetailsScheduleofCostofSalesLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofCostofSalesTable" ], "xbrltype": "stringItemType" }, "syta_CostofSalesDetailsScheduleofCostofSalesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Sales (Details) - Schedule of Cost of Sales [Table]" } } }, "localname": "CostofSalesDetailsScheduleofCostofSalesTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofCostofSalesTable" ], "xbrltype": "stringItemType" }, "syta_CreditFactoring": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of credit factoring.", "label": "Credit Factoring", "terseLabel": "Credit factoring (in Dollars)" } } }, "localname": "CreditFactoring", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/BankLoanDetails" ], "xbrltype": "monetaryItemType" }, "syta_CurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Abstract", "terseLabel": "Current" } } }, "localname": "CurrentAbstract", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet0" ], "xbrltype": "stringItemType" }, "syta_CurrentAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Abstract0", "terseLabel": "Current" } } }, "localname": "CurrentAbstract0", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet0" ], "xbrltype": "stringItemType" }, "syta_CurrentAbstract1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Abstract1", "terseLabel": "Current" } } }, "localname": "CurrentAbstract1", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "stringItemType" }, "syta_CurrentAbstract2": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Abstract2", "terseLabel": "Current" } } }, "localname": "CurrentAbstract2", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "stringItemType" }, "syta_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Customer One Member", "terseLabel": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/FinancialInstrumentsDetails" ], "xbrltype": "domainItemType" }, "syta_Day1LossFVChangeInWarrantLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Day 1 Loss - FV Change in Warrant Liability.", "label": "Day1 Loss FVChange In Warrant Liability", "terseLabel": "Day 1 Loss - FV Change in Warrant Liability" } } }, "localname": "Day1LossFVChangeInWarrantLiability", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofChangeinWarrantFairValueTable" ], "xbrltype": "monetaryItemType" }, "syta_DeferredRevenuecurrent": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 3.0, "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of deferred revenue.", "label": "Deferred Revenuecurrent", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenuecurrent", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "syta_DeficitAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total deficit amount.", "label": "Deficit Amount", "terseLabel": "Total deficit" } } }, "localname": "DeficitAmount", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/NatureofOperationsandGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "syta_DescriptionOfAccountingPolicyForBasisOfConsolidationAndPresentationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of the entity's material accounting policy basis of consolidation and presentation.", "label": "Description Of Accounting Policy For Basis Of Consolidation And Presentation Text Block", "terseLabel": "Basis of consolidation and presentation" } } }, "localname": "DescriptionOfAccountingPolicyForBasisOfConsolidationAndPresentationTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "syta_DescriptionOfAccountingPolicyForRecentAdoptionsOfAccountingPronouncementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The description of the entity's material accounting policy information for recent adoptions of accounting pronouncements.", "label": "Description Of Accounting Policy For Recent Adoptions Of Accounting Pronouncements Text Block", "terseLabel": "Recent adoptions of accounting pronouncements" } } }, "localname": "DescriptionOfAccountingPolicyForRecentAdoptionsOfAccountingPronouncementsTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "syta_DisclosureOfBasisOfPreparationOfFinancialStatementsTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basis Of Preparation Of Financial Statements Text Block [Abstract]" } } }, "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfBorrowingsTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Bank Loan [Abstract]" } } }, "localname": "DisclosureOfBorrowingsTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfCashFlowStatementTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Information with Respect to Cash Flows [Abstract]" } } }, "localname": "DisclosureOfCashFlowStatementTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfClassesOfShareCapitalTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital [Abstract]" } } }, "localname": "DisclosureOfClassesOfShareCapitalTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfConsolidatedFinancialStatementsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of consolidated financial statements.", "label": "Disclosure Of Consolidated Financial Statements Table Text Block", "terseLabel": "Schedule of Consolidated Financial Statements" } } }, "localname": "DisclosureOfConsolidatedFinancialStatementsTableTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/BasisofPreparationTables" ], "xbrltype": "textBlockItemType" }, "syta_DisclosureOfConvertibleDebenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Debentures [Abstract]" } } }, "localname": "DisclosureOfConvertibleDebenturesAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfCostOfSalesTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost Of Sales Text Block [Abstract]" } } }, "localname": "DisclosureOfCostOfSalesTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfDerivativeFinancialInstrumentsTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Financial Instruments Text Block [Abstract]" } } }, "localname": "DisclosureOfDerivativeFinancialInstrumentsTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfDetailedInformationAboutInventories": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of detailed information about inventories.", "label": "Disclosure Of Detailed Information About Inventories", "terseLabel": "Schedule of Inventory" } } }, "localname": "DisclosureOfDetailedInformationAboutInventories", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/InventoryTables" ], "xbrltype": "textBlockItemType" }, "syta_DisclosureOfEventsAfterReportingPeriodTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "DisclosureOfEventsAfterReportingPeriodTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfFinanceIncomeCostTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Finance Income Cost Text Block Abstract" } } }, "localname": "DisclosureOfFinanceIncomeCostTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfFinancialLiabilitiesTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liability [Abstract]" } } }, "localname": "DisclosureOfFinancialLiabilitiesTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfGeneralAndAdministrativeExpenseTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of General And Administrative Expense Text Block Abstract" } } }, "localname": "DisclosureOfGeneralAndAdministrativeExpenseTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfGeneralAndAdministrativeExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "General and Administrative Expenses [Abstract]" } } }, "localname": "DisclosureOfGeneralAndAdministrativeExpensesAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of general and administrative expenses.", "label": "Disclosure Of General And Administrative Expenses Table Text Block", "terseLabel": "Schedule of General and Administrative Eexpenses" } } }, "localname": "DisclosureOfGeneralAndAdministrativeExpensesTableTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/GeneralandAdministrativeExpensesTables" ], "xbrltype": "textBlockItemType" }, "syta_DisclosureOfGeneralAndAdministrativeExpensesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of General And Administrative Expenses Text Block", "terseLabel": "GENERAL AND ADMINISTRATIVE EXPENSES" } } }, "localname": "DisclosureOfGeneralAndAdministrativeExpensesTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/GeneralandAdministrativeExpenses" ], "xbrltype": "textBlockItemType" }, "syta_DisclosureOfGeographicalSegmentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Geographical Segment Text Block", "terseLabel": "Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers" } } }, "localname": "DisclosureOfGeographicalSegmentTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/SegmentedInformationTables" ], "xbrltype": "textBlockItemType" }, "syta_DisclosureOfInventoriesTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory [Abstract]" } } }, "localname": "DisclosureOfInventoriesTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfRelatedPartyTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Text Block [Abstract]" } } }, "localname": "DisclosureOfRelatedPartyTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfSeparateFinancialStatementsTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Separate Financial Statements Text Block Abstract" } } }, "localname": "DisclosureOfSeparateFinancialStatementsTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DisclosureOfTradeAndOtherReceivablesTextBlockAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Trade and Other Receivables [Abstract]" } } }, "localname": "DisclosureOfTradeAndOtherReceivablesTextBlockAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_DiscountForLackOfMarketabilityPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discount For Lack Of Marketability Percentage", "terseLabel": "Discount for lack of marketability percentage" } } }, "localname": "DiscountForLackOfMarketabilityPercentage", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "percentItemType" }, "syta_DividendYieldPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dividend Yield Percentage", "terseLabel": "Dividend yield percentage" } } }, "localname": "DividendYieldPercentage", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "percentItemType" }, "syta_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_EMEAOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EMEAOne Member", "terseLabel": "EMEA [Member]" } } }, "localname": "EMEAOneMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable", "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable0", "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable0" ], "xbrltype": "domainItemType" }, "syta_EighteenthJanuaryTwoThousandAndTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Eighteenth January Two Thousand And Twenty One Member", "terseLabel": "18-Jan-21 [Member]" } } }, "localname": "EighteenthJanuaryTwoThousandAndTwentyOneMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_ElevenJanuaryTwoThousandAndTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Eleven January Two Thousand And Twenty Two Member", "terseLabel": "11-Jan-22 [Member]" } } }, "localname": "ElevenJanuaryTwoThousandAndTwentyTwoMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_EquipmentTotal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of equipment.", "label": "Equipment Total", "terseLabel": "Equipment total" } } }, "localname": "EquipmentTotal", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable", "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable0" ], "xbrltype": "monetaryItemType" }, "syta_EuropeTheMiddleEastAndAfricaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Europe The Middle East And Africa Member", "terseLabel": "EMEA [Member]" } } }, "localname": "EuropeTheMiddleEastAndAfricaMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable" ], "xbrltype": "domainItemType" }, "syta_ExchangeOfCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exchange Of Common Shares", "terseLabel": "Exchange of common shares (in Shares)" } } }, "localname": "ExchangeOfCommonShares", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "syta_ExercisablePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercisable Per Share", "terseLabel": "Exercisable per share (in Dollars per share)" } } }, "localname": "ExercisablePerShare", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "syta_ExerciseOfThePrefundedWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of exercise of the pre-funded warrants.", "label": "Exercise Of The Prefunded Warrants", "terseLabel": "Exercise of warrants", "verboseLabel": "Change in fair value of warrants exercised" } } }, "localname": "ExerciseOfThePrefundedWarrants", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable", "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable" ], "xbrltype": "monetaryItemType" }, "syta_ExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Price", "terseLabel": "Exercise price (in Dollars per share)", "verboseLabel": "Exercise price per share (in Dollars per share)" } } }, "localname": "ExercisePrice", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "syta_ExercisePriceOfWarrantsOrRight": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the exercise of share purchase warrants.", "label": "Exercise Price Of Warrants Or Right", "terseLabel": "Gross proceeds" } } }, "localname": "ExercisePriceOfWarrantsOrRight", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConvertibleDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "syta_ExercisePricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price per share.", "label": "Exercise Price Per Share", "terseLabel": "Exercise price per share (in Dollars per share)" } } }, "localname": "ExercisePricePerShare", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "syta_ExerciseWarrantIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise warrant issued.", "label": "Exercise Warrant Issued", "terseLabel": "EXercise warrants issued" } } }, "localname": "ExerciseWarrantIssued", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "syta_ExerciseWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise warrants.", "label": "Exercise Warrants", "terseLabel": "Exercise warrants" } } }, "localname": "ExerciseWarrants", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "syta_ExerciseWarrantsTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exercise Warrants Term", "terseLabel": "Exercise warrants term" } } }, "localname": "ExerciseWarrantsTerm", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "syta_ExpectedVolatilityPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expected Volatility Percentage", "terseLabel": "Expected volatility percentage" } } }, "localname": "ExpectedVolatilityPercentage", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "percentItemType" }, "syta_ExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses Abstract", "terseLabel": "EXPENSES" } } }, "localname": "ExpensesAbstract", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "stringItemType" }, "syta_ExpiredTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expired term.", "label": "Expired Terms", "terseLabel": "Expired term" } } }, "localname": "ExpiredTerms", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "dateItemType" }, "syta_ExpiryDate": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expiry Date", "terseLabel": "Expiry date" } } }, "localname": "ExpiryDate", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "stringItemType" }, "syta_ExternalRevenues": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "External revenues.", "label": "External Revenues", "terseLabel": "Revenue" } } }, "localname": "ExternalRevenues", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable" ], "xbrltype": "monetaryItemType" }, "syta_FaceValuerate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Face value.rate.", "label": "Face Valuerate", "terseLabel": "Face value.rate" } } }, "localname": "FaceValuerate", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/BankLoanDetails" ], "xbrltype": "percentItemType" }, "syta_FairValueChangesOnConvertibleDebenture": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of fair value changes on convertible debenture.", "label": "Fair Value Changes On Convertible Debenture", "terseLabel": "Fair value changes on convertible debenture" } } }, "localname": "FairValueChangesOnConvertibleDebenture", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0" ], "xbrltype": "monetaryItemType" }, "syta_FairValueChangesOnDerivative": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 7.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments for fair value losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]", "label": "Fair Value Changes On Derivative", "terseLabel": "Fair value changes on warrant liability" } } }, "localname": "FairValueChangesOnDerivative", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0" ], "xbrltype": "monetaryItemType" }, "syta_FairValueChangesOnDerivatives": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of fair value changes on derivatives.", "label": "Fair Value Changes On Derivatives", "terseLabel": "Fair value changes on derivatives" } } }, "localname": "FairValueChangesOnDerivatives", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "syta_FairValueOfTheOutstandingWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of fair value of the outstanding warrants.", "label": "Fair Value Of The Outstanding Warrants", "terseLabel": "Fair value of the outstanding warrants (in Dollars)" } } }, "localname": "FairValueOfTheOutstandingWarrants", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "syta_FairValueOfTheWaiverWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of fair value of the waiver warrants.", "label": "Fair Value Of The Waiver Warrants", "terseLabel": "Fair value of the waiver warrants (in Dollars)" } } }, "localname": "FairValueOfTheWaiverWarrants", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "syta_FairValueOfTheWarrantsAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of fair value of the warrants.", "label": "Fair Value Of The Warrants Amount", "terseLabel": "Fair value of the warrants amount (in Dollars)" } } }, "localname": "FairValueOfTheWarrantsAmount", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "syta_FairValueOfWarrantsIssuedAsInducement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of warrants issued as inducement.", "label": "Fair Value Of Warrants Issued As Inducement", "terseLabel": "Fair value of warrants issued as inducement" } } }, "localname": "FairValueOfWarrantsIssuedAsInducement", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofChangeinWarrantFairValueTable" ], "xbrltype": "monetaryItemType" }, "syta_FifteenJanuaryTwoThousandNineteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fifteen January Two Thousand Nineteen Member", "terseLabel": "15-Jan-19 [Member]" } } }, "localname": "FifteenJanuaryTwoThousandNineteenMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_FifteenNovemberThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fifteen November Thousand Twenty One Member", "terseLabel": "15-Nov-20 [Member]" } } }, "localname": "FifteenNovemberThousandTwentyOneMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_FifteenNovemberTwoThousandTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fifteen November Two Thousand Twenty Member", "terseLabel": "15-Nov-20 [Member]" } } }, "localname": "FifteenNovemberTwoThousandTwentyMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_FinanceExpense": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": -1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 3.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of finance expense.", "label": "Finance Expense", "terseLabel": "Finance expense", "verboseLabel": "Finance expense (Note 11)" } } }, "localname": "FinanceExpense", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "syta_FinancialInstrumentsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments (Details) [Line Items]" } } }, "localname": "FinancialInstrumentsDetailsLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "syta_FinancialInstrumentsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Instruments (Details) [Table]" } } }, "localname": "FinancialInstrumentsDetailsTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/FinancialInstrumentsDetails" ], "xbrltype": "stringItemType" }, "syta_FinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing Activities Abstract", "terseLabel": "Financing activities" } } }, "localname": "FinancingActivitiesAbstract", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "syta_FinancingActivitiesAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing Activities Abstract0", "terseLabel": "Financing activities" } } }, "localname": "FinancingActivitiesAbstract0", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0" ], "xbrltype": "stringItemType" }, "syta_FinancingActivitiesAbstract1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing Activities Abstract1", "terseLabel": "Financing activities" } } }, "localname": "FinancingActivitiesAbstract1", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "stringItemType" }, "syta_ForeignExchangeAmount": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Foreign exchange loss amount.", "label": "Foreign Exchange Amount", "terseLabel": "Foreign exchange" } } }, "localname": "ForeignExchangeAmount", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "syta_FuturePurhaseConsideration": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Future Purhase Consideration", "negatedLabel": "Acquisition of ClearRF" } } }, "localname": "FuturePurhaseConsideration", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "syta_GrossProceeds": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross proceeds.", "label": "Gross Proceeds", "terseLabel": "Gross proceeds (in Dollars)" } } }, "localname": "GrossProceeds", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "syta_GrossProceedsAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Gross Proceeds Amount", "terseLabel": "Gross proceeds (in Dollars)" } } }, "localname": "GrossProceedsAmount", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "syta_GrossProceedsAmounts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of gross proceeds.", "label": "Gross Proceeds Amounts", "terseLabel": "Gross proceeds amount (in Dollars)" } } }, "localname": "GrossProceedsAmounts", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "syta_ImpairmentOfAccessoriesAndSpareParts": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ScheduleofInventoryTable": { "order": 4.0, "parentTag": "syta_TotalInventories", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Impairment of accessories and spare parts.", "label": "Impairment Of Accessories And Spare Parts", "terseLabel": "Impairment of accessories and spare parts" } } }, "localname": "ImpairmentOfAccessoriesAndSpareParts", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "syta_ImpairmentOfFinishedProducts": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ScheduleofInventoryTable": { "order": 2.0, "parentTag": "syta_TotalInventories", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Impairment of finished products.", "label": "Impairment Of Finished Products", "terseLabel": "Impairment of finished products" } } }, "localname": "ImpairmentOfFinishedProducts", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "syta_ImpairmentOfInventory": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of inventory write-down, also referred to as \u201cinventory impairment,\u201d is an accounting term that recognizes when your inventory's market value falls below the book value, but it still considered sellable.", "label": "Impairment Of Inventory", "terseLabel": "Impairment of inventory" } } }, "localname": "ImpairmentOfInventory", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0" ], "xbrltype": "monetaryItemType" }, "syta_InitialStockPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial Stock Price", "terseLabel": "Initial stock price (in Dollars per share)" } } }, "localname": "InitialStockPrice", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "syta_IntangiblesTotal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill.", "label": "Intangibles Total", "terseLabel": "Intangibles total" } } }, "localname": "IntangiblesTotal", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable", "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable0" ], "xbrltype": "monetaryItemType" }, "syta_InterestAmountPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest amount paid.", "label": "Interest Amount Paid", "terseLabel": "Interest amount paid" } } }, "localname": "InterestAmountPaid", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlowsDetails" ], "xbrltype": "monetaryItemType" }, "syta_InterestExpenseNetOfRepayments": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 6.0, "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest expense, net of repayments.", "label": "Interest Expense Net Of Repayments", "terseLabel": "Interest expense, net of repayments", "verboseLabel": "Fair value changes on opening warrant liability" } } }, "localname": "InterestExpenseNetOfRepayments", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0" ], "xbrltype": "monetaryItemType" }, "syta_InventoryExpensed": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ScheduleofCostofSalesTable": { "order": 1.0, "parentTag": "syta_CostOfSalesTotal", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory expensed.", "label": "Inventory Expensed", "terseLabel": "Inventory expensed" } } }, "localname": "InventoryExpensed", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofCostofSalesTable" ], "xbrltype": "monetaryItemType" }, "syta_InventoryImpairment": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 5.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of Inventory Impairment.", "label": "Inventory Impairment", "terseLabel": "Inventory impairment (Note 4)" } } }, "localname": "InventoryImpairment", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "syta_InvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investing Activities Abstract", "terseLabel": "Investing activities" } } }, "localname": "InvestingActivitiesAbstract", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "syta_InvestingActivitiesAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investing Activities Abstract0", "terseLabel": "Investing activities" } } }, "localname": "InvestingActivitiesAbstract0", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0" ], "xbrltype": "stringItemType" }, "syta_InvestingActivitiesAbstract1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investing Activities Abstract1", "terseLabel": "Investing activities" } } }, "localname": "InvestingActivitiesAbstract1", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "stringItemType" }, "syta_IssuedOfCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issued of common shares.", "label": "Issued Of Common Shares", "terseLabel": "Additional warrants purchased" } } }, "localname": "IssuedOfCommonShares", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "syta_IssuedWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issued warrants exercised.", "label": "Issued Warrants Exercised", "terseLabel": "Warrants exercised (in Shares)" } } }, "localname": "IssuedWarrantsExercised", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "sharesItemType" }, "syta_ItemsNotAffectingCashAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Items Not Affecting Cash Abstract", "terseLabel": "Items not affecting cash:" } } }, "localname": "ItemsNotAffectingCashAbstract", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "syta_ItemsNotAffectingCashAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Items Not Affecting Cash Abstract0", "terseLabel": "Items not affecting cash:" } } }, "localname": "ItemsNotAffectingCashAbstract0", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0" ], "xbrltype": "stringItemType" }, "syta_ItemsNotAffectingCashAbstract1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Items Not Affecting Cash Abstract1", "terseLabel": "Items not affecting cash:" } } }, "localname": "ItemsNotAffectingCashAbstract1", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "stringItemType" }, "syta_January112022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "January112022 Member", "terseLabel": "Warrants Jan 11, 2022 [Member]", "verboseLabel": "January 11, 2022 [Member]" } } }, "localname": "January112022Member", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable", "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable" ], "xbrltype": "domainItemType" }, "syta_January192023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "January192023 Member", "terseLabel": "January 19, 2023 [Member]" } } }, "localname": "January192023Member", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable", "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable" ], "xbrltype": "domainItemType" }, "syta_January192023WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "January192023 Warrants Member", "terseLabel": "January 19, 2023 Warrants [Member]" } } }, "localname": "January192023WarrantsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "syta_LongTermReceivable": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedBalanceSheet0": { "order": 2.0, "parentTag": "ifrs-full_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long term receivable.", "label": "Long Term Receivable", "terseLabel": "Long term receivable" } } }, "localname": "LongTermReceivable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet", "http://www.siyata.com/role/ConsolidatedBalanceSheet0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "monetaryItemType" }, "syta_LongtermReceivableTotal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of long term receivables.", "label": "Longterm Receivable Total", "terseLabel": "Long-term receivable total" } } }, "localname": "LongtermReceivableTotal", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable", "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable0" ], "xbrltype": "monetaryItemType" }, "syta_MarketValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of market value.", "label": "Market Value", "terseLabel": "Market value" } } }, "localname": "MarketValue", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConvertibleDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "syta_MinimalExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimal exercise price.", "label": "Minimal Exercise Price", "terseLabel": "Minimal exercise price (in Dollars per share)" } } }, "localname": "MinimalExercisePrice", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "syta_MonthlyPayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Monthly payments .", "label": "Monthly Payments", "terseLabel": "Monthly payment" } } }, "localname": "MonthlyPayments", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConvertibleDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "syta_NatureOfOperationsAndGoingConcernAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature Of Operations And Going Concern Abstract" } } }, "localname": "NatureOfOperationsAndGoingConcernAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_NatureOfOperationsAndGoingConcernTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature Of Operations And Going Concern Text Block", "terseLabel": "NATURE OF OPERATIONS AND GOING CONCERN" } } }, "localname": "NatureOfOperationsAndGoingConcernTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/NatureofOperationsandGoingConcern" ], "xbrltype": "textBlockItemType" }, "syta_NatureofOperationsandGoingConcernLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Operations and Going Concern [Abstract]" } } }, "localname": "NatureofOperationsandGoingConcernLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/NatureofOperationsandGoingConcern" ], "xbrltype": "stringItemType" }, "syta_NatureofOperationsandGoingConcernTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Operations and Going Concern [Table]" } } }, "localname": "NatureofOperationsandGoingConcernTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/NatureofOperationsandGoingConcern" ], "xbrltype": "stringItemType" }, "syta_NewAccountingPronouncementsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Accounting Pronouncements Policy Text Block.", "label": "New Accounting Pronouncements Policy Text Block", "terseLabel": "Future accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "syta_NineMarchTwoThousandAndTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nine March Two Thousand And Twenty Two Member", "terseLabel": "09-Mar-22 [Member]" } } }, "localname": "NineMarchTwoThousandAndTwentyTwoMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_NineteenJanuaryTwoThousandAndTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nineteen January Two Thousand And Twenty Three Member", "terseLabel": "19-Jan-23 [Member]" } } }, "localname": "NineteenJanuaryTwoThousandAndTwentyThreeMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable" ], "xbrltype": "domainItemType" }, "syta_NonAdjustingEventMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used.", "label": "Non Adjusting Event Member", "terseLabel": "Non adjusting Events [Member]", "verboseLabel": "Non-Adjusting Events After Reporting Period [Member]" } } }, "localname": "NonAdjustingEventMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "syta_November32021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "November32021 Member", "terseLabel": "Warrants Nov 3, 2021 [Member]" } } }, "localname": "November32021Member", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable" ], "xbrltype": "domainItemType" }, "syta_November32021WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "November32021 Warrants Member", "terseLabel": "November 3, 2021 Warrants [Member]" } } }, "localname": "November32021WarrantsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "syta_NumberOfFairValueGranted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Number of fair value granted.", "label": "Number Of Fair Value Granted", "terseLabel": "Fair value granted (in Dollars)" } } }, "localname": "NumberOfFairValueGranted", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "syta_NumberOfFairValueOption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Number of fair value option.", "label": "Number Of Fair Value Option", "terseLabel": "Fair value options (in Dollars)" } } }, "localname": "NumberOfFairValueOption", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "syta_NumberOfOptionsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options exercised.", "label": "Number Of Options Exercised", "terseLabel": "Number of options, Exercised", "verboseLabel": "Number of options, Expired/Cancelled" } } }, "localname": "NumberOfOptionsExercised", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "sharesItemType" }, "syta_NumberOfOptionsGranted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options granted.", "label": "Number Of Options Granted", "terseLabel": "Number of options, Granted" } } }, "localname": "NumberOfOptionsGranted", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "sharesItemType" }, "syta_NumberOfOptionsOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding.", "label": "Number Of Options Outstanding", "periodEndLabel": "Number of options, Outstanding at ending", "periodStartLabel": "Number of options, Outstanding at beginning" } } }, "localname": "NumberOfOptionsOutstanding", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofStockOptionActivityTable" ], "xbrltype": "sharesItemType" }, "syta_NumberOfOptionsOutstandingAtBeginning": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options, outstanding.", "label": "Number Of Options Outstanding At Beginning", "periodEndLabel": "Number of options, Outstanding at ending", "periodStartLabel": "Number of options, Outstanding at beginning" } } }, "localname": "NumberOfOptionsOutstandingAtBeginning", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "sharesItemType" }, "syta_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Stock Options, Expired.", "label": "Number Of Share Options Expired In Sharebased Payment Arrangement1", "terseLabel": "Number of options, Expired/Cancelled" } } }, "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement1", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "sharesItemType" }, "syta_NumberOfShareOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of share outstanding.", "label": "Number Of Share Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "NumberOfShareOutstanding", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "sharesItemType" }, "syta_NumberOfSharesIssued1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued 1.", "label": "Number Of Shares Issued1", "terseLabel": "Shares issued pre-funded units" } } }, "localname": "NumberOfSharesIssued1", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "syta_October122022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "October122022 Member", "terseLabel": "October 12, 2022 [Member]" } } }, "localname": "October122022Member", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable", "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable" ], "xbrltype": "domainItemType" }, "syta_October122022WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "October122022 Warrants Member", "terseLabel": "October 12, 2022 Warrants [Member]" } } }, "localname": "October122022WarrantsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "syta_OfficeAndGeneralExpense": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable": { "order": 5.0, "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Office and general expense.", "label": "Office And General Expense", "terseLabel": "Office and general" } } }, "localname": "OfficeAndGeneralExpense", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable" ], "xbrltype": "monetaryItemType" }, "syta_OneJanuaryTwoThousandAndTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One January Two Thousand And Twenty Member", "terseLabel": "01-Jan-20 [Member]" } } }, "localname": "OneJanuaryTwoThousandAndTwentyMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_OneJanuaryTwoThousandAndTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One January Two Thousand And Twenty Two Member", "terseLabel": "01-Jan-22 [Member]" } } }, "localname": "OneJanuaryTwoThousandAndTwentyTwoMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_OperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Activities Abstract", "terseLabel": "Operating activities" } } }, "localname": "OperatingActivitiesAbstract", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "syta_OperatingActivitiesAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Activities Abstract0", "terseLabel": "Operating activities" } } }, "localname": "OperatingActivitiesAbstract0", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow0" ], "xbrltype": "stringItemType" }, "syta_OperatingActivitiesAbstract1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Activities Abstract1", "terseLabel": "Operating activities" } } }, "localname": "OperatingActivitiesAbstract1", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "stringItemType" }, "syta_OperatingActivitiesofTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of operating activities of transaction costs.", "label": "Operating Activitiesof Transaction Costs", "terseLabel": "Transaction costs" } } }, "localname": "OperatingActivitiesofTransactionCosts", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "syta_OptionWarrantsIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Option Warrants Issued", "terseLabel": "Option warrants issued (in Dollars)" } } }, "localname": "OptionWarrantsIssued", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "syta_OptionWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Option Warrants Member", "terseLabel": "Over-Allotment Option [Member]" } } }, "localname": "OptionWarrantsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "syta_OtherExpensecAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Expensec Abstract", "terseLabel": "OTHER EXPENSES" } } }, "localname": "OtherExpensecAbstract", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "syta_OutstandingWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding Warrant", "terseLabel": "Outstanding warrants (in Shares)" } } }, "localname": "OutstandingWarrant", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "syta_OutstandingWarrantsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Outstanding Warrants Per Share", "terseLabel": "Outstanding warrants per share (in Dollars per share)" } } }, "localname": "OutstandingWarrantsPerShare", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "syta_OverallotmentOptionPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Overallotment Option Per Share", "terseLabel": "Over-allotment option per share (in Dollars per share)" } } }, "localname": "OverallotmentOptionPerShare", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "syta_OverdueReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Overdue receivables.", "label": "Overdue Receivables", "terseLabel": "Overdue receivables" } } }, "localname": "OverdueReceivables", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/FinancialInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "syta_PaymentsToKeyManagementPersonnelAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payments To Key Management Personnel Abstract", "terseLabel": "Payments to key management personnel:" } } }, "localname": "PaymentsToKeyManagementPersonnelAbstract", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable" ], "xbrltype": "stringItemType" }, "syta_PaymentsToKeyManagementPersonnelAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payments To Key Management Personnel Abstract0", "terseLabel": "Payments to key management personnel:" } } }, "localname": "PaymentsToKeyManagementPersonnelAbstract0", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofRemunerationofDirectorsandKeyManagementPersonnelTable0" ], "xbrltype": "stringItemType" }, "syta_PercentageOfGrossProceeds": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of gross proceeds to the lender.", "label": "Percentage Of Gross Proceeds", "terseLabel": "Percentage of gross proceeds" } } }, "localname": "PercentageOfGrossProceeds", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConvertibleDebenturesDetails" ], "xbrltype": "percentItemType" }, "syta_PlacementAgentWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Placement Agent Warrants Member", "terseLabel": "Placement Agent Warrants [Member]", "verboseLabel": "Placement Agent Warrants [member]" } } }, "localname": "PlacementAgentWarrantsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "syta_PreFundedUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Pre Funded Units Member", "terseLabel": "Pre-Funded Units [member]" } } }, "localname": "PreFundedUnitsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "syta_PrefundedWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prefunded Warrants", "terseLabel": "Pre-funded warrants (in Shares)" } } }, "localname": "PrefundedWarrants", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "syta_PrefundedWarrantsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Pre-funded warrants exercised.", "label": "Prefunded Warrants Exercised", "terseLabel": "Pre-funded warrants exercised" } } }, "localname": "PrefundedWarrantsExercised", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "monetaryItemType" }, "syta_PrefundedWarrantsExercisedShare": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Pre-funded warrants exercised.", "label": "Prefunded Warrants Exercised Share", "terseLabel": "Issued pre-funded units (in Dollars)" } } }, "localname": "PrefundedWarrantsExercisedShare", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "syta_PrefundedWarrantsExercisedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre-funded warrants exercised shares.", "label": "Prefunded Warrants Exercised Shares", "terseLabel": "Pre-funded warrants exercised (in Shares)" } } }, "localname": "PrefundedWarrantsExercisedShares", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "sharesItemType" }, "syta_PrefundedWarrantsIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Pre-funded warrants issued.", "label": "Prefunded Warrants Issued", "terseLabel": "Pre-funded warrants issued (in Dollars)" } } }, "localname": "PrefundedWarrantsIssued", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "syta_PrincipaLAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The disclosure of principal amount.", "label": "Principa LAmount", "terseLabel": "Principal amount" } } }, "localname": "PrincipaLAmount", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConvertibleDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "syta_PrincipalRepayments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Principal repayments.", "label": "Principal Repayments", "terseLabel": "Principal repayment (in Dollars)" } } }, "localname": "PrincipalRepayments", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "syta_PriorToExerciseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prior To Exercise Member", "terseLabel": "Prior to Exercise [Member]" } } }, "localname": "PriorToExerciseMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "syta_ProceedsFromInducementWarrantsIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Proceeds from Inducement warrants issued.", "label": "Proceeds From Inducement Warrants Issued", "terseLabel": "Proceeds from Inducement warrants issued" } } }, "localname": "ProceedsFromInducementWarrantsIssued", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable" ], "xbrltype": "monetaryItemType" }, "syta_ProceedsFromIssuedOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Proceeds from issued of warrants.", "label": "Proceeds From Issued Of Warrants", "terseLabel": "Warrants issued" } } }, "localname": "ProceedsFromIssuedOfWarrants", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "syta_ProceedsFromToBorrowingsClassifiedAsFinancingActivities": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 1.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]", "label": "Proceeds From To Borrowings Classified As Financing Activities", "terseLabel": "Bank loan" } } }, "localname": "ProceedsFromToBorrowingsClassifiedAsFinancingActivities", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "syta_ProceedsOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Proceeds of Warrants.", "label": "Proceeds Of Warrants", "terseLabel": "Proceeds received on warrants (in Dollars)" } } }, "localname": "ProceedsOfWarrants", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "monetaryItemType" }, "syta_QueensgateResourcesCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Queensgate Resources Corp Member", "terseLabel": "Queensgate Resources Corp. [Member]" } } }, "localname": "QueensgateResourcesCorpMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0" ], "xbrltype": "domainItemType" }, "syta_QueensgateResourcesUSCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Queensgate Resources USCorp Member", "terseLabel": "Queensgate Resources US Corp. [Member]" } } }, "localname": "QueensgateResourcesUSCorpMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0" ], "xbrltype": "domainItemType" }, "syta_RedemptionOfPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption of price per share.", "label": "Redemption Of Price Per Share", "terseLabel": "Pre-funded per unit (in Dollars per share)" } } }, "localname": "RedemptionOfPricePerShare", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "syta_RegulatoryAndFilingFees": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable": { "order": 6.0, "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Regulatory and filing fees.", "label": "Regulatory And Filing Fees", "terseLabel": "Regulatory and filing fees" } } }, "localname": "RegulatoryAndFilingFees", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable" ], "xbrltype": "monetaryItemType" }, "syta_RelatedPartyTransactionsDetailsScheduleofClassifiedWithinProfitandLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) - Schedule of Classified Within Profit and Loss [Line Items]" } } }, "localname": "RelatedPartyTransactionsDetailsScheduleofClassifiedWithinProfitandLossLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofClassifiedWithinProfitandLossTable" ], "xbrltype": "stringItemType" }, "syta_RelatedPartyTransactionsDetailsScheduleofClassifiedWithinProfitandLossTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) - Schedule of Classified Within Profit and Loss [Table]" } } }, "localname": "RelatedPartyTransactionsDetailsScheduleofClassifiedWithinProfitandLossTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofClassifiedWithinProfitandLossTable" ], "xbrltype": "stringItemType" }, "syta_RelatedPartyTransactionsDetailsScheduleofClassifiedwithinProfitandLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) - Schedule of Classified within Profit and Loss [Line Items]" } } }, "localname": "RelatedPartyTransactionsDetailsScheduleofClassifiedwithinProfitandLossLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofClassifiedwithinProfitandLossTable" ], "xbrltype": "stringItemType" }, "syta_RelatedPartyTransactionsDetailsScheduleofClassifiedwithinProfitandLossTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) - Schedule of Classified within Profit and Loss [Table]" } } }, "localname": "RelatedPartyTransactionsDetailsScheduleofClassifiedwithinProfitandLossTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofClassifiedwithinProfitandLossTable" ], "xbrltype": "stringItemType" }, "syta_RemainingContractualLifeyears": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options.", "label": "Remaining Contractual Lifeyears", "terseLabel": "Remaining contractual life (years)" } } }, "localname": "RemainingContractualLifeyears", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "durationItemType" }, "syta_ReservesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Reserves Member", "terseLabel": "Reserves" } } }, "localname": "ReservesMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "domainItemType" }, "syta_RestatedUnauditedCondensedInterimConsolidatedStatementOfChangesInShareholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restated Unaudited Condensed Interim Consolidated Statement Of Changes In Shareholders Equity Abstract" } } }, "localname": "RestatedUnauditedCondensedInterimConsolidatedStatementOfChangesInShareholdersEquityAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_RestatementofFinancialStatementsDetailsScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Changes in Shareholder\u2019s Equity [Line Items]" } } }, "localname": "RestatementofFinancialStatementsDetailsScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable" ], "xbrltype": "stringItemType" }, "syta_RestatementofFinancialStatementsDetailsScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restatement of Financial Statements (Details) - Schedule of restated in the Consolidated Statements of Changes in Shareholder\u2019s Equity [Table]" } } }, "localname": "RestatementofFinancialStatementsDetailsScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofChangesinShareholdersEquityTable" ], "xbrltype": "stringItemType" }, "syta_RestrictedShareUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restricted Share Units Member", "terseLabel": "Restricted Share Units [Member]" } } }, "localname": "RestrictedShareUnitsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "domainItemType" }, "syta_RevenueByProduct": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Revenue by product", "label": "Revenue By Product", "terseLabel": "Revenue by product" } } }, "localname": "RevenueByProduct", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofProductInformationTable", "http://www.siyata.com/role/ScheduleofProductInformationTable0" ], "xbrltype": "monetaryItemType" }, "syta_ReverseStockSplitShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse stock split shares.", "label": "Reverse Stock Split Shares", "terseLabel": "Reverse Stock Split Shares", "verboseLabel": "Reverse stock split shares" } } }, "localname": "ReverseStockSplitShares", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "syta_RightOfUseAssetTotal": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount from right of use assets.", "label": "Right Of Use Asset Total", "terseLabel": "Right of use asset total" } } }, "localname": "RightOfUseAssetTotal", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable", "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable0" ], "xbrltype": "monetaryItemType" }, "syta_RiskfreeRatePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of Risk-free rate.", "label": "Riskfree Rate Percentage", "terseLabel": "Risk-free rate percentage" } } }, "localname": "RiskfreeRatePercentage", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "percentItemType" }, "syta_RuggedDevicesAndRelatedAccessoriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Rugged Devices And Related Accessories Member", "terseLabel": "Rugged devices and related accessories [Member]" } } }, "localname": "RuggedDevicesAndRelatedAccessoriesMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofProductInformationTable", "http://www.siyata.com/role/ScheduleofProductInformationTable0" ], "xbrltype": "domainItemType" }, "syta_SalariesAndRelatedExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Salaries and related expenses.", "label": "Salaries And Related Expenses", "terseLabel": "Salaries and related expenses" } } }, "localname": "SalariesAndRelatedExpenses", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofSellingandMarketingExpensesTable" ], "xbrltype": "monetaryItemType" }, "syta_SaleOfPublicShareUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of Sale of public share units as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Sale Of Public Share Units", "terseLabel": "Sale to public share units" } } }, "localname": "SaleOfPublicShareUnits", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "syta_ScheduleOfChangeInWarrantFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Change In Warrant Fair Value Abstract" } } }, "localname": "ScheduleOfChangeInWarrantFairValueAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfClassifiedWithinProfitAndLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Classified Within Profit And Loss Abstract" } } }, "localname": "ScheduleOfClassifiedWithinProfitAndLossAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfConsolidatedFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Consolidated Financial Statements Abstract" } } }, "localname": "ScheduleOfConsolidatedFinancialStatementsAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfCostOfSalesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Cost Of Sales Abstract" } } }, "localname": "ScheduleOfCostOfSalesAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfCostOfSalesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Cost of Sales.", "label": "Schedule Of Cost Of Sales Table Text Block", "terseLabel": "Schedule of Cost of Sales" } } }, "localname": "ScheduleOfCostOfSalesTableTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/CostofSalesTables" ], "xbrltype": "textBlockItemType" }, "syta_ScheduleOfGeneralAndAdministrativeEexpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of General And Administrative Eexpenses Abstract" } } }, "localname": "ScheduleOfGeneralAndAdministrativeEexpensesAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfGeographicalSegmentsSegmentRevenueIsBasedOnTheGeographicalLocationOfTheCustomersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Geographical Segments Segment Revenue Is Based On The Geographical Location Of The Customers Abstract" } } }, "localname": "ScheduleOfGeographicalSegmentsSegmentRevenueIsBasedOnTheGeographicalLocationOfTheCustomersAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfInventoryAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of inventory [Abstract]" } } }, "localname": "ScheduleOfInventoryAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfNonCurrentAssetGeographicAreaInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Non Current Asset Geographic Area Information Abstract" } } }, "localname": "ScheduleOfNonCurrentAssetGeographicAreaInformationAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfNonCurrentAssetGeographicAreaInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Non Current Asset Geographic Area Information Table Text Block", "terseLabel": "Schedule of Non Current Asset Geographic Area Information" } } }, "localname": "ScheduleOfNonCurrentAssetGeographicAreaInformationTableTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/SegmentedInformationTables" ], "xbrltype": "textBlockItemType" }, "syta_ScheduleOfOtherRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Other Related Party Transactions Table Text Block", "terseLabel": "Schedule of Classified within Profit and Loss", "verboseLabel": "Schedule of Classified Within Profit and Loss" } } }, "localname": "ScheduleOfOtherRelatedPartyTransactionsTableTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "syta_ScheduleOfProductInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Product Information Abstract" } } }, "localname": "ScheduleOfProductInformationAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfProductTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Product Table Text Block", "terseLabel": "Schedule of Product Information" } } }, "localname": "ScheduleOfProductTableTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/SegmentedInformationTables" ], "xbrltype": "textBlockItemType" }, "syta_ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Remuneration Of Directors And Key Management Personnel Abstract" } } }, "localname": "ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Remuneration Of Directors And Key Management Personnel Table Text Block", "terseLabel": "Schedule of Remuneration of Directors and Key Management Personnel" } } }, "localname": "ScheduleOfRemunerationOfDirectorsAndKeyManagementPersonnelTableTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "syta_ScheduleOfRestatedInTheConsolidatedStatementsOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Restated In The Consolidated Statements Of Cash Flows Abstract" } } }, "localname": "ScheduleOfRestatedInTheConsolidatedStatementsOfCashFlowsAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfRestatedInTheConsolidatedStatementsOfChangesInShareholderSEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Restated In The Consolidated Statements Of Changes In Shareholder SEquity Abstract" } } }, "localname": "ScheduleOfRestatedInTheConsolidatedStatementsOfChangesInShareholderSEquityAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfRestatedInTheConsolidatedStatementsOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Restated In The Consolidated Statements Of Financial Position Abstract" } } }, "localname": "ScheduleOfRestatedInTheConsolidatedStatementsOfFinancialPositionAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfRestatedInTheConsolidatedStatementsOfLossAndComprehensiveLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Restated In The Consolidated Statements Of Loss And Comprehensive Loss Abstract" } } }, "localname": "ScheduleOfRestatedInTheConsolidatedStatementsOfLossAndComprehensiveLossAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfSellingAndMarketingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Selling And Marketing Expenses Abstract" } } }, "localname": "ScheduleOfSellingAndMarketingExpensesAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfSellingAndMarketingExpensesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Selling and Marketing Expenses.", "label": "Schedule Of Selling And Marketing Expenses Table Text Block", "terseLabel": "Schedule of Selling and Marketing Expenses" } } }, "localname": "ScheduleOfSellingAndMarketingExpensesTableTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/SellingandMarketingExpensesTables" ], "xbrltype": "textBlockItemType" }, "syta_ScheduleOfShareholdersEquityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of shareholder's Equity.", "label": "Schedule Of Shareholders Equity Table Text Block", "terseLabel": "Schedule of restated in the Consolidated Statements of Changes in Shareholder\u2019s Equity" } } }, "localname": "ScheduleOfShareholdersEquityTableTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/RestatementofFinancialStatementsTables" ], "xbrltype": "textBlockItemType" }, "syta_ScheduleOfStockOptionActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of stock option activity [Abstract]" } } }, "localname": "ScheduleOfStockOptionActivityAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfStockOptionsOutstandingTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of stock options outstanding", "label": "Schedule Of Stock Options Outstanding Table Text Block", "terseLabel": "Schedule Stock Options Outstanding" } } }, "localname": "ScheduleOfStockOptionsOutstandingTableTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "syta_ScheduleOfSupplementalInformationWithRespectToCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Supplemental Information With Respect To Cash Flows Abstract" } } }, "localname": "ScheduleOfSupplementalInformationWithRespectToCashFlowsAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfSupplementalInformationWithRespectToCashFlowsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Supplemental Information With Respect To Cash Flows Table Text Block", "terseLabel": "Schedule of Supplemental Information with Respect to Cash Flows" } } }, "localname": "ScheduleOfSupplementalInformationWithRespectToCashFlowsTableTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/SupplementalInformationwithRespecttoCashFlowsTables" ], "xbrltype": "textBlockItemType" }, "syta_ScheduleOfTheCompanysStockOptionActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The disclosure of the Company\u2019s stock option activity.", "label": "Schedule Of The Companys Stock Option Activity Table Text Block", "terseLabel": "Schedule of Stock Option Activity" } } }, "localname": "ScheduleOfTheCompanysStockOptionActivityTableTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalTables" ], "xbrltype": "textBlockItemType" }, "syta_ScheduleOfTheWarrantLiabilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of The Warrant Liability Abstract" } } }, "localname": "ScheduleOfTheWarrantLiabilityAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleOfTradeAndOtherReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Trade And Other Receivables Abstract" } } }, "localname": "ScheduleOfTradeAndOtherReceivablesAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_ScheduleStockOptionsOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule stock options outstanding [Abstract]" } } }, "localname": "ScheduleStockOptionsOutstandingAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_SecondJanuaryTwoThousandAndTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Second January Two Thousand And Twenty One Member", "terseLabel": "02-Jan-21 [Member]" } } }, "localname": "SecondJanuaryTwoThousandAndTwentyOneMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_SecondJanuaryTwoThousandTwentyOneOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Second January Two Thousand Twenty One One Member", "terseLabel": "02-Jan-21 [Member]" } } }, "localname": "SecondJanuaryTwoThousandTwentyOneOneMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_SegmentedInformationDetailsScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers [Line Items]" } } }, "localname": "SegmentedInformationDetailsScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable", "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable0" ], "xbrltype": "stringItemType" }, "syta_SegmentedInformationDetailsScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segmented Information (Details) - Schedule of Geographical Segments, Segment Revenue Is Based on the Geographical Location of the Customers [Table]" } } }, "localname": "SegmentedInformationDetailsScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable", "http://www.siyata.com/role/ScheduleofGeographicalSegmentsSegmentRevenueIsBasedontheGeographicalLocationoftheCustomersTable0" ], "xbrltype": "stringItemType" }, "syta_SegmentedInformationDetailsScheduleofNonCurrentAssetGeographicAreaInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information [Line Items]" } } }, "localname": "SegmentedInformationDetailsScheduleofNonCurrentAssetGeographicAreaInformationLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable", "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable0" ], "xbrltype": "stringItemType" }, "syta_SegmentedInformationDetailsScheduleofNonCurrentAssetGeographicAreaInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segmented Information (Details) - Schedule of Non Current Asset Geographic Area Information [Table]" } } }, "localname": "SegmentedInformationDetailsScheduleofNonCurrentAssetGeographicAreaInformationTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable", "http://www.siyata.com/role/ScheduleofNonCurrentAssetGeographicAreaInformationTable0" ], "xbrltype": "stringItemType" }, "syta_SegmentedInformationDetailsScheduleofProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segmented Information (Details) - Schedule of Product Information [Line Items]" } } }, "localname": "SegmentedInformationDetailsScheduleofProductInformationLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofProductInformationTable", "http://www.siyata.com/role/ScheduleofProductInformationTable0" ], "xbrltype": "stringItemType" }, "syta_SegmentedInformationDetailsScheduleofProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segmented Information (Details) - Schedule of Product Information [Table]" } } }, "localname": "SegmentedInformationDetailsScheduleofProductInformationTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofProductInformationTable", "http://www.siyata.com/role/ScheduleofProductInformationTable0" ], "xbrltype": "stringItemType" }, "syta_SegmentedInformationDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segmented Information Disclosure [Abstract]" } } }, "localname": "SegmentedInformationDisclosureAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_SegmentedInformationDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segmented Information Disclosure Text Block", "terseLabel": "SEGMENTED INFORMATION" } } }, "localname": "SegmentedInformationDisclosureTextBlock", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/SegmentedInformation" ], "xbrltype": "textBlockItemType" }, "syta_SellingandMarketingExpensesDetailsScheduleofSellingandMarketingExpensesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of selling and marketing expenses [Abstract]" } } }, "localname": "SellingandMarketingExpensesDetailsScheduleofSellingandMarketingExpensesLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofSellingandMarketingExpensesTable" ], "xbrltype": "stringItemType" }, "syta_SellingandMarketingExpensesDetailsScheduleofSellingandMarketingExpensesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Selling and Marketing Expenses (Details) - Schedule of Selling and Marketing Expenses [Table]" } } }, "localname": "SellingandMarketingExpensesDetailsScheduleofSellingandMarketingExpensesTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofSellingandMarketingExpensesTable" ], "xbrltype": "stringItemType" }, "syta_SellingandMarketingExpensesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Selling and Marketing Expenses [Abstract]" } } }, "localname": "SellingandMarketingExpensesLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/SellingandMarketingExpenses" ], "xbrltype": "stringItemType" }, "syta_SellingandMarketingExpensesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Selling and Marketing Expenses [Table]" } } }, "localname": "SellingandMarketingExpensesTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/SellingandMarketingExpenses" ], "xbrltype": "stringItemType" }, "syta_ShareCapitalDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital (Details) [Line Items]" } } }, "localname": "ShareCapitalDetailsLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "syta_ShareCapitalDetailsScheduleStockOptionsOutstandingLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital (Details) - Schedule Stock Options Outstanding [Line Items]" } } }, "localname": "ShareCapitalDetailsScheduleStockOptionsOutstandingLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "stringItemType" }, "syta_ShareCapitalDetailsScheduleStockOptionsOutstandingTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital (Details) - Schedule Stock Options Outstanding [Table]" } } }, "localname": "ShareCapitalDetailsScheduleStockOptionsOutstandingTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "stringItemType" }, "syta_ShareCapitalDetailsScheduleofStockOptionActivityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital (Details) - Schedule of Stock Option Activity [Line Items]" } } }, "localname": "ShareCapitalDetailsScheduleofStockOptionActivityLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "stringItemType" }, "syta_ShareCapitalDetailsScheduleofStockOptionActivityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital (Details) - Schedule of Stock Option Activity [Table]" } } }, "localname": "ShareCapitalDetailsScheduleofStockOptionActivityTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "stringItemType" }, "syta_ShareCapitalDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Capital (Details) [Table]" } } }, "localname": "ShareCapitalDetailsTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "syta_ShareIssuanceCostsOnCapitalRaise": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share Issuance costs on capital raise.", "label": "Share Issuance Costs On Capital Raise", "terseLabel": "Share issuance costs on capital raise" } } }, "localname": "ShareIssuanceCostsOnCapitalRaise", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "monetaryItemType" }, "syta_ShareIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of common shares.", "label": "Share Issued", "terseLabel": "Share issued" } } }, "localname": "ShareIssued", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "syta_ShareIssuedForDebt": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for debt.", "label": "Share Issued For Debt", "terseLabel": "Shares issued for debt (in Shares)" } } }, "localname": "ShareIssuedForDebt", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "sharesItemType" }, "syta_ShareIssuedOnCapitalRaise": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share issued on capital raise.", "label": "Share Issued On Capital Raise", "terseLabel": "Shares issued on capital raise (in Shares)", "verboseLabel": "Share issued on capital raise (in Shares)" } } }, "localname": "ShareIssuedOnCapitalRaise", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "sharesItemType" }, "syta_SharePrices": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Prices", "terseLabel": "Share price (in Dollars per share)" } } }, "localname": "SharePrices", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "syta_SharePurchaseWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Purchase Warrants Member", "terseLabel": "Share Purchase Warrants [Member]" } } }, "localname": "SharePurchaseWarrantsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable" ], "xbrltype": "domainItemType" }, "syta_ShareholderRelations": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable": { "order": 7.0, "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Shareholder relations.", "label": "Shareholder Relations", "terseLabel": "Shareholder relations" } } }, "localname": "ShareholderRelations", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable" ], "xbrltype": "monetaryItemType" }, "syta_ShareholdersEquityAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders Equity Abstract0", "terseLabel": "Shareholders' equity" } } }, "localname": "ShareholdersEquityAbstract0", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofFinancialPositionTable" ], "xbrltype": "stringItemType" }, "syta_SharesIssuedForDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Shares issued for debt.", "label": "Shares Issued For Debt", "terseLabel": "Shares issued for debt" } } }, "localname": "SharesIssuedForDebt", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "monetaryItemType" }, "syta_SharesIssuedOnAcquisition": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued on acquisition.", "label": "Shares Issued On Acquisition", "terseLabel": "Shares issued on acquisition of ClearRF (in Shares)" } } }, "localname": "SharesIssuedOnAcquisition", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "sharesItemType" }, "syta_SharesIssuedOnWarrantExercises": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued on warrant exercises.", "label": "Shares Issued On Warrant Exercises", "terseLabel": "Issue of common shares for warrants (in Shares)" } } }, "localname": "SharesIssuedOnWarrantExercises", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "syta_SharesIssuedToVendor": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued to vendor.", "label": "Shares Issued To Vendor", "terseLabel": "Shares issued to vendor" } } }, "localname": "SharesIssuedToVendor", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "syta_SharesbasedPayments": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 7.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 7.0, "parentTag": "ifrs-full_OperatingExpense", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of Share-based payments.", "label": "Sharesbased Payments", "terseLabel": "Share-based payments (Note 7)", "verboseLabel": "Share-based payments" } } }, "localname": "SharesbasedPayments", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "syta_SignifiMobileIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Signifi Mobile Inc [Member]", "label": "Signifi Mobile Inc Member", "terseLabel": "Signifi Mobile Inc. [Member]" } } }, "localname": "SignifiMobileIncMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0" ], "xbrltype": "domainItemType" }, "syta_SiyataMobileCanadaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Siyata Mobile Canada Inc Member", "terseLabel": "Siyata Mobile (Canada) Inc. [Member]" } } }, "localname": "SiyataMobileCanadaIncMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0" ], "xbrltype": "domainItemType" }, "syta_SiyataMobileIsraelLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Siyata Mobile Israel Ltd Member", "terseLabel": "Siyata Mobile Israel Ltd. [Member]" } } }, "localname": "SiyataMobileIsraelLtdMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable", "http://www.siyata.com/role/ScheduleofConsolidatedFinancialStatementsTable0" ], "xbrltype": "domainItemType" }, "syta_StockIssuedDuringPeriodValueIssuedForAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued on acquisition.", "label": "Stock Issued During Period Value Issued For Acquisition", "terseLabel": "Shares issued on acquisition of ClearRF" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForAcquisition", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3", "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "monetaryItemType" }, "syta_StockIssuedDuringPeriodValueIssuedOnWarrantExercises": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value issued on warrant exercises.", "label": "Stock Issued During Period Value Issued On Warrant Exercises", "terseLabel": "Issue of common shares for warrants" } } }, "localname": "StockIssuedDuringPeriodValueIssuedOnWarrantExercises", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "syta_StockIssuedDuringValueOfWarrantsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of warrants exercised.", "label": "Stock Issued During Value Of Warrants Exercised", "terseLabel": "Warrants exercised" } } }, "localname": "StockIssuedDuringValueOfWarrantsExercised", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "monetaryItemType" }, "syta_StockOptionExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock option exercise price per common share.", "label": "Stock Option Exercise Price", "terseLabel": "Stock option exercise price (in Dollars per share)" } } }, "localname": "StockOptionExercisePrice", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "syta_StockOptionIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of stock option issued.", "label": "Stock Option Issued", "terseLabel": "Stock option issued" } } }, "localname": "StockOptionIssued", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "syta_StockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock Options Member", "terseLabel": "Stock Options [Member]", "verboseLabel": "Stock Options [member]" } } }, "localname": "StockOptionsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0", "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "syta_StockPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Stock Price", "terseLabel": "Initial stock price (in Dollars per share)" } } }, "localname": "StockPrice", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "syta_StockSharesConverted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock shares converted.", "label": "Stock Shares Converted", "terseLabel": "Stock Shares Converted", "verboseLabel": "Stock shares converted" } } }, "localname": "StockSharesConverted", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "syta_StrikeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A strike price is a set price at which a derivative contract can be bought or sold when it is exercised. For call options, the strike price is where the security can be bought by the option holder; for put options, the strike price is the price at which the security can be sold.", "label": "Strike Rate", "terseLabel": "Strike rate (in Dollars per share)" } } }, "localname": "StrikeRate", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "syta_StrikeRatePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Strike Rate Per Share", "terseLabel": "Strike rate (in Dollars per share)" } } }, "localname": "StrikeRatePerShare", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "perShareItemType" }, "syta_SubsequentEventsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Line Items]" } } }, "localname": "SubsequentEventsDetailsLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "syta_SubsequentEventsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "localname": "SubsequentEventsDetailsTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "syta_ThirteenthAprilTwoThousandAndTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Thirteenth April Two Thousand And Twenty Two Member", "terseLabel": "13-Apr-22 [Member]" } } }, "localname": "ThirteenthAprilTwoThousandAndTwentyTwoMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_ThirteenthAprilTwoThousandAndTwentyTwoOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Thirteenth April Two Thousand And Twenty Two One Member", "terseLabel": "01-Apr-22 [Member]" } } }, "localname": "ThirteenthAprilTwoThousandAndTwentyTwoOneMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_ThirtyfirstDecemberTwoThousandTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Thirtyfirst December Two Thousand Twenty Member", "terseLabel": "31-Dec-20 [Member]" } } }, "localname": "ThirtyfirstDecemberTwoThousandTwentyMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_TotalChangeInWarrantFairValueJanuary12023June302023": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total change in warrant fair value.", "label": "Total Change In Warrant Fair Value January12023 June302023", "totalLabel": "Total change in warrant fair value January 1, 2023-June 30, 2023" } } }, "localname": "TotalChangeInWarrantFairValueJanuary12023June302023", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofChangeinWarrantFairValueTable" ], "xbrltype": "monetaryItemType" }, "syta_TotalInventories": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ScheduleofInventoryTable": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of total inventories.", "label": "Total Inventories", "totalLabel": "Total" } } }, "localname": "TotalInventories", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofInventoryTable" ], "xbrltype": "monetaryItemType" }, "syta_TotalNumberOfLiabilityWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of total number of liability warrants.", "label": "Total Number Of Liability Warrants", "terseLabel": "Warrants issued" } } }, "localname": "TotalNumberOfLiabilityWarrants", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable", "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable" ], "xbrltype": "monetaryItemType" }, "syta_TotalSellingMarketingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Selling and Marketing Expenses.", "label": "Total Selling Marketing Expenses", "terseLabel": "Total" } } }, "localname": "TotalSellingMarketingExpenses", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofSellingandMarketingExpensesTable" ], "xbrltype": "monetaryItemType" }, "syta_TradeAndOtherReceivablesNonCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Trade and other receivables.", "label": "Trade And Other Receivables Non Current", "terseLabel": "Trade and other receivables" } } }, "localname": "TradeAndOtherReceivablesNonCurrent", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofSupplementalInformationwithRespecttoCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "syta_TransactionCost": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 5.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction costs.", "label": "Transaction Cost", "terseLabel": "Transaction costs (Note 11)", "verboseLabel": "Transaction costs (Note 12)" } } }, "localname": "TransactionCost", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "syta_TransactionCosts": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 6.0, "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction costs.", "label": "Transaction Costs", "terseLabel": "Transaction costs" } } }, "localname": "TransactionCosts", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/TransactionCostsDetails" ], "xbrltype": "monetaryItemType" }, "syta_TransactionCostsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Transaction Costs (Details) [Line Items]" } } }, "localname": "TransactionCostsDetailsLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/TransactionCostsDetails" ], "xbrltype": "stringItemType" }, "syta_TransactionCostsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Transaction Costs (Details) [Table]" } } }, "localname": "TransactionCostsDetailsTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/TransactionCostsDetails" ], "xbrltype": "stringItemType" }, "syta_TransactionCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Transaction Costs [Abstract]" } } }, "localname": "TransactionCostsLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/TransactionCosts" ], "xbrltype": "stringItemType" }, "syta_TransactionCostsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Transaction Costs [Table]" } } }, "localname": "TransactionCostsTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/TransactionCosts" ], "xbrltype": "stringItemType" }, "syta_TransactionsCost": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 }, "http://www.siyata.com/role/ConsolidatedCashFlow0": { "order": 4.0, "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of transactions Cost.", "label": "Transactions Cost", "terseLabel": "Transaction costs" } } }, "localname": "TransactionsCost", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedCashFlow", "http://www.siyata.com/role/ConsolidatedCashFlow0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "syta_TransactionsDuringTheYearDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transactions during the year description.", "label": "Transactions During The Year Description", "terseLabel": "Transactions during the year, description" } } }, "localname": "TransactionsDuringTheYearDescription", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "stringItemType" }, "syta_TransferToEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Transfer To Equity", "terseLabel": "Transfer to equity" } } }, "localname": "TransferToEquity", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleoftheWarrantLiabilityTable", "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable" ], "xbrltype": "monetaryItemType" }, "syta_TranslationAdjustment": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": -1.0 }, "http://www.siyata.com/role/ConsolidatedIncomeStatement0": { "order": 2.0, "parentTag": "ifrs-full_ComprehensiveIncome", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Translation Adjustment", "negatedLabel": "Translation adjustment", "terseLabel": "Translation adjustment" } } }, "localname": "TranslationAdjustment", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement", "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "monetaryItemType" }, "syta_TravelAndConferences": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Travel and conferences.", "label": "Travel And Conferences", "terseLabel": "Travel and conferences" } } }, "localname": "TravelAndConferences", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofSellingandMarketingExpensesTable" ], "xbrltype": "monetaryItemType" }, "syta_TravelExpenses": { "auth_ref": [], "calculation": { "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable": { "order": 4.0, "parentTag": "ifrs-full_SellingGeneralAndAdministrativeExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Travel expenses.", "label": "Travel Expenses", "terseLabel": "Travel" } } }, "localname": "TravelExpenses", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofGeneralandAdministrativeEexpensesTable" ], "xbrltype": "monetaryItemType" }, "syta_TwelveOctoberTwoThousandAndTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twelve October Two Thousand And Twenty Two Member", "terseLabel": "12-Oct-22 [Member]" } } }, "localname": "TwelveOctoberTwoThousandAndTwentyTwoMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable" ], "xbrltype": "domainItemType" }, "syta_TwelveOctoberTwoThousandAndTwentyTwoTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twelve October Two Thousand And Twenty Two Two Member", "terseLabel": "12-Oct-22 [Member]" } } }, "localname": "TwelveOctoberTwoThousandAndTwentyTwoTwoMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable" ], "xbrltype": "domainItemType" }, "syta_TwentyFourDecemberTwoThousandEighteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Four December Two Thousand Eighteen Member", "terseLabel": "24-Dec-18 [Member]" } } }, "localname": "TwentyFourDecemberTwoThousandEighteenMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_TwentyNineSeptemberTwoThousandTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Nine September Two Thousand Twenty Member", "terseLabel": "29-Sep-20 [Member]" } } }, "localname": "TwentyNineSeptemberTwoThousandTwentyMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_TwentyNineSeptemberTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty Nine September Two Thousand Twenty One Member", "terseLabel": "29-Sep-20 [Member]" } } }, "localname": "TwentyNineSeptemberTwoThousandTwentyOneMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_TwentyOneMarchTwoThousandNineteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twenty One March Two Thousand Nineteen Member", "terseLabel": "21-Mar-19 [Member]" } } }, "localname": "TwentyOneMarchTwoThousandNineteenMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "syta_UnauditedCondensedInterimConsolidatedStatementOfChangesInShareholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unaudited Condensed Interim Consolidated Statement Of Changes In Shareholders Equity Abstract" } } }, "localname": "UnauditedCondensedInterimConsolidatedStatementOfChangesInShareholdersEquityAbstract", "nsuri": "http://www.siyata.com/20230630", "xbrltype": "stringItemType" }, "syta_UnexercisedWarrantsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unexercised warrants issued.", "label": "Unexercised Warrants Issued", "terseLabel": "Unexercised warrants (in Shares)" } } }, "localname": "UnexercisedWarrantsIssued", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "syta_VPTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "VPTechnology Member", "terseLabel": "VP Technology/VP Sales International [Member]" } } }, "localname": "VPTechnologyMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofClassifiedWithinProfitandLossTable", "http://www.siyata.com/role/ScheduleofClassifiedwithinProfitandLossTable" ], "xbrltype": "domainItemType" }, "syta_VolatilityPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of volatility.", "label": "Volatility Percentage", "terseLabel": "Volatility percentage" } } }, "localname": "VolatilityPercentage", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "percentItemType" }, "syta_WarrantExpirationTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant expiration term.", "label": "Warrant Expiration Term", "terseLabel": "Warrant term years" } } }, "localname": "WarrantExpirationTerm", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "durationItemType" }, "syta_WarrantIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrant issued.", "label": "Warrant Issued", "terseLabel": "Warrants issued" } } }, "localname": "WarrantIssued", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "sharesItemType" }, "syta_WarrantLiabilityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liability (Details) [Line Items]" } } }, "localname": "WarrantLiabilityDetailsLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "syta_WarrantLiabilityDetailsScheduleofthewarrantliabilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liability (Details) - Schedule of the warrant liability [Line Items]" } } }, "localname": "WarrantLiabilityDetailsScheduleofthewarrantliabilityLineItems", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable" ], "xbrltype": "stringItemType" }, "syta_WarrantLiabilityDetailsScheduleofthewarrantliabilityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liability (Details) - Schedule of the warrant liability [Table]" } } }, "localname": "WarrantLiabilityDetailsScheduleofthewarrantliabilityTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable" ], "xbrltype": "stringItemType" }, "syta_WarrantLiabilityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liability (Details) [Table]" } } }, "localname": "WarrantLiabilityDetailsTable", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "stringItemType" }, "syta_WarrantLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant Liability Member", "terseLabel": "Warrant Liability [Member]" } } }, "localname": "WarrantLiabilityMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/TransactionCostsDetails" ], "xbrltype": "domainItemType" }, "syta_WarrantTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant term.", "label": "Warrant Term", "terseLabel": "Warrant term" } } }, "localname": "WarrantTerm", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "syta_Warrants": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants", "terseLabel": "Warrants (in Shares)" } } }, "localname": "Warrants", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "syta_WarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Exercised", "terseLabel": "Warrants exercised (in Shares)" } } }, "localname": "WarrantsExercised", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "sharesItemType" }, "syta_WarrantsIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of warrants issued,", "label": "Warrants Issued", "terseLabel": "Warrants issued (in Dollars)" } } }, "localname": "WarrantsIssued", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "syta_WarrantsLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Liability Member", "terseLabel": "Warrants Liability [Member]" } } }, "localname": "WarrantsLiabilityMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "domainItemType" }, "syta_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Member", "terseLabel": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails", "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "domainItemType" }, "syta_WarrantsNov32021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Nov32021 Member", "terseLabel": "Warrants Nov 3, 2021 [Member]" } } }, "localname": "WarrantsNov32021Member", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofthewarrantliabilityTable" ], "xbrltype": "domainItemType" }, "syta_WarrantsOrRightsOutstandingTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants or rights outstanding term.", "label": "Warrants Or Rights Outstanding Term", "terseLabel": "Exercisable term" } } }, "localname": "WarrantsOrRightsOutstandingTerm", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "durationItemType" }, "syta_WarrantsPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants price.", "label": "Warrants Price", "terseLabel": "Warrants price (in Dollars per share)" } } }, "localname": "WarrantsPrice", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "syta_WarrantsTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Term", "terseLabel": "Warrants term" } } }, "localname": "WarrantsTerm", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/WarrantLiabilityDetails" ], "xbrltype": "durationItemType" }, "syta_WarrantsTransferredFromLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of warrants transferred from liability.", "label": "Warrants Transferred From Liability", "terseLabel": "Warrants transferred from liability" } } }, "localname": "WarrantsTransferredFromLiability", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareholdersEquityType2or30" ], "xbrltype": "monetaryItemType" }, "syta_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]", "label": "Weighted Average Exercise Price Of Share Options Exercisable In Sharebased Payment Arrangements", "terseLabel": "Exercisable per share (in Dollars per share)" } } }, "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangements", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ShareCapitalDetails" ], "xbrltype": "perShareItemType" }, "syta_WeightedAverageExercisePriceOutstandingAtBeginninginDollarsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]", "label": "Weighted Average Exercise Price Outstanding At Beginningin Dollars Per Share", "periodEndLabel": "Weighted average exercise price, Outstanding at ending", "periodStartLabel": "Weighted average exercise price, Outstanding at beginning" } } }, "localname": "WeightedAverageExercisePriceOutstandingAtBeginninginDollarsPerShare", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "perShareItemType" }, "syta_WorkingCapitalOne": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Working capital one.", "label": "Working Capital One", "terseLabel": "Total" } } }, "localname": "WorkingCapitalOne", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofSupplementalInformationwithRespecttoCashFlowsTable" ], "xbrltype": "monetaryItemType" }, "syta_afterThe1001ReverseSplitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "after The1001 Reverse Split Member", "terseLabel": "after the 100-1 reverse split [Member]" } } }, "localname": "afterThe1001ReverseSplitMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ConsolidatedIncomeStatement_Parentheticals0" ], "xbrltype": "domainItemType" }, "syta_afterThe1001ReverseStockSplitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "after The1001 Reverse Stock Split Member", "terseLabel": "after the 100-1 reverse stock split [Member]" } } }, "localname": "afterThe1001ReverseStockSplitMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "domainItemType" }, "syta_beforeThe1001ReverseSplitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "before The1001 Reverse Split Member", "terseLabel": "before the 100-1 reverse split [Member]" } } }, "localname": "beforeThe1001ReverseSplitMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ConsolidatedIncomeStatement_Parentheticals0" ], "xbrltype": "domainItemType" }, "syta_beforeThe1001ReverseStockSplitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "before The1001 Reverse Stock Split Member", "terseLabel": "before the 100-1 reverse stock split [Member]" } } }, "localname": "beforeThe1001ReverseStockSplitMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0", "http://www.siyata.com/role/ScheduleofStockOptionActivityTable0" ], "xbrltype": "domainItemType" }, "syta_otherChangesInFairValueOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other changes in fair value of warrants.", "label": "other Changes In Fair Value Of Warrants", "terseLabel": "other changes in fair value of warrants" } } }, "localname": "otherChangesInFairValueOfWarrants", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleofChangeinWarrantFairValueTable" ], "xbrltype": "monetaryItemType" }, "syta_twelveJulyTwoThousandAndTwentyTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "twelve July Two Thousand And Twenty Two Member", "terseLabel": "12-Jul-22 [Member]" } } }, "localname": "twelveJulyTwoThousandAndTwentyTwoMember", "nsuri": "http://www.siyata.com/20230630", "presentation": [ "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable", "http://www.siyata.com/role/ScheduleStockOptionsOutstandingTable0" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Expenses [Abstract]", "terseLabel": "OTHER EXPENSES" } } }, "localname": "OtherExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ScheduleofrestatedintheConsolidatedStatementsofLossandComprehensiveLossTable" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ConsolidatedIncomeStatement_Parentheticals0" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.siyata.com/role/ConsolidatedIncomeStatement0", "http://www.siyata.com/role/ConsolidatedIncomeStatement_Parentheticals0" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders\u2019 equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.siyata.com/role/ConsolidatedBalanceSheet0" ], "xbrltype": "stringItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r1": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_104&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r10": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r100": { "Clause": "v", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_v&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Clause": "vi", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Clause": "vii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "3", "Paragraph": "B64", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B64_h_i&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "5", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2022-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_h&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r110": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "8", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_8_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r120": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_32&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_33&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_120&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Expiry date 2023-01-01", "Number": "1", "Paragraph": "29", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2017-en-b&anchor=para_29&doctype=Standard&forcepdf=true", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "12", "Subsection": "04", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r130": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "a", "Publisher": "SEC", "Section": "12", "Subsection": "04", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "5", "Subparagraph": "Schedule I", "Subsection": "04", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r140": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "c", "Publisher": "SEC", "Section": "7", "Subparagraph": "Schedule II", "Subsection": "05", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "9", "Subsection": "06", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_102&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r143": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_103&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r144": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r145": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_68&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r146": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r147": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r148": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r149": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r15": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r150": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r151": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "138", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r152": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "32", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2022-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r153": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r154": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r155": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r156": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Section": "A Statement of cash flows for an entity other than a financial institution", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r157": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r158": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r159": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r16": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_69&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r160": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r161": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "B89", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r162": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r163": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "B11D", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_B11D_e&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r164": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "IG20D", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_IG20D&doctype=Implementation%20Guidance", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r165": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_23&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r166": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r167": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r168": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r169": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective 2023-01-01", "Number": "17", "Paragraph": "96", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2022-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r17": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r170": { "IssueDate": "2022-03-24", "Name": "IFRS", "Note": "Effective on first application of IFRS 9", "Number": "4", "Paragraph": "39L", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2022-en-b&anchor=para_39L_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r171": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r172": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r173": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r174": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_108&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r175": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r176": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_55&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r177": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r178": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r179": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_85&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r18": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r180": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r181": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "57", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_57_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r182": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "19", "Paragraph": "9", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2022-en-r&anchor=para_9&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r183": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "2", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_37&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r184": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r185": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r186": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r187": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r188": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_20&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r189": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r19": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r190": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "7", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2022-en-r&anchor=para_7&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r191": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "8", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2022-en-r&anchor=para_34&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r192": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "12", "Subsection": "04", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r2": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r20": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "79", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_79_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_99&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r30": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "10", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&anchor=para_21&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "10", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS10_g17-22_IAS10_g17-22_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "12", "Paragraph": "81", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2022-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "16", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2022-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "2", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "2", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS02_g36-39__IAS02_g36-39_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "21", "Paragraph": "52", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2022-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_17&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r40": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&anchor=para_19&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "24", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS24_g13-24__IAS24_g13-24_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "26", "Paragraph": "36", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2022-en-r&anchor=para_36_f&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "27", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS27_g15-17__IAS27_g15-17_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r50": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_66&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_67&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "33", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2022-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "34", "Paragraph": "15", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=34&code=ifrs-tx-2022-en-r&anchor=para_15&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "34", "Paragraph": "16A", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=34&code=ifrs-tx-2022-en-r&anchor=para_16A_f&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "36", "Paragraph": "130", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "36", "Paragraph": "130", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2022-en-r&anchor=para_130_f_iii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "38", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2022-en-r&anchor=para_126&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_106&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r60": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_25&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_28&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_35&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_45&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "7", "Section": "Presentation of a statement of cash flows", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IAS07_g10-17__IAS07_g10-17_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "8", "Paragraph": "28", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2022-en-r&anchor=para_28_f_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r68": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "8", "Paragraph": "29", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2022-en-r&anchor=para_29_c_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r69": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IAS", "Number": "8", "Paragraph": "49", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2022-en-r&anchor=para_49_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r7": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_35&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r70": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r71": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r72": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "29A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_29A&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r73": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r74": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "1", "Paragraph": "32", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2022-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_12_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "19B", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_19B_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r80": { "Clause": "iii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Clause": "ix", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Clause": "v", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Clause": "vi", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_vi&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Clause": "viii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B13", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "12", "Section": "Objective", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2022-en-r&doctype=Standard&dita_xref=IFRS12_g1-4__IFRS12_g1-4_TI", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "IssueDate": "2022-03-24", "Name": "IAS", "Number": "1", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2022-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r90": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "13", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "14", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2022-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "15", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2022-en-r&anchor=para_115&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "16", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2022-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Clause": "i", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Clause": "ii", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Clause": "iv", "IssueDate": "2022-03-24", "Name": "IFRS", "Number": "2", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2022-03-24", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 121 0001213900-23-067282-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-067282-xbrl.zip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c:T-"I1&6./S;19\*98=29U\N8J,F\FC;76N?1M*,K/7E]R+ MY;P"ZS=O0J1)^J(CNDTNO5]*8Y[\T+27W*T&,9ZB44IX)BWZQ[K2TGLH5BX_ MUZ:;6BB-JG)K\CQ7DJSGT@SLG30'HP]_05^EZ>PP.L3[^]Z+3] MTP_U1GMG;VU:-0_BH'W@=^]?U>/5(EI(U"KU3)TMUY.:(Y@M63?2C@E/'YV)!:@BU'A[,I05=GCF"&)/T=6/[QV65 MG(J@E^Q>^P(,I: N5A($O_!9NNZA/IC?S$P.VB!"IQQRZGQ;5+)#+C&2=.M" MCP6)T%0:Q<<6-*V#"="[ MU[V]>; W:%K&919R$=YP+>$UP*SO]L L V8]V .S;JFN^Q>D2Z7,HQ";D!00 M29"H/%S[AAUBZF5OL(MRW8Q?.*JP_(TS5$_R"J9X!A\ /\B2K+/MT_SE;_+; M-/CY7@Q]S9UE='B0JK"$O9N65RMX2JVU"0P1EUQ+IO?I .KE&_T8PU&X=$)4 M; \EVD<)_M4AJ,F0]ML&X0B/8]*U!;/0BE[1[R(#QH19=:[,\>+ SFATTD,S M\@CMX[-[B?W2R0;AK &I+BUCM81CX#5G2-BR7&H=.VGA6 CIR#=BT&0OJGM1 M_?(AV)@&(".AH5^:\Z,I7#0(!M>YND/&8NYXF/:2N9?,+XTL$#*$@1*53UUV M@"L0)S7=_0$N#TM@+Y![@?S2JK)G ECQI5A-,BX+B29-NR9QJ:+>])%G6AI" M]D)3R%W,RV:VA[KLY?37*;W03!^):?!X#%0[(J.2$20[0,"*W,?X+&12)"C* M_)ZN/"L8J26-?0%P[V2#0EOWOO%7G1>:V94BH_0=:E;X3&5)SARJ8L.K;N? MD/06TP]G'?LY)@!"68?K(\/Y48[*S1E MO1?,O6#>7%T2^'];T;2A#D.).R*9YEY;[H7RQH32F0C%%%4/FG[@EG-U4)L= MW>JK\W;&E7*W5I.PE]"O44*1ZN_U2@^AK,DF%IS=>DAK+YA?HV#R_7T6<;"Q M5,'N=('NZ'=N$8Z]%\^O43RM/#C/DK)A&<99V<9/79*6"]_1&.%V\-:?+JDW MALNX8DA@G%&(K'3C$ B%P-E1_;D%&$311BB:'@&H<8LC ]?X+@B,K1%03*Q( M!>8-^\5@/6LDAQK3KBQFS.=O&#QAJMG&*?+#,/A+!N\YLAS']"I88*V?V@;A M)#U/T(H/2)ZB7_&(M:Q\B)HL-/?/G;X M#042YZ=M[41Z0" 9%\$!',%3";M MUFJ-S$*,5TWK@JF@ID+\Z95S[&)H82MY,,>&2X&"XAV^24C(2=AHM%N[:\P7 M>[FBN8T [\ENYE_&?6.4/$?19N5<&\A;UV=ZQE'V#IV!PC/E(0!9SBK6?[&+ M/,#/*]0VQUH?J0I =S5LNP?PWT*[JEL^OX9@>Q\%;OR0*3B->Y.T%PR3BJ<' MF.%B5OX#!S"(_E?0#/"5/^:K9 F%=BU=PUFY)(%&I67A>K!MP\@D/KRCH\X6 M7$(ZA,7G.6VPC87+!^/,>NGB.H0;6_LWIH89M/JP43I 4MHN M&EQ>TZ)1T4&3,:67X7,)T!U4= !MAY?JLYZK_@&(,@3PBV%IQ1BD'J'V\_92 M95+#\KX68U*J!LM2W+;B[^UUY2QW\LY' ;HUE%#$2V-P,VGUQ@9[<@>:X5T# MIGZ\!U,;F/KA'DQ]2V#J=]PHF,T#K;IYU?NR!'A:& :'QW:"+TVE; W0:K'RQ& "116#++G/UD3U3%= M/I#MAZ_@@HM5;Q&<0OJ?#,<.="QL3DOK5NLIN[4%8<>RN&'*_6*%+V9*DFE( M-CA,PV5-.AD >-D&>D99=-Q0L->6I@)16'=)JR=$%;KVD@P2?D*/+GSKGJ'P M9=V7E]RD6)"RH<4.^E-V9&IV.."8!ZE_,G- ;;RF*^S9E+[-ETV]202*5B[T M_A,R53$#JBT NI0TJ3^SI'MP*@57WD%I2J[YZZ'Q)0VWHZ9>%% O1M:=0)NW-O9-#VX++>K 7_3D,:-[C0,XV5C9PVU?7C;O/VK)OO6*_!*;& MI9:(B9RI>(>-'[>9YU(>1@M>KY49;]NEW*HJCH4=H_[C395&_I9""\^DE_Q? MUTV9/3C.L]/CTP>Y-$><92,BL<%^_/Z/N#UQ31GV?_]=%)_O#1<7Y\?,SN,[]-BW=X+%(D*:_%#3.K M.K[@0F$A7VUSX^?#,\IZI&EAW [JI+OT:UZ'QOT MK?A=L2*9&U_W[%7.8GWSNQ^?XZ#1L[DI+G?C6S?&@ZH*8=Z5I1;QE](9VXBI M);0&Q>Y'0TKA8]E-JYZQDF26-Q$:V2ZU]U\;K]FG#T[R1\>/,S_TK=I;6A25 MV9.'06@+F,5#U;:U7(1FCWD:LK;-Y'N"I5%B+]E%GY3[I+# [5@#?"]PXK5XZ;[%UCA='>= M#M7#3OZ8,3H;X$ LAJ=TQ)7AV9V@K)3'0Q_467?-U,?-%+_M#-TE'U? M2A:._T3[5O5(#=%\8;#Z]52OW#HYF"VJ.\Z!;M;IVT6MV[F_2;EIFYGB4L!8 M*-FA5&IY10P=+0*Y8.Q5SCH"5D&7-86.1:ZV=&3H=\&)IU!+'_)4?)'(YO8? MI"=>F)<&AL() 8DS0A^?II2$<8XI;D-&49-S]')$,V@=U[^^Y7[+YN#UM\AE M./=D.2G[ :<>.?YA-EO!33&G^"L+2M6P"U63:2?)$/";2 L&OF'8*"LZ<9Y^ M+OI9\8]<_V^X*OBWVYMVZU?''3317S8<[-/8:&+;V?KO%/](9R4_T#UXKL&_ MGW"&<.(14.N+5=7/-Z3>FFJQ7@QKA>7FNF;[4#A^LX,-7JU59)F_)#P]LC#[M;08_?Y.)Y<-W>$5$50CE1R3. MMF;?@H="8-._"/Q/'10BF]M-RXSPZTX4DN2T+DO+9V5CAP>WACL]MFAAC?8N MZK61@\,#=<-.OX-'=TTOGH,1BZ^_'U!> M ?@!G9CW\3R\P[4@IR%[]>HY>;1_K&?3HT?&]XMM[ MI]]F]_B1.KSOZ8EO\$3^5ARFQ$<0T+(UF1=&D0-D2=V"+C9&"^<^/#@&=149+4CNAMY0LV)#I^K-NN-K'>:< M;H+.]_! )OSDY/C>]-M[#[Z]]^S;/*SR&??:2MYS\H1>1$89'R8\'.8C(\/K M[$4YZ=;,ZWEZJNZ[7[SG<:O>X'%A_6!UL:8:V5"3"%V>*_<6)O6LFJE)/7S> M1'WKF5%"D]D*94+_D76)5T++(A)")17Y/Z,,5WQ M3;I?DD'H^)6:T?9Z\8MU8,8OST\"(?,1H,#H"?J,P^]4HW+TZ%GS%Q*^:JXW;1Y^0 ?SIAS\6B^6?G^4QNFM[0'_UKX"] M,,_0\()MHWYK $4C+L]WZ;OYR2,HETFY2XOK*.C>WMQ0D/E?ZI;Z9(\C,1S) MHSV.Y.ZX/+O=F[D#G'RZSLMFZ\[PJ2.77[A+@N.)XRWV6S#>MKTF4P+BH):S M([(]S6Y"0)1])<;"+)=E4>M-:C:],;S*[ J[1DR U)1.91KM'$LWM MM)QQQ:^S ]6[..+"TY9L$ CI:^ M2Y=%#E<4W*B]C5DJ4M!W$-+I@4HR978;>P7FUD(3V0I^5X_&.PP-U M\>(6]YO%I*W-(WCW/^^?':D7<*<6]0[N\\NYQ&$'9U4]85&>O VZ!=[>-I+I MJ@\18E>3@,;#CJ8UA-9C-V*V)^4R[P&S,@;0.[A,7VG)VN^L.JT(O?E\*BZ0 M=&@N HV%Y<:Q0HZ8M/G5:WWQO[1)JT\1V_NT2<$TWV25"8A;4L&X8&<"A%[2QOQVGHCJL7/P#+E/;LZ$/- M:3&#P\/YL!:98K8A..#7K2-WX[+M^VI2;UPT7*L*]* PB0V,2PM=L9/"$(M8 M2M5R6'FKEXP5/203W1^W_7'[](^N+-*K?B]+U7%T7_)>M(EY2*7VU7**.@> MY>YKC95'O7[__(C_Y_ K4*+J?5-N&CK"^OUYS96HHD, 2GZOIU*(RN)P:6_ M3X"#.NQA:7, #=(B2R"REVC$#H +R=F/^HO[&II SK\_HJ^004+S$*-$7TFV M0<_4%%*%PD@^P%*R?E'4O%(TQ_5"$"#-\,F'!_;HI'8M-J8)FX*7Q/KHAK-8 MX8^!YH*>4_=M'G'12)FY$2/5"*H);)=14R!.NS6Z,.]GX6+.41(:R'!T,,ZPULR^WUEWPYEG50Z'SL4&2@X.# J+/A^CI"SF-S M1ZOBV/=T?*]5/P AS-HE"R963Y-)2C9JGI]=2,N.KX6I()ZG3($K321&KPVW M,PPP 4H[7M/5J+6G ,TA'%"F9]98N" &,(A7DG-,?-9G'M/*7[0"' M$M!'A=\3"57X-P">']/.;JR4;5K2ZT*)"RB)!.M!N6Z!RE(Z47Q@7<9J\/FBZ#C#@_&PV+):QG E#%]5B%5,%;;%J)*H9@/BZ<(O#]E M]ZIOTS\'#)QA\](5ML;;?IF+K3TG@5CA1/Z97D!O*.+3SKI24'3;VH)M?##O M.BV+$ ,_!$^)VT^+@OV?MLN-C,'>((L@QDT8!XY67_HQ)GHC, !!(6GJ>!Z* M0X2!;#N@)[=WC.A=1;@5>NYV4NR=5*QF?E9>+&G>[R8X<6^ MV^/%?@-X,6W[&EI&\P$E-A!55*!YI MRCGNH(U47B+LX/5DUEYJD^M(AJ-:,D1ER!*5$B%]@A7[#2HY R5.?G@P69,_ M4,#>)DNB1/YFM S4NFH/[$ FO9Q7'ZU-NJ*OS1U.ZYN/LG=BWTPE#")]DZ3( M<% 5;W6( \;/,M98+0 [% X"78ZML8YST#"YEGM4?(HV>@^0\CP:.G->MTU9 M&(7J^%@%:B,I-BTSV'BJ!->AGJ, 2FS 8\(=1P:UD>@@?G!T>' 'Q?=.*"2K MWI5B2O87^$*@1_"67?#2(Q#>AB=VAKR M@AYA(^SGX0%V$0X4^7(K=9_A2^$["#;B.X(018U-01I@P9&]J0YY7]#_B:C' M 4 WN(/JC0J=;R4I;%[UG/-Y#'#4Z *C;',P>OZ][;36OZ*S.8%'O2BYD+V7 M$H50(:FD8P-A8\>9MXZUE6*$M:JK8[0E(#=56() L[-Y26=NL,$6D%4M+1'V.+:_K]6% MMM!N #+(8WB9>B$H, J80+O;L"1T01V>L&+O@8$EK8>$S$QY5= MD'1Z,/I>-+UXQJ&L-^?=8>9W=IF;LW\?W>Y8!,P/:4$IV*PJX?_;L7&YYL6S M8CVK?!VQ4";[Z_(Q5!Y2K:U\O3#UIZ?#HJO&*VZ(Y MQU*0[1<,4F:#9;M ><%LVMZRDH>(V\EX_)1602LEA12$.T.N&\TAD$4&?'3! M][V$0I.M 7FC1'@"\K8K+T!'T<0SI@]% !#KI:N7:=R*OMM6?(*B6%=#&/-_76-5P+?DD M4]-HV2+'TLA), D:*!FQ]6F9JUK2VJR<.,S,UT8+8A;:0U:['/V5RQY=A?M5 M0E^09\BO)^!WD- T*^F7*;I;PHBXN0>\ WQAK)*?*ZD+[H1P")S:NXY4,7)H(TO+M!3MEZ.LEUBM&K/1*-!5$Q^O$Q%,@D: M,KO+:[I_^?9,)2S(5=2,N,U9:I1S(2A(^T@8#O./:_ +: M(C" [Z^-D2&]Z-K%X0&JWMARM@IBP<0S.09,\AW[F._<2#*J7R?[8SLB&E6X_9[X5DFDJK''DM5W0I:IC G ?DS(=@]GC.>I+I3)E)7:"_6DGK==MZ;% M?6/(CL.#9].5*+Z_'?W74?9]5Y$3MLGP*2?G<"LRE1^M+'[+ ^$&1%=2,Q6] MO7EK?G:&DGDQXBF9F-(_"WE=BMM:V2LO>*#<+ZG>2-:=>R9=O5[NL68ZHJ"1 MXP78K,,#U]7*3N/85M\$'FM;'UZ=3'QXO$\F6C+Q\3Z9>'=T]O4'GG)),_H:J>?T1%E1E D8;I$M89O%Q/20DG?,P\YB@ N M13 <'BB2ZXX1[-[!FQ8YS)$ZK;0*-^%(9= @7<$6)HV;))=HVZV4)B2M6-B6 M#1, [.[A@?3\39K;T;23%E\[Y4NQ?)R,M(:'C02:MB6OR5PH%ZQ637N](&N. MLXRU0NKTZ8/R!$(3D'^\7E>2M?[IG2949>[1G#]WMWIN+YA)OZ98ZHALUQ&'G=M\?8 MNU%..;K>AUG!\?-!^);Y>*M:">IMET7^6J:H57QLQU(Q:,?I6TJ:CD T/[2W M028@,@N[:2B,3W=:-0T,&5,SOVOU)RA8HGL?]X,UP[D;V*'XN9Q*922"4Z;VIGLL9C^7)'=ARS!(.T M!&=&5-,(7*2:>C@B,(V&N99SNDV"+#]W6M_J<-BS 0?@TP__*$;Y?*!.<3J^$Z4B?. G,LB Y9A1 M.BJJ"A>US&K0:B&J*>3NVY'/KI3'3>D]_RREC7-XM.6162&BOIO1X^ZH)*O< ME,PVA0)M\OXN6F9JK+EY#W?VO&I9H+3I+7:XK_YVI&2L',M@;3CF@IT MV5+XHF,;K5A44 >67<$CVJ-@T!):^@/NU'TV.>WS/'K[T)$ATZVF/9PB9VFI M4(F\V(44R8Z51D^?>46>_,O9#SN(:G[5HBDDK8>K1I]HE;->V9PHM_L]1D,E M)50,]TQ-A+\UE11BTE*YH^-0&CZ##7L,.7O?U,(BB@U--'+:L7T+$YKTPM=7 M9/9LYY(?'@S6_')L.5+*P/8X4/R[WE])S6:,V566\B L1B[(,GX.-+5FTT+_'C)=(.L4[ !2.7GQ@G M:O7=]\BB^Y83<+NF*C%]>Z8UH:' 2X0 O#\D&HDY*$@TL;%0 A"?VF/$!:W< MVY+CO7S J[Y6E!-@D'U&(M"A)%U;UR88S2AHI*8V=F7W0]#2!0K>M/)0 >8\ MI/5R%U";W>_(;(DFLA7TNJHOHT4<8*=6Q8<2M=F%(4*$19%O 3>Y/&,,O?;P M05*D!-QWZPH?F+-QNB.S[-NVL1)8QGXU*(HTWVJR44W(V/*ED(P'7U8X!PQE M@IJL?I%KP:"6KK:<-IG2"I3-1=6U30)PM&^=5V?G$>TH0B>E;D!=P]&C=UUE M%[QJO-?&>56JP5"FVI6_P)6AL1%3B JZ7M WS)-P3>;G9)_YLN_, Z'14#W.T/W(%Q M45JE*C]>0C4TV_M3W-FP&06;RIEF:R8ZU,\SKOB6:3',3S2AAF2<:X%R(_*\ MF4RAE@M)#,>@?>BMY-TVL"'+C8.,"(Y^P,4;R9O3B/F(=:@+/08= =)_Z%RE M#0SY\4T)@YL63',;[F^\6*PA8&'P%SD0%),H!KE>*QLX4P#J>[B&0% &_+10 M(6#KX5\4V KL:QS8:.E9VO>,[B"UU1#[*OA"A;<1A:[?(79!'IA.).41P1S: MKM0;E>T)#O_+5*0$GP.C6I4 IT7",!D)G48SJL88X5W)Q_#^%Y?(W8VR0,.V M8WVQ$ J(:E'511<2&P*/WNH=F(VT#H39JV31@&>A7(:=#E>)+X\/D*>J>2]KD[^]F)>I!C>U78+A^FY)"^%4/;&$FZ M2"QB+$\^5[0-U-JF2.G37/*0),HZ1R]N+(ETM^[XEZY[4=!;.(NAM\!UW1#' M@OT^'FY2^BDB,4#&L6*R%HA)?\+/Z6%H'RK.(7![B:U"HSPON1>W8[.X*#H. M4"5QWU2)_LCU0G)Z]$1PNPX.(R3!Z_&SX<[CIZR)ZG=0VB1]$[>.Z)BI@\*N MP0LMHR/-Y.V![B'C0\FF=)#8HI&R*Q,7:77?V:RWSO4T-CP)4;Y U*A).Z&U MHIW.6=Y^HNF>2#_XDWS0OE ;8\R!%=5A,LA_6JRLO"OWQ7F@?R6M0D89_DZG MAK9JCMP0#_09(GS96T3R^.4OV/\]/;[_(G#,S,G!I:^@XA)1Q>P'&@\:)3\X MR0\/:)C'L>O>CMZ&(_5*V:/31^C;=_+M,$[IQFG7?J1\GL5,:[ <8PXMQB]3 MS1="I8R'IQL (4@=53RZ&O60YGH<(JZ+!E11Q'"=' 4!O5ED[(#(07X6=OPQO>W5C?XM_2@7J)@MP!025[ MNR@^#W@_%Z(8W1*[GB5=L'TQH_FQWE*\U7)-\[-=#3R.E/%2:O1*DYI@>@'0 M1KQ95+[G=!-]%,FY;&.$Y[(L/G A)=-\X#P2W(C71B>E('TV_7]A4O1OE1Y M\1T4(M;*@L0I/C ]WJI<:K3*6J6),3RZ11I2-+J>?M65S1D;%W*SQJ0VB=M\ MGHVJ.JAPTDY3+L+A] Y#[(R0;T$:"HT*,400@C-Z6OR$,,299CJV1NC%C@0( M7;Q5A$_PVA38A\R7>/%P$MKCB_BF551A+A M=4=D.6]@PJRUN8A=([92..17:WHQ0'K&; ,+W8 S>VC>F%DC[%8PT\?K[;*= MY7:'!\I;7')]_ZIWK!36A#$64(VME<9$MI:JY;%MX5E#Q#!Z5S)R12%NEZ+% M*6Z;:?1N7Z,B&GCTV$QV780>QJ[FCF=D:=K9C$V MW2*[F/U#*-3E=9 9Q4(Q:0[9/_WB=BT\\Y?O?_PI>TBNRL\O7K_]Z=G[EZ]_SNC_O?_/'[/G MKW]Z\^SG__G"9?2_MX8^7ZY)#NW&LR-9[9%./5_V1?]9]7(A-.Q D-G>+HUU MVW%,# =S8UUU[EK*X!<-=')R6?-.(#QY/5VUY'H='IP\RK.3IT^^8TOU^^J, MWDYZ]2\MW52O5K,C"<[:3]EJBZAOH_/02,GW?#OWY_1QO5Y,JL*]$CV2UW#U MOG^>'3\X^>[X^,E1]KK)GI'U46>/['S\'$)?2@3QW7U8_-?B:K VL@CN[Q[O']4G'XZ"V8[@>/XSGJZ![@*;L'][[L MR73+AH^1M7K9Z,S&^D_0YN(A5EOP23/51LHB>]EW15G?%QJG:5G77$M*4YR>-V2PGFT" M6CXBDM,S\J[:%*LB^ZF=,)K\93.]Q9V_Y?TGV7^,[?\N][O /%RA:' '%Y81 MA\UI/0&B]@L*GTH_A]XQ7D&Y%S@P*,2/48 P@&51L:L,]@$Y_[%%Y/-G/WQ# MNB(_UJ8I.JX3_@ ?WOLN?_+TL0W,VK*7VO&F[3H>_W^^7__WZT!'A[8"/_GV?L7 M-D:\'7EQ!+9/'F<Y1KBYK0.-!\*GUPS8"QONJ;C%75?J\8R M(\U!#SBJNB:7>B:U%9P6LXR\E]3PM5#7MZR+J01\:JG/>7/>EDWU,7NQ%J$Y M.7V:/WQTG#'9[) 691&B*-]0[X;)_WQ74%?%&=GG/!BS%?7"EDIDR7U\O73 M_.G#1U!;?WOW UF,!4D#EW49A;,$E+BO3*JKAJ/@DS'X4NBIJ3W+Y)&IFFSA*L7X^2(EDU:%0@2 M4F#T\S>L+J M_ J._Z],XY)(OR@G'63ZZ2Z9IL5]PVS!\-!(,E!0T1OKKR1>!;VIS4R?GQ=5 M1Z.T7?K>T)P_.#1G%_^4#[93TM6VMVI4>UL7@T'! MB4Q@O(52@MO;GB&;^#QP9YM.;-L/!L2.+,2K[;L)(UH/:[ 9XP7:8L:,M6Y] M3Q_( A]E/X$$+8R[*Z$)9NS-TJ)]OYX%Y:O-WP3#]5-W)'^4Q(L "^XKY3*V MRJ%HXZ_U(EHOI^TB&$XRVG#+ZJ!'AJ:Y]7!@="_C-7:JOGN/\V '*.#$%O41]FS5;@<+X-9?\J4 MK$\'#X M#,G]YN3IP_SIDT>F6M213JQY5P#[S-1]N6RKI;*7^$VX>-&F?J&3D^?O?N?]\_P;?Z/7X8HFBN] M%3>\2_1ZN&@_B(D TFC:_R=WYA*[)K/Y8)_9U,SFP^.O,[/Y6U'\.S'ZTJ,F M@/3]N?U7MJK?ZD>T1'$[&.-6XV(4.A.,ZZU<8Q(:D?(DKODS4,RZSE$."WS9'+ M&JGQB,W%9-&_>9Q;FHN7TSJ\G3Z\C^ I(QYY9\GF/OZWZ(-(FSYN-:NX36L; M*YL&M:$TN1*N/M* =3\2SPTZ)W$5TK#@@-4-=>B1%I%<_%"6/Q M T5,>J&N\05<=MJEEKYYG,V8*T:2=[Q%B(H]$S^&-6!7FOIRX\VMWL?>JBT- M%L6,43#2;9[C"MH6/O6 [N%M2"YYOPBMVJWRX-M$UM_:F_3+)BE_1CD\FRJ3 MJ@EZEJS8XUG!::__\\NS-W0I MK#N+CI)3:8H3:R@F]I: Z;+Y^8_-[/#@#8_+9I;N_;E&@T)#X,EZGLF !'I-',F[ M=._*6JSI5 \/9N6$)E5^ MM#ILJR7@SWG4C,JOK(:BZH/V!OXY)&QH]"NID !SQ'Q=(Y6JG*R*,']C*NU9 M4&F%:OFCPX/ X+:Z1OM)NB#L@J*AI5=V,1#&\!S+58&S1C_33G;)(UVC]9?"GXLOEUBGP:O0]%/R4;I*4'&"-BX2;]_ @ MF&5":F*: K&=>L/_'+;>@KM>B'AE@\F6[)HC(Y'I;'*)#K= MS,A6EO&X?HWN2].JFZX7K#*F@TLF[.0XY7 ZJW0J;HY1Z\219:_E$$HB(]S%*(L(9D&HTZ)[ M+'7T@?S!:[]YDI\\>)P_/CY-L@'JFKT"3/+D07YR\X#RI8*7I@K@ 2LA2YL9:SBP"=PMVI][ L"O:+K^9)24^13N]!U].0MU:1M4E4^JRQ59VC6@7+4I 8\K#4#$!A;M?3T0KZ MNDI1 FPC.E9;T$):4_#! )R;\]3J1/%2]7-LH?UU,]Q7X$$8E0AB"BQ:RM69 MIK%84+D"$'R$LI>CMXJQ68K*C5Y!<$P%G')JI-YTS<$#MIVW@[%2%O]Q[(;= M?T'-;Z-6'%)#+L:3_/&#IW1XCD?P;?%2 GNYWDK'1Z,2^V N.J:-+PVDP5+B MP1O@F<63SD7/<7E<"R>UKK6<&.J+P<%6%1GHS)(L,,KVBJZN.')'LSW/_33Y M'RNEA&!V_UX?8M$QKD-B ML+]$HK#PBSM@B5R3'GNX3X]9>NQDGQZ[LS;N:V_!/K(PJA0&I$"W3P&4:IS* MV2+71CY)\5X9]RP:-K<_/=ZI(4A[&7#$ZU[T$VQQ18IV E8+OE?Y4?-GP]CN MUU@.H^#BD\!,DF#.U=*KK N*F>L#DG/>Z"?Y=T\?Y=\].AV&(%HT5[C/V\E- MT,T>\C&.@4?>9'2#K6'*,CQ7P@/,?X%!\?M^&7N*&(2[QB$)7;5QM^5T@#4[ M/3:Q%4ZA!@0"'LS\)'_PZ$E^?/KDZQ,:SK*?/C2!&639ZW*%.#:[B#\4Y#WU MM =_+!;+/P>?Z-6K-R$R95\)B0=IU[A2(A+Z[_ 0,YXO.<$IM!%T<7CP[2A@ MUO'J9#MI=1"WK1R0:9"VY[]OT?@;A9S?=$Y)1Y M7AJ)5K]G);JUM/ M7\W/S.AQB"^//.!;V:.PR4C,@Y%D)3Z DPD-@=62#0AM4/*Q'+HC=Y.>Z>PV M((303TEXY %*\V8XEV2-0!LL+0')6KXH0]]R(1"54!3J 73HN;;A@W\%LA@G MNY;@_T!4 M)PT'+ZT2-:NZ3@#'2:K3E:ECIW+?>W%Q04NTS1.)U"$E.VZ\/_ZN:0\<),N. M)MLZ0->);8G6!$@S72WB/URC1E6U-JK03&O4,OV'A4@4Y(AB%87C45(2BM(] MB]2@8S3@U0LGH[H'D@GF,VUFO$/[I6!L\ ;HUI:D[V@I-< MK=SE*.=MH\))UAML72U41TO3T#/4<\A8?'C'3$4AP/;$-A(SK3JG=Y,N 2)63[Y;A, (O?=)B\#?5^U&3G[M*@V MBQ6E#L* M&X-0#\^&*I%X&'-)*"NU/L=Q9IH]6KE-=L9+JI M8]PH_C_=_.4 YO$M)C#> M1M.8;5 G?P61 !!1QR6Q:4;<<)ELD>GE/)N\[$;:@:#!+5'M]CZJK:+:C7U4 M>V=-CZ.4DJES?/-J)4*H7Z\ S]HS6(?GL%IKU MHYFN_S+=ML U29*8"[NI0E-I'[E%;--!AJ,CI9GT?UR,V6;91KZ^5']70=+? M?_WZTA0HZX:/5"E)#IPA7)UC_6;QI%*Z(;9 ^7T78YM2_-1G_I3A(3_1GZI5 M*Z?:MXIBW?\I4LGTJ04!+"^\MU(35*+/7&N,EI V# /R MR[B]F>6BSR*%W"S"($H0G$04Q8*6A1W0*FN#K.$*ZB#3^K=QB-@!7; GS@*)C5-RKR/!S;8<5NV\J$0:TCU)K9VZ*< M9J/6(5'/LMDM; 9 7^SS#(8!.L5*[H0V7%6V&>'F@EI6*>:W:@;$8'R4Q=)1 MKULVWMSR=<(UZ;O]/OU/I7"$*AF,SE6X:DX=KZ%[Q(715;U$JJ0%2=,I691P60Z()?*IQ(M^ M-K7@4>S>L)Y4J V=;J6*(FP@P'@!*G2$-;DBEG7=R$2A('[JG6R()/A.P]]$ M$39_L&A*9MJNC,^]X^LL_@[F*F%$)%MO3K95N'FH%(G.V]'RZFIQO>7V9AGJ M/55F#ETP6K?2QWD%P;$O,%M['A?,P$@R M8H^#<2G&4JUX;KO/GRHIKG#M18(_O^4_VPX!CI*>!:^D819K;9D.@T'F]4XN MAO':1<.SI6HD2M^LMB?[WJE&BU'D5#YS6WTN+FK^@9CRDP>(7LH!VF@T^, & M/;"X%$L^MN2;BEZN\&7%,\<6@):DC#)#_MW,[&S:.+:QKE0+H;FT=-,2;N4N53K2!"25VV3T\7YWBZ M"\5?RJBYQ8"AFTTI.=/H#!'5KDAO.-:T :ZZ#U%#YJCAJIIS0 MA\X$AFG) \3'ZU-1 O\L QPPTD:B,287J.#,W\4ZHA9O(4+3!+\3SG02X5'GI[<+&!'H?J.3>0+>*@RDT:AW7><#FL'@A[O.OV?!63!PG6/PAH:^J^,X MSBCPOQ.S';UU$DXTF.1\%./E@&VXG ,V5/A7@G8<:2_4$J47->?KA&"*3'(E MW%RDAV7X9*X)ATMFC>QN2:9&PA_[%YH_1"_&D,RPB,HNX/F96 T8T)@*XPN! MD LCYRR.4;6D+E^I0VP-8KGR8H=1[HPNKM&-(#JE]!?T I%X"(L?UF)(+ @# M&"EG>B?Q-+!'G:HJ(T)_".I?)1LQ^&)6B=M'20Q(5?"HWE_G$D)!10"_3&$H MQJM52RGN!P63>,VH#^J52MT1:1K*'R.,X6:G^)#TF 2S%+S\ 2L0!+LIQ4U5 M.ZRGN7GA&,>!<\P^!'UO;&SMR'/HS6E&2VO;@L=G;6'->150^12>(&0I]5O)7-=)E6TY2T&!-.0?!CPF%BEZHVK-BP0,. MP=PHV-I4X;TT%X[5QN#9FQT9@T+! QI-@@T\6QV 60[3."#;6 Z MFW07DYZ+$8^OLCOX*0Z1'476^3 6(-+(\35/.W\\6:)E B@&%RZ,+ M0V1"AV!88*!V._6>V^YZKN3 R?+#B]Z:-A8)SL0W!*'#F;EZH9>P=FQNJM'WP$['*J?RJ M\4*]T'++CP93U:"GT \L?T;<;!4>L4*8@"];,-F 0X8,J62#4 PY0@!'])=(R$FSF=AMS?EG?(UMP_@PRMH6%X"HCTBRI 4$K+488_Y(##P"J0@5 MDGJILLT8IJ&;/U4KB@,@EIP"QILO9]%0^0#4F.[&.?!Z]1?$9N)'$;)5I'ZB M"V_"*"1W6,^0XL\'^IIABA(PAU79)]OG-S(.'73"NGJM:>>$J;073YX?J%QR MNOA8YP'_!"L>^5@>N[<9"I]2N:/DG=P\P)LW+H.KECN/0=8(RM< M678B\S*;OE>.*!^>PEL;;K_''#,8KE(&S[G4*F#;;&Z:8:C+ M;HDV6W= (=%%DE<2)OY\KBPP-3C!EG>'BPFV.)TS M@%R&31W1%_.3BV6$7]7*@0*UR)XI)5-.6&86B9YF:;J%K-;9=**BQR[)"MIA MY&):4(K=.!O97/,QW]Z1_H>#C+T720S+B]WFX^0WO#^G 9SU62)()Z$,%"^/ MCG(9-;T"36'=C_:\Y!AD0+[J7IH'-[:PX63*XT!NQ8#/!Q<6>2H0_8JY,8H# MS ,QH^Y0I<<6:%D%_..(YW0V@Z?8J FB.H,S-;I29:O<7/3V&0QCZ7.AB^ZL M-E9RYZ$UH\Q#'<"!X5*@7A446P!SL C/J3\W,A5)/6 @ZT1#@"E$L*V*F,)& M9E^%I"G5#%W3I%3WV?-OJI41*0YZ?V(U4 L3FZP=-;0J$\>T+3;9LT(M\?FY M96EI5%XF/=P#*^4;"7(+:.9G"B9A*GMKY&^6IP33+):J=?S;_ M//3^Z*B$-8N#1,)@R;[63FK.>3 D4CQ+N8W\:U1PB,^D@0Q^18I.^-K@1E%& M<9MEK]%PWF#.I=7X_>3KYY?1\/=?\?]7*VJ 7H_^,+WD/SAO,??M:G)\^-?_ M!B7C=;;!W;- !:U5*W(RX)>7K=::7W"G7$IWGTM1N936D\ZE;,3F+V%]-MU6 M02?"C3QVPM%H1D83EK'312;TE&A!(5 8;Q1?QTQ462;=1!]>$]/5T6]K'OD& M-,4===?OK_2@7KW\^8$M/&#EPYT_M+>?/I[: SD\]\?AZ.:WVX9"GTW#_P0\ M$AA+04( M8:BN-BH&U'H86WH$47H9PU_P)7__FU?_!_WG=6"0%_X,BV:GX8#2XTPC"S?S M+VHJEQ3&!25:[TY^_ ,,U>'T\C>G76]/?L!0?\59KV G%LCAMJZRQ3X[&CS! M68HFBC\!S44^)H)'VP,6S!K+\8W<2%H.\RG#"8 MZA=Q""^63TCW.(P*QC]NI(3)+&F>#X/+P>Q/8.P[&6I*B42< RV5"L4O7K_QCE^\_[]YZ/7K]]]_.._?JG_0C^??#XZ5C^O1_V*JL%\+FB: MTR_J-<2F"MNC9@5/F1, P F\5E^3Q]5QKK__>OKZ9D\5OMZN22JE4^PDE=A<)T?#BS;KZ=?\-^X^R\?. 4\ M.5"2S"ZPY!/KB2_!(%<3LBNGX!9?A8!3,7Q7.&Z%^A-\)97YV"F[I^%UI M7\:5Q.Y*D-110+($4N'RP$2#7( MF@J$P.LXA[,%3M YSR9_17Z>I9<@A(>G_NB[- 54NE,1D7^.CW7",H6W3">7 M6#8EMRI[B*F^?)4_CP_5*1'=Q;'Q2C\JB*Y"<%JD3S!!?0#H@&@2X[55S1"H3($:[J>+/N 8U'%CI M+;@FQK-4,JZPU'+OBHDAKW80FSE&G.V$2JOXNM] ^X0=##=\5G7 =CL-LJBJ M%4L*N?,D%2X)M2@;F\[7+VU:8?UCE]QP2@MFR'M$\*GDZ=\-R>O)ZV;15:") M8"@A)]$B$A@9!DLR%SZ=O.Z*H_^ZBS9WSB)E$53-P@>8H,$=>IF ZBX2(3$94SQ&:'WD M.J_02*._$'?1:3#"P?$\__S\T>S;%UY-6'?S8I M$.1 <= NYY& 3E'SL^JY MN)4*=M<5"1P%%_[@Q@%3\_#:OW'>X^/$=_L"GXJM=J,?OFA1 #N2EH]+_284 M;7)\[8>H6F3NLXS"5>8GI'YC$(8WRE(SD' $>@$N#S/B;HH* 3.&ZV&%3CW.HTU!LY_ MRC7I[UT3Y9IT]J[)QET3ZVK;_4!+F9.QU"39#KF4?H=.MB$:+,'_8IWR*A[> M@&,"NP#"3$4KA+ YOP+[ IV3O)WV__R\L8L*< M"I9 ,OH7R>$_?%$W,'(=@E[D>Q!Q:"%7[MB/%BL-HS@$[@^,VV 8TE1X":]I MJ0-.R:R@D-OM \6R: *R#831]BRX0,"%98TQ*\*8\414)+;[DK2;MV5KP6U) M+NL][DD$1\W&"Z]*S"J;J[)5W]A5N=W$,RF__T6'WH$S_YBGNK(B6E PV(,L ME\*@\D:I[Z,X_A0\V<._RK(4.NA"OFXKZUJ/?%!"EZ*6__JS"WX >SJ'\?DA M^+^'WV&P2-7G(Z'+X42:MZDX]_=0JO-]=K O^!AX=="HTRG2N_C?L:@2>7XP M(>.D(_1(LAV=TE& 9"6J!#:C[$D;(_)"=>'QX2U1Y-O?/^?F#)%@R! O)1_" MR@ L2%+D;E8B!Q4L>*.*^0U?/$M5CX7\#819/K M@)-M P+5I;%Z /,>2:RDF$^BA3GC!H3ZK^K=5_K.4C+!(F*88'&N2B#_#&UW M,AA39D65]F #H+,;+)V=*L(S_"X)R6B8B?E)ZBN.1[E/7F+W<.N#4H."?]6S M/B-<*?/&**%5@D7-FJ>!DEAG' Z2F&.6:D^_G'PP;15C>%O*$\#E,C! BL8< MGDL.TIQ"D!8L6&:^QYU*U;3K>W](^4/=I^D//5[[KGU;0:&I@\($O?Y!A\4N M_.$%:EY473'\-%8=!>]F&9:8@!W+!&PV^EN+EFP\O9"[&![';.=51,^K@OGZ M5[-==UI__/K^](TKR/R[F'/&:)"&72QPY]R6ZSR@9(.I2$A-MB29#3 1=>5' M6'QR-B,BP@ \4@:'8,==?'ZF"(6+"ZUHMZX5 1, +5&XU[#P$"=B6S/G_@ # M[UC4+:ZW8B@@%U9(^(Q9YDHF[% FB46.L_00+EVYL1U$7>GR'$?QC)M(P%5, MQ_9S?.QB,;GO2DV-U;7$%.V8J1U%PR1&)C&J?;)7$$Q.TSM-0$B\>614I+,) ME6DZK_!A7DM;DY2C0!9]SA> ='%5R=%L>AGKB('*9.0%Q"7# MXI&#)A"0DE MVX6@G]P+4A$F7;Y""P;K ;01'=TX!7S0\8BJW"(?T'FE*0BV)1-;U(PU%(+ M4DXHK.#QAAJV5?3>61"#0+M[G8&(5LN^A3QO@X&(K7KBO[SD,VQIV=>D4G8J M +"#,0G*^/IHZ:(N!1%$=6E5C-B%HLC*Q0J+*92XZ@U5$HHGPF2MUE3#$%&< MJ/R#E+6U#1C@;6&CU0KE\S=:-$9&](90Q9%!)*8SF;H M+&MJHG0TRM[ESU,-KB1M,84KSB^VX\-JSA$1Y\BW_WI]C%=8@(!Y+J; CW)U!NX@R"#!R8A8JEWK/Z=[$>42 M4PH(N,!/(#TFJ#T5'\''X+CY,71K6L_QFK7.<^?XZ(\O$EVBQ^#G,<1N2HOL M$#Q^G^^J[I@5-'1D\HELH[I99B4 MY#O8_\LPB#9-;R_=7DKA-@B%P6 2^&1 !,G(ZJ'N.C0Q9MC9>98$=OUKWE]' MC!#^4#)@O#P&V/.4$"4D'<9#+E2>2N0Z2FR*L213NUM6OH*T0&)*#NZ3_H&P[.;K" MM33UD?UZ2AFAA($OZ)NGE\3>&E]'H]@?@N<1S=)_<#0"QLAWZA2L,S\9^UA) M2U^+A/<3F[6=WZ"UAMU^&.JH'\6^CCPL.VQ\2+6BN@FD.!YL9X/<+3GP2\K4 M8'2 \W5\U])RP>0UP-"9(I_&2-'S*?M4D)V*]6@4GO.*@5[!,K=#7E^8$;)+ MX:;"L0E^8$)%D>HJ%:.P?1I<:FQH UTJ5)):^2LR!7-UV:;0.B6B&3X13$R" M69 SC"U%PU%@>LZ7\81JNF+Y)CP_"D8;UT8&DFE#,/,0S3N/Q$);:CMF@$TP M)BE"WF-LMN%:PO.3@>U& M/5,&V,R$% AU.6?%6MM8L=Z"X O?):NOE/3:-L6 U^\MO41;$:I^9HFXAK20 M*7&D2<&0QK>&-<,,B54RT\FO&4%Y;SFT8*&7G-CU+JB"(G3KGS':]$HPESR* M5VQ,+-S[S0SO0S88MD,#:WRX96!FYU<'Y-XY@_F;=.Q#JV(V&E$LA@ETV="I M5G1C)P,#UE80TM1/N$V0 6@3Z)I-E?(L%?5Y(B"#=#X0L@VBTU!$Z&0^G=W( M(ZH59;4>2TZ&&S[GC=J(F//"82@X"4_SCI&24U5-0GCW_6AOMM$'5[85 U6=Z=H7P#;RZF?J3Q2&I1L.2# M> -5RUWB?'4MXGT5R,2BDXC 0,&/24A,ICF6P:8'HR303!K#C) *#;(;6XL3$X&S^ZJM2_9Q*+#I,"#UL/$ MN[%N!]6ZJ>:\\KE96;7R%OE3OJ$X("#GAV_>RSX8!HK5][2E*KX[V]NV5RX? MP'#R1W[F<8 ;,&*" ?B]EKJ:EJW\J<%*-G(:KX04F%9T$L>9LS,$CQZKA_ " M@T&/\(P-&6\U9#R@0GFISE7R+,JZS:B#)PP6C&MT7TT)6K6"LD ^:CZ.06X# M4J3[Z0V";+ #+T8>!CE_E"> 3K3.OZ*W(VC_@7\6XO8R4V(!_H^DFV/T(@/F M4L\?';T$"$^$-<$'***O21!/1G+\ HFSZ.]+.%Z^):X6H8,L:-1 \_8,8]@" MU#K(+(]0)-)XXW@([D=V7LI!=;F4^]HTY%+"F%&',KLL+X(]*Z)&\$T$B*L MJY5A AXA%UW#60K\[X6UP=!\K5!$E]!^M]Q&.A[B&86FZ J,5C#3GEB#:(*"I-DZ1A+FSDTJ=W M,YS7D^Z@Z?_4G/.I,)#J(Y.?&W4"9&R?XU]$\%LD M(52BP3I3R M')(\Q[DT_G"=)ORO]0<'8T#M.>T_G(,P4G!E5&HO3&R.2#Q0!>/0%;*0@WYE MF,7=*KEK[,/P*@S?WX?AM\2.<*QCD&352)CGB7 E8 B:P,>*RL>8@KI504 1O@G[.@)_3,H0VES;AV+EYC4X'__5G%P=BJKJE@PI2/Y65K*M7 MX!TQ]O\[QLKJ$38^BP*SY+JGF&8/S<4]N7<[=8PQ)I,D\EG9&X(F;1=Q%R6= MRG'UY2XFE#)YT_A\BIS.&L"@>Y]<^0GAE3, 9\UP80#Z<"5F2LKP07S/JFMQ MD)&UU=U%V^<;>QR)N>D^,6JN8'X4P2;/((EQ;'F;KL%[!T\17@T3BT_I6I%S:DF1*?Z+M(L'#+; M#*D97$NFMR3,',[@B+@!#91XT6NUEAG2FE0KC[H!!Y>8YW;L%,7/L^)?>N=L MAI@PI:-(G389MX2Q-#SD#G; "(R"5>1&N6P@F"$"H=)M.!MMK0B,\C:\@M;Q M[M9,ZCYO$QG7WK8-TD"(2'*SE5(QGZ-&- &48_(K9Q&53M,X46]-T5UG$F.B MKI7ODLO[S.L[9SPB9;/P0CK%=92NA=\Q!TSW [XRC#1Y31GZS?2(LQ6!HO&; M4XPJ[$8W%HH1^XR>O/N @QERAW:Q7\.HY,94]HAJ*GGTY?-7.E[8$DVRO+E2 M!%U+SWHRMSERRTJ=G2;'P5$52AH8W^@:++U+,'AE*ZW]5*Z81/W6E^'5^1FD M$A9D$V_/@ MF#(5?BH.@5U!RRK''.90=(#Q4Q)N!*EJ43FG\!\5QHQ3T^N>!X#=LA(*_\=V M.QN47_LP:5?&3]-X$))V(Z8%,'>.)$3W!7MGS@+G,SSM:XHI=!@]'K!'?-V\ MP0:>R(T^B_1:#RDA!?X8;;8OF%C0"\PJC/H[D6@G6=38_^9:B')GXH,QK94\ M6VU5:O9SZ,J^4P-#-L\GNM18M7W69>9DI!I]5!R#Y:]A7!1G=0$J$E3Y0_/- M2/,FDJ#LWEAJ.^0V*Y:005B M6UA,*<0TH2FG;(6*(@, R6#?8 4CS+_$?%?)"R-B#P"7+N#<*[XI9^7)2F*Z MIK!ANL!3I6(D1&1MS8FIWWO$=\B[2)%6N-1;CM8H$*9 ,',/Z=I>P#&K2GQU M(HU+,)G5GKJ#J,#=\24B5N02BL*,"P(^:.R"_0$B&%L=-%*]ASH#K9JZ:L>3 MS!3TD>!565$N2OMP1I;0B$@X*+LW&JD;3B-W;0IYZ>,W1M"JE+9**\XEG'-U ME#5[/89=83D1 X4%T?-X4'&(E^$%FC=\C:O[ M#-K.]CS.*3MAWR&-IPJ#+$Y830;[X8N^B>@KWZ/X.L)H@"0?B';Z#(Y^IDNW M2<0/'0ZU1GSCG04CCC7,%'X1'?%L[8_FY-8]++#'KQ066%!&"A'A ,%H'L82 M#Z14D9HIZ3OZ6#YZ$"<7H(;_XYM4B?ZHB1Q7*U9SCU..?IALU&W%0+$JA<"B M!\(_4U7AT Z.9)]/_;PM5<]UJ2/D5**FI]3.8WEK)DZ*Q@Q&Z6PZ\3G,P19Y MKIA>/G9)1R[F^'P:1+JIE0HR^2-YT56PV#Z32+!YD]PR"H&A6R$GP83<(+4[ MU]0K.\9FOM&-/0]BA702 4@*PQB>1%Z%):>HX@9X-@RLI M'\/&]APIQI8+18? *BVU\M<2DS8T?WG]8E-S9XA*J MH NR\XA4T&0@H7C!]5,'.[W=[^+3+"E+6K27*1^;G74CX;@P587AG/P0X6'AJE:"Z)(;C&$3^5C5T[J2PU54"%+ M"2N&W0R"!'UK^Z'4-0$LJM21-HV*!E'1+.(!M.@(8U* MCA7)N)0VD/$\%3M%Y(&HD(94TL\)<<*)L_PQJ(!5::3'<'V9?2VG&N.2SJA5L:2RNEUS$.S?%4K?<^3 M/U-1MM@Y_&1\' 4\4C5(KG*G5BI"9_JX!8HUY1+R9-V IY;S)APRVG=++=^- M"6.5YX:1SBFO+&ZBV5+:2:D*EWW"\!"ED+4=*SO%"13S71%3,J:5&*K*<@E( MS5)-KY,OT,JJ+%^ST63YP10^H5HYRB2Q&=M#*3L-XJ9LNZ)8 [,@U7H8C>. MB7GPAAB3K6!L":4"X<_?PL.W(?*\@M7"%33GK*(ST.UJ)9X8[Q*U]R.75.GC MLT!4">!@-0)5+3:-#T_7?*E5I["=BI??)R<.Q6)N7-:U+0*4:XES$/O3=>1\ M>O-!UPP2*[YAUW/5;K/6(15D=P_+&+8IEBV!A 7\016DO\D*'0G; 54M4*V8 M;LSUQ^<3= T'WZEL;(2V 5-\G@>8;0RF@]H+R@*0GRTL?,H$\JV#R8LPM1L= M6= =F(:US@1O8FNBN,AV^,38?>SV]#"9I M3TV$PA]0BFG(CL@QDJ=\>4MNRS!,00VAQCT+1O&U#@X4 <%*U$Q,T%5>%386"UHC!/9=Q%8,F.1C>'H.Z0&=M0#.0(#!1I@-93'+N:O]BD$>%( M1%A*?T!.F+ASZCOJ288LU-!_F[^:3$<>_&0 U):&S+PCCPF3-V$FP@K_F8)% MKH](%3A]""8FECX349?*F06J!["F0",KLV"=NO.@S7D:M&J%*^_I,4A-4$3B MTL*8E==(H22(@FMXLO+@P*&!H1:9$83<%7;WOZ6)B5PBSCB,PO%L["3QC4]$ ML@_-0IFO!XJ&&MIICUL'O#DG@!^8&__RHQD>8Q(!KT@8:H$T#,[AF" C/S(KV0.G<'Y^$(=JA&K$(=*6 MH/\I- 43_\9X$M5*8<%\.8XWZ%IS3R$U/55F8(V1M4-A,@GHPY!1#O $L#MF M$0R:OBB?5<-C)%"U(JZ1R>T3U\H*PT$;//Q_A;[S7AO7&[4!=JV@QM(),Q#2 MGBB$[&','&UT>U3"I=Q%H?,^=XWM$T)L.EB>4'9^&7+ Y%Y2-& ]XC.;^Q1V63IP7S3Q$>8\(IS@U$\Y:R,?HB" M;ZG&YJ,;6_ND#$_A."+V\($_\QN(:Y8+G56W=5PL=*N$CF4,QH]\DX9%L!%= M%H7H%-9G@E3 !!)<6!9ITE"CO>2/6.TJ#*X"4L%*%A7ZLS.S49PS;7@VJ'HY MRFE3JD]MZ^KQ&$#!-XP[R'7_?CJL/17;Y]-@&J.4L>W314*Q/"$;W)0I%KM_ M5L5,1UE;IK!VA%6BW[K:$=&54,0JQP9U!@1*YSQ5/,9$<<80>ZL7HP9.:>." M?(I,G1ZAL-ZEB1^,](L&^>)N,RK.-TPQW\"N"@V>C@M-ZX1S[0@&SYLFS[I" M9(1O\--+.=OI#(__I9\PK &K8[ -Y30>?%!(V:?%O>$#52KO^G'0"^2_//+=M1@&*FNHS-',&,GLE4CG ^B=WHV0FF4B- M3J/]'/^8!/[YE!40H]CTPV$9@H"O(C. -2N#[9D*%B2)(I@.AC WXA[MFGGT M*7(^8"\-Q5[@E3I%>%)TNHG"NG/")A(/AG%>^4.?O"Q'1XPI^<62)V>*4!2S M*5*5#9F7A<'1=,PR.X-G&.PU'6YVOL'QA*],X2">3-E2XZSS*%39-ZD_<\4^ M83RWUEJ,6X#W?#VQCSV6D([/Q#2@TZ[TP#$?^Q/2 S4]&+$&8'.0>?1@[ \0 M1()UJ_+/%R6M4E-I0ILILX,U1FH#_!$?9;<1XY7BC"M;:QBOT8E;[LY:]AHB MU%!?0#Y=YP+5)_-=Q.D@%%X;W5@UPYI'PX GB!')=,&ME#?FI MX<++R9HF Q(L[RA.Q98FGDN2PC3< )!\J2.^VV3EY;S'\O 6T4^K^2Q@GVZT MB'-Y90R_86UI>F&CYU?V=I"TSRA^<+F^NIGX&!?5[$(\EB BB 7\GJ[:H;9- MIK&%G0@R7/JF>;*X9"ZCB\/SW)^1:%QZ,Y,]0^AG_(AB2:2R!AZ(P,"&+I%. MW)A2P1!YE."A,1S=0HJ7"CVQHY;/G9R%FO00SBRW'B@HI'EUP3P*LE=4LP7B MYT&(?J[=@NE8Q5:BZ16];L9F_B]W+WOX[05V],1N]\@>X7WWA[GO/IG[CH=R MK"\].,L2^QPA,)0KH^" 4/4MGS"XF@,P."Y5YN/\T!_BH%,T82:SJ31.-T2F M8_\'N>"Y[TO013K0\4#@YRMB*B W)A@%1'L/=R87_[TH&@1GP-84_+0G]61Y-@.,6WIN8RI(SN.B",7:!B@>\3&678]K%XQ:S^L MY5T,[I2:;^]3\RHUWWB:J?GUU >=!'XJ+1576A6T&P@E0Z") =EJ): P$_EG MJ9DX5E8BO<$95@D':(TMDKA8 ME\,GFOXQ(0GDL%;I*!UJ)$FY'QP41TDF"$M)UL&E^;CLA'GQDM4UC'GU\KC& M)V5[E@&R;UG88KC-3H@]$B[D_- VUBUDYT)#>'94:(?011F^2QY8TW.),['A M2%J*W?#TM_7IP=T^8'/[?.4,A[,2PV&5XHV7/FP7#^-$1^CF'KR%[L%M8U][ MDZE7+S\G8'^&$^2'Q,$=L9L(8OEP9X3X,1X8'*MWT?\"A\_*]? M&K_LT/P^74O+GZ5FLTP[+IY-6>_9OQT?OWGS]NV"]GJMYZN\S%# M+NJY)ZUT2S=UB-;]?GAB+FG>TAG<6*/>]3.^F:LY*M%3G<)G5%D3J"P7X7^O:A"#-4])OYYC1 MLNSE^H'IZ@)28"O"\VUWY!CLL+-@L-?3#U!/YZIDMJ:A]X;S8Q7>M2IC);Y4 MG+E%L75 &5.)HE2S;>=&T#6/>U&^5917EZUYG(F^%4=[7\_/Z:TZ$< 4'*[S M>>0+.>Z;_YF%U.]WG[RSDG>(%+N,L4A(=Z$/L?<<)\0O W\HH"?.T!.X".ML MIX[7;7O.EW" W+8I55@G >(H3F:( _U;HU'ONF ?1_!K?^0Z;!XZ_VS^>>C] MT3&-$QE@GNG]UW8[7L=)\<5!M7*.I/582C#Q!P'V\2[@[K$-E86TQ?(HZ?9. M0B"EW8WZ(3'H$JP+F?1@S2*J_HVR>YS::#?5' M!<-"!'K,Q+^$&\$R>^+>)#2;C1RQ]I+6"GY.>7%HOQKMNO,65(7S*IZ-P-9) M$%6&%"Y81G\)8_!G%S/_1NV4Z_RK\Z_#UO_=*-NAAMMK=D%(9%ZKVJ&.,W>' MCB9).%+[D]D> @+>9WL\K]:^R_XT&VZGT9Z_/]4* WLR^[,#9>0;>_,"K^4; M'.0, 3 6W>AN<>?^ -$85#^ %0)#7,@IDUZC; UF2<* ;=.Z0BI]X%$I*!Q& M+)JC$'-9PC2<(C1,CD.(':7.X'-7?CCB;Z3$5BZDA ,";0VY3=V-QJI.+F]2 MJFV65O<,^="MHJ3,.6:B.'L,Y^=8V?U8T)*O7KX[??/!:1W!^?KXYCM6^?XTXGJR?\FJW)!Z\QCA:-QOD5B%PLNOMFO/I\YLO1Z=@ MLCI''U\[;]]]//IX_.[HO?/ES5_OWGS#7U8KG[]\.OG\YOCTQ-D"^=G>UK9- MX*--V=J?6!&"&O\2I+/1M%!LLS'[>IMZX/=WU#;7=)L7ICN"$1 J#:X$N$>H M/ XOO_,P\B/N'**J5X6MF18Q=\6DET35?A80F[.4[O^W*I$E"PT?BO7\6+E# M-KIY0XK@1VGXI/@"%"(XBJ>![OP&5M4H#8B\F5C,T8(Z GL'GO$E0/9=YD$P M'HSBF-L#FS::;#*$&JA4B/*!!R^V.!;J#J76GHDD^TBY M-448!NVA0":/?8K:^\C>\#&F.H8+GZD7WLIZOI?U/-'KJ4"5_%*T=^5I7V L MSEL?&Z/K#]VZJ[L!:KX%G='9HS,4.J/Y--$9V[: /UUAWYW@^NG9N;E4/F+V M;?[O:D4(P%7+Q(31<5&,W8^O#"'\(6/&LFW"K,9+1'RMN7@8V:9@KZDHNJGF M0,RS%U8KFL68N(5YT&<)ME="G2Z#S&%2T[G-LVKR"$W\-KW$+M3LF:@B/R4W!+1V_FVG30XSE M^2[NFDX 5UAS@931!!0'09QK6;Y_A32FGF+.94RR=S8+*3$BYH<:P88\XZT2 M9YP$DZD0CK8I/%7/LHJ-PG3*&$I%]:I M]=HD!L3_.2Q__SS\U3EVFF]Z*JZ^]H4$451KN8'>X*]4P$TU;T=K UX]"-OE$^<'O XIL::K[ )LC8% M8^$T&(&.&^L+#/ZNKRWAGOQ(1"@CLM"8EO":Z-T4UV.Q2^;37'O,2BZ27B9F M"2<^]^:)G&-%R7*V"_-)[K\K5N4!R]9(^. MTJW86.JU\R$<)#&XGDB"(BFV01P1:=& 3,SW,<:U+@+J.GH,@P4;. *+B6Q- M8O;MH"#WGJH'??#C1&M[NS,W4F5ZMX8Q#4.[RBT)+ +%MN!X@@C4PSC5U&Y5!?PG@W;@N MSE]A0%UDT(T6_Y8Z;H'/@Z15%(,6-_J);GA[_H;[%Q?@DI#!F% 7 Q]:I >R@;WJQ$>D0$BD\ MW3WQF2*+;][T$$9PY[U"4WY'^C7\%1)3[T\#MKZ].R MO7^"=QMO7VO^]I6J+*2F,-WPJ?I%9PF3G-CB]8CZ88#;S#A,\FGGD[9*&O7;%"(?FU.PZ/QA[/Q!K4D_ MCP9,5\>-.G&+DQA4WS3?!%3%5_?.I%IO[R[GB.H+P)],P_2/6)TJ^MP'YO\T MSB8M/%9;:U/Q"^4HX 1^T)U2B[7 MN5/U+L)*97\2CT*Z'>DG?:H:/3I5_9TY5;?DMKO[W+;*;;?VN>W=UQ\+#%BT M?\H\BUPY=2?O9Q1T\Z([6CD;TKZ!7F#\#.([UTX&NQVC&),OX>"IFDZ-[J(K MEKGNA0Q=;-C9&=R??+?*'["%O+COJL$%=[S O&"]5F^UN9X>?\FE8A=)G%*A M/[:.H!R\2LK32:66,Y*EYJLDU8E#;*;(,6$NS^(J[;, @16-MAJ(:UC<*[X"VPM%0@%*-N.<@,+. L8?M(=Z/( M-1-4;6X0;X(X!S:9PN@*]@_]%&PJJ+[:ADUKY\YNM6(.KV]:7?S$.7;N>HR; M6I! !90>8US!YI,^QK?&BO#T4NI!?- _@HA:17X(@JGH;3K@V(H($R%4E_39'T)[I?BP() MI6G2H\_'XGE*@1L61\/O=,G?.VIHHSQ2.6.6*TK>[H])S'U+V69*V6'-!O*D MSB?$"#EK0'7ZY-!1=JJOQH\MCOWT\@I.:@"K%&#<* V>[+X6 G^1/Z;+T5YP M?WA%!52T*:^$:!P/A*J4@3L(+E:J2'T=SRZ<8SBCWZGYTYCZ.M+9/3JEJIE3 M\/.2=/H1BZW\E*0'S>(CN-^X:<)?(7*S?H8KE,KZ86BZUR-7[H'V?7K;)<+L MU9GTN9EI%N;XQ U/<7*O7L<.6!XH4+ =$;5,S?+2R2B<2O*<6TJ $FZ[S7[3 M;=5;RN$ \Q)=P(#[F#J$.97N8+'CN;UVT^VWV_+I1[L)7)0^FR+(C@^J?V$9W&43YPRO*5:SUO!3;A\KB,)\'Y;,2V&57AC6/\VVS,5A=BI<)H%J 7 M1CV>T-#5*M_T5Q*E0[UFL/L1:R <,G,S(/PI"D8R9)IGR!VI>>Q<87H.D[HL MF\FZSL2]^J[T]M%/%?UL[Z.?.Z!8YX \7[VMS-^\+HW%T-(NW*POQJ58LS X7/B#4 5TYJX%N M-I;=ZNK0BH7"F?KI=^ZM*39J@)A,A;-Q_ &%5#)WB9&3? 1;%W-D8]FNU0P< MOH4HH""Y8'PL]9='#J2,CP.!2ALETHB=@K;)6YL? 1R,$"RQ=-\R(+ M"\+XJAO3#YH'JOK%HMO,562N"D."A8 #%@HCB41ZA9EPB N_3YBV"*7G@J(H M9$/P0RU$F9$5+I@I=$'$!M-HVU*#:5F.FO/_G! [^6_.U]I)#;P2O.O'PD9S MFBG6<9V_7A]CYC3 OKNU__?QVG78Z4=AQUXAG R/QO_!8UFMX*:0:(Q!>M'R M W]Y@L#V64"=\F*$V0=C53"8@^J=J:>QAJQSCVO8?NFMIZVR=!1?<^2::OW! M<$2Z('#P.$X0\%%$X YL%=M>HG2WHD$WCKR9C<<(<_QT[OR;S]'H)DOU\&B0 M1LO <&:1#PJ:K@*D$*I66-.!T*0(=L@2+X011A:,BV)[PC'WD;8(&\Y\Y(=0 MGQOYH%D"ZG@_C@GK.>!^QXP^Q2]H:C:A5*!'3N"Z0M?:RZ7H2KSL+:'$#%&+ M3,B>DY"VW>T"4&6W6W=]?$2D+JK'\Z$N'6O*ZS/1_ )K<3K8&"O1.,)3?TDF*@3\-2F#J?_J4X]=_0; M](\#=?)?/*&5R!U][PE-/7?T5S3UGZ)&3R[.#AKUEMMH]MQ&N_UB/DN M>NG?;LD>]G$6:G*CX!Q^UV?JV[^S%.W,!%INO]MW.YW"-?%0 M)M"&P<,9:-Y3D_[4O?8MUZ]FR;LC5 M"Z[6IE<#%''3;79W0$KAM'3[[2V/ U0CG)9&M[7T.-9MY:_6LG]/]=JJB'N= M*UFOU0LAQ UO)@QAV^>\7MOZ!; 3&[%UM5^O->M;'\+6+V&OYBU_(HH$[1M. M"=U2'M;?EX>I\K#.OCQL&\3/7]ZN)\>JOZ8'SZ>.*\_?3%.?WG&_C? MES=OG ^?/I[^\Z1:>?/Q]9O7SK^^?GR#H4;)L#WFVMQL@AQ+:"+=[@!!#V6$ MLZJY 7Q!T?0KCXTYEJFI4NH$5!FDDI92)\O,Q<2PG%(2'1Z=A-B$S+_ -@33 MPG.JE>*#&H^.)/63;ACQVY.HS,"#&5P%T2R@2I2L!%4KBT3H&ILA/&NX7:\. M_^N*#'&!W[-^I^^V&[UE);(A%44@D@EU.B.4K-MM>:[7ZU\,L^#M\E@#B($[V-0I=%\3E2=7/<$ MC[7+JGC 8Q5DJ3G;TT';K6##^AQL@(>+I"214=:W*S.61-BL>L=M-'*2V.O4 MW5Z[?2=)5&!=GE"U,L2"F61Y_4KJ-?-4ZB3XK ?N:ZM?=PX:_5KWN9[O"_K\ M,Z_> X^ZZ1QX7JUA_=4EDOJ 2J)'-T3O,HG3D(3K"K2V+W0N]IA1+)]U^FT0 MRBX\L%=K/\\,[+GU M7EWDK/B94'VAP'SG.SHJU@VTV)[=^BTH A@XRRM8@8Y SNC M:^SOPT"2^"+QQRQXPY":@'&G37I0$E*3+)KM@%M1*-&BEK+Q-9*MB:4A8QX3 M"40\F*5!AIK>H=;H3&2!S!/Z<50[*[7]&]2$6]2!)\)JCD=XK/#!, H8$>_H M7275<^O-KMNK-W/"ZGJ=)MS%RUL-66G%PGO$791+:P-NY6ZCW)C50HO7Q(2(X,MY&H!D8N/I03Q#8<6O-1MDQ_+%H93J-/%A MO.JTT^-I;(^XB0A(D6+WH(M@. XC1+O2-?1SHM3%[%"OD1>E7ML#[=187O-5 M*T75-T^66CT7FYP<],#'4$9;1J*,H*2,(TIGB1B,TJ\0Y8>[I^""7,CBH('W MK-'."QM6VPNJG$0I3 B2I54FDMBP'+'?)+HMPDY'T0P',4'LL=S+62FF- O3 MJ_!GS7Z]#:\REFDZ4L9'RU[X\/9.@\(>*#T>P1/!&0AHRGX031BWEL^?X1SRI[ N47"C^P59?8VS$B;\[)^/CSZ] M<@@:X>8I"B9Q'Y@W!>#**;P)NH&C%?-!5;8#"JVDA'-]%5_ ;7(IW<(S#A*Y@K1;N;@Q]?/<^JQ$P M?]GOU>]K"3V%>_Z5C[?4&9P1'(0L%*']EU/%=1<48W;5NW6WTVKNZJ)O5>*I ML9ET%61!'Z-JL1W+.]^&C4X=[L.\#^!ZC8[;K-];]AG06+@S3$=$/>Y\!./* M'\VT:\?XK5C:T2+9&UKG@X6*C//+ MR5?3ZS#6-R3#T_FB3:25K[PY'(^#84@XZ.V<[L6YPTY]GSM4NXRW?W M6X*-!H8S4:Z/NP626Y[;:'LYU=5SN\W[AL-RP:YJ)6/#PZ?;7L,1A#29GR5A ML4@L3Z2XQ%"YH/.I2;5D,"A,!0-'15/V!//5$:I/\ O/8%E]Z1I+OE^[XSUV M1/9\X8'3"1\$X>&VZ Y6P;)'>(?;ST^EBI96M MBT\EZA'YDQ).#5QVW=WNF MK%HIERT6+;W+G.!"!#52GIS+E+@__.#&.1_-L+$[;[G(E&2>'K6)<\P[BOX: MF/1D#03DXG+8CXC0*+:,,1>XX='\C["/_!UWO]SB;X/QV>Q["[:X6EFH/MY% M\NLI)V?L/=9>:1)8_-/Y>9T'_G26Z%AH?IK7EP%81MA&$$E"N'5NXH^1O77=I"D]:]O1Y_Q ML3B0,)G>T"_%V&,22[7*9.?YU)59=4^U9 AUA!H>&HQ/PCU;>)JD"[(S"KD_ MQM_MM>M+5RZ4W,WSA\7)W#&&46V/ M(K8BMDF0\2WP5WV$$.#_^L6FT/_RHQER@6R@>F9WK]J/P91/3AYBLIT1;;?N M2[&9H%60A('TE0,++K=&2[O>"DR3.S/Z@=2B3B'CEK^4LAE>IZP((3YWG0,L MQ( +K]7U7LR-7>,ASR8__C<7/KE3,)5^J%4? %+8 ] PN\JN!B:X"(Y M 1P4Q&7-S(\37C@(VV24#!('=.W/_R'-JK,?YR1!=LSL/6CMS0HULHAWP%?' M-GFP;5SM\:R)F?MN>WY,_3SO?1GOQLU_-I]MUW4!3^'^)& )]W&TT'?52HE* M=)Z>3CPJ%NJ9#'BU,@S3P2S% ^^?Q5=!EAO9TJ%2U6K C3^I3)'Z:9:BYA0T MVM*I@'QQ#%GJIFGOO-2>VV^UW%:O_;@]LZ,A?@)6[,VK=Z>OCYZ@O+]=\@(6 M&G _MV!V%17?O4@[T'NA!-;Z8]-MMCMNH^/IUO&%2'?IOT8<[]B1P';:,*Z"L55 M5TI)1_7 G$8/1FD ;G02:-I-:73P)4!2RMVQ]6^)]GO[:+^*]O?VT?[=0PJ= MO/N_!"?D$$P(E.0>)W1/G% :_E@!2BC_E)S?^)A,^CU&R(KEP;XO@Q!J@0.( MED>K4!A7!]^PWEA.&DL10@P^ZK4;B!!J_RQ"B)_8]SR%^&GU6Q9JP@ISSP$. M52O_;JIZ L;A+XWUJ-D'/L]&.A>8*#;-)84H+L-#SRW5CW<0 MN2P4R!$DD/']%@]H'A (;.DZBEG7.6CT:KT"%*C9:;K=1@O^6E\-%*C?[+J- M7M,YZ-4ZSS.2N$<"K<"^WKJ"OC,Z:+F#U&NW7:^9PP:UVGVWWV@M>8B61@8U M^VTXMNTM((/@'^ 5M]V"A,_#!)GR93,@.MS9+^ 5!*\.HTBZ=7!9Y! #EEXB_'+XP2W,@I4S^GDYYJPD;\\@#1K?#E)85;;>%;6 R MI;D=Y'>JWTNRYT.4-@9+1U&AV&99A%!D5I>12/F D5"MS44I<@-;6("6C MWTM 2E[+;;7V**4[BU;3K5,6-8=1:H*'5D>2SOLIOH6RU8*]ZK7ZSH'7F =1 MN@>Z",W[4G@1]B/(D 5+?BDQ!WY7IM;S? 2;MQNRR+1UI. M Q1J$YL(6O26O53V6"2%15INN 07J,(*3&/BVITI+]?5IREZ/7BT%(RRFN;MMMM@IAMSMX?W<" M(/7=3J-Y.P!I(?@(?Y'I"!I1N[WP"N,!J05/XJ+%DJ$4 $I.'I\$1G]G[>04 MNULUO01 Z5;IRA;7=WMN.\?\Y)L:8;3%.\OF2G*L%7M8TC([2BUK?>I/[.@0 M_4^;]/U.VVVTNO?2%!IJ)&VPK<'9OB:C=31^ISQN.;V.'<3D3&\4EF@&KT^F M_O= !Z_1P'$%<4/3\4>C>.";/M$:06$ )63$B'8=,G1)O?IQB\M]46SW2/P4 M_42WT:Z[O=9\?;#'L.TQ; _49,L>++1)^&31DL2@:% B%P/;EKEY"Z?*NHK[ MG4:MV:XO65Q3"F(K#$'2 !DGE,N'E61G]$AFMF?^2,0:,[9%'2P'QG%/P(DD&8LI9.@D-;WSYKUA7OEPGG#\IV M0K_01SMS)!\BM5@ 09WG(3A2_(ZM\-K=FG.4PATY&KFB7>6R&J!A$T:.QGN> M!; _^,>!GUZ""Y127@#>Q?MIZ6*TG#%;:N7TH]GX+$CPN?IY\6R:3F$1.$#D M3\U=8[6[TQ!^690VUR4MXUE/.%:CVR&[BP+__(4B"HY&+SGSW/QQ7HN5VW"R.P M/DK:LA3JVFZZ7K-; D)=;AD1= &6JHK2GD*F:P]+O3NLVX[8 U)W!)"Z.,"S%!RU"7Z(Y[:[7ADWV>VVWTVS= M"X[:0#IYM][9PU$?#!PU*]*W)'R;^X2O)'P[]7W"5RUS02]2NT7G^,W[]R>? MCX[???SCOWZI_T(_?SYZ_5K]?.>!2'=OKUY_KF5H@-B?20J+J?[%+6@7=+.% MA2YI4RL/;_4F/V"QWW[Z>&H/\/#<'X>CF]]N&R)]-@W_$_",N%BIQM<5/O-E MMAOF:E_T/OR?63A4R9ACB0%^"5+040,NR+='4=(?\]%:TI:3;2"X9__-MA8Y M4? R_X(N(KV*29A^QTL!"^Y]O''0+9QAH4X84.10?1#=/I1&^F1@KC6JJN3" M::SH8;0O!8C8 ?7Q3H6A4Y@LQ_J4F7H)ER5<%)C3!Q$&OUF\)WCF M-#7O2?&:AL4)T;.^3.+9Q25C@\_@X\IQ&@9C',PH!@=05Y@JW&4F3U*M@/]W M[=_@'R;DU&&XSN> XOI+/+?K4$SS!CYE/,V&$(N-GU[J<#R:/8V.VVG5G8/7 MP< !ZXH,^D/J5==TNZW&B_RNDI?K#P8SS$-1F5F S^UTFB_ :X$MO(Z3[QS0Y-/.?G>WA>W_FO3M@**6]I@ZK:;; @OO$>\C M1A=IC\Y'\75J9X8AQG.Q66'+:[XH"_S;X1N:%0T7OYFE$,)Z(G4 M'V5A=90>C6!Z45Z\P,P=*[*Z!KBLC6[=S<>8J%1IJC*8RJ#WAT-L'Z_2#MT& MLO!N)_R]W5COW+55KE2JJKXDBY$+PE4K)B(X3?PA9V$HQUZH[NIW.FZ[U2VR MS)E'3#"K'@XEOMGK@2"6L-*9S^LH+7M\+1?CK5Z]15"!^5_SAU<\-RQ4F4TF MHQ"+71DU47<[[5Z!C:[XB &!DK!;S0T!VDCN!H-DAFZPRN.I ]#N-Y"HJRP MFGDJZ-V "F02IE,0\$3?[=172'SW2PZ3O'6-J!2>L4PL!8)V3JD2S$4;[J,% M/;?9)$*'%UE.=/Q+N]5Q6]UV00<>S8TWP.W:[K3F4EJJI*AE'$G&?0!F6!JJ M])Y5KGT\"OSDRUL6 \2^>2TGTU N0;B.!LC82.&" .?]V1[UW3FG-$5Z(M!=$MN\/+&F4O+[[/VF!Q];'KL32% M;;M>"^RH=J4X^C[(->BC3A=CO#I1;V\YO0WOS4D2#X* %7*V>$D*I_QS M\+G+J_U(0L"X:Z"92/DG&#H8@X5$CC0;4*FPTKP++7EYMJC;ZJ%^M+%R^-1G MC,YC#%PN>[Z@%,YE4];'AD"@=WN=S##._.@[^2PB]4]#YD^IZ(U*Z]+9 "[. M5!(HJ*[H.*13@(.IY%X%,J[Y&QX2Y]>!S# M51HH3/OD,HX"=ACQCT*.8[I<@B1?!&1^7(=2,J@*DD#&5;:/([XX)&3:SMD^ M+KG"6(5'%SL\?HRE&6PJQ DCY2^2^!J>+WF>LUD:PK#2VN8NUFW+0SZ ,8LD M\(Q +/RX,&_ F\9D0V(LU<\&IM,I_(*C#Y<^:*DS+&@D&S!AK8I65C+DC#UN M)\7"J4:8=Q84SGAB@N)62JU:P= [QL=Y$V-0 D@^$)#8T&66"H0X!?LKN> _ MV(:;JK3!V#DB7F<)^Q-JLT$%DJ#!J[%VDE0ERS@X0Q@4X9@,";6 PC+K4 S4 M6^LQC.E^EV@]169,89[XD%3HHSCF!S%H-+O^>3""65(!D0JYX(<2,IPT#0J9 ML.6?MI>"5G=,/"-G]LF1+(2=RH2_@RC(FBL-@&L9_ O L/2C\+39SSB/X^^ MO'&.CSZ_.SUZOSVFMP<#;%LG N@=E2+'V[C3BY M80:JKT^F]G$CE(LKGC?_M]:%F;.\MM+*MB6?*9F,XN'X;? M$T"C[(*>QA3AMM8RO^ .MH+P^K0;*U[!A7/:TB(>S2[@%TY?W%E;-OWS<_!* MB7$?;I-#C\);:$TQQCV=@)E1K:2QL>+L=34Z,%7*CRT[+'0'>6^O+011GE&^ MI2RAM2]+4&4)WM,L2Y 3L^D3.O]]O[^S@:1EQ81S0E((MTR%3QJYC-^M[F)= M9M!JG=YMTM9=13/:.E#B1 M1O" BL= 93Q+#:H%995KVNU8Y+.FV\&>3%T/B_L4:136J4X7#4(_ED=#40$J M)8"OQ6E@WDH7$85;U>"&A.OAJ"16P5X%'#1ENB^*H.IYX!A*7EHV.%D600!9 M XAE2-8;\F/BO!.MQP<_&5P:'(^!()%I&(^&DN"BP&B]UFAFI\JCX&J"Q)\. M+CGT>Q6F5/$X@JOY+!@@\;0:*:^&E#O#6S&]Z[G]7C>WQ31>V0 M8OYUO4[,QFVGN_DSOW]]>3([2^F:G#IO,+6)2O?KRT=287RKRK=F+W$MD^]S ML]$]$:FVAQRM%.3/RAT<%9#SED ^S= #/N M W3W"]"=[4* [M@2<3L#*3;$%@M9'X8;T=BN&['Q:O!U^0_W\O>72BK0VM!; MUO0&N(M45V//4Y0"]G6$&)91H*/>8&53DN\Z":=33 G.SD;A //[02)$^?CM MKQ'ESTXP* <#PHH$!J=);(Z(^]VZUP1+O&FPL0,AO,P M2:>F:B?/V1#B&'32.0FP2EO*L#D9;MV4->II9AV[V8VRM]1G'800MMU.NT'++,H.K:I&K5G'L=#O9<:! M#]X'_@RSD%#H)$&G"9\41]G9T.]>V Y/ MR4#HJ3QQ^KIV+?RS^AFP<5+G0.1EL_PA[?\!Y)2+3 L'XT^R4?N4S7G#8IK M[K<8L,^(K8\R>FA>;7C&#GRG^'Z163T"V.S)#)QR*D+.G0"W< 06?9HEV[RJ M6I%WD?Q=,WZ1?7PB,A@0J*-X[++-WQCO86(6S'2%HEZOU3U:M^*0?6O L"UJ MQ'[N?,][E1D<1H(^9YW(-I9/ MHJ"6$M0YEOB:V5+IGNO5.VZWU2U7#:*?"^1 #ZV XE958-_#PP!WF*"YVO[OQQP*O@:[("^O!!6 MJ-G.1#""^CH(DO0PG M5 &%D\K%6R(J_+*T@-JH%U)4+'M)Y73JE;:HEZU49B*\K7KT,E(:7(8&EC=& MR9-R4F:%)[S(7CME@I<92HF(C6#51S<:T()&80 M7T14]>-GR-!\?3:2X$(:NL HJ#I!C4R]N%H1NC5^^F)K5)T7UB2K+NE87J1N MR9ZW]]ESE3UO/,WL^6,"\.^CITM$3P^P2ECJR(OI"R$8> <6QK'G M!Z/"+X9V=XFYMX262<\ MPWZ74E[EO.5FL'GW#E/KTRS!77:9+,,B^(&O$^9J93TAK@NQMX9IW9"$,BBK MWB) 5AD+:[_3<)%G&!?1,E-4L%!50#)<-SX/F=.(ODY+99ZIP<'*AYC'D_RX M[=N2?,,9S3""S--!T8JK:&R<0Z/!EE,\ZA6:(@N_"X)OP=8CA*PPG*=87@5#@,8T@T:'D[]N43# M6O<'.\R:4L4!:RY_L;2:+;?;:Q:++.8%^MK-.??+9_V:(WQ-X:)QJQ66UGP\ MT.O54;A%\1;S271)E&EJEO'B(9PWDMS)H\:$9]@;L]XEU.UBF==WU?(B[Y1+ M?+N9E_AJ92=$7F2NL5M:5@MYF@;$LZFC.,9Y%]DW",)<;LRU2/\6BDBA<[)( M-V/E,:Q#_Q*AAD&G?$WZF#J:JI@'5A_&R919"&V\738FH#B4M*XSGHHIE ML@'U;^.,G'3(X?Q!=BI&W8MUHE:-UX: E@WG]W?<<\]Y162%GS5"&W/X,&8. M)ARFP70Z"K+$AIK86,?N*<&I,(B$"*1O/W:Y'-J97JM#CC(=-8%$,61#D>&B M98P?5/J/"BP6IGMUSVBO@W0-KD6#@P^R56*U,D_@A0B#YU0K T0Y,MUIU7-HS\UD@5H @ *"@'0S;/SIEFIN@6 MN[ZHY&1M/8(T5W*+Q69M$YK9F[1[DW8=]_NCJ:G*53-OI*CJ4Z1J\K6!BM1G M?J+3;<+M(Y4D%@70P4=L']5\45X5T>RY_79/W1"J<2Q(4)PH$SA[.)]Y?=!L M?05!7&>=ERT7ZWQ/"="DUVZY#:^?5T,XBCFK MH>27 \W!>=.++;,9 ZPK)& M4/MPCJ-!./%S?;^>M81A1B7RA+R'$!E\Y6$I)(^#KFI%%Q;J2WXBIF@F,9HC MI7F(>U>.!VJWB[>L6[I%/(QGR #7AF\<@ [UK*#E"^&7P#PU5U1DCE>89*FU M<8/2(+D*D?8MP2I5TPQP1=.U$R7;"EXOF67K[+-L*LO6?)I9MDT'2N^&H3@A MX^F3V%2/!/YTSS9,G( @G<=%?H?^!+%Y&)F2J$,24WL@%6VP.\=C6"_*!^ B MG=6A/,MX,@H-Q])'/QWZ_^-,X /0BQ5_JJC)?A5L=)_A./96(! Y+W*;88] M0I(K<< TE\+8IWM,LA5P"^A^E5RJ;0!%(3%=2B5248EKDBFFU"Q8]"P]#,4I M0<-P^7$^,4Y1V0;\93;!:ZS1?EY3TNY@8VRI=53+K&*:Z-YS\HE*06XF0L/- M'A6^K*]BI,HYX=BN^H!5,,[S#0(]] #$(!;+)G&"Z +4#3>RP%V;3#5WGM#J M)L%4N,/Q\\/ GU[6G+\"S10;RWRPD<64AX$SQZ^94;R*_83B51Q>0)BKO85F MH%S@0PNY]B:^NZ8-CASP+\<8[2F7NFHE(\)"0'E3((S1!41*+O'?'UY+([ " M2F?K2VS\2MN/S/N9ZD:>5\&1J_18=A:WNIQ\K9=XG8L81- N-)^D@HGK 'G5 M\'FCX9Q:D>-/.../__5+(S_=N::75&/8#R_G-OFH5>_OK[Z\%&5(_Y2#=[=! M[]CLOM$GD%L+9W2$%'D7 ?W[C;H,Z*?/J-3O.%-MW]\F(V HP_@O$E#Z0Q30 M./G-22[.#AIU\%G!GV^TVR_F1R^ZG>>ETYU@74AT88A/$=J>W8(E* MU^.GIO$ UO_9!I;>:]9ZFUCXGSJZWR[#:6"=UY=_L%6BQKUP7Y85B++%<;T6 M14\6?;;LF7<<4&&CR\92\]IW&\:ZM>6<,_+FQP1;(/]ZC'[(:&1VZ9;O_=S9 M6IWV*EG[@S9V3"E(P9RS41S*BRTMP3T42,GLF_5:__YS7YL2F&LS%$?Q>_4JM[CE"VWH,U:N[FNM=RY MHWCON+7R: ]5-O^.%2J_O[+5 ,]IV?_3D1+JR8!Z8"ZUSXO;%0OZ1?!^6[W< M<3AY7:2BN/<_/[D:RC4>H^*;UG"D2G,!&#%9/D@!X_3 *.QX:GE7>407+L*. M[MJSM6[8JY?-=K.&)GCQ)2M>Z6+Z<-V [SV?T$[GQ6P6G1(2G6I%HN-.@VL2 M[* P$^*U0'*MLFRJ;4-V20SM][ :"ZN]2J:$8"'$>UZ(H' M"%6B?W%B@%ZO<##Y(K&H8*/2Q[F J]W"\COGX%FCUFVT:(0\['5WA=QDI+^X MFT>3)!PYV!JIR(BD]K+;;S,'2G8WF6UT,$,>4LX&JAPVRJN?R7WNXYI?C6*.8*2@ARTNGVW'8# M!:5>Z[6;[6K%E(-LF!3CE@*+[K[ 0A58M/8%%CM1B\XL_=G805:IQ+;CL=%T MX&-)_2V5E5KF6%-(V7D-6G#%P8:29-O*!JU3B>(ZJ@2B_&2DZ[Z6\YH",-M; M$PO?]H361"5E91&LK"S\I/*R\F-I8G;+:[/J)#7E*&[(YMGQD7XA5DMF>(RF M"3ANZ#)0!GT4G@?. 9F*+S::'V]VGY<+HEHH]+!_<]JU%BY3HW7X.A@<>O.S MC$OQ=7C/;PMI%K[2?UX:4O :;J_?69#SO',*>3^!NTV@W:H5P(9;[_1W19IV:C#;U.%K4N'>CJEPN*L^QE<;D/+^)DH M'^AH.MLT57#[FW??_D5RWJTU=\4$WXQP>QTLV]H9>=JQX6Q=O!OME8IW8S7B MO5)+G*\K;]U;V>[NDMYL]=U>=V<,<<^KM;=EB//V=U8LYBNQ5GY:BV],MG=* MM-WF7K+UYC?OOOF+[9-V8\<4N-?;D)0C2&QWQ-QKN)TBSLUFNW%4AK]PT^#Z:IENUEKKB),N%(EWCP\FB0;D//N M;L4OFDT/FU'ORG"P7G1+6EP$H+MB2>_VMZ3%/?CA052; MS5*5?2^8YD->!Z_\ZGIZZU"B23:_"*LZH 5__J'6\4"[#_@+JTWXVA^?>O+[\$V,]B@"AE;A)$ MC9BKE0,A&OYR\E5W]?K]UZ\OMT7CO,;&:TT0@H+76MZ52CB;$>#\-CA+$,9? MK7@MW1PBF,8 MZ,_=5T+32A3QXQGLYQ;ZX:U8?&_'O]["HFLM6[5BULW0Z0Y-2R*$.3F\6P4: M'=H_1641HB8,QP*>+P)PB^1=8:H9<]8.PGV4]+M9+5VO>1;;DL7.Y!5)F$K( M>I>XYY8'4.;NH;/%,1_U])6V8\[!44%%*_&_4Z_H)[!269!J!J/Z#CGJ'?ZW MX%-_;NW6'KF[RYE8\3K:I(8@;J5MR>+=I M_^1:K'3HSVZ5]^TO+R_7NO^[W":N)]9TMWO.D(FOI>\V(=R[JI4[OUH^K-V9^=NEHW;2XOP?]MA1"<93+K*[1$UVW6P97: MD2OUI\>\::-XW6O#=]O:[=$=OLW6<'[F)4W9^[_W(7H4ERB>1\_MM%=Q&/>N M[/QS76_7EE1XI3FHE;:VW7CON[38QJX\4)_AK]R%;G:_O]/KMD*"ZOE2=EOYL1[@6Y /I%AK#SYQ7\PUR$#$/G8UV$6W,=B[,<.VM; M:O75::TT[%GO,U]38_.!O3D]IMMM__3X-W40'WH8=8XLMNZ4C8 MVWH8-(>XS2_U\,>+[*S>9W7#?R'4 XWYJ \#[J)=O@:\WP=J#7/]=KW%K M%^9SQ^,]=NSG%YHSRT96*[JCKB!-_2B&7R7Z*30,M'!OK#/HS&#W1XX_&F6: M\L(C[)=>^E0 =B8N5RL^Z][EF>2@X((J[H>B%-)TPW7:1Z9ZS83ZS MP-(E>!NL,EQ/#>&&*P1]NT(P4 V[5YM'V#TIV8%"3:W:'VLEZN2!%YJN&%^? MRT[1U:6NK+LP:=RW&/'Q8/%A)5NMMMM'VMD5+]). O*72N;LU/9TJ4W6O?;F M<16:+"+5V+'RBE:OR_2>#[0\A%NS/:2;9K7D#Y,P>7K4#Y[;K<^I!]UQYH<= M7M5&O=;J/^V*P%NLLU+@N1W%U9CS9=LA/)A:PGX3FR!T]P5X19NTUEMN61[M M);2V0[0OVYM['-VFMUS9Y[Y([;[GNM?=+F?#SG&&EQ YN'S:36A>!>,S1 YP MP"T0]BX0.SR.F/N>/&$E$7UA E*B^Q2I$TJ7X$D1)S@9Y@3Y27$K+L44O?I; M=P/3IP#"#=E?C^)0?PG&?ACAK<-;-H#/)/Y@.O-'/(M1>*ZV\P![ *3+69#W MRGK=[W#\;-1M-Q^U(,VYGO&LW=V2R[Y57VF^J-$_/ DFAXTM,%>LGT;":[KM M)TU+LLT%>&RD))U:9QLKZ3U?]S76Z+$*N _-]:Z?@$;M7N*_VJCSQM3UCL5Q M&YW.@R:%6='X'P4I3*?6*]2!M[\.D5N]6FK6#_\UBPY_>M\VLZSK5TMKM)$\[_!? M?O1 B/-:33C-#[@>:D7C?Q3:J%%K_^Q";$89J1/2?1 GY+'82'7OSH2>CZ)^ MH-V8&X1:1^7 ?B6>&+-@H]9\ @O<@P==H3O[^ZN5I//5' M^R++QS^-IUHKNH%DZE9%I%'K+\>Q]Q#L2*.0-ERPVJ(;8QC/SD;!/2X<^^N/ MI&1UOR*+5V07JG@WN\AW*./=@-)]/,)[#PV^]N+HC3"9\'\7L,K=DP]Q_72( MBP8]MR#:+H#.%TC?>4Q6??2M5<_3>+*@Z*HW^;%404.CA1]3__6_]3K?_ MCZ6M2",5*QO"J452%F)OKZ%S[2=8FYWR4*8QR=L$M$(P1BP.\^7@[R>S9'#I M@T4B86)G$(]!)AUB\:+R?C]2M?J!<'W%Y\XSC*0BBPY_T#G Y_]]-,2B_\_Z M-<1AY'R3L?P]H3^_<'E0UY?AX))DW(8">+VZ,_1O0.J3>.S\RX]FR/OC::00 M$:SY(++)&,=Q'EX%#E5MUIS3+-^=@(?FC089RW@@PP"?%D:P;+ @9X'SK%GO MNEZO[\Q2K!O%IQ#7U^')X#(>P:J,XV$PLKC>Z( 2L %6?\PET[\Y811.0S " M;9JT9UZMVW0=['7Y/7 2!#G14LJ:#,.K$%35T+E!$BRG_MSEF;9YCJYS%8_\ M:3A"4J-.O59_3E"*)$R_'YXC]QL]$$YU_3DOAY(*?Y3&2C0XQ)6%:2APENP, MKW%V+9]U/+??KLL?Y\A$LUZS#T*)IE\;?7(9:]=B6KAN?4\+IVCANGM:N TC MJDAD3TAY?E8Z6.FFW];/\3;GQ.P6K9O<8D4BMPQ]6Z&7\"89W!X+@W/;3;F._OK+;=?]3[> MB5)K_819G=:>,.MA$68U^J[7A/\U;N?*>0HU5O5:__82RIVZ)%8Y^Z?*O]7H MNYT$R<#V1(IQFL]:ZO:[E<=TBMYEIC0=4"])LP373<.O=^;;ETZVC\&K= M^22P3^+B>4 &D]=SZZV&VVO_;'7S]J90KRT!I'IO.C'T_7N&G6 MEER6QW7A_,SYV!.%SC]IGENOK\*'V(:'_4"H0IN]UIXJ-$\5"H[+0/5GHKB=/YZ6+BVRA),%/B$#S27-DKMU;$271:>U)!I<--[F] M>MMMSV%'>D#)ZEUAV=O*2FZ)96^U+M53Y7/RW$:_M0)D_>/(D#]P3J2U77'; M91AZ% Y^W^WWZ7\/T+??Z>SY@Z&P*&4.VME;[/%2-^PCVJN(:-__1#U8RH U M'(2%.O1!@8PW%+U^ZACY.\2O5WQ"'PX4P>'-M8+#5Q$* MW\/$=PTF;LJN3*+E.L $#(Y#X7V&3AP9W'6?I2V+)H8/D(3Z8TR_WK@*65SV M@FD,]Q76-AX)MY2(GC%!1(+X;GA%&5P'K@:4V9-..U$":P/?C*X5-6CL"Q'N(2C MD>O@FR[C$2CN5&6CG]5K<$ZS\[WTAXZ/,.W!93!U)DE\%:9P[!F@?18,<$G5 M2/'I/ [X1I#.1E-X*UQ_\/9^KULRH>QBPK2 MVZZ2"%?;)'5213#.IHX-+B [M1]',RTQQZ,9[;F E5]_UK?6ZIX>(0%V '6 M0QQ FI[5W>M^)0 8T&5591\Z6EL.>_HV[GJ_K3=6W/59I@-!^&#:D+5#8 M.F8CQ2&@3 O5,E_[NQ:O'R]+'K.+O2"R6P_4LF85%!YI#,)+/5%)=%4E4F M(QP5A)PP_4XK>Q'.'NQ6U: MEB*);L-=;V@6LK%J%F*;A;Q=-0M91K.0]X='>T?[AWL?@L.CT[.3/SX>')V= MWFGSCJ]M"G;O[VNW="H7-@J!+DS\K0ACP^PGIV\5I#1')KD MZ+WAU&4U]"2 M)^%4&!A]C_Y8@ VF":%ZFE0)6E[1W],\&_69><5F0&IW."%5_4LR1JYI1&QN MBK0>AJFG?:P2@@*@A6.\!:\&H9E 2UU[OO=)ZO@^*4!)Q3VKEMK0[M[?YVT4'6F !?RSE=2D#)J(T*';27.R MXA+ZIB29&55U(Q!1!TIF[)C0P9E0OCM#;@- MC,Z#B/=QF1<$4,9FZ<

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end

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ex99-4_003.jpg GRAPHIC begin 644 ex99-4_003.jpg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end GRAPHIC 19 ex99-4_004.jpg GRAPHIC begin 644 ex99-4_004.jpg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end GRAPHIC 20 ex99-4_005.jpg GRAPHIC begin 644 ex99-4_005.jpg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end GRAPHIC 21 ex99-4_006.jpg GRAPHIC begin 644 ex99-4_006.jpg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ex99-4_007.jpg GRAPHIC begin 644 ex99-4_007.jpg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ex99-4_008.jpg GRAPHIC begin 644 ex99-4_008.jpg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end GRAPHIC 24 ex99-4_009.jpg GRAPHIC begin 644 ex99-4_009.jpg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